PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dietl, GP; Vermeij, GJ				Dietl, Gregory P.; Vermeij, Geerat J.			Comment on "Statistical independence of escalatory ecological trends in phanerozoic marine invertebrates"	SCIENCE			English	Editorial Material									Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	Yale University; University of California System; University of California Davis	Dietl, GP (corresponding author), Paleontol Res Inst, 1259 Trumansburg Rd, Ithaca, NY 14850 USA.	gpd3@cornell.edu						Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; Vermeij G.J., 1987, EVOLUTION ESCALATION	2	15	15	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801								10.1126/science.1130419	http://dx.doi.org/10.1126/science.1130419			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095680				2022-12-28	WOS:000241896000026
J	Gravelle, H; Dusheiko, M; Sheaff, R; Sargent, P; Boaden, R; Pickard, S; Parker, S; Roland, M				Gravelle, Hugh; Dusheiko, Mark; Sheaff, Rod; Sargent, Penny; Boaden, Ruth; Pickard, Susan; Parker, Stuart; Roland, Martin			Impact of case management (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine the impact on outcomes in patients of the Evercare approach to case management of elderly people. Design Practice level before and after analysis of hospital admissions data with control group. Setting Nine primary care trusts in England that, in 2003-5, piloted case management of elderly people selected as being at high risk of emergency admission. Main outcome measures Rates of emergency admission, emergency bed days, and mortality from April 2001 to March 2005 in 62 Evercare practices and 6960-7695 control practices in England (depending on the analysis being carried out). Results The intervention had no significant effect on rates of emergency admission (increase 16.5%, 95% confidence interval -5.7% to 38.7%), emergency bed days (increase 19.0%,-5.3% to 43.2%), and mortality (increase 34.4%, -1.7% to 70.3%) for a high risk population aged >65 with a history of two or more emergency admissions in the preceding 13 months. For the general population aged >= 65 effects on the rates of emergency admission (increase 2.5%, -2.1% to 7.0%), emergency bed days (decrease -4.9%, -10.8% to 1.0%), and mortality (increase 5.5%, -3.5% to 14.5%) were also non-significant. Conclusions Case management of frail elderly people introduced an additional range of services into primary care without an associated reduction in hospital admissions. This may have been because of identification of additional cases. Employment of community matrons is now a key feature of case management policy in the NHS in England. Without more radical system redesign this policy is unlikely to reduce hospital admissions.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Univ York, Ctr Hlth Econ, Natl Primary Care Res & Dev Ctr, York YO10 5DD, N Yorkshire, England; Univ Plymouth, Peninsula Allied Hlth Ctr, Coll St Mark & St John, Plymouth PL6 8BH, Devon, England; Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England; Univ Sheffield, Barnsley Hosp NHS Fdn Trust, Sheffield Inst Studies Ageing, Barnsley S75 2EP, England	University of Manchester; University of York - UK; University of Plymouth; University of Manchester; University of Sheffield	Roland, M (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	m.roland@manchester.ac.uk	Sheaff, Rod/I-5187-2013; Boaden, Ruth/L-3443-2016; Sheaff, Rod/N-2404-2019; Allen, Penny/J-7567-2014	Sheaff, Rod/0000-0002-7984-2627; Boaden, Ruth/0000-0003-1927-6405; Sheaff, Rod/0000-0002-7984-2627; Allen, Penny/0000-0003-1945-8049; Pickard, Susan/0000-0003-3429-8880; Gravelle, Hugh/0000-0002-7753-4233; Parker, Stuart/0000-0002-8675-6276				Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; BOADEN R, 2006, EVALUATION EVERCARE; BOADEN R, 2006, EVALUATOIN EVERCARE; Department of Health, 2005, SUPP PEOPL LONG TERM; Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719; Hutt R, 2004, CASE MANAGING LONG T; Johri M, 2003, INT J GERIATR PSYCH, V18, P222, DOI 10.1002/gps.819; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Singh D, 2005, TRANSFORMING CHRONIC; *UN HLTH EUR, ASS EV PROGR ENGL 20; *UN HLTH GROUP, 2004, IMPL EV PROGR INT RE; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	13	163	168	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2007	334	7583					31	34		10.1136/bmj.39020.413310.55	http://dx.doi.org/10.1136/bmj.39020.413310.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125CH	17107984	Green Published, Bronze			2022-12-28	WOS:000243418600037
J	O'Brien, CA; Pollett, A; Gallinger, S; Dick, JE				O'Brien, Catherine A.; Pollett, Aaron; Gallinger, Steven; Dick, John E.			A human colon cancer cell capable of initiating tumour growth in immunodeficient mice	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; SELF-RENEWAL; COLORECTAL-CANCER; XENOGRAFT MODELS; EPITHELIAL-CELLS; IDENTIFICATION; EXPRESSION	Colon cancer is one of the best-understood neoplasms from a genetic perspective(1-3), yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies(4,5). What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cells - cancer stem cells - possess such potential(6,7). Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133(+); the CD133(-) cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7 x 10(4) unfractionated tumour cells, whereas there was one CC-IC in 262 CD133(+) cells, representing >200-fold enrichment. CC-ICs within the CD133(+) population were able to maintain themselves as well as differentiate and reestablish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.	Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Gallinger, Steven/E-4575-2013; Pollett, Aaron/J-2308-2016; Pollett, Aaron/AAQ-2540-2021	Pollett, Aaron/0000-0001-5121-8788; Pollett, Aaron/0000-0001-5121-8788; Dick, John/0000-0002-9527-8317; O'Brien, Catherine/0000-0003-0682-3879				Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1992, FASEB J, V6, P2783, DOI 10.1096/fasebj.6.10.1321771; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ishida H, 2004, CANCER LETT, V207, P109, DOI 10.1016/j.canlet.2003.10.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liang JT, 2004, BRIT J SURG, V91, P355, DOI 10.1002/bjs.4447; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Nelson H, 2001, JNCI-J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pocard M, 1996, IN VIVO, V10, P463; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; PORTER EH, 1963, BRIT J CANCER, V17, P583, DOI 10.1038/bjc.1963.78; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sack MJ, 1997, DIAGN CYTOPATHOL, V16, P132, DOI 10.1002/(SICI)1097-0339(199702)16:2<132::AID-DC7>3.0.CO;2-J; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	26	3165	3379	18	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					106	110		10.1038/nature05372	http://dx.doi.org/10.1038/nature05372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17122772				2022-12-28	WOS:000243225100045
J	Dequeant, ML; Glynn, E; Gaudenz, K; Wahl, M; Chen, J; Mushegian, A; Pourquie, O				Dequeant, Mary-Lee; Glynn, Earl; Gaudenz, Karin; Wahl, Matthias; Chen, Jie; Mushegian, Arcady; Pourquie, Olivier			A complex oscillating network of signaling genes underlies the mouse segmentation clock	SCIENCE			English	Article							BETA-CATENIN; C-MYC; EXPRESSION; ACTIVATION; MESODERM; PATHWAY; SOMITOGENESIS; TRANSCRIPTION; TARGETS; DKK1	The segmental pattern of the spine is established early in development, when the vertebral precursors, the somites, are rhythmically produced from the presomitic mesoderm. Microarray studies of the mouse presomitic mesoderm transcriptome reveal that the oscillator associated with this process, the segmentation clock, drives the periodic expression of a large network of cyclic genes involved in cell signaling. Mutually exclusive activation of the notch-fibroblast growth factor and Wnt pathways during each cycle suggests that coordinated regulation of these three pathways underlies the clock oscillator.	Howard Hughes Med Inst, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA	Howard Hughes Medical Institute; University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; University of Missouri System; University of Missouri Kansas City	Pourquie, O (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; Chen, Jie/S-1161-2019; Mushegian, Arcady/ABF-5387-2021	Pourquié, Olivier/0000-0001-5189-1227; Chen, Jie/0000-0003-2151-5276; Mushegian, Arcady/0000-0002-6809-9225				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Buttitta L, 2003, DEV BIOL, V258, P91, DOI 10.1016/S0012-1606(03)00116-7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; EBIAGHIE MC, 2003, CURR BIOL, V13, P1009; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ishikawa A, 2004, MECH DEVELOP, V121, P1443, DOI 10.1016/j.mod.2004.08.003; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Minowada G, 1999, DEVELOPMENT, V126, P4465; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041	21	326	345	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1595	1598		10.1126/science.1133141	http://dx.doi.org/10.1126/science.1133141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17095659				2022-12-28	WOS:000242624600041
J	Beck, MR; Morgan, EA; Strand, SS; Woolsey, TA				Beck, Moriah R.; Morgan, Elizabeth A.; Strand, Stephanie S.; Woolsey, Thomas A.			Volunteers bring passion to science Outreach	SCIENCE			English	Editorial Material									Washington Univ, Sch Med, Young Scientist Program, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Beck, MR (corresponding author), Washington Univ, Sch Med, Young Scientist Program, St Louis, MO 63110 USA.	mrwillia@artsci.wustl.edu	Beck, Moriah/ABH-5841-2020	Beck, Moriah/0000-0003-1004-7147; Morgan, Elizabeth/0000-0001-5880-9337				Colwell RR, 1999, SCIENCE, V286, P237, DOI 10.1126/science.286.5438.237; *COMM SCI ENG PUBL, 2006, RIS GATH STORM EN EM; MCIVER SR, 2006, 2006 BRAIN AWARENESS; *MO MISS SCH DISTR, 2006, MISS SCH DISTR PROF; *SAINT LOUIS PUBL, 2004, ANN REP COMM 2003 20; MAD SCI NETWORK; YOUNG SCI PROGRAM	7	26	27	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1246	1247		10.1126/science.1131917	http://dx.doi.org/10.1126/science.1131917			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17124309				2022-12-28	WOS:000242215800025
J	Gitlin, JD				Gitlin, Jonathan D.			Distributing nutrition	SCIENCE			English	Editorial Material							IRON; WHEAT		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Gitlin, JD (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	gitlin@kids.wustl.edu						Conway G, 1997, DOUBLY GREEN REVOLUT, P163; Danforth WH, 2006, SCIENCE, V314, P223, DOI 10.1126/science.1134637; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Serageldin I, 2002, SCIENCE, V296, P54, DOI 10.1126/science.1072035; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649	10	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1252	1253		10.1126/science.1136251	http://dx.doi.org/10.1126/science.1136251			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17124312				2022-12-28	WOS:000242215800029
J	Darieva, Z; Bulmer, R; Pic-Taylor, A; Doris, KS; Geymonat, M; Sedgwick, SG; Morgan, BA; Sharrocks, AD				Darieva, Zoulfia; Bulmer, Richard; Pic-Taylor, Aline; Doris, Kathryn S.; Geymonat, Marco; Sedgwick, Steven G.; Morgan, Brian A.; Sharrocks, Andrew D.			Polo kinase controls cell-cycle-dependent transcription by targeting a coactivator protein	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-TRANSCRIPTION; MITOTIC PROGRAM; FHA DOMAIN; YEAST; FKH2P; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; EXECUTION	Polo kinases have crucial conserved functions in controlling the eukaryotic cell cycle through orchestrating several events during mitosis(1,2). An essential element of cell cycle control is exerted by altering the expression of key regulators(3). Here we show an important function for the polo kinase Cdc5p in controlling cell-cycle-dependent gene expression that is crucial for the execution of mitosis in the model eukaryote Saccharomyces cerevisiae. In particular, we find that Cdc5p is temporally recruited to promoters of the cell-cycle-regulated CLB2 gene cluster, where it targets the Mcm1p-Fkh2p-Ndd1p transcription factor complex, through direct phosphorylation of the coactivator protein Ndd1p. This phosphorylation event is required for the normal temporal expression of cell-cycle-regulated genes such as CLB2 and SWI5 in G2/M phases. Furthermore, severe defects in cell division occur in the absence of Cdc5p-mediated phosphorylation of Ndd1p. Thus, polo kinase is required for the production of key mitotic regulators, in addition to previously defined roles in controlling other mitotic events.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Natl Inst Med Res, Div Yeast Genet, London NW7 1AA, England	University of Manchester; Newcastle University - UK; MRC National Institute for Medical Research	Morgan, BA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	b.a.morgan@ncl.ac.uk; a.d.sharrocks@man.ac.uk	Pic-Taylor, Aline/AGY-4728-2022	Pic-Taylor, Aline/0000-0002-5121-8814	Biotechnology and Biological Sciences Research Council [BBS/B/02509] Funding Source: Medline; Medical Research Council [MC_U117531949] Funding Source: Medline; Wellcome Trust [078085] Funding Source: Medline; MRC [MC_U117531949] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zilahi E, 2000, FEBS LETT, V481, P105, DOI 10.1016/S0014-5793(00)01990-6	30	51	53	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					494	498		10.1038/nature05339	http://dx.doi.org/10.1038/nature05339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122856	Green Accepted			2022-12-28	WOS:000242215700048
J	Margolis, SS; Perry, JA; Forester, CM; Nutt, LK; Guo, YX; Jardim, MJ; Thomenius, MJ; Freel, CD; Darbandi, R; Ahn, JH; Arroyo, JD; Wang, XF; Shenolikar, S; Nairn, AC; Dunphy, WG; Hahn, WC; Virshup, DM; Kornbluth, S				Margolis, Seth S.; Perry, Jennifer A.; Forester, Craig M.; Nutt, Leta K.; Guo, Yanxiang; Jardim, Melanie J.; Thomenius, Michael J.; Freel, Christopher D.; Darbandi, Rashid; Ahn, Jung-Hyuck; Arroyo, Jason D.; Wang, Xiao-Fan; Shenolikar, Shirish; Nairn, Angus C.; Dunphy, William G.; Hahn, William C.; Virshup, David M.; Kornbluth, Sally			Role for the PP2A/B56 delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis	CELL			English	Article							CHECKPOINT CONTROL; IN-VITRO; PHOSPHORYLATION; KINASE; 2A; SUBUNIT; BINDING; PROGRESSION; ACTIVATION; KERATINS	DNA-responsive checkpoints prevent cell-cycle progression following DNA damage or replication inhibition. The mitotic activator Cdc25 is suppressed by checkpoints through inhibitory phosphorylation at Ser287 (Xenopus numbering) and docking of 14-3-3. Ser287 phosphorylation is a major locus of G2/M checkpoint control, although several checkpoint-independent kinases can phosphorylate this site. We reported previously that mitotic entry requires 14-3-3 removal and Ser287 dephosphorylation. We show here that DNA-responsive checkpoints also activate PP2A/B56 delta phosphatase complexes to dephosphorylate Cdc25 at a site distinct from Ser287 (T138), the phosphorylation of which is required for 14-3-3 release. However, phosphorylation of T138 is not sufficient for 14-3-3 release from Cdc25. Our data suggest that creation of a 14-3-3 "sink," consisting of phosphorylated 14-3-3 binding intermediate filament proteins, including keratins, coupled with reduced Cdc25-14-3-3 affinity, contribute to Cdc25 activation. These observations identify PP2A/B56 delta as a central checkpoint effector and suggest a mechanism for controlling 14-3-3 interactions to promote mitosis.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; MIT, Boston, MA 02115 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Duke University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Pfizer; Yale University; California Institute of Technology; Massachusetts Institute of Technology (MIT); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu	Virshup, David M/C-1449-2009; Forester, Craig/HCI-4174-2022	Virshup, David M/0000-0001-6976-850X; Arroyo, Jason/0000-0002-5674-6739; Ahn, Jung-Hyuck/0000-0001-9589-3881; Darbandi, Rashid/0000-0002-1239-6191; Nairn, Angus/0000-0002-7075-0195	NATIONAL CANCER INSTITUTE [P01CA050661, P01CA073992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067225, R01GM070891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA50661, P01 CA050661, P01 CA050661-190009, P01 CA073992] Funding Source: Medline; NIDA NIH HHS [P01 DA010044] Funding Source: Medline; NIGMS NIH HHS [R01 GM067225-03, R01 GM 067225, R01 GM 070891, R01 GM067225] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CLARK DB, 1993, BIOTROPICA, V25, P397, DOI 10.2307/2388863; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Inoue R, 1999, J BIOCHEM-TOKYO, V126, P1127, DOI 10.1093/oxfordjournals.jbchem.a022558; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Stanford JS, 2005, MOL BIOL CELL, V16, P5749, DOI 10.1091/mbc.E05-06-0541; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Wang YC, 1997, MOL CELL BIOL, V17, P620, DOI 10.1128/MCB.17.2.620; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	37	158	163	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					759	773		10.1016/j.cell.2006.10.035	http://dx.doi.org/10.1016/j.cell.2006.10.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110335	Bronze, Green Accepted			2022-12-28	WOS:000242330600022
J	Curiel, TJ				Curiel, Tyler J.			Murder or mercy? Hurricane Katrina and the need for disaster training.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									San Antonio Canc Inst, San Antonio, TX USA; Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Curiel, TJ (corresponding author), San Antonio Canc Inst, San Antonio, TX USA.								0	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2067	2069		10.1056/NEJMp068196	http://dx.doi.org/10.1056/NEJMp068196			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104YU	17108341	Bronze			2022-12-28	WOS:000241997300003
J	Hammerman, C; Bin-Nun, A; Kaplan, M				Hammerman, Cathy; Bin-Nun, Alona; Kaplan, Michael			Safety of probiotics: comparison of two popular strains	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LACTOBACILLUS-RHAMNOSUS-GG; NECROTIZING ENTEROCOLITIS; BACTEREMIA		Shaare Zedek Med Ctr, Dept Neonatol, IL-91031 Jerusalem, Israel; Univ Chicago, Med Ctr, Dept Neonatol, Chicago, IL 60637 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Chicago; University of Chicago Medical Center	Hammerman, C (corresponding author), Shaare Zedek Med Ctr, Dept Neonatol, POB 3235, IL-91031 Jerusalem, Israel.	cathy@cc.huji.ac.il	Hammerman, Cathy/AAI-5643-2021					Agostoni C, 2004, J PEDIATR GASTR NUTR, V38, P365, DOI 10.1097/00005176-200404000-00001; ALFALEH K, 2006, COCHRANE DB SYST REV; Allen S.J., 2004, COCHRANE DB SYST REV, pCD003048, DOI [10.1002/14651858.CD003048.pub2, DOI 10.1002/14651858.CD003048]; Antony SJ, 1996, CLIN INFECT DIS, V23, P773, DOI 10.1093/clinids/23.4.773; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Cunningham-Rundles S, 2000, AM J GASTROENTEROL, V95, pS22, DOI 10.1016/S0002-9270(99)00813-8; Floch MH, 2005, GASTROENTEROL CLIN N, V34, P547, DOI 10.1016/j.gtc.2005.05.004; Ha GY, 1999, J CLIN MICROBIOL, V37, P1227, DOI 10.1128/JCM.37.4.1227-1228.1999; Hammerman C, 2006, CURR OPIN INFECT DIS, V19, P277, DOI 10.1097/01.qco.0000224823.73223.29; Husni RN, 1997, CLIN INFECT DIS, V25, P1048, DOI 10.1086/516109; Kullen MJ, 2005, CURR PHARM DESIGN, V11, P55, DOI 10.2174/1381612053382359; Kunz AN, 2004, J PEDIATR GASTR NUTR, V38, P457, DOI 10.1097/00005176-200404000-00017; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Mackay Andrew D., 1999, Clin Microbiol Infect, V5, P290, DOI 10.1111/j.1469-0691.1999.tb00144.x; O'Sullivan GC, 2005, CURR PHARM DESIGN, V11, P3, DOI 10.2174/1381612053382368; O'Sullivan GC, 2001, BRIT J SURG, V88, P161, DOI 10.1046/j.1365-2168.2001.01656.x; Rautio M, 1999, CLIN INFECT DIS, V28, P1159, DOI 10.1086/514766; Salminen MK, 2004, HIV CLIN TRIALS, V5, P183, DOI 10.1310/6F83-N39Q-9PPP-LMVV; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Salminen MK, 2002, CLIN INFECT DIS, V35, P1155, DOI 10.1086/342912; von Wright A, 2005, CURR PHARM DESIGN, V11, P17	24	58	60	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2006	333	7576					1006	1008		10.1136/bmj.39010.630799.BE	http://dx.doi.org/10.1136/bmj.39010.630799.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108GX	17095783	Green Published			2022-12-28	WOS:000242229400018
J	Yoshida, S; Handa, Y; Suzuki, T; Ogawa, M; Suzuki, M; Tamai, A; Abe, A; Katayama, E; Sasakawa, C				Yoshida, Sei; Handa, Yutaka; Suzuki, Toshihiko; Ogawa, Michinaga; Suzuki, Masato; Tamai, Asuka; Abe, Akio; Katayama, Eisaku; Sasakawa, Chihiro			Microtubule-severing activity of Shigella is pivotal for intercellular spreading	SCIENCE			English	Article							ACTIN-BASED MOTILITY; LISTERIA-MONOCYTOGENES; VIRULENCE GENE; BURKHOLDERIA-PSEUDOMALLEI; RICKETTSIA-CONORII; ARP2/3 COMPLEX; LARGE PLASMID; N-WASP; FLEXNERI; PROTEIN	Some pathogenic bacteria actually invade the cytoplasm of their target host cells. Invasive bacteria acquire the propulsive force to move by recruiting actin and inducing its polymerization. Here we show that Shigella movement within the cytoplasm was severely hindered by microtubules and that the bacteria destroyed surrounding microtubules by secreting VirA by means of the type III secretion system. Degradation of microtubules by VirA was dependent on its alpha- tubulin - specific cysteine protease - like activity. virA mutants did not move within the host cytoplasm and failed to move into adjacent cells.	Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Basic Med Sci,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Control,Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Kitasato Univ, Kitasato Inst Life Sci, Lab Bacterial Infect, Minato Ku, Tokyo 1088641, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kitasato University	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Suzuki, Masato/B-7568-2013; Abe, Akio/AAQ-2464-2020	Suzuki, Masato/0000-0001-8975-2193; Yoshida, Sei/0000-0002-4771-3900				Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Giardini PA, 2001, BIOPHYS J, V81, P3193, DOI 10.1016/S0006-3495(01)75955-3; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; OGAWA H, 1968, JPN J MED SCI BIOL, V21, P259, DOI 10.7883/yoken1952.21.259; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pfeuffer T, 2000, CELL MICROBIOL, V2, P101, DOI 10.1046/j.1462-5822.2000.00034.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Suzuki T, 2000, J EXP MED, V191, P1905, DOI 10.1084/jem.191.11.1905; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319	28	80	85	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					985	989		10.1126/science.1133174	http://dx.doi.org/10.1126/science.1133174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095701				2022-12-28	WOS:000241896000051
J	Siemens, J; Zhou, S; Piskorowski, R; Nikai, T; Lumpkin, EA; Basbaum, AI; King, D; Julius, D				Siemens, Jan; Zhou, Sharleen; Piskorowski, Rebecca; Nikai, Tetsuro; Lumpkin, Ellen A.; Basbaum, Allan I.; King, David; Julius, David			Spider toxins activate the capsaicin receptor to produce inflammatory pain	NATURE			English	Article							DEPENDENT K+ CHANNELS; ION-CHANNEL; TRP CHANNELS; POTASSIUM CHANNELS; TARANTULA TOXINS; GATING MODIFIER; PEPTIDES; SENSITIVITY; INHIBITION; PEPPERS	Bites and stings from venomous creatures can produce pain and inflammation as part of their defensive strategy to ward off predators or competitors(1,2). Molecules accounting for lethal effects of venoms have been extensively characterized, but less is known about the mechanisms by which they produce pain. Venoms from spiders, snakes, cone snails or scorpions contain a pharmacopoeia of peptide toxins that block receptor or channel activation as a means of producing shock, paralysis or death(3-5). We examined whether these venoms also contain toxins that activate ( rather than inhibit) excitatory channels on somatosensory neurons to produce a noxious sensation in mammals. Here we show that venom from a tarantula that is native to the West Indies contains three inhibitor cysteine knot (ICK) peptides that target the capsaicin receptor (TRPV1), an excitatory channel expressed by sensory neurons of the pain pathway(6). In contrast with the predominant role of ICK toxins as channel inhibitors(5,7), these previously unknown 'vanillotoxins' function as TRPV1 agonists, providing new tools for understanding mechanisms of TRP channel gating. Some vanillotoxins also inhibit voltage-gated potassium channels, supporting potential similarities between TRP and voltage-gated channel structures. TRP channels can now be included among the targets of peptide toxins, showing that animals, like plants ( for example, chilli peppers), avert predators by activating TRP channels on sensory nerve fibres to elicit pain and inflammation.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu	Piskorowski, Rebecca Ann/G-6610-2017	Piskorowski, Rebecca Ann/0000-0003-0120-2360; Lumpkin, Ellen/0000-0002-1166-3374; Siemens, Jan/0000-0001-9051-9217	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR051219-03, R01 AR051219] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAHL LA, 1975, PAIN, V1, P3, DOI 10.1016/0304-3959(75)90003-2; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung J, 1999, J NEUROSCI, V19, P529; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; SCHMIDT JO, 1982, ANNU REV ENTOMOL, V27, P339, DOI 10.1146/annurev.en.27.010182.002011; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Zhang PF, 2003, TOXICON, V42, P15, DOI 10.1016/S0041-0101(03)00095-3; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	30	248	260	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					208	212		10.1038/nature05285	http://dx.doi.org/10.1038/nature05285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093448				2022-12-28	WOS:000241867200041
J	Kamper, J; Kahmann, R; Bolker, M; Ma, LJ; Brefort, T; Saville, BJ; Banuett, F; Kronstad, JW; Gold, SE; Muller, O; Perlin, MH; Wosten, HAB; de Vries, R; Ruiz-Herrera, J; Reynaga-Pena, CG; Snetselaar, K; McCann, M; Perez-Martin, J; Feldbrugge, M; Basse, CW; Steinberg, G; Ibeas, JI; Holloman, W; Guzman, P; Farman, M; Stajich, JE; Sentandreu, R; Gonzalez-Prieto, JM; Kennell, JC; Molina, L; Schirawski, J; Mendoza-Mendoza, A; Greilinger, D; Munch, K; Rossel, N; Scherer, M; Vranes, M; Ladendorf, O; Vincon, V; Fuchs, U; Sandrock, B; Meng, S; Ho, ECH; Cahill, MJ; Boyce, KJ; Klose, J; Klosterman, SJ; Deelstra, HJ; Ortiz-Castellanos, L; Li, WX; Sanchez-Alonso, P; Schreier, PH; Hauser-Hahn, I; Vaupel, M; Koopmann, E; Friedrich, G; Voss, H; Schluter, T; Margolis, J; Platt, D; Swimmer, C; Gnirke, A; Chen, F; Vysotskaia, V; Mannhaupt, G; Guldener, U; Munsterkotter, M; Haase, D; Oesterheld, M; Mewes, HW; Mauceli, EW; DeCaprio, D; Wade, CM; Butler, J; Young, S; Jaffe, DB; Calvo, S; Nusbaum, C; Galagan, J; Birren, BW				Kaemper, Joerg; Kahmann, Regine; Boelker, Michael; Ma, Li-Jun; Brefort, Thomas; Saville, Barry J.; Banuett, Flora; Kronstad, James W.; Gold, Scott E.; Mueller, Olaf; Perlin, Michael H.; Woesten, Han A. B.; de Vries, Ronald; Ruiz-Herrera, Jose; Reynaga-Pena, Cristina G.; Snetselaar, Karen; McCann, Michael; Perez-Martin, Jose; Feldbruegge, Michael; Basse, Christoph W.; Steinberg, Gero; Ibeas, Jose I.; Holloman, William; Guzman, Plinio; Farman, Mark; Stajich, Jason E.; Sentandreu, Rafael; Gonzalez-Prieto, Juan M.; Kennell, John C.; Molina, Lazaro; Schirawski, Jan; Mendoza-Mendoza, Artemio; Greilinger, Doris; Muench, Karin; Roessel, Nicole; Scherer, Mario; Vranes, Miroslav; Ladendorf, Oliver; Vincon, Volker; Fuchs, Uta; Sandrock, Bjoern; Meng, Shaowu; Ho, Eric C. H.; Cahill, Matt J.; Boyce, Kylie J.; Klose, Jana; Klosterman, Steven J.; Deelstra, Heine J.; Ortiz-Castellanos, Lucila; Li, Weixi; Sanchez-Alonso, Patricia; Schreier, Peter H.; Haeuser-Hahn, Isolde; Vaupel, Martin; Koopmann, Edda; Friedrich, Gabi; Voss, Hartmut; Schlueter, Thomas; Margolis, Jonathan; Platt, Darren; Swimmer, Candace; Gnirke, Andreas; Chen, Feng; Vysotskaia, Valentina; Mannhaupt, Gertrud; Gueldener, Ulrich; Muensterkoetter, Martin; Haase, Dirk; Oesterheld, Matthias; Mewes, Hans-Werner; Mauceli, Evan W.; DeCaprio, David; Wade, Claire M.; Butler, Jonathan; Young, Sarah; Jaffe, David B.; Calvo, Sarah; Nusbaum, Chad; Galagan, James; Birren, Bruce W.			Insights from the genome of the biotrophic fungal plant pathogen Ustilago maydis	NATURE			English	Article							PROTEINS; SEQUENCE; CELLS; DNA; CENTROMERES; HAUSTORIA; SYSTEM; GENES; YEAST; MAP	Ustilago maydis is a ubiquitous pathogen of maize and a well-established model organism for the study of plant - microbe interactions(1). This basidiomycete fungus does not use aggressive virulence strategies to kill its host. U. maydis belongs to the group of biotrophic parasites ( the smuts) that depend on living tissue for proliferation and development(2). Here we report the genome sequence for a member of this economically important group of biotrophic fungi. The 20.5-million-base U. maydis genome assembly contains 6,902 predicted protein-encoding genes and lacks pathogenicity signatures found in the genomes of aggressive pathogenic fungi, for example a battery of cell-wall-degrading enzymes. However, we detected unexpected genomic features responsible for the pathogenicity of this organism. Specifically, we found 12 clusters of genes encoding small secreted proteins with unknown function. A significant fraction of these genes exists in small gene families. Expression analysis showed that most of the genes contained in these clusters are regulated together and induced in infected tissue. Deletion of individual clusters altered the virulence of U. maydis in five cases, ranging from a complete lack of symptoms to hypervirulence. Despite years of research into the mechanism of pathogenicity in U. maydis, no 'true' virulence factors(3) had been previously identified. Thus, the discovery of the secreted protein gene clusters and the functional demonstration of their decisive role in the infection process illuminate previously unknown mechanisms of pathogenicity operating in biotrophic fungi. Genomic analysis is, similarly, likely to open up new avenues for the discovery of virulence determinants in other pathogens.	Max Planck Inst Terr Microbiol, Dept Organism Interact, D-35043 Marburg, Germany; Univ Marburg, Dept Biol, D-35032 Marburg, Germany; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; Univ Louisville, Dept Biol, Program Dis Evolut, Louisville, KY 40292 USA; Univ Utrecht, Inst Biomembranes, Dept Microbiol, NL-3705 SN Utrecht, Netherlands; IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Biotecnol & Ingn Genet Plantas, Irapuato 36500, Gto, Mexico; St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA; CSIC, Ctr Nacl Biotecnol, Dept Microbiol Biotechnol, E-28049 Madrid, Spain; Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; CINVESTAV, Dept Plant Genet Engn, Guanajuato 36821, Mexico; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Valencia, Fac Farm, Dept Microbiol & Ecol, Valencia 46100, Spain; IPN, Ctr Biotecnol Genom, Dept Biotecnol Vegetal 2, Tamaulipas 88710, Mexico; St Louis Univ, Dept Biol, St Louis, MO 63103 USA; Univ Kentucky, Dept Biol, Lexington, KY 40546 USA; Bayer CropSci AG, D-40789 Monheim, Germany; LION Biosci AG, D-69123 Heidelberg, Germany; Exelixis Inc, San Francisco, CA 94080 USA; GSF NAtl Res Ctr Environm & Hlth, Inst Bioinformat MIPS, D-85764 Neuherberg, Germany; Tech Univ Munich, D-85354 Freising Weihenstephan, Germany	Max Planck Society; Philipps University Marburg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University Toronto Mississauga; California State University System; California State University Long Beach; University of British Columbia; University System of Georgia; University of Georgia; University of Louisville; Utrecht University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Saint Joseph's University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Cornell University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Kentucky; Duke University; University of Valencia; Instituto Politecnico Nacional - Mexico; Saint Louis University; University of Kentucky; Bayer AG; Bayer CropScience; Exelixis, Inc.; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Kahmann, R (corresponding author), Max Planck Inst Terr Microbiol, Dept Organism Interact, Karl von Frisch Str, D-35043 Marburg, Germany.	kaemper@mpi-marburg.mpg.de; kahmann@mpi-marburg.mpg.de; boelker@staff.uni-marburg.de	Stajich, Jason Eric/C-7297-2008; Münsterkötter, Martin/L-3436-2019; Güldener, Ulrich/G-5227-2012; Li, WeiXi/AAM-5381-2021; Mendoza, Artemio Mendoza/P-7540-2019; Wösten, Han AB/K-2769-2016; Mendoza, Artemio Mendoza/F-3519-2013; Guzman, Plinio/A-3073-2012; Perez-Martin, Jose/K-5117-2014; Feldbrügge, Michael/AAS-3939-2021; Corcelles, Jose Ignacio Ibeas/B-7615-2015; Schirawski, Jan/Q-9393-2019; Ma, Li-Jun/AAG-2359-2020; Reynaga Peña, Cristina/D-4803-2016; Reynaga-Peña, Cristina G./GMX-3386-2022; Münsterkötter, Martin/C-5288-2017; de Vries, Ronald P./F-8125-2011; Kahmann, Regine/AAS-1230-2021; Molina, Lazaro/K-9645-2014; Mewes, Hans-Werner/A-8204-2019	Stajich, Jason Eric/0000-0002-7591-0020; Münsterkötter, Martin/0000-0002-0044-2381; Güldener, Ulrich/0000-0001-5052-8610; Mendoza, Artemio Mendoza/0000-0002-1532-3406; Wösten, Han AB/0000-0002-0399-3648; Mendoza, Artemio Mendoza/0000-0002-1532-3406; Perez-Martin, Jose/0000-0001-9849-7382; Feldbrügge, Michael/0000-0003-0046-983X; Corcelles, Jose Ignacio Ibeas/0000-0002-2394-7075; Schirawski, Jan/0000-0003-1615-1201; Reynaga-Peña, Cristina G./0000-0003-3039-551X; Münsterkötter, Martin/0000-0002-0044-2381; de Vries, Ronald P./0000-0002-4363-1123; Molina, Lazaro/0000-0002-8483-9203; Wade, Claire/0000-0003-3413-4771; Mewes, Hans-Werner/0000-0002-9713-6398; DeCaprio, Dave/0000-0001-8931-9461; Schlueter, Thomas/0000-0001-5829-9381; Ma, Li-Jun/0000-0002-2733-3708; Boyce, Kylie J./0000-0002-7167-5414; Galagan, James/0000-0003-0542-3291				Banuett F, 1995, ANNU REV GENET, V29, P179, DOI 10.1146/annurev.ge.29.120195.001143; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Brachmann A, 2003, EMBO J, V22, P2199, DOI 10.1093/emboj/cdg198; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Holliday R, 2004, DNA REPAIR, V3, P671, DOI 10.1016/j.dnarep.2004.02.002; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Meksem K, 2005, GENOME, V48, P207, DOI [10.1139/G04-099, 10.1139/g04-099]; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Vernis L, 2001, J MOL BIOL, V305, P203, DOI 10.1006/jmbi.2000.4300; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Zarnack K, 2006, FUNGAL GENET BIOL, V43, P727, DOI 10.1016/j.fgb.2006.05.006	29	827	1224	7	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					97	101		10.1038/nature05248	http://dx.doi.org/10.1038/nature05248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080091	hybrid			2022-12-28	WOS:000241701500053
J	Weinberger, SE				Weinberger, Steven E.			A 47-year-old woman with sarcoidosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISLE-OF-MAN; PULMONARY SARCOIDOSIS; LOFGRENS-SYNDROME; LYMPH-NODES; STAGE-II; THERAPY; EPIDEMIOLOGY; MYCOBACTERIAL; TISSUE; RISK	Ms K, a 47-year-old woman, was found to have sarcoidosis after evaluation of an abnormal chest radiograph obtained during work-up of a recently diagnosed melanoma. She has symptoms of fatigue, achiness, and exertional dyspnea. She believes her symptoms are due to sarcoidosis and would like to get some symptomatic improvement, though she is reluctant to be treated with corticosteroids. She is interested in knowing about the likely course of her disease and the potential treatment options. The various presentations, protean manifestations, variable natural history, and attempts to understand the etiology of sarcoidosis are discussed. The principles underlying the decision of whether to institute treatment, the options for treatment, and the effectiveness of treatment are reviewed.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	American College of Physicians; University of Pennsylvania	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	sweinberger@acponline.org						[Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Askling J, 1999, AM J RESP CRIT CARE, V160, P1668, DOI 10.1164/ajrccm.160.5.9904045; Bachelez H, 2001, ARCH DERMATOL, V137, P69; Baltzan M, 1999, AM J RESP CRIT CARE, V160, P192, DOI 10.1164/ajrccm.160.1.9809024; Baughman R.P., 2005, EUR RESP MON, V32, P301; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 2006, QJM-INT J MED, V99, P307, DOI 10.1093/qjmed/hcl038; Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60; Baughman RP, 2002, SARCOIDOSIS VASC DIF, V19, P198; BRESNITZ EA, 1983, EPIDEMIOL REV, V5, P124, DOI 10.1093/oxfordjournals.epirev.a036255; Doty JD, 2005, CHEST, V127, P1064, DOI 10.1378/chest.127.3.1064; Drake WP, 2002, EMERG INFECT DIS, V8, P1334, DOI 10.3201/eid0811.020318; Du Bois R, 2005, EUR RESP MON, V32, P64, DOI DOI 10.1183/1025448X.00032005; Du Bois RM, 2003, J INTERN MED, V253, P4, DOI 10.1046/j.1365-2796.2003.01073.x; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; HILLS SE, 1987, THORAX, V42, P427, DOI 10.1136/thx.42.6.427; Ishige I, 2005, SARCOIDOSIS VASC DIF, V22, P33; James D G, 1991, Sarcoidosis, V8, P6; Johns CJ, 1999, MEDICINE, V78, P65, DOI 10.1097/00005792-199903000-00001; JONES E, 1990, J AM ACAD DERMATOL, V23, P487, DOI 10.1016/0190-9622(90)70246-E; King TE, 2005, AM J RESP CRIT CARE, V172, P268, DOI 10.1164/rccm.200503-483OE; LYNCH JP, 2005, EUR RESP MON, V32, P105; Mana J, 1999, AM J MED, V107, P240, DOI 10.1016/S0002-9343(99)00223-5; MANGIAPAN G, 1995, SARCOIDOSIS, V12, P20; Martin WJ, 2004, AM J RESP CRIT CARE, V170, P567, DOI 10.1164/rccm.200308-1073WS; Mrazek F, 2005, TISSUE ANTIGENS, V65, P163, DOI 10.1111/j.1399-0039.2005.00370.x; Muller C, 1996, TRANSPLANTATION, V61, P1117; Muller-Quernheim J, 1999, EUR RESPIR J, V14, P1117, DOI 10.1183/09031936.99.14511179; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Newman LS, 2005, EUR RESP MON, V10, P23, DOI [10.1183/1025448x.00032003, DOI 10.1183/1025448X.00032003]; Padilla ML, 2002, SARCOIDOSIS VASC DIF, V19, P18; Paramothayan NS, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002994.pub2, 10.1002/14651858.CD001114.pub2]; Paramothayan S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003536.pub2; Paramothayan S, 2002, JAMA-J AM MED ASSOC, V287, P1301, DOI 10.1001/jama.287.10.1301; PARKES SA, 1987, THORAX, V42, P420, DOI 10.1136/thx.42.6.420; Pietinalho A, 2002, CHEST, V121, P24, DOI 10.1378/chest.121.1.24; Romer FK, 1998, EUR RESPIR J, V12, P906, DOI 10.1183/09031936.98.12040906; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; SEMENZATO G, 2005, EUR RESP MON, V32, P49; Song ZM, 2005, J EXP MED, V201, P755, DOI 10.1084/jem.20040429; Spagnolo P, 2005, AM J RESP CRIT CARE, V172, P721, DOI 10.1164/rccm.200412-1707OC; STERN BJ, 1985, ARCH NEUROL-CHICAGO, V42, P909, DOI 10.1001/archneur.1985.04060080095022; Taylor AN, 2004, AM J RESP CRIT CARE, V170, P1268, DOI 10.1164/rccm.2409006; Utz JP, 2003, CHEST, V124, P177, DOI 10.1378/chest.124.1.177; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wuyts, 2005, EUR RESP MON, V32, P13; Wyser CP, 1997, AM J RESP CRIT CARE, V156, P1371, DOI 10.1164/ajrccm.156.5.9506031	52	0	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2133	2140		10.1001/jama.296.17.2133	http://dx.doi.org/10.1001/jama.296.17.2133			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077378				2022-12-28	WOS:000241668000025
J	Berezovsky, J; Mikkelsen, MH; Gywat, O; Stoltz, NG; Coldren, LA; Awschalom, DD				Berezovsky, J.; Mikkelsen, M. H.; Gywat, O.; Stoltz, N. G.; Coldren, L. A.; Awschalom, D. D.			Nondestructive optical measurements of a single electron spin in a quantum dot	SCIENCE			English	Article							ORIENTATION	Kerr rotation measurements on a single electron spin confined in a charge-tunable semiconductor quantum dot demonstrate a means to directly probe the spin off-resonance, thus minimally disturbing the system. Energy-resolved magneto-optical spectra reveal information about the optically oriented spin polarization and the transverse spin lifetime of the electron as a function of the charging of the dot. These results represent progress toward the manipulation and coupling of single spins and photons for quantum information processing.	Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA.	awsch@physics.ucsb.edu	Mikkelsen, Maiken H/D-8211-2011	Mikkelsen, Maiken H/0000-0002-0487-7585				Awschalom DD, 2002, NANOSCI TECHNOL, P147; Bracker AS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035332; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Cortez S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.207401; Dzhioev RI, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.153409; Dzhioev RI, 1998, PHYS SOLID STATE+, V40, P1587, DOI 10.1134/1.1130606; Ebbens A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.073307; ELKHALIFI Y, 1989, PHYS REV B, V39, P13533, DOI 10.1103/PhysRevB.39.13533; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Gammon D, 1996, SCIENCE, V273, P87, DOI 10.1126/science.273.5271.87; Geremia JM, 2004, SCIENCE, V304, P270, DOI 10.1126/science.1095374; Guest JR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.241310; Hogele A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1940733; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; KUPRIYANOV DV, 1992, QUANTUM OPT, V4, P55, DOI 10.1088/0954-8998/4/1/006; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Lehmann J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045328; Leuenberger MN, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.075312; Leuenberger MN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.107401; Li XQ, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195330; Li YQ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202393; Meier F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205315; Meier F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.205329; Meier F., 1984, OPTICAL ORIENTATION; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Salis G, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115325; Stievater TH, 2002, APPL PHYS LETT, V81, P4251, DOI 10.1063/1.1526912; SUGITA M, HTTPARXIVORGABSQUANT; Tischler JG, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.081310; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030; ZRENNER A, 1994, PHYS REV LETT, V72, P3382, DOI 10.1103/PhysRevLett.72.3382	32	165	167	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1916	1920		10.1126/science.1133862	http://dx.doi.org/10.1126/science.1133862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17095655				2022-12-28	WOS:000242996800045
J	Huang, J; Perez-Burgos, L; Placek, BJ; Sengupta, R; Richter, M; Dorsey, JA; Kubicek, S; Opravil, S; Jenuwein, T; Berger, SL				Huang, Jing; Perez-Burgos, Laura; Placek, Brandon J.; Sengupta, Roopsha; Richter, Mario; Dorsey, Jean A.; Kubicek, Stefan; Opravil, Susanne; Jenuwein, Thomas; Berger, Shelley L.			Repression of p53 activity by Smyd2-mediated methylation	NATURE			English	Article							LYSINE METHYLATION; HISTONE; METHYLTRANSFERASE; TRANSCRIPTION; HETEROCHROMATIN; DEACETYLASE; PATHWAY	Specific sites of lysine methylation on histones correlate with either activation or repression of transcription(1-3). The tumour suppressor p53 ( refs 4 - 7) is one of only a few non-histone proteins known to be regulated by lysine methylation(8). Here we report a lysine methyltransferase, Smyd2, that methylates a previously unidentified site, Lys 370, in p53. This methylation site, in contrast to the known site Lys 372, is repressing to p53-mediated transcriptional regulation. Smyd2 helps to maintain low concentrations of promoter-associated p53. We show that reducing Smyd2 concentrations by short interfering RNA enhances p53-mediated apoptosis. We find that Set9-mediated methylation of Lys 372 inhibits Smyd2-mediated methylation of Lys 370, providing regulatory cross-talk between post-translational modifications. In addition, we show that the inhibitory effect of Lys 372 methylation on Lys 370 methylation is caused, in part, by blocking the interaction between p53 and Smyd2. Thus, similar to histones, p53 is subject to both activating and repressing lysine methylation. Our results also predict that Smyd2 may function as a putative oncogene by methylating p53 and repressing its tumour suppressive function.	Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	The Wistar Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA.	berger@wistar.org	Kubicek, Stefan/C-2089-2017; Huang, Jing/A-2566-2009	Kubicek, Stefan/0000-0003-0855-8343; Huang, Jing/0000-0002-7163-5156; Berger, Shelley/0000-0001-5398-4400				Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Olivier Magali, 2004, IARC Sci Publ, P247; Prives C, 1999, J PATHOL, V187, P112; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	15	457	480	5	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					629	632		10.1038/nature05287	http://dx.doi.org/10.1038/nature05287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17108971				2022-12-28	WOS:000242377600050
J	Madin, JS; Connolly, SR				Madin, Joshua S.; Connolly, Sean R.			Ecological consequences of major hydrodynamic disturbances on coral reefs	NATURE			English	Article							RESILIENCE; ECOSYSTEMS; TSUNAMI	A recent tsunami(1,2) and an apparent increase in the frequency of severe tropical storms(3-5) underscore the need to understand and predict the ecological consequences of major hydrodynamic disturbances(6). Reef corals provide the habitat structure that sustains the high biodiversity of tropical reefs(7), and thus provide the foundation for the ecosystem goods and services that are critical to many tropical societies(6,8). Here we integrate predictions from oceanographic models(9) with engineering theory, to predict the dislodgement of benthic reef corals during hydrodynamic disturbances. This generalizes earlier work(10,11), by incorporating colonies of any shape and by explicitly examining the effects of hydrodynamic gradients on coral assemblage structure. Afield test shows that this model accurately predicts changes in the mechanical vulnerability of coral colonies, and thus their size and shape, with distance from the reef crest. This work provides a general framework for understanding and predicting the effects of hydrodynamic disturbances on coral reef communities; such disturbances have a major role in determining species zonation(12,13) and coexistence(14) on coral reefs, and are critical determinants of how coral assemblages will respond to changes in the frequency and intensity of tropical storms associated with a changing climate(3-5,15).	James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; James Cook Univ N Queensland, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	James Cook University; James Cook University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Madin, JS (corresponding author), James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	madin@nceas.ucsb.edu	Connolly, Sean R./E-7773-2011	Connolly, Sean R./0000-0003-1537-0859; Madin, Joshua/0000-0002-5005-6227				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Baird AH, 2005, CURR BIOL, V15, P1926, DOI 10.1016/j.cub.2005.09.036; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DENNY M, 1995, ECOL MONOGR, V65, P371, DOI 10.2307/2963496; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Done T., 1983, PERSPECTIVES CORAL R, P107; DONE TJ, 1996, FUNCTIONAL ROLES BIO, P393; ELSNER JB, 1999, HURRICANES N ATLANTI, P339; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Kench PS, 1998, CORAL REEFS, V17, P155, DOI 10.1007/s003380050110; Liu PLF, 2005, SCIENCE, V308, P1595, DOI 10.1126/science.1110730; Madin JS, 2006, CORAL REEFS, V25, P635, DOI 10.1007/s00338-006-0137-2; Madin JS, 2005, CORAL REEFS, V24, P630, DOI 10.1007/s00338-005-0042-0; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; MASSEL SR, 1999, FLUID MECH MARINE EC, P428; MERIAM JL, 1986, ENG MECH; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; ROSENBERG CS, 1975, SIGNS, V1, P1; TAYLOR HM, 1994, INTRO STOCHASTIC MOD, P36; Wainwright S.A., 1982, MECH DESIGN ORGANISM; WATSON RT, 2001, 3 ASSESSMENT REPORT	24	227	232	5	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					477	480		10.1038/nature05328	http://dx.doi.org/10.1038/nature05328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122855				2022-12-28	WOS:000242215700044
J	Brennan, PA; Zufall, F				Brennan, Peter A.; Zufall, Frank			Pheromonal communication in vertebrates	NATURE			English	Review							MAJOR URINARY PROTEINS; ACCESSORY OLFACTORY-BULB; VOMERONASAL SENSORY NEURONS; MEDIAL AMYGDALA; MUTANT MICE; MATE CHOICE; RECOGNITION MEMORY; MATING PREFERENCES; SOCIAL RECOGNITION; PEPTIDE LIGANDS	Recent insights have revolutionized our understanding of the importance of chemical signals in influencing vertebrate behaviour. Previously unknown families of pheromonal signals have been identified that are expanding the traditional definition of a pheromone. Although previously regarded as functioning independently, the main olfactory and vomeronasal systems have been found to have considerable overlap in terms of the chemosignals they detect and the effects that they mediate. Studies using gene- targeted mice have revealed an unexpected diversity of chemosensory systems and their underlying cellular and molecular mechanisms. Future developments could show how the functions of the different chemosensory systems are integrated to regulate innate and learned behavioural and physiological responses to pheromones.	Univ Bristol, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University of Bristol; University System of Maryland; University of Maryland Baltimore	Brennan, PA (corresponding author), Univ Bristol, Dept Physiol, Med Sch Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	p.brennan@bristol.ac.uk; fzufa001@umaryland.edu	Zufall, Frank/AAE-5290-2021	Zufall, Frank/0000-0002-4383-8618	Biotechnology and Biological Sciences Research Council [BB/C005015/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 2014, PHEROMONES ANIMAL BE; Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836; Binns KE, 2005, EUR J NEUROSCI, V21, P2529, DOI 10.1111/j.1460-9568.2005.04090.x; Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BOYSE EA, 1987, TRENDS GENET, V3, P97, DOI 10.1016/0168-9525(87)90192-2; BRENNAN PA, 1995, NEUROSCIENCE, V69, P1075, DOI 10.1016/0306-4522(95)00309-7; Carroll LS, 2002, P NATL ACAD SCI USA, V99, P2187, DOI 10.1073/pnas.042244899; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dorries KM, 1997, BRAIN BEHAV EVOLUT, V49, P53, DOI 10.1159/000112981; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Eisthen HL, 2004, J COMP NEUROL, V477, P341, DOI 10.1002/cne.20258; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Flower DR, 1996, BIOCHEM J, V318, P1; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Halem HA, 2001, EUR J NEUROSCI, V13, P389, DOI 10.1046/j.1460-9568.2001.01382.x; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hansen A, 2004, J COMP NEUROL, V477, P347, DOI 10.1002/cne.20202; HUDSON R, 1985, DEV PSYCHOBIOL, V18, P575, DOI 10.1002/dev.420180612; HUDSON R, 1986, PHYSIOL BEHAV, V37, P123, DOI 10.1016/0031-9384(86)90394-X; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Jordan WC, 1998, HEREDITY, V81, P127, DOI 10.1038/sj.hdy.6884281; KABA H, 1995, REV NEUROSCIENCE, V6, P125; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Keller M, 2004, EUR J NEUROSCI, V20, P3433, DOI 10.1111/j.1460-9568.2004.03812.x; Kelliher KR, 2006, EUR J NEUROSCI, V23, P3385, DOI 10.1111/j.1460-9568.2006.04866.x; Keverne EB, 2005, NAT NEUROSCI, V8, P1637, DOI 10.1038/nn1205-1637; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kippin TE, 2003, NEUROSCIENCE, V117, P971, DOI 10.1016/S0306-4522(02)00972-7; Kouros-Mehr H, 2001, CHEM SENSES, V26, P1167, DOI 10.1093/chemse/26.9.1167; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Ma MH, 2003, J NEUROSCI, V23, P317; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; Meredith M, 2004, J NEUROSCI, V24, P5719, DOI 10.1523/JNEUROSCI.1139-04.2004; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Meredith M, 2001, CHEM SENSES, V26, P433, DOI 10.1093/chemse/26.4.433; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; MITCHELL JB, 1991, BRAIN RES, V551, P20, DOI 10.1016/0006-8993(91)90908-E; Moncho-Bogani J, 2005, EUR J NEUROSCI, V21, P2186, DOI 10.1111/j.1460-9568.2005.04036.x; More L, 2006, CHEM SENSES, V31, P393, DOI 10.1093/chemse/bjj043; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Olson R, 2005, PLOS BIOL, V3, P1436, DOI 10.1371/journal.pbio.0030257; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5489, DOI 10.1073/pnas.0402581102; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, CURR BIOL, V12, pR409, DOI 10.1016/S0960-9822(02)00909-0; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schaefer ML, 2002, J NEUROSCI, V22, P9513; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Singh PB, 2001, REPRODUCTION, V121, P529, DOI 10.1530/reprod/121.4.529; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Sugai T, 1997, NEUROSCIENCE, V79, P871, DOI 10.1016/S0306-4522(96)00690-2; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WEST CHK, 1992, BRAIN RES, V585, P49, DOI 10.1016/0006-8993(92)91189-L; Witt M, 2006, INT REV CYTOL, V248, P209, DOI 10.1016/S0074-7696(06)48004-9; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zeng CH, 1996, P NATL ACAD SCI USA, V93, P6626, DOI 10.1073/pnas.93.13.6626; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	100	329	344	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					308	315		10.1038/nature05404	http://dx.doi.org/10.1038/nature05404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108955				2022-12-28	WOS:000242018300037
J	Yoon, KH; Lee, JH; Kim, JW; Cho, JH; Choi, YH; Ko, SH; Zimmet, P; Son, HY				Yoon, Kun-Ho; Lee, Jin-Hee; Kim, Ji-Won; Cho, Jae Hyoung; Choi, Yoon-Hee; Ko, Seung-Hyun; Zimmet, Paul; Son, Ho-Young			Epidemic obesity and type 2 diabetes in Asia	LANCET			English	Review							IMPAIRED GLUCOSE-TOLERANCE; HONG-KONG CHINESE; CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; SIMPLE ANTHROPOMETRIC INDEXES; LIFE-STYLE INTERVENTION; NUTRITION TRANSITION; INSULIN-SECRETION; NATIONAL NUTRITION; METABOLIC SYNDROME	The proportions of people with type 2 diabetes and obesity have increased throughout Asia, and the rate of increase shows no sign of slowing. People in Asia tend to develop diabetes with a lesser degree of obesity at younger ages, suffer longer with complications of diabetes, and die sooner than people in other regions. Childhood obesity has increased substantially and the prevalence of type 2 diabetes has now reached epidemic levels in Asia. The health consequences of this epidemic threaten to overwhelm health-care systems in the region. Urgent action is needed, and advocacy for lifestyle changes is the first step. Countries should review and implement interventions, and take a comprehensive and integrated public-health approach. At the level of primary prevention, such programmes can be linked to other non-communicable disease prevention programmes that target lifestyle-related issues. The cost of inaction is clear and unacceptable.	Catholic Univ Korea, Coll Med, Div Endocrinol & Metab, Seoul, South Korea; Int Diabet Inst, Melbourne, Vic, Australia	Catholic University of Korea	Yoon, KH (corresponding author), Kangnam St Marys Hosp, Dept Internal Med, 505 Banpo Dong, Seoul, South Korea.	yoonk@catholic.ac.kr	Zimmet, Paul/O-8486-2019; choi, Yoon Hee/AAK-5172-2021	Zimmet, Paul/0000-0003-0627-0776; choi, Yoon Hee/0000-0002-0661-8392				Aekplakorn W, 2003, DIABETES CARE, V26, P2758, DOI 10.2337/diacare.26.10.2758; Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798; Alberti KG, 1999, DEFINITION DIAGNOS 1; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; Araneta MRG, 2002, DIABETES CARE, V25, P494, DOI 10.2337/diacare.25.3.494; Baltazar JC, 2004, DIABETES RES CLIN PR, V64, P107, DOI 10.1016/j.diabres.2003.10.013; Bar-Or O, 1998, MED SCI SPORT EXER, V30, P2, DOI 10.1097/00005768-199801000-00002; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P833; Chang CJ, 2000, DIABETES RES CLIN PR, V50, pS49, DOI 10.1016/S0168-8227(00)00179-0; CHAU I, 1987, J ASEAN FED ENDOC SO, V6, P74; Cheah J S, 1985, Ann Acad Med Singap, V14, P232; CHEN KW, 1995, DIABETES CARE, V18, P747, DOI 10.2337/diacare.18.6.747; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Cockram C. S., 2000, Hong Kong Medical Journal, V6, P43; COCKRAM CS, 1993, DIABETES RES CLIN PR, V21, P67, DOI 10.1016/0168-8227(93)90099-Q; Cooper ME, 2006, J HYPERTENS, V24, pS57, DOI 10.1097/01.hjh.0000220408.91987.eb; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Deurenberg-Yap M, 2000, ASIA PAC J CLIN NUTR, V9, P282, DOI 10.1046/j.1440-6047.2000.00187.x; Dong Y, 2005, DIABETIC MED, V22, P1427, DOI 10.1111/j.1464-5491.2005.01658.x; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Gan, 2003, DIABETES ATLAS, P15; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ge KeYou, 1997, Asia Pacific Journal of Clinical Nutrition, V6, P175; GEPTS W, 1981, AM J MED, V70, P105, DOI 10.1016/0002-9343(81)90417-4; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; HE J, 1994, AM J EPIDEMIOL, V139, P380, DOI 10.1093/oxfordjournals.aje.a117010; HE MZ, 1998, HK PRACT S2, V20, P6; He Q, 2002, J CLIN ENDOCR METAB, V87, P2164, DOI 10.1210/jc.87.5.2164; Hodge A M, 1993, Asia Pac J Clin Nutr, V2, P35; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; KEN S, 1979, TOHOKU J EXP MED, V129, P273; Khalid B A, 1990, Med J Malaysia, V45, P8; Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x; Kim KS, 1972, J KOREAN DIABETES AS, V1, P17; Kim S, 2000, AM J CLIN NUTR, V71, P44; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kitagawa T, 1998, CLIN PEDIATR, V37, P111, DOI 10.1177/000992289803700208; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko GTC, 1997, INT J OBESITY, V21, P995, DOI 10.1038/sj.ijo.0800508; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Ko GTC, 2001, ANN ACAD MED SINGAP, V30, P393; Ko SH, 2006, J CELL BIOCHEM, V98, P343, DOI 10.1002/jcb.20797; Ko SH, 2004, BIOCHEM BIOPH RES CO, V316, P114, DOI 10.1016/j.bbrc.2004.02.023; *KOR MIN HLTH WELF, 2002, KOR NAT HLTH NUTR SU; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1; Lu FH, 1998, DIABETIC MED, V15, P564, DOI 10.1002/(SICI)1096-9136(199807)15:7<564::AID-DIA615>3.0.CO;2-H; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; *NIH, 2006, 2005 ANN DAT REP ATL; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; OWADA M, 1995, CHIRYO, V77, P3047; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PAN XR, 1993, DIABETES CARE, V16, P150, DOI 10.2337/diacare.16.1.150; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; PATANDIN S, 1994, DIABETES RES CLIN PR, V24, P47, DOI 10.1016/0168-8227(94)90085-X; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Popkin BM, 1998, NUTR REV, V56, P106; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; RAMACHANDRAN A, 1992, DIABETES CARE, V15, P1348, DOI 10.2337/diacare.15.10.1348; Ramachandran A, 2002, DIABETES RES CLIN PR, V58, P55, DOI 10.1016/S0168-8227(02)00125-0; Ramachandran A, 1997, DIABETOLOGIA, V40, P232, DOI 10.1007/s001250050668; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rattarasarn C, 2006, DIABETES CARE, V29, P742, DOI 10.2337/diacare.29.03.06.dc05-2250; Roglic G, 2000, Hong Kong Med J, V6, P10; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P309, DOI 10.1016/j.diabres.2004.04.009; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P301, DOI 10.1016/j.diabres.2004.04.008; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Segi M., 1960, CANC MORTALITY SELEC; Shin CS, 1997, DIABETES CARE, V20, P1842, DOI 10.2337/diacare.20.12.1842; Son LENTD, 2004, DIABETIC MED, V21, P371, DOI 10.1111/j.1464-5491.2004.01159.x; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Sung RYT, 2003, DIABETES CARE, V26, P250, DOI 10.2337/diacare.26.1.250; Sutanegara D, 2000, DIABETES RES CLIN PR, V50, pS9, DOI 10.1016/S0168-8227(00)00173-X; Takahashi Y, 2000, DIABETES CARE, V23, P1092, DOI 10.2337/diacare.23.8.1092; Tam T T, 1999, Asia Pac J Clin Nutr, V8, P129, DOI 10.1046/j.1440-6047.1999.00082.x; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang J, 1996, OBES RES, V4, P377, DOI 10.1002/j.1550-8528.1996.tb00245.x; *WHO, 2003, DIET NUTTR PREV CHRO; *WHO, 2005, PREV CHRON DIS VIT; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; *WORLD BANK, 1998, WORLD DEV IND 1998 S; World Health Organization, 1985, WHO TECHN REP SER, V727; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; XIANG HD, 1998, CHINESE J DIABETES, V6, P131; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651; YOSHIIKE N, 1996, J EPIDEMIOL, V6, P189, DOI DOI 10.2188/JEA.6.3SUP_189; Yusuf S, 2006, LANCET, V367, P1054, DOI 10.1016/S0140-6736(06)68465-1; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x	113	1089	1131	1	101	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1681	1688		10.1016/S0140-6736(06)69703-1	http://dx.doi.org/10.1016/S0140-6736(06)69703-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098087				2022-12-28	WOS:000242099000036
J	Samanta, MP; Tongprasit, W; Istrail, S; Cameron, RA; Tu, Q; Davidson, EH; Stolc, V				Samanta, Manoj P.; Tongprasit, Waraporn; Istrail, Sorin; Cameron, R. Andrew; Tu, Qiang; Davidson, Eric H.; Stolc, Viktor			Report - The transcriptome of the sea urchin embryo	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; GENOME; IDENTIFICATION; ARRAY	The sea urchin Strongylocentrotus purpuratus is a model organism for study of the genomic control circuitry underlying embryonic development. We examined the complete repertoire of genes expressed in the S. purpuratus embryo, up to late gastrula stage, by means of high-resolution custom tiling arrays covering the whole genome. We detected complete spliced structures even for genes known to be expressed at low levels in only a few cells. At least 11,000 to 12,000 genes are used in embryogenesis. These include most of the genes encoding transcription factors and signaling proteins, as well as some classes of general cytoskeletal and metabolic proteins, but only a minor fraction of genes encoding immune functions and sensory receptors. Thousands of small asymmetric transcripts of unknown function were also detected in intergenic regions throughout the genome. The tiling array data were used to correct and authenticate several thousand gene models during the genome annotation process.	NASA, Ames Genome Res Facil, Moffett Field, CA 94035 USA; Systemix Inst, Los Altos, CA 94024 USA; Brown Univ, Providence, RI 02912 USA; CALTECH, Pasadena, CA 91125 USA; Eloret Corp, Sunnyvale, CA 94086 USA	National Aeronautics & Space Administration (NASA); Brown University; California Institute of Technology	Stolc, V (corresponding author), NASA, Ames Genome Res Facil, Moffett Field, CA 94035 USA.	vstolc@arc.nasa.gov	Tu, Qiang/AAJ-1582-2020	Tu, Qiang/0000-0002-7579-8315; Cameron, R. Andrew/0000-0003-3947-6041	NICHD NIH HHS [HD-37105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Davidson E. H., 1986, GENE ACTIVITY EARLY; Davidson EH, 1998, DEVELOPMENT, V125, P3269; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Howard-Ashby M, 2006, DEV BIOL, V300, P27, DOI 10.1016/j.ydbio.2006.10.016; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; MATERNA SC, IN PRESS DEV BIOL, DOI DOI 10.1016/J.YDBIO.2006.08.32; Peterson KJ, 1997, BIOESSAYS, V19, P623, DOI 10.1002/bies.950190713; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Ransick A, 2002, DEV BIOL, V246, P132, DOI 10.1006/dbio.2002.0607; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Yuh CH, 2002, DEV BIOL, V246, P148, DOI 10.1006/dbio.2002.0618	17	60	62	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					960	962		10.1126/science.1131898	http://dx.doi.org/10.1126/science.1131898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095694				2022-12-28	WOS:000241896000042
J	Branzei, D; Sollier, J; Liberi, G; Zhao, XL; Maeda, D; Seki, M; Enomoto, T; Ohta, K; Foiani, M				Branzei, Dana; Sollier, Julie; Liberi, Giordano; Zhao, Xiaolan; Maeda, Daisuke; Seki, Masayuki; Enomoto, Takemi; Ohta, Kunihiro; Foiani, Marco			Ubc9-and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks	CELL			English	Article							UBIQUITIN-CONJUGATING ENZYME; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; BLOOMS-SYNDROME; SUMO LIGASE; GENE ENCODES; RECOMBINATION; PROTEIN; HELICASE; SRS2	The Ubc9 SUMO-conjugating enzyme and the Siz1 SUMO ligase sumoylate several repair and recombination proteins, including PCNA. Sumoylated PCNA binds Srs2, a helicase counteracting certain recombination events. Here we show that ubc9 mutants depend on checkpoint, recombination, and replication genes for growth. ubc9 cells maintain stalled-fork stability but exhibit a Rad51-dependent accumulation of cruciform structures during replication of damaged templates. Mutations in the Mms21 SUMO ligase resemble the ubc9 mutations. However, siz1, srs2, or pcna mutants altered in sumoylation do not exhibit the ubc9/mms21 phenotype. Like ubc9/mms21 mutants, sgs1 and top3 mutants also accumulate X molecules at damaged forks, and Sgs1/BLM is sumoylated. We propose that Ubc9 and Mms21 act in concert with Sgs1 to resolve the X structures formed during replication. Our results indicate that Ubc9- and Mms21-mediated sumoylation functions as a regulatory mechanism, different from that of replication checkpoints, to prevent pathological accumulation of cruciform structures at damaged forks.	Univ Degli Studi Milano, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; Univ Degli Studi Milano, Dept Biomed Sci & Biotechnol, I-20139 Milan, Italy; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Tohoku Univ, Mol Cell Biol Lab, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Tohoku Univ, 21st Century COE Program, Sendai, Miyagi 9808578, Japan; RIKEN, Discovery Res Inst, Genet Syst Regulat Lab, Wako, Saitama 3510198, Japan	IFOM - FIRC Institute of Molecular Oncology; Memorial Sloan Kettering Cancer Center; Tohoku University; Tohoku University; RIKEN	Branzei, D (corresponding author), Univ Degli Studi Milano, FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	dana.branzei@ifom-ieo-campus.it	Branzei, Dana/GOG-9093-2022; Branzei, Dana/A-2806-2015; Foiani, Marco/M-8234-2014; LIBERI, GIORDANO/AAY-7273-2020	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Foiani, Marco/0000-0003-4795-834X; LIBERI, GIORDANO/0000-0003-3160-2242; Zhao, Xiaolan/0000-0002-8302-6905	NCI NIH HHS [P30 CA-08478-41] Funding Source: Medline; Telethon [GGP030412] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon)		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2004, GENES CELLS, V9, P1031, DOI 10.1111/j.1365-2443.2004.00787.x; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HORIUCHI T, 1994, J BACTERIOL, V176, P4656, DOI 10.1128/JB.176.15.4656-4663.1994; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Onoda F, 2000, MUTAT RES-DNA REPAIR, V459, P203, DOI 10.1016/S0921-8777(99)00071-3; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; PRAKASH S, 1977, GENETICS, V87, P229; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; RONG L, 1991, GENETICS, V127, P75; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WANG JC, 1991, J BIOL CHEM, V266, P6659; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; YAKAHASHI Y, 2006, GENETICS, V172, P783; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	58	235	237	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					509	522		10.1016/j.cell.2006.08.050	http://dx.doi.org/10.1016/j.cell.2006.08.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081974	Bronze			2022-12-28	WOS:000241937000016
J	Leslie, M				Leslie, Mitchell			Jumpstarting research into neglected diseases	CELL			English	Editorial Material								Unwilling to wait and hope for a cure, patients suffering from rare or little-studied diseases and their families are galvanizing research efforts and driving innovative approaches to develop new treatments.											0	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					443	445		10.1016/j.cell.2006.10.022	http://dx.doi.org/10.1016/j.cell.2006.10.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081963	Bronze			2022-12-28	WOS:000241937000005
J	Polo, SE; Roche, D; Almouzni, G				Polo, Sophie E.; Roche, Daniele; Almouzni, Genevieve			New histone incorporation marks sites of UV repair in human cells	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; ASSEMBLY FACTOR-I; NEWLY SYNTHESIZED HISTONES; DNA-REPLICATION INVITRO; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; VARIANT H3.3; HUMAN ASF1; CHROMATIN; DAMAGE	Chromatin organization is compromised during the repair of DNA damage. It remains unknown how and to what extent epigenetic information is preserved in vivo. A central question is whether chromatin reorganization involves recycling of parental histones or new histone incorporation. Here, we devise an approach to follow new histone deposition upon UV irradiation in human cells. We show that new H3.1 histones get incorporated in vivo at repair sites. Remarkably we find that H3.1, which is deposited during S phase, is also incorporated outside of S phase. Histone deposition is dependent on nucleotide excision repair (NER), indicating that it occurs at a postrepair stage. The histone chaperone chromatin assembly factor 1 (CAF-1) is directly involved in the histone deposition process in vivo. We conclude that chromatin restoration after damage cannot rely simply on histone recycling. New histone incorporation at repair sites both challenges epigenetic stability and possibly contributes to damage memory.	Inst Curie, Lab Nucl Dynam & Genome Plast, UMR 218 CNRS, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Almouzni, G (corresponding author), Inst Curie, Lab Nucl Dynam & Genome Plast, UMR 218 CNRS, 26 Rue Ulm, F-75248 Paris 05, France.	genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021	Almouzni, Genevieve/0000-0001-5570-0723; Polo, Sophie/0000-0003-4821-9354				Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Conconi A, 2005, MOL CELL BIOL, V25, P9773, DOI 10.1128/MCB.25.22.9773-9783.2005; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gaillard PHL, 1997, EMBO J, V16, P6281, DOI 10.1093/emboj/16.20.6281; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Game JC, 1999, GENETICS, V151, P485; Gerard A, 2006, METHOD ENZYMOL, V409, P358, DOI 10.1016/S0076-6879(05)09021-X; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gunjan A, 2005, BIOCHIMIE, V87, P625, DOI 10.1016/j.biochi.2005.02.008; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaufman Paul D., 2006, V47, P121; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lewis LK, 2005, NUCLEIC ACIDS RES, V33, P4928, DOI 10.1093/nar/gki806; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Polo SE, 2004, CANCER RES, V64, P2371, DOI 10.1158/0008-5472.CAN-03-2893; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THIRIET C, 1995, ELECTROPHORESIS, V16, P357, DOI 10.1002/elps.1150160161; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; VAQUERO A, 2003, SCI AGING KNOWLEDGE, V14, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	64	201	205	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					481	493		10.1016/j.cell.2006.08.049	http://dx.doi.org/10.1016/j.cell.2006.08.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081972	Bronze			2022-12-28	WOS:000241937000014
J	Salge, JR; Dreyer, BJ; Dauenhauer, PJ; Schmidt, LD				Salge, J. R.; Dreyer, B. J.; Dauenhauer, P. J.; Schmidt, L. D.			Renewable hydrogen from nonvolatile fuels by reactive flash volatilization	SCIENCE			English	Article							HEAT-TRANSFER; SURFACE	Droplets of nonvolatile fuels such as soy oil and glucose-water solutions can be flash evaporated by catalytic partial oxidation to produce hydrogen in high yields with a total time in the reactor of less than 50 milliseconds. Pyrolysis, coupled with catalytic oxidation of the fuels and their fragments upon impact with a hot rhodium-cerium catalyst surface, avoids the formation of deactivating carbon layers on the catalyst. The catalytic reactions of these products generate approximately 1 megawatt of heat per square meter, which maintains the catalyst surface above 800 degrees C at high drop impact rates. At these temperatures, heavy fuels can be catalytically transformed directly into hydrogen, carbon monoxide, and other small molecules in very short contact times without the formation of carbon.	Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Salge, JR (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.		Dauenhauer, Paul/V-4392-2019; Dauenhauer, Paul/A-5674-2009	Dauenhauer, Paul/0000-0001-5810-1953; 				Boutin O, 2002, CHEM ENG SCI, V57, P15, DOI 10.1016/S0009-2509(01)00360-8; Bridgwater AV, 2003, CHEM ENG J, V91, P87, DOI 10.1016/S1385-8947(02)00142-0; Bussmann M, 2000, PHYS FLUIDS, V12, P3121, DOI 10.1063/1.1321258; CHANDRA S, 1992, INT J HEAT MASS TRAN, V35, P2377, DOI 10.1016/0017-9310(92)90080-C; DEB S, 1989, INT J HEAT MASS TRAN, V32, P2099, DOI 10.1016/0017-9310(89)90117-8; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; Garcia L, 2000, APPL CATAL A-GEN, V201, P225, DOI 10.1016/S0926-860X(00)00440-3; Ge Y, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1844791; GOTTFRIED BS, 1966, INT J HEAT MASS TRAN, V9, P1167, DOI 10.1016/0017-9310(66)90112-8; GRIFFITHS DC, 1997, Patent No. 5663473; Krummenacher JJ, 2003, J CATAL, V215, P332, DOI 10.1016/S0021-9517(03)00011-3; Subramanian R, 2005, ANGEW CHEM INT EDIT, V44, P302, DOI 10.1002/anie.200460790; WACHTERS LH, 1966, CHEM ENG SCI, V21, P1047, DOI 10.1016/0009-2509(66)85100-X	13	80	86	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					801	804		10.1126/science.1131244	http://dx.doi.org/10.1126/science.1131244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082454				2022-12-28	WOS:000241729800041
J	Arcizet, O; Cohadon, PF; Briant, T; Pinard, M; Heidmann, A				Arcizet, O.; Cohadon, P. -F.; Briant, T.; Pinard, M.; Heidmann, A.			Radiation-pressure cooling and optomechanical instability of a micromirror	NATURE			English	Article							QUANTUM; CAVITY; MIRROR; NOISE	Recent table-top optical interferometry experiments(1,2) and advances in gravitational-wave detectors(3) have demonstrated the capability of optical interferometry to detect displacements with high sensitivity. Operation at higher powers will be crucial for further sensitivity enhancement, but dynamical effects caused by radiation pressure on the interferometer mirrors must be taken into account, and the appearance of optomechanical instabilities may jeopardize the stable operation of the next generation of interferometers(4-6). These instabilities(7,8) are the result of a nonlinear coupling between the motion of the mirrors and the optical field, which modifies the effective dynamics of the mirror. Such 'optical spring' effects have already been demonstrated for the mechanical damping of an electromagnetic waveguide with a moving wall(9), the resonance frequency of a specially designed flexure oscillator(10), and the optomechanical instability of a silica microtoroidal resonator(11). Here we present an experiment where amicromechanical resonator is used as a mirror in a very high-finesse optical cavity, and its displacements are monitored with unprecedented sensitivity. By detuning the laser frequency with respect to the cavity resonance, we have observed a drastic cooling of the microresonator by intracavity radiation pressure, down to an effective temperature of 10 kelvin. For opposite detuning, efficient heating is observed, as well as a radiation-pressure-induced instability of the resonator. Further experimental progress and cryogenic operation may lead to the experimental observation of the quantum ground state of a micromechanical resonator(12-14), either by passive(15) or active cooling techniques(16-18).	Univ Paris 06, Lab Kastler Brossel, F-75252 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Cohadon, PF (corresponding author), Univ Paris 06, Lab Kastler Brossel, Case 74,4 Pl Jussieu, F-75252 Paris 05, France.	cohadon@spectro.jussieu.fr	Heidmann, Antoine/G-4295-2016	Heidmann, Antoine/0000-0002-0784-5175				Abbott B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.221101; Arcizet O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.133601; Arcizet O, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.033819; Bose S, 1997, PHYS REV A, V56, P4175, DOI 10.1103/PhysRevA.56.4175; BRAGINSKY VB, 1970, SOV PHYS JETP-USSR, V31, P829; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Cohadon PF, 2005, PROC SPIE, V5846, P124, DOI 10.1117/12.609402; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; DORSEL A, 1983, PHYS REV LETT, V51, P1550, DOI 10.1103/PhysRevLett.51.1550; FABRE C, 1994, PHYS REV A, V49, P1337, DOI 10.1103/PhysRevA.49.1337; Garrett TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019928; Hadjar Y, 1999, EUROPHYS LETT, V47, P545, DOI 10.1209/epl/i1999-00422-6; Heidmann A, 1997, APPL PHYS B-LASERS O, V64, P173, DOI 10.1007/s003400050162; Heinzel G, 1998, PHYS REV LETT, V81, P5493, DOI 10.1103/PhysRevLett.81.5493; Huang XMH, 2003, NATURE, V421, P496, DOI 10.1038/421496a; JAEKEL MT, 1990, EUROPHYS LETT, V13, P301, DOI 10.1209/0295-5075/13/4/003; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; Pai A, 2000, EUR PHYS J D, V8, P333, DOI 10.1007/s100530050043; Pinard M, 2005, EUROPHYS LETT, V72, P747, DOI 10.1209/epl/i2005-10317-6; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Sheard BS, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.051801	26	756	770	2	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					71	74		10.1038/nature05244	http://dx.doi.org/10.1038/nature05244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080085	Green Submitted			2022-12-28	WOS:000241701500046
J	Fisher, ES				Fisher, Elliott S.			Paying for performance - Risks and recommendations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Coll Sch Med, Hanover, NH 03756 USA; VA Outcomes Grp, White River Jct, VT USA	Dartmouth College; VA Outcomes Group	Fisher, ES (corresponding author), Dartmouth Coll Sch Med, Hanover, NH 03756 USA.							*AG HEALTHC RES QU, 2004, AMB CAR QUAL ALL REC; Institute of Medicine, 2006, REW PROV PERF AL INC	2	63	63	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1845	1847		10.1056/NEJMp068221	http://dx.doi.org/10.1056/NEJMp068221			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100TM	17079757				2022-12-28	WOS:000241691700001
J	Steinbrook, R				Steinbrook, Robert			Public report cards - Cardiac surgery and beyond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY; INFORMATION					rsteinbrook@attglobal.net						Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; Hannan EL, 2003, MED CARE, V41, P1164, DOI 10.1097/01.MLR.0000088452.82637.40; Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844; STEINBROOK R, 1988, HEALTH AFFAIR, V7, P235, DOI 10.1377/hlthaff.7.3.235; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239	5	43	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1847	1849		10.1056/NEJMp068222	http://dx.doi.org/10.1056/NEJMp068222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100TM	17079758				2022-12-28	WOS:000241691700002
J	Joe, S; Baser, RE; Breeden, G; Neighbors, HW; Jackson, JS				Joe, Sean; Baser, Raymond E.; Breeden, Gregory; Neighbors, Harold W.; Jackson, James S.			Prevalence of and risk factors for lifetime suicide attempts among blacks in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL COMORBIDITY SURVEY; WORLD-HEALTH-ORGANIZATION; AFRICAN-AMERICAN SUICIDE; FALSE DISCOVERY RATE; MENTAL-DISORDERS; ADOLESCENT SUICIDE; TRENDS; EPIDEMIOLOGY; REPLICATION; PATTERNS	Context Lack of data on the lifetime prevalence and age at onset of suicide ideation, plans, and attempts among blacks in the United States limits the creation and evaluation of interventions to reduce suicide among black Americans. Objective To examine the prevalence and correlates of suicide ideation, planning, and attempts across 2 ethnic classifications of blacks in a nationally representative sample. Design, Setting, and Participants Data are from the National Survey of American Life, a national household probability sample of 5181 black respondents aged 18 years and older, conducted between February 2001 and June 2003, using a slightly modified adaptation of the World Health Organization World Mental Health version of the Composite International Diagnostic Interview. Bivariate and survival analyses were used to delineate patterns and correlates of nonfatal suicidal behavior. Main Outcome Measures Self-reports of lifetime suicide ideation, planning, and attempts. Results Survey respondents, categorized as African Americans and Caribbean Americans, reported lifetime prevalence of 11.7% for suicide ideation and 4.1% for attempts. Among the respondents who reported ideation, 34.6% transitioned to making a plan and only 21% made an unplanned attempt. Among 4 ethnic-sex groups, the 7.5% lifetime prevalence for attempts among Caribbean black men was the highest among black Americans. The greatest risk of progressing to suicide planning or attempt among ideators occurred within the first year after ideation onset. Blacks at higher risk for suicide attempts were in younger birth cohorts, less educated, Midwest residents, and had 1 or more Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition disorders. Conclusions This study documents the burden of nonfatal suicidality among US blacks, notably Caribbean black men, and individuals making planned attempts. Advancing research on the transition from suicide planning to attempt is vital to the efficacy of health care professionals' ability to screen blacks at risk for suicide.	Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Joe, S (corresponding author), Univ Michigan, Sch Social Work, 1080 S Univ Ave, Ann Arbor, MI 48109 USA.	sjoe@umich.edu			NIMH NIH HHS [K01-MH65499, U01-MH57716, U01 MH057716, K01 MH065499-05, K01 MH065499] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH057716, K01MH065499] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDERSON RN, 2003, DEATHS LEADING CAUSE, V52; [Anonymous], 1998, MMWR MORB MORTAL WKL; [Anonymous], STAND DEF FIN DISP C; Bell CC, 1998, PEDIATR CLIN N AM, V45, P365, DOI 10.1016/S0031-3955(05)70012-2; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; EATON DK, 2006, YOUTH RISK BEHAV SUR, V55, P1; First MB, 2002, STRUCTURED CLIN INTE; Garlow SJ, 2005, AM J PSYCHIAT, V162, P319, DOI 10.1176/appi.ajp.162.2.319; Garlow SJ, 2002, AM J PSYCHIAT, V159, P615, DOI 10.1176/appi.ajp.159.4.615; GIBBS JT, 1988, SUICIDE LIFE-THREAT, V18, P73; Gibbs JT, 1997, SUICIDE LIFE-THREAT, V27, P68; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; GRIFFITH EEH, 1989, JAMA-J AM MED ASSOC, V262, P2265, DOI 10.1001/jama.262.16.2265; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2001, SUICIDE LIFE-THREAT, V32, P76, DOI 10.1521/suli.32.1.5.76.24215; Heeringa SG, 2004, INT J METH PSYCH RES, V13, P221, DOI 10.1002/mpr.179; Hosmer D.W., 2000, J STAT PLANN INFEREN, V91, P173; HOYERT DL, 2006, NATL VITAL STAT REPO, V54; *I MED, 2002, RED SUIC NAT IMP; Ialongo N, 2002, SUICIDE LIFE-THREAT, V32, P256, DOI 10.1521/suli.32.3.256.22176; Jackson JS, 2004, INT J METH PSYCH RES, V13, P196, DOI 10.1002/mpr.177; Joe S, 2003, PSYCHIAT SERV, V54, P454, DOI 10.1176/appi.ps.54.4.454; Joe S, 2001, SUICIDE LIFE-THREAT, V31, P106, DOI 10.1521/suli.31.1.5.106.24223; JOE S, 2003, REDUCING ADOLESCENT, P325; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; KOVAR JG, 1988, CAN J STAT, V16, P25, DOI 10.2307/3315214; Little R.J.A., 2002, STAT ANAL MISSING DA; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Maris R.W., 2000, COMPREHENSIVE TXB SU; MOSCICKI EK, 1995, SUICIDE LIFE-THREAT, V25, P22; MOSCICKI EK, 1988, YALE J BIOL MED, V61, P259; Nisbet PA, 1996, SUICIDE LIFE-THREAT, V26, P325; Pennell BE, 2004, INT J METH PSYCH RES, V13, P241, DOI 10.1002/mpr.180; Regier DA, 2002, DEFINING PSYCHOPATHO, P19; SAS Institute Inc, 2005, SAS STAT US GUID VER; SHAFFER D, 1994, AM J PSYCHIAT, V151, P1810; Shaffer D, 1996, ARCH GEN PSYCHIAT, V53, P339; SLAP GB, 1989, PEDIATRICS, V84, P762; United States Census Bureau, US INT PROJ AG SEX R; *US CENS BUR, CENS REG DIV US; *US PHS, 2000, SURG GEN CALL ACT PR; US Public Health Service, 2001, NAT STRAT SUIC PREV; WAKEFIELD J, 2002, DEFINING PSYCHOPATHO; Willis LA, 2003, SUICIDE LIFE-THREAT, V33, P412, DOI 10.1521/suli.33.4.412.25230	52	159	160	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2112	2123		10.1001/jama.296.17.2112	http://dx.doi.org/10.1001/jama.296.17.2112			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100KM	17077376	Bronze, Green Accepted			2022-12-28	WOS:000241668000023
J	Huber, C; Wachterschauser, G				Huber, Claudia; Waechterschaeuser, Guenter			alpha-hydroxy and alpha-amino acids under possible hadean, volcanic origin-of-life conditions	SCIENCE			English	Article							HYDROTHERMAL CONDITIONS; ABIOTIC SYNTHESIS; SULFUR-COMPOUNDS; IRON SULFIDE; EVOLUTION; SURFACES	To test the theory of a chemoautotrophic origin of life in a volcanic, hydrothermal setting, we explored mechanisms for the buildup of bio-organic compounds by carbon fixation on catalytic transition metal precipitates. We report the carbon monoxide - dependent formation of carbon-fixation products, including an ordered series of alpha-hydroxy and alpha-amino acids of the general formula R-CHA-COOH (where R is H, CH3, C2H5, or HOCH2 and A is OH or NH2) by carbon fixation at 80 degrees to 120 degrees C, catalyzed by nickel or nickel, iron precipitates with carbonyl, cyano, and methylthio ligands as carbon sources, with or without sulfido ligands. Calcium or magnesium hydroxide was added as a pH buffer. The results narrow the gap between biochemistry and volcanic geochemistry and open a new gateway for the exploration of a volcanic, hydrothermal origin of life.	Tech Univ Munich, Dept Organ Chem & Biochem, D-85747 Garching, Germany	Technical University of Munich	Wachterschauser, G (corresponding author), 209 Mill Race Dr, Chapel Hill, NC 27514 USA.	gwmunich@yahoo.com						Amend JP, 1998, SCIENCE, V281, P1659, DOI 10.1126/science.281.5383.1659; Armstrong FA, 2005, PHILOS T ROY SOC A, V363, P937, DOI 10.1098/rsta.2004.1528; BECK MT, 1987, PURE APPL CHEM, V59, P1703, DOI 10.1351/pac198759121703; Cockell CS, 2006, PHILOS T R SOC B, V361, P1845, DOI 10.1098/rstb.2006.1908; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; Colin N., 1984, MINERAL MAG, V48, P237; DEGENS ET, 1989, PERSPECTIVES BIOGEOC, P308; Dorr M, 2003, ANGEW CHEM INT EDIT, V42, P1540, DOI 10.1002/anie.200250371; FERRIS JP, 1984, TETRAHEDRON, V40, P1093, DOI 10.1016/S0040-4020(01)99315-9; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; HAZEN RM, 1978, AM MINERAL, V63, P885; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HENNET RJC, 1992, NATURWISSENSCHAFTEN, V79, P361, DOI 10.1007/BF01140180; HOLLOWAY JR, 1994, REV MINERAL, V30, P187; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; HUME DN, 1950, J AM CHEM SOC, V72, P4423, DOI 10.1021/ja01166a022; Jauregui-Haza UJ, 2004, LAT AM APPL RES, V34, P71; Martin W, 2003, PHILOS T R SOC LON B, V358, P27; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; MUKHIN L, 1974, NATURE, V251, P50, DOI 10.1038/251050a0; Russell MJ, 2004, TRENDS BIOCHEM SCI, V29, P358, DOI 10.1016/j.tibs.2004.05.007; Seewald JS, 2006, GEOCHIM COSMOCHIM AC, V70, P446, DOI 10.1016/j.gca.2005.09.002; SHOCK EL, 1992, ORIGINS LIFE EVOL B, V22, P67, DOI 10.1007/BF01808019; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wachtershauser G, 2006, PHILOS T R SOC B, V361, P1787, DOI 10.1098/rstb.2006.1904; ZENKEVICH VA, 1991, VULKANOL SEISMOL, V3, P19; Zolotov M, 1999, J GEOPHYS RES-PLANET, V104, P14033, DOI 10.1029/1998JE000627	31	134	140	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					630	632		10.1126/science.1130895	http://dx.doi.org/10.1126/science.1130895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068257				2022-12-28	WOS:000241557800041
J	Heo, WD; Inoue, T; Park, WS; Kim, ML; Park, BO; Wandless, TJ; Meyer, T				Heo, Won Do; Inoue, Takanari; Park, Wei Sun; Kim, Man Lyang; Park, Byung Ouk; Wandless, Thomas J.; Meyer, Tobias			PI(3,4,5)P-3 and PI(4,5)P-2 lipids target proteins with polybasic clusters to the plasma membrane	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; RAS PROTEINS; LOCALIZATION; CELLS; BINDING; TRANSLOCATION; ORGANIZATION; EXPRESSION; PATHWAY; GTPASES	Many signaling, cytoskeletal, and transport proteins have to be localized to the plasma membrane ( PM) in order to carry out their function. We surveyed PM-targeting mechanisms by imaging the subcellular localization of 125 fluorescent protein - conjugated Ras, Rab, Arf, and Rho proteins. Out of 48 proteins that were PM-localized, 37 contained clusters of positively charged amino acids. To test whether these polybasic clusters bind negatively charged phosphatidylinositol 4,5-bisphosphate [PI(4,5) P-2] lipids, we developed a chemical phosphatase activation method to deplete PM PI(4,5) P-2. Unexpectedly, proteins with polybasic clusters dissociated from the PM only when both PI(4,5) P-2 and phosphatidylinositol 3,4,5-trisphosphate [PI( 3,4,5) P-3] were depleted, arguing that both lipid second messengers jointly regulate PM targeting.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju 660701, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea	Stanford University; Gyeongsang National University; Gyeongsang National University	Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 318 Campus Dr,Clark Bldg, Stanford, CA 94305 USA.	tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	NIGMS NIH HHS [R01 GM030179-25, R01 GM030179, R01 GM030179-24A1, R01 GM063702] Funding Source: Medline; NIMH NIH HHS [R01 MH064801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CHAPLINE C, 1993, J BIOL CHEM, V268, P6858; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Heo WD, 2003, CELL, V113, P315; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; KOH A, UNPUB; Lee CHJ, 1996, J NEUROSCI, V16, P6784; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Poh TW, 2005, CANCER RES, V65, P6264, DOI 10.1158/0008-5472.CAN-05-0152; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200	24	583	592	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1458	1461		10.1126/science.1134389	http://dx.doi.org/10.1126/science.1134389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17095657	Green Accepted			2022-12-28	WOS:000242406100043
J	de Graaf, BHJ; Rudd, JJ; Wheeler, MJ; Perry, RM; Bell, EM; Osman, K; Franklin, FCH; Franklin-Tong, VE				de Graaf, Barend H. J.; Rudd, Jason J.; Wheeler, Michael J.; Perry, Ruth M.; Bell, Elizabeth M.; Osman, Kim; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.			Self-incompatibility in Papaver targets soluble inorganic pyrophosphatases in pollen	NATURE			English	Article							PROGRAMMED CELL-DEATH; STREPTOCOCCUS-AGALACTIAE; MOLECULAR-CLONING; ESCHERICHIA-COLI; STARCH SYNTHESIS; PROTEIN-KINASE; RHOEAS; POTATO; ACTIN; DEPOLYMERIZATION	In higher plants, sexual reproduction involves interactions between pollen and pistil. A key mechanism to prevent inbreeding is self-incompatibility through rejection of incompatible ('self') pollen(1). In Papaver rhoeas, S proteins encoded by the stigma interact with incompatible pollen, triggering a Ca2+-dependent signalling network(2-5) resulting in pollen tube inhibition and programmed cell death(6). The cytosolic phosphoprotein p26.1, which has been identified in incompatible pollen, shows rapid, self-incompatibility-induced Ca2+-dependent hyperphosphorylation in vivo(3). Here we show that p26.1 comprises two proteins, Pr-p26.1a and Pr-p26.1b, which are soluble inorganic pyrophosphatases (sPPases). These proteins have classic Mg2+-dependent sPPase activity, which is inhibited by Ca2+, and unexpectedly can be phosphorylated in vitro. We show that phosphorylation inhibits sPPase activity, establishing a previously unknown mechanism for regulating eukaryotic sPPases. Reduced sPPase activity is predicted to result in the inhibition of many biosynthetic pathways, suggesting that there may be additional mechanisms of self-incompatibility-mediated pollen tube inhibition. We provide evidence that sPPases are required for growth and that self-incompatibility results in an increase in inorganic pyrophosphate, implying a functional role for Pr-p26.1.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Franklin-Tong, VE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	v.e.franklin-tong@bham.ac.uk	Franklin-Tong, Vernonica E/D-1287-2012; De Graaf, Barend HJ/A-5880-2010	Rudd, Jason/0000-0002-4743-1401; Franklin-Tong, Noni/0000-0003-1782-8413; de Graaf, Barend H J/0000-0003-0542-5510; Franklin, F. Chris H./0000-0003-3507-722X				CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; DUJARDIN P, 1995, PLANT PHYSIOL, V109, P853, DOI 10.1104/pp.109.3.853; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; Franklin-Tong VE, 1997, PLANT J, V12, P1375, DOI 10.1046/j.1365-313x.1997.12061375.x; FRANKLINTONG VE, 1993, PLANT J, V4, P163, DOI 10.1046/j.1365-313X.1993.04010163.x; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; Geitmann A, 2000, PLANT CELL, V12, P1239, DOI 10.1105/tpc.12.7.1239; GROSS P, 1986, PLANTA, V167, P140, DOI 10.1007/BF00446381; JACOB JL, 1989, PLANT PHYSIOL BIOCH, V27, P355; KORNBERG A, 1962, METABOLIC SIGNIFICAN; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Moutinho A, 2001, SEX PLANT REPROD, V14, P101, DOI 10.1007/s004970100086; Perez-Castineira JR, 2002, P NATL ACAD SCI USA, V99, P15914, DOI 10.1073/pnas.242625399; PLAXTON WC, 2004, PLANT RESPONSE STRES; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rojas-Beltran JA, 1999, PLANT MOL BIOL, V39, P449, DOI 10.1023/A:1006136624210; Rudd JJ, 1996, PLANT CELL, V8, P713, DOI 10.1105/tpc.8.4.713; Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; SONNEWALD U, 1992, PLANT J, V2, P571; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VENER AV, 1990, FEBS LETT, V264, P40, DOI 10.1016/0014-5793(90)80759-C; Visser K, 1998, PLANT MOL BIOL, V37, P131, DOI 10.1023/A:1005931003483	26	63	66	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					490	493		10.1038/nature05311	http://dx.doi.org/10.1038/nature05311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086195				2022-12-28	WOS:000242215700047
J	Gruen, RL; Campbell, EG; Blumenthal, D				Gruen, Russell L.; Campbell, Eric G.; Blumenthal, David			Public roles of US physicians - Community participation, political involvement, and collective advocacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROFESSIONALISM	Context Whether physicians have a professional responsibility to address health-related issues beyond providing care to individual patients has been vigorously debated. Yet little is known about practicing physicians' attitudes about or the extent to which they participate in public roles, which we defined as community participation, political involvement, and collective advocacy. Objectives To determine the importance physicians assign to public roles, their participation in related activities, and sociodemographic and practice factors related to physicians' rated levels of importance and activity. Design, Setting, and Participants Mail survey conducted between November 2003 and June 2004 of 1662 US physicians engaged in direct patient care selected from primary care specialties (family practice, internal medicine, pediatrics) and 3 non primary care specialties (anesthesiology, general surgery, cardiology). Main Outcome Measures Rated importance of community participation, political involvement, collective advocacy, and relevant self-reported activities encompassing the previous 3 years; rated importance of physician action on different issues. Results Community participation, political involvement, and collective advocacy were rated as important by more than 90% of respondents, and a majority rated community participation and collective advocacy as very important. Nutrition, immunization, substance abuse, and road safety issues were rated as very important by more physicians than were access-to-care issues, unemployment, or illiteracy. Two thirds of respondents had participated in at least 1 of the 3 types of activities in the previous 3 years. Factors independently related to high overall rating of importance (civic-mindedness) included age, female sex, underrepresented race/ethnicity, and graduation from a non-US or non-Canadian medical school. Civic mindedness, medical specialty, practice type, underrepresented race/ethnicity, preceptors of physicians in training, rural practice, and graduation from a non-US or non-Canadian medical school were independently related to civic activity. Conclusions Public roles are definable entities that have widespread support among physicians. Civic-mindedness is associated primarily with sociodemographic factors, but civic action is associated with specialty and practice-based factors.	Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3050, Australia; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Royal Melbourne Hospital; University of Melbourne; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gruen, RL (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia.	rgruen@unimelb.edu.au						*AM ASS MED COLL, 2006, UND MED DEF; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Benson J A Jr, 2000, Pharos Alpha Omega Alpha Honor Med Soc, V63, P4; GREENLICK MR, 1992, JAMA-J AM MED ASSOC, V267, P1645, DOI 10.1001/jama.267.12.1645; Gruen RL, 2004, JAMA-J AM MED ASSOC, V291, P94, DOI 10.1001/jama.291.1.94; May W., 2001, BELEAGUERED RULERS P; MURRAY CJL, 1998, US PATTERNS MORTALIT; Pathman DE, 1998, J FAM PRACTICE, V46, P293; Putnam RD., 2000, BOWLING ALONE COLLAP; Rothman DJ, 2000, NEW ENGL J MED, V342, P1284, DOI 10.1056/NEJM200004273421711; ROTHMAN DJ, 2002, IDEAS OPEN SOC PHYS; SCHOEN C, 2005, HLTH AFF MILLWOOD, DOI DOI 10.1377/HLTH-AFF.W5.289; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; *STAT CORP, 2003, STAT STAT SOFTW REL; Stevens RA, 2001, MILBANK Q, V79, P327, DOI 10.1111/1468-0009.00211; Sullivan, 2004, SEXUAL MINORITIES DI; Sullivan WM, 2000, CAN MED ASSOC J, V162, P673; *USDA EC RES SERV, 2003, MEAS RUR RUR URB CON	18	123	125	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2467	2475		10.1001/jama.296.20.2467	http://dx.doi.org/10.1001/jama.296.20.2467			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119143	Bronze			2022-12-28	WOS:000242171000028
J	Links, M				Links, Matthew			Evidence based medicine - Analogies between reading of medical and religious texts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL CARCINOMATOSIS; SURGERY; TRIAL; AGENT		Univ New S Wales, St George Hosp, Canc Care Ctr, Sch Clin, Kogarah, NSW 2217, Australia	St George Hospital; University of New South Wales Sydney	Links, M (corresponding author), Univ New S Wales, St George Hosp, Canc Care Ctr, Sch Clin, Kogarah, NSW 2217, Australia.	Matthew.Links@sesiahs.health.nsw.gov.au	Links, Matthew/U-3578-2019	Links, Matthew/0000-0003-3779-3705				Antman EM, 2003, CIRCULATION, V108, P2604, DOI 10.1161/01.CIR.0000090571.83005.CE; *AUSTR CANC NETW M, 2004, CLIN PRACT GUID PREV; *BRIT COL CANC AG, CHEM PROT; Devereaux PJ, 2003, J INTERN MED, V254, P105, DOI 10.1046/j.1365-2796.2003.01201.x; Fuchs CS, 2003, J CLIN ONCOL, V21, P807, DOI 10.1200/JCO.2003.08.058; Glehen O, 2004, J CLIN ONCOL, V22, P3284, DOI 10.1200/JCO.2004.10.012; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Jett JR, 2003, CHEST, V123, p221S, DOI 10.1378/chest.123.1_suppl.221S; Julian DG, 2003, J CARDIOVASC ELECTR, V14, pS2, DOI 10.1046/j.1540-8167.14.s9.18.x; Loefler I, 2004, BRIT MED J, V328, P842, DOI 10.1136/bmj.328.7443.842; Rose PG, 2001, GYNECOL ONCOL, V82, P323, DOI 10.1006/gyno.2001.6272; Schattner A, 2003, QJM-INT J MED, V96, P1, DOI 10.1093/qjmed/hcg001; Socinski MA, 2004, CLIN CANCER RES, V10, p4210S, DOI 10.1158/1078-0432.CCR-040009; VARDY JL, 2003, P AN M AM SOC CLIN, V22, P663; Verwaal VJ, 2003, J CLIN ONCOL, V21, P3737, DOI 10.1200/JCO.2003.04.187	16	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1068	1070		10.1136/bmj.38966.487350.68	http://dx.doi.org/10.1136/bmj.38966.487350.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	108HB	17110727	Green Published			2022-12-28	WOS:000242229800025
J	Sharp, D				Sharp, David			Expertise unusually redefined	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							HEARNDEN I, 2004, HOME OFFICE FINDINGS, P1; *HOM OFF, CRIM RED TOOLK DOM B; Nee C, 2006, BRIT J CRIMINOL, V46, P935, DOI 10.1093/bjc/azl013; PAYNE S, 2006, DAILY TELEGRAPH 0927	4	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2006	368	9549					1756	1756		10.1016/S0140-6736(06)69715-8	http://dx.doi.org/10.1016/S0140-6736(06)69715-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FJ	17113410				2022-12-28	WOS:000242225400011
J	Revyakin, A; Liu, CY; Ebright, RH; Strick, TR				Revyakin, Andrey; Liu, Chenyu; Ebright, Richard H.; Strick, Terence R.			Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching	SCIENCE			English	Article							LAC UV5 PROMOTER; TRANSCRIPTION INITIATION; BUBBLE COLLAPSE; COMPLEX; ELONGATION; CLEARANCE; NANOMANIPULATION; RELEASE; ESCAPE	Using single-molecule DNA nanomanipulation, we show that abortive initiation involves DNA "scrunching" - in which RNA polymerase (RNAP) remains stationary and unwinds and pulls downstream DNA into itself - and that scrunching requires RNA synthesis and depends on RNA length. We show further that promoter escape involves scrunching, and that scrunching occurs in most or all instances of promoter escape. Our results support the existence of an obligatory stressed intermediate, with approximately one turn of additional DNA unwinding, in escape and are consistent with the proposal that stress in this intermediate provides the driving force to break RNAP-promoter and RNAP-initiation-factor interactions in escape.	Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Inst Jacques Monod, CNRS, UMR 7592, F-75251 Paris 05, France; Univ Paris 06, F-75251 Paris 05, France; Univ Paris 07, F-75251 Paris 05, France	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Revyakin, A (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; strick@ijm.jussieu.fr	Ebright, Richard/O-3321-2019; Strick, Terence R/J-1886-2012	Ebright, Richard/0000-0001-8915-7140; Strick, Terence/0000-0003-1744-3679	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM041376-15, R01 GM041376-18, R01 GM041376-16, R37 GM041376, R01 GM041376-17, R01 GM041376, GM41376] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, BIOPHYS J, V89, pL61, DOI 10.1529/biophysj.105.074195; Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; GRACHEV MA, 1980, FEBS LETT, V115, P23, DOI 10.1016/0014-5793(80)80718-6; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; MUNSON LM, 1981, BIOCHEMISTRY-US, V20, P2081, DOI 10.1021/bi00511a003; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; RECORD MT, 1996, ESCHERICHIA COLI SAL, V1, P792; Revyakin A, 2005, NAT METHODS, V2, P127, DOI 10.1038/nmeth0205-127; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; SPASSKY A, 1986, J MOL BIOL, V188, P99, DOI 10.1016/0022-2836(86)90484-5; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	30	264	273	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1139	1143		10.1126/science.1131398	http://dx.doi.org/10.1126/science.1131398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110577	Green Accepted			2022-12-28	WOS:000242045800043
J	Strauss, E				Strauss, Evelyn			Arrays of hope	CELL			English	Editorial Material																			0	26	28	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					657	659		10.1016/j.cell.2006.11.005	http://dx.doi.org/10.1016/j.cell.2006.11.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110319	Bronze			2022-12-28	WOS:000242330600006
J	Garfield, CF; Clark-Kauffman, E; Davis, MM				Garfield, Craig F.; Clark-Kauffman, Elizabeth; Davis, Matthew M.			Fatherhood as a component of men's health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTPARTUM DEPRESSION; CHILD HEALTH; POPULATION; PARENTHOOD; TRANSITION; MODEL; CARE		Evanston NW Healthcare Res Inst, Dept Pediat, Evanston, IL 60201 USA; Northwestern Univ, Dept Pediat, Feinberg Sch Med, Evanston, IL USA; Univ Michigan, Child Hlth Evaluat & Res Unit, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Child Hlth Evaluat & Res Unit, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Garfield, CF (corresponding author), Evanston NW Healthcare Res Inst, Dept Pediat, 1001 Univ PI, Evanston, IL 60201 USA.	c-garfield@northwestern.edu	Garfield, Craig/AAE-2525-2020	Garfield, Craig/0000-0002-6512-6005				Coleman WL, 2004, PEDIATRICS, V113, P1406, DOI 10.1542/peds.113.5.1406; Condon JT, 2004, AUST NZ J PSYCHIAT, V38, P56, DOI 10.1177/000486740403800102; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Garfield CF, 2006, PEDIATRICS, V117, pE637, DOI 10.1542/peds.2005-1612; Garfield CF, 2006, AMBUL PEDIATR, V6, P215, DOI 10.1016/j.ambp.2006.04.001; Goodman JH, 2004, J ADV NURS, V45, P26, DOI 10.1046/j.1365-2648.2003.02857.x; *I ED SCI, EARL CHILDH LONG STU; LAMB M, 2004, CONCEPTUALIZING MEAS; LAROCHE H, IN PRESS J AM BOARD; Lindau ST, 2003, PERSPECT BIOL MED, V46, pS74, DOI 10.1353/pbm.2003.0069; Matthey S, 2000, J AFFECT DISORDERS, V60, P75, DOI 10.1016/S0165-0327(99)00159-7; Noonan K, 2005, SOC SCI QUART, V86, P1399, DOI 10.1111/j.0038-4941.2005.00352.x; Paulson JF, 2006, PEDIATRICS, V118, P659, DOI 10.1542/peds.2005-2948; *PRINC U COL U, FRAG FAM CHILD WELLB; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Reichman NE, 2004, DEMOGRAPHY, V41, P569, DOI 10.1353/dem.2004.0026; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; Teitler JO, 2003, PUBLIC OPIN QUART, V67, P126, DOI 10.1086/346011; *US BUR CENS, 2006, FACTS FEAT FATH DAY; *US DEP ED, 2001, MEAS FATH INV YOUNG; *US DEP HHS, FRAM OFFSPR STUD	21	56	56	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2365	2368		10.1001/jama.296.19.2365	http://dx.doi.org/10.1001/jama.296.19.2365			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104ZI	17105800				2022-12-28	WOS:000241998700025
J	Wellings, K; Collumbien, M; Slaymaker, E; Singh, S; Hodges, Z; Patel, D; Bajos, N				Wellings, Kaye; Collumbien, Martine; Slaymaker, Emma; Singh, Susheela; Hodges, Zoe; Patel, Dhaval; Bajos, Nathalie			Sexual and reproductive health 2 - Sexual behaviour in context: a global perspective	LANCET			English	Review							HIV PREVENTION INTERVENTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; TEEN PREGNANCY RATES; CONDOM USE; RISK BEHAVIOR; STRUCTURAL INTERVENTIONS; YOUNG-PEOPLE; DRUG-USERS; TRANSMITTED INFECTIONS; CHANGING PATTERNS	Research aimed at investigating sexual behaviour and assessing interventions to improve sexual health has increased in recent decades. The resulting data, despite regional differences in quantity and quality; provide a historically unique opportunity to describe patterns of sexual behaviour and their implications for attempts to protect sexual health at the beginning of the 21st century. In this paper we present original analyses of sexual behaviour data from 59 countries for which they were available. The data show substantial diversity in sexual behaviour by region and sex. No universal trend towards earlier sexual intercourse has occurred, but the shift towards later marriage in most countries has led to an increase in premarital sex, the prevalence of which is generally higher in developed countries than in developing countries, and is higher in men than in women. Monogamy is the dominant pattern everywhere, but having had two or more sexual partners in the past year is more common in men than in women, and reported rates are higher in industrialised than in non-industrialised countries. Condom use has increased in prevalence almost everywhere, but rates remain low in many developing countries. The huge regional variation indicates mainly social and economic determinants of sexual behaviour, which have implications for intervention. Although individual behaviour change is central to improving sexual health, efforts are also needed to address the broader determinants of sexual behaviour, particularly those that relate to the social context. The evidence from behavioural interventions is that no general approach to sexual-health promotion will work everywhere and no single-component intervention will work anywhere. Comprehensive behavioural interventions are needed that take account of the social context in mounting individual-level programmes, attempt to modify social norms to support uptake and maintenance of behaviour change, and tackle the structural factors that contribute to risky sexual behaviour.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Populat Serv Int, Johannesburg, South Africa; INSERM, Paris, France; Alan Guttmacher Inst, New York, NY 10005 USA	University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm)	Wellings, K (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	kaye.wellings@lshtm.ac.uk	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056; Slaymaker, Emma/0000-0002-4941-5739				Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Adimora AA, 2002, EPIDEMIOLOGY, V13, P707, DOI 10.1097/00001648-200211000-00016; Adrien A, 2001, INT J STD AIDS, V12, P108, DOI 10.1258/0956462011916884; Agha S, 2002, CULT HEALTH SEX, V4, P191, DOI 10.1080/13691050110095568; AHMED FH, 2005, REDUCING UNINTENDED; Albarracin D, 2003, HEALTH PSYCHOL, V22, P166, DOI 10.1037/0278-6133.22.2.166; Allen T., 2004, Journal of International Development, V16, P1141, DOI 10.1002/jid.1168; Alonso A, 2004, LANCET, V364, P1033, DOI 10.1016/S0140-6736(04)17050-5; Amirkhanian YA, 2005, AIDS CARE, V17, P58, DOI 10.1080/09540120412331305133; Amirkhanian YA, 2001, AIDS, V15, P407, DOI 10.1097/00002030-200102160-00014; [Anonymous], WORLD POP PROSP 2004; [Anonymous], 2005, NOR GEOGR TIDSSKR NO, DOI DOI 10.1080/00291950510020556; ARREDONDO A, 2000, ESTUDIO NACIONAL COM; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Bajos N, 2000, SOC SCI MED, V50, P1533, DOI 10.1016/S0277-9536(99)00463-3; BAJOS N, 1995, AIDS, V9, P735, DOI 10.1097/00002030-199507000-00011; BARKER G, 2000, DO WE KNOW IF MEN HA; Barnett T, 2005, LANCET INFECT DIS, V5, P590, DOI 10.1016/S1473-3099(05)70219-X; BELTZER N, 2005, CONNAISSANCES ATTITU; BERNSTEIN S, 2006, UN MILLENNIUM PROJEC; Bertrand JT, 2006, HEALTH EDUC RES, V21, P567, DOI 10.1093/her/cyl036; Biddlecom AE, 2004, SEX TRANSM INFECT, V80, P74, DOI 10.1136/sti.2004.011676; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Bonell C, 2006, SOC SCI MED, V63, P1135, DOI 10.1016/j.socscimed.2006.03.026; Bowley DMG, 2002, BMJ-BRIT MED J, V324, P1586, DOI 10.1136/bmj.324.7353.1586; Brown A., 2001, SEXUAL RELATIONS YOU; Busza J, 2006, SEX CULT HEALTH, P134; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Cameron KA, 2005, J ADOLESCENCE, V28, P535, DOI 10.1016/j.adolescence.2004.10.006; Carael M, 2006, SEX TRANSM INFECT, V82, pIII26, DOI 10.1136/sti.2006.021196; Chapman S, 2004, EVALUATING HLTH PROM, P93; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Cleland J, 1995, SEXUAL BEHAV AIDS DE; CLELAND JGF, IN PRESS LANCET; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Collumbien M., 2004, COMP QUANTIFICATION, P1255; COOMBES Y, 2004, EVALUATING HLTH PROM; Coyle SL, 1999, PUBLIC HEALTH, V113, P19; Curtis SL, 2004, SEX TRANSM INFECT, V80, P22, DOI 10.1136/sti.2004.011650; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; DARROCH JE, 1999, WHY IS EENAGE PREGNA; del Rio C, 2002, AIDS, V16, P1445, DOI 10.1097/00002030-200207260-00001; Dickson N, 1998, BRIT MED J, V316, P29, DOI 10.1136/bmj.316.7124.29; Donovan B, 2000, LANCET, V355, P1897, DOI 10.1016/S0140-6736(00)02302-3; Donovan P, 1998, Guttmacher Rep Public Policy, V1, P6; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Ellis S., 2004, PREVENTION SEXUALLY; Elwy AR, 2002, ARCH INTERN MED, V162, P1818, DOI 10.1001/archinte.162.16.1818; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; *FAC U SAINT LOUIS, 2003, EU NEW ENC MOD PROJ; Ferguson A, 2004, SEX TRANSM INFECT, V80, P435, DOI 10.1136/sti.2004.010462; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Furber AS, 2002, TROP MED INT HEALTH, V7, P140, DOI 10.1046/j.1365-3156.2002.00844.x; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Genuis SJ, 2004, BMJ-BRIT MED J, V328, P894, DOI 10.1136/bmj.328.7444.894; Gibson DR, 1998, AIDS, V12, P919, DOI 10.1097/00002030-199808000-00015; GIESECKE J, 1992, INT J STD AIDS, V3, P255, DOI 10.1177/095646249200300405; *GLOB COAL WOM AID, 2004, HIV PREV PROT EFF FA; Gregson S, 1998, SOC SCI MED, V46, P321, DOI 10.1016/S0277-9536(97)00165-2; Grier S, 2005, ANNU REV PUBL HEALTH, V26, P319, DOI 10.1146/annurev.publhealth.26.021304.144610; GROVES RM, 2005, VITAL HLTH STAT, V42, P1; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Halton K, 2003, AIDS, V17, P97, DOI 10.1097/00002030-200301030-00013; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Harrison A, 2005, SEX TRANSM INFECT, V81, P259, DOI 10.1136/sti.2004.011486; Helie A, 2004, REPROD HEALTH MATTER, V12, P120, DOI 10.1016/S0968-8080(04)23114-7; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; HEROLD J, 2003, REPROD HLTH SURVEY A; Hubert M., 1998, SEXUAL BEHAV HIV AID; INGHAM R, 2006, SEXUAL HLTH YOUNG PE, P155; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; *JOINT UN PROGR HI, 2000, EV 100 COND PROGR T; *JOINT UN PROGR HI, 1998, REL HIV STD DECL THA; JONES JM, 1999, CONSORTIUM STATE PHY; Kapiga SH, 2002, AIDS CARE, V14, P455, DOI [10.1080/09540120208629665, 10.1080/09540120220132991]; Kaufmann RB, 1998, PEDIATRICS, V102, P1141, DOI 10.1542/peds.102.5.1141; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; KIM J, 2006, 16 INT AIDS C TOR 13; Kim JC, 2005, BMJ-BRIT MED J, V331, P769, DOI 10.1136/bmj.331.7519.769; Kincaid DL, 2000, SOC SCI MED, V50, P215, DOI 10.1016/S0277-9536(99)00276-2; KIRBY D, 2006, 2 FHI; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Kordoutis PS, 2000, AIDS CARE, V12, P767, DOI 10.1080/09540120020014318; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; Lagarde E, 1996, AIDS, V10, P327, DOI 10.1097/00002030-199603000-00012; Lambert H, 2006, SOC SCI MED, V62, P2633, DOI 10.1016/j.socscimed.2005.11.023; Lambert H, 2006, SOC SCI MED, V62, P2613, DOI 10.1016/j.socscimed.2005.11.022; LERIDON H, 1998, EUROPEANS THEIR SEXU; Lesch E, 2005, SOC SCI MED, V61, P1072, DOI 10.1016/j.socscimed.2005.01.005; LIU Dalin, 1997, SEXUAL BEHAV MODERN; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Logan TK, 2002, PSYCHOL BULL, V128, P851, DOI 10.1037/0033-2909.128.6.851; LOWBEER D, 2004, BEHAV COMMUNICATION; Macintyre K, 2001, AIDS EDUC PREV, V13, P160, DOI 10.1521/aeap.13.2.160.19736; MARIE A., 1997, AFRIQUE INDIVIDUS; McIntyre JA, 2005, LANCET, V366, P1141, DOI 10.1016/S0140-6736(05)67458-2; *MEASURE DHS, DEM HLTH SURV; MENSCH BS, 2005, CHANGING CONTEXT SEX; Michael RT, 1998, AM J PUBLIC HEALTH, V88, P749, DOI 10.2105/AJPH.88.5.749; Miller A. M., 2004, HLTH HUMAN RIGHTS, V7, P5; Mize SJS, 2002, AIDS CARE, V14, P163, DOI 10.1080/09540120220104686; MOHN JK, 1995, ADOLESC FAM HLTH, V3, P39; Mufune P, 2003, CULT HEALTH SEX, V5, P425, DOI 10.1080/136910501165631; Mullen PD, 2002, J ACQ IMMUN DEF SYND, V30, pS94, DOI 10.1097/01.QAI.0000019980.12814.DF; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Neumann MS, 2002, J ACQ IMMUN DEF SYND, V30, pS106, DOI 10.1097/01.QAI.0000018919.84759.50; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Nyanzi S, 2004, CULT HEALTH SEX, V6, P239, DOI 10.1080/13691050310001658208; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Parkhurst JO, 2002, LANCET, V360, P78, DOI 10.1016/S0140-6736(02)09340-6; Parkhurst JO, 2004, SOC SCI MED, V59, P1913, DOI 10.1016/j.socscimed.2004.02.026; PATEL V, 2003, ADULTHOOD EXPLORING, P99; *POP REF BUR, 2000, WORLDS YOUTH 2000; Powles J, 2003, LANCET, V361, P2086, DOI 10.1016/S0140-6736(03)13663-X; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Puri MC, 2004, CULT HEALTH SEX, V6, P145, DOI 10.1080/13691050310001619653; Quigley MA, 2004, AIDS, V18, P2055, DOI 10.1097/00002030-200410210-00010; Rees R, 2004, HIV HLTH PROMOTION M; Richens J, 2003, J R STAT SOC A STAT, V166, P207, DOI 10.1111/1467-985X.00268; Roberts AB, 2005, SOC SCI MED, V60, P1487, DOI 10.1016/j.socscimed.2004.08.012; Rotheram-Borus MJ, 2000, AIDS, V14, pS59; Sangi-Haghpeykar H, 2003, AIDS CARE, V15, P505, DOI 10.1080/0954012031000134746; Santelli JS, 2004, J ADOLESCENT HEALTH, V35, P80, DOI 10.1016/j.jadohealth.2004.05.001; SANTELLI JS, IN PRESS AM J PUBLIC; Saul R, 1999, Guttmacher Rep Public Policy, V2, P6; Schuler SR, 1997, WORLD DEV, V25, P563, DOI 10.1016/S0305-750X(96)00119-2; Seeley J, 2004, SAHARA J, V1, P87; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS73, DOI 10.1097/01.QAI.0000017613.32101.90; SERBANESCU F, 1998, YOUNG ADULT REPROD H; SERBANESCU F, 2003, YOUNG ADULT REPROD H; Shepherd R., 2011, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD001035, DOI 10.1002/14651858.CD001035]; Simon S, 2004, CULT HEALTH SEX, V6, P393, DOI 10.1080/13691050410001680519; SINGH CM, 2004, INDIAN J SOCIAL MED, V35, P179; Slap GB, 2003, BMJ-BRIT MED J, V326, P15, DOI 10.1136/bmj.326.7379.15; Slater M D, 1996, J Health Commun, V1, P267, DOI 10.1080/108107396128059; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P13, DOI 10.1136/sti.2004.011635; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P106, DOI 10.1111/j.1467-842X.2003.tb00797.x; Soler H, 2000, FAM PLANN PERSPECT, V32, P82, DOI 10.2307/2648216; Tangmunkongvorakul A, 2005, CULT HEALTH SEX, V7, P361, DOI 10.1080/13691050500100740; *US NIH, 1997, NIH CONSENSUS STATE, V15, P15; Usdin S, 2005, SOC SCI MED, V61, P2434, DOI 10.1016/j.socscimed.2005.04.035; van Empelen P, 2003, SOC SCI MED, V57, P1593, DOI 10.1016/S0277-9536(02)00557-9; VERMA R, 2005, SEXUAL HLTH EXCHANGE, V2, P5; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4; Wellings K, 2002, LEA COMMUN SER, P131; WIGHT D, 2000, BMJ-BRIT MED J, V44, P1245, DOI DOI 10.1136/BMJ.320.7244.1243; WILKINSON P, IN PRESS LANCET; Williams BG, 2003, AIDS, V17, P2099, DOI 10.1097/00002030-200309260-00011; Zheng ZZ, 2001, REPROD HEALTH MATTER, V9, P118, DOI 10.1016/S0968-8080(01)90015-1; 2005, CONTRACEPT TECHNOL U, V26, P4; [No title captured]	156	542	564	5	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1706	1728		10.1016/S0140-6736(06)69479-8	http://dx.doi.org/10.1016/S0140-6736(06)69479-8			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098090				2022-12-28	WOS:000242099000039
J	Wild, SH; Byrne, CD				Wild, Sarah H.; Byrne, Christopher D.			Risk factors for diabetes and coronary heart disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Southampton, Southampton SO9 5NH, Hants, England	University of Edinburgh; University of Southampton	Wild, SH (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.			Byrne, Christopher D/0000-0001-6322-7753				BYRNE CD, 2005, METABOLIC SYNDROME; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Sattar N, 1998, INT J OBESITY, V22, P432, DOI 10.1038/sj.ijo.0800604	6	96	100	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2006	333	7576					1009	1011		10.1136/bmj.39024.568738.43	http://dx.doi.org/10.1136/bmj.39024.568738.43			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108GX	17095784	Green Published			2022-12-28	WOS:000242229400019
J	Woodside, MT; Anthony, PC; Behnke-Parks, WM; Larizadeh, K; Herschlag, D; Block, SM				Woodside, Michael T.; Anthony, Peter C.; Behnke-Parks, William M.; Larizadeh, Kevan; Herschlag, Daniel; Block, Steven M.			Direct measurement of the full, sequence-dependent folding landscape of a nucleic acid	SCIENCE			English	Article							STRUCTURE PREDICTION; SMALL PROTEINS; FORCE; RNA; MOLECULES	Nucleic acid hairpins provide a powerful model system for understanding macromolecular folding, with free-energy landscapes that can be readily manipulated by changing the hairpin sequence. The full shapes of energy landscapes for the reversible folding of DNA hairpins under controlled loads exerted by an optical force clamp were obtained by deconvolution from high-resolution, single-molecule trajectories. The locations and heights of the energy barriers for hairpin folding could be tuned by adjusting the number and location of G: C base pairs, and the presence and position of folding intermediates were controlled by introducing single-nucleotide mismatches.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; Stanford Univ, Biophys Program, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; National Research Council Canada; Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	sblock@stanford.edu			NIGMS NIH HHS [P01-GM066275, R01 GM057035-12, R01 GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066275, R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Buchner J, 2005, PROTEIN FOLDING HANDBOOK, P1, DOI 10.1002/9783527619498; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fernandez JM, 2001, SCIENCE, V292, P653, DOI 10.1126/science.1060884; FRESHT A, 1999, STRUCTURE MECH PROTE; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Hyeon CB, 2003, P NATL ACAD SCI USA, V100, P10249, DOI 10.1073/pnas.1833310100; Jansson P., 1997, DECONVOLUTION IMAGES; Jeney S, 2004, CHEMPHYSCHEM, V5, P1150, DOI 10.1002/cphc.200301027; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Li PTX, 2006, BIOPHYS J, V90, P250, DOI 10.1529/biophysj.105.068049; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; McCann LI, 1999, NATURE, V402, P785, DOI 10.1038/45492; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Walther KA, 2006, BIOPHYS J, V90, P3806, DOI 10.1529/biophysj.105.076224; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	21	292	318	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					1001	1004		10.1126/science.1133601	http://dx.doi.org/10.1126/science.1133601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095702	Green Accepted			2022-12-28	WOS:000241896000056
J	Zhang, GY; Qi, PF; Wang, XR; Lu, YR; Li, XL; Tu, R; Bangsaruntip, S; Mann, D; Zhang, L; Dai, HJ				Zhang, Guangyu; Qi, Pengfei; Wang, Xinran; Lu, Yuerui; Li, Xiaolin; Tu, Ryan; Bangsaruntip, Sarunya; Mann, David; Zhang, Li; Dai, Hongjie			Selective etching of metallic carbon nanotubes by gas-phase reaction	SCIENCE			English	Article							PREFERENTIAL GROWTH; TRANSISTORS; ROUTE	Metallic and semiconducting carbon nanotubes generally coexist in as-grown materials. We present a gas-phase plasma hydrocarbonation reaction to selectively etch and gasify metallic nanotubes, retaining the semiconducting nanotubes in near-pristine form. With this process, 100% of purely semiconducting nanotubes were obtained and connected in parallel for high-current transistors. The diameter- and metallicity-dependent "dry" chemical etching approach is scalable and compatible with existing semiconductor processing for future integrated circuits.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Adv Mat Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Lu, Yuerui/D-7841-2016; Wang, Xinran/E-8392-2010; Dai, Hongjie/ABC-4574-2021; Zhang, Guangyu/G-7892-2011	Lu, Yuerui/0000-0001-6131-3906; Wang, Xinran/0000-0002-3975-1667; 				An L, 2004, J AM CHEM SOC, V126, P10520, DOI 10.1021/ja046482m; Appenzeller J, 2005, IEEE T ELECTRON DEV, V52, P2568, DOI 10.1109/TED.2005.859654; Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Balasubramanian K, 2004, NANO LETT, V4, P827, DOI 10.1021/nl049806d; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; DRABNER G, 1990, INT J MASS SPECTROM, V97, P1, DOI 10.1016/0168-1176(90)85037-3; Guo J, 2002, APPL PHYS LETT, V81, P1486, DOI 10.1063/1.1502188; Heitz T, 1998, PHYS REV B, V58, P13957, DOI 10.1103/PhysRevB.58.13957; Javey A, 2004, NANO LETT, V4, P1319, DOI 10.1021/nl049222b; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Kim WS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1954884; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; Li YM, 2004, NANO LETT, V4, P317, DOI 10.1021/nl035097c; Li YM, 2005, J PHYS CHEM B, V109, P6968, DOI 10.1021/jp050868h; Lin YM, 2005, IEEE ELECTR DEVICE L, V26, P823, DOI 10.1109/LED.2005.857704; McEuen PL, 2002, IEEE T NANOTECHNOL, V1, P78, DOI 10.1109/TNANO.2002.1005429; Park H, 2005, NANOTECHNOLOGY, V16, P635, DOI 10.1088/0957-4484/16/6/003; Seidel R, 2004, NANO LETT, V4, P831, DOI 10.1021/nl049776e; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Zhang GY, 2006, J AM CHEM SOC, V128, P6026, DOI 10.1021/ja061324b; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; Zhou W, 2001, CHEM PHYS LETT, V350, P6, DOI 10.1016/S0009-2614(01)01237-4	24	436	466	7	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					974	977		10.1126/science.1133781	http://dx.doi.org/10.1126/science.1133781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095698				2022-12-28	WOS:000241896000047
J	Meschke, M; Guichard, W; Pekola, JP				Meschke, Matthias; Guichard, Wiebke; Pekola, Jukka P.			Single-mode heat conduction by photons	NATURE			English	Article							THERMAL CONDUCTANCE; QUANTUM; TRANSPORT; STATISTICS	The thermal conductance of a single channel is limited by its unique quantum value G(Q), as was shown theoretically(1) in 1983. This result closely resembles the well-known quantization of electrical conductance in ballistic one-imensional conductors(2,3). Interestingly, all particles - irrespective of whether they are bosons or fermions - have the same quantized thermal conductance(4,5) when they are confined within dimensions that are small compared to their characteristic wavelength. The single-mode heat conductance is particularly relevant in nanostructures. Quantized heat transport through submicrometre dielectric wires by phonons has been observed(6), and it has been predicted to influence cooling of electrons in metals at very low temperatures due to electromagnetic radiation(7). Here we report experimental results showing that at low temperatures heat is transferred by photon radiation, when electron - phonon(8) as well as normal electronic heat conduction is frozen out. We study heat exchange between two small pieces of normal metal, connected to each other only via superconducting leads, which are ideal insulators against conventional thermal conduction. Each superconducting lead is interrupted by a switch of electromagnetic ( photon) radiation in the form of a DC-SQUID ( a superconducting loop with two Josephson tunnel junctions). We find that the thermal conductance between the two metal islands mediated by photons indeed approaches the expected quantum limit of GQ at low temperatures. Our observation has practical implications - for example, for the performance and design of ultra-sensitive bolometers ( detectors of far-infrared light) and electronic micro-refrigerators(9), whose operation is largely dependent on weak thermal coupling between the device and its environment.	Helsinki Univ Technol, Low Temp Lab, Helsinki 02015, Finland; Univ Grenoble 1, F-38042 Grenoble 9, France; LCMI CNRS, F-38042 Grenoble 9, France	Aalto University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Pekola, JP (corresponding author), Helsinki Univ Technol, Low Temp Lab, POB 3500, Helsinki 02015, Finland.	jukka.pekola@tkk.fi	Meschke, Matthias/G-5166-2012; Gramich, Matthias/AAE-5772-2020; Pekola, Jukka/A-4211-2013					AMBEGAOKAR V, 1963, PHYS REV LETT, V10, P486, DOI 10.1103/PhysRevLett.10.486; Blencowe MP, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052104; Clark AM, 2004, APPL PHYS LETT, V84, P625, DOI 10.1063/1.1644326; Giazotto F, 2006, REV MOD PHYS, V78, P217, DOI 10.1103/RevModPhys.78.217; Greiner A, 1997, PHYS REV LETT, V78, P1114, DOI 10.1103/PhysRevLett.78.1114; HALDANE FDM, 1991, PHYS REV LETT, V67, P937, DOI 10.1103/PhysRevLett.67.937; Kane CL, 1996, PHYS REV LETT, V76, P3192, DOI 10.1103/PhysRevLett.76.3192; Kane CL, 1997, PHYS REV B, V55, P15832, DOI 10.1103/PhysRevB.55.15832; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; NAHUM M, 1993, APPL PHYS LETT, V63, P3075, DOI 10.1063/1.110237; Pashkin YA, 2000, APPL PHYS LETT, V76, P2256, DOI 10.1063/1.126313; PENDRY JB, 1983, J PHYS A-MATH GEN, V16, P2161, DOI 10.1088/0305-4470/16/10/012; Rego LGC, 1999, PHYS REV B, V59, P13080, DOI 10.1103/PhysRevB.59.13080; ROUKES ML, 1985, PHYS REV LETT, V55, P422, DOI 10.1103/PhysRevLett.55.422; Savin AM, 2006, J APPL PHYS, V99, DOI 10.1063/1.2187276; Schmidt DR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.045901; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WILCZEK F, 1982, PHYS REV LETT, V49, P957, DOI 10.1103/PhysRevLett.49.957; [No title captured]	20	213	216	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					187	190		10.1038/nature05276	http://dx.doi.org/10.1038/nature05276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093446	Green Submitted			2022-12-28	WOS:000241867200036
J	Shuchman, M				Shuchman, Miriam			Trading restenosis for thrombosis? New questions about drug electing stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shuchman, M (corresponding author), Univ Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA.							Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; CAMENZIND E, 2006, WORLD C CARD 2006 BA; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; PFISTERER ME, IN PRESS J AM COLL C; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138	6	107	118	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1949	1952		10.1056/NEJMp068234	http://dx.doi.org/10.1056/NEJMp068234			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093244				2022-12-28	WOS:000241833000001
J	Go, AS; Lee, WY; Yang, JR; Lo, JC; Gurwitz, JH				Go, Alan S.; Lee, Wendy Y.; Yang, Jingrong; Lo, Joan C.; Gurwitz, Jerry H.			Statin therapy and risks for death and hospitalization in chronic heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; SERUM CREATININE; ATORVASTATIN; SURVIVAL; INFLAMMATION; METAANALYSIS; CHOLESTEROL; MORTALITY; OUTCOMES	Context Whether statin therapy has beneficial effects on clinical outcomes in patients with heart failure is unclear. Objective To evaluate the association between initiation of statin therapy and risks for death and hospitalization among adults with chronic heart failure. Design, Setting, and Patients Propensity-adjusted cohort study of adults diagnosed with heart failure who were eligible for lipid-lowering therapy but had no previous known statin use, within an integrated health care delivery system in northern California between January 1, 1996, and December 31, 2004. Statin use was estimated from filled outpatient prescriptions in pharmacy databases. Main Outcome Measures All-cause death and hospitalization for heart failure during a median of 2.4 years of follow-up. We examined the independent relationships between statin therapy and risks for adverse events overall and stratified by the presence or absence of coronary heart disease after multivariable adjustment for potential confounders. Results Among 24 598 adults diagnosed with heart failure who had no prior statin use, those initiating statin therapy (n = 12 648; 51.4%) were more likely to be younger, male, and have known cardiovascular disease, diabetes, and hypertension. There were 8235 patients who died. Using an intent-to-treat approach, incident statin use was associated with lower risks of death (age- and sex-adjusted rate of 14.5 per 100 person-years with statin therapy vs 25.3 per 100 person-years without statin therapy; adjusted hazard ratio, 0.76 [95% confidence interval, 0.72-0.80]) and hospitalization for heart failure (age- and sex-adjusted rate of 21.9 per 100 person-years with statin therapy vs 31.1 per 100 person-years without statin therapy; adjusted hazard ratio, 0.79 [95% confidence interval, 0.74-0.85]) even after adjustment for the propensity to take statins, cholesterol level, use of other cardiovascular medications, and other potential confounders. Incident statin use was associated with lower adjusted risks of adverse outcomes in patients with or without known coronary heart disease. Conclusion Among adults diagnosed with heart failure who had no prior statin use, incident statin use was independently associated with lower risks of death and hospitalization among patients with or without coronary heart disease.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Tufts Sch Med, Dept Med, Boston, MA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Endocrinol, San Francisco, CA USA; Univ Massachusetts, Sch Med, Fallon Clin Fdn, Meyers Primary Care Inst, Worcester, MA USA; Fallon Community Hlth Plan, Worcester, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Floor, Oakland, CA 94612 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019					American Heart Association, 2005, HEART DIS STROKE STA; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Bleske BE, 2006, J AM COLL CARDIOL, V47, P338, DOI 10.1016/j.jacc.2005.06.087; Bohm M, 2005, Z KARDIOL, V94, P223, DOI 10.1007/s00392-005-0210-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Henke PK, 2004, J VASC SURG, V39, P357, DOI 10.1016/j.jvs.2003.08.030; Horwich TB, 2004, J AM COLL CARDIOL, V43, P642, DOI 10.1016/j.jacc.2003.07.049; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Kjekshus J, 2005, EUR J HEART FAIL, V7, P1059, DOI 10.1016/j.ejheart.2005.09.005; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lee WY, 2004, AM J CARDIOL, V94, P1147, DOI 10.1016/j.amjcard.2004.07.081; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Mozaffarian D, 2005, AM J CARDIOL, V96, P1699, DOI 10.1016/j.amjcard.2005.07.092; Mozaffarian D, 2004, AM J CARDIOL, V93, P1124, DOI 10.1016/j.amjcard.2004.01.039; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016; Ray JG, 2005, ARCH INTERN MED, V165, P62, DOI 10.1001/archinte.165.1.62; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rundek T, 2004, ARCH NEUROL-CHICAGO, V61, P889, DOI 10.1001/archneur.61.6.889; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Strey CH, 2005, ATHEROSCLEROSIS, V179, P201, DOI 10.1016/j.atherosclerosis.2004.10.009; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; TM Therneau., 2000, MODELING SURVIVAL DA, DOI DOI 10.1007/978; Tousoulis D, 2005, ATHEROSCLEROSIS, V178, P359, DOI 10.1016/j.atherosclerosis.2004.08.037; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; van der Harst P, 2006, PLOS MED, V3, P1403, DOI 10.1371/journal.pmed.0030333; Vrtovec B, 2005, J CARD FAIL, V11, P684, DOI 10.1016/j.cardfail.2005.06.439; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	44	209	223	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2105	2111		10.1001/jama.296.17.2105	http://dx.doi.org/10.1001/jama.296.17.2105			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077375	Bronze			2022-12-28	WOS:000241668000022
J	Paterson, DS; Trachtenberg, FL; Thompson, EG; Belliveau, RA; Beggs, AH; Darnall, R; Chadwick, AE; Krous, HF; Kinney, HC				Paterson, David S.; Trachtenberg, Felicia L.; Thompson, Eric G.; Belliveau, Richard A.; Beggs, Alan H.; Darnall, Ryan; Chadwick, Amy E.; Krous, Henry F.; Kinney, Hannah C.			Multiple serotonergic brainstem abnormalities in sudden infant death syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							5-HT1A RECEPTOR-BINDING; TRANSPORTER GENE; IN-VITRO; NEURONS; MEDULLA; NUCLEUS; RHYTHM; RISK; AGE; POLYMORPHISM	Context The serotonergic (5-hydroxytryptamine [5-HT]) neurons in the medulla oblongata project extensively to autonomic and respiratory nuclei in the brainstem and spinal cord and help regulate homeostatic function. Previously, abnormalities in 5-HT receptor binding in the medullae of infants dying from sudden infant death syndrome (SIDS) were identified, suggesting that medullary 5-HT dysfunction may be responsible for a subset of SIDS cases. Objective To investigate cellular defects associated with altered 5-HT receptor binding in the 5-HT pathways of the medulla in SIDS cases. Design, Setting, and Participants Frozen medullae from infants dying from SIDS (cases) or from causes other than SIDS (controls) were obtained from the San Diego Medical Examiner's office between 1997 and 2005. Markers of 5-HT function were compared between SIDS cases and controls, adjusted for postconceptional age and postmortem interval. The number of samples available for each analysis ranged from 16 to 31 for SIDS cases and 6 to 10 for controls. An exploratory analysis of the correlation between markers and 6 recognized risk factors for SIDS was performed. Main Outcome Measures 5-HT neuron count and density, 5-HT1A receptor binding density, and 5-HT transporter (5-HTT) binding density in the medullary 5-HT system; correlation between these markers and 6 recognized risk factors for SIDS. Results Compared with controls, SIDS cases had a significantly higher 5-HT neuron count (mean [SD], 148.04 [51.96] vs 72.56 [52.36] cells, respectively; P < .001) and 5-HT neuron density (P < .001), as well as a significantly lower density of 5-HT1A receptor binding sites (P <. 01 for all 9 nuclei) in regions of the medulla involved in homeostatic function. The ratio of 5-HTT binding density to 5-HT neuron count in the medulla was significantly lower in SIDS cases compared with controls (mean [SD], 0.70 [0.33] vs 1.93 [1.25] fmol/mg, respectively; P =. 001). Male SIDS cases had significantly lower 5-HT1A binding density in the raphe obscurus compared with female cases (mean [SD], 16.2 [2.0] vs 29.6 [16.5] fmol/mg, respectively; P =. 04) or with male and female controls combined (mean [SD], 53.9 [19.8] fmol/mg; P =. 005). No association was found between 5-HT neuron count or density, 5-HT1A receptor binding density, or 5-HTT receptor binding density and other risk factors. Conclusions Medullary 5-HT pathology in SIDS is more extensive than previously delineated, potentially including abnormal 5-HT neuron firing, synthesis, release, and clearance. This study also provides preliminary neurochemical evidence that may help explain the increased vulnerability of boys to SIDS.	Childrens Hosp Boston, Dept Pathol, Boston, MA USA; Childrens Hosp Boston, Dept Pediat, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; New England Res Inst, Watertown, MA 02172 USA; Rady Childrens Hosp & Hlth Ctr, San Diego, CA USA; Univ Calif San Diego, San Diego Sch Med, San Diego, CA 92103 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; HealthCore, Inc; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Paterson, DS (corresponding author), 300 Longwood Ave,Enders Bldg Room 1109, Boston, MA 02115 USA.	david.paterson@childrens.harvard.edu	Paterson, David/C-1517-2009	Beggs, Alan/0000-0001-8818-0568	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379, P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020991] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD36379, R37-HD20991, P30-HD18655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; BARTLETT D, 1990, PROG CLIN BIOL RES, V345, P99; Berner NJ, 1999, BRAIN RES, V831, P155, DOI 10.1016/S0006-8993(99)01426-2; Blair PS, 2006, BRIT MED J, V332, P178, DOI 10.1136/bmj.332.7534.178-a; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Bou-Flores C, 2000, J NEUROSCI, V20, P4646, DOI 10.1523/JNEUROSCI.20-12-04646.2000; Darnall RA, 2005, J NEUROSCI, V25, P8322, DOI 10.1523/JNEUROSCI.1770-05.2005; DILLON KA, 1991, BRAIN RES, V554, P56, DOI 10.1016/0006-8993(91)90171-Q; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; EMERIT MB, 1992, BIOL NEONATE, V62, P193; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; GILLIS RA, 1989, J PHARMACOL EXP THER, V248, P851; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Henderson LA, 2000, NEUROSCIENCE, V98, P779, DOI 10.1016/S0306-4522(00)00117-2; Johns JM, 2002, DEV NEUROSCI-BASEL, V24, P522, DOI 10.1159/000069363; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KING KA, 1991, EUR J PHARMACOL, V200, P357, DOI 10.1016/0014-2999(91)90596-I; Kinney HC, 2005, J NEUROPATH EXP NEUR, V64, P689, DOI 10.1097/01.jnen.0000174334.27708.43; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KINNEY HC, 2004, PATHOLOGY GENETICS D; KRAMMER EB, 1979, BRAIN RES, V170, P533, DOI 10.1016/0006-8993(79)90970-3; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; LALLEY PM, 1994, BRAIN RES, V648, P87, DOI 10.1016/0006-8993(94)91909-7; LALLEY PM, 1994, J PHYSIOL-LONDON, V476, P117; Messier ML, 2004, J APPL PHYSIOL, V96, P1909, DOI 10.1152/japplphysiol.00805.2003; Narita N, 2001, PEDIATRICS, V107, P690, DOI 10.1542/peds.107.4.690; Olszewski J., 1954, CYTOARCHITECTURE HUM; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Parsey RV, 2002, BRAIN RES, V954, P173, DOI 10.1016/S0006-8993(02)03243-2; Paterson DS, 2006, AUTON NEUROSCI-BASIC, V124, P112, DOI 10.1016/j.autneu.2005.12.009; Paterson DS, 2004, J COMP NEUROL, V472, P221, DOI 10.1002/cne.20105; Pena F, 2002, J NEUROSCI, V22, P11055; Penatti EM, 2006, J APPL PHYSIOL, V101, P1177, DOI 10.1152/japplphysiol.00376.2006; Raydo LJL, 2005, NEONATAL NETW, V24, P9; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Tappin D, 2004, LANCET, V363, P994, DOI 10.1016/S0140-6736(04)15806-6; Tryba AK, 2006, J NEUROSCI, V26, P2623, DOI 10.1523/JNEUROSCI.4186-05.2006; Weese-Mayer DE, 2003, AM J MED GENET A, V122A, P238, DOI 10.1002/ajmg.a.20427; Weese-Mayer DE, 2003, AM J MED GENET A, V117A, P268, DOI 10.1002/ajmg.a.20005; WILLINGER M, 1991, Pediatric Pathology, V11, P677; 2006, CHILD HLTH ALERT, V24, P3	43	352	368	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2124	2132		10.1001/jama.296.17.2124	http://dx.doi.org/10.1001/jama.296.17.2124			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077377	Bronze			2022-12-28	WOS:000241668000024
J	Pak, J; Fire, A				Pak, Julia; Fire, Andrew			Distinct populations of primary and secondary effectors during RNAi in C-elegans	SCIENCE			English	Article							GENE; INTERFERENCE; RECOGNITION; POLYMERASE; SIRNAS	RNA interference (RNAi) is a phylogenetically widespread gene-silencing process triggered by double-stranded RNA. In plants and Caenorhabditis elegans, two distinct populations of small RNAs have been proposed to participate in RNAi: "Primary siRNAs" ( derived from DICER nuclease-mediated cleavage of the original trigger) and "secondary siRNAs" [ additional small RNAs whose synthesis requires an RNA-directed RNA polymerase (RdRP)]. Analyzing small RNAs associated with ongoing RNAi in C. elegans, we found that secondary siRNAs constitute the vast majority. The bulk of secondary siRNAs exhibited structure and sequence indicative of a biosynthetic mode whereby each molecule derives from an independent de novo initiation by RdRP. Analysis of endogenous small RNAs indicated that a fraction derive from a biosynthetic mechanism that is similar to that of secondary siRNAs formed during RNAi, suggesting that small antisense transcripts derived from cellular messenger RNAs by RdRP activity may have key roles in cellular regulation.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fire, A (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	afire@stanford.edu		Fire, Andrew/0000-0001-6217-8312	NIGMS NIH HHS [R01-GM-37706, R01 GM037706] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Cerutti H, 2003, TRENDS GENET, V19, P39, DOI 10.1016/S0168-9525(02)00010-0; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; NEU HC, 1964, J BIOL CHEM, V239, P2927; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Van Houdt H, 2003, PLANT PHYSIOL, V131, P245, DOI 10.1104/pp.009407; VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3	26	431	445	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					241	244		10.1126/science.1132839	http://dx.doi.org/10.1126/science.1132839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17124291				2022-12-28	WOS:000243407400047
J	Bowen, JL				Bowen, Judith L.			Medical education: Educational strategies to promote clinical diagnostic reasoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROBLEM REPRESENTATION; SEMANTIC STRUCTURES; THINKING; KNOWLEDGE; EXPERTS		Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA	Oregon Health & Science University	Bowen, JL (corresponding author), Oregon Hlth & Sci Univ, Dept Med, 3181 SW Sam Jackson Pk Rd,L-475, Portland, OR 97239 USA.	bowenj@ohsu.edu						Aagaard E, 2004, ACAD MED, V79, P42, DOI 10.1097/00001888-200401000-00010; BORDAGE G, 1990, ACAD MED, V65, pS23, DOI 10.1097/00001888-199009000-00026; BORDAGE G, 1991, ACAD MED, V66, pS70, DOI 10.1097/00001888-199109000-00045; BORDAGE G, 1987, MED EDUC, V21, P183, DOI 10.1111/j.1365-2923.1987.tb00689.x; BORDAGE G, 1994, ACAD MED, V69, P883, DOI 10.1097/00001888-199411000-00004; Bordage G, 1999, ACAD MED, V74, pS138, DOI 10.1097/00001888-199910000-00065; Chang RW, 1998, ACAD MED, V73, pS109, DOI 10.1097/00001888-199810000-00062; Coderre S, 2003, MED EDUC, V37, P695, DOI 10.1046/j.1365-2923.2003.01577.x; Connell KJ, 1999, ACAD MED, V74, pS10, DOI 10.1097/00001888-199910000-00025; Custers EJFM, 1996, ACAD MED, V71, pS55, DOI 10.1097/00001888-199610000-00044; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Eva KW, 2005, MED EDUC, V39, P753; Hatala R, 1999, TEACH LEARN MED, V11, P110, DOI 10.1207/S15328015TL110210; Hatala RM, 2003, ADV HEALTH SCI EDUC, V8, P17, DOI 10.1023/A:1022687404380; IRBY DM, 1994, ACAD MED, V69, P333, DOI 10.1097/00001888-199405000-00003; IRBY DM, 1992, ACAD MED, V67, P630, DOI 10.1097/00001888-199210000-00002; Koens F, 2005, MED EDUC, V39, P1243, DOI 10.1111/j.1365-2929.2005.02338.x; Mandin H, 1997, ACAD MED, V72, P173, DOI 10.1097/00001888-199703000-00009; Neher J O, 1992, J Am Board Fam Pract, V5, P419; Nendaz MR, 2002, MED EDUC, V36, P760, DOI 10.1046/j.1365-2923.2002.01279.x; Norman G, 2005, MED EDUC, V39, P418, DOI 10.1111/j.1365-2929.2005.02127.x; SCHMIDT HG, 1992, ACAD MED, V67, P287; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; WIGTON RS, 1986, J MED EDUC, V61, P816	24	490	507	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2217	2225		10.1056/NEJMra054782	http://dx.doi.org/10.1056/NEJMra054782			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124019				2022-12-28	WOS:000242170900008
J	Duncan, RE; Foddy, B; Delatycki, MB				Duncan, Rony E.; Foddy, Bennett; Delatycki, Martin B.			Ethical debate - Refusing to provide a prenatal test: can it ever be ethical?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HUNTINGTONS-DISEASE; CHILDREN		Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Eth Unit, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Delatycki, MB (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia.	martin.delatycki@ghsv.org.au	Delatycki, Martin B/A-5409-2013					CLARKE A, 1994, J MED GENET, V31, P785, DOI 10.1136/jmg.31.10.785; Duncan RE, 2005, GENET MED, V7, P390, DOI 10.1097/01.GIM.0000170775.390921.44; Human Genetics Society of Australasia, 2005, PRED TEST CHILDR AD; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; TOLMIE JL, 1995, J MED GENET, V32, P97, DOI 10.1136/jmg.32.2.97; WENT L, 1994, J MED GENET, V31, P555; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; WILFOND BS, 1995, AM J HUM GENET, V57, P1233	8	18	19	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 18	2006	333	7577					1066	1068		10.1136/bmj.38950.645799.55	http://dx.doi.org/10.1136/bmj.38950.645799.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108HB	17110726	Green Published			2022-12-28	WOS:000242229800024
J	Langer, A; Catino, J				Langer, Ana; Catino, Jennifer			A gendered look at Mexico's health-sector reform	LANCET			English	Editorial Material									EngenderHlth, New York, NY 10001 USA		Langer, A (corresponding author), EngenderHlth, New York, NY 10001 USA.	alanger@engenderhealth.org						DOYAL L, 2003, WORKSH FOR, V7; Freedman LP, 2005, WHOS GOT POWER TRANS; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; GOMEZ EG, 2000, EQUITY GENDER HLTH P; *PROGR MUJ SAL, 2006, VIS STAT; Sachs JD, 2001, MACR HLTH INV HLTH E; Standing H, 1997, HEALTH POLICY PLANN, V12, P1, DOI 10.1093/heapol/12.1.1	7	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1753	1755		10.1016/S0140-6736(06)69527-5	http://dx.doi.org/10.1016/S0140-6736(06)69527-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113408				2022-12-28	WOS:000242225400009
J	Balazs, AC; Emrick, T; Russell, TP				Balazs, Anna C.; Emrick, Todd; Russell, Thomas P.			Nanoparticle polymer composites: Where two small worlds meet	SCIENCE			English	Review							PHASE-SEPARATION; NANOSCOPIC PARTICLES; DIBLOCK COPOLYMERS; ELECTRIC-FIELD; QUANTUM DOTS; BLENDS; MIXTURES; BINARY; FILMS; NANOCOMPOSITES	The mixing of polymers and nanoparticles is opening pathways for engineering flexible composites that exhibit advantageous electrical, optical, or mechanical properties. Recent advances reveal routes to exploit both enthalpic and entropic interactions so as to direct the spatial distribution of nanoparticles and thereby control the macroscopic performance of the material. For example, by tailoring the particle coating and size, researchers have created self-healing materials for improved sustainability and self-corralling rods for photovoltaic applications. A challenge for future studies is to create hierarchically structured composites in which each sublayer contributes a distinct function to yield a mechanically integrated, multifunctional material.	Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.	russell@mail.pse.umass.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826; Balazs, Anna/0000-0002-5555-2692				Ajayan P.M., 2003, NANOCOMPOSITE SCI TE; Araki T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061506; Baekeland L. H., 1909, SCI AM, V68, P322; BAIN CD, 1988, SCIENCE, V240, P62, DOI 10.1126/science.240.4848.62; Balazs AC, 2000, J PHYS CHEM B, V104, P3411, DOI 10.1021/jp993356+; Barnes KA, 2000, MACROMOLECULES, V33, P4177, DOI 10.1021/ma990614s; Bockstaller MR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166106; Bockstaller MR, 2003, J AM CHEM SOC, V125, P5276, DOI 10.1021/ja034523t; Buxton GA, 2004, MOL SIMULAT, V30, P249, DOI 10.1080/08927020310001659142; Buxton GA, 2003, MACROMOLECULES, V36, P9631, DOI 10.1021/ma034322+; Buxton GA, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031802; Chung HJ, 2004, EUROPHYS LETT, V68, P219, DOI 10.1209/epl/i2004-10242-2; Ginzburg VV, 2005, MACROMOLECULES, V38, P2362, DOI 10.1021/ma0482821; Goodyear, 1856, DINGLERS POLYTECH J, V139, P376; Gupta S, 2006, NAT MATER, V5, P229, DOI 10.1038/nmat1582; Gupta S, 2006, NANO LETT, V6, P2066, DOI 10.1021/nl061336v; He G, 2006, J POLYM SCI POL PHYS, V44, P2389, DOI 10.1002/polb.20887; Hong R, 2004, J AM CHEM SOC, V126, P13572, DOI 10.1021/ja0461163; Hong Y, 1999, J RHEOL, V43, P781, DOI 10.1122/1.550999; Hooper JB, 2006, MACROMOLECULES, V39, P5133, DOI 10.1021/ma060577m; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v; Karim A, 1999, MACROMOLECULES, V32, P5917, DOI 10.1021/ma990439f; Kim BJ, 2005, ADV MATER, V17, P2618, DOI 10.1002/adma.200500502; KIM BJ, 2006, IN PRESS P NATL ACAD; Kim BJ, 2006, MACROMOLECULES, V39, P4108, DOI 10.1021/ma060308w; Kim JU, 2006, MACROMOLECULES, V39, P413, DOI 10.1021/ma050817i; KOJIMA Y, 1993, J MATER RES, V8, P1185, DOI 10.1557/JMR.1993.1185; Korth BD, 2006, J AM CHEM SOC, V128, P6562, DOI 10.1021/ja0609147; Kotov NA, 2001, MRS BULL, V26, P992, DOI 10.1557/mrs2001.255; Lee BP, 1999, PHYS REV E, V60, P5812, DOI 10.1103/PhysRevE.60.5812; Lee J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080201; Lee JY, 2006, MACROMOLECULES, V39, P7392, DOI 10.1021/ma061210k; Lee JY, 2004, J CHEM PHYS, V121, P5531, DOI 10.1063/1.1784432; Lee JY, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.155503; Lee JY, 2002, MACROMOLECULES, V35, P4855, DOI 10.1021/ma0200266; Lin Y, 2005, NATURE, V434, P55, DOI 10.1038/nature03310; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; Liu JS, 2004, J AM CHEM SOC, V126, P6550, DOI 10.1021/ja0489184; Lopes WA, 2001, NATURE, V414, P735, DOI 10.1038/414735a; Mackay ME, 2006, SCIENCE, V311, P1740, DOI 10.1126/science.1122225; Mackay ME, 2002, LANGMUIR, V18, P1877, DOI 10.1021/la011542c; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Peng GW, 2000, SCIENCE, V288, P1802, DOI 10.1126/science.288.5472.1802; Ryan KM, 2006, NANO LETT, V6, P1479, DOI 10.1021/nl060866o; Si M, 2006, MACROMOLECULES, V39, P4793, DOI 10.1021/ma060125+; Skaff H, 2002, J AM CHEM SOC, V124, P5729, DOI 10.1021/ja012576+; Stratford K, 2005, SCIENCE, V309, P2198, DOI 10.1126/science.1116589; Sun YS, 2006, POLYMER, V47, P1101, DOI 10.1016/j.polymer.2005.12.055; TANAKA H, 1994, PHYS REV LETT, V72, P2581, DOI 10.1103/PhysRevLett.72.2581; Thompson RB, 2004, NANO LETT, V4, P2455, DOI 10.1021/nl048407f; Thompson RB, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031801; Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585; Tyagi S, 2004, MACROMOLECULES, V37, P9160, DOI 10.1021/ma048773l; USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179; Watson KJ, 1999, J AM CHEM SOC, V121, P462, DOI 10.1021/ja983173l; Yeh SW, 2005, MACROMOLECULES, V38, P6559, DOI 10.1021/ma047653a; Yurekli K, 2003, MACROMOLECULES, V36, P7256, DOI 10.1021/ma020755l	59	2099	2142	37	2073	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1107	1110		10.1126/science.1130557	http://dx.doi.org/10.1126/science.1130557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110567				2022-12-28	WOS:000242045800033
J	Cox, B; Yang, QD				Cox, Brian; Yang, Qingda			In quest of virtual tests for structural composites	SCIENCE			English	Review							FIBER-REINFORCED COMPOSITES; II DELAMINATION CRACKS; FINITE-ELEMENT-METHOD; LAMINATED COMPOSITES; MATERIALS FAILURE; GROWTH; FRACTURE; DAMAGE; INITIATION; INTERFACE	The difficult challenge of simulating diffuse and complex fracture patterns in tough structural composites is at last beginning to yield to conceptual and computational advances in fracture modeling. Contributing successes include the refinement of cohesive models of fracture and the formulation of hybrid stress-strain and traction-displacement models that combine continuum ( spatially averaged) and discrete damage representations in a single calculation. Emerging hierarchical formulations add the potential of tracing the damage mechanisms down through all scales to the atomic. As the models near the fidelity required for their use as virtual experiments, opportunities arise for reducing the number of costly tests needed to certify safety and extending the design space to include material configurations that are too complex to certify by purely empirical methods.	Teledyne Sci Co, Thousand Oaks, CA 91360 USA; Univ Miami, Dept Mech & Aerosp Engn, Coral Gables, FL 33124 USA	University of Miami	Cox, B (corresponding author), Teledyne Sci Co, 1049 Camino Dos Rios, Thousand Oaks, CA 91360 USA.	bcox@teledyne.com	Yang, Qingda/H-3983-2014	Yang, Qingda/0000-0003-0574-6461				Abraham FF, 2003, ADV PHYS, V52, P727, DOI 10.1080/00018730310001594198; Abraham FF, 2002, P NATL ACAD SCI USA, V99, P5777, DOI 10.1073/pnas.062012699; ARGON AS, 1972, TREATISE MAT SCI TEC, V0001; Barenblatt GI, 1962, ADV APPL MECH, V7, P55, DOI DOI 10.1016/S0065-2156(08)70121-2; BOGY DB, 1975, J APPL MECH-T ASME, V42, P93, DOI 10.1115/1.3423560; Borg R, 2004, COMPOS SCI TECHNOL, V64, P269, DOI 10.1016/S0266-3538(03)00255-0; BROWN AS, 1998, AEROSPACE AM     AUG, P26; BUDIANSKY B, 1983, COMPUT STRUCT, V16, P3, DOI 10.1016/0045-7949(83)90141-4; Buehler MJ, 2006, J COMPUT THEOR NANOS, V3, P603, DOI 10.1166/jctn.2006.3046; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; BUEHLER MJ, 2005, HDB THEORETICAL COMP, V2, P427; Cai W, 2004, DISLOCAT S, V12, P1; CASE SW, 1999, MRLIFE12 THEORY MANU; CHANG KY, 1991, J COMPOS MATER, V25, P274, DOI 10.1177/002199839102500303; COX BN, 1994, ACTA METALL MATER, V42, P341, DOI 10.1016/0956-7151(94)90492-8; COX BN, 1991, INT J FRACTURE, V49, P159; DUGDALE DS, 1960, J MECH PHYS SOLIDS, V8, P100, DOI 10.1016/0022-5096(60)90013-2; ENGQUIST WEB, IN PRESS COMMUN COMP; FAWCETT A, 1997, 11 INT C COMP MAT GO; FLECK NA, 1995, J MECH PHYS SOLIDS, V43, P1887, DOI 10.1016/0022-5096(95)00057-P; FLECK NA, 1991, INELASTIC DEFORMATION OF COMPOSITE MATERIALS, P235; GALILEI G, 1636, DIALOGUES 2 NEW SCI; Gonzalez C, 2006, ACTA MATER, V54, P4171, DOI 10.1016/j.actamat.2006.05.007; Griffith A.A., 1921, PHILOS T R SOC LOND, V221, P163, DOI [10.1098/rsta.1921.0006, DOI 10.1098/RSTA.1921.0006]; GUMBSCH P, 2001, MAT SCI 21 CENTURY, VA, P50; HIRSCH PB, 1975, DEFECTS, V2; Jegley D.C., 2003, 44 AIAA ASME ASCE AH; Marder M, 1999, COMPUT SCI ENG, V1, P48, DOI 10.1109/5992.790587; MARSHALL DB, 1994, ACTA METALL MATER, V42, P2657, DOI 10.1016/0956-7151(94)90207-0; Massabo R, 1998, INT J FRACTURE, V92, P1, DOI 10.1023/A:1007520324207; Massabo R, 1999, J MECH PHYS SOLIDS, V47, P1265, DOI 10.1016/S0022-5096(98)00107-0; McCartney LN, 1998, COMPOS SCI TECHNOL, V58, P1069, DOI 10.1016/S0266-3538(96)00142-X; Moes N, 1999, INT J NUMER METH ENG, V46, P131, DOI 10.1002/(SICI)1097-0207(19990910)46:1<131::AID-NME726>3.0.CO;2-J; Moes N, 2002, ENG FRACT MECH, V69, P813, DOI 10.1016/S0013-7944(01)00128-X; NEEDLEMAN A, 1990, INT J FRACTURE, V42, P21, DOI 10.1007/BF00018611; Park HS, 2005, J COMPUT PHYS, V207, P588, DOI 10.1016/j.jcp.2005.01.028; Petrossian Z, 1998, COMPOS PART A-APPL S, V29, P503, DOI 10.1016/S1359-835X(97)00134-6; Pinho ST, 2006, COMPOS PART A-APPL S, V37, P63, DOI 10.1016/j.compositesa.2005.04.016; Remmers JJC, 2003, COMPUT MECH, V31, P69, DOI 10.1007/s00466-002-0394-z; Rice J.R., 1980, PHYS EARTHS INTERIOR, V78, P555; ROSE LRF, 1987, J MECH PHYS SOLIDS, V35, P383, DOI 10.1016/0022-5096(87)90044-5; SCHELLEKENS JCJ, 1996, KEY ENG MATER, V121, P131; SPEARING SM, 1992, COMPOS SCI TECHNOL, V44, P159, DOI 10.1016/0266-3538(92)90109-G; STIGH U, 1988, INT J FRACTURE, V37, pR13, DOI 10.1007/BF00017826; Strouboulis T, 2001, COMPUTATIONAL MECH A, V190, P4801; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; THOULESS MD, 2001, MECH ADHESION, V1, P235; Tosh MW, 2001, COMPOS STRUCT, V53, P133, DOI 10.1016/S0263-8223(00)00184-7; Wagner GJ, 2003, J COMPUT PHYS, V190, P249, DOI 10.1016/S0021-9991(03)00273-0; Wells GN, 2002, INT J NUMER METH ENG, V54, P1333, DOI 10.1002/nme.462; Wisnom MR, 2000, COMPOS SCI TECHNOL, V60, P2849, DOI 10.1016/S0266-3538(00)00170-6; Yang QD, 2005, INT J FRACTURE, V133, P107, DOI 10.1007/s10704-005-4729-6; [No title captured]	53	148	151	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1102	1107		10.1126/science.1131624	http://dx.doi.org/10.1126/science.1131624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110566				2022-12-28	WOS:000242045800032
J	Hallet, B				Hallet, Bernard			Geology - Why do freezing rocks break?	SCIENCE			English	Editorial Material							ICE		Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hallet, B (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	hallet@u.washington.edu						Akagawa S., 1991, Permafrost and Periglacial Processes, V2, P301, DOI 10.1002/ppp.3430020405; Dash JG, 2006, REV MOD PHYS, V78, P695, DOI 10.1103/RevModPhys.78.695; DAVIDSON GP, 1985, COLD REG SCI TECHNOL, V11, P141, DOI 10.1016/0165-232X(85)90013-8; HALL K, 1986, EARTH SURF PROC LAND, V11, P131, DOI 10.1002/esp.3290110204; Hallet B., 1991, Permafrost and Periglacial Processes, V2, P283, DOI 10.1002/ppp.3430020404; Murton JB, 2006, SCIENCE, V314, P1127, DOI 10.1126/science.1132127; Scherer GW, 1999, CEMENT CONCRETE RES, V29, P1347, DOI 10.1016/S0008-8846(99)00002-2; SNYDER MB, 1992, SHRPC203 NAT RES COU; Taber S, 1929, J GEOL, V37, P428, DOI 10.1086/623637; WALDER J, 1985, GEOL SOC AM BULL, V96, P336, DOI 10.1130/0016-7606(1985)96<336:ATMOTF>2.0.CO;2	10	49	54	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1092	1093		10.1126/science.1135200	http://dx.doi.org/10.1126/science.1135200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110559				2022-12-28	WOS:000242045800025
J	Kubas, GJ				Kubas, Gregory J.			Chemistry - Breaking the H-2 marriage and reuniting the couple	SCIENCE			English	Editorial Material							BASE-CATALYZED HYDROGENATION; DIHYDROGEN; LECTURE		Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Kubas, GJ (corresponding author), Los Alamos Natl Lab, Div Chem, POB 1663, Los Alamos, NM 87545 USA.	kubas@lanl.gov						Alper J, 2003, SCIENCE, V299, P1686, DOI 10.1126/science.299.5613.1686; Berkessel A, 2002, J AM CHEM SOC, V124, P8693, DOI 10.1021/ja016152r; Brothers PJ, 1981, PROG INORG CHEM, V28, P1; Chan B, 2005, J AM CHEM SOC, V127, P2443, DOI 10.1021/ja0450253; DuBois M. Rakowski, 1989, CHEM REV, V89, P1; Kubas G.J., 2001, METAL DIHYDROGEN SIG; Kubas GJ, 2004, ADV INORG CHEM, V56, P127, DOI 10.1016/S0898-8838(04)56005-1; KUBAS GJ, 1984, J AM CHEM SOC, V106, P451, DOI 10.1021/ja00314a049; Kubas GJ, 2001, J ORGANOMET CHEM, V635, P37, DOI 10.1016/S0022-328X(01)01066-X; LIU X, 2005, COORDIN CHEM REV, P1641; MARX D, 1995, NATURE, V375, P216, DOI 10.1038/375216a0; Morris RH, 1996, CAN J CHEM, V74, P1907, DOI 10.1139/v96-215; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Schwarz DE, 2005, CHEM COMMUN, P5919, DOI 10.1039/b511884k; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230	15	77	79	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1096	1097		10.1126/science.1135430	http://dx.doi.org/10.1126/science.1135430			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110562				2022-12-28	WOS:000242045800028
J	Holm, AN; Nellson, WK				Holm, Adrian N.; Nellson, Wayne K.			Minocycline-induced hyperpigmentation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Holm, AN (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	holm.adrian@mayo.edu		Holm, Adrian/0000-0002-7290-0185					0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					E23	E23		10.1056/NEJMicm053666	http://dx.doi.org/10.1056/NEJMicm053666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108338				2022-12-28	WOS:000241997300010
J	Lindstrom, J; Ilanne-Parikka, P; Peltonen, M; Aunola, S; Eriksson, JG; Hemio, K; Hamalainen, H; Harkonen, P; Keinanen-Kiukaanniemi, S; Laakso, M; Louheranta, A; Mannelin, M; Paturi, M; Sundvall, J; Valle, TT; Uusitupa, M; Tuomilehto, J				Lindstrom, Jaana; Ilanne-Parikka, Pirjo; Peltonen, Markku; Aunola, Sirkka; Eriksson, Johan G.; Hemio, Katri; Hamalainen, Helena; Harkonen, Pirjo; Keinanen-Kiukaanniemi, Sirkka; Laakso, Mauri; Louheranta, Anne; Mannelin, Marjo; Paturi, Merja; Sundvall, Jouko; Valle, Timo T.; Uusitupa, Matti; Tuomilehto, Jaakko		Finnish Diabet Prevention Study Gr	Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MELLITUS; PREVALENCE; METFORMIN; EXERCISE; PEOPLE; TRIAL; DIET; IGT	Background Lifestyle interventions can prevent the deterioration of impaired glucose tolerance to manifest type 2 diabetes, at least as long as the intervention continues. In the extended follow-up of the Finnish Diabetes Prevention Study, we assessed the extent to which the originally-achieved lifestyle changes and risk reduction remain after discontinuation of active counselling. Methods Overweight, middle-aged men (n=172) and women (n=350) with impaired glucose tolerance were randomly assigned to intensive lifestyle intervention or control group. After a median of 4 years of active intervention period, participants who were still free of diabetes were further followed up for a median of 3 years, with median total follow-up of 7 years. Diabetes incidence, bodyweight, physical activity and dietary intakes of fat, saturated fat, and fibre were measured. Findings During the total follow-up, the incidence of type 2 diabetes was 4.3 and 7.4 per 100 person-years in the intervention and control group, respectively (log-rank test p=0.0001), indicating 43% reduction in relative risk. The risk reduction was related to the success in achieving the intervention goals of weight loss, reduced intake of total and saturated fat and increased intake of dietary fibre, and increased physical activity. Beneficial lifestyle changes achieved by participants in the intervention group were maintained after the discontinuation of the intervention, and the corresponding incidence rates during the post-intervention follow-up were 4.6 and 7.2 (p=0.0401), indicating 36% reduction in relative risk. Interpretation Lifestyle intervention in people at high risk for type 2 diabetes resulted in sustained lifestyle changes and a reduction in diabetes incidence, which remained after the individual lifestyle counselling was stopped.	Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; Finnish Diabet Assoc, Ctr Diabet, Tampere, Finland; Tampere Univ Hosp, Res Unit, Tampere, Finland; Natl Publ Hlth Inst, Lab Populat Res, Turku, Finland; Social Insurance Inst, Res Dept, Turku, Finland; Oulu Deaconess Inst, Dept Sports Med, Oulu, Finland; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; Univ Kuopio, Dept Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Nutr Unit, Helsinki, Finland; Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Lab Analyt Biochem, Helsinki, Finland; Hlth Ctr Oulu, Oulu, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; S Ostrobothnia Cent Hosp, Seinajoki, Finland	Finland National Institute for Health & Welfare; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Eastern Finland; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki	Lindstrom, J (corresponding author), Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, Mannerheimintie 166, SF-00300 Helsinki, Finland.	jaana.lindstrom@ktl.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Peltonen, Markku/F-3037-2015	Peltonen, Markku/0000-0002-3767-4223; Aunola, Sirkka/0000-0003-2681-1541; Eriksson, Johan/0000-0002-2516-2060; Lindstrom, Jaana/0000-0001-9255-020X				Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Finnish Diabetes Association, 2003, PROGR PREV TYP 2 DIA; Haapa E., 1985, ANNOSKUVAKIRJA PICTU; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2003, DIABETES CARE, V26, P977; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Ovaskainen ML, 1996, FOOD CHEM, V57, P133, DOI 10.1016/0308-8146(96)00113-6; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pereira MA, 1998, ARCH INTERN MED, V158, P1695, DOI 10.1001/archinte.158.15.1695; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Simkin-Silverman LR, 2003, ANN BEHAV MED, V26, P212, DOI 10.1207/S15324796ABM2603_06; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Uusitupa M, 2003, DIABETES, V52, P2532, DOI 10.2337/diabetes.52.10.2532; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 1985, WHO TECHN REP SER, V727; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	25	1164	1223	4	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1673	1679		10.1016/S0140-6736(06)69701-8	http://dx.doi.org/10.1016/S0140-6736(06)69701-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098085				2022-12-28	WOS:000242099000034
J	Darouiche, RO				Darouiche, Rabih O.			Current concepts: Spinal epidural abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROGNOSTIC FACTORS; CLINICAL PRESENTATION; MEDICAL-MANAGEMENT; INFECTIONS; ASPIRATION; INJECTION; ANALGESIA; PATHOLOGY		Baylor Coll Med, Ctr Protheses Infect, Houston, TX 77030 USA; Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Infect Dis Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Darouiche, RO (corresponding author), Baylor Coll Med, Ctr Protheses Infect, 1333 Moursund Ave,Suite A221, Houston, TX 77030 USA.	rdarouiche@aol.com						Akalan N, 2000, ACTA NEUROCHIR, V142, P17, DOI 10.1007/s007010050002; Alcock E, 2003, PAIN, V103, P209, DOI 10.1016/S0304-3959(02)00326-3; Arxer A, 2003, EUR J ANAESTH, V20, P755, DOI 10.1097/00003643-200309000-00015; BAKER AS, 1975, NEW ENGL J MED, V293, P463, DOI 10.1056/NEJM197509042931001; Bang MS, 2006, SPINAL CORD, V44, P258, DOI 10.1038/sj.sc.3101819; Bremer AA, 2004, J EMERG MED, V26, P51, DOI 10.1016/j.jemermed.2003.04.005; Browder J, 1941, SURGERY, V10, P296; Chowfin A, 1999, CLIN INFECT DIS, V29, P225, DOI 10.1086/520174; CURLING OD, 1990, NEUROSURGERY, V27, P185, DOI 10.1227/00006123-199008000-00002; Curry WT, 2005, SURG NEUROL, V63, P364, DOI 10.1016/j.surneu.2004.08.081; DANNER RL, 1987, REV INFECT DIS, V9, P265; DAROUICHE RO, 1992, MEDICINE, V71, P369, DOI 10.1097/00005792-199211000-00004; Davis DP, 2004, J EMERG MED, V26, P285, DOI 10.1016/j.jemermed.2003.11.013; FELDENZER JA, 1988, J NEUROSURG, V69, P110, DOI 10.3171/jns.1988.69.1.0110; Grewal S, 2006, BRIT J ANAESTH, V96, P292, DOI 10.1093/bja/ael006; Harrington P, 2001, ANN RHEUM DIS, V60, P218, DOI 10.1136/ard.60.3.218; HEUSNER AP, 1948, NEW ENGL J MED, V239, P845, DOI 10.1056/NEJM194812022392301; HLAVIN ML, 1990, NEUROSURGERY, V27, P177, DOI 10.1227/00006123-199008000-00001; HOLLIS PH, 1986, J NEUROSURG, V64, P253, DOI 10.3171/jns.1986.64.2.0253; Huang RC, 2004, SPINE, V29, pE7, DOI 10.1097/01.BRS.0000106764.40001.84; Joshi SM, 2003, BRIT J NEUROSURG, V17, P160, DOI 10.1080/0268869031000108918; KAUFMAN DM, 1980, NEUROLOGY, V30, P844, DOI 10.1212/WNL.30.8.844; Khan SNH, 2003, SURG NEUROL, V59, P28, DOI 10.1016/S0090-3019(02)00925-4; Khanna RK, 1996, NEUROSURGERY, V39, P958, DOI 10.1097/00006123-199611000-00016; Lechiche C, 2006, SCAND J INFECT DIS, V38, P229, DOI 10.1080/00365540500349018; Lin YC, 2005, PEDIATR ANESTH, V15, P767, DOI 10.1111/j.1460-9592.2005.01572.x; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P306, DOI 10.1016/S0303-8467(02)00020-3; Lyu RK, 2002, NEUROSURGERY, V51, P509, DOI 10.1097/00006123-200208000-00039; NUSSBAUM ES, 1992, SURG NEUROL, V38, P225, DOI 10.1016/0090-3019(92)90173-K; Parkinson Jonathon F, 2004, Neurosurg Focus, V17, pE12; Pereira CE, 2005, SURG NEUROL, V63, P26, DOI 10.1016/j.surneu.2004.09.021; Philipneri M, 2003, AM J NEPHROL, V23, P202, DOI 10.1159/000071479; Reihsaus E, 2000, NEUROSURG REV, V23, P175, DOI 10.1007/PL00011954; Rigamonti D, 1999, SURG NEUROL, V52, P189, DOI 10.1016/S0090-3019(99)00055-5; Rust TM, 2005, J CLIN NEUROSCI, V12, P453, DOI 10.1016/j.jocn.2004.08.009; Savage K, 2005, CLIN ORTHOP RELAT R, P56, DOI 10.1097/01.blo.0000183089.37768.2d; Siddiq F, 2004, ARCH INTERN MED, V164, P2409, DOI 10.1001/archinte.164.22.2409; Smitt PS, 1999, J NEUROL, V246, P815, DOI 10.1007/s004150050460; Soehle M, 2002, NEUROSURGERY, V51, P79, DOI 10.1097/00006123-200207000-00013; Solomou E, 2004, MAGN RESON IMAGING, V22, P747, DOI 10.1016/j.mri.2004.01.072; Sorensen P, 2003, BRIT J NEUROSURG, V17, P513, DOI 10.1080/02688690310001627731; Tang HJ, 2002, J INFECTION, V45, P76, DOI 10.1053/jinf.2002.1013; Tung GA, 1999, NEURORADIOLOGY, V41, P904, DOI 10.1007/s002340050865; WHEELER D, 1992, CLIN INFECT DIS, V15, P22, DOI 10.1093/clinids/15.1.22; Zafonte RD, 2003, J SPINAL CORD MED, V26, P345, DOI 10.1080/10790268.2003.11753704	45	382	398	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					2012	2020		10.1056/NEJMra055111	http://dx.doi.org/10.1056/NEJMra055111			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093252				2022-12-28	WOS:000241833000009
J	Van Heuverswyn, F; Li, YY; Neel, C; Bailes, E; Keele, BF; Liu, WM; Loul, S; Butel, C; Liegeois, F; Bienvenue, Y; Ngolle, EM; Sharp, PM; Shaw, GM; Delaporte, E; Hahn, BH; Peeters, M				Van Heuverswyn, Fran; Li, Yingying; Neel, Cecile; Bailes, Elizabeth; Keele, Brandon F.; Liu, Weimin; Loul, Severin; Butel, Christelle; Liegeois, Florian; Bienvenue, Yanga; Ngolle, Eitel Mpoudi; Sharp, Paul M.; Shaw, George M.; Delaporte, Eric; Hahn, Beatrice H.; Peeters, Martine			Human immunodeficiency viruses - SIV infection in wild gorillas	NATURE			English	Article							CHIMPANZEES		Univ Montpellier 1, UMR145, Inst Rech Dev, F-34394 Montpellier 5, France; Univ Montpellier 1, Dept Int Hlth, F-34394 Montpellier, France; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England; Projet Prevent Sida Cameroun PRESICA, Yaounde, Cameroon; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Hosp Montpellier, Dept Trop & Infect Dis, F-34295 Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Nottingham; Howard Hughes Medical Institute; Universite de Montpellier; CHU de Montpellier	Van Heuverswyn, F (corresponding author), Univ Montpellier 1, UMR145, Inst Rech Dev, F-34394 Montpellier 5, France.	martine.peeters@mpl.ird.fr	Florian, Liegeois/D-3798-2013; Sharp, Paul/Y-3787-2019; Delaporte, Eric/J-5397-2018; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010	Florian, Liegeois/0000-0003-1048-0661; Delaporte, Eric/0000-0002-1822-9853; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887				Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Butynski Thomas M., 2001, P3; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; Meder A, 1999, GORILLA J, V18, P11; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; USONGO L, 2001, GORILLA J, V22, P29	8	228	237	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					164	164		10.1038/444164a	http://dx.doi.org/10.1038/444164a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093443				2022-12-28	WOS:000241867200031
J	Weidle, PJ; Wamai, N; Solberg, P; Liechty, C; Sendagala, S; Were, W; Mermin, J; Buchacz, K; Behumbiize, P; Ransom, RL; Bunnell, R				Weidle, Paul J.; Wamai, Nafuna; Solberg, Peter; Liechty, Cheryl; Sendagala, Sam; Were, Willy; Mermin, Jonathan; Buchacz, Kate; Behumbiize, Prosper; Ransom, Ray L.; Bunnell, Rebecca			Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTH-AFRICA; DRUG-RESISTANCE; EXPERIENCE; KHAYELITSHA; OUTCOMES; ADULTS; COUNT	Background Poverty and limited health services in rural Africa present barriers to adherence to antiretroviral therapy that necessitate innovative options other than facility-based methods for delivery and monitoring of such therapy. We assessed adherence to antiretroviral therapy in a cohort of HIV-infected people in a home-based AIDS care programme that provides the therapy and other AIDS care, prevention, and support services in rural Uganda. Methods HIV-infected individuals with advanced HIV disease or a CD4-cell count of less than 250 cells per mu L were eligible for antiretroviral therapy. Adherence interventions included group education, personal adherence plans developed with trained counsellors, a medicine companion, and weekly home delivery of antiretroviral therapy by trained lay field officers. We analysed factors associated with pill count adherence (PCA) of less than 95%, medication possession ratio (MPR) of less than 95%, and HIV viral load of 1000 copies per mL or more at 6 months (second quarter) and 12 months (fourth quarter) of follow-up. Findings 987 adults who had received no previous antiretroviral therapy (median CD4-cell count 124 cells per mu L, median viral load 217 000 copies per mL) were enrolled between July, 2003, and May, 2004. PICA of less than 95% was calculated for 0.7-2.6% of participants in any quarter and MPR of less than 95% for 3.3-11.1%. Viral load was below 1000 copies per mL for 894 (98%) of 913 participants in the second quarter and for 860 (96%) of 894 of participants in the fourth quarter. In separate multivariate models, viral load of at least 1000 copies per mL was associated with both PICA below 95% (second quarter odds ratio 10.6 [95% CI 2.45-45.7]; fourth quarter 14.5 [2.51-83.6]) and MPR less than 95% (second quarter 9.44 [3.40-26.2]; fourth quarter 10.5 [4.22-25.9]). Interpretation Good adherence and response to antiretroviral therapy can be achieved in a home-based AIDS care Programme in a resource-limited rural African setting. Health-care systems must continue to implement, evaluate, and modify interventions to overcome barriers to comprehensive AIDS care programmes, especially the barriers to adherence with antiretroviral therapy.	Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Global Programme AIDS, Ctr Dis Control & Prevent Uganda, Entebbe, Uganda; Univ Calif San Francisco, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Weidle, PJ (corresponding author), Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd,MS E-45, Atlanta, GA 30333 USA.	pweidle@cdc.gov	Mermin, Jonathan/J-9847-2012					Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Colebunders R, 2005, PLOS MED, V2, P941, DOI 10.1371/journal.pmed.0020276; Demeester R, 2005, JAIDS-J ACQ IMM DEF, V40, P113, DOI 10.1097/01.qai.0000176590.68430.59; Dezii C M, 2001, Manag Care, V10, P42; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; *GLOB FUND FIGHT A, 2005, FORC CHANG GLOB FUND; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; *HOR POP COUNC INT, 2004, ADH ANT THER AD GUID; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Macharia DK, 2003, AIDS, V17, P938, DOI 10.1097/00002030-200304110-00028; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Office of the US Global AIDS Coordinator, 2004, PRES EM PLAN AIDS RE; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tassie JM, 2003, AIDS, V17, P1995, DOI 10.1097/00002030-200309050-00023; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; Uganda Bureau of Statistics, 2005, 2005 STAT ABSTR; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2003, WHO UNAIDS UNV PLAN; World Health Organization, 2003, SCAL ANT THER RES LT	30	171	172	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1587	1594		10.1016/S0140-6736(06)69118-6	http://dx.doi.org/10.1016/S0140-6736(06)69118-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084759				2022-12-28	WOS:000242180900028
J	Frenkel, D				Frenkel, Daan			Colloidal encounters: A matter of attraction	SCIENCE			English	Editorial Material									FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	AMOLF	Frenkel, D (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	frenkel@amolf.nl	Frenkel, Daan/G-2580-2014	Frenkel, Daan/0000-0002-6362-2021				BOLHUIS P, 1994, PHYS REV LETT, V72, P2211, DOI 10.1103/PhysRevLett.72.2211; Cacciuto A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166105; CAHN JW, 1969, J AM CERAM SOC, V52, P118, DOI 10.1111/j.1151-2916.1969.tb11194.x; FRENKEN JWM, 1985, PHYS REV LETT, V54, P134, DOI 10.1103/PhysRevLett.54.134; LEKKERKERKER HNW, 1992, EUROPHYS LETT, V20, P559, DOI 10.1209/0295-5075/20/6/015; Renth F, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031402; Savage JR, 2006, SCIENCE, V314, P795, DOI 10.1126/science.1128649	7	40	41	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					768	769		10.1126/science.1135544	http://dx.doi.org/10.1126/science.1135544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17082442				2022-12-28	WOS:000241729800029
J	Frey, S; Richter, RP; Goerlich, D				Frey, Steffen; Richter, Ralf P.; Goerlich, Dirk			FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties	SCIENCE			English	Article							STRUCTURAL BASIS; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; COMPLEX; NUCLEOPORINS; DOMAIN; TRAFFICKING; DOCKING; REGION; EXPORT	Nuclear pore complexes permit rapid passage of cargoes bound to nuclear transport receptors, but otherwise suppress nucleocytoplasmic fluxes of inert macromolecules >= 30 kilodaltons. To explain this selectivity, a sieve structure of the permeability barrier has been proposed that is created through reversible cross-linking between Phe and Gly (FG) - rich nucleoporin repeats. According to this model, nuclear transport receptors overcome the size limit of the sieve and catalyze their own nuclear pore-passage by a competitive disruption of adjacent inter-repeat contacts, which transiently opens adjoining meshes. Here, we found that phenylalanine-mediated inter-repeat interactions indeed cross-link FG-repeat domains into elastic and reversible hydrogels. Furthermore, we obtained evidence that such hydrogel formation is required for viability in yeast.	Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Heidelberg, Inst Phys Chem, D-69120 Heidelberg, Germany; Max Planck Inst Met Res, D-70569 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; Max Planck Society	Goerlich, D (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, INF 282, D-69120 Heidelberg, Germany.	dg@zmbh.uni-heidelberg.de	Görlich, Dirk/B-8296-2017; Li, Chia Cheng/D-9906-2015; Richter, Ralf Peter/B-3343-2013	Görlich, Dirk/0000-0002-4343-5210; Richter, Ralf Peter/0000-0003-3071-2837; Steffen, Frey/0000-0002-5134-9961				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	24	420	424	4	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					815	817		10.1126/science.1132516	http://dx.doi.org/10.1126/science.1132516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082456	Green Published			2022-12-28	WOS:000241729800046
J	Goedert, M; Spillantini, MG				Goedert, Michel; Spillantini, Maria Grazia			A century of Alzheimer's disease	SCIENCE			English	Review							AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; HEREDITARY CEREBRAL-HEMORRHAGE; MILD COGNITIVE IMPAIRMENT; FRONTOTEMPORAL DEMENTIA; TRANSGENIC MICE; BETA-PROTEIN; TAU GENE; NEUROFIBRILLARY TANGLES		MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England	MRC Laboratory Molecular Biology; University of Cambridge	Goedert, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	mg@mrc-lmb.cam.ac.uk			MRC [MC_U105184291, G0301152] Funding Source: UKRI; Medical Research Council [MC_U105184291, G0301152] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen B, 2002, J NEUROSCI, V22, P9340; Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bielschowsky M., 1902, NEUROL CENTRALBL, V21, P579; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Blocq P., 1892, SEM MED, V12, P445; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Di Maria E, 2000, ANN NEUROL, V47, P374, DOI 10.1002/1531-8249(200003)47:3<374::AID-ANA15>3.3.CO;2-#; Doglio LE, 2006, NEURON, V50, P359, DOI 10.1016/j.neuron.2006.03.038; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KRAEPELIN E, 1910, PSYCHIAT LEHBRUCH ST, V2; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lippa CF, 1998, LANCET, V352, P1117, DOI 10.1016/S0140-6736(05)79757-9; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nicoll JAR, 2004, NEUROBIOL AGING, V25, P589, DOI 10.1016/j.neurobiolaging.2004.02.003; Pastor P, 2000, ANN NEUROL, V47, P242; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Pick A., 1892, PRAGER MEDIZINISCHE, V17, P165, DOI DOI 10.1080/02687030600739463; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Revesz T, 1999, ACTA NEUROPATHOL, V97, P170, DOI 10.1007/s004010050970; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Smith MJ, 2001, ANN NEUROL, V49, P125, DOI 10.1002/1531-8249(200101)49:1<125::AID-ANA21>3.0.CO;2-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TERRY RD, 1964, AM J PATHOL, V44, P269; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	88	1471	1553	4	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					777	781		10.1126/science.1132814	http://dx.doi.org/10.1126/science.1132814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082447				2022-12-28	WOS:000241729800034
J	Gruber, S; Arumugam, P; Katou, Y; Kuglitsch, D; Helmhart, W; Shirahige, K; Nasmyth, K				Gruber, Stephan; Arumugam, Prakash; Katou, Yuki; Kuglitsch, Daria; Helmhart, Wolfgang; Shirahige, Katsuhiko; Nasmyth, Kim			Evidence that loading of cohesin onto chromosomes involves opening of its SMC hinge	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; COMPLEX; DNA; PROTEINS; ARCHITECTURE; BINDING; YEAST; REPLICATION; ACTIVATION	Cohesin is a multisubunit complex that mediates sister-chromatid cohesion. Its Smc1 and Smc3 subunits possess ABC-like ATPases at one end of 50 nm long coiled coils. At the other ends are pseudosymmetrical hinge domains that interact to create V-shaped Smc1/Smc3 heterodimers. N- and C-terminal domains within cohesin's kleisin subunit Scc1 bind to Smc3 and Smc1 ATPase heads respectively, thereby creating a huge tripartite ring. It has been suggested that cohesin associates with chromosomes by trapping DNA within its ring. Opening of the ring due to cleavage of Scc1 by separase destroys sister-chromatid cohesion and triggers anaphase. We show that cohesin's hinges are not merely dimerization domains. They are essential for cohesin's association with chromosomes, which is blocked by artificially holding hinge domains together but not by preventing Scc1's dissociation from SMC ATPase heads. Our results suggest that entry of DNA into cohesin's ring requires transient dissociation of Smc1 and Smc3 hinge domains.	Inst Mol Pathol, A-1030 Vienna, Austria; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Oxford; Tokyo Institute of Technology	Nasmyth, K (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	kim.nasmyth@bioch.ox.ac.uk	Gruber, Stephan/AFC-4848-2022; Arumugam, Prakash/AAZ-6422-2020; Gruber, Stephan/G-5686-2012	Gruber, Stephan/0000-0002-0150-0395; Arumugam, Prakash/0000-0001-6217-8128; Shirahige, Katsuhiko/0000-0002-7862-1144; Nasmyth, Kim/0000-0001-7030-4403				Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barsky D, 2005, CURR BIOL, V15, pR989, DOI 10.1016/j.cub.2005.11.047; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lorenz A, 2003, EUKARYOT CELL, V2, P856, DOI 10.1128/EC.2.5.856-866.2003; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	29	213	214	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					523	537		10.1016/j.cell.2006.08.048	http://dx.doi.org/10.1016/j.cell.2006.08.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081975	Bronze			2022-12-28	WOS:000241937000017
J	McGill, BJ				McGill, Brian J.			A renaissance in the study of abundance	SCIENCE			English	Editorial Material							ECOLOGY; TRAITS		McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	McGill, BJ (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	mail@brianmcgill.org	McGill, Brian J/A-3476-2008	McGill, Brian J/0000-0002-0850-1913				ALLISON TD, 1986, ECOLOGY, V67, P1101, DOI 10.2307/1939835; Andrewartha H.G., 1984, ECOLOGICAL WEB MORE; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Hubbell Stephen P., 2001, V32, pi; Jaynes E T, 1963, STAT PHYS, P181; Lorenz R, 2003, SCIENCE, V299, P837, DOI 10.1126/science.1081280; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; *PAT WILDL RES CTR, 2001, BREED BIRD SURV; Poole A., 2005, BIRDS N AM ONLINE; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2	14	43	47	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					770	772		10.1126/science.1134920	http://dx.doi.org/10.1126/science.1134920			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082444				2022-12-28	WOS:000241729800031
J	Speer, NJ; Tang, SJ; Miller, T; Chiang, TC				Speer, N. J.; Tang, S. -J.; Miller, T.; Chiang, T. -C.			Coherent electronic fringe structure in incommensurate silver-silicon quantum wells	SCIENCE			English	Article							STATES; FILMS	Atomically uniform silver films grown on highly doped n-type Si( 111) substrates show fine-structured electronic fringes near the silicon valence band edge as observed by angle-resolved photoemission. No such fringes are observed for silver films grown on lightly doped n-type substrates or p-type substrates, although all cases exhibited the usual quantum-well states corresponding to electron confinement in the film. The fringes correspond to electronic states extending over the silver film as a quantum well and reaching into the silicon substrate as a quantum slope, with the two parts coherently coupled through an incommensurate interface structure.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chiang, TC (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	chiang@mrl.uiuc.edu	Chiang, Tai C/H-5528-2011; Tang, Shu-Jung/AAZ-8752-2021	Tang, Shu-Jung/0000-0003-1217-5177				Aballe L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.156801; Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Czoschke P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035305; Davies J.H., 1998, PHYS LOW DIMENSIONAL; Himpsel FJ, 1998, ADV PHYS, V47, P511, DOI 10.1080/000187398243519; HUFNER S, 1996, PHOTOELECTRON SPECTR; KURTIN S, 1969, PHYS REV LETT, V22, P1433, DOI 10.1103/PhysRevLett.22.1433; LINDGREN SA, 2000, HDB SURFACE SCI, V2; Madelung O, 1978, INTRO SOLID STATE PH; Matsuda I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085327; Milun M, 2002, REP PROG PHYS, V65, P99, DOI 10.1088/0034-4885/65/2/201; Nicolay G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.033407; Paggel JJ, 1999, SCIENCE, V283, P1709, DOI 10.1126/science.283.5408.1709; PAPACONSTANTOPO.DA, 1986, HDB BAND STRUCTURE E; Takeda SN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.037401; Tang SJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.216804; WACHS AL, 1986, PHYS REV B, V33, P1460, DOI 10.1103/PhysRevB.33.1460	17	61	61	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					804	806		10.1126/science.1132941	http://dx.doi.org/10.1126/science.1132941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082455				2022-12-28	WOS:000241729800042
J	Eder, W; Ege, MJ; von Mutius, E				Eder, Waltraud; Ege, Markus J.; von Mutius, Erika			Current concepts: The asthma epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC RESPIRATORY SYMPTOMS; PHYSICIAN-DIAGNOSED ASTHMA; 5-YEAR FOLLOW-UP; ISAAC PHASE-I; INCREASING PREVALENCE; ALLERGIC RHINITIS; CHANGING PREVALENCE; CHILDHOOD ASTHMA; HAY-FEVER; SCHOOL-CHILDREN		Univ Chldrens Hosp, D-80337 Munich, Germany	University of Munich	von Mutius, E (corresponding author), Univ Chldrens Hosp, Lindwurmstr 4, D-80337 Munich, Germany.	erika.von.mutius@med.uni-muenchen.de	Ege, Markus/C-1962-2012; Connett, Gary/AAU-3686-2020	Ege, Markus/0000-0001-6643-3923; Connett, Gary/0000-0003-1310-3239; von Mutius, Erika/0000-0002-8893-4515				ABERG N, 1995, CLIN EXP ALLERGY, V25, P815, DOI 10.1111/j.1365-2222.1995.tb00023.x; Allmers H, 2005, J ALLERGY CLIN IMMUN, V116, P859, DOI 10.1016/j.jaci.2005.07.019; Anderson HR, 2004, BRIT MED J, V328, P1052, DOI 10.1136/bmj.38057.583727.47; ANDERSON HR, 1994, BRIT MED J, V308, P1600, DOI 10.1136/bmj.308.6944.1600; Annus T, 2005, PEDIAT ALLERG IMM-UK, V16, P315, DOI 10.1111/j.1399-3038.2005.00276.x; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; AUERBACH I, 1993, THORAX, V48, P139, DOI 10.1136/thx.48.2.139; Barraclough R, 2002, EUR RESPIR J, V20, P826, DOI 10.1183/09031936.02.00822002; Bjorksten B, 1998, EUR RESPIR J, V12, P432, DOI 10.1183/09031936.98.12020432; Braun-Fahrlander C, 2003, CLIN EXP ALLERGY, V33, P409, DOI 10.1046/j.1365-2222.2003.01650.x; Braun-Fahrlander C, 2004, EUR RESPIR J, V23, P407, DOI 10.1183/09031936.04.00074004; Brogger J, 2003, EUR RESPIR J, V21, P468, DOI 10.1183/09031936.03.00056103; BURR M L, 1989, Archives of Disease in Childhood, V64, P1452, DOI 10.1136/adc.64.10.1452; Carter ER, 2005, ANN ALLERG ASTHMA IM, V94, P634, DOI 10.1016/S1081-1206(10)61320-8; Chinn S, 2001, THORAX, V56, P845, DOI 10.1136/thorax.56.11.845; Ciprandi G, 1996, INT ARCH ALLERGY IMM, V111, P279, DOI 10.1159/000237378; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Cullinan P, 2004, THORAX, V59, P855, DOI 10.1136/thx.2003.019877; Devenny A, 2004, BMJ-BRIT MED J, V329, P489, DOI 10.1136/bmj.38139.666447.F7; Downs SH, 2001, ARCH DIS CHILD, V84, P20, DOI 10.1136/adc.84.1.20; Eder W, 2004, CURR OPIN ALLERGY CL, V4, P113, DOI 10.1097/01.all.0000123970.96233.fc; Ellwood P, 2001, EUR RESPIR J, V17, P436, DOI 10.1183/09031936.01.17304360; Emeryk A, 2004, ANN AGR ENV MED, V11, P63; FALTHMAGNUSSON K, 1992, J ALLERGY CLIN IMMUN, V89, P709, DOI 10.1016/0091-6749(92)90378-F; Frank PI, 2005, BRIT J GEN PRACT, V55, P596; Friedman NJ, 2005, J ALLERGY CLIN IMMUN, V115, P1238, DOI 10.1016/j.jaci.2005.01.069; Frye C, 2001, EUR RESPIR J, V18, P451, DOI 10.1183/09031936.01.00067001; Garcia-Marcos L, 2004, ALLERGY, V59, P1301, DOI 10.1111/j.1398-9995.2004.00562.x; Goren AI, 1997, EUR RESPIR J, V10, P2279, DOI 10.1183/09031936.97.10102279; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; HAAHTELA T, 1990, BRIT MED J, V301, P266, DOI 10.1136/bmj.301.6746.266; Health United States, 2005, HLTH US 2005, P63; Heinrich J, 1998, EUR J EPIDEMIOL, V14, P239, DOI 10.1023/A:1007465205976; Heinrich J, 2002, EUR RESPIR J, V19, P1040, DOI 10.1183/09031936.02.00261802; Hirsch T, 1999, EUR RESPIR J, V14, P669, DOI 10.1034/j.1399-3003.1999.14c29.x; Hong SJ, 2004, CLIN EXP ALLERGY, V34, P1556, DOI 10.1111/j.1365-2222.2004.02084.x; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; KEELEY DJ, 1991, THORAX, V46, P549, DOI 10.1136/thx.46.8.549; Kosunen TU, 2002, CLIN EXP ALLERGY, V32, P373, DOI 10.1046/j.1365-2222.2002.01330.x; Krause TG, 2002, LANCET, V360, P691, DOI 10.1016/S0140-6736(02)09841-0; Kuehni C, 2001, LANCET, V358, P846; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kwong GNM, 2001, THORAX, V56, P312, DOI 10.1136/thorax.56.4.312; LARSSON L, 1995, THORAX, V50, P260, DOI 10.1136/thx.50.3.260; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Lee SL, 2004, PEDIAT ALLERG IMM-UK, V15, P72, DOI 10.1046/j.0905-6157.2003.00109.x; Lee YL, 2005, PEDIAT ALLERG IMM-UK, V16, P157, DOI 10.1111/j.1399-3038.2005.00211.x; Linehan MF, 2005, ARCH DIS CHILD, V90, P516, DOI 10.1136/adc.2004.061879; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Martinez FD, 2001, J ALLERGY CLIN IMMUN, V107, pS449, DOI 10.1067/mai.2001.114993; Maziak W, 2003, ALLERGY, V58, P572, DOI 10.1034/j.1398-9995.2003.00161.x; McKeever TM, 2004, AM J RESP CRIT CARE, V170, P725, DOI 10.1164/rccm.200405-611PP; Mommers M, 2005, THORAX, V60, P97, DOI 10.1136/thx.2004.024786; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Nystad W, 1997, EUR RESPIR J, V10, P1046, DOI 10.1183/09031936.97.10051046; Oosterlee A, 1996, OCCUP ENVIRON MED, V53, P241, DOI 10.1136/oem.53.4.241; Ownby DR, 2003, CURR OPIN ALLERGY CL, V3, P517, DOI 10.1097/01.all.0000104444.09202.ae; PEAT JK, 1992, BMJ-BRIT MED J, V305, P1326, DOI 10.1136/bmj.305.6865.1326; PEAT JK, 1994, BMJ-BRIT MED J, V308, P1591, DOI 10.1136/bmj.308.6944.1591; Priftanji A, 2001, LANCET, V358, P1426, DOI 10.1016/S0140-6736(01)06521-7; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Riikjarv MA, 2000, EUR RESPIR J, V16, P86, DOI 10.1034/j.1399-3003.2000.16a15.x; RIMPELA AH, 1995, SCAND J SOC MED, V23, P60, DOI 10.1177/140349489502300111; Rizwan S, 2004, J PUBLIC HEALTH-UK, V26, P337, DOI 10.1093/pubmed/fdh180; Robertson CF, 2004, MED J AUSTRALIA, V180, P273, DOI 10.5694/j.1326-5377.2004.tb05924.x; ROBERTSON CF, 1991, BMJ-BRIT MED J, V302, P1116, DOI 10.1136/bmj.302.6785.1116; Ronchetti R, 2001, EUR RESPIR J, V17, P881, DOI 10.1183/09031936.01.17508810; Russell G, 1997, BRIT MED J, V315, P1014, DOI 10.1136/bmj.315.7114.1014; Schaub B, 2005, CURR OPIN ALLERGY CL, V5, P185, DOI 10.1097/01.all.0000162313.64308.b5; Selnes A, 2005, ALLERGY, V60, P894, DOI 10.1111/j.1398-9995.2005.00797.x; Senthilselvan A, 2003, CHEST, V124, P438, DOI 10.1378/chest.124.2.438; Senthilselvan A, 1998, CHEST, V114, P388, DOI 10.1378/chest.114.2.388; Simpson A, 2004, CURR OPIN ALLERGY CL, V4, P45, DOI [10.1097/00130832-200402000-00010, 10.1097/01.all.0000113678.18759.38]; SKJONSBERG OH, 1995, ALLERGY, V50, P806; Strachan DP, 1996, BRIT MED J, V312, P1195; Strachan DP, 1998, THORAX, V53, P204, DOI 10.1136/thx.53.3.204; Tatum AJ, 2005, IMMUNOL ALLERGY CLIN, V25, P15, DOI 10.1016/j.iac.2004.09.003; Thomsen SF, 2004, ANN ALLERG ASTHMA IM, V92, P506, DOI 10.1016/S1081-1206(10)61757-7; Toelle BG, 2004, BRIT MED J, V328, P386, DOI 10.1136/bmj.328.7436.386; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; van Schayck CP, 2000, THORAX, V55, P562, DOI 10.1136/thorax.55.7.562; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI 10.1016/j.jaci.2004.01.078; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Venn A, 1998, EUR RESPIR J, V11, P1324, DOI 10.1183/09031936.98.11061324; Venn AJ, 2001, AM J RESP CRIT CARE, V164, P2177, DOI 10.1164/ajrccm.164.12.2106126; Verlato G, 2003, J ALLERGY CLIN IMMUN, V111, P1232, DOI 10.1067/mai.2003.1484; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3; von Mutius E, 2001, EUR RESPIR J, V18, P872, DOI 10.1183/09031936.01.00268401; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wang XS, 2004, ARCH DIS CHILD, V89, P423, DOI 10.1136/adc.2003.031112; WEITZMAN M, 1992, JAMA-J AM MED ASSOC, V268, P2673, DOI 10.1001/jama.268.19.2673; Wilson DH, 2003, MED J AUSTRALIA, V178, P483, DOI 10.5694/j.1326-5377.2003.tb05320.x; Withers NJ, 1998, AM J RESP CRIT CARE, V158, P352, DOI 10.1164/ajrccm.158.2.9705079; Wong GWK, 2004, CLIN EXP ALLERGY, V34, P1550, DOI 10.1111/j.1365-2222.2004.02064.x; Wong GWK, 2004, BMJ-BRIT MED J, V329, P486, DOI 10.1136/bmj.329.7464.486; Yazdanbakhsh M, 2005, CURR OPIN ALLERGY CL, V5, P386, DOI 10.1097/01.all.0000182541.52971.eb; Zollner I, 2006, THORAX, V61, P274, DOI 10.1136/thx.2005.029651corrr1; Zollner IK, 2005, THORAX, V60, P545, DOI 10.1136/thx.2004.029561	100	1154	1198	1	157	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2226	2235		10.1056/NEJMra054308	http://dx.doi.org/10.1056/NEJMra054308			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124020				2022-12-28	WOS:000242170900009
J	Oner, AF; Bay, A; Arslan, S; Akdeniz, H; Sahin, HA; Cesur, Y; Epcacan, S; Yilmaz, N; Deger, I; Kizilyildiz, B; Karsen, H; Ceyhan, M				Oner, Ahmet Faik; Bay, Ali; Arslan, Sukru; Akdeniz, Hayrettin; Sahin, Huseyin Avni; Cesur, Yasar; Epcacan, Serdar; Yilmaz, Neziha; Deger, Ibrahim; Kizilyildiz, Baran; Karsen, Hasan; Ceyhan, Mehmet			Avian influenza A (H5N1) infection in eastern Turkey in 2006	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; HUMAN-DISEASE; DIAGNOSIS	Background: An outbreak of highly pathogenic avian influenza A (H5N1) that had previously been detected throughout Asia, with major economic and health repercussions, extended to eastern Turkey in late December 2005 and early January 2006. Methods: We documented the epidemiologic, clinical, and radiologic features of all cases of confirmed H5N1 virus infection in patients who were admitted to Yuzuncu Yil University Hospital in Van, Turkey, between December 31, 2005, and January 10, 2006. Results: H5N1 virus infection was diagnosed in eight patients. The patients were 5 to 15 years of age, and all eight had a history of close contact with diseased or dead chickens. The mean (+/- SD) time between exposure and the onset of illness was 5.0 +/- 1.3 days. All the patients had fever, and seven had clinical and radiologic evidence of pneumonia at presentation; four patients died. Results of enzyme-linked immunosorbent assay and rapid influenza tests were negative in all patients, and the diagnosis was made by means of a polymerase-chain-reaction assay. Conclusions: H5N1, which causes a spectrum of illnesses in humans, including severe and fatal respiratory disease, can be difficult to diagnose.	Saydam Hyg Inst, Ankara, Turkey; Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey; Yuzuncu Yil Univ, Fac Med, Van, Turkey	Refik Saydam Hifzissihha Merkezi Baskanligi; Hacettepe University; Yuzuncu Yil University	Oner, AF (corresponding author), Arastirma Hst Cocuk Hst Srv, Van, Turkey.	afo59@yahoo.com	yılmaz, neziha/AAH-3524-2020; Arslan, Şükrü/ABC-4250-2021	Arslan, Şükrü/0000-0001-5632-8273				Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Hien TT, 2004, NEW ENGL J MED, V351, P2363, DOI 10.1056/NEJMp048267; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Schultsz C, 2005, EMERG INFECT DIS, V11, P1158; Spackman E, 2005, J VET DIAGN INVEST, V17, P76, DOI 10.1177/104063870501700117; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; WHO, 2005, REC LAB TESTS ID AV; *WHO, 2005, WHO INT COUNS INFL A; *WHO, 2006, CUM NUMB CONF HUM CA; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	14	146	162	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2179	2185		10.1056/NEJMoa060601	http://dx.doi.org/10.1056/NEJMoa060601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124015				2022-12-28	WOS:000242170900004
J	Al-Khadra, E				Al-Khadra, Eman			Capturing life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												eman.al-khadra@cchmc.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2419	2420		10.1001/jama.296.20.2419	http://dx.doi.org/10.1001/jama.296.20.2419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119129				2022-12-28	WOS:000242171000001
J	Qin, Y; Polacek, N; Vesper, O; Staub, E; Einfeldt, E; Wilson, DN; Nierhaus, KH				Qin, Yan; Polacek, Norbert; Vesper, Oliver; Staub, Eike; Einfeldt, Edda; Wilson, Daniel N.; Nierhaus, Knud H.			The highly conserved LepA is a ribosomal elongation factor that back-translocates the ribosorne	CELL			English	Article							TRANSFER-RNA; ESCHERICHIA-COLI; SIGNAL PEPTIDASE; FACTOR-TU; P-SITES; A-SITES; BINDING; PROTEIN; GENE; SUBUNIT	The ribosomal elongation cycle describes a series of reactions prolonging the nascent poly-pepticle chain by one amino acid and driven by two universal elongation factors termed EF-Tu and EF-G in bacteria. Here we demonstrate that the extremely conserved LepA protein, present in all bacteria and mitochondria, is a third elongation factor required for accurate and efficient protein synthesis. LepA has the unique function of back-translocating post-translocational ribosomes, and the results suggest that it recognizes ribosomes after a defective translocation reaction and induces a back-translocation, thus giving EF-G a second chance to translocate the tRNAs correctly. We suggest renaming LepA as elongation factor 4 (EF4).	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Innsbruck Med Univ, Div Genom & RNomics, Bioctr, A-6020 Innsbruck, Austria	Max Planck Society; Medical University of Innsbruck	Nierhaus, KH (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	nierhaus@molgen.mpg.de	Staub, Eike/B-9801-2009; Wilson, Daniel/AAE-8504-2019; Polacek, Norbert/AAV-7346-2020	Wilson, Daniel/0000-0003-3816-3828; Polacek, Norbert/0000-0001-5317-3990; Staub, Eike/0000-0002-5039-3098				Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; Blaha G, 2000, METHOD ENZYMOL, V317, P292; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074/jbc.M302109200; Connell SR, 2003, EMBO J, V22, P945, DOI 10.1093/emboj/cdg093; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DIBB NJ, 1986, J BACTERIOL, V166, P83, DOI 10.1128/jb.166.1.83-87.1986; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Frank J, 2001, COLD SPRING HARB SYM, V66, P67, DOI 10.1101/sqb.2001.66.67; HAPKE B, 1976, J MOL BIOL, V105, P97, DOI 10.1016/0022-2836(76)90196-0; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HARTZ D, 1991, J MOL BIOL, V218, P99, DOI 10.1016/0022-2836(91)90876-8; HARTZ D, 1990, RIBOSOME, P275; ISKAKOVA MB, 2006, IN PRESS NUCL ACIDS; KISER GL, 1995, YEAST, V11, P1311, DOI 10.1002/yea.320111312; Knight J, 2004, NATURE, V429, P236, DOI 10.1038/429236a; MARCH PE, 1985, J BIOL CHEM, V260, P7206; MARCH PE, 1985, P NATL ACAD SCI USA, V82, P7500, DOI 10.1073/pnas.82.22.7500; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Martemyanov KA, 1999, FEBS LETT, V452, P155, DOI 10.1016/S0014-5793(99)00635-3; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Nierhaus K. H., 2004, PROTEIN SYNTHESIS RI; Nierhaus KH, 1996, NATURE, V379, P491, DOI 10.1038/379491a0; Nierhaus KH, 1996, ANGEW CHEM INT EDIT, V35, P2198, DOI 10.1002/anie.199621981; Nissen P, 2000, EMBO J, V19, P489, DOI 10.1093/emboj/19.4.489; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; Polacek N, 1998, RNA, V4, P1282, DOI 10.1017/S1355838298980347; Polacek N, 2000, MOL CELL, V6, P159, DOI 10.1016/S1097-2765(00)00017-4; RHEINBERGER HJ, 1981, P NATL ACAD SCI-BIOL, V78, P5310, DOI 10.1073/pnas.78.9.5310; Schafer MA, 2002, J BIOL CHEM, V277, P19095, DOI 10.1074/jbc.M108902200; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Wolf YI, 1999, GENOME RES, V9, P689; ZIMMERMANN RA, 1971, P NATL ACAD SCI USA, V68, P2263, DOI 10.1073/pnas.68.9.2263; ZWIZINSKI C, 1980, J BIOL CHEM, V255, P7973	38	160	171	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					721	733		10.1016/j.cell.2006.09.037	http://dx.doi.org/10.1016/j.cell.2006.09.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110332	Bronze			2022-12-28	WOS:000242330600019
J	Boolchand, V; Olds, G; Singh, J; Singh, P; Chak, A; Cooper, GS				Boolchand, Vikram; Olds, Gregory; Singh, Joseph; Singh, Pankaj; Chak, Amitabh; Cooper, Gregory S.			Colorectal screening after polypectomy: A national survey study of primary care physicians	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	70th Annual Meeting of the American-College-of-Gastroenterology	OCT 30-NOV 02, 2005	Honolulu, HI	Amer Coll Gastroenterol			AMERICAN-CANCER-SOCIETY; UNITED-STATES; COLONOSCOPIC POLYPECTOMY; SURVEILLANCE INTERVALS; ASYMPTOMATIC ADULTS; MEDICAL-CENTER; GUIDELINES; ADENOMAS; CAPACITY; UPDATE	Background: Recommendations by primary care physicians for colorectal screening after polypectomy will influence rates of colonoscopy in open-access systems that do not require consultation by a gastroenterologist before colonoscopy. Objective: To determine the surveillance recommendations of primary care physicians after polypectomy and compare them with recommendations from the U.S. Multisociety Task Force on Colorectal Cancer. Design: Cross-sectional study of physicians. Setting: United States. Participants: A random sample of 500 physicians from the American College of Physicians and 500 physicians from the American Academy of Family Physicians, obtained by using a mail survey. Measurements: Physicians were asked when they would recommend repeated colonoscopy for a hypothetical 55-year-old man with no family history of colorectal cancer after the following 6 results on colonoscopy: hyperplastic polyp, one 6-mm tubular adenoma, two 6-mm tubular adenomas, one 12-mm tubulovillous adenoma, one 12-mm tubular adenoma with focal high-grade dysplasia, and no polyp but a previous tubular adenoma. Results: The overall response rate was 57% (568 physicians). Of the respondents, 48% were internists and 52% were family practitioners. Sixty-one percent of respondents would survey a hyperplastic polyp in 5 years or less, 71% would survey a single tubular adenoma in 3 years or less, and 80% would survey 2 tubular adenomas in 3 years or less. Limitations: The results are based on physicians' self-reported practices from clinical vignettes and may not match actual practice. Conclusion: Primary care physicians recommend postpolypectomy colonoscopic surveillance more frequently than is recommended by practice guidelines, especially if the colonoscopy showed a hyperplastic polyp or a single small adenoma.	Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA; Henry Ford Hosp, Detroit, MI 48202 USA; Cent Texas Vet Hlth Care Syst, Temple, TX USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Henry Ford Health System; Henry Ford Hospital	Boolchand, V (corresponding author), Univ Arizona, Dept Med, Div Gastroenterol, 1501 N Campbell Ave,POB 245028, Tucson, AZ 85724 USA.	vikramboolchand@yahoo.com	Singh, P/AAD-7207-2020; Wilkins, Thad/G-2541-2010; Singh, Jaikaran/O-5363-2015	Singh, Jaikaran/0000-0002-9273-6765	NCI NIH HHS [K05 CA90677] Funding Source: Medline; NIDDK NIH HHS [K24 DK002800] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K05CA090677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002800] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; [Anonymous], 2002, GASTROINTEST ENDOSC, V56, P793, DOI 10.1016/S0016-5107(02)70349-0; Baron TH, 2004, CLIN GASTROENTEROL H, V2, P178, DOI 10.1016/S1542-3565(03)00317-3; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; Charles RJ, 1999, GASTROINTEST ENDOSC, V50, P480, DOI 10.1016/S0016-5107(99)70069-6; Eisen GM, 2000, GASTROINTEST ENDOSC, V51, P777, DOI 10.1053/ge.2000.v51.age516777; Field TS, 2002, MED CARE, V40, P596, DOI 10.1097/00005650-200207000-00006; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Levin TR, 2004, GASTROENTEROLOGY, V127, P1841, DOI 10.1053/j.gastro.2004.10.014; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2004, GASTROENTEROLOGY, V126, pA22; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Sanaka MR, 2006, GASTROINTEST ENDOSC, V63, P97, DOI 10.1016/j.gie.2005.08.048; Schoen RE, 2003, JAMA-J AM MED ASSOC, V290, P41, DOI 10.1001/jama.290.1.41; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 1997, GASTROENTEROLOGY, V112, pA50; 2003, MMWR MORB MORTAL WKL, V52, P193	31	112	114	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					654	659		10.7326/0003-4819-145-9-200611070-00007	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	100ZD	17088578				2022-12-28	WOS:000241707800003
J	Bao, YH; Shen, XT				Bao, Yunhe; Shen, Xuetong			Asf1, a loveseat for a histone couple	CELL			English	Editorial Material							DEPOSITION; COMPLEX; CORE	In this issue of Cell, English et al. (2006) present the first crystal structure of a histone chaperone (Asf1) bound to histones (the H3/H4 heterodimer). The structure provides insights into how histone chaperones participate in nucleosome disassembly. It reveals that Asf1 physically blocks (H3/H4)(2) tetramer formation and that the C terminus of H4 undergoes a dramatic conformational change upon binding to Asf1.	MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Shen, XT (corresponding author), MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA.	snowshen@mac.com		Shen, Xuetong/0000-0002-4267-5298				Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147	9	3	5	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					458	460		10.1016/j.cell.2006.10.021	http://dx.doi.org/10.1016/j.cell.2006.10.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081967	Bronze			2022-12-28	WOS:000241937000009
J	Savage, JR; Blair, DW; Levine, AJ; Guyer, RA; Dinsmore, AD				Savage, J. R.; Blair, D. W.; Levine, A. J.; Guyer, R. A.; Dinsmore, A. D.			Imaging the sublimation dynamics of colloidal crystallites	SCIENCE			English	Article							MELTING TEMPERATURE; PHASE-BEHAVIOR; NUCLEATION; SURFACE; TRANSITION; MIXTURES; DEFECTS; SCIENCE; MODEL; SIZE	We studied the kinetics of sublimating crystals with single-particle resolution by experiments with colloidal spheres and by computer simulations. A short-range attraction between spheres led to crystallites one to three layers thick. The spheres were tracked with optical microscopy while the attraction was reduced and the crystals sublimated. Large crystallites sublimated by escape of particles from the perimeter. The rate of shrinkage was greatly enhanced, however, when the size decreased to less than 20 to 50 particles, depending on the location in the phase diagram. At this size, the crystallites transformed into a dense amorphous structure, which rapidly vaporized. The enhancement of kinetics by metastable or unstable phases may play a major role in the melting, freezing, and annealing of crystals.	Univ Massachusetts, Dept Phys, Hasbrouck Lab 411, Amherst, MA 01003 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Savage, JR (corresponding author), Univ Massachusetts, Dept Phys, Hasbrouck Lab 411, 666 N Pleasant St, Amherst, MA 01003 USA.							Alsayed AM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.057801; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; BOLHUIS P, 1994, PHYS REV LETT, V72, P2211, DOI 10.1103/PhysRevLett.72.2211; BOLHUIS PG, 1996, THESIS U UTRECHT NET; Born M, 1939, J CHEM PHYS, V7, P591, DOI 10.1063/1.1750497; Cacciuto A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166105; CAHN JW, 1969, J AM CERAM SOC, V52, P118, DOI 10.1111/j.1151-2916.1969.tb11194.x; CAHN RW, 1986, NATURE, V323, P668, DOI 10.1038/323668a0; Cahn RW, 2001, NATURE, V413, P582, DOI 10.1038/35098169; COUCHMAN PR, 1978, PHILOS MAG A, V37, P369, DOI 10.1080/01418617808239174; Dash JG, 1999, REV MOD PHYS, V71, P1737, DOI 10.1103/RevModPhys.71.1737; Evans RML, 1997, EUROPHYS LETT, V38, P595, DOI 10.1209/epl/i1997-00289-y; Filobelo LF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1943413; GOLDSTEIN AN, 1992, SCIENCE, V256, P1425, DOI 10.1126/science.256.5062.1425; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; ILETT SM, 1995, PHYS REV E, V51, P1344, DOI 10.1103/PhysRevE.51.1344; Jin ZH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.055703; KAPLAN PD, 1994, PHYS REV LETT, V72, P582, DOI 10.1103/PhysRevLett.72.582; LAAKSONEN A, 1995, ANNU REV PHYS CHEM, V46, P489, DOI 10.1146/annurev.pc.46.100195.002421; Larsen AE, 1997, NATURE, V385, P230, DOI 10.1038/385230a0; LEKKERKERKER HNW, 1992, EUROPHYS LETT, V20, P559, DOI 10.1209/0295-5075/20/6/015; Lu K, 1998, PHYS REV LETT, V80, P4474, DOI 10.1103/PhysRevLett.80.4474; Lutsko JF, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1943987; Lutsko JF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.046102; Marcus AH, 1996, PHYS REV LETT, V77, P2577, DOI 10.1103/PhysRevLett.77.2577; MURRAY CA, 1987, PHYS REV LETT, V58, P1200, DOI 10.1103/PhysRevLett.58.1200; Quinn RA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051404; Shen YC, 1996, PHYS REV LETT, V77, P3585, DOI 10.1103/PhysRevLett.77.3585; Talanquer V, 1998, J CHEM PHYS, V109, P223, DOI 10.1063/1.476554; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; TENWOLDE PR, 1995, PHYS REV LETT, V75, P2714, DOI 10.1103/PhysRevLett.75.2714; von Grunberg HH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255703; WAUTELET M, 1991, J PHYS D APPL PHYS, V24, P343, DOI 10.1088/0022-3727/24/3/017; Zhou YJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224113	35	85	85	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					795	798		10.1126/science.1128649	http://dx.doi.org/10.1126/science.1128649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082452	Green Submitted			2022-12-28	WOS:000241729800039
J	Shirane, M; Nakayama, KI				Shirane, Michiko; Nakayama, Keiichi I.			Protrudin induces neurite formation by directional membrane trafficking	SCIENCE			English	Article							GDP-DISSOCIATION INHIBITOR; RECYCLING ENDOSOMES; SECRETORY PATHWAYS; RAB11; PROTEINS; MECHANISMS; TRANSPORT; OUTGROWTH; NEURONS; FUSION	Guanosine triphosphatases of the Rab family are key regulators of membrane trafficking, with Rab11 playing a specific role in membrane recycling. We identified a mammalian protein, protrudin, that promoted neurite formation through interaction with the guanosine diphosphate (GDP) - bound form of Rab11. Phosphorylation of protrudin by extracellular signal - regulated kinase (ERK) in response to nerve growth factor promoted protrudin association with Rab11-GDP. Down-regulation of protrudin by RNA interference induced membrane extension in all directions and inhibited neurite formation. Thus, protrudin regulates Rab11-dependent membrane recycling to promote the directional membrane trafficking required for neurite formation.	Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp		Shirane, Michiko/0000-0002-8297-9245				An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Anderson E, 2005, J CELL BIOL, V170, P595, DOI 10.1083/jcb.200506051; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	27	154	162	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					818	821		10.1126/science.1134027	http://dx.doi.org/10.1126/science.1134027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082457				2022-12-28	WOS:000241729800047
J	Rigaud, S; Fondaneche, MC; Lambert, N; Pasquier, B; Mateo, V; Soulas, P; Galicier, L; Le Deist, F; Rieux-Laucat, F; Revy, P; Fischer, A; Basile, GD; Latour, S				Rigaud, Stephaine; Fondaneche, Marie-Claude; Lambert, Nathalie; Pasquier, Benoit; Mateo, Veronique; Soulas, Pauline; Galicier, Lionel; Le Deist, Francoise; Rieux-Laucat, Frederic; Revy, Patrick; Fischer, Alain; de Saint Basile, Genevieve; Latour, Sylvain			XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome	NATURE			English	Article							NKT CELL-DEVELOPMENT; ENCODING GENE; T-CELLS; DISEASE; SAP; MUTATIONS; PRODUCT; MICE	The homeostasis of the immune response requires tight regulation of the proliferation and apoptosis of activated lymphocytes(1,2). In humans, defects in immune homeostasis result in lymphoproliferation disorders including autoimmunity, haemophagocytic lymphohystiocytosis and lymphomas. The X-linked lymphoproliferative syndrome (XLP) is a rare, inherited immunodeficiency that is characterized by lymphohystiocytosis, hypogammaglobulinaemia and lymphomas, and that usually develops in response to infection with Epstein - Barr virus (EBV)(3-5). Mutations in the signalling lymphocyte activation molecule ( SLAM)- associated protein SAP, a signalling adaptor molecule, underlie 60% of cases of familial XLP6-8. Here, we identify mutations in the gene that encodes the X-linked inhibitor-of-apoptosis XIAP ( also termed BIRC4) in patients with XLP from three families without mutations in SAP. These mutations lead to defective expression of XIAP. We show that apoptosis of lymphocytes from XIAP-deficient patients is enhanced in response to various stimuli including the T-cell antigen receptor (TCR) - CD3 complex, the death receptor CD95 ( also termed Fas or Apo-1) and the TNF-associated apoptosis-inducing ligand receptor (TRAIL-R). We also found that XIAP-deficient patients, like SAP-deficient patients, have low numbers of natural killer T-lymphocytes (NKT cells)(9,10), indicating that XIAP is required for the survival and/or differentiation of NKT cells. The observation that XIAP-deficiency and SAP-deficiency are both associated with a defect in NKT cells strengthens the hypothesis that NKT cells have a key role in the immune response to EBV. Furthermore, by identifying an XLP immunodeficiency that is caused by mutations in XIAP, we show that XIAP is a potent regulator of lymphocyte homeostasis in vivo.	Univ Paris 05, INSERM, U768, Lab Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Hop Necker Enfants Malad, APHP, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; Hop St Louis, APHP, Serv Immunohematol, F-75010 Paris, France; Hop Necker Enfants Malad, APHP, Unite Immunol Hematol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Latour, S (corresponding author), Univ Paris 05, INSERM, U768, Lab Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France.	latour@necker.fr	Mateo, Véronique/AAD-1379-2019; Rieux-Laucat, Frédéric/A-7916-2017; Revy, Patrick/H-8137-2017; Mateo, Véronique/O-9738-2017; Latour, Sylvain/H-3652-2017; de Saint Basile, Genevieve/G-9731-2017	Mateo, Véronique/0000-0002-9327-1277; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Mateo, Véronique/0000-0002-9327-1277; Latour, Sylvain/0000-0001-8238-4391; Soulas-Sprauel, Pauline/0000-0002-2058-4811; Revy, Patrick/0000-0003-0758-8022; de Saint Basile, Genevieve/0000-0002-1913-5269				BASILE GD, 2003, CURR OPIN RHEUMATOL, V15, P436; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Gaspar HB, 2002, BRIT J HAEMATOL, V119, P585, DOI 10.1046/j.1365-2141.2002.03851.x; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; PURTILO D T, 1975, Lancet, V1, P935; RATHMELL JC, 2002, CELL S, V109, P97; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Strauss G, 2003, J IMMUNOL, V171, P1172, DOI 10.4049/jimmunol.171.3.1172; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wasem C, 2003, J CLIN INVEST, V111, P1191, DOI 10.1172/JCI200316344; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	21	514	537	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					110	114		10.1038/nature05257	http://dx.doi.org/10.1038/nature05257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080092				2022-12-28	WOS:000241701500056
J	Sick, S; Reinker, S; Timmer, J; Schlake, T				Sick, Stefanie; Reinker, Stefan; Timmer, Jens; Schlake, Thomas			WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism	SCIENCE			English	Article							BETA-CATENIN; EXPRESSION; PATHWAY; TARGET; MICE; SKIN; MORPHOGENESIS; TRANSCRIPTION; TOOTH; LEF1	Mathematical reaction-diffusion models have been suggested to describe formation of animal pigmentation patterns and distribution of epidermal appendages. However, the crucial signals and in vivo mechanisms are still elusive. Here we identify WNT and its inhibitor DKK as primary determinants of murine hair follicle spacing, using a combined experimental and computational modeling approach. Transgenic DKK overexpression reduces overall appendage density. Moderate suppression of endogenous WNT signaling forces follicles to form clusters during an otherwise normal morphogenetic program. These results confirm predictions of a WNT/DKK-specific mathematical model and provide in vivo corroboration of the reaction-diffusion mechanism for epidermal appendage formation.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany	Max Planck Society; University of Freiburg	Schlake, T (corresponding author), Max Planck Inst Immunbiol, Stubeweg 51, D-79108 Freiburg, Germany.	schlake@immunbio.mpg.de						Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Atit R, 2003, DEV CELL, V4, P231, DOI 10.1016/S1534-5807(03)00021-2; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dry FW, 1926, J GENET, V16, P287, DOI 10.1007/BF02983004; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nonchev S, 1996, DEVELOPMENT, V122, P543; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	25	410	457	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1447	1450		10.1126/science.1130088	http://dx.doi.org/10.1126/science.1130088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17082421				2022-12-28	WOS:000242406100040
J	Avorn, J				Avorn, Jerry			Dangerous deception - Hiding the evidence of adverse drug effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Berenson A., 2003, NY TIMES        0518; BURTON TM, 2004, WALL STREET J   0518; *FOOD DRUG ADM, 1993, STAT APR; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106	5	42	42	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2169	2171		10.1056/NEJMp068246	http://dx.doi.org/10.1056/NEJMp068246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107KQ	17124012	Bronze			2022-12-28	WOS:000242170900001
J	Calvin, JE; Roe, MT; Chen, AY; Mehta, RH; Brogan, GX; DeLong, ER; Fintel, DJ; Gibler, B; Ohman, M; Smith, SC; Peterson, ED				Calvin, James E.; Roe, Matthew T.; Chen, Anita Y.; Mehta, Rajendra H.; Brogan, Gerard X., Jr.; DeLong, Elizabeth R.; Fintel, Dan J.; Gibler, Brian; Ohman, Magnus; Smith, Sidney C., Jr.; Peterson, Eric D.			Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; HEALTH-INSURANCE; UNSTABLE ANGINA; ETHNIC DISPARITIES; AMERICAN-COLLEGE; MANAGED CARE; QUALITY; MEDICAID	Background: The impact of insurance coverage on the care of patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) is unclear. Objective: To compare NSTE ACS care patterns by insurance type. Design: Comparison of Medicaid patients younger than 65 years of age and Medicare patients 65 years of age or older with patients of similar age who have health maintenance organization (HMO) or private insurance coverage. Setting: 521 U.S. hospitals participating in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC [American College of Cardiology]/AHA [American Heart Association] Guidelines) quality improvement initiative from January 2001 through March 2005. Patients: 37 345 NSTE ACS patients younger than 65 years of age and 59 550 patients 65 years of age or older. Measurements: Guideline-recommended treatments, and in-hospital outcomes. Results: Medicaid was the primary payer for 18.7% (6999 of 37 345) of patients younger than age 65 years, whereas Medicare was the primary payer for 67.5% (40 199 of 59 550) of patients age 65 years or older. Medicaid patients were statistically significantly less likely to receive short-term (less than 24 hours) medications and to undergo invasive cardiac procedures than patients covered by HMO and private insurance. They also had higher mortality rates (2.9% vs. 1.2%; adjusted odds ratio, 1.33; 95% Cl, 1.08 to 1.63). Medications and invasive procedures were used to a similar extent in patients with Medicare and HMO or private insurance, and respective mortality rates were not significantly different (6.2% vs. 5.6%; adjusted odds ratio, 1.08; 95% Cl, 0.99 to 1.18). Limitations: Self-pay patients and patients without insurance were not assessed. Conclusions: NSTE ACS patients with Medicaid (but not Medicare) as the primary payer were less likely to receive evidence-based therapies and had worse outcomes than patients with HMO or private insurance as the primary payer. The causes of these treatment differences and solutions for narrowing the gaps in quality require further investigation.	Rush Univ, Med Ctr, Cardiol Sect, Chicago, IL 60612 USA; Duke Clin Res Inst, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA; N Shore Univ Hosp, Long Isl City, NY USA; Northwestern Univ Hosp, Chicago, IL USA; Univ Cincinnati, Sch Med, Cincinnati, OH USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA	Rush University; Duke University; Duke University; Northwell Health; North Shore University Hospital; Northwestern University; University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Calvin, JE (corresponding author), Rush Univ, Med Ctr, Cardiol Sect, 1653 W Congress Pkwy,Room 1021,Jelke SC, Chicago, IL 60612 USA.	James_Calvin@rush.edu	Peterson, Eric David/ABF-5033-2021					[Anonymous], 1998, Jt Comm J Qual Improv, V24, P480; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Boden W E, 2001, Conn Med, V65, P597; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Burwen DR, 2003, ARCH INTERN MED, V163, P1430, DOI 10.1001/archinte.163.12.1430; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Canto JG, 2000, ARCH INTERN MED, V160, P817, DOI 10.1001/archinte.160.6.817; Carlisle DM, 1997, AM J PUBLIC HEALTH, V87, P263, DOI 10.2105/AJPH.87.2.263; Devlin TF., 1986, P 11 ANN SAS US GROU, P646; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Gold MR, 2001, J HEALTH POLIT POLIC, V26, P581, DOI 10.1215/03616878-26-3-581; Iliadis EA, 1999, J AM COLL CARDIOL, V34, P1689, DOI 10.1016/S0735-1097(99)00405-2; Institute of Medicine (US) Committee, 2001, CROSSING QUALITY CHA, P1, DOI [DOI 10.17226/10027, 10.17226/10027]; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kreindel S, 1997, ARCH INTERN MED, V157, P758, DOI 10.1001/archinte.157.7.758; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; Levknecht L, 1997, JOINT COMM J QUAL IM, V23, P162, DOI 10.1016/S1070-3241(16)30307-8; Liang H Z, 1986, Zhong Xi Yi Jie He Za Zhi, V6, P13; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Nelson AR, 2003, ANN THORAC SURG, V76, pS1377, DOI 10.1016/S0003-4975(03)01205-0; PEAR R, 2005, NY TIMES        0224, pA20; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Philbin EF, 2001, AM J PUBLIC HEALTH, V91, P1082, DOI 10.2105/AJPH.91.7.1082; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; Seddon ME, 2001, AM J MED, V111, P24, DOI 10.1016/S0002-9343(01)00741-0; SIU AL, 1988, JAMA-J AM MED ASSOC, V259, P1343, DOI 10.1001/jama.259.9.1343; Sloan FA, 2000, AM HEART J, V139, P567, DOI 10.1016/S0002-8703(00)90032-2; Stone CJ, 1986, STAT SCI, V1, P312, DOI DOI 10.1214/ss/1177013607; Stone CJ, 1985, P STAT COMP SECT AM, P45; Topol E, 1998, NEW ENGL J MED, V339, P436	33	47	47	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					739	748		10.7326/0003-4819-145-10-200611210-00006	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110OB	17116918				2022-12-28	WOS:000242387100003
J	Chandrashekar, J; Hoon, MA; Ryba, NJP; Zuker, CS				Chandrashekar, Jayaram; Hoon, Mark A.; Ryba, Nicholas J. P.; Zuker, Charles S.			The receptors and cells for mammalian taste	NATURE			English	Review							GATED CATION CHANNEL; BITTER-TASTE; SWEET TASTE; UMAMI TASTE; SOUR TASTE; SACCHARIN PREFERENCE; AMINO-ACIDS; TRANSIENT RECEPTOR; POSITIONAL CLONING; K+ CHANNELS	The emerging picture of taste coding at the periphery is one of elegant simplicity. Contrary to what was generally believed, it is now clear that distinct cell types expressing unique receptors are tuned to detect each of the five basic tastes: sweet, sour, bitter, salty and umami. Importantly, receptor cells for each taste quality function as dedicated sensors wired to elicit stereotypic responses.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ryba, NJP (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	nick.ryba@nih.gov; czuker@ucsd.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Brecht M, 2004, J NEUROSCI, V24, P9223, DOI 10.1523/JNEUROSCI.3344-04.2004; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; CUMMINGS TA, 1992, J GEN PHYSIOL, V99, P591, DOI 10.1085/jgp.99.4.591; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Di Lorenzo PM, 2000, PHYSIOL BEHAV, V69, P87, DOI 10.1016/S0031-9384(00)00191-8; Dotson CD, 2005, CHEM SENSES, V30, P593, DOI 10.1093/chemse/bji053; Erickson RP, 2000, PHYSIOL BEHAV, V69, P3, DOI 10.1016/S0031-9384(00)00193-1; ERICKSON RP, 1980, BRAIN RES, V196, P513, DOI 10.1016/0006-8993(80)90417-5; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Gilbertson TA, 2003, NEUROREPORT, V14, P905, DOI 10.1097/01.wnr.0000074346.81633.76; Gilbertson TA, 2001, J NEUROSCI, V21, P4931, DOI 10.1523/JNEUROSCI.21-13-04931.2001; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Ikeda K, 2002, CHEM SENSES, V27, P847, DOI 10.1093/chemse/27.9.847; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; IWASAKI K, 1982, PHYSIOL BEHAV, V28, P829, DOI 10.1016/0031-9384(82)90199-8; IWASAKI K, 1985, PHYSIOL BEHAV, V34, P531, DOI 10.1016/0031-9384(85)90045-9; Jiang P, 2005, CHEM SENSES, V30, pI17, DOI 10.1093/chemse/bjh091; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kusakabe Y, 2000, CHEM SENSES, V25, P525, DOI 10.1093/chemse/25.5.525; Kuze B, 1999, J COMP NEUROL, V414, P80; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lin W, 2004, J NEUROPHYSIOL, V92, P2909, DOI 10.1152/jn.01198.2003; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; LUSH IE, 1988, GENET RES, V52, P207, DOI 10.1017/S0016672300027671; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2004, J PHYSIOL-LONDON, V556, P159, DOI 10.1113/jphysiol.2003.057745; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Pin JP, 2002, CNS NEUROL DISORD-DR, V1, P297, DOI 10.2174/1568007023339328; PRITCHARD TC, 1982, BRAIN RES, V253, P81, DOI 10.1016/0006-8993(82)90675-8; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; Rolls E, 2000, BRAIN EMOTION; Rosenzweig S, 1999, J NEUROPHYSIOL, V81, P1661, DOI 10.1152/jn.1999.81.4.1661; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Ruiz CJ, 2003, CHEM SENSES, V28, P573, DOI 10.1093/chemse/bjg049; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sato T, 1997, CHEM SENSES, V22, P287, DOI 10.1093/chemse/22.3.287; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Smith DV, 2000, PHYSIOL BEHAV, V69, P77, DOI 10.1016/S0031-9384(00)00190-6; Smith DV, 1999, CURR OPIN NEUROBIOL, V9, P427, DOI 10.1016/S0959-4388(99)80064-6; Smith DV, 2001, SCI AM, V284, P32, DOI 10.1038/scientificamerican0301-32; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Varkevisser B, 2000, J NEUROPHYSIOL, V83, P2526, DOI 10.1152/jn.2000.83.5.2526; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; YAMAGUCHI S, 1967, J FOOD SCI, V32, P473, DOI 10.1111/j.1365-2621.1967.tb09715.x; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	100	1012	1071	50	719	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					288	294		10.1038/nature05401	http://dx.doi.org/10.1038/nature05401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108952				2022-12-28	WOS:000242018300034
J	Temirov, R; Soubatch, S; Luican, A; Tautz, FS				Temirov, R.; Soubatch, S.; Luican, A.; Tautz, F. S.			Free-electron-like dispersion in an organic monolayer film on a metal substrate	NATURE			English	Article							AROMATIC-MOLECULES; BAND DISPERSION; THIN-FILMS; SURFACES; AG(111); PTCDA; TRANSISTORS; PERYLENE; STATES	Thin films of molecular organic semiconductors are attracting much interest for use in electronic and optoelectronic applications. The electronic properties of these materials and their interfaces are therefore worth investigating intensively(1 - 3), particularly the degree of electron delocalization that can be achieved (2,4). If the delocalization is appreciable, it should be accompanied by an observable electronic band dispersion. But so far only limited experimental data on the intermolecular dispersion of electronic states in molecular materials is available (5 - 8), and the mechanism( s) of electron delocalization in molecular materials are also not well understood. Here we report scanning tunnelling spectroscopy observations of an organic monolayer film on a silver substrate, revealing a completely delocalized two- dimensional band state that is characterized by a metal- like parabolic dispersion with an effective mass of m* = 0.47m(e), where m(e) is the bare electron mass. This dispersion is far stronger than expected for the organic film alone(7), and arises as a result of strong substrate- mediated coupling between the molecules within the monolayer.	Int Univ Bremen, Sch Sci & Engn, D-28725 Bremen, Germany	Jacobs University	Tautz, FS (corresponding author), Int Univ Bremen, Sch Sci & Engn, POB 750561, D-28725 Bremen, Germany.	s.tautz@iu-bremen.de	Temirov, Ruslan/D-9749-2011; Luican-Mayer, Adina/AAO-1111-2020; Tautz, Frank Stefan/L-4500-2016	Temirov, Ruslan/0000-0001-8290-6831; Luican-Mayer, Adina/0000-0001-9537-4600; Tautz, Frank Stefan/0000-0003-3583-2379; Subach, Sergey/0000-0002-1455-0260				ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; Cahen D, 2005, MATER TODAY, V8, P32, DOI 10.1016/S1369-7021(05)70985-8; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Eremtchenko M, 2003, NATURE, V425, P602, DOI 10.1038/nature01901; Forrest SR, 1997, CHEM REV, V97, P1793, DOI 10.1021/cr941014o; GENSTERBLUM G, 1993, PHYS REV B, V48, P14756, DOI 10.1103/PhysRevB.48.14756; Glockler K, 1998, SURF SCI, V405, P1, DOI 10.1016/S0039-6028(97)00888-1; HASEGAWA S, 1994, J CHEM PHYS, V100, P6969, DOI 10.1063/1.467013; Hauschild A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.209602; Hauschild A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036106; JUNG M, 1993, J MOL STRUCT, V293, P239, DOI 10.1016/0022-2860(93)80058-4; Karl N, 2003, SYNTHETIC MET, V133, P649, DOI 10.1016/S0379-6779(02)00398-3; Kaufman DL, 1999, AM J PHYS, V67, P133, DOI 10.1119/1.19208; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; Kraft A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041402; Kroger J, 2005, PROG SURF SCI, V80, P26, DOI 10.1016/j.progsurf.2005.10.002; Li JT, 1998, PHYS REV LETT, V80, P3332, DOI 10.1103/PhysRevLett.80.3332; MOBUS M, 1992, J CRYST GROWTH, V116, P495, DOI 10.1016/0022-0248(92)90658-6; NORSKOV JK, 1990, REP PROG PHYS, V53, P1253, DOI 10.1088/0034-4885/53/10/001; Rurali R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.209601; Sun YM, 2005, J MATER CHEM, V15, P53, DOI 10.1039/b411245h; Witte G, 2004, J MATER RES, V19, P1889, DOI 10.1557/JMR.2004.0251; Yamane H, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.033102; Zou Y, 2006, SURF SCI, V600, P1240, DOI 10.1016/j.susc.2005.12.050	24	229	231	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					350	353		10.1038/nature05270	http://dx.doi.org/10.1038/nature05270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108961				2022-12-28	WOS:000242018300044
J	Holness, M				Holness, Marian			Geochemistry - How melted rock migrates	SCIENCE			English	Editorial Material							AUREOLE		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Holness, M (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	marian@esc.cam.ac.uk		Holness, Marian/0000-0001-9911-8292				German RM, 1985, LIQUID PHASE SINTERI; Holness MB, 2005, J PETROL, V46, P1565, DOI 10.1093/petrology/egi026; Holness MB, 2005, J METAMORPH GEOL, V23, P29, DOI 10.1111/j.1525-1314.2005.00560.x; Holness MB, 2002, J PETROL, V43, P511, DOI 10.1093/petrology/43.3.511; Laporte D., 2000, PHYS CHEM PARTIALLY, P93, DOI 10.1007/978-94-011-4016-4_4; Schiano P, 2006, SCIENCE, V314, P970, DOI 10.1126/science.1132485; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15	7	2	2	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					934	935		10.1126/science.1135922	http://dx.doi.org/10.1126/science.1135922			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095685				2022-12-28	WOS:000241896000034
J	Aury, JM; Jaillon, O; Duret, L; Noel, B; Jubin, C; Porcel, BM; Segurens, B; Daubin, V; Anthouard, V; Aiach, N; Arnaiz, O; Billaut, A; Beisson, J; Blanc, I; Bouhouche, K; Camara, F; Duharcourt, S; Guigo, R; Gogendeau, D; Katinka, M; Keller, AM; Kissmehl, R; Klotz, C; Koll, F; Le Mouel, A; Lepere, G; Malinsky, S; Nowacki, M; Nowak, JK; Plattner, H; Poulain, J; Ruiz, F; Serrano, V; Zagulski, M; Dessen, P; Betermier, M; Weissenbach, J; Scarpelli, C; Schachter, V; Sperling, L; Meyer, E; Cohen, J; Wincker, P				Aury, Jean-Marc; Jaillon, Olivier; Duret, Laurent; Noel, Benjamin; Jubin, Claire; Porcel, Betina M.; Segurens, Beatrice; Daubin, Vincent; Anthouard, Veronique; Aiach, Nathalie; Arnaiz, Olivier; Billaut, Alain; Beisson, Janine; Blanc, Isabelle; Bouhouche, Khaled; Camara, Francisco; Duharcourt, Sandra; Guigo, Roderic; Gogendeau, Delphine; Katinka, Michael; Keller, Anne-Marie; Kissmehl, Roland; Klotz, Catherine; Koll, France; Le Mouel, Anne; Lepere, Gersende; Malinsky, Sophie; Nowacki, Mariusz; Nowak, Jacek K.; Plattner, Helmut; Poulain, Julie; Ruiz, Francoise; Serrano, Vincent; Zagulski, Marek; Dessen, Philippe; Betermier, Mireille; Weissenbach, Jean; Scarpelli, Claude; Schaechter, Vincent; Sperling, Linda; Meyer, Eric; Cohen, Jean; Wincker, Patrick			Global trends of whole-genome duplications revealed by the ciliate Paramecium tetraurelia	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; YEAST GENOME; GENE; EVOLUTION; ARABIDOPSIS; EUKARYOTES; SEQUENCES; ELIMINATION	The duplication of entire genomes has long been recognized as having great potential for evolutionary novelties, but the mechanisms underlying their resolution through gene loss are poorly understood. Here we show that in the unicellular eukaryote Paramecium tetraurelia, a ciliate, most of the nearly 40,000 genes arose through at least three successive whole-genome duplications. Phylogenetic analysis indicates that the most recent duplication coincides with an explosion of speciation events that gave rise to the P. aurelia complex of 15 sibling species. We observed that gene loss occurs over a long timescale, not as an initial massive event. Genes from the same metabolic pathway or protein complex have common patterns of gene loss, and highly expressed genes are over-retained after all duplications. The conclusion of this analysis is that many genes are maintained after whole-genome duplication not because of functional innovation but because of gene dosage constraints.	Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Ecole Normale Super, Genet Mol Lab, CNRS, UMR 8541, F-75005 Paris, France; Univ Pompeu Fabra, Ctr Genom Regulat, Inst Municipal Invest Med, Barcelona, Catalonia, Spain; Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Polish Acad Sci, Inst Biochem & Biophys, DNA Sequencing Lab, PL-02106 Warsaw, Poland; Inst Gustave Roussy, Lab Genomes & Canc, FRE 2939, CNRS, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Konstanz; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Wincker, P (corresponding author), Genoscope, 2 Rue Gaston Cremieux,CP5706, F-91057 Evry, France.	pwincker@genoscope.cns.fr	Ferreira, Francisco Câmara/G-9841-2015; Jaillon, Olivier/GRY-6287-2022; Duharcourt, Sandra/ABD-4460-2020; Guigo, Roderic/D-1303-2010; Aury, Jean-Marc/N-1621-2019; Bouhouche, khaled/AGR-4456-2022; Nowacki, Mariusz/E-4485-2011; Sperling, Linda/C-9734-2014	Ferreira, Francisco Câmara/0000-0002-1971-5466; Duharcourt, Sandra/0000-0002-8913-8799; Guigo, Roderic/0000-0002-5738-4477; Aury, Jean-Marc/0000-0003-1718-3010; Nowacki, Mariusz/0000-0003-4894-2905; ARNAIZ, Olivier/0000-0002-9626-1015; Nowak, Jacek/0000-0003-2569-4080; Meyer, Eric/0000-0002-3161-8597; lepere, gersende/0000-0002-4609-7587; Sperling, Linda/0000-0002-7772-4774; Duret, Laurent/0000-0003-2836-3463; Porcel, Betina/0000-0003-0169-5302; Noel, Benjamin/0000-0002-5830-3253; Daubin, Vincent/0000-0001-8269-9430; Jaillon, Olivier/0000-0002-7237-9596; Poulain, Julie/0000-0002-8744-3116; Betermier, Mireille/0000-0002-5407-6292				Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; BERGER JD, 1978, J CELL BIOL, V76, P116, DOI 10.1083/jcb.76.1.116; Betermier M, 2004, RES MICROBIOL, V155, P399, DOI 10.1016/j.resmic.2004.01.017; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Coleman AW, 2005, J EUKARYOT MICROBIOL, V52, P68, DOI 10.1111/j.1550-7408.2005.3327r.x; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; de Loubresse NG, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-4; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dubrana K, 2000, CHROMOSOMA, V109, P460, DOI 10.1007/s004120000108; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fokin SI, 2004, EUR J PROTISTOL, V40, P225, DOI 10.1016/j.ejop.2004.02.001; Force A, 1999, GENETICS, V151, P1531; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Ohno S., 1970, EVOLUTION GENE DUPLI; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Ruiz F, 2000, CURR BIOL, V10, P1451, DOI 10.1016/S0960-9822(00)00804-6; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Sonneborn TM, 1974, HDB GENETICS PLANTS, V2, P469, DOI DOI 10.1007/978-1-4684-2994-7_20; Veitia RA, 2005, PLANT CELL, V17, P4, DOI 10.1105/tpc.104.170130; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zagulski M, 2004, CURR BIOL, V14, P1397, DOI 10.1016/j.cub.2004.07.029	48	597	677	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					171	178		10.1038/nature05230	http://dx.doi.org/10.1038/nature05230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17086204	hybrid, Green Published			2022-12-28	WOS:000241867200033
J	Friedman, A; Perrimon, N				Friedman, Adam; Perrimon, Norbert			A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling	NATURE			English	Article							MAP KINASE; DROSOPHILA; PROTEIN; PATHWAY; RAS; PHOSPHATASE; ACTIVATION; CANCER; PHOSPHORYLATION; PROGRESSION	Receptor tyrosine kinase (RTK) signalling through extracellular-signal-regulated kinases ( ERKs) has pivotal roles during metazoan development, underlying processes as diverse as fate determination, differentiation, proliferation, survival, migration and growth. Abnormal RTK/ERK signalling has been extensively documented to contribute to developmental disorders and disease, most notably in oncogenic transformation by mutant RTKs(1) or downstream pathway components such as Ras and Raf(2). Although the core RTK/ERK signalling cassette has been characterized by decades of research using mammalian cell culture and forward genetic screens in model organisms, signal propagation through this pathway is probably regulated by a larger network of moderate, context-specific proteins. The genes encoding these proteins may not have been discovered through traditional screens owing, in particular, to the requirement for visible phenotypes. To obtain a global view of RTK/ERK signalling, we performed an unbiased, RNA interference (RNAi), genome-wide, high-throughput screen in Drosophila cells using a novel, quantitative, cellular assay monitoring ERK activation. Here we show that ERK pathway output integrates a wide array of conserved cellular processes. Further analysis of selected components - in multiple cell types with different RTK ligands and oncogenic stimuli - validates and classifies 331 pathway regulators. The relevance of these genes is highlighted by our isolation of a Ste20-like kinase and a PPM-family phosphatase that seem to regulate RTK/ERK signalling in vivo and in mammalian cells. Novel regulators that modulate specific pathway outputs may be selective targets for drug discovery.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Asha H, 2003, GENETICS, V163, P203; Baril C, 2006, DEV BIOL, V294, P232, DOI 10.1016/j.ydbio.2006.02.046; Chang FM, 2003, INT J ONCOL, V22, P469; Chen X, 2003, DEV CELL, V4, P179, DOI 10.1016/S1534-5807(03)00024-8; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Gabay L, 1997, DEVELOPMENT, V124, P3535; Halfar K, 2001, DEVELOPMENT, V128, P1687; Hilger RA, 2002, ONKOLOGIE, V25, P511, DOI 10.1159/000068621; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jordan KC, 2005, DEV DYNAM, V232, P709, DOI 10.1002/dvdy.20318; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lipsick JS, 2004, GENE DEV, V18, P2837, DOI 10.1101/gad.1274804; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Sung V, 2003, CANCER RES, V63, P3356; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	30	173	177	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					230	234		10.1038/nature05280	http://dx.doi.org/10.1038/nature05280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17086199				2022-12-28	WOS:000241867200046
J	English, CM; Adkins, MW; Carson, JJ; Churchill, MEA; Tyler, JK				English, Christine M.; Adkins, Melissa W.; Carson, Joshua J.; Churchill, Mair E. A.; Tyler, Jessica K.			Structural basis for the histone chaperone activity of Asf1	CELL			English	Article							NUCLEOSOME CORE PARTICLE; ASSEMBLY FACTOR-I; CRYSTAL-STRUCTURE; DNA-REPLICATION; S-PHASE; CHROMATIN; ACTIVATION; DEPOSITION; COMPLEX; H3	Anti-silencing function 1 (Asf1) is a highly conserved chaperone of histones H3/H4 that assembles or disassembles chromatin during transcription, replication, and repair. The structure of the globular domain of Asf1 bound to H3/H4 determined by X-ray crystallography to a resolution of 1.7 angstrom shows how Asf1 binds the H3/H4 heterodimer, enveloping the C terminus of histone H3 and physically blocking formation of the H3/H4 heterotetramer. Unexpectedly, the C terminus of histone H4 that forms a mini-beta sheet with histone H2A in the nucleosome undergoes a major conformational change upon binding to Asf1 and adds a beta strand to the Asf1 0 sheet sandwich. Interactions with both H3 and H4 were required for Asf1 histone chaperone function in vivo and in vitro. The Asf1-H3/H4 structure suggests a "strand-capture" mechanism whereby the H4 tail acts as a lever to facilitate chromatin disassembly/assembly that may be used ubiquitously by histone chaperones.	Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Churchill, MEA (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	mair.churchill@uchsc.edu; jessica.tyler@uchsc.edu	Churchill, Mair E. A./C-5549-2014	Churchill, Mair E. A./0000-0003-0862-235X; Tyler, Jessica/0000-0001-9765-1659	NCI NIH HHS [R01 CA095641] Funding Source: Medline; NIGMS NIH HHS [R01 GM064475, R01 GM079154, R01 GM079154-01A1, GM064475] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079154, R01GM064475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DeLano W.L, PYMOL MOL GRAPHICS S; DeSilva H, 1998, GENETICS, V148, P657; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; MOSS T, 1976, BIOCHEMISTRY-US, V15, P2261, DOI 10.1021/bi00656a003; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; Padmanabhan B, 2005, J BIOCHEM, V138, P821, DOI 10.1093/jb/mvi182; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TAMBURINI B, 2006, GENETICS; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005	47	332	340	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					495	508		10.1016/j.cell.2006.08.047	http://dx.doi.org/10.1016/j.cell.2006.08.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081973	Green Accepted, Bronze			2022-12-28	WOS:000241937000015
J	Ensslin, TA				Ensslin, Torsten A.			Radio traces of cosmic shock waves	SCIENCE			English	Editorial Material							EMISSION		Max Planck Inst Astrophys, D-85741 Garching, Germany	Max Planck Society	Ensslin, TA (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85741 Garching, Germany.	ensslin@mpa-gardching.mpg.de						Bagchi J, 2006, SCIENCE, V314, P791, DOI 10.1126/science.1131189; COSTAIN CH, 1972, ASTROPHYS J, V175, pL15, DOI 10.1086/180975; Ensslin TA, 1998, ASTRON ASTROPHYS, V332, P395; Kang H, 1997, MON NOT R ASTRON SOC, V286, P257, DOI 10.1093/mnras/286.2.257; Loeb A, 2000, NATURE, V405, P156, DOI 10.1038/35012018; Miniati F, 2002, MON NOT R ASTRON SOC, V337, P199, DOI 10.1046/j.1365-8711.2002.05903.x; Pfrommer C, 2006, MON NOT R ASTRON SOC, V367, P113, DOI 10.1111/j.1365-2966.2005.09953.x; Roettiger K, 1999, ASTROPHYS J, V518, P603, DOI 10.1086/307327; Schilizzi R. T., 1975, Memoirs of the Royal Astronomical Society, V79, P1; Waxman E, 2000, ASTROPHYS J, V545, pL11, DOI 10.1086/317326	10	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					772	773		10.1126/science.1133949	http://dx.doi.org/10.1126/science.1133949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082445				2022-12-28	WOS:000241729800032
J	Kelley, AE				Kelley, Ann E.			Worms clear the smoke surrounding nicotine addiction	CELL			English	Editorial Material							RESPONSES; ETHANOL; COCAINE	In this issue of Cell, Feng et al. (2006) report a worm model of nicotine dependence that shows behavioral adaptations surprisingly similar to those in humans. These authors show a critical link between nicotinic receptors and TRIP channels, which may represent a new therapeutic target for treating nicotine addiction.	Univ Wisconsin, Dept Psychiat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Kelley, AE (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53705 USA.	aekelley@wisc.edu						Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; DANI JA, 2006, ANN REV PHARM TOXICO, V47, DOI DOI 10.1146/ANNUREV.PHARMTOX.47.120505.105214.; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Panksepp JB, 2004, BEHAV BRAIN RES, V153, P171, DOI 10.1016/j.bbr.2003.11.014; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Sullivan RJ, 2002, ADDICTION, V97, P389, DOI 10.1046/j.1360-0443.2002.00024.x	11	3	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					460	462		10.1016/j.cell.2006.10.024	http://dx.doi.org/10.1016/j.cell.2006.10.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081968	Bronze			2022-12-28	WOS:000241937000010
J	Trautt, ZT; Upmanyu, M; Karma, A				Trautt, Zachary T.; Upmanyu, Moneesh; Karma, Alain			Interface mobility from interface random walk	SCIENCE			English	Article							GRAIN-BOUNDARY MIGRATION; ALUMINUM BICRYSTALS; SINGLE CRYSTALS; SIMULATION; RECRYSTALLIZATION; DYNAMICS; MOTION; ORIENTATION; DEPENDENCE; CURVATURE	Computational studies aimed at extracting interface mobilities require driving forces orders of magnitude higher than those occurring experimentally. We present a computational methodology that extracts the absolute interface mobility in the zero driving force limit by monitoring the one-dimensional random walk of the mean interface position along the interface normal. The method exploits a fluctuation-dissipation relation similar to the Stokes-Einstein relation, which relates the diffusion coefficient of this Brownian-like random walk to the interface mobility. Atomic-scale simulations of grain boundaries in model crystalline systems validate the theoretical predictions and highlight the profound effect of impurities. The generality of this technique, combined with its inherent spatiotemporal efficiency, should allow computational studies to effectively complement experiments in understanding interface kinetics in diverse material systems.	Colorado Sch Mines, Grp Simulat & Theory Atom Scale Mat Phenomena, Div Engn, Golden, CO 80401 USA; Colorado Sch Mines, Mat Sci Program, Golden, CO 80401 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Colorado School of Mines; Colorado School of Mines; Northeastern University; Northeastern University	Upmanyu, M (corresponding author), Colorado Sch Mines, Grp Simulat & Theory Atom Scale Mat Phenomena, Div Engn, Golden, CO 80401 USA.	mupmanyu@mines.edu	Karma, Alain/AAL-7090-2020	Karma, Alain/0000-0001-7032-9862; Trautt, Zachary/0000-0001-5929-0354				AUST KT, 1959, T AM I MIN MET ENG, V215, P820; BRON WE, 1956, T AM I MIN MET ENG, V206, P513; Cahn JW, 2000, ACTA MATER, V48, P3425, DOI 10.1016/S1359-6454(00)00144-0; COBLE RL, 1961, J APPL PHYS, V32, P793, DOI 10.1063/1.1736108; DERSCHMITTEN WI, 1960, Z METALLKD, V51, P101; DETERT K, 1965, ACTA METALL MATER, V13, P845, DOI 10.1016/0001-6160(65)90149-5; FINE ME, 1964, INTRO PHASE TRANSFOR; Foiles SM, 2006, ACTA MATER, V54, P3351, DOI 10.1016/j.actamat.2006.03.037; Godiksen RB, 2005, MATER SCI TECH-LOND, V21, P1373, DOI 10.1179/174328405X71620; Gottstein G, 1998, INTERFACE SCI, V6, P7, DOI 10.1023/A:1008641617937; GOTTSTEIN G, 1999, GRAIN BOUNDARY MIGRA; GRAHAM CD, 1956, T AM I MIN MET ENG, V206, P517; Grujicic M, 1998, INTERFACE SCI, V6, P155, DOI 10.1023/A:1008676806550; GRUNWALD W, 1970, ACTA METALL MATER, V18, P217, DOI 10.1016/0001-6160(70)90026-X; HERRING C, 1951, PHYS REV, V82, P87, DOI 10.1103/PhysRev.82.87; HILLIG WB, 1956, J CHEM PHYS, V24, P914, DOI 10.1063/1.1742646; Hoyt JJ, 2002, INTERFACE SCI, V10, P181, DOI 10.1023/A:1015828330917; HUANG Y, 1999, ACTA MAT, V47, P7; Humphreys F.J., 2004, RECRYSTALLIZATION RE, DOI 10.1016/B978-0-08-044164-1.X5000-2; Ivanov VA, 2004, MATER SCI FORUM, V467-470, P751, DOI 10.4028/www.scientific.net/MSF.467-470.751; Janssens KGF, 2006, NAT MATER, V5, P124, DOI 10.1038/nmat1559; LIEBMANN B, 1956, Z METALLKD, V47, P57; LUCKE K, 1955, ACTA METALL MATER, V3, P204, DOI 10.1016/0001-6160(55)90097-3; Mendelev MI, 2002, MODEL SIMUL MATER SC, V10, pR79, DOI 10.1088/0965-0393/10/6/201; Palumbo G, 1998, JOM-J MIN MET MAT S, V50, P40, DOI 10.1007/s11837-998-0248-z; Powers JD, 1998, INTERFACE SCI, V6, P23, DOI 10.1023/A:1008656302007; RATH BB, 1969, T METALL SOC AIME, V245, P1577; RATH BB, 1966, T METALL SOC AIME, V236, P8; Schonfelder B, 1997, INTERFACE SCI, V5, P245, DOI 10.1023/A:1008663804495; Schwartz AJ, 1998, JOM-J MIN MET MAT S, V50, P50, DOI 10.1007/s11837-998-0250-5; Sutton A. P., 1995, INTERFACES CRYSTALLI; TURNBULL D, 1951, T AM I MIN MET ENG, V191, P661; Upmanyu M, 1999, ACTA MATER, V47, P3901, DOI 10.1016/S1359-6454(99)00240-2; Vandermeer RA, 1997, METALL MATER TRANS A, V28, P749, DOI 10.1007/s11661-997-1002-9; Veprek S, 1999, J VAC SCI TECHNOL A, V17, P2401, DOI 10.1116/1.581977; Winning M, 2001, ACTA MATER, V49, P211, DOI 10.1016/S1359-6454(00)00321-9; Yoon DY, 1995, INT MATER REV, V40, P149, DOI 10.1179/095066095790151197; Zhang H, 2005, ACTA MATER, V53, P79, DOI 10.1016/j.actamat.2004.09.004; Zhang H, 2004, ACTA MATER, V52, P2569, DOI 10.1016/j.actamat.2004.02.005	39	89	89	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					632	635		10.1126/science.1131988	http://dx.doi.org/10.1126/science.1131988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068258				2022-12-28	WOS:000241557800042
J	Bakker, A; Fazey, C				Bakker, Adam; Fazey, Cindy			Methadone tolerance testing in drug misusers	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAINTENANCE TREATMENT; FOLLOW-UP; ADDICTS; DEATHS; MORTALITY; IMPACT		Lisson Grove Hlth Ctr, London NW8 8EG, England; Univ Liverpool, Dept Sociol Social Policy & Social Work Studies, Liverpool L69 7ZA, Merseyside, England	University of Liverpool	Bakker, A (corresponding author), Lisson Grove Hlth Ctr, London NW8 8EG, England.	bakker@nhs.net						Caplehorn JRM, 1996, SUBST USE MISUSE, V31, P177, DOI 10.3109/10826089609045806; Caplehorn JRM, 1998, DRUG ALCOHOL REV, V17, P9, DOI 10.1080/09595239800187551; *DEP HLTH SCOTT OF, 1999, DRUG MIS DEP GUID CL; Drummer OH, 2004, FORENSIC SCI INT, V142, P101, DOI 10.1016/j.forsciint.2004.02.013; DRUMMER OH, 1992, AM J FOREN MED PATH, V13, P346, DOI 10.1097/00000433-199212000-00017; *EUR MON CTR DRUG, ANN REP 2004 STAT DR; FAGGIANO F, 2003, COCHRANE DB SYST REV; GHODSE AH, 1985, BRIT MED J, V290, P425, DOI 10.1136/bmj.290.6466.425; Greenwald MK, 2006, EXP CLIN PSYCHOPHARM, V14, P52, DOI 10.1037/1064-1297.14.1.52; GRONBLADH L, 1990, ACTA PSYCHIAT SCAND, V82, P223, DOI 10.1111/j.1600-0447.1990.tb03057.x; Hutchinson SJ, 2000, ADDICTION, V95, P1055, DOI 10.1046/j.1360-0443.2000.95710557.x; Keen J, 2003, BRIT J GEN PRACT, V53, P461; KLEE H, 1995, ADDICTION, V90, P837, DOI 10.1111/j.1360-0443.1995.tb02233.x; LEAVITT SB, 2003, METHADONE DOSING SAF; Maxwell S, 1999, J PSYCHOACTIVE DRUGS, V31, P95, DOI 10.1080/02791072.1999.10471730; *NAT DRUG TREATM M, INJ STAT IND CONT ST; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; Pirnay S, 2004, ADDICTION, V99, P978, DOI 10.1111/j.1360-0443.2004.00790.x; Strang J, 2005, BRIT J GEN PRACT, V55, P444; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; van Ameijden EJC, 1999, ADDICT BEHAV, V24, P559, DOI 10.1016/S0306-4603(98)00083-5; Zador D, 2000, ADDICTION, V95, P77, DOI 10.1046/j.1360-0443.2000.951778.x	22	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1056	1059		10.1136/bmj.39016.471840.68	http://dx.doi.org/10.1136/bmj.39016.471840.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108HB	17110724	Green Published			2022-12-28	WOS:000242229800022
J	Rodriguez, LAG; Patrignani, P				Garcia Rodriguez, Luis Alberto; Patrignani, Paola			The ever growing story of cyclo-oxygenase inhibition	LANCET			English	Editorial Material							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HEALTHY-SUBJECTS; THERAPY; ATHEROTHROMBOSIS; PHARMACOLOGY; PLATELET; NAPROXEN; COX-2; RISK		Ctr Espanol Invest Farmacoepidemiol, Madrid 28004, Spain; Univ G DAnnunzio, Sch Med, Dept Med, Chieti, Italy; Univ G DAnnunzio, Sch Med, Ctr Excellence Aging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Rodriguez, LAG (corresponding author), Ctr Espanol Invest Farmacoepidemiol, Madrid 28004, Spain.	lagarcia@ceife.es	Patrignani, Paola/B-4844-2011; rodriguez, luis a garcia/B-1980-2010	Patrignani, Paola/0000-0003-1419-2691; 				CANNON CP, 2006, LANCET          1113, DOI DOI 10.1016/S0140-6736(06)69666-9; Capone ML, 2004, CIRCULATION, V109, P1468, DOI 10.1161/01.CIR.0000124715.27937.78; Capone ML, 2005, J AM COLL CARDIOL, V45, P1295, DOI 10.1016/j.jacc.2005.01.045; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; *EUR MED AG, 2006, CHMP REV NONS NONST; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hernandez-Diaz S, 2006, BASIC CLIN PHARMACOL, V98, P266, DOI 10.1111/j.1742-7843.2006.pto_302.x; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; REILLY IAG, 1987, BLOOD, V69, P180; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004	13	23	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1745	1747		10.1016/S0140-6736(06)69667-0	http://dx.doi.org/10.1016/S0140-6736(06)69667-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FJ	17113403				2022-12-28	WOS:000242225400004
J	Horton, R; Gilmore, I				Horton, Richard; Gilmore, Ian			The evolving doctor	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England; Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Horton, R (corresponding author), Lancet, London NW1 7BY, England.							BATTY D, 2006, GUARDIAN        1023; General Medical Council, 2006, GOOD MED PRACT; Royal College of Physicians, 2005, DOCT SOC MED PROF CH	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2006	368	9549					1750	1751		10.1016/S0140-6736(06)69641-4	http://dx.doi.org/10.1016/S0140-6736(06)69641-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FJ	17113406				2022-12-28	WOS:000242225400007
J	Lakha, F; Glasier, A				Lakha, Fatim; Glasier, Anna			Unintended pregnancy and use of emergency contraception among a large cohort of women attending for antenatal care or abortion in Scotland	LANCET			English	Article							ADVANCED PROVISION; KNOWLEDGE; REDUCE; PERCEPTION; PILLS	Background Unintended pregnancy is common. Although many unintended pregnancies end in induced abortion, up to a third. of those proceeding to birth might be unplanned. Some of these pregnancies could be prevented by emergency contraception. We have sought to establish how many pregnancies ending in either childbirth or abortion are unintended, and what proportion of women use emergency contraception to try to prevent pregnancy. Methods 291018 women who attended an Edinburgh hospital for antenatal care and 907 attending for abortion fully completed a self-administered questionnaire including a validated measure of pregnancy intention and questions about emergency contraceptive use. Findings 814 (89.7%) of 907 pregnancies among women requesting abortion were unintended compared with only 250 (8.6%) among 2908 women who planned to continue pregnancy However, only 1909 (65.6%) of continuing pregnancies were intended. The rest of the women were ambivalent about pregnancy intention. In women who continued with their pregnancies intendedness was related to age, with unintended pregnancy most probable in young women (p<0.0001). Emergency contraception was used by 113 (11.8%) of women who requested abortion but only 40 (1%) of those planning to continue pregnancy. in those whose pregnancy was continuing, the proportions reporting use of emergency contraception were higher in young women than in older women and in those who reported that their pregnancies were unintended than in those who meant to become pregnant (both p<0.0001). Interpretation Unintended pregnancy is common, even among women planning to continue pregnancy. However, EC use is low even among women with no intention of conceiving, and is thus unlikely to reduce unintended pregnancy rates. Rather, we need to find ways to improve the use of regular contraception.	NHS Lothian, Family Planning Serv, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh, Midlothian, Scotland; Univ London, London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London, England	University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Glasier, A (corresponding author), NHS Lothian, Family Planning Serv, 18 Dean Terrace, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk		Lakha, Fatim/0000-0003-1865-4419				Aneblom G, 2002, BJOG-INT J OBSTET GY, V109, P155, DOI 10.1016/S1470-0328(02)01239-9; Arora N, 2005, J FAM PLAN REPROD H, V31, P294, DOI 10.1783/147118905774480626; Aziken ME, 2003, INT FAM PLAN PERSPEC, V29, P84, DOI 10.2307/3181062; Baird DT, 1999, BRIT MED J, V319, P969, DOI 10.1136/bmj.319.7215.969; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Dawe F, 2004, CONTRACEPTION SEXUAL; FLEISSIG A, 1991, BRIT MED J, V302, P147, DOI 10.1136/bmj.302.6769.147; Free C, 2002, BMJ-BRIT MED J, V325, P1393, DOI 10.1136/bmj.325.7377.1393; Garg M, 2001, J FAM PLAN REPROD H, V27, P77, DOI 10.1783/147118901101195290; Glasier A, 2004, CONTRACEPTION, V69, P361, DOI 10.1016/j.contraception.2004.01.002; Gordon AF, 1999, BRIT J FAM PLAN, V24, P121; Grimes D, 1998, LANCET, V352, P428; Hu XY, 2005, CONTRACEPTION, V72, P111, DOI 10.1016/j.contraception.2005.02.004; JOHNSTON TA, 1985, BRIT MED J, V290, P1040, DOI 10.1136/bmj.290.6474.1040-a; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P294, DOI 10.2307/3097748; Lo SST, 2004, HUM REPROD, V19, P2404, DOI 10.1093/humrep/deh425; Marston C, 2005, BRIT MED J, V331, P271, DOI 10.1136/bmj.38519.440266.8F; Moreau C, 2005, CONTRACEPTION, V71, P202, DOI 10.1016/j.contraception.2004.09.004; *NAT I HLTH CLIN E, LONG ACT REV CONTR; Potter L, 1996, FAM PLANN PERSPECT, V28, P154, DOI 10.2307/2136191; Rosenberg M, 1999, AM J OBSTET GYNECOL, V180, pS276, DOI 10.1016/S0002-9378(99)70718-0; Schunmann C, 2006, CONTRACEPTION, V73, P520, DOI 10.1016/j.contraception.2005.12.009; Smallbone S. W., 2005, CHILDREN YOUNG PEOPL, P6; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4	26	115	117	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1782	1787		10.1016/S0140-6736(06)69737-7	http://dx.doi.org/10.1016/S0140-6736(06)69737-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113427				2022-12-28	WOS:000242225400031
J	Quek, R; Lim, ST; Tan, EH				Quek, Richard; Lim, Soon Thye; Tan, Eng Huat			Pneumoperitoneum following percutaneous lung biopsy	LANCET			English	Editorial Material									Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore	National Cancer Centre Singapore (NCCS)	Quek, R (corresponding author), Natl Canc Ctr, Dept Med Oncol, 11 Hosp Dr, Singapore 169610, Singapore.	dmorqhh@nccs.com.sg							0	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1794	1794		10.1016/S0140-6736(06)69739-0	http://dx.doi.org/10.1016/S0140-6736(06)69739-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FJ	17113429				2022-12-28	WOS:000242225400033
J	Grassly, NC; Fraser, C; Wenger, J; Deshpande, JM; Sutter, RW; Heymann, DL; Aylward, RB				Grassly, Nicholas C.; Fraser, Christophe; Wenger, Jay; Deshpande, Jagadish M.; Sutter, Roland W.; Heymann, David L.; Aylward, R. Bruce			New strategies for the elimination of polio from India	SCIENCE			English	Article							VACCINE; EFFICACY; POLIOMYELITIS; IMMUNOGENICITY; ERADICATION; POPULATION; TRIVALENT; DIARRHEA	The feasibility of global polio eradication is being questioned as a result of continued transmission in a few localities that act as sources for outbreaks elsewhere. Perhaps the greatest challenge is in India, where transmission has persisted in Uttar Pradesh and Bihar despite high coverage with multiple doses of vaccine. We estimate key parameters governing the seasonal epidemics in these areas and show that high population density and poor sanitation cause persistence by not only facilitating transmission of poliovirus but also severely compromising the efficacy of the trivalent vaccine. We analyze strategies to counteract this and show that switching to monovalent vaccine may finally interrupt virus transmission.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; World Hlth Org, Natl Polio Surveillance Project, New Delhi, India; Enterovirus Res Ctr, Bombay, Maharashtra, India; World Hlth Org, Global Polio Eradicat Initiat, Geneva, Switzerland	Imperial College London; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; World Health Organization	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London, England.	n.grassly@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Grassly, Nicholas C/C-6381-2008	Fraser, Christophe/0000-0003-2399-9657; Grassly, Nicholas C/0000-0001-6067-4507; Deshpande, Jagadish/0000-0001-5194-0375				ANDERSON R M, 1991; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; BALRAJ V, 1990, INT J EPIDEMIOL, V19, P711, DOI 10.1093/ije/19.3.711; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P238; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; DEIVANAYAGAM N, 1993, B WORLD HEALTH ORGAN, V71, P307; EAM DJD, 2000, SCIENCE, V287, P667; Huttly SRA, 1997, B WORLD HEALTH ORGAN, V75, P163; JOHN TJ, 1976, B WORLD HEALTH ORGAN, V54, P115; KIMFARLEY RJ, 1989, B WORLD HEALTH ORGAN, V67, P663; MARTINES J, 1993, DIS CONTROL PRIORITI, P91; MELNICK JL, 1953, AM J HYG, V58, P207, DOI 10.1093/oxfordjournals.aje.a119602; PAL SR, 1966, INDIAN J MED RES, V54, P507; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Paul Y, 2005, VACCINE, V23, P3097, DOI 10.1016/j.vaccine.2004.10.049; PENTTINEN K, 1961, ANN MED EXP BIOL FEN, V39, P195; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Sharma B, 1986, Indian J Pathol Microbiol, V29, P101; Sutter R. W., 2004, VACCINES, P651; Thacker Naveen, 2004, Indian Journal of Pediatrics, V71, P241, DOI 10.1007/BF02724277; Webster P, 2005, LANCET, V366, P359, DOI 10.1016/S0140-6736(05)67008-0	24	191	201	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1150	1153		10.1126/science.1130388	http://dx.doi.org/10.1126/science.1130388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110580				2022-12-28	WOS:000242045800046
J	Kowarik, M; Numao, S; Feldman, MF; Schulz, BL; Callewaert, N; Kiermaier, E; Catrein, I; Aebi, M				Kowarik, Michael; Numao, Shin; Feldman, Mario F.; Schulz, Benjamin L.; Callewaert, Nico; Kiermaier, Eva; Catrein, Ina; Aebi, Markus			N-linked glycosylation of folded proteins by the bacterial oligosaccharyltransferase	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; ENDOPLASMIC-RETICULUM; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; TAT PATHWAY; COMPLEX; TRANSLOCATION; TRANSFERASE; SPECIFICITY; RECOGNITION	N-linked protein glycosylation is found in all domains of life. In eukaryotes, it is the most abundant protein modification of secretory and membrane proteins, and the process is coupled to protein translocation and folding. We found that in bacteria, N-glycosylation can occur independently of the protein translocation machinery. In an in vitro assay, bacterial oligosaccharyltransferase glycosylated a folded endogenous substrate protein with high efficiency and folded bovine ribonuclease A with low efficiency. Unfolding the eukaryotic substrate greatly increased glycosylation. We propose that in the bacterial system, glycosylation sites are located in flexible parts of folded proteins, whereas the eukaryotic cotranslational glycosylation evolved to a mechanism presenting the substrate in a flexible form before folding.	ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland; ETH, Zurich Glycom Initiat, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Schulz, Benjamin L/B-3911-2009; Feldman, Mario/A-2637-2014	Schulz, Benjamin L/0000-0002-4823-7758; Feldman, Mario/0000-0003-4497-0976; Kiermaier, Eva/0000-0001-6165-5738; Numao, Shin/0000-0002-6204-7117; Callewaert, Nico/0000-0003-2069-6917				Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Liu Y L, 1994, Bioorg Med Chem, V2, P1133, DOI 10.1016/S0968-0896(00)82065-9; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	22	181	199	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1148	1150		10.1126/science.1134351	http://dx.doi.org/10.1126/science.1134351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110579				2022-12-28	WOS:000242045800045
J	La Spada, AR				La Spada, Albert R.			Neurodegeneration: A case of arrested development?	CELL			English	Editorial Material							SCA1 TRANSGENIC MICE; HISTONE ACETYLTRANSFERASE; ROR-ALPHA; DEGENERATION; STAGGERER; DISEASE; MODEL	The neurodegenerative disease Spinocerebellar ataxia type 1 (SCA1) is a polyglutamine expansion disorder characterized by the death of Purkinje neurons in the brain. In this issue, Serra et al. (2006) implicate the impaired function of the orphan nuclear receptor ROR alpha in SCA1 pathogenesis. Their intriguing results suggest that derailing a transcription program during embryonic development may render adult neurons more susceptible to toxic insults.	Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020					BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; Skinner PJ, 2002, NEUROMOL MED, V1, P33, DOI 10.1385/NMM:1:1:33; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	10	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					669	671		10.1016/j.cell.2006.11.010	http://dx.doi.org/10.1016/j.cell.2006.11.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110325	Bronze			2022-12-28	WOS:000242330600012
J	Einwogerer, T; Friesinger, H; Handel, M; Neugebauer-Maresch, C; Simon, U; Teschler-Nicola, M				Einwoegerer, Thomas; Friesinger, Herwig; Haendel, Marc; Neugebauer-Maresch, Christine; Simon, Ulrich; Teschler-Nicola, Maria			Upper Palaeolithic infant burials	NATURE			English	Article									Austrian Acad Sci, Prehist Commiss, A-1010 Vienna, Austria; Nat Hist Museum Vienna, Dept Anthropol, A-1010 Vienna, Austria	Austrian Academy of Sciences	Einwogerer, T (corresponding author), Austrian Acad Sci, Prehist Commiss, A-1010 Vienna, Austria.	christine.neugebauer-maresch@oeaw.ac		Teschler-Nicola, Maria Eva/0000-0003-3080-3085; Handel, Marc/0000-0003-2472-4006; Simon, Ulrich/0000-0002-0195-467X				EINWOGERER T, 2000, MITT PRAHIST KOMM OS, V34; Neugebauer-Maresch C., 2003, PREISTORIA ALPINA, V39, P165; Ruff C.B., 2002, TRABALHOS ARQUEOLOGI, V22, P435; SVOBODA J, 2004, PREHLED VYZKUMU, V46, P63; SVOBODA J, 2004, PREHLED VYZKUMU, V45, P256; Teschler-Nicola M, 2001, J HUM EVOL, V40, P451, DOI 10.1006/jhev.2001.0470; TeschlerNicola M, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P1, DOI 10.1007/978-3-211-49294-9	7	85	91	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					285	285		10.1038/444285a	http://dx.doi.org/10.1038/444285a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105GL	17108949	Bronze			2022-12-28	WOS:000242018300029
J	Wesnousky, SG				Wesnousky, Steven G.			Predicting the endpoints of earthquake ruptures	NATURE			English	Article							STRIKE-SLIP FAULTS; GEOMETRY; SIMULATIONS; TERMINATION; DYNAMICS; TURKEY	The active fault traces on which earthquakes occur are generally not continuous(1), and are commonly composed of segments that are separated by discontinuities that appear as steps in map- view. Stress concentrations resulting from slip at such discontinuities may slow or stop rupture propagation and hence play a controlling role in limiting the length of earthquake rupture (2). Here I examine the mapped surface rupture traces of 22 historical strike- slip earthquakes with rupture lengths ranging between 10 and 420 km. I show that about two- thirds of the endpoints of strike- slip earthquake ruptures are associated with fault steps or the termini of active fault traces, and that there exists a limiting dimension of fault step ( 3 - 4 km) above which earthquake ruptures do not propagate and below which rupture propagation ceases only about 40 per cent of the time. The results are of practical importance to seismic hazard analysis where effort is spent attempting to place limits on the probable length of future earthquakes on mapped active faults. Physical insight to the dynamics of the earthquake rupture process is further gained with the observation that the limiting dimension appears to be largely independent of the earthquake rupture length. It follows that the magnitude of stress changes and the volume affected by those stress changes at the driving edge of laterally propagating ruptures are largely similar and invariable during the rupture process regardless of the distance an event has propagated or will propagate.	Univ Nevada, Ctr Neotecton Studies, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Wesnousky, SG (corresponding author), Univ Nevada, Ctr Neotecton Studies, Mail Stop 169, Reno, NV 89557 USA.	stevew@seismo.unr.edu						BARKA AA, 1988, TECTONICS, V7, P663, DOI 10.1029/TC007i003p00663; Bodin P, 1996, B SEISMOL SOC AM, V86, P1292; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; GRAYMER RW, IN PRESS GEOLOGICAL; Harris RA, 1999, GEOPHYS RES LETT, V26, P2089, DOI 10.1029/1999GL900377; HARRIS RA, 1991, GEOPHYS RES LETT, V18, P893, DOI 10.1029/91GL01061; Harris RA, 2002, B SEISMOL SOC AM, V92, P245, DOI 10.1785/0120000825; HARRIS RA, 1993, J GEOPHYS RES-SOL EA, V98, P4461, DOI 10.1029/92JB02272; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Kase Y, 1998, GEOPHYS J INT, V135, P911, DOI 10.1046/j.1365-246X.1998.00672.x; KING G, 1985, SCIENCE, V228, P984, DOI 10.1126/science.228.4702.984; MCCANN WR, 1979, PURE APPL GEOPHYS, V117, P1082, DOI 10.1007/BF00876211; Oglesby DD, 2005, B SEISMOL SOC AM, V95, P1604, DOI 10.1785/0120050058; SCHWARTZ DP, 1989, FAULT SEGMENTATION C; SEGALL P, 1980, J GEOPHYS RES, V85, P4337, DOI 10.1029/JB085iB08p04337; SIBSON RH, 1985, NATURE, V316, P248, DOI 10.1038/316248a0; SIBSON RH, 1986, EARTHQUAKE SOURCE ME, P157; Simpson RW, 2006, B SEISMOL SOC AM, V96, pS28, DOI 10.1785/0120050824; WESNOUSKY SG, 1988, NATURE, V335, P340, DOI 10.1038/335340a0; ZHANG P, 1991, J STRUCT GEOL, V13, P165, DOI 10.1016/0191-8141(91)90064-P	20	417	434	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					358	360		10.1038/nature05275	http://dx.doi.org/10.1038/nature05275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108963				2022-12-28	WOS:000242018300046
J	Lefebvre, P; Silink, M				Lefebvre, Pierre; Silink, Martin			Diabetes fights for recognition	LANCET			English	Editorial Material									Int Diabet Federat, B-1000 Brussels, Belgium		Lefebvre, P (corresponding author), Int Diabet Federat, B-1000 Brussels, Belgium.							*INT DIAB FED, 2006, DIAB ATL; *INT DIAB FED, 2006, WORLD DIAB DAY; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; WHO, 2006, PREV CHRON DIS VIT I; World Health Organization, 2006, GLOB STRAT DIET PHYS	6	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1625	1626		10.1016/S0140-6736(06)69671-2	http://dx.doi.org/10.1016/S0140-6736(06)69671-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098061				2022-12-28	WOS:000242099000004
J	Levine, R				Levine, Ruth			Open letter to the incoming director general of the World Health Organization: time to refocus	BRITISH MEDICAL JOURNAL			English	Editorial Material									Ctr Global Dev, Washington, DC 20036 USA		Levine, R (corresponding author), Ctr Global Dev, 1776 Massachusetts Ave NW, Washington, DC 20036 USA.	rlevine@cgdev.org						Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831; GODLEE F, 1995, BRIT MED J, V310, P178, DOI 10.1136/bmj.310.6973.178a; JACK A, 2006, FINANCIAL TIMES 1022; Lee K, 2006, J ROY SOC MED, V99, P494, DOI 10.1258/jrsm.99.10.494; Levine Ruth, 2004, MILLIONS SAVED PROVE; Ruger JP, 2005, BMJ-BRIT MED J, V330, P1099, DOI 10.1136/bmj.330.7500.1099; World Health Organization, GLOB MAL PROGR	7	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 11	2006	333	7576					1015	1017		10.1136/bmj.39020.383102.68	http://dx.doi.org/10.1136/bmj.39020.383102.68			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108GX	17095785	Green Published			2022-12-28	WOS:000242229400020
J	Jorgensen, BB; D'Hondt, S				Jorgensen, Bo Barker; D'Hondt, Steven			Ecology - A starving majority deep beneath the seafloor	SCIENCE			English	Editorial Material							SUBSEAFLOOR SEDIMENTS; PROKARYOTES; BIOSPHERE		Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Max Planck Society; University of Rhode Island	Jorgensen, BB (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	bjoergen@mpi-bremen.de; dhondt@gso.uri.edu	Jorgensen, Bo B/C-2214-2013	Jorgensen, Bo B/0000-0001-9398-8027				Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; JORGENSEN BB, 2006, P OCEAN DRILLING PRO, V0201; Lin LH, 2005, GEOCHIM COSMOCHIM AC, V69, P893, DOI 10.1016/j.gca.2004.07.032; Mauclaire L, 2004, GEOBIOLOGY, V2, P217, DOI 10.1111/j.1472-4677.2004.00035.x; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Smith DC, 2000, GEOMICROBIOL J, V17, P207; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	15	77	81	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					932	934		10.1126/science.1133796	http://dx.doi.org/10.1126/science.1133796			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095684				2022-12-28	WOS:000241896000033
J	Rast, JP; Smith, LC; Loza-Coll, M; Hibino, T; Litman, GW				Rast, Jonathan P.; Smith, L. Courtney; Loza-Coll, Mariano; Hibino, Taku; Litman, Gary W.			Review - Genomic insights into the immune system of the sea urchin	SCIENCE			English	Review							TOLL-LIKE RECEPTORS; STRONGYLOCENTROTUS-PURPURATUS; PATHOGEN RECOGNITION; INNATE IMMUNITY; GENE CHOICE; VERTEBRATE; DIVERSITY; EVOLUTION; INVERTEBRATE; DIVERSIFICATION	Comparative analysis of the sea urchin genome has broad implications for the primitive state of deuterostome host defense and the genetic underpinnings of immunity in vertebrates. The sea urchin has an unprecedented complexity of innate immune recognition receptors relative to other animal species yet characterized. These receptor genes include a vast repertoire of 222 Toll-like receptors, a superfamily of more than 200 NACHT domain - leucine- rich repeat proteins ( similar to nucleotide-binding and oligomerization domain ( NOD) and NALP proteins of vertebrates), and a large family of scavenger receptor cysteine-rich proteins. More typical numbers of genes encode other immune recognition factors. Homologs of important immune and hematopoietic regulators, many of which have previously been identified only from chordates, as well as genes that are critical in adaptive immunity of jawed vertebrates, also are present. The findings serve to underscore the dynamic utilization of receptors and the complexity of immune recognition that may be basal for deuterostomes and predicts features of the ancestral bilaterian form.	Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Univ S Florida, All Childrens Hosp, Coll Med, Dept Pediat,Childrens Res Inst, St Petersburg, FL 33701 USA; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; George Washington University; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Rast, JP (corresponding author), Univ Toronto, Sunnybrook Res Inst, 2075 Bayview Ave,Room S-126B, Toronto, ON M4N 3M5, Canada.	jrast@sri.utoronto.ca	拓, 日比野/D-8115-2013	拓, 日比野/0000-0002-4789-7375; Loza Coll, Mariano/0000-0002-3123-1229	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI023338, R37AI023338, R01AI023338] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23338, R01 AI023338, R37 AI023338, R56 AI023338, R01 AI023338-22] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; BROCKTON KM, UNPUB; BUCKLEY V, UNPUB; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Ebert TA, 2003, FISH B-NOAA, V101, P915; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; HIBINO T, 2006, DEV BIOL, DOI DOI 10.1016/J.YD23.2006.08.065; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hughes AL, 1997, MOL BIOL EVOL, V14, P1, DOI 10.1093/oxfordjournals.molbev.a025694; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Millet ACM, 2004, CURR OPIN IMMUNOL, V16, P4, DOI 10.1016/j.coi.2003.11.005; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Pancer Z, 1999, IMMUNOGENETICS, V49, P773, DOI 10.1007/s002510050551; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rast JP, 2000, CURR TOP MICROBIOL, V248, P3; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	43	318	332	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					952	956		10.1126/science.1134301	http://dx.doi.org/10.1126/science.1134301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095692	Green Accepted			2022-12-28	WOS:000241896000040
J	Yavuz, CT; Mayo, JT; Yu, WW; Prakash, A; Falkner, JC; Yean, S; Cong, LL; Shipley, HJ; Kan, A; Tomson, M; Natelson, D; Colvin, VL				Yavuz, Cafer T.; Mayo, J. T.; Yu, William W.; Prakash, Arjun; Falkner, Joshua C.; Yean, Sujin; Cong, Lili; Shipley, Heather J.; Kan, Amy; Tomson, Mason; Natelson, Douglas; Colvin, Vicki L.			Low-field magnetic separation of monodisperse Fe3O4 nanocrystals	SCIENCE			English	Article							FREQUENCY-DEPENDENCE; REMOVAL; NANOPARTICLES; SIZE; ADSORPTION; DEVICES; WATER	Magnetic separations at very low magnetic field gradients (< 100 tesla per meter) can now be applied to diverse problems, such as point-of-use water purification and the simultaneous separation of complex mixtures. High - surface area and monodisperse magnetite (Fe3O4) nanocrystals (NCs) were shown to respond to low fields in a size-dependent fashion. The particles apparently do not act independently in the separation but rather reversibly aggregate through the resulting high-field gradients present at their surfaces. Using the high specific surface area of Fe3O4 NCs that were 12 nanometers in diameter, we reduced the mass of waste associated with arsenic removal from water by orders of magnitude. Additionally, the size dependence of magnetic separation permitted mixtures of 4- and 12-nanometer - sized Fe3O4 NCs to be separated by the application of different magnetic fields.	Rice Univ, Dept Chem, Houston, TX 77005 USA; Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; Rice Univ, Dept Civil & Environm Engn, Houston, TX 77005 USA; Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University; Rice University; Rice University; Rice University	Colvin, VL (corresponding author), Rice Univ, Dept Chem, 6100 Main St, Houston, TX 77005 USA.	colvin@rice.edu	Yavuz, Cafer T/B-8330-2011; Yu, William/H-5164-2012	Yavuz, Cafer T/0000-0003-0580-3331; Yu, William/0000-0001-5354-6718; Natelson, Douglas/0000-0003-2370-9859				Ambashta RD, 2003, J MAGN MAGN MATER, V267, P335, DOI 10.1016/S0304-8853(03)00401-3; Bucak S, 2003, BIOTECHNOL PROGR, V19, P477, DOI 10.1021/bp0200853; Butler R.F., 1992, PALEOMAGNETISM MAGNE; BUTLER RF, 1975, J GEOPHYS RES, V80, P4049, DOI 10.1029/JB080i029p04049; Butter K, 2003, NAT MATER, V2, P88, DOI 10.1038/nmat811; Chang SC, 2005, J IND MICROBIOL BIOT, V32, P629, DOI 10.1007/s10295-005-0238-x; Chiba A, 2002, IEEE T APPL SUPERCON, V12, P952, DOI 10.1109/TASC.2002.1018557; Cotten GB, 2002, SEP SCI TECHNOL, V37, P3755, DOI 10.1081/SS-120014830; Dearing JA, 1996, GEOPHYS J INT, V124, P228, DOI 10.1111/j.1365-246X.1996.tb06366.x; DELATOUR C, 1973, IEEE T MAGN, VMAG9, P314, DOI 10.1109/TMAG.1973.1067685; Ditsch A, 2005, IND ENG CHEM RES, V44, P6824, DOI 10.1021/ie048841s; FLETCHER D, 1991, IEEE T MAGN, V27, P3655, DOI 10.1109/20.102936; Gerber R., 1983, HIGH GRADIENT MAGNET; Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959; Gunther C.G., 1909, ELECTROMAGNETIC ORE; Hatch GP, 2001, J MAGN MAGN MATER, V225, P262, DOI 10.1016/S0304-8853(00)01250-6; HAUKANES BI, 1993, BIO-TECHNOL, V11, P60, DOI 10.1038/nbt0193-60; HIRSCHBEIN BL, 1982, CHEMTECH, V12, P172; Horak D, 2004, MACROMOL MATER ENG, V289, P341, DOI 10.1002/mame.200300271; Hossain MA, 2005, ENVIRON SCI TECHNOL, V39, P4300, DOI 10.1021/es048703u; Hubbuch JJ, 2001, BIOSEPARATION, V10, P99, DOI 10.1023/A:1012034923621; Hutten A, 2004, J BIOTECHNOL, V112, P47, DOI 10.1016/j.jbiotec.2004.04.019; Iacob G., 2002, EUR CELLS MATER, V3, P167; Kakihara Y, 2004, IEEE T APPL SUPERCON, V14, P1565, DOI 10.1109/TASC.2004.830709; Kanel SR, 2005, ENVIRON SCI TECHNOL, V39, P1291, DOI 10.1021/es048991u; Kelland DR, 1998, IEEE T MAGN, V34, P2123, DOI 10.1109/20.706824; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Liu GD, 2004, ANAL CHEM, V76, P7126, DOI 10.1021/ac049107l; Moeser GD, 2004, AICHE J, V50, P2835, DOI 10.1002/aic.10270; Muxworthy AR, 2001, GEOPHYS J INT, V144, P441, DOI 10.1046/j.1365-246x.2001.00342.x; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; OBERTEUF.JA, 1974, IEEE T MAGN, VMA10, P223, DOI 10.1109/TMAG.1974.1058315; PARKER MR, 1981, PHYS TECHNOL, V12, P263, DOI 10.1088/0305-4624/12/6/I03; Reiss G, 2005, NAT MATER, V4, P725, DOI 10.1038/nmat1494; SETCHELL CH, 1985, J CHEM TECHNOL BIOT, V35, P175, DOI 10.1002/jctb.280350302; Sun SH, 2002, J AM CHEM SOC, V124, P8204, DOI 10.1021/ja026501x; Twidwell LG, 1999, REWAS'99 GLOBAL SYMPOSIUM ON RECYCLING, WASTE TREATMENT AND CLEAN TECHNOLOGY VOLUME I-III, P1715; US Environmental Protection Agency (EPA), 2001, FED REGISTER, V66, P6976; WATSON JHP, 1973, J APPL PHYS, V44, P4209, DOI 10.1063/1.1662920; Worm HU, 1998, GEOPHYS J INT, V133, P201, DOI 10.1046/j.1365-246X.1998.1331468.x; Yean S, 2005, J MATER RES, V20, P3255, DOI 10.1557/JMR.2005.0403; Yu WW, 2004, CHEM COMMUN, P2306, DOI 10.1039/b409601k	42	1026	1066	14	805	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					964	967		10.1126/science.1131475	http://dx.doi.org/10.1126/science.1131475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095696				2022-12-28	WOS:000241896000044
J	White, NJ				White, Nicholas J.			Focus on research - Malaria - Time to act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Mahidol University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Bangkok, Thailand.		White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978					0	15	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1956	1957		10.1056/NEJMp068214	http://dx.doi.org/10.1056/NEJMp068214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102SG	17093246				2022-12-28	WOS:000241833000003
J	Koulaouzidis, A; Bhat, S				Koulaouzidis, Anastasicis; Bhat, Shivaram			Investigating iron status in microcytic anaemia - Zincprotoporphyrin and soluble transferrin receptor have a role	BRITISH MEDICAL JOURNAL			English	Letter							CHRONIC DISEASE; DEFICIENCY		Warrington Hosp, Warrington WA5 1QG, Cheshire, England		Koulaouzidis, A (corresponding author), Warrington Hosp, Warrington WA5 1QG, Cheshire, England.	akoulaouzidis@hotmail.com	Koulaouzidis, Anastasios/G-9060-2014	Koulaouzidis, Anastasios/0000-0002-2248-489X				FERGUSON BJ, 1992, J LAB CLIN MED, V119, P385; Galloway MJ, 2006, BRIT MED J, V333, P791, DOI 10.1136/bmj.38979.358032.BE; HASTKA J, 1993, BLOOD, V81, P1200; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2006	333	7575					972	972		10.1136/bmj.333.7575.972-b	http://dx.doi.org/10.1136/bmj.333.7575.972-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107GE	17082561	Green Published			2022-12-28	WOS:000242157900036
J	Maurer, K; McKeith, I; Cummings, J; Ames, D; Burns, A				Maurer, Konrad; McKeith, Ian; Cummings, Jeffrey; Ames, David; Burns, Alistair			Has the management of Alzheimer's disease changed over the past 100 years?	LANCET			English	Editorial Material							DEMENTIA		Univ Manchester, Wythenshawe Hosp, Div Psychiat, Manchester M23 9PL, Lancs, England; Univ Hosp Frankfurt Main, Dept Psychiat Psychosomat & Psychotherapy, Frankfurt, Germany; Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; Univ Melbourne, Melbourne, Vic, Australia	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Newcastle University - UK; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Melbourne	Burns, A (corresponding author), Univ Manchester, Wythenshawe Hosp, Div Psychiat, Manchester M23 9PL, Lancs, England.	Alistair.Burns@manchester.ac.uk	McKeith, Ian/AAH-3382-2021	Burns, Alistair/0000-0002-9837-0645; McKeith, Ian/0000-0002-9250-0568				Curran S, 2005, INT J GERIATR PSYCH, V20, P842, DOI 10.1002/gps.1365; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Maurer K, 2003, ALZHEIMER LIFE PHYS; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934	6	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1619	1621		10.1016/S0140-6736(06)69663-3	http://dx.doi.org/10.1016/S0140-6736(06)69663-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084762				2022-12-28	WOS:000242180900031
J	Schaap, P; Winckler, T; Nelson, M; Alvarez-Curto, E; Elgie, B; Hagiwara, H; Cavender, J; Milano-Curto, A; Rozen, DE; Dingermann, T; Mutzel, R; Baldauf, SL				Schaap, Pauline; Winckler, Thomas; Nelson, Michaela; Alvarez-Curto, Elisa; Elgie, Barrie; Hagiwara, Hiromitsu; Cavender, James; Milano-Curto, Alicia; Rozen, Daniel E.; Dingermann, Theodor; Mutzel, Rupert; Baldauf, Sandra L.			Molecular phylogeny and evolution of morphology in the social amoebas	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM	The social amoebas (Dictyostelia) display conditional multicellularity in a wide variety of forms. Despite widespread interest in Dictyostelium discoideum as a model system, almost no molecular data exist from the rest of the group. We constructed the first molecular phylogeny of the Dictyostelia with parallel small subunit ribosomal RNA and alpha-tubulin data sets, and we found that dictyostelid taxonomy requires complete revision. A mapping of characters onto the phylogeny shows that the dominant trend in dictyostelid evolution is increased size and cell type specialization of fruiting structures, with some complex morphologies evolving several times independently. Thus, the latter may be controlled by only a few genes, making their underlying mechanisms relatively easy to unravel.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; Univ Jena, Lehrstuhl Pharmazeut Biol, D-07743 Jena, Germany; Tokyo Natl Sci Museum, Tsukuba Bot Garden, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; Univ Frankfurt, Inst Pharmazeut Biol, D-60439 Frankfurt, Germany; ZAFES, Frankfurt, Germany; Free Univ Berlin, Inst Biol, Fachbereich Biol Chem Pharm, D-14195 Berlin, Germany	University of York - UK; University of Dundee; Friedrich Schiller University of Jena; National Museum of Nature and Science; University System of Ohio; Ohio University; Goethe University Frankfurt; Free University of Berlin	Baldauf, SL (corresponding author), Univ York, Dept Biol, Box 373, York YO10 5YW, N Yorkshire, England.	slb14@york.ac.uk	Rozen, Daniel/M-9896-2014; Schaap, Pauline/A-3682-2009; Schaap, Pauline/M-5355-2019; Dingermann, Theodor/M-6970-2014	Rozen, Daniel/0000-0002-7772-0239; Schaap, Pauline/0000-0003-4500-2555; Schaap, Pauline/0000-0003-4500-2555; Baldauf, Sandra/0000-0003-4485-6671; Dingermann, Theodor/0000-0002-2788-1085	BBSRC [BB/D013453/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D013453/1, COD16760] Funding Source: Medline; Wellcome Trust [076618, 057137] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvarez-Curto E, 2005, P NATL ACAD SCI USA, V102, P6385, DOI 10.1073/pnas.0502238102; Bonner JT, 2004, EVOLUTION, V58, P1883; Brefeld O., 1869, ABH SENCKENB NAT, V7, P85; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; HAGIWARA H, 1989, TAXONOMIC STUDY JAPA, P131; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Nikolaev SI, 2005, PROTIST, V156, P191, DOI 10.1016/j.protis.2005.03.002; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Raper K. B., 1984, DICTYOSTELIDS; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087	11	188	193	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					661	663		10.1126/science.1130670	http://dx.doi.org/10.1126/science.1130670			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068267	Green Accepted			2022-12-28	WOS:000241557800052
J	Smart, N; Risebro, CA; Melville, AAD; Moses, K; Schwartz, RJ; Chien, KR; Riley, PR				Smart, Nicola; Risebro, Catherine A.; Melville, Athalie A. D.; Moses, Kelvin; Schwartz, Robert J.; Chien, Kenneth R.; Riley, Paul R.			Thymosin beta 4 induces adult epicardial progenitor mobilization and neovascularization	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ASPARTYL-LYSYL-PROLINE; HEART; MORPHOGENESIS; GROWTH; CELLS; ANGIOGENESIS; INVOLVEMENT; REPAIR	Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insufficiency. Molecules that regulate collateral growth in the ischaemic heart also regulate coronary vasculature formation during embryogenesis. Here we identify thymosin beta 4 (T beta 4) as essential for all aspects of coronary vessel development in mice, and demonstrate that T beta 4 stimulates significant outgrowth from quiescent adult epicardial explants, restoring pluripotency and triggering differentiation of fibroblasts, smooth muscle cells and endothelial cells. T beta 4 knockdown in the heart is accompanied by significant reduction in the pro-angiogenic cleavage product N-acetyl-seryl-aspartyl-lysyl-proline ( AcSDKP). Although injection of AcSDKP was unable to rescue T beta 4 mutant hearts, it significantly enhanced endothelial cell differentiation from adult epicardially derived precursor cells. This study identifies T beta 4 and AcSDKP as potent stimulators of coronary vasculogenesis and angiogenesis, and reveals T beta 4-induced adult epicardial cells as a viable source of vascular progenitors for continued renewal of regressed vessels at low basal level or sustained neovascularization following cardiac injury.	UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	University of London; University College London; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Riley, PR (corresponding author), UCL Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.	P.Riley@ich.ucl.ac.uk	Smart, Nicola/AAN-4011-2020; Smart, Nicola/AAD-3874-2020	Smart, Nicola/0000-0002-3501-7254	MRC [G0200073] Funding Source: UKRI; Medical Research Council [G0200073] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GRILLON C, 1990, FEBS LETT, V274, P30, DOI 10.1016/0014-5793(90)81322-F; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Peng HM, 2005, CIRCULATION, V112, P2436, DOI 10.1161/CIRCULATIONAHA.104.528695; Poelmann RE, 2002, TEX HEART I J, V29, P255; Pokharel S, 2004, CIRCULATION, V110, P3129, DOI 10.1161/01.CIR.0000147180.87553.79; Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/00004872-200403000-00023; RIEGER KJ, 1993, BIOCHEM J, V296, P373, DOI 10.1042/bj2960373; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Smart N, 2002, MECH DEVELOP, V119, pS65, DOI 10.1016/S0925-4773(03)00093-5; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tomanek RJ, 2004, MOL CELL BIOCHEM, V264, P3, DOI 10.1023/B:MCBI.0000044369.88528.a3; von Kodpolitsch Y, 2004, Z KARDIOL, V93, P929, DOI 10.1007/s00392-004-0152-7; Wang DH, 2004, AM J PHYSIOL-HEART C, V287, pH2099, DOI 10.1152/ajpheart.00592.2004; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769	27	499	525	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					177	182		10.1038/nature05383	http://dx.doi.org/10.1038/nature05383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17108969				2022-12-28	WOS:000243384300044
J	Cho, US; Xu, WQ				Cho, Uhn Soo; Xu, Wenqing			Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme	NATURE			English	Article							REGULATORY B SUBUNITS; MIDDLE TUMOR-ANTIGEN; CATALYTIC SUBUNIT; CARBOXYL METHYLATION; B56 SUBUNIT; CORE ENZYME; A-SUBUNIT; PP2A; ALPHA; IDENTIFICATION	Protein phosphatase 2A (PP2A) is a principal Ser/Thr phosphatase, the deregulation of which is associated with multiple human cancers, Alzheimer's disease and increased susceptibility to pathogen infections. How PP2A is structurally organized and functionally regulated remains unclear. Here we report the crystal structure of an AB'C heterotrimeric PP2A holoenzyme. The structure reveals that the HEAT repeats of the scaffold A subunit form a horseshoe-shaped fold, holding the catalytic C and regulatory B' subunits together on the same side. The regulatory B' subunit forms pseudo-HEAT repeats and interacts with the C subunit near the active site, thereby defining substrate specificity. The methylated carboxy-terminal tail of the C subunit interacts with a highly negatively charged region at the interface between A and B' subunits, suggesting that the C-terminal carboxyl methylation of the C subunit promotes B' subunit recruitment by neutralizing charge repulsion. Together, our structural results establish a crucial foundation for understanding PP2A assembly, substrate recruitment and regulation.	Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	wxu@u.washington.edu		cho, uhn-soo/0000-0002-6992-2455; Xu, Wenqing/0000-0002-2884-3101				CAI LW, 1995, BIOCHEM BIOPH RES CO, V208, P274, DOI 10.1006/bbrc.1995.1334; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrotti D, 2006, BRIT J CANCER, V95, P775, DOI 10.1038/sj.bjc.6603317; PHILIPS MR, 2004, SCI STKE, pPE13; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruediger R, 1999, J VIROL, V73, P839, DOI 10.1128/JVI.73.1.839-842.1999; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	40	327	345	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					53	57		10.1038/nature05351	http://dx.doi.org/10.1038/nature05351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17086192				2022-12-28	WOS:000243225100033
J	Urakawa, I; Yamazaki, Y; Shimada, T; Iijima, K; Hasegawa, H; Okawa, K; Fujita, T; Fukumoto, S; Yamashita, T				Urakawa, Itaru; Yamazaki, Yuji; Shimada, Takashi; Iijima, Kousuke; Hasegawa, Hisashi; Okawa, Katsuya; Fujita, Toshiro; Fukumoto, Seiji; Yamashita, Takeyoshi			Klotho converts canonical FGF receptor into a specific receptor for FGF23	NATURE			English	Article							FIBROBLAST GROWTH FACTOR-23; VITAMIN-D METABOLISM; PHOSPHATE REABSORPTION; PROTEIN; GENE; HYPOPHOSPHATEMIA; REGULATOR; MICE; OSTEOMALACIA; SUPPRESSION	FGF23 is a unique member of the fibroblast growth factor (FGF) family because it acts as a hormone that derives from bone and regulates kidney functions, whereas most other family members are thought to regulate various cell functions at a local level(1-5). The renotropic activity of circulating FGF23 indicates the possible presence of an FGF23-specific receptor in the kidney(6). Here we show that a previously undescribed receptor conversion by Klotho, a senescence-related molecule(7), generates the FGF23 receptor. Using a renal homogenate, we found that Klotho binds to FGF23. Forced expression of Klotho enabled the high-affinity binding of FGF23 to the cell surface and restored the ability of a renal cell line to respond to FGF23 treatment. Moreover, FGF23 incompetence was induced by injecting wild-type mice with an anti-Klotho monoclonal antibody. Thus, Klotho is essential for endogenous FGF23 function. Because Klotho alone seemed to be incapable of intracellular signalling, we searched for other components of the FGF23 receptor and found FGFR1(IIIc), which was directly converted by Klotho into the FGF23 receptor. Thus, the concerted action of Klotho and FGFR1( IIIc) reconstitutes the FGF23 receptor. These findings provide insights into the diversity and specificity of interactions between FGF and FGF receptors.	Kirin Brewery Co Ltd, Pharmaceut Res Labs, Gunma 3701295, Japan; Tokyo Univ Hosp, Dept Internal Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan	Kirin Brewery Company Limited; University of Tokyo	Urakawa, I (corresponding author), Kirin Brewery Co Ltd, Pharmaceut Res Labs, 3 Miyahara, Gunma 3701295, Japan.	iurakawa@kirin.co.jp	Fukumoto, Seiji/B-7853-2015	Fukumoto, Seiji/0000-0003-3610-3469; Fujita, Toshiro/0000-0001-9141-7060				CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2; Ornitz D.M., 2001, GENOME BIOL, V2; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wikvall K, 2001, INT J MOL MED, V7, P201; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	30	1308	1428	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					770	774		10.1038/nature05315	http://dx.doi.org/10.1038/nature05315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17086194				2022-12-28	WOS:000242581100063
J	Pfingsten, JS; Costantino, DA; Kieft, JS				Pfingsten, Jennifer S.; Costantino, David A.; Kieft, Jeffrey S.			Structural basis for ribosome recruitment and manipulation by a viral IRES RNA	SCIENCE			English	Article							METHIONINE-INDEPENDENT INITIATION; ENTRY SITE; TRANSLATION; PROTEIN; VISUALIZATION; ELONGATION; SUBUNIT; BINDING	Canonical cap - dependent translation initiation requires a large number of protein factors that act in a stepwise assembly process. In contrast, internal ribosomal entry sites (IRESs) are cis-acting RNAs that in some cases completely supplant these factors by recruiting and activating the ribosome using a single structured RNA. Here we present the crystal structure of the ribosome-binding domain from a Dicistroviridae intergenic region IRES at 3.1 angstrom resolution, providing a view of the prefolded architecture of an all-RNA translation initiation apparatus. Docking of the structure into cryo - electron microscopy reconstructions of an IRES-ribosome complex suggests a model for ribosome manipulation by a dynamic IRES RNA.	Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kieft, JS (corresponding author), Univ Colorado Denver, Dept Biochem & Mol Genet, Mail Stop 8101,POB 6511, Aurora, CO 80045 USA.	Jeffrey.Kieft@uchsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072560] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072560-01, R01 GM072560-04, R01 GM072560-05, R01 GM072560-03, R01 GM072560-02, R01 GM072560] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Bonnal S, 2003, NUCLEIC ACIDS RES, V31, P427, DOI 10.1093/nar/gkg003; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Fukushi S, 2001, J BIOL CHEM, V276, P20824, DOI 10.1074/jbc.C100206200; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hilbers CW, 1998, BIOPOLYMERS, V48, P137, DOI 10.1002/(SICI)1097-0282(1998)48:2<137::AID-BIP4>3.0.CO;2-H; Jan E, 2001, COLD SPRING HARB SYM, V66, P285, DOI 10.1101/sqb.2001.66.285; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JUCKER FM, 1995, RNA, V1, P219; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	25	126	130	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1450	1454		10.1126/science.1133281	http://dx.doi.org/10.1126/science.1133281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17124290	Green Accepted			2022-12-28	WOS:000242406100041
J	Kiessling, W				Kiessling, Wolfgang			Life's complexity cast in stone	SCIENCE			English	Editorial Material							ALPHA-DIVERSITY; INCREASE		Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Kiessling, W (corresponding author), Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany.	wolfgang.kiessling@museum.hu-berlin.de	Kiessling, Wolfgang/E-2259-2015	Kiessling, Wolfgang/0000-0002-1088-2014				BAMBACH R K, 1977, Paleobiology, V3, P152; Bambach Richard K., 2002, Paleontological Society Papers, V8, P319; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Erwin D. H., 2006, EXTINCTION LIFE EART; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Kiessling W, 2005, NATURE, V433, P410, DOI 10.1038/nature03152; Knoll AH, 2000, PALEOBIOLOGY, V26, P1, DOI 10.1666/0094-8373(2000)26[1:DITHOL]2.0.CO;2; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; Maguran AE, 2004, MEASURING BIOL DIVER; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795	15	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1254	1255		10.1126/science.1135738	http://dx.doi.org/10.1126/science.1135738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124314				2022-12-28	WOS:000242215800031
J	Roberts, JW				Roberts, Jeffrey W.			Biochemistry - RNA polymerase, a scrunching machine	SCIENCE			English	Editorial Material							LAC UV5 PROMOTER; INITIATION; COMPLEX; INVITRO; DNA		Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Roberts, JW (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jwr7@cornell.edu						CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Johnston D. E., 1976, RNA POLYMERASE, P413; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X	12	17	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1097	1098		10.1126/science.1135746	http://dx.doi.org/10.1126/science.1135746			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110563				2022-12-28	WOS:000242045800029
J	Okada, A; Charron, F; Morin, S; Shin, DS; Wong, K; Fabre, PJ; Tessier-Lavigne, M; McConnell, SK				Okada, Ami; Charron, Frederic; Morin, Steves; Shin, David S.; Wong, Karen; Fabre, Pierre J.; Tessier-Lavigne, Marc; McConnell, Susan K.			Boc is a receptor for sonic hedgehog in the guidance of commissural axons	NATURE			English	Article							IG SUPERFAMILY MEMBER; CDO; PROTEINS; PATHWAY; GENE; EXPRESSION; COMPONENTS; NETRIN-1; ENCODES; FAMILY	In the spinal cord, sonic hedgehog ( Shh) is secreted by the floor plate to control the generation of distinct classes of ventral neurons along the dorsoventral axis (1). Genetic and in vitro studies have shown that Shh also later acts as a midline- derived chemoattractant for commissural axons(2). However, the receptor( s) responsible for Shh attraction remain unknown. Here we show that two Robo-related proteins, Boc and Cdon, bind specifically to Shh and are therefore candidate receptors for the action of Shh as an axon guidance ligand. Boc is expressed by commissural neurons, and targeted disruption of Boc in mouse results in the misguidance of commissural axons towards the floor plate. RNA- interference-mediated knockdown of Boc impairs the ability of rat commissural axons to turn towards an ectopic source of Shh in vitro. Taken together, these data suggest that Boc is essential as a receptor for Shh in commissural axon guidance.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Genentech Inc, San Francisco, CA 94080 USA	Stanford University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Roche Holding; Genentech	Okada, A (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.	amio@stanford.edu	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Fabre, Pierre/O-5763-2019; Fabre, Pierre J/A-6800-2017	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Fabre, Pierre J/0000-0002-5936-8120				Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cheng HJ, 2000, METH MOL B, V124, P313; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Connor RM, 2005, J COMP NEUROL, V485, P32, DOI 10.1002/cne.20503; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ericson J, 1995, INT J DEV BIOL, V39, P809; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Ming JE, 1998, CLIN GENET, V53, P155; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Mulieri PJ, 2000, DEV DYNAM, V219, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1032>3.0.CO;2-M; Mulieri PJ, 2002, DEV DYNAM, V223, P379, DOI 10.1002/dvdy.10063; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	30	218	226	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					369	373		10.1038/nature05246	http://dx.doi.org/10.1038/nature05246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17086203				2022-12-28	WOS:000242018300049
J	Kesselheim, AS; Mello, MM				Kesselheim, Aaron S.; Mello, Michelle M.			Medical-process patents - Monopolizing the delivery of health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTELLECTUAL PROPERTY; SCIENCE; POLICY; LAW		Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	PHS HHS [6T32HP1101] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN RH, 1990, Patent No. 4940658; *AM MED ASS, E9095 AM MED ASS; Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; [Anonymous], 2002, US Patent, Patent No. [6,469,012 B1, 6469012]; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Burk DL, 2003, VA LAW REV, V89, P1575, DOI 10.2307/3202360; Eisenberg RS, 2003, SCIENCE, V299, P1018, DOI 10.1126/science.1081790; Glasson J, 1998, FOOD DRUG LAW J, V53, P341; Jackson CT, 1846, United States Patent Office, Patent No. 4848; Jaffe A.B., 2004, INNOVATION ITS DISCO; Kesselheim AS, 2005, JAMA-J AM MED ASSOC, V293, P850, DOI 10.1001/jama.293.7.850; KESSELHEIM AS, IN PRESS HLTH AFF MI; McCormick B., 1994, AM MEDICAL NEWS 0905, P3; Mitnovetski O, 2004, J MED ETHICS, V30, P470, DOI 10.1136/jme.2002.000786; NAIR MG, 1994, Patent No. 5279949; Resnik DB, 2003, HEALTH POLICY, V65, P181, DOI 10.1016/S0168-8510(02)00206-3; STABLER SP, 1988, J CLIN INVEST, V81, P466, DOI 10.1172/JCI113343; ZIMMERMAN R, 2001, WALL STREET J   1119; 1973, EUR PAT CONV; 2004, Patent No. 6770279	20	17	17	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					2036	2041		10.1056/NEJMhpr063626	http://dx.doi.org/10.1056/NEJMhpr063626			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102SG	17093256				2022-12-28	WOS:000241833000015
J	Ledford, H				Ledford, Heidi			A breed apart	NATURE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					137	137		10.1038/444137a	http://dx.doi.org/10.1038/444137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093424	Bronze			2022-12-28	WOS:000241867200010
J	Riley, L				Riley, Lisa			Family medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lisa.riley@ucsf.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2181	2182		10.1001/jama.296.18.2181	http://dx.doi.org/10.1001/jama.296.18.2181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090756				2022-12-28	WOS:000241827700001
J	Gandhi, NR; Moll, A; Sturm, AW; Pawinski, R; Govender, T; Lalloo, U; Zeller, K; Andrews, J; Friedland, G				Gandhi, Neel R.; Moll, Anthony; Sturm, A. Willem; Pawinski, Robert; Govender, Thiloshini; Lalloo, Umesh; Zeller, Kimberly; Andrews, Jason; Friedland, Gerald			Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; COUNTRIES; OUTBREAK; EMERGENCE; RATES; ERA	Background The epidemics of HIV-1 and tuberculosis in South Africa are closely related. High mortality rates in co-infected patients have improved with antiretroviral. therapy, but drug-resistant tuberculosis has emerged as a major cause of death. We assessed the prevalence and consequences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in a rural area in KwaZulu Natal, South Africa. Methods We undertook enhanced surveillance for drug-resistant tuberculosis with sputum culture and drug susceptibility testing in patients with known or suspected tuberculosis. Genotyping was done for isolates resistant to first-line and second-line drugs. Results From January, 2005, to March, 2006, sputum was obtained from 1539 patients. We detected MDR tuberculosis in 221 patients, of whom 53 had XDR tuberculosis. Prevalence among 475 patients with culture-confirmed tuberculosis was 39% (185 patients) for MDR and 6% (30) for XDR tuberculosis. Only 55% (26 of 47) of patients with XDR tuberculosis had never been previously treated for tuberculosis; 67% (28 of 42) had a recent hospital admission. All 44 patients with XDR tuberculosis who were tested for HIV were co-infected. 52 of 53 patients with XDR tuberculosis died, with median survival of 16 days from time of diagnosis (IQR 6-37) among the 42 patients with confirmed dates of death. Genotyping of isolates showed that 39 of 46 (85%, 95% Cl 74-95) patients with XDR tuberculosis had similar strains. Conclusions MDR tuberculosis is more prevalent than previously realised in this setting. XDR tuberculosis has been transmitted to HIV co-infected patients and is associated with high mortality. These observations warrant urgent intervention and threaten the success of treatment programmes for tuberculosis and HIV.	Yale Univ, Sch Med, AIDS Program, Infect Dis Sect,Dept Internal Med, New Haven, CT 06520 USA; Church Scotland Hosp & Philanjalo, Tugela Ferry, South Africa; Nelson R Mandela Sch Med, Dept Med Microbiol, Durban, South Africa; Nelson R Mandela Sch Med, Dept Med, Durban, South Africa; Kwazulu Natal Dept Hlth, Kwa Zulu, South Africa; Brown Univ, Sch Med, Providence, RI 02912 USA; Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA	Yale University; University of Kwazulu Natal; University of Kwazulu Natal; Brown University; Yeshiva University; Albert Einstein College of Medicine	Gandhi, NR (corresponding author), Yale Univ, Sch Med, AIDS Program, Infect Dis Sect,Dept Internal Med, New Haven, CT 06520 USA.	negandhi@montefiore.org		Andrews, Jason/0000-0002-5967-251X				Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; BARNES L, 2006, WITNESS         0821; Campos PE, 2003, EMERG INFECT DIS, V9, P1571, DOI 10.3201/eid0912.020731; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Davies GR, 1999, INT J TUBERC LUNG D, V3, P799; De Cock KM, 2005, AM J RESP CRIT CARE, V172, P3, DOI 10.1164/rccm.2504003; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Farmer P, 1999, INT J TUBERC LUNG D, V3, P643; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Friedland G, 2004, CLIN INFECT DIS, V38, pS421, DOI 10.1086/421407; GANDHI N, 2006, TOR 16 INT AIDS C; Hannan MM, 2001, J HOSP INFECT, V47, P91, DOI 10.1053/jhin.2000.0884; Harries AD, 1997, T ROY SOC TROP MED H, V91, P15, DOI 10.1016/S0035-9203(97)90376-X; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Joseph P, 2006, AIDS, V20, P415, DOI 10.1097/01.aids.0000206505.09159.9a; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Lalloo UG, 2006, CURR OPIN PULM MED, V12, P179, DOI 10.1097/01.mcp.0000219266.27439.52; LAWN S, 2006, TOR 16 INT AIDS C; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; O'Brien RJ, 2005, CLIN CHEST MED, V26, P327, DOI 10.1016/j.ccm.2005.02.013; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; RAVIGLIONE MC, 1997, AIDS, V11, P115; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; *S AFR TUB CONTR P, 2000, S AFR TUB CONTR PROG; Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; STURM AW, 2006, UKZN OUTBREAK EXPERT; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WEYER K, 2003, SURVEY TUBERCULOSIS; *WHO, 2006, GEN M GLOB XDR TB TA; *WHO, 2003, 7 WHO; *WHO IUATLD GLOB P, 2004, 3 WHOIUATLD GLOB PRO; Wilkinson D, 1997, S AFR MED J, V87, P447; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, WHOHTM2006361; World Health Organization, 1994, WHOTB94179; World Health Organization, 2006, WHOHTMTB2006362; 1991, MMWR MORB MORTAL WKL, V40, P585; 2006, MMWR MORB MORTAL WKL, V55, P301	45	1182	1238	1	86	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1575	1580		10.1016/S0140-6736(06)69573-1	http://dx.doi.org/10.1016/S0140-6736(06)69573-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084757				2022-12-28	WOS:000242180900026
J	Axtell, MJ; Jan, C; Rajagopalan, R; Bartel, DP				Axtell, Michael J.; Jan, Calvin; Rajagopalan, Ramya; Bartel, David P.			A two-hit trigger for siRNA biogenesis in plants	CELL			English	Article							TRANS-ACTING SIRNAS; INTERFERING RNA; ARABIDOPSIS; MICRORNAS; EXPRESSION; TARGETS; DICER; ACCUMULATION; DCL4	In Arabidopsis, microRNA-directed cleavage can define one end of RNAs that then generate phased siRNAs. However, most miRNA-targeted RNAs do not spawn siRNAs, suggesting the existence of additional determinants within those that do. We find that in moss, phased siRNAs arise from regions flanked by dual miR390 cleavage sites. AtTAS3, an siRNA locus important for development and conserved among higher plants, also has dual miR390 complementary sites. Both sites bind miR390 in vitro and are functionally required in Arabidopsis, but cleavage is undetectable at the 5' site-demonstrating that noncleavable sites can be functional in plants. Phased siRNAs also emanate from the bounded regions of every Arabidopsis gene with two known microRNA/siRNA complementary sites, but only rarely from genes with single sites. Therefore, two "hits,"-often, but not always, two cleavage events-constitute a conserved trigger for siRNA biogenesis, a finding with implications for recognition and silencing of aberrant RNA.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu						Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SMITH HA, 1994, PLANT CELL, V6, P1441, DOI 10.1105/tpc.6.10.1441; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	33	462	524	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					565	577		10.1016/j.cell.2006.09.032	http://dx.doi.org/10.1016/j.cell.2006.09.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081978	Bronze			2022-12-28	WOS:000241937000020
J	Clarke, PR; Sanderson, HS				Clarke, Paul R.; Sanderson, Helen S.			A mitotic role for BRCA1/BARD1 in tumor suppression?	CELL			English	Editorial Material							BRCA1	The tumor-suppressor protein BRCA1 is thought to act by preserving genomic integrity. In this issue of Cell, Joukov et al. (2006) demonstrate that the BRCA1/BARD1 heterodimer participates in mitotic spindle assembly, a process conducted by the GTPase Ran. Loss of this mitotic function might contribute to tumorigenesis.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland	University of Dundee	Clarke, PR (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.	p.r.clarke@dundee.ac.uk	Clarke, Paul R./AAA-6803-2020; Clarke, Paul/B-1684-2009	Clarke, Paul/0000-0003-3525-2622; Sanderson, Helen/0000-0002-0701-219X	Biotechnology and Biological Sciences Research Council [BB/C007778/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Choudhury AD, 2005, J BIOL CHEM, V280, P24669, DOI 10.1074/jbc.M502446200; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; JOUKOV V, 2006, CELL; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Sankaran S, 2006, J CELL BIOCHEM, V99, P1240, DOI 10.1002/jcb.21003; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837	10	4	6	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					453	455		10.1016/j.cell.2006.10.020	http://dx.doi.org/10.1016/j.cell.2006.10.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081965	Bronze			2022-12-28	WOS:000241937000007
J	Muller, H; Fogeron, ML; Lehmann, V; Lehrach, H; Lange, BMH				Mueller, Hannah; Fogeron, Marie-Laure; Lehmann, Verena; Lehrach, Hans; Lange, Bodo M. H.			A centrosome-independent role for gamma-TuRC proteins in the spindle assembly checkpoint	SCIENCE			English	Article							TUBULIN COMPLEXES; VERTEBRATES	The spindle assembly checkpoint guards the fidelity of chromosome segregation. It requires the close cooperation of cell cycle regulatory proteins and cytoskeletal elements to sense spindle integrity. The role of the centrosome, the organizing center of the microtubule cytoskeleton, in the spindle checkpoint is unclear. We found that the molecular requirements for a functional spindle checkpoint included components of the large gamma-tubulin ring complex (gamma-TuRC). However, their localization at the centrosome and centrosome integrity were not essential for this function. Thus, the spindle checkpoint can be activated at the level of microtubule nucleation.	Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany	Max Planck Society	Lange, BMH (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	lange_b@molgen.mpg.de						Barbosa V, 2003, J CELL SCI, V116, P929, DOI 10.1242/jcs.00295; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Colornbie N, 2006, MOL BIOL CELL, V17, P272, DOI 10.1091/mbc.e05-08-0722; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Prigozhina NL, 2004, MOL BIOL CELL, V15, P1374, DOI 10.1091/mbc.E03-06-0405; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Sluder G, 2005, NAT REV MOL CELL BIO, V6, P743, DOI 10.1038/nrm1712; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	29	32	34	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					654	657		10.1126/science.1132834	http://dx.doi.org/10.1126/science.1132834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068266	Green Submitted			2022-12-28	WOS:000241557800050
J	Daniels, MA; Teixeiro, E; Gill, J; Hausmann, B; Roubaty, D; Holmberg, K; Werlen, G; Hollander, GA; Gascoigne, NRJ; Palmer, E				Daniels, Mark A.; Teixeiro, Emma; Gill, Jason; Hausmann, Barbara; Roubaty, Dominique; Holmberg, Kaisa; Werlen, Guy; Hollaender, Georg A.; Gascoigne, Nicholas R. J.; Palmer, Ed			Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling	NATURE			English	Article							T-CELL-RECEPTOR; THYMOCYTE POSITIVE SELECTION; CLASS-I MOLECULES; NEGATIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; ANTIGEN-RECEPTOR; IMMUNE-RESPONSE; LIGAND; SELF; CD8	A healthy individual can mount an immune response to exogenous pathogens while avoiding an autoimmune attack on normal tissues. The ability to distinguish between self and non-self is called 'immunological tolerance' and, for T lymphocytes, involves the generation of a diverse pool of functional T cells through positive selection and the removal of overtly self-reactive thymocytes by negative selection during T-cell ontogeny. To elucidate how thymocytes arrive at these cell fate decisions, here we have identified ligands that define an extremely narrow gap spanning the threshold that distinguishes positive from negative selection. We show that, at the selection threshold, a small increase in ligand affinity for the T-cell antigen receptor leads to a marked change in the activation and subcellular localization of Ras and mitogen-activated protein kinase ( MAPK) signalling intermediates and the induction of negative selection. The ability to compartmentalize signalling molecules differentially in the cell endows the thymocyte with the ability to convert a small change in analogue input ( affinity) into a digital output ( positive versus negative selection) and provides the basis for establishing central tolerance.	Univ Basel Hosp, Dept Res, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland; Univ Childrens Hosp basel, Ctr Biomed, CH-4058 Basel, Switzerland; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Basel; University of Basel; Scripps Research Institute; Rutgers State University New Brunswick	Palmer, E (corresponding author), Univ Basel Hosp, Dept Res, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland.	ed.palmer@unibas.ch		Daniels, Mark/0000-0002-5175-9901; Gill, Jason/0000-0003-0955-6470; Hollander, Georg/0000-0002-8790-0874				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Germain RN, 2001, J BIOL CHEM, V276, P35223, DOI 10.1074/jbc.R100025200; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hare KJ, 1999, J IMMUNOL, V162, P3978; Hare KJ, 1999, SEMIN IMMUNOL, V11, P3, DOI 10.1006/smim.1998.0151; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Sommers CL, 2004, BIOESSAYS, V26, P61, DOI 10.1002/bies.10384; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; Teixeiro E, 2002, J BIOL CHEM, V277, P3993, DOI 10.1074/jbc.M107797200; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	50	433	440	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					724	729		10.1038/nature05269	http://dx.doi.org/10.1038/nature05269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17086201				2022-12-28	WOS:000242581100052
J	Tang, HW; Ng, JHK				Tang, Hangwri; Ng, Jennifer Hwee Kwoon			Googling for a diagnosis - use of Googgle as a diagnostic aid: internet based study	BRITISH MEDICAL JOURNAL			English	Article								Objective To determine how often searching with Google (the most popular search engine on the world wide web) leads doctors to the correct diagnosis. Design Internet based study using Google to search for diagnoses; researchers were blind to the correct diagnoses. Setting One year's (2005) diagnostic cases published in the case records of the New England journal of Medicine. Cases 26 cases from the New England journal of Medicine; management cases were excluded. Main outcome measure Percentage of correct diagnoses from Google searches (compared with the diagnoses as published in the New England journal of Medicine). Results Google searches revealed the correct diagnosis in 15 (58%,95% confidence interval 38% to 77%) cases. Conclusion As internet access becomes more readily available in outpatient clinics and hospital wards, the web is rapidly becoming an important clinical tool for doctors. The use of web based searching may help doctors to diagnose difficult cases.	Princess Alexandra Hosp, Dept Resp & Sleep Med, Brisbane, Qld 4102, Australia; Princess Alexandra Hosp, Dept Rheumatol, Brisbane, Qld 4102, Australia		Tang, HW (corresponding author), Princess Alexandra Hosp, Dept Resp & Sleep Med, Brisbane, Qld 4102, Australia.	hangwitang@yahoo.com						[Anonymous], 2005, OXFORD ADV LEARNERS; Chaudhry MA, 2003, CLIN J SPORT MED, V13, P269, DOI 10.1097/00042752-200307000-00012; Giustini D, 2005, BRIT MED J, V331, P1487, DOI 10.1136/bmj.331.7531.1487; Greenwald R, 2005, NEW ENGL J MED, V353, P2089, DOI 10.1056/NEJM200511103531923; HOFFER EP, 1996, NEW ENGL J MED, V334, P1403; Keljo DJ, 1996, NEW ENGL J MED, V334, P46, DOI 10.1056/NEJM199601043340111; PAUKER SG, 1976, AM J MED, V60, P981, DOI 10.1016/0002-9343(76)90570-2; Powell J, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.1.e4; SCOTT C, 2005, MED PROTECTION SOC C, V13, P22; Steinbrook R, 2006, NEW ENGL J MED, V354, P4, DOI 10.1056/NEJMp058128; Vise David A., 2005, GOOGLE STORY; Wikipedia, FREE ENC	12	223	235	1	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 2	2006	333	7579					1143	1145		10.1136/bmj.39003.640567.AE	http://dx.doi.org/10.1136/bmj.39003.640567.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114LG	17098763	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000242667100014
J	Barrett, A; Roques, T; Small, M; Smith, RD				Barrett, Ann; Roques, Tom; Small, Matthew; Smith, Richard D.			Rationing - How much will Herceptin really cost?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HER2-POSITIVE BREAST-CANCER; ADJUVANT CHEMOTHERAPY; TRASTUZUMAB; NICE		Norfolk & Norwich Univ Hosp NHS Trust, Dept Oncol, Norwich NR4 7UY, Norfolk, England; Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; University of East Anglia	Barrett, A (corresponding author), Norfolk & Norwich Univ Hosp NHS Trust, Dept Oncol, Norwich NR4 7UY, Norfolk, England.	ann.barrett@uea.ac.uk		Smith, Richard/0000-0003-3837-6559				Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Baum M, 2002, LANCET, V359, P2131; *BREAST CLIN STUD, 2005, UK CLIN GUID US ADJ; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dakin HA, 2006, HEALTH POLICY, V77, P352, DOI 10.1016/j.healthpol.2005.08.008; Dent R, 2005, BMJ-BRIT MED J, V331, P1035, DOI 10.1136/bmj.331.7524.1035; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Devlin Nancy, 2003, J Health Serv Res Policy, V8, P183, DOI 10.1258/135581903322029557; Donaldson C, 2005, EC HLTH CARE FINANCI, V2nd; Dyer C, 2006, BRIT MED J, V332, P443, DOI 10.1136/bmj.332.7539.443-c; HIGGINS G, 2005, I WANT LIVE LONG I C; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; McKie J, 2003, SOC SCI MED, V56, P2407, DOI 10.1016/S0277-9536(02)00244-7; Mitton C., 2004, COST EFFECTIVENESS R, V2; *NAT I CLIN EXC, 2005, CLIN GUID, V24; *NAT I HLTH CLIN E, 2002, GUID US TRAST TREATM; *NAT I HLTH CLIN E, 2006, TRAST TREATM EARL ST; *NAT I HLTH CLIN E, 2006, NICE PUBL FAST TRACK; *NICE, 2001, NAT I CLIN EXC TECHN, V30; *NICE, 2005, NAT I CLIN EXC TECHN, V93; *NICE, 2003, NAT I CLIN EXC TECHN, V55; *NICE, 2001, NAT I CLIN EXC TECHN, V25; *NICE, 2001, NAT I CLIN EXC TECHN, V23; *NICE, 2002, NAT I CLIN EXC TECHN, V34; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pisters KMW, 2005, J CLIN ONCOL, V23, P3270, DOI 10.1200/JCO.2005.11.478; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Rogers W, 2006, HEALTH EXPECT, V9, P197, DOI 10.1111/j.1369-7625.2006.00389.x; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; TIMMINS N, 2001, FINANCIAL TIMES 0810; Wong R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002092.pub2; 2005, LANCET, V366, P1673	32	88	88	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 25	2006	333	7578					1118	1120A		10.1136/bmj.39008.624051.BE	http://dx.doi.org/10.1136/bmj.39008.624051.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124225	Green Published, Green Accepted			2022-12-28	WOS:000242520200021
J	McMillan, DC; Sattar, N; Lean, M; McArdle, CS				McMillan, Donald C.; Sattar, Naveed; Lean, Mike; McArdle, Colin S.			ABC of obesity - Obesity and cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERWEIGHT		Royal Infirm, Univ Dept Surg, Glasgow G31 2ER, Lanark, Scotland; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	Royal Infirmary of Edinburgh; University of Glasgow; University of Glasgow	McMillan, DC (corresponding author), Royal Infirm, Univ Dept Surg, Glasgow G31 2ER, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk		McMillan, Donald/0000-0003-4260-5334				Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Vigneri P, 2006, NUTR METAB CARDIOVAS, V16, P1, DOI 10.1016/j.numecd.2005.10.013	3	87	89	2	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 25	2006	333	7578					1109	1111		10.1136/bmj.39042.565035.BE1	http://dx.doi.org/10.1136/bmj.39042.565035.BE1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124223	Green Published			2022-12-28	WOS:000242520200019
J	Halic, M; Blau, M; Becker, T; Mielke, T; Pool, MR; Wild, K; Sinning, I; Beckmann, R				Halic, Mario; Blau, Michael; Becker, Thomas; Mielke, Thorsten; Pool, Martin R.; Wild, Klemens; Sinning, Irmgard; Beckmann, Roland			Following the signal sequence from ribosomal tunnel exit to signal recognition particle	NATURE			English	Article							ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; TRIGGER FACTOR; CRYSTAL-STRUCTURE; NASCENT MEMBRANE; PROTEIN; SRP; RECEPTOR; CORE; VISUALIZATION	Membrane and secretory proteins can be co-translationally inserted into or translocated across the membrane 1. This process is dependent on signal sequence recognition on the ribosome by the signal recognition particle (SRP), which results in targeting of the ribosome-nascent-chain complex to the protein-conducting channel at the membrane(2,3). Here we present an ensemble of structures at subnanometre resolution, revealing the signal sequence both at the ribosomal tunnel exit and in the bacterial and eukaryotic ribosome-SRP complexes. Molecular details of signal sequence interaction in both prokaryotic and eukaryotic complexes were obtained by fitting high-resolution molecular models. The signal sequence is presented at the ribosomal tunnel exit in an exposed position ready for accommodation in the hydrophobic groove of the rearranged SRP54 M domain. Upon ribosome binding, the SRP54 NG domain also undergoes a conformational rearrangement, priming it for the subsequent docking reaction with the NG domain of the SRP receptor. These findings provide the structural basis for improving our understanding of the early steps of co-translational protein sorting.	Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany; Max Planck Inst Mol Genet, USN, UltraStructureNetwork, D-14195 Berlin, Germany; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	University of Munich; Max Planck Society; University of Manchester; Ruprecht Karls University Heidelberg	Beckmann, R (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Halic, Mario/X-2163-2018; Pool, Martin R./AAB-9181-2021; Sinning, Irmgard/A-2982-2010	Pool, Martin R./0000-0003-3071-1535; 	Biotechnology and Biological Sciences Research Council [C20431] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	29	157	163	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					507	511		10.1038/nature05326	http://dx.doi.org/10.1038/nature05326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086193	Green Published			2022-12-28	WOS:000242215700051
J	Morimoto, RI				Morimoto, Richard I.			Clinical implications of basic research: Stress, aging, and neurodegenerative disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS		Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA.				NIGMS NIH HHS [R37 GM038109] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hsu AL, 2003, SCIENCE, V300, P2033; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099	5	58	61	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2254	2255		10.1056/NEJMcibr065573	http://dx.doi.org/10.1056/NEJMcibr065573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107KQ	17124027				2022-12-28	WOS:000242170900017
J	Han, JH; Gong, P; Reddig, K; Mitra, MY; Guo, P; Li, HS				Han, Junhai; Gong, Ping; Reddig, Keith; Mitra, Mirna; Guo, Peiyi; Li, Hong-Sheng			The fly CAMTA transcription factor potentiates deactivation of rhodopsin, a G protein-coupled light receptor	CELL			English	Article							PHOTOTRANSDUCTION CASCADE; DROSOPHILA PHOTORECEPTORS; VISUAL TRANSDUCTION; SIGNALING PATHWAYS; BINDING PROTEIN; GENE-EXPRESSION; DELETED REGION; BETA-ARRESTIN; RAT-BRAIN; IN-VIVO	Control of membrane-receptor activity is required not only for the accuracy of sensory responses, but also to protect cells from excitotoxicity. Here we report the isolation of two noncomplementary fly mutants with slow termination of photoresponses. Genetic and electrophysiological analyses of the mutants revealed a defect in the deactivation of rhodopsin, a visual G protein-coupled receptor (GPCR). The mutant gene was identified as the calmodulinbinding transcription activator (dCAMTA). The known rhodopsin regulator Arr2 does not mediate this visual function of dCAMTA. A genome-wide screen identified five dCAMTA target genes. Of these, overexpression of the F box gene dFbxl4 rescued the mutant phenotypes. We further showed that dCAMTA is stimulated in vivo through interaction with the Ca2+ sensor calmodulin. Our data suggest that calmodulin/ CAMTA/Fbxl4 may mediate a long-term feedback regulation of the activity of Ca2+ -Stimulating GPCRs, which could prevent cell damage due to extra Ca2+ influx.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Li, HS (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	hong-sheng.li@umassmed.edu			NIA NIH HHS [R01-AG022508] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG022508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bird GS, 2004, CURR MOL MED, V4, P291, DOI 10.2174/1566524043360681; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Chen B, 1998, GENETICS, V149, P157; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Gudermann T, 2000, N-S ARCH PHARMACOL, V361, P345, DOI 10.1007/s002109900208; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hurle MA, 2001, J NEUROCHEM, V77, P486, DOI 10.1046/j.1471-4159.2001.00268.x; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Katoh M, 2003, INT J ONCOL, V23, P1219; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Oyama N, 2005, CIRC J, V69, P987, DOI 10.1253/circj.69.987; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200	45	58	60	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					847	858		10.1016/j.cell.2006.09.030	http://dx.doi.org/10.1016/j.cell.2006.09.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110341	Bronze			2022-12-28	WOS:000242330600028
J	Maynard, AD; Aitken, RJ; Butz, T; Colvin, V; Donaldson, K; Oberdorster, G; Philbert, MA; Ryan, J; Seaton, A; Stone, V; Tinkle, SS; Tran, L; Walker, NJ; Warheit, DB				Maynard, Andrew D.; Aitken, Robert J.; Butz, Tilman; Colvin, Vicki; Donaldson, Ken; Oberdoerster, Guenter; Philbert, Martin A.; Ryan, John; Seaton, Anthony; Stone, Vicki; Tinkle, Sally S.; Tran, Lang; Walker, Nigel J.; Warheit, David B.			Safe handling of nanotechnology	NATURE			English	Editorial Material									Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA		Maynard, AD (corresponding author), Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA.	Andrew.Maynard@wilsoncenter.org	Maynard, Andrew/D-1076-2010; Walker, Nigel J/D-6583-2012; Aitken, Robert John/AAY-8238-2020	Walker, Nigel J/0000-0002-9111-6855; Aitken, Robert John/0000-0002-9152-156X; Maynard, Andrew/0000-0003-2117-5128				DAVIS JMG, 1986, BRIT J EXP PATHOL, V67, P415; Donaldson K, 1998, ANN OCCUP HYG, V42, P287, DOI 10.1093/annhyg/42.5.287; *LUX RES, 2006, TAK ACT NAN ENV HLTH; Maynard AD, 2006, NANOTECHNOLOGY RES S; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; OECD, 2006, OECD WORKSH SAF MAN; *ROYAL SOC ROYAL A, 2006, 2 YEAR REV PROGR GOV; Royal Society and the Royal Academy of Engineering, 2004, NAN NAN OPP UNC; *W WILS INT CTR SC, 2006, NAN CONS PROD INV	9	1111	1174	2	284	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					267	269		10.1038/444267a	http://dx.doi.org/10.1038/444267a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108940	Bronze			2022-12-28	WOS:000242018300019
J	Singh, AK; Szczech, L; Tang, KL; Barnhart, H; Sapp, S; Wolfson, M; Reddan, D				Singh, Ajay K.; Szczech, Lynda; Tang, Kezhen L.; Barnhart, Huiman; Sapp, Shelly; Wolfson, Marsha; Reddan, Donal		CHOIR Investigators	Correction of anemia with epoetin alfa in chronic kidney disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INCIDENT HEMODIALYSIS-PATIENTS; LEFT-VENTRICULAR MASS; HEMATOCRIT VALUES; HEMOGLOBIN LEVEL; RENAL-FAILURE; QUALITY; HEALTH; LIFE; NORMALIZATION; MAINTENANCE		Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Duke Univ, Med Ctr, Div Renal, Durham, NC USA; Duke Clin Res Inst, Durham, NC USA; Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; Ortho Biotech Clin Affairs, Bridgewater, NJ USA; Natl Univ Ireland Univ Coll Galway, Dept Med, Galway, Ireland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Duke University; Duke University; Johnson & Johnson; Johnson & Johnson USA; Ollscoil na Gaillimhe-University of Galway	Singh, AK (corresponding author), Brigham & Womens Hosp, Div Renal, 75 Francis St, Boston, MA 02115 USA.	asingh@partners.org	Singh, Ajay/AAF-4414-2020; Wilson, Matthew H/K-3193-2013					[Anonymous], 2001, Am J Kidney Dis, V37, pS182; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; COATES A, 1983, EUR J CANCER CLIN ON, V19, P1633, DOI 10.1016/0277-5379(83)90096-2; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Furuland H, 2003, NEPHROL DIAL TRANSPL, V18, P353, DOI 10.1093/ndt/18.2.353; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; JENNISON C, 2000, GROUP SEQUENTIAL MET, P29; Jones M, 2004, KIDNEY INT, V65, P757, DOI 10.1111/j.1523-1755.2004.00450.x; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Levin Adeera, 2002, Kidney Int Suppl, P35; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; McMahon LP, 2004, J AM SOC NEPHROL, V15, P1640, DOI 10.1097/01.ASN.0000130566.69170.5E; Parfrey PS, 2006, AM J KIDNEY DIS, V47, P171, DOI 10.1053/j.ajkd.2005.11.001; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Ross SD, 2003, CLIN THER, V25, P1786, DOI 10.1016/S0149-2918(03)80170-4; Rossert J, 2006, AM J KIDNEY DIS, V47, P738, DOI 10.1053/j.ajkd.2006.02.170; Strippoli GF, 2003, COCHRANE DB SYST REV, V1; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P3154, DOI 10.1097/01.ASN.0000145436.09176.A7; Wanner C, 2005, NEW ENGL J MED, V353, P1640; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Xue JL, 2002, AM J KIDNEY DIS, V40, P1153, DOI 10.1053/ajkd.2002.36861	31	1979	2076	2	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2085	2098		10.1056/NEJMoa065485	http://dx.doi.org/10.1056/NEJMoa065485			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108343	Bronze			2022-12-28	WOS:000241997300005
J	Cassel, CK; Leatherman, S; Black, C; T Gilmore, I; Armitage, M				Cassel, Christine K.; Leatherman, Sheila; Black, Carol; T Gilmore, Ian; Armitage, Mary			Physicians' assessment and competence: USA and UK	LANCET			English	Editorial Material									Royal Coll Physicians, London NW1 4LE, England; Amer Board Internal Med, Philadelphia, PA USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27515 USA; Acad Med Royal Coll, London, England	Royal College of Physicians; American Board of Internal Medicine; University of North Carolina; University of North Carolina Chapel Hill	Armitage, M (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	mary.armitage@rcplondon.ac.uk						Donaldson L., 2006, GOOD DOCTORS SAFER P; *HEALTHC COMM, WECL HEALTHC COMM; *PMETB, 2006, WELC PMETB	3	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1557	1559		10.1016/S0140-6736(06)69609-8	http://dx.doi.org/10.1016/S0140-6736(06)69609-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084743				2022-12-28	WOS:000242180900009
J	Gilmore, I				Gilmore, Ian			Good doctors, safer patients - Reactions to the chief medical officer's report - A new role for the royal colleges?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Gilmore, I (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	ian.gilmore@rcplondon.ac.uk						Donaldson L., 2006, GOOD DOCTORS SAFER P; *JOINT COMM HIGH M, 2003, ASS GUID ABR; O'Neill TM, 2000, PROC BRIGHTON CROP, V1-3, P267; RCP (Royal College of Physicians), 2005, DOCT SOC MED PROF CH; Williams JG, 2002, CLIN MED, V2, P34, DOI 10.7861/clinmedicine.2-1-34	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2006	333	7575					969	969		10.1136/bmj.39013.584479.47	http://dx.doi.org/10.1136/bmj.39013.584479.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107GE	17082553	Green Published			2022-12-28	WOS:000242157900027
J	Inzucchi, SE				Inzucchi, Silvio E.			Management of hyperglycemia in the hospital setting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; INPATIENT GLUCOSE MANAGEMENT; INSULIN INFUSION PROTOCOL; TIGHT GLYCEMIC CONTROL; DIABETIC-PATIENTS; INFECTIOUS COMPLICATIONS; STRESS HYPERGLYCEMIA; WOUND-INFECTION; BLOOD-GLUCOSE; MORTALITY		Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA	Yale University	Inzucchi, SE (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, 333 Cedar St,LLCI 101, New Haven, CT 06520 USA.	silvio.inzucchi@yale.edu	Inzucchi, Silvio/ABF-4121-2021					*AACE ADA CONS DEV, 2006, INP DIAB GLYC CONTR; [Anonymous], 2005, DIABETES CARE, V28, pS4; Bryer-Ash M, 2005, DIABETES CARE, V28, P973, DOI 10.2337/diacare.28.4.973; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chaudhuri A, 2004, CIRCULATION, V109, P849, DOI 10.1161/01.CIR.0000116762.77804.FC; Cheung NW, 2006, DIABETES CARE, V29, P765, DOI 10.2337/diacare.29.04.06.dc05-1894; Clausen TD, 2005, DIABETES CARE, V28, P990; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Clement S, 2004, DIABETES CARE, V27, P1255; Clement S, 2004, DIABETES CARE, V27, P856; *CLINICALTRIALS GO, NORM INT CAR EV SURV; Cryer PE, 2006, DIABETOLOGIA, V49, P1722, DOI 10.1007/s00125-006-0306-4; Edelman SV, 2005, SOUTH MED J, V98, P363, DOI 10.1097/01.SMJ.0000149424.50849.00; Falciglia M D, 2006, 66 SCI SESS AM DIAB; FathOrdoubadi F, 1997, CIRCULATION, V96, P1152, DOI 10.1161/01.CIR.96.4.1152; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Garber Alan J, 2004, Endocr Pract, V10, P77; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; GOLDBERG PA, 2005, DIABETES SPECTRUM, V18, P188, DOI DOI 10.2337/DIASPECT.18.3.188]; Golden SH, 1999, DIABETES CARE, V22, P1408, DOI 10.2337/diacare.22.9.1408; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hruska LA, 2005, J CARDIAC SURG, V20, P403, DOI 10.1111/j.1540-8191.2005.200472.x; Inzucchi SE, 2005, DIABETES CARE, V28, P976, DOI 10.2337/diacare.28.4.976; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Krinsley, 2005, MAYO CLIN PROC, V80, P1101; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Ku SY, 2005, JT COMM J QUAL PATIE, V31, P141, DOI 10.1016/S1553-7250(05)31019-1; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Malmberg K, 1999, CIRCULATION, V99, P2626, DOI 10.1161/01.CIR.99.20.2626; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Markovitz Lawrence J, 2002, Endocr Pract, V8, P10; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Meijering S, 2006, CRIT CARE, V10, DOI 10.1186/cc3981; Metchick LN, 2002, AM J MED, V113, P317, DOI 10.1016/S0002-9343(02)01213-5; Moghissi ES, 2005, ENDOCRIN METAB CLIN, V34, P99, DOI 10.1016/j.ecl.2004.11.001; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Pomposelli JJ, 1998, JPEN-PARENTER ENTER, V22, P77, DOI 10.1177/014860719802200277; Queale WS, 1997, ARCH INTERN MED, V157, P545, DOI 10.1001/archinte.157.5.545; Riddle MC, 2005, ENDOCRIN METAB CLIN, V34, P77, DOI 10.1016/j.ecl.2004.12.002; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Trence DL, 2003, J CLIN ENDOCR METAB, V88, P2430, DOI 10.1210/jc.2003-030347; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Zerr KJ, 1997, ANN THORAC SURG, V63, P356	51	252	267	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1903	1911		10.1056/NEJMcp060094	http://dx.doi.org/10.1056/NEJMcp060094			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079764				2022-12-28	WOS:000241691700008
J	Kleckner, D; Bouwmeester, D				Kleckner, Dustin; Bouwmeester, Dirk			Sub-kelvin optical cooling of a micromechanical resonator	NATURE			English	Article							QUANTUM; DECOHERENCE	Micromechanical resonators, when cooled down to near their ground state, can be used to explore quantum effects such as superposition and entanglement at a macroscopic scale(1-3). Previously, it has been proposed to use electronic feedback to cool a high frequency ( 10 MHz) resonator to near its ground state(4). In other work, a low frequency resonator was cooled from room temperature to 18 K by passive optical feedback(5). Additionally, active optical feedback of atomic force microscope cantilevers has been used to modify their response characteristics(6), and cooling to approximately 2 K has been measured(7). Here we demonstrate active optical feedback cooling to 135 +/- 15 mK of a micromechanical resonator integrated with a high-quality optical resonator. Additionally, we show that the scheme should be applicable at cryogenic base temperatures, allowing cooling to near the ground state that is required for quantum experiments - near 100 nK for a kHz oscillator.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Kleckner, D (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	dkleckner@physics.ucsb.edu		Kleckner, Dustin/0000-0002-2043-1639				Bose S, 1999, PHYS REV A, V59, P3204, DOI 10.1103/PhysRevA.59.3204; Bruland KJ, 1996, J APPL PHYS, V80, P1959, DOI 10.1063/1.363086; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; Courty JM, 2001, EUR PHYS J D, V17, P399, DOI 10.1007/s100530170014; Hopkins A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.235328; Joos E., 2003, DECOHERENCE APPEARAN; Kleckner D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.173901; Mamin HJ, 2001, APPL PHYS LETT, V79, P3358, DOI 10.1063/1.1418256; Mancini S, 2003, EUR PHYS J D, V22, P417, DOI 10.1140/epjd/e2002-00243-7; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; MERTZ J, 1993, APPL PHYS LETT, V62, P2344, DOI 10.1063/1.109413; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; Moussy N, 2001, REV SCI INSTRUM, V72, P128, DOI 10.1063/1.1331328; PARPIA JM, 1985, REV SCI INSTRUM, V56, P437, DOI 10.1063/1.1138319; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; Turner LD, 2002, OPT COMMUN, V201, P391, DOI 10.1016/S0030-4018(01)01689-3; Vitali D, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063803	18	516	532	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					75	78		10.1038/nature05231	http://dx.doi.org/10.1038/nature05231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080086				2022-12-28	WOS:000241701500047
J	Logtenberg, SJ; Pasma, FH; Wolfhagen, MJ; Dikkeschei, LD; Bilo, HJ				Logtenberg, Susan J.; Pasma, Frans H.; Wolfhagen, Maurice J.; Dikkeschei, Lambert D.; Bilo, Henk J.			Disappearance of immunoglobulins in acute phase of influenza A infection	LANCET			English	Editorial Material									Isala Clin, Dept Internal Med, NL-8000 GK Zwolle, Netherlands; Isala Clin, Dept Cardiothorac Anesthesiol & Intens Care, NL-8000 GK Zwolle, Netherlands; Isala Clin, Lab Clin Microbiol & Infect Dis, NL-8000 GK Zwolle, Netherlands; Isala Clin, Dept Clin Chem, NL-8000 GK Zwolle, Netherlands	Isala Clinics; Isala Clinics; Isala Clinics; Isala Clinics	Logtenberg, SJ (corresponding author), Isala Clin, Dept Internal Med, NL-8000 GK Zwolle, Netherlands.	s.j.j.logtenberg@isala.nl						Hayden Frederick G., 1997, American Journal of Medicine, V102, P55, DOI 10.1016/S0002-9343(97)80013-7; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Rose ME, 2006, CLEV CLIN J MED, V73, P133, DOI 10.3949/ccjm.73.2.133; Sedger LM, 2002, J IMMUNOL, V169, P6193, DOI 10.4049/jimmunol.169.11.6193	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1546	1546		10.1016/S0140-6736(06)69640-2	http://dx.doi.org/10.1016/S0140-6736(06)69640-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071289				2022-12-28	WOS:000241582700033
J	Ramsay, S				Ramsay, Sarah			Lancet/Global Forum essay competition winners 2006	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Ramsay, S (corresponding author), The Lancet, London NW1 7BY, England.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2006	368	9546					1480	1480		10.1016/S0140-6736(06)69617-7	http://dx.doi.org/10.1016/S0140-6736(06)69617-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071269				2022-12-28	WOS:000241582700009
J	McDonel, P; Jans, J; Peterson, BK; Meyer, BJ				McDonel, Patrick; Jans, Judith; Peterson, Brant K.; Meyer, Barbara J.			Clustered DNA motifs mark X chromosomes for repression by a dosage compensation complex	NATURE			English	Article							CONDENSIN SUBUNIT; GENE; HETEROCHROMATIN	Gene expression in metazoans is regulated not only at the level of individual genes but also in a coordinated manner across large chromosomal domains ( for example centromeres, telomeres and imprinted gene clusters(1-3)) and along entire chromosomes ( for example X-chromosome dosage compensation(4-6)). The primary DNA sequence usually specifies the regulation of individual genes, but the nature of cis-acting information that controls genes over large regions has been elusive: higher-order DNA structure, specific histone modifications, subnuclear compartmentalization and primary DNA sequence are possibilities. One paradigm of chromosome-wide gene regulation is Caenorhabditis elegans dosage compensation in which a large dosage compensation complex (DCC) is targeted to both X chromosomes of hermaphrodites to repress transcript levels by half(6). This essential process equalizes X-linked gene expression between the sexes (XO males and XX hermaphrodites). Here we report the discovery and dissection of cis-acting sites that mark nematode X chromosomes as targets for gene repression by the DCC. These rex ( recruitment element on X) sites are widely dispersed along X and reside in promoters, exons and intergenic regions. rex sites share at least two distinct motifs that act in combination to recruit the DCC. Mutating these motifs severely reduces or abolishes DCC binding in vivo, demonstrating the importance of primary DNA sequence in chromosome-wide regulation. Unexpectedly, the motifs are not enriched on X, but altering motif numbers within rex sites demonstrates that motif co-occurrence in unusually high densities is essential for optimal DCC recruitment. Thus, X-specific repression is established through sequences not specific to X. The distribution of common motifs provides the foundation for repression along an entire chromosome.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 16 Barker Hall, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Peterson, Brant/0000-0002-0433-3035; Meyer, Barbara/0000-0002-6530-4588; Jans, Judith/0000-0003-0960-6263	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030702] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM030702-28, R01 GM030702] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Cobbe N, 2006, GENETICS, V172, P991, DOI 10.1534/genetics.105.050567; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Dahlsveen IK, 2006, PLOS GENET, V2, P104, DOI 10.1371/journal.pgen.0020005; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; MEYER BJ, 2005, X CHROMOSOME DOSAGE; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Nusinow DA, 2005, CURR OPIN GENET DEV, V15, P206, DOI 10.1016/j.gde.2005.02.002; Reik W, 2004, COLD SPRING HARB SYM, V69, P29, DOI 10.1101/sqb.2004.69.29; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002	21	78	83	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					614	618		10.1038/nature05338	http://dx.doi.org/10.1038/nature05338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17122774	Green Accepted			2022-12-28	WOS:000242377600047
J	Van Waeyenberge, B; Puzic, A; Stoll, H; Chou, KW; Tyliszczak, T; Hertel, R; Fahnle, M; Bruckl, H; Rott, K; Reiss, G; Neudecker, I; Weiss, D; Back, CH; Schutz, G				Van Waeyenberge, B.; Puzic, A.; Stoll, H.; Chou, K. W.; Tyliszczak, T.; Hertel, R.; Faehnle, M.; Brueckl, H.; Rott, K.; Reiss, G.; Neudecker, I.; Weiss, D.; Back, C. H.; Schuetz, G.			Magnetic vortex core reversal by excitation with short bursts of an alternating field	NATURE			English	Article							DYNAMICS; MOTION; PERMALLOY; DOTS	The vortex state, characterized by a curling magnetization, is one of the equilibrium configurations of soft magnetic materials(1-4) and occurs in thin ferromagnetic square and disk-shaped elements of micrometre size and below. The interplay between the magneto-static and the exchange energy favours an in-plane, closed flux domain structure. This curling magnetization turns out of the plane at the centre of the vortex structure, in an area with a radius of about 10 nanometres-the vortex core(5-7). The vortex state has a specific excitation mode: the in-plane gyration of the vortex structure about its equilibrium position(8-10). The sense of gyration is determined by the vortex core polarization(11). Here we report on the controlled manipulation of the vortex core polarization by excitation with small bursts of an alternating magnetic field. The vortex motion was imaged by time-resolved scanning transmission X-ray microscopy(12). We demonstrate that the sense of gyration of the vortex structure can be reversed by applying short bursts of the sinusoidal excitation field with amplitude of about 1.5 mT. This reversal unambiguously indicates a switching of the out-of-plane core polarization. The observed switching mechanism, which can be understood in the framework of micromagnetic theory, gives insights into basic magnetization dynamics and their possible application in data storage.	Max Planck Inst Met Res, D-70569 Stuttgart, Germany; Univ Ghent, Dept Subatom & Radiat Phys, B-9000 Ghent, Belgium; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Forschungszentrum Julich, Inst Festkorperforsch Elektron Eigenschaften IFF9, D-52425 Julich, Germany; Univ Bielefeld, Fak Phys, D-33615 Bielefeld, Germany; Univ Regensburg, Inst Expt & Angew Phys, D-93040 Regensburg, Germany	Max Planck Society; Ghent University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Helmholtz Association; Research Center Julich; University of Bielefeld; University of Regensburg	Stoll, H (corresponding author), Max Planck Inst Met Res, D-70569 Stuttgart, Germany.	stoll@mf.mpg.de	Reiss, Gunter/A-3423-2010; Back, Christian/A-8969-2012; Chou, Kang Wei/AAG-5374-2021; Hertel, Riccardo/H-9964-2016; Hertel, Riccardo/AAS-4329-2021; Hertel, Riccardo/P-5806-2016; Back, Christian/AAD-7824-2021; Weiss, Dieter/G-4883-2016	Reiss, Gunter/0000-0002-0918-5940; Back, Christian/0000-0003-3840-0993; Hertel, Riccardo/0000-0002-0646-838X; Hertel, Riccardo/0000-0002-0646-838X; Hertel, Riccardo/0000-0002-0646-838X; Back, Christian/0000-0003-3840-0993; Weiss, Dieter/0000-0002-9630-9787; Chou, Kang Wei/0000-0001-9220-4120				ARGYLE BE, 1984, PHYS REV LETT, V53, P190, DOI 10.1103/PhysRevLett.53.190; Choe SB, 2004, SCIENCE, V304, P420, DOI 10.1126/science.1095068; Donahue M. J., 1999, 6376 NISTIR; DORING W, 1968, J APPL PHYS, V39, P1006; FELDTKELLER E, 1965, PHYS KONDENS MATER, V4, P8, DOI 10.1007/BF02423256; Guslienko KY, 2002, J APPL PHYS, V91, P8037, DOI 10.1063/1.1450816; Hollinger R, 2003, J MAGN MAGN MATER, V261, P178, DOI 10.1016/S0304-8853(02)01471-3; HUBER DL, 1982, J APPL PHYS, V53, P1899, DOI 10.1063/1.330661; Hubert A., 1998, MAGNETIC DOMAINS ANA; Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739; Lee KS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2128478; Miltat J, 2002, SCIENCE, V298, P555, DOI 10.1126/science.1077704; Novosad V, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024455; Okuno T, 2002, J MAGN MAGN MATER, V240, P1, DOI 10.1016/S0304-8853(01)00708-9; Park JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.167201; Park JP, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020403; Puzic A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1860971; Raabe J, 2000, J APPL PHYS, V88, P4437, DOI 10.1063/1.1289216; Ross CA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144417; SCHUTZ G, 1987, PHYS REV LETT, V58, P737, DOI 10.1103/PhysRevLett.58.737; Shinjo T, 2000, SCIENCE, V289, P930, DOI 10.1126/science.289.5481.930; Stoll H, 2004, APPL PHYS LETT, V84, P3328, DOI 10.1063/1.1723698; Taniuchi T, 2005, J APPL PHYS, V97, DOI 10.1063/1.1862032; Thiaville A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094410; THIELE AA, 1973, PHYS REV LETT, V30, P230, DOI 10.1103/PhysRevLett.30.230; Vavassori P, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866212; Wachowiak A, 2002, SCIENCE, V298, P577, DOI 10.1126/science.1075302	27	692	696	1	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					461	464		10.1038/nature05240	http://dx.doi.org/10.1038/nature05240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122851				2022-12-28	WOS:000242215700040
J	Uza, N; Nakase, H; Kuwabara, Y; Fujii, S; Chiba, T				Uza, Norimitsu; Nakase, Hiroshi; Kuwabara, Yasuhide; Fujii, Shigehiko; Chiba, Tsutomu			Caecal cancer associated with longstanding Crohn's disease	LANCET			English	Editorial Material							COLORECTAL-CANCER; METAANALYSIS; PREVENTION; RISK		Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 6068507, Japan	Kyoto University	Nakase, H (corresponding author), Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 6068507, Japan.	hiropy@kuhp.kyoto-u.ac.jp	Nakase, Hiroshi/AAZ-4425-2020	Uza, Norimitsu/0000-0002-1334-5740				Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; CHOI PM, 1994, GUT, V35, P950, DOI 10.1136/gut.35.7.950; Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x; Munkholm P, 2006, DIGESTION, V73, P11, DOI 10.1159/000090763; Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1842	1842		10.1016/S0140-6736(06)69741-9	http://dx.doi.org/10.1016/S0140-6736(06)69741-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FJ	17113433				2022-12-28	WOS:000242225400037
J	Serra, HG; Duvick, L; Zu, T; Carlson, K; Stevens, S; Jorgensen, N; Lysholm, A; Burright, E; Zoghbi, HY; Clark, HB; Andresen, JM; Orr, HT				Serra, Heliane G.; Duvick, Lisa; Zu, Tao; Carlson, Kerri; Stevens, Sam; Jorgensen, Nathan; Lysholm, Alana; Burright, Eric; Zoghbi, Huda Y.; Clark, H. Brent; Andresen, J. Michael; Orr, Harry T.			ROR alpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice	CELL			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; ORPHAN NUCLEAR RECEPTOR; POLYGLUTAMINE-INDUCED DISEASE; STAGGERER MUTANT MICE; LONG-TERM DEPRESSION; TRANSGENIC MICE; NEURODEGENERATIVE DISORDER; EXPRESSION ANALYSIS; DEFICIENT MICE; AXH DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is one of nine inherited, typically adult onset, polyglutamine neurodegenerative diseases. To examine whether development impacts SCA1, we used a conditional transgenic mouse model of SCA1 to delay the postnatal expression of mutant ATXN1 until after completion of cerebellar development. Delayed postnatal expression of mutant ATXN1 led to a substantial reduction in severity of disease in adults in comparison with early postnatal gene expression. This was linked to a destabilization of ROR alpha, a transcription factor critical for cerebellar development. In SCA1 mice, there was a depletion of ROR alpha and a reduction in expression of genes controlled by ROR alpha. Partial loss of RORa enhanced mutant ATXN1 pathogenicity. Additionally, evidence points to the existence of a complex containing ATXN1, ROR alpha, and the ROR alpha coactivator Tip60. These studies indicate ROR alpha and Tip60 have a role in SCA1 and suggest a mechanism by which compromising cerebellar development contributes to severity of neurodegeneration in an adult.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Orr, HT (corresponding author), Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA.	orrxx002@umn.edu		Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349; Andresen, J. Michael/0000-0002-8791-1266	NINDS NIH HHS [NS22920, NS27699, NS45667] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R37NS022920, R01NS022920, R01NS045667] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; Banfi S, 1996, HUM MOL GENET, V5, P33, DOI 10.1093/hmg/5.1.33; Boukhtouche F, 2006, J NEUROSCI, V26, P1531, DOI 10.1523/JNEUROSCI.4636-05.2006; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Clark HB, 2000, J NEUROPATH EXP NEUR, V59, P265, DOI 10.1093/jnen/59.4.265; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HATTEN ME, 1978, NATURE, V276, P504, DOI 10.1038/276504a0; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; MATSUMOTO M, 1996, NATURE, V379, P169; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Moraitis AN, 2003, J BIOL CHEM, V278, P52511, DOI 10.1074/jbc.M308152200; Nakagawa S, 1997, NEUROSCI RES, V28, P177, DOI 10.1016/S0168-0102(97)00042-4; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Skinner PJ, 2002, NEUROMOL MED, V1, P33, DOI 10.1385/NMM:1:1:33; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; TSUDA H, 2005, IN PRESS CELL; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	50	161	165	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					697	708		10.1016/j.cell.2006.09.036	http://dx.doi.org/10.1016/j.cell.2006.09.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110330	Bronze			2022-12-28	WOS:000242330600017
J	Ginsburg, PB				Ginsburg, Paul B.			Recalibrating Medicare payments for inpatient care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Studying Hlth Syst Change, Washington, DC USA		Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.							BERENSON RA, 2006, HLTH AFFAIRS    0725; GINSBURG PB, 2005, PRICE ISNT RIGHT INA; *MED PAYM ADV COMM, 2005, REP C PHYS OWN SPEC; 2006, FED REG, V71, P47915	4	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2061	2064		10.1056/NEJMp068203	http://dx.doi.org/10.1056/NEJMp068203			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104YU	17108339				2022-12-28	WOS:000241997300001
J	Wadman, M				Wadman, Meredith			The chips are down	NATURE			English	News Item																			0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					256	257		10.1038/444256a	http://dx.doi.org/10.1038/444256a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108930				2022-12-28	WOS:000242018300011
J	McCarthy, EP; Ngo, LH; Roetzheim, RG; Chirikos, TN; Li, DL; Drews, RE; Iezzoni, LI				McCarthy, Ellen P.; Ngo, Long H.; Roetzheim, Richard G.; Chirikos, Thomas N.; li, Dongn Li; Drews, Reed E.; Iezzoni, Lisa I.			Disparities in breast cancer treatment and survival for women with disabilities	ANNALS OF INTERNAL MEDICINE			English	Article							20-YEAR FOLLOW-UP; OLDER WOMEN; CONSERVING SURGERY; STAGE-I; CONSERVATION THERAPY; AXILLARY DISSECTION; CARCINOMA TREATMENT; RADICAL-MASTECTOMY; RANDOMIZED-TRIAL; PATTERNS	Background: Breast-conserving surgery combined with axillary lymph node dissection and radiotherapy or mastectomy are definitive treatments for women with early-stage breast cancer. Little is known about breast cancer treatment for women with disabilities. Objective: To compare initial treatment for early-stage breast cancer between women with and without disabilities and to examine the association of treatment differences and survival. Design:Retrospective cohort study. Setting: 11 Surveillance, Epidemiology, and End Results (SEER) Program tumor registries. Participants: 100 311 women who received a diagnosis of stage I to IIIA breast cancer at 21 to 64 years of age from 1988 to 1999. Women who qualified for Social Security Disability Insurance (SSDI) and Medicare at breast cancer diagnosis were considered disabled. Measurements: Receipt of breast-conserving surgery versus mastectomy. For women who had breast-conserving surgery (n = 49 166), the authors examined receipt of radiotherapy and axillary lymph node dissection. Survival was measured from diagnosis until death or until 31 December 2001. Results: Women with SSDI and Medicare coverage had lower rates of breast-conserving surgery than other women (43.2% vs. 49.2%; adjusted relative risk, 0.80 [95% Cl, 0.76 to 0.84]). Among women who had breast-conserving surgery, women with SSDI and Medicare coverage were less likely than other women to receive radiotherapy (adjusted relative risk, 0.83 [Cl, 0.77 to 0.90]) and axillary lymph node dissection (adjusted relative risk, 0.81 [Cl, 0.74 to 0.90]). Women with SSDI and Medicare coverage had lower survival rates than those of other women in all-cause mortality (adjusted hazard ratio, 2.02 [Cl, 1.88 to 2.16]) and breast cancer-specific mortality (adjusted hazard ratio, 1.31 [Cl, 1.18 to 1.45]). Results were similar after adjustment for treatment differences. Limitations: Findings are limited to women who qualified for SSDI and Medicare. No data on adjuvant chemotherapy and hormonal therapy were available, and details about the underlying disability were lacking. Conclusions: Women with disabilities had higher breast cancer mortality rates and were less likely to undergo standard therapy after breast-conserving surgery than other women. Differences in treatment did not explain the differences in breast cancer mortality rates.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	McCarthy, EP (corresponding author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr,Dept Med, 1309 Beacon St,Suite 220, Brookline, MA 02444 USA.	emccarth@bidmc.harvard.edu	Roetzheim, Richard/J-4696-2012		NCI NIH HHS [R01 CA100029, R01 CA100029-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE O, 1995, NEW ENGL J MED, V333, P1444; Albain KS, 1996, J CLIN ONCOL, V14, P3009, DOI 10.1200/JCO.1996.14.11.3009; Asch Adrienne, 1988, WOMEN DISABILITIES E, P1; Basnett Ian, 2001, HDB DISABILITY STUDI, P450; Brown P, 2004, SOCIOL HEALTH ILL, V26, P50, DOI 10.1111/j.1467-9566.2004.00378.x; Buchholz TA, 2006, J CLIN ONCOL, V24, P361, DOI 10.1200/JCO.2005.02.3127; Caban ME, 2002, CANCER-AM CANCER SOC, V94, P1391, DOI 10.1002/cncr.10369; Cooper GS, 2002, MED CARE, V40, P43; Du XL, 2002, BREAST CANCER RES TR, V72, P23, DOI 10.1023/A:1014908802632; Du XL, 2001, J CLIN ONCOL, V19, P1455, DOI 10.1200/JCO.2001.19.5.1455; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Eddey GE, 2005, ACAD MED, V80, P706, DOI 10.1097/00001888-200507000-00019; Edge SB, 2002, CANCER, V94, P2534, DOI 10.1002/cncr.10540; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; GERHART KA, 1994, ANN EMERG MED, V23, P807, DOI 10.1016/S0196-0644(94)70318-3; Gill C., 2001, HDB DISABILITY STUDI, P351, DOI DOI 10.4135/9781412976251.N14; Goodwin JS, 2004, J AM GERIATR SOC, V52, P106, DOI 10.1111/j.1532-5415.2004.52018.x; Guadagnoli E, 1998, CANCER-AM CANCER SOC, V83, P302, DOI 10.1002/(SICI)1097-0142(19980715)83:2<302::AID-CNCR14>3.3.CO;2-C; Guadagnoli E, 1998, J CLIN ONCOL, V16, P101, DOI 10.1200/JCO.1998.16.1.101; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hiotis K, 2005, CANCER-AM CANCER SOC, V103, P892, DOI 10.1002/cncr.20853; HOSMER DW, 1989, APPL LOGISTIC REGRES; IEZZONI L, 2003, WHEN WALKING FAILS M; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Iezzoni LI, 2002, MILBANK Q, V80, P347, DOI 10.1111/1468-0009.t01-1-00007; IEZZONI LI, 2003, RISK ADJUSTMENT MEAS, P363; Iezzoni Lisa I., 2006, MORE RAMPS GUIDE IMP; Joslyn SA, 2002, CANCER, V95, P1759, DOI 10.1002/cncr.10827; Keating NL, 2002, J CLIN ONCOL, V20, P1473, DOI 10.1200/JCO.20.6.1473; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Lanz NK, 2004, J CLIN ONCOL, V22, P3091, DOI 10.1200/JCO.2004.09.069; Lee E, 2013, STAT METHODS SURVIVA; LICHTER AS, 1992, J CLIN ONCOL, V10, P976, DOI 10.1200/JCO.1992.10.6.976; LIJEGREN G, 1994, JNCI-J NATL CANCER I, V86, P717; Maggard MA, 2005, ANN SURG ONCOL, V12, P41, DOI 10.1007/s10434-004-1168-y; Maly RC, 2004, J AM GERIATR SOC, V52, P1138, DOI 10.1111/j.1532-5415.2004.52312.x; Mandelblatt JS, 2000, CANCER, V89, P561, DOI 10.1002/1097-0142(20000801)89:3<561::AID-CNCR11>3.0.CO;2-A; MCCARTHY EP, 2006, HLTH SERV RES   0817, P17; Michalski TA, 1997, CANCER-AM CANCER SOC, V79, P314; MORRIS J, 1996, PRIDE AGAINST PREJUD; National Comprehensive Cancer Network, 2006, CLIN PRACT GUID ONC; Olkin R., 1999, WHAT PSYCHOTHERAPIST; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Pierce LJ, 2005, INT J RADIAT ONCOL, V62, P183, DOI 10.1016/j.ijrobp.2004.09.019; POTOSKY AL, 1993, MED CARE, V31, P732; Prehn AW, 2002, CANCER, V95, P2268, DOI 10.1002/cncr.10965; Roetzheim RG, 2000, CANCER-AM CANCER SOC, V89, P2202, DOI 10.1002/1097-0142(20001201)89:11<2202::AID-CNCR8>3.0.CO;2-L; SARRAZIN D, 1984, CANCER, V53, P1209, DOI 10.1002/1097-0142(19840301)53:5<1209::AID-CNCR2820530531>3.0.CO;2-Y; SATARIANO ER, 1992, AM J PUBLIC HEALTH, V82, P195, DOI 10.2105/AJPH.82.2.195; SCHACHTER H, 2004, AHRQ PUBLICATION; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; U.S Department of Health and Human Services, 2005, SURG GEN CALL ACT IM; *US SOC SEC ADM, 2003, ANN STAT S 2003 BALT; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Warren JL, 2002, MED CARE, V40, P3; White J, 2003, CANCER-AM CANCER SOC, V97, P893, DOI 10.1002/cncr.11141	58	96	97	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					637	645		10.7326/0003-4819-145-9-200611070-00005	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ZD	17088576	Green Accepted			2022-12-28	WOS:000241707800001
J	Buckley, M				Buckley, Michael			Good doctors, safer patients - Reactions to the chief medical officer's report - Many questions remain unanswered	BRITISH MEDICAL JOURNAL			English	Editorial Material												mnjbuckley@btinternet.com						Chief Medical Officer, 2006, GOOD DOCT SAF PAT	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2006	333	7575					967	968		10.1136/bmj.39010.460579.68	http://dx.doi.org/10.1136/bmj.39010.460579.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107GE	17082552	Green Published			2022-12-28	WOS:000242157900026
J	Gilmore, I				Gilmore, Ian			The future for specialists and the Medical Royal Colleges?	LANCET			English	Editorial Material									Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Gilmore, I (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	Ian.Gilmore@rcplondon.ac.uk						CASSEL CK, 2006, LANCET          1027, DOI DOI 10.1016/S0140-6736(06)69609-8; Donaldson L., 2006, GOOD DOCTORS SAFER P; *NHS, 2006, MOD MED CAR; O'Neill O, 2004, CLIN MED, V4, P269, DOI 10.7861/clinmedicine.4-3-269; *PMETB, 2006, WECL PMETB; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Smith R, 2001, BMJ-BRIT MED J, V322, P1073, DOI 10.1136/bmj.322.7294.1073; Williams JG, 2002, CLIN MED, V2, P34, DOI 10.7861/clinmedicine.2-1-34	8	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1559	1560		10.1016/S0140-6736(06)69610-4	http://dx.doi.org/10.1016/S0140-6736(06)69610-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084744				2022-12-28	WOS:000242180900010
J	Burke, B				Burke, Brian			Nuclear pore complex models gel	SCIENCE			English	Editorial Material							TRANSPORT		Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32606 USA	State University System of Florida; University of Florida	Burke, B (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 1600 SW Archer Rd, Gainesville, FL 32606 USA.	bburke@ufl.edu						Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027	9	13	13	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					766	767		10.1126/science.1135739	http://dx.doi.org/10.1126/science.1135739			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17082440				2022-12-28	WOS:000241729800027
J	Conti, B; Sanchez-Alavez, M; Winsky-Sommerer, R; Morale, MC; Lucero, J; Brownell, S; Fabre, V; Huitron-Resendiz, S; Henriksen, S; Zorrilla, EP; de Lecea, L; Bartfai, T				Conti, Bruno; Sanchez-Alavez, Manuel; Winsky-Sommerer, Raphaelle; Morale, Maria Concetta; Lucero, Jacinta; Brownell, Sara; Fabre, Veronique; Huitron-Resendiz, Salvador; Henriksen, Steven; Zorrilla, Eric P.; de Lecea, Luis; Bartfai, Tamas			Transgenic mice with a reduced core body temperature have an increased life span	SCIENCE			English	Article							DIETARY RESTRICTION; DROSOPHILA-MELANOGASTER; OREXIN-A; HYPOTHALAMUS; NEURONS; THERMOREGULATION; HYPOCRETINS; MORTALITY; DISEASE; GROWTH	Reduction of core body temperature has been proposed to contribute to the increased life span and the antiaging effects conferred by calorie restriction (CR). Validation of this hypothesis has been difficult in homeotherms, primarily due to a lack of experimental models. We report that transgenic mice engineered to overexpress the uncoupling protein 2 in hypocretin neurons (Hcrt-UCP2) have elevated hypothalamic temperature. The effects of local temperature elevation on the central thermostat resulted in a 0.3 degrees to 0.5 degrees C reduction of the core body temperature. Fed ad libitum, Hcrt-UCP2 transgenic mice had the same caloric intake as their wild-type littermates but had increased energy efficiency and a greater median life span (12% increase in males; 20% increase in females). Thus, modest, sustained reduction of core body temperature prolonged life span independent of altered diet or CR.	Scripps Res Inst, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA; Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Conti, B (corresponding author), Scripps Res Inst, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA.	bconti@scripps.edu	Morale, Maria Concetta/D-5847-2017; de Lecea, Luis/B-3171-2009; de Lecea, Luis/ABE-4005-2021	Morale, Maria Concetta/0000-0003-0624-7234; de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Fabre, Veronique/0000-0003-3230-9435; Sanchez-Alavez, Manuel/0000-0002-8164-8452; Conti, Bruno/0000-0002-9185-5201	NIMH NIH HHS [MH58543] Funding Source: Medline; NINDS NIH HHS [NS043501] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043501] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Austad SN, 2003, AGING CELL, V2, P201, DOI 10.1046/j.1474-9728.2003.00053.x; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duffy PH, 1997, ENVIRON RES, V73, P242, DOI 10.1006/enrs.1997.3714; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Jaszberenyi M, 2002, REGUL PEPTIDES, V104, P55, DOI 10.1016/S0167-0115(01)00339-1; KOIZUMI A, 1992, J NUTR, V122, P1446, DOI 10.1093/jn/122.7.1446; LIU RK, 1966, NATURE, V212, P1277, DOI 10.1038/2121277a0; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Monda M, 2004, BRAIN RES, V1018, P265, DOI 10.1016/j.brainres.2004.05.084; PARMAR M, 1995, SURVIVAL ANAL PRACTI; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Szekely M, 2002, REGUL PEPTIDES, V104, P47, DOI 10.1016/S0167-0115(01)00348-2; Tatar Marc, 2001, P128; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yoshimichi G, 2001, EXP BIOL MED, V226, P468, DOI 10.1177/153537020122600513; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2	29	262	278	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					825	828		10.1126/science.1132191	http://dx.doi.org/10.1126/science.1132191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082459				2022-12-28	WOS:000241729800049
J	Blendon, RJ; Altman, DE				Blendon, Robert J.; Altman, Drew E.			Voters and health care in the 2006 election.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSEQUENCES; POLITICS		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Rm 402, Boston, MA 02115 USA.	rblendon@hsph.harvard.edu						Blendon RJ, 2004, NEW ENGL J MED, V351, P1314, DOI 10.1056/NEJMsa042360; Blendon RJ, 2003, J HEALTH COMMUN, V8, P83, DOI 10.1080/10810730390224884; BLENDON RJ, 2005, HLTH AFF W, V5, P86; BRADY HE, 1992, MEDIA POLLS AM POLIT; COHEN RE, 2006, NATL J WASH, V38, P26; COOK C, 2006, NATL J WASH S, P3; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; DANIEL WW, 1991, BIOSTATISTICS FDN AN, P225; DeNavas-Walt C, 2006, CURRENT POPULATION R; *HARR INT, 2006, HARR INT POLL; JACKSON JE, 1975, AM J POLIT SCI, V19, P161, DOI 10.2307/2110431; Jacobson GC, 2005, POLIT SCI QUART, V120, P199, DOI 10.1002/j.1538-165X.2005.tb00544.x; Jacobson GC., 2000, POLARIZED POLITICS C; Keeter S, 2000, PUBLIC OPIN QUART, V64, P125, DOI 10.1086/317759; Layman GC, 2006, ANNU REV POLIT SCI, V9, P83, DOI 10.1146/annurev.polisci.9.070204.105138; McCarty Nolan, 2006, WALRAS PARETO LECT; Mitofsky W., 1991, POLLING PRESIDENTIAL, P83; Mosteller F, 1949, PREELECTION POLLS 19; NIEMI RG, 1993, CLASSICS VOTING BEHA, P93; PAGE BI, 1979, AM POLIT SCI REV, V73, P1071, DOI 10.2307/1953990; *PEW RES CTR PEOPL, 2004, POLLS FAC GROW RES B; Poole KT., 1997, C POLITICAL EC HIST; *ROP CTR PUBL OP R, 2006, CBS NEWS NEW YO 0915; *ROP CTR PUBL OP R, 2006, LOS ANG TIM POLL; *ROP CTR PUBL OP R, 2006, ABC NEWS WASH POST P; *ROP CTR PUBL OP R, 2006, KAIS FAM FDN POLL; *ROP CTR PUBL OP R, 2006, NBC NEWS WALL S 0908; *ROP CTR PUBL OP R, 2006, GALL POLL; SERAFINI MW, 2006, NATL J WASH, V38, P54; Traugott MW, 2001, PUBLIC OPIN QUART, V65, P389, DOI 10.1086/322850; VOSS DS, 1995, PUBLIC OPIN QUART, V59, P98, DOI 10.1086/269461; *VOT NEWS SERV, 1998, 1998 EL DAY EX POLL; *VOT NEWS SERV, 2002, 2002 EL DAY EX POLL	33	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1928	1933		10.1056/NEJMsr066042	http://dx.doi.org/10.1056/NEJMsr066042			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100TM	17079771				2022-12-28	WOS:000241691700017
J	Michalowicz, BS; Hodges, JS; DiAngelis, AJ; Lupo, VR; Novak, MJ; Ferguson, JE; Buchanan, W; Bofill, J; Papapanou, PN; Mitchell, DA; Matseoane, S; Tschida, PA				Michalowicz, Bryan S.; Hodges, James S.; DiAngelis, Anthony J.; Lupo, Virginia R.; Novak, M. John; Ferguson, James E.; Buchanan, William; Bofill, James; Papapanou, Panos N.; Mitchell, Dennis A.; Matseoane, Stephen; Tschida, Pat A.		OPT Study	Treatment of periodontal disease and the risk of preterm birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL HYGIENE; PREGNANCY; WEIGHT; THERAPY; WOMEN; METAANALYSIS; MANAGEMENT; INFECTION; DELIVERY; OUTCOMES	BACKGROUND: Maternal periodontal disease has been associated with an increased risk of preterm birth and low birth weight. We studied the effect of nonsurgical periodontal treatment on preterm birth. METHODS: We randomly assigned women between 13 and 17 weeks of gestation to undergo scaling and root planing either before 21 weeks (413 patients in the treatment group) or after delivery (410 patients in the control group). Patients in the treatment group also underwent monthly tooth polishing and received instruction in oral hygiene. The gestational age at the end of pregnancy was the prespecified primary outcome. Secondary outcomes were birth weight and the proportion of infants who were small for gestational age. RESULTS: In the follow-up analysis, preterm birth (before 37 weeks of gestation) occurred in 49 of 407 women (12.0%) in the treatment group (resulting in 44 live births) and in 52 of 405 women (12.8%) in the control group (resulting in 38 live births). Although periodontal treatment improved periodontitis measures (P<0.001), it did not significantly alter the risk of preterm delivery (P=0.70; hazard ratio for treatment group vs. control group, 0.93; 95% confidence interval [CI], 0.63 to 1.37). There were no significant differences between the treatment and control groups in birth weight (3239 g vs. 3258 g, P=0.64) or in the rate of delivery of infants that were small for gestational age (12.7% vs. 12.3%; odds ratio, 1.04; 95% CI, 0.68 to 1.58). There were 5 spontaneous abortions or stillbirths in the treatment group, as compared with 14 in the control group (P=0.08). CONCLUSIONS: Treatment of periodontitis in pregnant women improves periodontal disease and is safe but does not significantly alter rates of preterm birth, low birth weight, or fetal growth restriction.	Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN USA; Univ Minnesota, Div Biostat, Minneapolis, MN USA; Hennepin Cty Med Ctr, Dept Dent, Minneapolis, MN USA; Hennepin Cty Med Ctr, Dept Obstet & Gynecol, Minneapolis, MN USA; Univ Kentucky, Ctr Oral Hlth Res, Lexington, KY 40506 USA; Univ Kentucky, Ctr Oral Hlth Res, Lexington, KY 40506 USA; Univ Kentucky, Dept Obstet & Gynecol, Lexington, KY 40506 USA; Univ Mississippi, Med Ctr, Dept Periodont & Prevent Sci, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Obstet & Gynecol, Jackson, MS 39216 USA; Columbia Univ, Div Periodont, New York, NY USA; Harlem Hosp Med Ctr, Dept Obstet & Gynecol, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; Hennepin County Medical Center; University of Kentucky; University of Kentucky; University of Kentucky; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Columbia University	Michalowicz, BS (corresponding author), 17-116 Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	micha002@umn.edu		Papapanou, Panos N./0000-0002-6538-3618	NIDCR NIH HHS [UO1 DE014338] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE014338] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Andersen B, 1999, ACTA OBSTET GYN SCAN, V78, P758, DOI 10.1034/j.1600-0412.1999.780903.x; Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1016/S1470-0328(02)01349-6; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1; Bonito AJ, 2006, J PERIODONTOL, V77, P326; Bonito AJ, 2005, J PERIODONTOL, V76, P1227, DOI 10.1902/jop.2005.76.8.1227; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Cobb CM, 2002, J CLIN PERIODONTOL, V29, P6; COLLINS JG, 1994, INFECT IMMUN, V62, P4356, DOI 10.1128/IAI.62.10.4356-4361.1994; Davenport ES, 2002, J DENT RES, V81, P313, DOI 10.1177/154405910208100505; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Dortbudak O, 2005, J CLIN PERIODONTOL, V32, P45, DOI 10.1111/j.1600-051X.2004.00630.x; Farrell S, 2006, J CLIN PERIODONTOL, V33, P115, DOI 10.1111/j.1600-051X.2005.00884.x; Gibbs R S, 2001, Ann Periodontol, V6, P153, DOI 10.1902/annals.2001.6.1.153; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Hujoel PP, 2006, EUR J ORAL SCI, V114, P2, DOI 10.1111/j.1600-0722.2006.00266.x; Iams JD, 2001, AM J OBSTET GYNECOL, V184, P652, DOI 10.1067/mob.2001.111248; Jeffcoat MK, 2003, J PERIODONTOL, V74, P1214, DOI 10.1902/jop.2003.74.8.1214; LOE H, 1976, J PERIODONTAL RES, V11, P135; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; Lopez NJ, 2002, J PERIODONTOL, V73, P911, DOI 10.1902/jop.2002.73.8.911; MacDorman Marian F, 2005, Natl Vital Stat Rep, V53, P1; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; Mombelli A, 2004, INT DENT J, V54, P3, DOI 10.1111/j.1875-595X.2004.tb00246.x; Moore S, 2004, BRIT DENT J, V197, P251, DOI 10.1038/sj.bdj.4811620; Noack B, 2005, J PERIODONTAL RES, V40, P339, DOI 10.1111/j.1600-0765.2005.00808.x; Offenbacher S, 2006, OBSTET GYNECOL, V107, P1171; Offenbacher S, 2006, OBSTET GYNECOL, V107, P29, DOI 10.1097/01.AOG.0000190212.87012.96; Omwandho Charles O. A., 2006, Archives of Gynecology and Obstetrics, V273, P258, DOI 10.1007/s00404-005-0081-3; Pavia M, 2003, J PERIODONTOL, V74, P916, DOI 10.1902/jop.2003.74.6.916; PIHLSTROM BL, 1987, J PERIODONTOL, V58, P291, DOI 10.1902/jop.1987.58.5.291; Preshaw PM, 2004, J CLIN PERIODONTOL, V31, P697, DOI 10.1111/j.1600-051X.2004.00558.x; Thomson WM, 2004, J CLIN PERIODONTOL, V31, P119, DOI 10.1111/j.0303-6979.2004.00460.x; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Yeo A, 2005, J PERIODONTOL, V76, P551, DOI 10.1902/jop.2005.76.4.551	37	339	352	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1885	1894		10.1056/NEJMoa062249	http://dx.doi.org/10.1056/NEJMoa062249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079762	Bronze			2022-12-28	WOS:000241691700006
J	Howard, EC; Henriksen, JR; Buchan, A; Reisch, CR; Buergmann, H; Welsh, R; Ye, WY; Gonzalez, JM; Mace, K; Joye, SB; Kiene, RP; Whitman, WB; Moran, MA				Howard, Erinn C.; Henriksen, James R.; Buchan, Alison; Reisch, Chris R.; Buergmann, Helmut; Welsh, Rory; Ye, Wenying; Gonzalez, Jose M.; Mace, Kimberly; Joye, Samantha B.; Kiene, Ronald P.; Whitman, William B.; Moran, Mary Ann			Bacterial taxa that limit sulfur flux from the ocean	SCIENCE			English	Article							MARINE BACTERIOPLANKTON; DIMETHYLSULFONIOPROPIONATE; DMSP; SEA; DIMETHYLSULFIDE; ALGAE	Flux of dimethylsulfide (DMS) from ocean surface waters is the predominant natural source of sulfur to the atmosphere and influences climate by aerosol formation. Marine bacterioplankton regulate sulfur flux by converting the precursor dimethylsulfoniopropionate (DMSP) either to DMS or to sulfur compounds that are not climatically active. Through the discovery of a glycine cleavage T-family protein with DMSP methyltransferase activity, marine bacterioplankton in the Roseobacter and SAR11 taxa were identified as primary mediators of DMSP demethylation to methylmercaptopropionate. One-third of surface ocean bacteria harbor a DMSP demethylase homolog and thereby route a substantial fraction of global marine primary production away from DMS formation and into the marine microbial food web.	Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Univ La Laguna, Dept Microbiol, Tenerife 38071, Spain; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; Universidad de la Laguna; University of South Alabama; Dauphin Island Sea Lab	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu	Buchan, Alison/A-9401-2010; Gonzalez, Jose M./C-3333-2013; Burgmann, Helmut/E-8804-2011; Moran, Mary Ann/B-6939-2012; Whitman, William/AAC-5896-2020	Gonzalez, Jose M./0000-0002-9926-3323; Burgmann, Helmut/0000-0002-5651-5906; Henriksen, James/0000-0003-2485-0889; Whitman, William/0000-0003-1229-0423; Moran, Mary Ann/0000-0002-0702-8167; Joye, Samantha/0000-0003-1610-451X				ANDREAE MO, 1990, MAR CHEM, V30, P1, DOI 10.1016/0304-4203(90)90059-L; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; VISSCHER PT, 1992, MAR ECOL PROG SER, V89, P293, DOI 10.3354/meps089293; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168	20	243	265	6	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					649	652		10.1126/science.1130657	http://dx.doi.org/10.1126/science.1130657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068264				2022-12-28	WOS:000241557800048
J	Bongard, J; Zykov, V; Lipson, H				Bongard, Josh; Zykov, Victor; Lipson, Hod			Resilient machines through continuous self-modeling	SCIENCE			English	Article							EVOLUTION; ROBOTS	Animals sustain the ability to operate after injury by creating qualitatively different compensatory behaviors. Although such robustness would be desirable in engineered systems, most machines fail in the face of unexpected damage. We describe a robot that can recover from such change autonomously, through continuous self-modeling. A four-legged machine uses actuation-sensation relationships to indirectly infer its own structure, and it then uses this self-model to generate forward locomotion. When a leg part is removed, it adapts the self-models, leading to the generation of alternative gaits. This concept may help develop more robust machines and shed light on self-modeling in animals.	Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Bongard, J (corresponding author), Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.	josh.bongard@uvm.edu						Alpaydin E., 2004, INTRO MACHINE LEARNI; Arkin R. C., 1998, BEHAV BASED ROBOTICS; Bongard J, 2005, J MACH LEARN RES, V6, P1651; Bongard JC, 2005, IEEE T EVOLUT COMPUT, V9, P361, DOI 10.1109/TEVC.2005.850293; BROOKS RA, 1992, FROM ANIM ANIMAT, P3; Caccavale F, 2002, FAULT DIAGNOSIS FAUL; Christaller T., 1999, Artificial Life and Robotics, V3, P221, DOI 10.1007/BF02481184; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Edelman GM, 1987, NEURAL DARWINISM THE; Full RJ, 1999, J EXP BIOL, V202, P3325; Hornby GS, 2005, IEEE T ROBOT, V21, P402, DOI 10.1109/TRO.2004.839222; Keymeulen D, 1998, ARTIF LIFE, V4, P359, DOI 10.1162/106454698568648; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Kouchmeshky B, 2007, INT J NUMER METH ENG, V69, P1085, DOI 10.1002/nme.1803; KOZLOWSKI K, 1998, MODELLING IDENTIFICA; Ljung L., 1999, SYSTEM IDENTIFICATIO; Mahdavi SH, 2006, AUTON ROBOT, V20, P149, DOI 10.1007/s10514-006-5941-6; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; PFEIFER R, 2002, INT J COGNITION TECH, V1, P125; Saranli U, 2001, INT J ROBOT RES, V20, P616, DOI 10.1177/02783640122067570; Scheier C, 1999, UNDERSTANDING INTELL; Sciavicco L., 2001, MODELLING CONTROL RO; Seung H. S., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P287, DOI 10.1145/130385.130417; Thrun S., 2005, PROBABILISTIC ROBOTI; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Zilberstein S, 2002, LECT NOTES ARTIF INT, V2466, P270	30	414	419	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1118	1121		10.1126/science.1133687	http://dx.doi.org/10.1126/science.1133687			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110570				2022-12-28	WOS:000242045800036
J	Knoblich, JA				Knoblich, Juergen A.			Cell biology - Sara splits the signal	SCIENCE			English	Editorial Material							ENDOSOMES		Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404				Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Hobdy-Henderson KC, 2003, TRAFFIC, V4, P681, DOI 10.1034/j.1600-0854.2003.00124.x; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8	12	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1094	1096		10.1126/science.1135825	http://dx.doi.org/10.1126/science.1135825			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110561				2022-12-28	WOS:000242045800027
J	Yigit, E; Batista, PJ; Bei, YX; Pang, KM; Chen, CCG; Tolia, NH; Joshua-Tor, L; Mitani, S; Simard, MJ; Mello, CC				Yigit, Erbay; Batista, Pedro J.; Bei, Yanxia; Pang, Ka Min; Chen, Chun-Chieh G.; Tolia, Niraj H.; Joshua-Tor, Leemor; Mitani, Shohei; Simard, Martin J.; Mello, Craig C.			Analysis of the C-elegans argonaute family reveals that distinct argonautes act sequentially during RNAi	CELL			English	Article							GENETIC INTERFERENCE; PROTEIN; DSRNA; PIWI; POLYMERASE; GERMLINE; HETEROCHROMATIN; MAINTENANCE; INITIATION; HELICASE	Argonaute (AGO) proteins interact with small RNAs to mediate gene silencing. C. elegans contains 27 AGO genes, raising the question of what roles these genes play in RNAi and related gene-silencing pathways. Here we describe 31 deletion alleles representing all of the previously uncharacterized AGO genes. Analysis of single- and multiple-AGO mutant strains reveals functions in several pathways, including (1) chromosome segregation, (2) fertility, and (3) at least two separate steps in the RNAi pathway. We show that RDE-1 interacts with trigger-derived sense and antisense RNAs to initiate RNAi, while several other AGO proteins interact with amplified siRNAs to mediate downstream silencing. Overexpression of downstream AGOs enhances silencing, suggesting that these proteins are limiting for RNAi. Interestingly, these AGO proteins lack key residues required for mRNA cleavage. Our findings support a two-step model for RNAi, in which functionally and structurally distinct AGOs act sequentially to direct gene silencing.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Gulbenkian PHD Programme Biomed, P-2780156 Oeiras, Portugal; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Cold Spring Harbor Laboratory; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Simard, MJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	martin.simard@crhdq.ulaval.ca; craig.mello@umassmed.edu	pang, Ka Ming Ming/AAW-4059-2021; Tolia, Niraj H/D-2332-2014; Batista, Pedro J/K-5303-2012; pang, ka ming/H-4082-2011	Tolia, Niraj H/0000-0002-2689-1337; pang, ka ming/0000-0001-7262-3918; Joshua-Tor, Leemor/0000-0001-8185-8049; Simard, Martin/0000-0002-3189-9309	NIGMS NIH HHS [GM58800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BRENNER S, 1974, GENETICS, V77, P71; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIMARD MJ, 2005, SCIENCE, V309, P1517; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yochem J, 1998, GENETICS, V149, P1323; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	48	444	488	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					747	757		10.1016/j.cell.2006.09.033	http://dx.doi.org/10.1016/j.cell.2006.09.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110334	Bronze			2022-12-28	WOS:000242330600021
J	Bargmann, CI				Bargmann, Cornelia I.			Comparative chemosensation from receptors to ecology	NATURE			English	Review							DROSOPHILA ANTENNAL LOBE; CANDIDATE ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTOR; MAMMALIAN OLFACTORY-BULB; MOTH MANDUCA-SEXTA; C-ELEGANS; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; MOLECULAR-BASIS; FUNCTIONAL EXPRESSION	Odour perception is initiated by specific interactions between odorants and a large repertoire of receptors in olfactory neurons. During the past few years, considerable progress has been made in tracing olfactory perception from the odorant receptor protein to the activity of olfactory neurons to higher processing centres and, ultimately, to behaviour. The most complete picture is emerging for the simplest olfactory system studied - that of the fruitfly Drosophila melanogaster. Comparison of rodent, insect and nematode olfaction reveals surprising differences and unexpected similarities among chemosensory systems.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BAIER H, 1994, J NEUROSCI, V14, P219; Bargmann C. I., 1997, C ELEGANS, P717; Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bernays EA, 1998, BIOSCIENCE, V48, P35, DOI 10.2307/1313226; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen NS, 2005, P NATL ACAD SCI USA, V102, P146, DOI 10.1073/pnas.0408307102; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lanjuin A, 2004, CURR OPIN NEUROBIOL, V14, P22, DOI 10.1016/j.conb.2004.01.006; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McCarroll SA, 2005, CURR BIOL, V15, P347, DOI 10.1016/j.cub.2005.02.023; Meister M, 2001, J NEUROSCI, V21, P1351; Mongeau R, 2003, J NEUROSCI, V23, P3855; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Nolan KM, 2002, GENE DEV, V16, P3061, DOI 10.1101/gad.1027702; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Qasba P, 1998, J NEUROSCI, V18, P227; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Robertson HM, 2006, WORMBOOK; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	100	223	234	6	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					295	301		10.1038/nature05402	http://dx.doi.org/10.1038/nature05402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108953				2022-12-28	WOS:000242018300035
J	Sommer, MA; Wurtz, RH				Sommer, Marc A.; Wurtz, Robert H.			Influence of the thalamus on spatial visual processing in frontal cortex	NATURE			English	Article							BRAIN-STEM TELLS; EYE FIELD; COROLLARY DISCHARGE; SUPERIOR COLLICULUS; SIGNALS SENT; REPRESENTATION; PATHWAY	Each of our movements activates our own sensory receptors, and therefore keeping track of self- movement is a necessary part of analysing sensory input. One way in which the brain keeps track of self- movement is by monitoring an internal copy, or corollary discharge, of motor commands(1 - 13). This concept could explain why we perceive a stable visual world despite our frequent quick, or saccadic, eye movements: corollary discharge about each saccade would permit the visual system to ignore saccade- induced visual changes(6 - 9). The critical missing link has been the connection between corollary discharge and visual processing. Here we show that such a link is formed by a corollary discharge from the thalamus that targets the frontal cortex. In the thalamus, neurons in the mediodorsal nucleus relay a corollary discharge of saccades from the midbrain superior colliculus to the cortical frontal eye field(10 - 12). In the frontal eye field, neurons use corollary discharge to shift their visual receptive fields spatially before saccades(14,15). We tested the hypothesis that these two components - a pathway for corollary discharge and neurons with shifting receptive fields - form a circuit in which the corollary discharge drives the shift. First we showed that the known spatial and temporal properties of the corollary discharge predict the dynamic changes in spatial visual processing of cortical neurons when saccades are made. Then we moved from this correlation to causation by isolating single cortical neurons and showing that their spatial visual processing is impaired when corollary discharge from the thalamus is interrupted. Thus the visual processing of frontal neurons is spatiotemporally matched with, and functionally dependent on, corollary discharge input from the thalamus. These experiments establish the first link between corollary discharge and visual processing, delineate a brain circuit that is well suited for mediating visual stability, and provide a framework for studying corollary discharge in other sensory systems.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sommer, MA (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	sommer@bns.pitt.edu		Sommer, Marc/0000-0001-5061-763X	NATIONAL EYE INSTITUTE [Z01EY000109, ZIAEY000109] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BELL CC, 1984, COMP PHYSL SENSORY S, P637; DELCOMYN F, 1977, NATURE, V269, P160, DOI 10.1038/269160a0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Sparks D L, 1989, Rev Oculomot Res, V3, P213; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Teuber H.L., 1964, FRONTAL GRANULAR COR, P410; Thier P, 2001, NEUROIMAGE, V14, pS33, DOI 10.1006/nimg.2001.0840; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; VONHELMHOLTZ H, 2000, HELMHOLTZS TREATISE; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3	23	347	348	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					374	377		10.1038/nature05279	http://dx.doi.org/10.1038/nature05279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17093408	Green Published			2022-12-28	WOS:000242018300050
J	Wenzel, RP; Fowler, AA				Wenzel, Richard P.; Fowler, Alpha A., III			Acute bronchitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-TRACT INFECTIONS; SYNCYTIAL VIRUS-INFECTIONS; DOUBLE-BLIND; HUMAN METAPNEUMOVIRUS; PULMONARY-FUNCTION; ANTIBIOTIC USE; PERTUSSIS; ADULTS; INFLUENZA; COMMUNITY		Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Wenzel, RP (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, 1101 E Broad St,POB 980663, Richmond, VA 23298 USA.	rwenzel@mcvh-vcu.edu						[Anonymous], 2006, Lancet, V367, P276; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; BENSON V, 1998, VITAL HLTH STAT S 10, V199; Bent S, 1999, AM J MED, V107, P62, DOI 10.1016/S0002-9343(99)00167-9; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; BOLDY DAR, 1990, RESP MED, V84, P377, DOI 10.1016/S0954-6111(08)80072-8; Braman SS, 2006, CHEST, V129, p95S, DOI 10.1378/chest.129.1_suppl.95S; Brunton S, 2004, AM J MANAG CARE, V10, P689; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; DeLozier J E, 1991, Adv Data, P1; Evans AT, 2002, LANCET, V359, P1648, DOI 10.1016/S0140-6736(02)08597-5; Freymuth F, 2004, REV MAL RESPIR, V21, P35, DOI 10.1016/S0761-8425(04)71233-4; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; Gonzales R, 2000, ANN INTERN MED, V133, P981, DOI 10.7326/0003-4819-133-12-200012190-00014; Gwaltney JM, 1997, CLIN INFECT DIS, V25, P1188, DOI 10.1086/516105; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; HALLETT JS, 1985, ANN ALLERGY, V55, P568; HUESTON WJ, 1994, J FAM PRACTICE, V39, P437; Jonsson JS, 1998, BRIT MED J, V317, P1433, DOI 10.1136/bmj.317.7170.1433; Kicska G, 2003, CLIN NUCL MED, V28, P511, DOI 10.1097/00003072-200306000-00017; Linder JA, 2003, CLIN THER, V25, P2419, DOI 10.1016/S0149-2918(03)80284-9; Linder JA, 2003, J GEN INTERN MED, V18, P802, DOI 10.1046/j.1525-1497.2003.21246.x; Littenberg B, 1996, J FAM PRACTICE, V42, P49; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Matthys H, 2003, PHYTOMEDICINE, V10, P7, DOI 10.1078/1433-187X-00308; McDonough EA, 2005, MOL CELL PROBE, V19, P314, DOI 10.1016/j.mcp.2005.05.002; MELBYE H, 1991, FAM PRACT, V8, P216, DOI 10.1093/fampra/8.3.216; Metlay JP, 1997, ARCH INTERN MED, V157, P1453, DOI 10.1001/archinte.157.13.1453; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Papadopoulos NG, 2003, CURR OPIN ALLERGY CL, V3, P39, DOI 10.1097/01.all.0000053266.39029.b4; Smith SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000245.pub2, 10.1002/14651858.CD000245, DOI 10.1002/14651858.CD000245.PUB2]; Smucny J, 2004, COCHRANE DB SYST REV, V1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; WALSH JJ, 1961, ARCH INTERN MED, V108, P376, DOI 10.1001/archinte.1961.03620090048006; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; WENZEL RP, 1974, AM REV RESPIR DIS, V109, P621; WILLIAMSON HA, 1987, J FAM PRACTICE, V25, P251	44	61	73	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2125	2130		10.1056/NEJMcp061493	http://dx.doi.org/10.1056/NEJMcp061493			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108344				2022-12-28	WOS:000241997300008
J	Laufer, MK; Thesing, PC; Eddington, ND; Masonga, R; Dzinjalamala, FK; Takala, SL; Taylor, TE; Plowe, CV				Laufer, Miriam K.; Thesing, Phillip C.; Eddington, Nicole D.; Masonga, Rhoda; Dzinjalamala, Fraction K.; Takala, Shannon L.; Taylor, Terrie E.; Plowe, Christopher V.			Return of chloroquine antimalarial efficacy in Malawi	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; INTERMITTENT SULFADOXINE-PYRIMETHAMINE; PLACEBO-CONTROLLED TRIAL; DRUG-RESISTANCE; PREVALENCE; MUTATIONS; IMPACT; TRIMETHOPRIM; PROPHYLAXIS; MORBIDITY	BACKGROUND: In 1993, Malawi became the first country in Africa to replace chloroquine with the combination of sulfadoxine and pyrimethamine for the treatment of malaria. At that time, the clinical efficacy of chloroquine was less than 50%. The molecular marker of chloroquine-resistant falciparum malaria subsequently declined in prevalence and was undetectable by 2001, suggesting that chloroquine might once again be effective in Malawi. METHODS: We conducted a randomized clinical trial involving 210 children with uncomplicated Plasmodium falciparum malaria in Blantyre, Malawi. The children were treated with either chloroquine or sulfadoxine-pyrimethamine and followed for 28 days to assess the antimalarial efficacy of the drug. RESULTS: In analyses conducted according to the study protocol, treatment failure occurred in 1 of 80 participants assigned to chloroquine, as compared with 71 of 87 participants assigned to sulfadoxine-pyrimethamine. The cumulative efficacy of chloroquine was 99% (95% confidence interval [CI], 93 to 100), and the efficacy of sulfadoxine-pyrimethamine was 21% (95% CI, 13 to 30). Among children treated with chloroquine, the mean time to parasite clearance was 2.6 days (95% CI, 2.5 to 2.8) and the mean time to the resolution of fever was 10.3 hours (95% CI, 8.1 to 12.6). No unexpected adverse events related to the study drugs occurred. CONCLUSIONS: Chloroquine is again an efficacious treatment for malaria, 12 years after it was withdrawn from use in Malawi.	Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA	University System of Maryland; University of Maryland Baltimore; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine	Plowe, CV (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, 685 W Baltimore St,HSF1-480, Baltimore, MD 21201 USA.	cplowe@medicine.umaryland.edu		Laufer, Miriam/0000-0001-8300-9593; Takala-Harrison, Shannon/0000-0003-4674-8500	NIAID NIH HHS [U01 AI044824, K23 AI059316, K23AI059316, U01AI044824] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI059316, U01AI044824] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 2003, ASS MON ANT DRUG EFF; Babiker HA, 1997, PARASITOL TODAY, V13, P262, DOI 10.1016/S0169-4758(97)01075-2; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Contreras CE, 2002, AM J TROP MED HYG, V67, P400, DOI 10.4269/ajtmh.2002.67.400; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Hastings IA, 2005, DRUG RESIST UPDATE, V8, P43, DOI 10.1016/j.drup.2005.03.003; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Huong NM, 2003, CLIN INFECT DIS, V37, P1461, DOI 10.1086/379323; Huong NM, 2001, T ROY SOC TROP MED H, V95, P325, DOI 10.1016/S0035-9203(01)90254-8; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Laufer MK, 2004, DRUG RESIST UPDATE, V7, P279, DOI 10.1016/j.drup.2004.08.003; LIU DQ, 1995, B WORLD HEALTH ORGAN, V73, P483; Mayor AG, 2001, J INFECT DIS, V183, P1413, DOI 10.1086/319856; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 2004, BRIT MED J, V328, P762; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schwenke A, 2001, WIEN KLIN WOCHENSCHR, V113, P63; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; *UNICEF, WORLD MAL REP 2005; Vieira PP, 2004, J INFECT DIS, V190, P417, DOI 10.1086/422006; Walliker D, 2005, ACTA TROP, V94, P251, DOI 10.1016/j.actatropica.2005.04.005; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858	32	298	304	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1959	1966		10.1056/NEJMoa062032	http://dx.doi.org/10.1056/NEJMoa062032			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093247				2022-12-28	WOS:000241833000004
J	Gonzalez-Pier, E; Gutierrez-Delgado, C; Stevens, G; Barraza-Llorens, M; Porras-Condey, R; Carvalho, N; Loncich, K; Dias, RH; Kulkarni, S; Casey, A; Murakami, Y; Ezzati, M; Salomon, JA				Gonzalez-Pier, Eduardo; Gutierrez-Delgado, Cristina; Stevens, Gretchen; Barraza-Llorens, Mariana; Porras-Condey, Raul; Carvalho, Natalie; Loncich, Kristen; Dias, Rodrigo H.; Kulkarni, Sandeep; Casey, Anna; Murakami, Yuki; Ezzati, Majid; Salomon, Joshua A.			Health System Reform in Mexico 2 - Priority setting for health interventions in Mexico's system of Social Protection in Health	LANCET			English	Article							COST-EFFECTIVENESS; COUNTRIES; INFLUENZA; CHILDREN; WOMEN	Explicit priority setting presents Mexico with the opportunity to match the pressure and complexity of an advancing epidemiological transition with evidence-based policies driven by a fundamental concern for how to make the best use of scarce resources to improve population health. The Mexican priority-setting experience describes how standardised analytical approaches to decision making, mainly burden of disease and cost-effectiveness analyses, combine with other criteria-eg, being responsive to the legitimate non-health expectations of patients and ensuring fair financing across households-to design and implement a set of three differentiated health intervention packages. This process is a key element of a wider set of reform components aimed at extending health insurance, especially to the poor. The most relevant policy implications include lessons on the use of available and proven analytical tools to set national health priorities, the usefulness of priority-setting results to guide long-term capacity development, the importance of favouring an institutionalised approach to cost-effectiveness analysis, and the need for local technical capacity strengthening as an essential step to balance health-maximising arguments and other non-health criteria in a transparent and systematic process.	Minist Hlth, Econ Anal Unit, Mexico City 06600, DF, Mexico; Harvard Initiat Global Hlth, Cambridge, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Gonzalez-Pier, E (corresponding author), Minist Hlth, Econ Anal Unit, Paseo Reforma 450,PH,Col Juarez, Mexico City 06600, DF, Mexico.	epier@salud.gob.mx	Salomon, Joshua/S-1929-2019; Gonzalez Pier, Eduardo/AIB-2488-2022; Salomon, Joshua A/D-3898-2009; Carvalho, Natalie/AAD-4321-2022	Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Carvalho, Natalie/0000-0002-5599-2209				ANAND S, 2006, PUBLIC HLTH ETHICS E; Baltussen Rob, 2006, Cost Eff Resour Alloc, V4, P14, DOI 10.1186/1478-7547-4-14; Baltussen R, 2006, HEALTH POLICY, V78, P149, DOI 10.1016/j.healthpol.2005.10.006; Baltussen R, 2006, HEALTH ECON, V15, P689, DOI 10.1002/hec.1092; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; *COM NAC PROT SOC, 2006, CAT UN SERV ES; DANIELS N, 2006, AM J PUBLIC HEALTH, V96, P3; Daniels N, 2002, SETTING LIMITS FAIRL; FRENK J, 1994, EC SALUD PROPUESTA A; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; GAKIDOU E, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69568-8; GUTIERREZ C, 2006, 28 INT C ACT PAR FRA; *INEGI, IND SOC MEX 1930 200; JAMISON D, 1990, DIS CONTROL PRIORITI; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; KNAUL FM, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69565-2; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; LOZANO R, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69566-4; Luce BR, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e24; Mitton C R, 2002, Eur J Health Econ, V3, P240, DOI 10.1007/s10198-002-0136-3; *NAT I HLTH CLIN E, SOC VAL JUDGM PRINC; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ries LA, 2002, SEER CANC STAT REV 1; Robinson R, 1999, HEALTH POLICY, V49, P13, DOI 10.1016/S0168-8510(99)00040-8; Rodriguez-Cuevas S, 2001, CANCER, V91, P863, DOI 10.1002/1097-0142(20010215)91:4<863::AID-CNCR1074>3.0.CO;2-Y; Salvany Joan Tomas, 1883, NACL DIARIO UNIVERSA, P2; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; *SECR SAL, 2000, PROGR AMPL COB 1996; *SECR SAL, 2004, B INF EST; *SECR SAL, 2004, SAL MEX 2004 INF REN; *SECR SAL, ENC NAC SAL NUTR 200; Secretaria de Salud, 2005, SIST PROT SOC SAL EL; SEPULVEDA J, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69569-X; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, WORLD HLTH REP 2000	36	79	86	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1608	1618		10.1016/S0140-6736(06)69567-6	http://dx.doi.org/10.1016/S0140-6736(06)69567-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084761				2022-12-28	WOS:000242180900030
J	Cho, YH; Yoo, SD; Sheen, J				Cho, Young-Hee; Yoo, Sang-Dong; Sheen, Jen			Regulatory functions of nuclear hexokinase1 complex in glucose signaling	CELL			English	Article							CARBON CATABOLITE REPRESSION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PROTEIN; GLUCOKINASE; PROTEASOME; ATPASE; LOCALIZATION; COACTIVATOR; RECRUITMENT	Arabidopsis hexokinase1 (HXK1) is a glucose sensor that integrates nutrient and hormone signals to govern gene expression and plant growth in response to environmental cues. How the metabolic enzyme mediates glucose signaling remains a mystery. By coupling proteomic and binary-interaction screens, we discover two nuclear-specific HXK1 unconventional partners: the vacuolar H+-ATPase B1 (VHA-B1) and the 19S regulatory particle of proteasome subunit (RPT5B). Remarkably, vha-B1 and rpt5b mutants uniquely share a broad spectrum of glucose response defects with the HXK1 mutant gin2 (glucose-insensitive2). Genetic and chromatin immunoprecipitation analyses suggest that the nuclear HXK1 forms a glucose signaling complex core with VHA-B1 and RPT5B that directly modulates specific target gene transcription independent of glucose metabolism. The findings support a model in which conserved metabolic enzymes and proteins of well-established activities may perform previously unrecognized nuclear functions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet,Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet,Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060493] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dettmer J, 2005, PLANT J, V41, P117, DOI 10.1111/j.1365-313X.2004.02282.x; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Harrington GN, 2003, PLANT CELL, V15, P2493, DOI 10.1105/tpc.151130; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Maxwell BB, 2003, PLANT PHYSIOL, V133, P1565, DOI 10.1104/pp.103.025114; Mayordomo I, 2001, YEAST, V18, P1309, DOI 10.1002/yea.780; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SHEEN J, 1993, EMBO J, V12, P3497, DOI 10.1002/j.1460-2075.1993.tb06024.x; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shimaoka T, 2004, PLANT CELL PHYSIOL, V45, P672, DOI 10.1093/pcp/pch099; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Strompen G, 2005, PLANT J, V41, P125, DOI 10.1111/j.1365-313X.2004.02283.x; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; WARD JM, 1992, PLANT PHYSIOL, V99, P161, DOI 10.1104/pp.99.1.161; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	49	319	341	7	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					579	589		10.1016/j.cell.2006.09.028	http://dx.doi.org/10.1016/j.cell.2006.09.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081979	Bronze			2022-12-28	WOS:000241937000021
J	Clevers, H				Clevers, Hans			Wnt/beta-catenin signaling in development and disease	CELL			English	Review							APC TUMOR-SUPPRESSOR; HAIR FOLLICLE MORPHOGENESIS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; COLORECTAL-CANCER; AXIS FORMATION; WNT PROTEINS; STEM-CELLS; DROSOPHILA HOMOLOG; NEGATIVE REGULATOR	A remarkable interdisciplinary effort has unraveled the WNT (Wingless and INT-1) signal transduction cascade over the last two decades. Wnt genes encode small secreted proteins that are found in all animal genomes. Wnt signaling is involved in virtually every aspect of embryonic development and also controls homeostatic self-renewal in a number of adult tissues. Germline mutations in the Wnt pathway cause several hereditary diseases, and somatic mutations are associated with cancer of the intestine and a variety of other tissues.	Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Clevers, H (corresponding author), Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; ISHITANI T, 1999, NATURE, V399, P789; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Katoh M, 2005, ONCOL REP, V14, P1583; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Parker DS, 2002, DEVELOPMENT, V129, P2565; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	113	4268	4543	22	787	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					469	480		10.1016/j.cell.2006.10.018	http://dx.doi.org/10.1016/j.cell.2006.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081971	Bronze			2022-12-28	WOS:000241937000013
J	Joukov, V; Groen, AC; Prokhorova, T; Gerson, R; White, E; Rodriguez, A; Walter, JC; Livingston, DM				Joukov, Vladimir; Groen, Aaron C.; Prokhorova, Tatyana; Gerson, Ruth; White, Erinn; Rodriguez, Alison; Walter, Johannes C.; Livingston, David M.			The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly	CELL			English	Article							BRCA1 TUMOR-SUPPRESSOR; CANCER SUSCEPTIBILITY; RING FINGER; CELL; BREAST; CENTROSOME; PROTEIN; GTPASE; PHOSPHORYLATION; UBIQUITINATION	The heterodimeric tumor-suppressor complex BRCA1/BARD1 exhibits E3 ubiquitin ligase activity and participates in cell proliferation and chromosome stability control by incompletely defined mechanisms. Here we show that, in both mammalian cells and Xenopus egg extracts, BRCA1/BARD1 is required for mitotic spindle-pole assembly and for accumulation of TPX2, a major spindle organizer and Ran target, on spindle poles. This function is centrosome independent, operates downstream of Ran GTPase, and depends upon BRCA1/BARD1 E3 ubiquitin ligase activity. Xenopus BRCA1/BARD1 forms endogenous complexes with three spindle-pole proteins, TPX2, NuMA, and XRHAMM-a known TPX2 partner-and specifically attenuates XRHAMM function. These observations reveal a previously unrecognized function of BRCA1/BARD1 in mitotic spindle assembly that likely contributes to its role in chromosome stability control and tumor suppression.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu; david_livingston@dfci.harvard.edu	高, 雨莉/HGU-8187-2022; Joukov, Vladimir/K-3525-2019	Walter, Johannes/0000-0002-4186-7570; Prokhorova, Tatyana/0000-0001-8768-8298; Gerson, Ruth/0000-0002-7987-0206	NIGMS NIH HHS [GM62267] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Desai A, 1999, METHOD CELL BIOL, V61, P385; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Fant X, 2004, INT REV CYTOL, V238, P1, DOI 10.1016/S0074-7696(04)38001-0; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; McCarthy EE, 2003, MOL CELL BIOL, V23, P5056, DOI 10.1128/MCB.23.14.5056-5063.2003; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Merdes A, 1998, J CELL SCI, V111, P71; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; O'Brien LL, 2006, J CELL BIOL, V173, P685, DOI 10.1083/jcb.200512107; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Smith LT, 2006, GENE CHROMOSOME CANC, V45, P957, DOI 10.1002/gcc.20354; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	46	219	223	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					539	552		10.1016/j.cell.2006.08.053	http://dx.doi.org/10.1016/j.cell.2006.08.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081976	Bronze			2022-12-28	WOS:000241937000018
J	Young, A				Young, Audrey			The hospitalist's story	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												auyoung@u.washington.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2067	2068		10.1001/jama.296.17.2067	http://dx.doi.org/10.1001/jama.296.17.2067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077363				2022-12-28	WOS:000241668000001
J	Althabe, F; Belizan, JM				Althabe, Fernando; Belizan, Jose M.			Caesarean section: the paradox	LANCET			English	Editorial Material							LATIN-AMERICA; RATES; AFRICA		Perinatal Res Unit, Montevideo, Uruguay; Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina		Althabe, F (corresponding author), Perinatal Res Unit, Montevideo, Uruguay.	althabef@gmail.com		Belizan, Jose/0000-0002-8412-3010				Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; ALTHABE F, IN PRESS BIRTH; [Anonymous], 1985, LANCET, V2, P436; Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; Belizan JM, 2006, BIRTH-ISS PERINAT C, V33, P167, DOI 10.1111/j.0730-7659.2006.0098b.x; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; *POP REF BUR, 2004, WEALTH GAP HLTH; Ronsmans C, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07992-8; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	13	104	121	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2006	368	9546					1472	1473		10.1016/S0140-6736(06)69616-5	http://dx.doi.org/10.1016/S0140-6736(06)69616-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071266				2022-12-28	WOS:000241582700006
J	Frenk, J; Gonzalez-Pier, E; Gomez-Dantes, O; Lezana, MA; Knaul, FM				Frenk, Julio; Gonzalez-Pier, Eduardo; Gomez-Dantes, Octavio; Lezana, Miguel A.; Knaul, Felicia Marie			Health system reform in Mexico 1 - Comprehensive reform to improve health system performance in Mexico	LANCET			English	Article							POLICY; CARE	Despite having achieved an average life expectancy of 75 years, much the same as that of more developed countries, Mexico entered the 21st century with a health system marred by its failure to offer financial protection in health to more than half of its citizens; this was both a result and a cause of the social inequalities that have marked the development process in Mexico. Several structural limitations have hampered performance and limited the progress of the health system. Conscious that the lack of financial protection was the major bottleneck, Mexico has embarked on a structural reform to improve health system performance by establishing the System of Social Protection in Health (SSPH), which has introduced new financial rules and incentives. The main innovation of the reform has been the Segura Popular (Popular Health Insurance), the insurance-based component of the SSPH, aimed at funding health care for all those families, most of them poor, who had been previously excluded from social health insurance. The reform has allowed for a substantial increase in public investment in health while realigning incentives towards better technical and interpersonal quality. This paper describes the main features and initial results of the Mexican reform effort, and derives lessons for other countries considering health-system transformations under similarly challenging circumstances.	Mexican Hlth Fdn, Mexico City 14610, DF, Mexico; Minist Hlth Mexico, Mexico City, DF, Mexico; Minist Publ Educ, Mexico City, DF, Mexico		Knaul, FM (corresponding author), Mexican Hlth Fdn, Periferico 4809,Col Arenal Tepepan, Mexico City 14610, DF, Mexico.	fknaul@funsalud.org.mx	Gonzalez Pier, Eduardo/AIB-2488-2022	Knaul, Felicia/0000-0002-0512-4788				Barraza-Llorens M, 2002, HEALTH AFFAIR, V21, P47, DOI 10.1377/hlthaff.21.3.47; Consejo Nacional de Poblacion (CONAPO), 2007, PROYECC POBL MEX 200; Frenk J, 1999, AM J PUBLIC HEALTH, V89, P1054, DOI 10.2105/AJPH.89.7.1054; FRENK J, 1994, HEALTH POLICY, V27, P19, DOI 10.1016/0168-8510(94)90155-4; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frenk J, 2004, GLOBAL FORUM UPDATE, P48; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; GAKIDOU E, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69565-2; GONZALEZPIER E, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69567-6; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; *INEGI, IND SOC MEX 1930 200; Knaul F., 2004, HEALTH POLICY EDUC, V27, P19, DOI [10.1016/0168-8510(94)90155-4, DOI 10.1016/0168-8510(94)90155-4]; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; KNAUL FM, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69565-2; KNAUL FM, PREVENTING IMPOVERIS; Londono JL, 1995, STRUCTURED PLURALISM; LOZANO R, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69566-4; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; PNUD (Programa de Naciones Unidas para el Desarrollo), 2004, DEM AM LAT HAC DEM C; Restrepo Zea Jairo Humberto, 2005, Rev.econ.inst., V7, P165; Roberts MJ., 2004, GETTING HLTH REFORM; Salvany Joan Tomas, 1883, NACL DIARIO UNIVERSA, P2; *SECR SAL, 2002, SAL MEX 2001 INF REN; *SECR SAL, 2004, SAL MEX 2003 INF REN; *SECR SAL, 2003, SAL MEX 2002 INF REN; *SECR SAL, 2006, SAL MEX 2001 2005 IN; *SECR SAL, 2005, SAL MEX 2004 INF REN; Secretaria de Salud, 2005, SIST PROT SOC SAL EL; SEPULVEDA J, 2006, LANCET          1025, DOI DOI 10.1016/S0140-6736(06)69569-X; Tena-Tamayo C, 2005, BMJ-BRIT MED J, V331, P448, DOI 10.1136/bmj.331.7514.448; World Health Organization, 2000, WORLD HLTH REP 2000; [No title captured]	34	228	243	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1524	1534		10.1016/S0140-6736(06)69564-0	http://dx.doi.org/10.1016/S0140-6736(06)69564-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071286				2022-12-28	WOS:000241582700030
J	Tirichine, L; Sandal, N; Madsen, LH; Radutoiu, S; Albrektsen, AS; Sato, S; Asamizu, E; Tabata, S; Stougaard, J				Tirichine, Leila; Sandal, Niels; Madsen, Lene H.; Radutoiu, Simona; Albrektsen, Anita S.; Sato, Shusei; Asamizu, Erika; Tabata, Satoshi; Stougaard, Jens			A gain-of-function mutation in a cytokinin receptor triggers spontaneous root nodule organogenesis	SCIENCE			English	Article							LEGUME LOTUS-JAPONICUS; SIGNAL-TRANSDUCTION; CHASE DOMAIN; ARABIDOPSIS; NODULATION; KINASE; GENE; PERCEPTION; MUTANTS; EXPRESSION	Legume root nodules originate from differentiated cortical cells that reenter the cell cycle and form organ primordia. We show that perception of the phytohormone cytokinin is a key element in this switch. Mutation of a Lotus japonicus cytokinin receptor gene leads to spontaneous development of root nodules in the absence of rhizobia or rhizobial signal molecules. The mutant histidine kinase receptor has cytokinin-independent activity and activates an Escherichia coli two-component phosphorelay system in vivo. Mutant analysis shows that cytokinin signaling is required for cell divisions that initiate nodule development and defines an autoregulated process where cytokinin induction of nodule stem cells is controlled by shoots.	Aarhus Univ, Dept Mol Biol, Gene Express Lab, DK-8000 Aarhus C, Denmark; Kazusa DNA Res Inst, Chiba 2920818, Japan	Aarhus University; Kazusa DNA Research Institute	Stougaard, J (corresponding author), Aarhus Univ, Dept Mol Biol, Gene Express Lab, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.	stougaard@mb.au.dk	Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366; Stougaard, Jens/0000-0002-9312-2685				Anantharaman V, 2001, TRENDS BIOCHEM SCI, V26, P579, DOI 10.1016/S0968-0004(01)01968-5; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; DEHIO C, 1992, PLANT J, V2, P117; Fang YW, 1998, PLANT PHYSIOL, V116, P53, DOI 10.1104/pp.116.1.53; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; HANSEN J, 1989, PLANT CELL REP, V8, P12, DOI 10.1007/BF00735768; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mathesius U, 1998, PLANT J, V14, P23, DOI 10.1046/j.1365-313X.1998.00090.x; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Nishimura N, 2004, PLANT CELL PHYSIOL, V45, P1485, DOI 10.1093/pcp/pch171; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Pas J, 2004, FEBS LETT, V576, P287, DOI 10.1016/j.febslet.2004.09.020; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; STOUGAARD J, 1987, MOL GEN GENET, V207, P251, DOI 10.1007/BF00331586; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862	26	369	388	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					104	107		10.1126/science.1132397	http://dx.doi.org/10.1126/science.1132397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17110537				2022-12-28	WOS:000243259100047
J	Macchiarelli, R; Bondioli, L; Debenath, A; Mazurier, A; Tournepiche, JF; Birch, W; Dean, C				Macchiarelli, Roberto; Bondioli, Luca; Debenath, Andre; Mazurier, Arnaud; Tournepiche, Jean-Francois; Birch, Wendy; Dean, Christopher			How Neanderthal molar teeth grew	NATURE			English	Article							LIFE-HISTORY; DENTAL DEVELOPMENT; ENAMEL THICKNESS; MODERN HUMANS; GROWTH; TOOTH; CROWN; HOMINIDAE; EVOLUTION; SERIAL	Growth and development are both fundamental components of demographic structure and life history strategy. Together with information about developmental timing they ultimately contribute to a better understanding of Neanderthal extinction. Primate molar tooth development tracks the pace of life history evolution most closely(1,2), and tooth histology reveals a record of birth as well as the timing of crown and root growth. High-resolution micro-computed tomography now allows us to image complex structures and uncover subtle differences in adult tooth morphology that are determined early in embryonic development(3). Here we show that the timing of molar crown and root completion in Neanderthals matches those known for modern humans but that a more complex enamel - dentine junction morphology and a late peak in root extension rate sets them apart. Previous predictions about Neanderthal growth, based only on anterior tooth surfaces(4,5), were necessarily speculative. These data are the first on internal molar microstructure; they firmly place key Neanderthal life history variables within those known for modern humans.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Bordeaux 1, CNRS, UMR 5199, F-33405 Bordeaux, France; Musee Angouleme, F-16000 Angouleme, France; Etud Rech Mat, F-86022 Poitiers, France; Univ Perpignan, F-66000 Perignan, France; Museo Nazl Preistorico Etnog L Pigorini, Sez Antropol, I-00144 Rome, Italy; Univ Poitiers, CNRS, UMR 6046, Lab Geobiol Biochronol & Paleontol Humaine, F-86022 Poitiers, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Universite de Poitiers; Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Dean, C (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	ucgacrd@ucl.ac.uk	Arnaud, Mazurier/Q-3199-2017; Self, Casey J/B-6871-2011; Arnaud, Mazurier/R-4577-2019	Arnaud, Mazurier/0000-0003-1894-0554; Arnaud, Mazurier/0000-0003-1894-0554; Bondlioli, Luca/0000-0002-8511-7667				ASHTON E. H., 1958, PROC ZOOL SOC LONDON, V130, P169; Avishai G, 2004, MICROSC RES TECHNIQ, V65, P263, DOI 10.1002/jemt.20131; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Boughner JC, 2004, J HUM EVOL, V46, P255, DOI 10.1016/j.jhevol.2003.11.007; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; Dean MC, 1998, ARCH ORAL BIOL, V43, P1009, DOI 10.1016/S0003-9969(98)00069-7; DEBENATH A, 2006, NEANDERTHALIENS CROM; Gleiser I, 1955, AM J PHYS ANTHROP-NE, V13, P253, DOI 10.1002/ajpa.1330130206; Guatelli-Steinberg D, 2005, P NATL ACAD SCI USA, V102, P14197, DOI 10.1073/pnas.0503108102; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kondo O., 2005, CURRENT TRENDS DENT, P243; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Liversidge HM, 2004, AM J PHYS ANTHROPOL, V123, P172, DOI 10.1002/ajpa.10318; Mazurier A, 2006, APPL PHYS A-MATER, V83, P229, DOI 10.1007/s00339-006-3511-6; Olejniczak AJ, 2004, ANN ANAT, V186, P479, DOI 10.1016/S0940-9602(04)80087-6; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Rossi P. F., 1999, DIGITAL ARCH HUMAN P; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; SMITH BH, 1995, ANNU REV ANTHROPOL, V24, P257, DOI 10.1146/annurev.an.24.100195.001353; STRINGER CB, 1990, MG PRIMATOL, V14, P115; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Thesleff I, 2001, Adv Dent Res, V15, P14; TILLIER AM, 1995, ANTHR PREHIST, V106, P97; Tompkins RL, 1996, AM J PHYS ANTHROPOL, V99, P103; TRINKAUS E, 1990, MG PRIMATOL, V14, P153; WOLPOFF MH, 1979, AM J PHYS ANTHROPOL, V50, P67, DOI 10.1002/ajpa.1330500110	30	199	204	4	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					748	751		10.1038/nature05314	http://dx.doi.org/10.1038/nature05314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113EL	17122777				2022-12-28	WOS:000242581100058
J	Weinstein, JN; Tosteson, TD; Lurie, JD; Tosteson, ANA; Hanscom, B; Skinner, JS; Abdu, WA; Hilibrand, AS; Boden, SD; Deyo, RA				Weinstein, James N.; Tosteson, Tor D.; Lurie, Jon D.; Tosteson, Anna N. A.; Hanscom, Brett; Skinner, Jonathan S.; Abdu, William A.; Hilibrand, Alan S.; Boden, Scott D.; Deyo, Richard A.			Surgical vs nonoperative treatment for lumbar disk herniation - The Spine Patient Outcomes Research Trial (SPORT): A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH SURVEY SF-36; QUALITY-OF-LIFE; SURGERY; CARE; RELIABILITY; DISKECTOMY; SCIATICA	Context Lumbar diskectomy is the most common surgical procedure performed for back and leg symptoms in US patients, but the efficacy of the procedure relative to nonoperative care remains controversial. Objective To assess the efficacy of surgery for lumbar intervertebral disk herniation. Design, Setting, and Patients The Spine Patient Outcomes Research Trial, a randomized clinical trial enrolling patients between March 2000 and November 2004 from 13 multidisciplinary spine clinics in 11 US states. Patients were 501 surgical candidates (mean age, 42 years; 42% women) with imaging-confirmed lumbar intervertebral disk herniation and persistent signs and symptoms of radiculopathy for at least 6 weeks. Interventions Standard open diskectomy vs nonoperative treatment individualized to the patient. Main Outcome Measures Primary outcomes were changes from baseline for the Medical Outcomes Study 36-item Short-Form Health Survey bodily pain and physical function scales and the modified Oswestry Disability Index ( American Academy of Orthopaedic Surgeons MODEMS version) at 6 weeks, 3 months, 6 months, and 1 and 2 years from enrollment. Secondary outcomes included sciatica severity as measured by the Sciatica Bothersomeness Index, satisfaction with symptoms, self-reported improvement, and employment status. Results Adherence to assigned treatment was limited: 50% of patients assigned to surgery received surgery within 3 months of enrollment, while 30% of those assigned to nonoperative treatment received surgery in the same period. Intent-to-treat analyses demonstrated substantial improvements for all primary and secondary outcomes in both treatment groups. Between-group differences in improvements were consistently in favor of surgery for all periods but were small and not statistically significant for the primary outcomes. Conclusions Patients in both the surgery and the nonoperative treatment groups improved substantially over a 2-year period. Because of the large numbers of patients who crossed over in both directions, conclusions about the superiority or equivalence of the treatments are not warranted based on the intent-to-treat analysis.	Dartmouth Med Sch, Dept Orthopaed, Lebanon, NH 03756 USA; Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA; Emory Univ, Atlanta, GA 30322 USA; Univ Washington, Ctr Cost & Outcomes Res, Seattle, WA 98195 USA	Dartmouth College; Jefferson University; Rothman Institute; Emory University; University of Washington; University of Washington Seattle	Weinstein, JN (corresponding author), Dartmouth Med Sch, Dept Orthopaed, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	james.n.weinstein@dartmouth.edu	Hilibrand, Alan/AAL-5114-2020		NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIAMS NIH HHS [U01 AR045444, U01 AR045444-09, 1 K23 AR 048138-01, K23 AR048138, P60-AR048094-01A1, U01-AR45444-01A1, P60 AR048094] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR048138, U01AR045444, P60AR048094] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AG HLTH CAR POL R, 1994, AC LOW BACK PROBL AD; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Atlas SJ, 1996, SPINE, V21, P2885, DOI 10.1097/00007632-199612150-00020; Balding DJ, 2004, APPL LONGITUDINAL AN; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Buttermann GR, 2004, J BONE JOINT SURG AM, V86A, P670, DOI 10.2106/00004623-200404000-00002; Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016; Cummins J, 2006, SPINE, V31, P806, DOI 10.1097/01.brs.0000207473.09030.0d; Daltroy LH, 1996, SPINE, V21, P741, DOI 10.1097/00007632-199603150-00017; DELAMARTER R, 1996, ADULT SPINE PRINCIPL; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Fardon DF, 2001, SPINE, V26, P461, DOI 10.1097/00007632-200103010-00007; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P61; GIBSON JN, 2000, COCHRANE DB SYST REV; Gibson JNA, 1999, SPINE, V24, P1820, DOI 10.1097/00007632-199909010-00012; HOFFMAN RM, 1993, J GEN INTERN MED, V8, P487, DOI 10.1007/BF02600110; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; JORDAN J, 2003, CLIN EVID        JUN, P1203; Kuppermann M, 2004, JAMA-J AM MED ASSOC, V291, P1447, DOI 10.1001/jama.291.12.1447; LITTLE R, 1996, STAT ANAL MISSING DA, V21, P1777; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Meinert CL., 1986, CLIN TRIALS DESIGN C; *N AM SPIN SOC, 2000, N AM SPIN SOC PHAS 3; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Phelan EA, 2001, SPINE, V26, P206, DOI 10.1097/00007632-200101150-00016; SAAL JA, 1989, SPINE, V14, P431, DOI 10.1097/00007632-198904000-00018; SPANGFORT EV, 1972, ACTA ORTHOP SCAND, P1; SPENGLER DM, 1982, SPINE, V7, P604, DOI 10.1097/00007632-198211000-00015; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; WEINSTEIN J, 2000, DARTMOUTH ATLAS MUSC; Weinstein JN, 2005, SPINE, V30, P269, DOI 10.1097/01.brs.0000155479.88200.32; Weinstein JN, 2004, HLTH AFF MILLWOOD S	38	723	756	5	83	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2441	2450		10.1001/jama.296.20.2441	http://dx.doi.org/10.1001/jama.296.20.2441			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119140	Green Accepted			2022-12-28	WOS:000242171000025
J	Grimberg, A; Baur, H; Bochsler, P; Buhler, F; Burnett, DS; Hays, CC; Heber, VS; Jurewicz, AJG; Wieler, R				Grimberg, Ansgar; Baur, Heinrich; Bochsler, Peter; Buehler, Fritz; Burnett, Donald S.; Hays, Charles C.; Heber, Veronika S.; Jurewicz, Amy J. G.; Wieler, Rainer			Solar wind neon from Genesis: Implications for the lunar noble gas record	SCIENCE			English	Article							ENERGETIC PARTICLES; ISOTOPES; ORIGIN; ARGON; SOIL	Lunar soils have been thought to contain two solar noble gas components with distinct isotopic composition. One has been identified as implanted solar wind, the other as higher-energy solar particles. The latter was puzzling because its relative amounts were much too large compared with present-day fluxes, suggesting periodic, very high solar activity in the past. Here we show that the depth-dependent isotopic composition of neon in a metallic glass exposed on NASA's Genesis mission agrees with the expected depth profile for solar wind neon with uniform isotopic composition. Our results strongly indicate that no extra high-energy component is required and that the solar neon isotope composition of lunar samples can be explained as implantation-fractionated solar wind.	ETH Zurich NW, CH-8092 Zurich, Switzerland; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ 85287 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Arizona State University; Arizona State University-Tempe	Grimberg, A (corresponding author), ETH Zurich NW, Clausiusstr 25, CH-8092 Zurich, Switzerland.	grimberg@erdw.ethz.ch	Hays, Charles C./P-8021-2015; Wieler, Rainer/A-1355-2010	Hays, Charles C./0000-0002-0420-1761; Wieler, Rainer/0000-0001-5666-7494; Jurewicz, Amy/0000-0002-3282-5782				Ballentine CJ, 2005, NATURE, V433, P33, DOI 10.1038/nature03182; BENKERT JP, 1993, J GEOPHYS RES-PLANET, V98, P13147, DOI 10.1029/93JE01460; BLACK DC, 1972, GEOCHIM COSMOCHIM AC, V36, P347, DOI 10.1016/0016-7037(72)90028-2; BLACK DC, 1969, EARTH PLANET SC LETT, V6, P395, DOI 10.1016/0012-821X(69)90190-3; BUCKER RH, 1998, LUN PLAN SCI C, V29; Burnett DS, 2003, SPACE SCI REV, V105, P509, DOI 10.1023/A:1024425810605; DIETRICH WF, 1979, ASTROPHYS J, V231, pL91, DOI 10.1086/183011; ETIQUE P, 1981, LUNAR PLANET SCI, V12, P265; Geiss J, 2004, SPACE SCI REV, V110, P307, DOI 10.1023/B:SPAC.0000023409.54469.40; Hashizume K, 2005, NATURE, V434, P619, DOI 10.1038/nature03432; HEBER V, 2002, THESIS ETH ZURICH; Jurewicz AJG, 2003, SPACE SCI REV, V105, P535, DOI 10.1023/A:1024469927444; LESKE RA, 2003, COSM RAY C, V28, P3237; Leya I, 2000, METEORIT PLANET SCI, V35, P259, DOI 10.1111/j.1945-5100.2000.tb01775.x; Mathew KJ, 1998, GEOPHYS RES LETT, V25, P4293, DOI 10.1029/1998GL900181; MEWALDT RA, 1984, ASTROPHYS J, V280, P892, DOI 10.1086/162065; Mewaldt RA, 2001, AIP CONF PROC, V598, P393, DOI 10.1063/1.1434028; Pepin RO, 1999, GEOCHIM COSMOCHIM AC, V63, P2145, DOI 10.1016/S0016-7037(99)00002-2; Pepin RO, 2000, METEORIT PLANET SCI, V35, P495, DOI 10.1111/j.1945-5100.2000.tb01431.x; REEDY RC, 2006, LUN PLAN SCI C, V37; REISENFELD DB, 2006, 37 LUN PLAN SCI C HO; TAMHANE AS, 1979, EARTH PLANET SC LETT, V42, P243, DOI 10.1016/0012-821X(79)90031-1; Trieloff M, 2000, SCIENCE, V288, P1036, DOI 10.1126/science.288.5468.1036; WIELER R, 1986, GEOCHIM COSMOCHIM AC, V50, P1997, DOI 10.1016/0016-7037(86)90255-3; Wieler R, 1998, SPACE SCI REV, V85, P303, DOI 10.1023/A:1005166904225; Wiens RC, 2004, EARTH PLANET SC LETT, V226, P547, DOI 10.1016/j.epsl.2004.07.010; Wimmer-Schweingruber RF, 2001, AIP CONF PROC, V598, P399, DOI 10.1063/1.1434029; Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208	28	111	116	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1133	1135		10.1126/science.1133568	http://dx.doi.org/10.1126/science.1133568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110575				2022-12-28	WOS:000242045800041
J	Randerson, JT; Liu, H; Flanner, MG; Chambers, SD; Jin, Y; Hess, PG; Pfister, G; Mack, MC; Treseder, KK; Welp, LR; Chapin, FS; Harden, JW; Goulden, ML; Lyons, E; Neff, JC; Schuur, EAG; Zender, CS				Randerson, J. T.; Liu, H.; Flanner, M. G.; Chambers, S. D.; Jin, Y.; Hess, P. G.; Pfister, G.; Mack, M. C.; Treseder, K. K.; Welp, L. R.; Chapin, F. S.; Harden, J. W.; Goulden, M. L.; Lyons, E.; Neff, J. C.; Schuur, E. A. G.; Zender, C. S.			The impact of boreal forest fire on climate warming	SCIENCE			English	Article							ALBEDO; SNOW; ATMOSPHERE; VEGETATION; AEROSOLS; GASES	We report measurements and analysis of a boreal forest fire, integrating the effects of greenhouse gases, aerosols, black carbon deposition on snow and sea ice, and postfire changes in surface albedo. The net effect of all agents was to increase radiative forcing during the first year ( 34 +/- 31 Watts per square meter of burned area), but to decrease radiative forcing when averaged over an 80-year fire cycle (- 2.3 +/- 2.2 Watts per square meter) because multidecadal increases in surface albedo had a larger impact than fire-emitted greenhouse gases. This result implies that future increases in boreal fire may not accelerate climate warming.	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Jackson State Univ, Dept Phys Atmospher Sci & Gen Sci, Jackson, MS 39217 USA; Australian Nucl Sci & Technol Org, Environm Div, Menai, NSW 2234, Australia; Natl Ctr Atmospher Res, Div Atmospher Chem, Boulder, CO 80301 USA; Univ Florida, Dept Bot, Gainesville, FL 32611 USA; CALTECH, Pasadena, CA 91125 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Irvine; Jackson State University; Australian Nuclear Science & Technology Organisation; National Center Atmospheric Research (NCAR) - USA; State University System of Florida; University of Florida; California Institute of Technology; University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder	Randerson, JT (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	jranders@uci.edu	Zender, Charles S/D-4485-2012; Pfister, Gabriele/A-9349-2008; , Scott/AAI-6917-2020; Randerson, James/Y-2550-2019; Neff, Jason/A-1211-2012; Flanner, Mark/C-6139-2011; Goulden, Michael L/B-9934-2008; Chapin, F Stuart/AAZ-3931-2020; Treseder, Kathleen K/E-5148-2011; Hess, Peter/M-3145-2015	Zender, Charles S/0000-0003-0129-8024; Randerson, James/0000-0001-6559-7387; Flanner, Mark/0000-0003-4012-174X; Chapin, F Stuart/0000-0002-2558-9910; Treseder, Kathleen K/0000-0003-2847-6935; Hess, Peter/0000-0003-2439-3796; Goulden, Michael/0000-0002-9379-3948; Welp, Lisa/0000-0001-7125-0478; Chambers, Scott/0000-0002-2521-959X; Lyons, Evan/0000-0003-0863-1619; Harden, Jennifer W/0000-0002-6570-8259; NEFF, JASON/0000-0002-8290-1472				ACIA, 2005, ARCTIC CLIMATE IMPAC; Amiro BD, 2001, CAN J FOREST RES, V31, P512, DOI 10.1139/cjfr-31-3-512; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; BRIEGLEB BP, 1992, J GEOPHYS RES-ATMOS, V97, P7603, DOI 10.1029/92JD00291; Brovkin V, 2004, GLOBAL CHANGE BIOL, V10, P1253, DOI 10.1111/j.1365-2486.2004.00812.x; Chambers SD, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000530; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; ENTING IG, 2001, 31 COMM SCI IND RES; Flanner MG, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006834; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Hansen J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005776; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Johnson EA, 1992, CAMBRIDGE STUDIES EC; Kasischke ES, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002300; KASISCHKE ES, 2000, ECOLOGICAL STUDIES; Kuang ZM, 2000, GEOPHYS RES LETT, V27, P1299, DOI 10.1029/1999GL011116; Kurz W.A., 1995, BIOTIC FEEDBACKS GLO, P119; Liu HP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005158; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Neff JC, 2005, CAN J FOREST RES, V35, P2178, DOI 10.1139/X05-154; Pfister G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022995; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P350; Rasch PJ, 2001, J GEOPHYS RES-ATMOS, V106, P7337, DOI 10.1029/2000JD900508; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; WARREN SG, 1980, J ATMOS SCI, V37, P2734, DOI 10.1175/1520-0469(1980)037<2734:AMFTSA>2.0.CO;2	33	573	581	7	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1130	1132		10.1126/science.1132075	http://dx.doi.org/10.1126/science.1132075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110574	Green Submitted			2022-12-28	WOS:000242045800040
J	Jones, JDG; Dangl, JL				Jones, Jonathan D. G.; Dangl, Jeffery L.			The plant immune system	NATURE			English	Review							PROGRAMMED CELL-DEATH; RECEPTOR-LIKE PROTEINS; III EFFECTOR PROTEINS; DISEASE-RESISTANCE; NONHOST RESISTANCE; DEFENSE RESPONSES; INNATE IMMUNITY; SALICYLIC-ACID; BASAL DEFENSE; FLAX RUST	Many plant- associated microbes are pathogens that impair plant growth and reproduction. Plants respond to infection using a two- branched innate immune system. The first branch recognizes and responds to molecules common to many classes of microbes, including non- pathogens. The second responds to pathogen virulence factors, either directly or through their effects on host targets. These plant immune systems, and the pathogen molecules to which they respond, provide extraordinary insights into molecular recognition, cell biology and evolution across biological kingdoms. A detailed understanding of plant immune function will underpin crop improvement for food, fibre and biofuels production.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ N Carolina, Dept Microbiol & Immunol, Curriculum Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, JDG (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	jonathan.jones@tsl.ac.uk; dangl@email.unc.edu	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X				Abramovitch RB, 2005, FEMS MICROBIOL LETT, V245, P1, DOI 10.1016/j.femsle.2005.02.025; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Badel JL, 2002, MOL PLANT MICROBE IN, V15, P1014, DOI 10.1094/MPMI.2002.15.10.1014; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Day B, 2006, PLANT CELL, V18, P2782, DOI 10.1105/tpc.106.044693; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Desveaux D, 2006, CURR OPIN PLANT BIOL, V9, P376, DOI 10.1016/j.pbi.2006.05.005; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; KOBAYASHI DY, 1989, P NATL ACAD SCI USA, V86, P157, DOI 10.1073/pnas.86.1.157; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; LAWRENCE GJ, 1981, PHYTOPATHOLOGY, V71, P12, DOI 10.1094/Phyto-71-12; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Palma K, 2005, CURR BIOL, V15, P1129, DOI 10.1016/j.cub.2005.05.022; Peyyala R, 2006, MOL PLANT PATHOL, V7, P157, DOI 10.1111/J.1364-3703.2006.00325.X; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Rivas S, 2005, ANNU REV PHYTOPATHOL, V43, P395, DOI 10.1146/annurev.phyto.43.040204.140224; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rohmer L, 2004, GENETICS, V167, P1341, DOI 10.1534/genetics.103.019638; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Schulze-Lefert P, 2003, ANNU REV PHYTOPATHOL, V41, P641, DOI 10.1146/annurev.phyto.41.061002.083300; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van der Hoorn RAL, 2002, TRENDS PLANT SCI, V7, P67, DOI 10.1016/S1360-1385(01)02188-4; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	102	7825	8292	176	2554	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					323	329		10.1038/nature05286	http://dx.doi.org/10.1038/nature05286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108957	Bronze			2022-12-28	WOS:000242018300039
J	Halton, TL; Willett, WC; Liu, SM; Manson, JE; Albert, CM; Rexrode, K; Hu, FB				Halton, Thomas L.; Willett, Walter C.; Liu, Simin; Manson, JoAnn E.; Albert, Christine M.; Rexrode, Kathryn; Hu, Frank B.			Low-carbohydrate-diet score and the risk of coronary heart disease in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-PROTEIN; WEIGHT-LOSS; FAT; COHORT; MEN	BACKGROUND: Low-carbohydrate diets have been advocated for weight loss and to prevent obesity, but the long-term safety of these diets has not been determined. METHODS: We evaluated data on 82,802 women in the Nurses' Health Study who had completed a validated food-frequency questionnaire. Data from the questionnaire were used to calculate a low-carbohydrate-diet score, which was based on the percentage of energy as carbohydrate, fat, and protein (a higher score reflects a higher intake of fat and protein and a lower intake of carbohydrate). The association between the low-carbohydrate-diet score and the risk of coronary heart disease was examined. RESULTS: During 20 years of follow-up, we documented 1994 new cases of coronary heart disease. After multivariate adjustment, the relative risk of coronary heart disease comparing highest and lowest deciles of the low-carbohydrate-diet score was 0.94 (95% confidence interval [CI], 0.76 to 1.18; P for trend=0.19). The relative risk comparing highest and lowest deciles of a low-carbohydrate-diet score on the basis of the percentage of energy from carbohydrate, animal protein, and animal fat was 0.94 (95% CI, 0.74 to 1.19; P for trend=0.52), whereas the relative risk on the basis of the percentage of energy from intake of carbohydrates, vegetable protein, and vegetable fat was 0.70 (95% CI, 0.56 to 0.88; P for trend=0.002). A higher glycemic load was strongly associated with an increased risk of coronary heart disease (relative risk comparing highest and lowest deciles, 1.90; 95% CI, 1.15 to 3.15; P for trend=0.003). CONCLUSIONS: Our findings suggest that diets lower in carbohydrate and higher in protein and fat are not associated with increased risk of coronary heart disease in women. When vegetable sources of fat and protein are chosen, these diets may moderately reduce the risk of coronary heart disease.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Liu, Simin/I-3689-2014; Rexrode, Kathryn M/I-1177-2018; Hu, Frank/C-1919-2013; Liu, Simin/GSN-4159-2022	Liu, Simin/0000-0003-2098-3844; Rexrode, Kathryn/0000-0003-3387-8429; Albert, Christine/0000-0002-2081-1121	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK040561] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NHLBI NIH HHS [HL34594, HL60712] Funding Source: Medline; NIDDK NIH HHS [DK58845, P30 DK040561, P30 DK040561-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AHA, 2006, AHA REC; *AM HEART ASS, 2002, AM HEART ASS STAT HI; [Anonymous], 1997, J AM DIET ASSOC, V97, P71; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; ATKINS RC, 1998, ATKINS NEWDIET REVOL; Cox D. R., 1984, ANAL SURVIVAL DATA; *DEP AGR, 1993, COMP FOODS RAW PROC; EADES MR, 1999, PROTEIN POWER; GABH Rose, 1982, WHO MONOGRAPH SERIES; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; HELLER RF, 1993, CARBOHYDRATE ADDICTS; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Knight EL, 2003, ANN INTERN MED, V138, P460, DOI 10.7326/0003-4819-138-6-200303180-00009; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MCGEE DL, 1984, AM J EPIDEMIOL, V119, P667, DOI 10.1093/oxfordjournals.aje.a113788; Nordmann, 2006, ARCH INTERN MED, V166, P932; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SEARS B, 1995, ZONE DIET ROAD MAP L; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stein K, 2000, J AM DIET ASSOC, V100, P760, DOI 10.1016/S0002-8223(00)00219-4; STEWARD HL, 1995, SUGAR BUSTERS; Thomas PR, 1995, WEIGHING OPTIONS CRI; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 1998, OBES RES, V6, P464	37	331	338	4	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1991	2002		10.1056/NEJMoa055317	http://dx.doi.org/10.1056/NEJMoa055317			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093250				2022-12-28	WOS:000241833000007
J	Lean, M; Lara, J; Hill, JO				Lean, Mike; Lara, Jose; Hill, James O.			ABC of obesity - Strategies for preventing obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; Univ Colorado, Ctr Human Nutr, Boulder, CO 80309 USA	University of Glasgow; University of Colorado System; University of Colorado Boulder	Lean, M (corresponding author), Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland.			Lara, Jose/0000-0002-4449-9304				Astrup A, 2000, INT J OBESITY, V24, P1545, DOI 10.1038/sj.ijo.0801453; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Rodearmel SJ, 2006, OBESITY, V14, P1392, DOI 10.1038/oby.2006.158; Swinburn B, 2002, Obes Rev, V3, P289; WHO, 1997, WHO TECHN REP SER, V894	7	62	68	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2006	333	7575					959	962		10.1136/bmj.333.7575.959	http://dx.doi.org/10.1136/bmj.333.7575.959			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107GE	17082548	Green Published			2022-12-28	WOS:000242157900023
J	Oransky, I				Oransky, Ivan			Wayne S Fenton - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1568	1568		10.1016/S0140-6736(06)69650-5	http://dx.doi.org/10.1016/S0140-6736(06)69650-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107OM	17099954				2022-12-28	WOS:000242180900014
J	Prabhakar, S; Noonan, JP; Paabo, S; Rubin, EM				Prabhakar, Shyam; Noonan, James P.; Paeaebo, Svante; Rubin, Edward M.			Accelerated evolution of conserved noncoding sequences in humans	SCIENCE			English	Article									US DOE, Joint Genome Inst, Walnut Breek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	United States Department of Energy (DOE); Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society	Rubin, EM (corresponding author), US DOE, Joint Genome Inst, Walnut Breek, CA 94598 USA.	emrubin@lbl.gov	Noonan, James/ABF-1320-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074367] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL066681] Funding Source: Medline; NIGMS NIH HHS [1-F32-GM074367] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488	2	288	296	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					786	786		10.1126/science.1130738	http://dx.doi.org/10.1126/science.1130738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082449				2022-12-28	WOS:000241729800036
J	Regula, J; Rupinski, M; Kraszewska, E; Polkowski, M; Pachlewski, J; Orlowska, J; Nowacki, MP; Butruk, E				Regula, Jaroslaw; Rupinski, Maciej; Kraszewska, Ewa; Polkowski, Marcin; Pachlewski, Jacek; Orlowska, Janina; Nowacki, Marek P.; Butruk, Eugeniusz			Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONIC NEOPLASIA; RISK; RECOMMENDATIONS; PREVENTION	BACKGROUND: Recommendations for colorectal-cancer screening are based solely on age and family history of cancer, not sex. METHODS: We performed a cross-sectional analysis of the data from a large colonoscopy-based screening program that included 50,148 participants who were 40 to 66 years of age. People 40 to 49 years of age were eligible only if they had a family history of cancer of any type. Of the 43,042 participants 50 to 66 years of age, 13.3% reported a family history of colorectal cancer, as did 66.3% of the 7106 participants who were 40 to 49 years of age. We defined advanced neoplasia as cancer or adenoma that was at least 10 mm in diameter, had high-grade dysplasia, or had villous or tubulovillous histologic characteristics, or any combination thereof. We used multivariate logistic regression to identify associations between participants' characteristics and advanced neoplasia in a primary (or derivation) data set, and we confirmed the associations in a secondary (or validation) data set. RESULTS: Advanced neoplasia was detected in 2553 (5.9%) participants 50 to 66 years of age and in 243 (3.4%) participants 40 to 49 years of age. The rate of complications during colonoscopy was 0.1%, and no participants died. In the validation set, a logistic-regression model showed that male sex was independently associated with advanced neoplasia (adjusted odds ratio, 1.73; 95% confidence interval, 1.52 to 1.98; P<0.001). In each age group (40 to 49 years, 50 to 54 years, 55 to 59 years, and 60 to 66 years), the number of persons who would have to undergo colorectal-cancer screening in order to detect one advanced neoplasia was significantly lower in men than in women (23 vs. 36, 17 vs. 28, 12 vs. 22, and 10 vs. 18, respectively). CONCLUSIONS: We detected advanced neoplasia at a significantly higher rate in men than in women, which may warrant refinement of the screening recommendations for colorectal cancer.	Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, PL-02784 Warsaw, Poland; Med Ctr Postgrad Educ, Dept Gastroenterol, Warsaw, Poland; Inst Oncol, Warsaw, Poland; Maria Sklodowska Curie Mem Canc Ctr, Dept Biostat, Warsaw, Poland; Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Regula, J (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, Roentgen St 5, PL-02784 Warsaw, Poland.	jregula@coi.waw.pl	Polkowski, Marcin/K-8897-2012	Polkowski, Marcin/0000-0003-4934-9759; Regula, Jaroslaw/0000-0001-7071-3151; Rupinski, Maciej/0000-0002-1041-1159				Anderson JC, 2004, AM J GASTROENTEROL, V99, P472, DOI 10.1111/j.1572-0241.2004.04093.x; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Butruk E, 2002, ENDOSCOPY, V34, P939; Corbett M, 2004, MED J AUSTRALIA, V181, P423, DOI 10.5694/j.1326-5377.2004.tb06365.x; GROSSMAN S, 1989, GASTROENTEROLOGY, V96, P299, DOI 10.1016/0016-5085(89)91551-5; Gupta AK, 2005, CLIN GASTROENTEROL H, V3, P150, DOI 10.1016/S1542-3565(04)00664-0; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; HOSMER DW, 1989, APPL LOGISTIC REGRES; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; *INT AG RES CANC, 2005, TABL POP REG SEX W E; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Neter J., 1996, APPL LINEAR STAT MOD; Regula J, 2006, CURR COLORECT CANC R, V2, P25, DOI 10.1007/s11888-006-0014-y; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; Winawer SJ, 2003, ANN INTERN MED, V139, P1034, DOI 10.7326/0003-4819-139-12-200312160-00013; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	30	622	642	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1863	1872		10.1056/NEJMoa054967	http://dx.doi.org/10.1056/NEJMoa054967			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079760				2022-12-28	WOS:000241691700004
J	Schopper, H				Schopper, Herwig			Islam and science: Where are the new patrons of science?	NATURE			English	Editorial Material									CERN, CH-1211 Geneva 23, Switzerland	European Organization for Nuclear Research (CERN)	Schopper, H (corresponding author), CERN, CH-1211 Geneva 23, Switzerland.							[Anonymous], ARAB HUMAN DEV REPOR; Atta-Ur-Rahman, 2004, Nature, V432, P273; Maziak W, 2005, SCIENCE, V308, P1416, DOI 10.1126/science.1114330; SAHEL W, 2004, SCIDEVNET       0603	4	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					35	36		10.1038/444035a	http://dx.doi.org/10.1038/444035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	100WS	17080067				2022-12-28	WOS:000241701500027
J	Garcia-Hernandez, DA; Garcia-Lario, P; Plez, B; D'Antona, F; Manchado, A; Trigo-Rodriguez, JM				Garcia-Hernandez, D. A.; Garcia-Lario, P.; Plez, B.; D'Antona, F.; Manchado, A.; Trigo-Rodriguez, J. M.			Rubidium-rich asymptotic giant branch stars	SCIENCE			English	Article							S-PROCESS; PROCESS NUCLEOSYNTHESIS; RED GIANTS; LITHIUM; RB-85; CLOUD	A long-debated issue concerning the nucleosynthesis of neutron-rich elements in asymptotic giant branch (AGB) stars is the identification of the neutron source. We report intermediate-mass ( 4 to 8 solar masses) AGB stars in our Galaxy that are rubidium-rich as a result of overproduction of the long-lived radioactive isotope Rb-87, as predicted theoretically 40 years ago. This finding represents direct observational evidence that the Ne-22(alpha, n)Mg-25 reaction must be the dominant neutron source in these stars. These stars challenge our understanding of the late stages of the evolution of intermediate-mass stars and would have promoted a highly variable Rb/Sr environment in the early solar nebula.	European Space Agcy, ISO Data Ctr, European Space Astron Ctr, Res & Sci Support Dept, E-28080 Madrid, Spain; European Space Agcy, Herschel Sci Ctr, European Space Astron Ctr, Res & Sci Support Dept, E-28080 Madrid, Spain; Univ Montpellier 2, Grp Rech Astron & Astrophys Languedoc, UMR 5024, F-34095 Montpellier 5, France; Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; CSIC, E-38200 San Cristobal la Laguna, Tenerife, Spain; Fac Ciencies, Inst Space Sci, Bellaterra 08193, Spain; Fac Ciencies, CSIC, Bellaterra 08193, Spain; Inst Estudis Espacials Catalunya, Barcelona 08034, Spain	European Space Agency; European Space Agency; Universite de Montpellier; Istituto Nazionale Astrofisica (INAF); Instituto de Astrofisica de Canarias; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Consejo Superior de Investigaciones Cientificas (CSIC); Institut d'Estudis Espacials de Catalunya (IEEC)	Garcia-Hernandez, DA (corresponding author), European Space Agcy, ISO Data Ctr, European Space Astron Ctr, Res & Sci Support Dept, Apdo 50727, E-28080 Madrid, Spain.	agarcia@astro.as.utexas.edu	Trigo-Rodriguez, Josep M./ABF-5444-2020; Manchado, Arturo/AAE-2787-2019; Plez, Bertrand/G-6697-2011; Trigo-Rodríguez, Josep M./L-3870-2014; Garcia-Hernandez, Domingo Anibal/AAB-9084-2019	Manchado, Arturo/0000-0002-3011-686X; Plez, Bertrand/0000-0002-0398-4434; Trigo-Rodríguez, Josep M./0000-0001-8417-702X; Garcia-Hernandez, Domingo Anibal/0000-0002-1693-2721; D'Antona, Francesca/0000-0003-4697-0945				Abia C, 2001, ASTROPHYS J, V559, P1117, DOI 10.1086/322383; Alexander CMO, 2001, PHILOS T R SOC A, V359, P1973, DOI 10.1098/rsta.2001.0891; Banerjee A, 2004, EUROPHYS LETT, V65, P172, DOI 10.1209/epl/i2003-10069-3; BEER H, 1989, ASTROPHYS J, V339, P962, DOI 10.1086/167351; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; CAMERON AGW, 1971, ASTROPHYS J, V164, P111, DOI 10.1086/150821; Chen PS, 2001, ASTRON ASTROPHYS, V368, P1006, DOI 10.1051/0004-6361:20010098; GARCIAHERNANDEZ DA, IN PRESS ASTRON ASTR; Grevesse N, 1998, SPACE SCI REV, V85, P161, DOI 10.1023/A:1005161325181; IBEN I, 1983, ANNU REV ASTRON ASTR, V21, P271, DOI 10.1146/annurev.aa.21.090183.001415; Jimenez-Esteban FM, 2005, AIP CONF PROC, V804, P141, DOI 10.1063/1.2146251; LAMBERT DL, 1995, ASTROPHYS J, V450, P302, DOI 10.1086/176141; Mazzitelli I, 1999, ASTRON ASTROPHYS, V348, P846; McKeegan KD, 2005, TREATISE GEOCHEM, V1, P431; PLEZ B, 1993, ASTROPHYS J, V418, P812, DOI 10.1086/173438; PODOSEK FA, 1991, GEOCHIM COSMOCHIM AC, V55, P1083, DOI 10.1016/0016-7037(91)90165-2; SACKMANN IJ, 1992, ASTROPHYS J, V392, pL71, DOI 10.1086/186428; SANDERS RH, 1967, ASTROPHYS J, V150, P971, DOI 10.1086/149397; SCHWARZS.M, 1967, ASTROPHYS J, V150, P961, DOI 10.1086/149396; SMITH VV, 1995, ASTROPHYS J, V441, P735, DOI 10.1086/175395; STRANIERO O, 1995, ASTROPHYS J, V440, pL85, DOI 10.1086/187767; Tomkin J, 1999, ASTROPHYS J, V523, P234, DOI 10.1086/307735; TRURAN JW, 1977, ASTROPHYS J, V216, P797, DOI 10.1086/155523; Ventura P, 2001, ASTROPHYS J, V550, pL65, DOI 10.1086/319496; Wallerstein G, 1998, ANNU REV ASTRON ASTR, V36, P369, DOI 10.1146/annurev.astro.36.1.369; Zinner E, 2005, GEOCHIM COSMOCHIM AC, V69, P4149, DOI 10.1016/j.gca.2005.03.050	26	105	105	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1751	1754		10.1126/science.1133706	http://dx.doi.org/10.1126/science.1133706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17095658	Green Submitted			2022-12-28	WOS:000242833600051
J	McLaughlin, S				McLaughlin, Stuart			Tools to tamper with phosphoinositides	SCIENCE			English	Editorial Material							PLASMA-MEMBRANE		SUNY Stony Brook, Dept Physiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	McLaughlin, S (corresponding author), SUNY Stony Brook, Dept Physiol, Stony Brook, NY 11794 USA.	smclaughlin@notes.cc.sunysb.edu						Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	7	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1402	1403		10.1126/science.1136314	http://dx.doi.org/10.1126/science.1136314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17095656				2022-12-28	WOS:000242406100023
J	Wald, DS; Morris, JK; Law, M; Wald, NJ				Wald, David S.; Morris, Joan K.; Law, Malcolm; Wald, Nicholas J.			Cardiovascular disease - Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; CORONARY-ARTERY-DISEASE; BETA-SYNTHASE DEFICIENCY; ISCHEMIC CEREBROVASCULAR-DISEASE; PLASMA TOTAL HOMOCYSTEINE; VITAMIN-E CONSUMPTION; MYOCARDIAL-INFARCTION; HEART-DISEASE; VASCULAR-DISEASE; YOUNG-WOMEN		Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Wald, DS (corresponding author), Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London EC1M 6BQ, England.	d.s.wald@qmul.ac.uk	Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021	Morris, Joan/0000-0002-7164-612X; 				BAKER F, 2002, CIRCULATION S2, V106, P2; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Chambers JC, 2000, ARTERIOSCL THROM VAS, V20, P2448, DOI 10.1161/01.ATV.20.11.2448; CHRISTENSEN B, 1997, ARTERIOSCLER THROMB, V17; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eikelboom JW, 2000, STROKE, V31, P1069, DOI 10.1161/01.STR.31.5.1069; Gaustadnes M, 1999, BLOOD COAGUL FIBRIN, V10, P251, DOI 10.1097/00001721-199907000-00006; GORACY I, 1999, POL ARCH MED WEWN, V4, P849; Hanson NQ, 2001, CLIN CHEM, V47, P661; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Huang Yining, 2002, Zhonghua Yi Xue Za Zhi, V82, P119; Jang YS, 2002, NUTR RES, V22, P965, DOI 10.1016/S0271-5317(02)00416-5; Kawashiri M, 2000, AM J CARDIOL, V86, P840, DOI 10.1016/S0002-9149(00)01103-6; Kim CH, 2001, INT J CARDIOL, V78, P13, DOI 10.1016/S0167-5273(00)00431-9; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; Kluijtmans LAJ, 1997, CIRCULATION, V96, P2573, DOI 10.1161/01.CIR.96.8.2573; Kolling K, 2004, AM J CARDIOL, V93, P1201, DOI 10.1016/j.amjcard.2004.02.009; Kostulas K, 1998, EUR J CLIN INVEST, V28, P285; Lalouschek W, 1999, J LAB CLIN MED, V133, P575, DOI 10.1016/S0022-2143(99)90187-7; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Liem A, 2005, HEART, V91, P1213, DOI 10.1136/hrt.2004.035030; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; Madonna P, 2002, STROKE, V33, P51, DOI 10.1161/hs0102.100483; Malinow MR, 1997, ARTERIOSCL THROM VAS, V17, P1157, DOI 10.1161/01.ATV.17.6.1157; Markus HS, 1997, STROKE, V28, P1739, DOI 10.1161/01.STR.28.9.1739; McIlroy SP, 2002, STROKE, V33, P2351, DOI 10.1161/01.STR.0000032550.90046.38; Meisel C, 2001, ATHEROSCLEROSIS, V154, P651, DOI 10.1016/S0021-9150(00)00679-1; Morita H, 1998, ARTERIOSCL THROM VAS, V18, P1465, DOI 10.1161/01.ATV.18.9.1465; MUDD SH, 1985, AM J HUM GENET, V37, P1; Nakai K, 2000, CORONARY ARTERY DIS, V11, P47, DOI 10.1097/00019501-200002000-00009; Nakata Y, 1998, AM J HYPERTENS, V11, P1019, DOI 10.1016/S0895-7061(98)00046-6; Ou T, 1998, ATHEROSCLEROSIS, V137, P23, DOI 10.1016/S0021-9150(97)00244-X; Press RD, 1999, DIAGN MOL PATHOL, V8, P54, DOI 10.1097/00019606-199903000-00009; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Schmitz C, 1996, CIRCULATION, V94, P1812, DOI 10.1161/01.CIR.94.8.1812; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Schwartz SM, 1997, CIRCULATION, V96, P412; SMITH GD, 1992, BMJ-BRIT MED J, V304, P431, DOI 10.1136/bmj.304.6824.431; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Tanis BC, 2004, J THROMB HAEMOST, V2, P35, DOI 10.1111/j.1538-7836.2004.00508.x; Tokgozoglu S, 1999, HEART, V81, P518, DOI 10.1136/hrt.81.5.518; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Verhoef P, 1998, J AM COLL CARDIOL, V32, P353, DOI 10.1016/S0735-1097(98)00244-7; Wald DS, 2004, EUR J CARDIOV PREV R, V11, P250, DOI 10.1097/01.hjr.0000129742.15346.ab; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yap S, 1998, J INHERIT METAB DIS, V21, P738, DOI 10.1023/A:1005445132327	54	156	170	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2006	333	7578					1114	1117		10.1136/bmj.39000.486701.68	http://dx.doi.org/10.1136/bmj.39000.486701.68			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124224	Green Published			2022-12-28	WOS:000242520200020
J	Kolano, C; Helbing, J; Kozinski, M; Sander, W; Hamm, P				Kolano, Christoph; Helbing, Jan; Kozinski, Mariusz; Sander, Wolfram; Hamm, Peter			Watching hydrogen-bond dynamics in a beta-turn by transient two-dimensional infrared spectroscopy	NATURE			English	Article							PICOSECOND CONFORMATIONAL TRANSITION; PHOTOSWITCHABLE PEPTIDE; PROTEIN; ISOTOPOMERS; DISULFIDE; IR	X-ray crystallography and nuclear magnetic resonance measurements provide us with atomically resolved structures of an ever-growing number of biomolecules. These static structural snapshots are important to our understanding of biomolecular function, but real biomolecules are dynamic entities that often exploit conformational changes and transient molecular interactions to perform their tasks. Nuclear magnetic resonance methods can follow such structural changes, but only on millisecond timescales under non-equilibrium conditions. Time-resolved X-ray crystallography has recently been used to monitor the photodissociation of CO from myoglobin on a subnanosecond timescale(1), yet remains challenging to apply more widely. In contrast, two-dimensional infrared spectroscopy, which maps vibrational coupling between molecular groups and hence their relative positions and orientations(2-11), is now routinely used to study equilibrium processes on picosecond timescales. Here we show that the extension of this method into the non-equilibrium regime(12,13) allows us to observe in real time in a short peptide the weakening of an intramolecular hydrogen bond and concomitant opening of a beta-turn. We find that the rate of this process is two orders of magnitude faster than the 'folding speed limit' established for contact formation between protein side chains(14).	Univ Zurich, Inst Phys Chem, CH-8057 Zurich, Switzerland; Ruhr Univ Bochum, Lehrstuhl Organ Chem 2, D-44801 Bochum, Germany	University of Zurich; Ruhr University Bochum	Kolano, C (corresponding author), Univ Zurich, Inst Phys Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	c.kolano@pci.unizh.ch; p.hamm@pci.unizh.ch	Helbing, Jan/A-5609-2013; Hamm, Peter/O-1247-2013	Hamm, Peter/0000-0003-1106-6032; Sander, Wolfram/0000-0002-1640-7505				Asbury JB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.237402; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Bredenbeck J, 2005, P NATL ACAD SCI USA, V102, P2379, DOI 10.1073/pnas.0406948102; Bredenbeck J, 2004, J CHEM PHYS, V121, P5943, DOI 10.1063/1.1779575; Bredenbeck J, 2003, J PHYS CHEM B, V107, P8654, DOI 10.1021/jp034552q; Bredenbeck J, 2003, P NATL ACAD SCI USA, V100, P6452, DOI 10.1073/pnas.1036583100; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Fang C, 2005, J PHYS CHEM B, V109, P18652, DOI 10.1021/jp052525p; Golonzka O, 2001, PHYS REV LETT, V86, P2154, DOI 10.1103/PhysRevLett.86.2154; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hamm P, 1997, J CHEM PHYS, V106, P519, DOI 10.1063/1.473392; Kolano C, 2004, EUR J ORG CHEM, V2004, P4167, DOI 10.1002/ejoc.200400174; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Lu HSM, 1997, J AM CHEM SOC, V119, P7173, DOI 10.1021/ja970567o; Mohanty D, 1997, J MOL BIOL, V272, P423, DOI 10.1006/jmbi.1997.1246; Mohanty D, 2000, INT J QUANTUM CHEM, V80, P1125, DOI 10.1002/1097-461X(2000)80:4/5<1125::AID-QUA62>3.0.CO;2-J; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Mukherjee P, 2006, P NATL ACAD SCI USA, V103, P3528, DOI 10.1073/pnas.0508833103; Nguyen PH, 2006, BIOPHYS J, V91, P1224, DOI 10.1529/biophysj.106.084996; Pimentel GC, 1960, HYDROGEN BOND, P67; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Satzger H, 2004, CHEM PHYS LETT, V396, P191, DOI 10.1016/j.cplett.2004.08.024; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Volk M, 1997, J PHYS CHEM B, V101, P8607, DOI 10.1021/jp971951a; Wang JP, 2006, J PHYS CHEM B, V110, P7545, DOI 10.1021/jp057564f; Woutersen S, 2002, J PHYS-CONDENS MAT, V14, pR1035, DOI 10.1088/0953-8984/14/39/202; Woutersen S, 2000, J PHYS CHEM B, V104, P11316, DOI 10.1021/jp001546a; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	28	287	290	1	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					469	472		10.1038/nature05352	http://dx.doi.org/10.1038/nature05352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122853				2022-12-28	WOS:000242215700042
J	Segers, P; Speekenbrink, RGH; Ubbink, DT; van Ogtrop, ML; de Mol, BA				Segers, Patrique; Speekenbrink, Ron G. H.; Ubbink, Dirk T.; van Ogtrop, Marc L.; de Mol, Bas A.			Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; STAPHYLOCOCCUS-AUREUS; SELECTIVE DECONTAMINATION; INTRANASAL MUPIROCIN; WOUND INFECTIONS; DIGESTIVE-TRACT; NASAL CARRIAGE; ORAL RINSE; PREVALENCE; RESISTANCE	Context Nosocomial infections are an important cause of morbidity and mortality after cardiac surgery. Decolonization of endogenous potential pathogenic microorganisms is important in the prevention of nosocomial infections. Objective To determine the efficacy of perioperative decontamination of the nasopharynx and oropharynx with 0.12% chlorhexidine gluconate for reduction of nosocomial infection after cardiac surgery. Design, Setting, and Participants A prospective, randomized, double-blind, placebo-controlled clinical trial conducted at the Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands, between August 1, 2003, and September 1, 2005. Of 991 patients older than 18 years undergoing elective cardiothoracic surgery during the study interval, 954 were eligible for analysis. Intervention Oropharyngeal rinse and nasal ointment containing either chlorhexidine gluconate or placebo. Main Outcome Measures Incidence of nosocomial infection, in addition to the rate of Staphylococcus aureus nasal carriage and duration of hospital stay. Results The incidence of nosocomial infection in the chlorhexidine gluconate group and placebo group was 19.8% and 26.2%, respectively (absolute risk reduction [ARR], 6.4%; 95% confidence interval [CI], 1.1%-11.7%; P = .002). In particular, lower respiratory tract infections and deep surgical site infections were less common in the chlorhexidine gluconate group than in the placebo group (ARR, 6.5%; 95% CI, 2.3%-10.7%; P =. 002; and 3.2%; 95% CI, 0.9%-5.5%; P =. 002, respectively). For the prevention of 1 nosocomial infection, 16 patients needed to be treated with chlorhexidine gluconate. A significant reduction of 57.5% in S aureus nasal carriage was found in the chlorhexidine gluconate group compared with a reduction of 18.1% in the placebo group (P < .001). Total hospital stay for patients treated with chlorhexidine gluconate was 9.5 days compared with 10.3 days in the placebo group (ARR, 0.8 days; 95% CI, 0.24-1.88; P = .04). Conclusion Decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate appears to be an effective method to reduce nosocomial infection after cardiac surgery. Trial Registration clinicaltrials.gov Identifier: NCT00272675.	Univ Amsterdam, Acad Med Ctr, Dept Cardiothorac Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Biostat & Bioinformat & Surg, NL-1105 AZ Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Cardiothorac Surg, Amsterdam, Netherlands; Onze Lieve Vrouw Hosp, Dept Med Microbiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Onze Lieve Vrouwe Gasthuis Hospital	Segers, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiothorac Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.segers@amc.uva.nl	Ubbink, Dirk/AAF-1266-2021	de Mol, Bastian/0000-0001-6888-9430; Ubbink, Dirk/0000-0001-9398-8879				Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003; BONTEN MJ, 1994, ROLE COLONIZATION UP, pCH2; Boyce JM, 1996, INFECT CONT HOSP EP, V17, P775; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cimochowski GE, 2001, ANN THORAC SURG, V71, P1572, DOI 10.1016/S0003-4975(01)02519-X; Collard HR, 2003, ANN INTERN MED, V138, P494, DOI 10.7326/0003-4819-138-6-200303180-00015; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; Denton GW, 2001, DISINFECTION STERILI, P321; DeRiso A, 1996, CHEST, V109, P1556, DOI 10.1378/chest.109.6.1556; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; ElOakley RM, 1996, ANN THORAC SURG, V61, P1030, DOI 10.1016/0003-4975(95)01035-1; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; Gaynes RP, 1996, NNIS E NATL NOSOCOMI, P1017; Gogbashian A, 2004, EUR J CARDIO-THORAC, V25, P695, DOI 10.1016/j.ejcts.2004.02.022; Gol MK, 1998, J CARDIAC SURG, V13, P252; Houston S, 2002, AM J CRIT CARE, V11, P567, DOI 10.4037/ajcc2002.11.6.567; Jonkers D, 2003, EUR J CARDIO-THORAC, V23, P97, DOI 10.1016/S1010-7940(02)00662-0; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; KLUYTMANS JAJW, 1994, J HOSP INFECT, V27, P139, DOI 10.1016/0195-6701(94)90007-8; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Krueger Wolfgang A, 2002, Curr Opin Crit Care, V8, P139, DOI 10.1097/00075198-200204000-00009; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mojon Philippe, 2002, J Can Dent Assoc, V68, P340; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Ridderstolpe L, 2001, EUR J CARDIO-THORAC, V20, P1168, DOI 10.1016/S1010-7940(01)00991-5; Russell AD, 2004, J HOSP INFECT, V57, P97, DOI 10.1016/j.jhin.2004.01.004; Silvestri L, 2000, J HOSP INFECT, V45, P185, DOI 10.1053/jhin.2000.0737; *SOC THOR SURG, SOC THOR SURG NAT DA; Sreenivasan P, 2002, J CLIN PERIODONTOL, V29, P965, DOI 10.1034/j.1600-051X.2002.291101.x; STOUTENBEEK CP, 1987, J TRAUMA, V27, P357, DOI 10.1097/00005373-198704000-00003; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; VandenBergh MFQ, 1996, INFECT CONT HOSP EP, V17, P786; VANDENBRINK A, 1998, NED TIJDSCHR GENEES, V142, P2602; WARREN PR, 1991, TODAYS DENT, P1	36	208	229	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2460	2466		10.1001/jama.296.20.2460	http://dx.doi.org/10.1001/jama.296.20.2460			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119142	Bronze			2022-12-28	WOS:000242171000027
J	Rubin, G; Dale, A				Rubin, Greg; Dale, Anne			Chronic constipation in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; FOLLOW-UP; LACTULOSE; PEG-3350		Univ Sunderland, Ctr Primary & Community Care, Sunderland SR1 3PZ, England; Queen Elizabeth Hosp, Childrens Unit, Gateshead NE9 6SX, England	University of Sunderland	Rubin, G (corresponding author), Univ Sunderland, Ctr Primary & Community Care, Sunderland SR1 3PZ, England.	Greg.rubin@sunderland.ac.uk						AGNARSSON U, 1990, MATERN CHILD HLTH, V15, P252; Baker SS, 1999, J PEDIATR GASTR NUTR, V29, P612, DOI 10.1097/00005176-199911000-00029; Benninga M, 2005, J PEDIATR GASTR NUTR, V40, P273, DOI 10.1097/01.MPG.0000158071.24327.88; Brazzelli M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002240.pub3; *BSPGHAN, 2006, BSPGHAN NEWSL; Clayden G.S., 2005, ARCH DIS CHILDHOOD-E, V90, P58; de Lorijn F, 2004, ARCH DIS CHILD, V89, P723, DOI 10.1136/adc.2003.040220; Dupont C, 2005, J PEDIATR GASTR NUTR, V41, P625, DOI 10.1097/01.mpg.0000181188.01887.78; FONTANA M, 1989, ACTA PAEDIATR SCAND, V78, P682, DOI 10.1111/j.1651-2227.1989.tb11126.x; GORDON J, 2001, TOUGH GOIN CHILDHOOD; HEATON K, UNDERSTANDING YOUR B; HEJL M, 1990, Ugeskrift for Laeger, V152, P1819; Hyman PE, 2006, GASTROENTEROLOGY, V130, P1519, DOI [10.1053/j.gastro.2005.11.065, 10.1053/j.gastro.2016.02.016]; Keshtgar AS, 2005, PEDIATR SURG INT, V21, P100, DOI 10.1007/s00383-004-1336-y; Levitt MA, 2005, J PEDIATR GASTR NUTR, V41, pS58, DOI 10.1097/01.scs.0000180308.02052.b2; LOENINGBAUCKE V, 1993, GASTROENTEROLOGY, V105, P1557, DOI 10.1016/0016-5085(93)90166-A; Marshall J, 2001, J PEDIATR SURG, V36, P1227, DOI 10.1053/jpsu.2001.25768; Martino A M, 1992, Minerva Pediatr, V44, P319; Morais MB, 1999, J PEDIATR GASTR NUTR, V29, P132, DOI 10.1097/00005176-199908000-00007; Nurko S, 2005, J PEDIATR GASTR NUTR, V41, pS53, DOI 10.1097/01.scs.0000180306.24923.a9; Pitzalis G, 1995, Pediatr Med Chir, V17, P223; Price KJ, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002040; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Reuchlin-Vroklage LM, 2005, ARCH PEDIAT ADOL MED, V159, P671, DOI 10.1001/archpedi.159.7.671; Roma E, 1999, J PEDIATR GASTR NUTR, V28, P169, DOI 10.1097/00005176-199902000-00015; RUBIN G, 2003, CLIN EVIDENCE, P350; RUBIN G, 2006, CLIN EVIDENCE CONCIS, P85; SONDHEIMER JM, 1982, J PEDIATR GASTR NUTR, V1, P223, DOI 10.1097/00005176-198201020-00012; The Royal College of Radiologists, 1998, MAK BEST US DEP CLIN, V4th; van Ginkel R, 2003, GASTROENTEROLOGY, V125, P357, DOI 10.1016/S0016-5085(03)00888-6; Voskuijl W, 2004, GUT, V53, P1590, DOI 10.1136/gut.2004.043620; Youssef NN, 2002, J PEDIATR-US, V141, P410, DOI 10.1067/mpd.2002.126603	32	46	63	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1051	1055		10.1136/bmj.39007.760174.47	http://dx.doi.org/10.1136/bmj.39007.760174.47			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108HB	17110723	Green Published			2022-12-28	WOS:000242229800021
J	Mora, JR; Iwata, M; Eksteen, B; Song, SY; Junt, T; Senman, B; Otipoby, KL; Yokota, A; Takeuchi, H; Ricciardi-Castagnoli, P; Rajewsky, K; Adams, DH; von Andrian, UH				Mora, J. Rodrigo; Iwata, Makoto; Eksteen, Bertus; Song, Si-Young; Junt, Tobias; Senman, Balimkiz; Otipoby, Kevin L.; Yokota, Aya; Takeuchi, Hajime; Ricciardi-Castagnoli, Paola; Rajewsky, Klaus; Adams, David H.; von Andrian, Ulrich H.			Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells	SCIENCE			English	Article							A-DEFICIENT RATS; T-CELLS; IMMUNOGLOBULIN-A; IMMUNE-SYSTEM; RECEPTOR; INTERLEUKIN-6; RESPONSES; LYMPHOCYTES; SPECIFICITY; EXPRESSION	Normal intestinal mucosa contains abundant immunoglobulin A (IgA) - secreting cells, which are generated from B cells in gut-associated lymphoid tissues (GALT). We show that dendritic cells ( DC) from GALT induce T cell - independent expression of IgA and gut-homing receptors on B cells. GALT-DC-derived retinoic acid (RA) alone conferred gut tropism but could not promote IgA secretion. However, RA potently synergized with GALT-DC-derived interleukin-6 (IL-6) or IL-5 to induce IgA secretion. Consequently, mice deficient in the RA precursor vitamin A lacked IgA-secreting cells in the small intestine. Thus, GALT-DC shape mucosal immunity by modulating B cell migration and effector activity through synergistically acting mediators.	Ctr Blood Res, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Tokushima Bunri University; University of Birmingham; University of Milano-Bicocca	Mora, JR (corresponding author), Ctr Blood Res, Inst Biomed Res, 800 Huntington Ave, Boston, MA 02115 USA.	mora@cbr.med.harvard.edu; uva@cbr.med.harvard.edu	Adams, David H/C-9092-2009; von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021; Castagnoli, Paola/E-8288-2010; Eckhardt, Erik/G-1567-2010	Adams, David H/0000-0001-6776-0336; Rajewsky, Klaus/0000-0002-6633-6370	Medical Research Council [G0601816] Funding Source: Medline; NHLBI NIH HHS [HL56949, HL62524, HL54936] Funding Source: Medline; NIAID NIH HHS [R37 AI054636, AI-061663] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062524, R01HL054936, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636, R01AI061663] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bjersing JL, 2002, CLIN EXP IMMUNOL, V130, P404, DOI 10.1046/j.1365-2249.2002.02009.x; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; CHENG L, 1993, EUR J CLIN NUTR, V47, P88; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Hiroi T, 1999, J IMMUNOL, V162, P821; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kantele A, 2005, J INFECT DIS, V191, P312, DOI 10.1086/426943; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nikawa T, 1999, J NUTR, V129, P934, DOI 10.1093/jn/129.5.934; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; SIRISINHA S, 1980, CLIN EXP IMMUNOL, V40, P127; SOMMER A, 1986, LANCET, V1, P1169; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; TOKUYAMA H, 1993, CELL IMMUNOL, V150, P353, DOI 10.1006/cimm.1993.1203; VanCott JL, 2000, J VIROL, V74, P5250, DOI 10.1128/JVI.74.11.5250-5256.2000; Williams MB, 1998, J IMMUNOL, V161, P4227	28	739	779	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1157	1160		10.1126/science.1132742	http://dx.doi.org/10.1126/science.1132742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110582				2022-12-28	WOS:000242045800048
J	Vohs, KD; Mead, NL; Goode, MR				Vohs, Kathleen D.; Mead, Nicole L.; Goode, Miranda R.			The psychological consequences of money	SCIENCE			English	Article								Money has been said to change people's motivation ( mainly for the better) and their behavior toward others ( mainly for the worse). The results of nine experiments suggest that money brings about a self-sufficient orientation in which people prefer to be free of dependency and dependents. Reminders of money, relative to nonmoney reminders, led to reduced requests for help and reduced helpfulness toward others. Relative to participants primed with neutral concepts, participants primed with money preferred to play alone, work alone, and put more physical distance between themselves and a new acquaintance.	Univ Minnesota, Carlson Sch Management, Dept Mkt, Minneapolis, MN 55455 USA; Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Univ British Columbia, Sauder Sch Business, Mkt Div, Vancouver, BC V6T 1Z2, Canada	University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; Florida State University; University of British Columbia	Vohs, KD (corresponding author), Univ Minnesota, Carlson Sch Management, Dept Mkt, 3-150 321 19th Ave S, Minneapolis, MN 55455 USA.	kvohs@csom.umn.edu	Mead, Nicole/L-7675-2019; Mead, Nicole/Q-7856-2016	Mead, Nicole/0000-0002-9621-4999				Amato PR, 1997, J MARRIAGE FAM, V59, P612, DOI 10.2307/353949; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; Furnham Adrian., 1998, PSYCHOL MONEY; Lea SEG, 2006, BEHAV BRAIN SCI, V29, P161; MACRAE CN, 1994, J PERS SOC PSYCHOL, V67, P808, DOI 10.1037/0022-3514.67.5.808; Price Richard H, 2002, J Occup Health Psychol, V7, P302, DOI 10.1037/1076-8998.7.4.302; SCHWAB RS, 1953, FATIGUE, P143; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; TWENGE JM, IN PRESS J PERS SOC	10	760	793	7	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1154	1156		10.1126/science.1132491	http://dx.doi.org/10.1126/science.1132491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105PW	17110581				2022-12-28	WOS:000242045800047
J	Brown, RH; Grant, PE; Pierson, CR; Harris, NL; Krishnamoorthy, KS				Brown, Robert H., Jr.; Grant, P. Ellen; Pierson, Christopher R.; Harris, Nancy Lee; Krishnamoorthy, Kalpathy S.			A newborn boy with hypotonia - Merosin-deficient congenital muscular dystrophy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LAMININ ALPHA-2-CHAIN; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; ALPHA-DYSTROGLYCAN; MUTATIONS		Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Brown, RH (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013				Batten F., 1903, BRAIN, V26, P147; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CARPENTER S, 2001, PATHOLOGY SKELETAL M, P406; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Guicheney P, 1997, NEUROMUSCULAR DISORD, V7, P180, DOI 10.1016/S0960-8966(97)00460-4; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kano H, 2002, BIOCHEM BIOPH RES CO, V293, P1579; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kirschner J, 2004, ARCH NEUROL-CHICAGO, V61, P189, DOI 10.1001/archneur.61.2.189; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Nissinen M, 1996, AM J HUM GENET, V58, P1177; Voit T, 2004, MYOLOGY, P1203	15	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2132	2142		10.1056/NEJMcpc069026	http://dx.doi.org/10.1056/NEJMcpc069026			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108346				2022-12-28	WOS:000241997300011
J	Drueke, TB; Locatelli, F; Clyne, N; Eckardt, K; Macdougall, IC; Tsakiris, D; Burger, H; Scherhag, A				Drueke, Tilman B.; Locatelli, Francesco; Clyne, Naomi; Eckardt, Kai-Uwe; Macdougall, Iain C.; Tsakiris, Dimitrios; Burger, Hans-Ulrich; Scherhag, Armin		CREATE Investigators	Normalization of hemoglobin level in patients with chronic kidney disease and anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; LEFT-VENTRICULAR MASS; QUALITY-OF-LIFE; HEMODIALYSIS-PATIENTS; RENAL-FUNCTION; EPOETIN-ALPHA; HEMATOCRIT LEVEL; PREDIALYSIS; MORTALITY; DIALYSIS	Background: Whether correction of anemia in patients with stage 3 or 4 chronic kidney disease improves cardiovascular outcomes is not established. Methods: We randomly assigned 603 patients with an estimated glomerular filtration rate (GFR) of 15.0 to 35.0 ml per minute per 1.73 m(sup 2) of body-surface area and mild-to-moderate anemia (hemoglobin level, 11.0 to 12.5 g per deciliter) to a target hemoglobin value in the normal range (13.0 to 15.0 g per deciliter, group 1) or the subnormal range (10.5 to 11.5 g per deciliter, group 2). Subcutaneous erythropoietin (epoetin beta) was initiated at randomization (group 1) or only after the hemoglobin level fell below 10.5 g per deciliter (group 2). The primary end point was a composite of eight cardiovascular events; secondary end points included left ventricular mass index, quality-of-life scores, and the progression of chronic kidney disease. Results: During the 3-year study, complete correction of anemia did not affect the likelihood of a first cardiovascular event (58 events in group 1 vs. 47 events in group 2; hazard ratio, 0.78; 95% confidence interval, 0.53 to 1.14; P=0.20). Left ventricular mass index remained stable in both groups. The mean estimated GFR was 24.9 ml per minute in group 1 and 24.2 ml per minute in group 2 at baseline and decreased by 3.6 and 3.1 ml per minute per year, respectively (P=0.40). Dialysis was required in more patients in group 1 than in group 2 (127 vs. 111, P=0.03). General health and physical function improved significantly (P=0.003 and P<0.001, respectively, in group 1, as compared with group 2). There was no significant difference in the combined incidence of adverse events between the two groups, but hypertensive episodes and headaches were more prevalent in group 1. Conclusions: In patients with chronic kidney disease, early complete correction of anemia does not reduce the risk of cardiovascular events.	INSERM, U507, Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Nephrol,Div Nephrol, Paris, France; Osped A Manzoni, Dept Nephrol & Dialysis, Lecce, Italy; Univ Lund Hosp, Dept Nephrol, S-22185 Lund, Sweden; Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; Heidelberg Univ, Mannheim Univ Hosp, Med Clin 1, Heidelberg, Germany; Kings Coll Hosp London, Dept Renal Med, London, England; Gen Hosp Veria, Dept Nephrol, Veria, Greece; F Hoffmann La Roche & Co Ltd, Div Pharmaceut, CH-4002 Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Lund University; Skane University Hospital; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; King's College Hospital NHS Foundation Trust; King's College Hospital; Roche Holding	Drueke, TB (corresponding author), INSERM, U507, Paris, France.	drueke@necker.fr	Wilson, Matthew H/K-3193-2013; DRUEKE, Tilman B./B-4958-2010	DRUEKE, Tilman B./0000-0002-0700-7681; Clyne, Naomi/0000-0001-5284-4406				Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; CLYNE N, 1994, NEPHRON, V67, P322, DOI 10.1159/000187987; Collins AJ, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1058; Cusick M, 2004, KIDNEY INT, V66, P1173, DOI 10.1111/j.1523-1755.2004.00869.x; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Furuland H, 2003, NEPHROL DIAL TRANSPL, V18, P353, DOI 10.1093/ndt/18.2.353; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Hayashi T, 2000, AM J KIDNEY DIS, V35, P250, DOI 10.1016/S0272-6386(00)70334-9; KISSLO J, 1995, J AM SOC ECHOCARDIOG, V8, pS1; Klang B, 1997, SCAND J CARING SCI, V11, P159, DOI 10.1111/j.1471-6712.1997.tb00449.x; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Macdougall LC, 2003, NEPHROL DIAL TRANSPL, V18, P13, DOI 10.1093/ndt/gfg1057; Madore F, 1997, J AM SOC NEPHROL, V8, P1921; McMahon LP, 2000, NEPHROL DIAL TRANSPL, V15, P1425, DOI 10.1093/ndt/15.9.1425; Mocks J, 2000, NEPHRON, V86, P455, DOI 10.1159/000045834; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; National Kidney Foundation, 2006, AM J KIDNEY DIS, V48, P518; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Portoles J, 1997, AM J KIDNEY DIS, V29, P541, DOI 10.1016/S0272-6386(97)90335-8; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; REVICKI DA, 1995, AM J KIDNEY DIS, V25, P548, DOI 10.1016/0272-6386(95)90122-1; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; Rossert J, 2006, AM J KIDNEY DIS, V47, P738, DOI 10.1053/j.ajkd.2006.02.170; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; ROTH D, 1994, AM J KIDNEY DIS, V24, P777, DOI 10.1016/S0272-6386(12)80671-8; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sharples EJ, 2004, J AM SOC NEPHROL, V15, P2115, DOI 10.1097/01.ASN.0000135059.67385.5D; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Valderrabano Fernando, 2000, Journal of the American Society of Nephrology, V11, p78A; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weiner DE, 2005, J AM SOC NEPHROL, V16, P1803, DOI 10.1681/ASN.2004070597	39	1544	1608	2	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2071	2084		10.1056/NEJMoa062276	http://dx.doi.org/10.1056/NEJMoa062276			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108342				2022-12-28	WOS:000241997300004
J	Marks, LS; Mazer, NA; Mostaghel, E; Hess, DL; Dorey, FJ; Epstein, JI; Veltri, RW; Makarov, DV; Partin, AW; Bostwick, DG; Macairan, ML; Nelson, PS				Marks, Leonard S.; Mazer, Norman A.; Mostaghel, Elahe; Hess, David L.; Dorey, Frederick J.; Epstein, Jonathan I.; Veltri, Robert W.; Makarov, Danil V.; Partin, Alan W.; Bostwick, David G.; Macairan, Maria Luz; Nelson, Peter S.			Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANDROGEN DEFICIENCY; SAW PALMETTO; OLDER MEN; CANCER; DIHYDROTESTOSTERONE; FINASTERIDE; BIOPSY; RISK; RECOMMENDATIONS; HYPERTROPHY	Context Prostate safety is a primary concern when aging men receive testosterone replacement therapy (TRT), but little information is available regarding the effects of TRT on prostate tissue in men. Objective To determine the effects of TRT on prostate tissue of aging men with low serum testosterone levels. Design, Setting, and Participants Randomized, double-blind, placebo-controlled trial of 44 men, aged 44 to 78 years, with screening serum testosterone levels lower than 300 ng/dL ( < 10.4 nmol/L) and related symptoms, conducted at a US community-based research center between February 2003 and November 2004. Intervention Participants were randomly assigned to receive 150 mg of testosterone enanthate or matching placebo intramuscularly every 2 weeks for 6 months. Main Outcome Measures The primary outcome measure was the 6-month change in prostate tissue androgen levels ( testosterone and dihydrotestosterone). Secondary outcome measures included 6-month changes in prostate-related clinical features, histology, biomarkers, and epithelial cell gene expression. Results Of the 44 men randomized, 40 had prostate biopsies performed both at baseline and at 6 months and qualified for per-protocol analysis ( TRT, n= 21; placebo, n= 19). Testosterone replacement therapy increased serum testosterone levels to the mid-normal range ( median at baseline, 282 ng/dL [9.8 nmol/L]; median at 6 months, 640 ng/dL [22.2 nmol/L]) with no significant change in serum testosterone levels in matched, placebo-treated men. However, median prostate tissue levels of testosterone (0.91 ng/g) and dihydrotestosterone (6.79 ng/g) did not change significantly in the TRT group. No treatment-related change was observed in prostate histology, tissue biomarkers ( androgen receptor, Ki-67, CD34), gene expression ( including AR, PSA, PAP2A, VEGF, NXK3, CLU [ Clusterin]), or cancer incidence or severity. Treatment-related changes in prostate volume, serum prostate-specific antigen, voiding symptoms, and urinary flow were minor. Conclusions These preliminary data suggest that in aging men with late-onset hypogonadism, 6 months of TRT normalizes serum androgen levels but appears to have little effect on prostate tissue androgen levels and cellular functions. Establishment of prostate safety for large populations of older men undergoing longer duration of TRT requires further study.	Univ Calif Los Angeles, Geffen Sch Med, Dept Urol, Los Angeles, CA 90024 USA; Urol Sci Res Fdn, Culver City, CA USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Oregon Natl Primate Res Ctr, Beaverton, OR USA; Univ So Calif, Childrens Hosp, Sch Med, Dept Biostat, Los Angeles, CA 90027 USA; Johns Hopkins Univ, Brady Urol Inst, Baltimore, MD USA; Bostwick Labs, Richmond, VA USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Boston University; Oregon Health & Science University; Oregon National Primate Research Center; Children's Hospital Los Angeles; University of Southern California; Johns Hopkins University; University of Washington; University of Washington Seattle	Marks, LS (corresponding author), Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA.	lsmarks@ucla.edu	Mazer, Norman A/HGU-8266-2022	Makarov, Danil/0000-0002-0565-9272	NATIONAL CANCER INSTITUTE [P50CA097186, P50CA058236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065204] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amory JK, 2002, J AM GERIATR SOC, V50, P1698, DOI 10.1046/j.1532-5415.2002.50462.x; Bhasin S, 2003, J ANDROL, V24, P299; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; COFFEY DS, 1990, UROL CLIN N AM, V17, P461; Dobs AS, 1999, J CLIN ENDOCR METAB, V84, P3469, DOI 10.1210/jc.84.10.3469; Ferrando AA, 2001, CRIT CARE MED, V29, P1936, DOI 10.1097/00003246-200110000-00015; FOWLER JE, 1981, J UROLOGY, V126, P372, DOI 10.1016/S0022-5347(17)54531-0; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; Gaylis FD, 2005, J UROLOGY, V174, P534, DOI 10.1097/01.ju.0000165166.36280.60; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Heller CG, 1944, J AMER MED ASSOC, V126, P472, DOI 10.1001/jama.1944.02850430006003; Hijazi RA, 2005, ANNU REV MED, V56, P117, DOI 10.1146/annurev.med.56.082103.104518; Hsing Ann W., 2002, Prostate, V52, P213, DOI 10.1002/pros.10108; Huggins C, 1940, J UROLOGY, V43, P705, DOI 10.1016/S0022-5347(17)71453-X; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213; JOHNSON D E, 1977, Urology, V9, P137, DOI 10.1016/0090-4295(77)90182-0; Kamischke A, 1999, J ANDROL, V20, P601; KARR JP, 1984, UROLOGY, V23, P276, DOI 10.1016/S0090-4295(84)90047-5; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Liverman CT, 2004, TESTOSTERONE AGING C; Loughlin KR, 1997, J UROLOGY, V157, P1845, DOI 10.1016/S0022-5347(01)64881-X; Marks LS, 2004, UROLOGY, V64, P765, DOI 10.1016/j.urology.2004.05.047; Marks LS, 1997, J UROLOGY, V157, P2171, DOI 10.1016/S0022-5347(01)64707-4; Marks LS, 2001, UROLOGY, V57, P191, DOI 10.1016/S0090-4295(00)00972-9; Marks LS, 2001, UROLOGY, V57, P999, DOI 10.1016/S0090-4295(00)01052-9; Marks LS, 2000, J UROLOGY, V163, P1451, DOI 10.1016/S0022-5347(05)67641-0; MCCONNELL JD, 1992, J CLIN ENDOCR METAB, V74, P505, DOI 10.1210/jc.74.3.505; Meikle AW, 1997, UROLOGY, V49, P191; Mohler JL, 2004, J UROLOGY, V171, P2277, DOI 10.1097/01.ju.0000127739.88383.79; Morley JE, 2000, J LAB CLIN MED, V135, P370, DOI 10.1067/mlc.2000.106455; Morley JE, 2000, METABOLISM, V49, P1239, DOI 10.1053/meta.2000.8625; Nelson PS, 2002, NUCLEIC ACIDS RES, V30, P218, DOI 10.1093/nar/30.1.218; Nieschlag E, 2005, EUR UROL, V48, P1, DOI 10.1016/j.eururo.2005.04.027; OESTERLING JE, 1986, J UROLOGY, V136, P1030, DOI 10.1016/S0022-5347(17)45198-6; Parsons JK, 2005, CANCER EPIDEM BIOMAR, V14, P2257, DOI 10.1158/1055-9965.EPI-04-0715; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; RESKO JA, 1980, J CLIN ENDOCR METAB, V50, P900, DOI 10.1210/jcem-50-5-900; Rhoden EL, 2003, J UROLOGY, V170, P2348, DOI 10.1097/01.ju.0000091104.71869.8e; Rhoden EL, 2004, NEW ENGL J MED, V350, P482, DOI 10.1056/NEJMra022251; Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3; Schaeffer EM, 2004, NEW ENGL J MED, V350, P2004; Schroeder ET, 2004, J CLIN ENDOCR METAB, V89, P4863, DOI 10.1210/jc.2004-0784; Shirai T, 2000, MUTAT RES-REV MUTAT, V462, P219, DOI 10.1016/S1383-5742(00)00039-9; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Tenover J L, 2000, Mayo Clin Proc, V75 Suppl, pS77; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Udayakumar TS, 1998, ANAT REC, V252, P637; WALSH PC, 1983, J CLIN INVEST, V72, P1772, DOI 10.1172/JCI111137; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; WU CP, 1991, PROG CLIN BIOL RES, V370, P249	53	285	301	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2351	2361		10.1001/jama.296.19.2351	http://dx.doi.org/10.1001/jama.296.19.2351			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104ZI	17105798	Bronze			2022-12-28	WOS:000241998700023
J	Eddingsaas, NC; Suslick, KS				Eddingsaas, Nathan C.; Suslick, Kenneth S.			Light from sonication of crystal slurries	NATURE			English	Article							INTERPARTICLE COLLISIONS DRIVEN; TRIBOLUMINESCENCE; SONOLUMINESCENCE; ULTRASOUND		Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Eddingsaas, NC (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	ksuslick@uiuc.edu	Suslick, Kenneth S/A-1841-2010	Suslick, Kenneth S/0000-0001-5422-0701				Arora M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.174501; Bacon F., 1915, ADV LEARNING; Chandra BP, 1998, CRYST RES TECHNOL, V33, P291, DOI 10.1002/(SICI)1521-4079(1998)33:2<291::AID-CRAT291>3.0.CO;2-3; Chandra BP, 1998, LUMINESCENCE OF SOLIDS, P361; DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118; McNamara WB, 2003, J PHYS CHEM B, V107, P7303, DOI 10.1021/jp034236b; McNamara WB, 1999, NATURE, V401, P772, DOI 10.1038/44536; Prozorov T, 2004, J AM CHEM SOC, V126, P13890, DOI 10.1021/ja049493o; Suslick KS., 1997, ENCYCL ACOUST, V1, P271, DOI DOI 10.1002/9780470172513.CH26; Sweeting LM, 2001, CHEM MATER, V13, P854, DOI 10.1021/cm0006087; WALTON AJ, 1984, ADV PHYS, V33, P595, DOI 10.1080/00018738400101711; WALTON AJ, 1977, ADV PHYS, V26, P887, DOI 10.1080/00018737700101483; ZINK JI, 1978, ACCOUNTS CHEM RES, V11, P289, DOI 10.1021/ar50128a001	13	125	129	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					163	163		10.1038/444163a	http://dx.doi.org/10.1038/444163a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093442	Bronze			2022-12-28	WOS:000241867200030
J	Chantler, C; Clarke, T; Granger, R				Chantler, Cyril; Clarke, Trevor; Granger, Richard			Information technology in the English National Health Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Kings Fund, London W1G 0AN, England; Great Ormond St Hosp Children, London WC1N 3JH, England; Dept Hlth, London SE1 6TE, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Chantler, C (corresponding author), Kings Fund, 11-13 Cavendish Sq, London W1G 0AN, England.	chantler@doctors.org.uk	Tao, Youyou/D-2367-2014					Cross M, 2006, BRIT MED J, V332, P599, DOI 10.1136/bmj.332.7541.599; Cross M, 2006, BRIT MED J, V332, P656, DOI 10.1136/bmj.332.7542.656; *HM TREAS, 2002, GOV SPEND REV 2002, pCH7; *NAT AUD OFF, NAT PROGR IT NHS; *NHS CONN HLTH, NHS NAT PROGR INF TE; *NHS CONN HLTH, NHS CONN HLTH FACT S; *NHS CONN HLTH, STAND PROP ANN NHS C; *NHS CONN HLTH, STAND LAUNCH INF STA; *NHS CONN HLTH CAR, NHS CAR REC GUAR; *NHS CONN HLTH NHS, SHAR WITH CAR; Souhami R, 2006, BRIT MED J, V333, P315, DOI 10.1136/bmj.333.7563.315; 2005, CHIEF EXECUTIVE REPO	12	20	21	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2255	2258		10.1001/jama.296.18.2255	http://dx.doi.org/10.1001/jama.296.18.2255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090773				2022-12-28	WOS:000241827700027
J	Olsen, JV; Blagoev, B; Gnad, F; Macek, B; Kumar, C; Mortensen, P; Mann, M				Olsen, Jesper V.; Blagoev, Blagoy; Gnad, Florian; Macek, Boris; Kumar, Chanchal; Mortensen, Peter; Mann, Matthias			Global, in vivo, and site-specific phosphorylation dynamics in signaling networks	CELL			English	Article							GROWTH-FACTOR RECEPTOR; MASS-SPECTROMETRY; TYROSINE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; PHOSPHOPROTEOME ANALYSIS; QUANTITATIVE PROTEOMICS; TRANSCRIPTIONAL CONTROL; CELL-CULTURE; AMINO-ACIDS; KINASE	Cell signaling mechanisms often transmit information via posttranslational protein modifications, most importantly reversible protein phosphorylation. Here we develop and apply a general mass spectrometric technology for identification and quantitation of phosphorylation sites as a function of stimulus, time, and subcellular location. We have detected 6,600 phosphorylation sites on 2,244 proteins and have determined their temporal dynamics after stimulating HeLa cells with epidermal growth factor (EGF) and recorded them in the Phosida database. Fourteen percent of phosphorylation sites are modulated at least 2-fold by EGF, and these were classified by their temporal profiles. Surprisingly, a majority of proteins contain multiple phosphorylation sites showing different kinetics, suggesting that they serve as platforms for integrating signals. In addition to protein kinase cascades, the targets of reversible phosphorylation include ubiquitin ligases, guanine nucleotide exchange factors, and at least 46 different transcriptional regulators. The dynamic phosphoproteorne provides a missing link in a global, integrative view of cellular regulation.	Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	University of Southern Denmark; Max Planck Society	Blagoev, B (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark.	bab@bmb.sdu.dk; mmann@biochem.mpg.de	Mann, Matthias/A-3454-2013; Macek, Boris/N-1442-2015; Olsen, Jesper/C-4738-2008; Kumar, Chanchal/C-2901-2008; Olsen, Jesper/ABH-4638-2020	Mann, Matthias/0000-0003-1292-4799; Macek, Boris/0000-0002-1206-2458; Olsen, Jesper/0000-0002-4747-4938; Gnad, Florian/0000-0002-2287-2251; Blagoev, Blagoy/0000-0002-3596-0066				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Amanchy R, 2005, J PROTEOME RES, V4, P1661, DOI 10.1021/pr050134h; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen WG, 2004, EXPERT REV PROTEOMIC, V1, P343, DOI 10.1586/14789450.1.3.343; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mumby M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-230; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; *RDC TEAM R DEV CO, 2006, R LANG ENV STAT COMP; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Soderling SH, 2006, BIOCHEM SOC T, V34, P73, DOI 10.1042/BST0340073; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; STOVER DR, 2004, CLIN PROTEOM, V1, P69; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	2691	4086	5	477	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					635	648		10.1016/j.cell.2006.09.026	http://dx.doi.org/10.1016/j.cell.2006.09.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081983	Bronze			2022-12-28	WOS:000241937000025
J	Saper, CB				Saper, Clifford B.			Life, the universe, and body temperature	SCIENCE			English	Editorial Material									Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol,Div Sleep Med, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Neurosci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saper, CB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol,Div Sleep Med, Boston, MA 02215 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019					Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; LIU RK, 1975, J GERONTOL, V30, P129, DOI 10.1093/geronj/30.2.129; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429	6	5	5	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					773	774		10.1126/science.1135375	http://dx.doi.org/10.1126/science.1135375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17082446				2022-12-28	WOS:000241729800033
J	Filippi, V; Ronsmans, C; Campbell, OMR; Graham, WJ; Mills, A; Borghi, J; Koblinsky, M; Osrin, D				Filippi, Veronique; Ronsmans, Carine; Campbell, Oona M. R.; Graham, Wendy J.; Mills, Anne; Borghi, Jo; Koblinsky, Marjorie; Osrin, David			Maternal survival 5 - Maternal health in poor countries: the broader context and a call for action	LANCET			English	Article							NEONATAL SURVIVAL; PERINATAL-MORTALITY; RISK-FACTORS; CARE; COMPLICATIONS; DISTRICT; MATLAB; BENIN; BIRTH; WOMEN	In this paper, we take a broad perspective on maternal health and place it in its wider context. We draw attention to the economic and social vulnerability of pregnant women, and stress the importance of concomitant broader strategies, including poverty reduction and women's empowerment. We also consider outcomes beyond mortality, in particular, near-misses and long-term sequelae, and the implications of the close association between the mother, the fetus, and the child. We make links to a range of global survival initiatives, particularly neonatal health, HIV, and malaria, and to reproductive health. Finally, after examining the political and financial context, we call for action. The need for strategic vision, financial resources, human resources, and information are discussed.	Univ London London Sch Hyg & Trop Med, Maternal & Neonatal Hlth Grp, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen, Scotland; ICDDR B, Div Publ Hlth Sci, Reprod Hlth Unit, Dhaka, Bangladesh; UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Aberdeen; International Centre for Diarrhoeal Disease Research (ICDDR); University of London; University College London	Filippi, V (corresponding author), Univ London London Sch Hyg & Trop Med, Maternal & Neonatal Hlth Grp, Keppel St, London WC1E 7HT, England.	veronique.filippi@lshtm.ac.uk		Mills, Anne/0000-0001-9863-9950; Osrin, David/0000-0001-9691-9684; Borghi, Josephine/0000-0002-0482-5451; Campbell, Oona/0000-0002-9311-0115; Graham, Wendy/0000-0003-1473-5342				Ashford L, HIDDEN SUFFERING DIS; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Beegle K, 2001, STUD FAMILY PLANN, V32, P130, DOI 10.1111/j.1728-4465.2001.00130.x; *BOARD GLOB HLTH, 2003, IMPR BIRTH OUTC M CH; Boerma J. T., 2001, WOMEN INFERTILITY SU; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; BORGHI J, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69383-5; BOUVIERCOLLE MH, 1998, MORBIDITE MAT AFRIQU; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; CAMPBELL O, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69381-1; Chapman Rachel R, 2004, Med Anthropol, V23, P229, DOI 10.1080/01459740490487107; Christian P, 2000, J NUTR, V130, P2675, DOI 10.1093/jn/130.11.2675; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; DUBOURG D, UON NETWORK TACKLING; FORTNEY JA, 1996, BASE ICEBERG PREVALE; Freedman LP, 2005, WHOS GOT POWER TRANS; GOHOU V, TROP MED HLTH, V9, P406; Graham WJ, 1999, LANCET, V353, P836, DOI 10.1016/S0140-6736(98)12374-7; Grossmann-Kendall F, 2001, REPROD HEALTH MATTER, V9, P90, DOI 10.1016/S0968-8080(01)90095-3; Grown C, 2005, LANCET, V365, P541, DOI 10.1016/S0140-6736(05)70278-6; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Katz J, 2003, B WORLD HEALTH ORGAN, V81, P717; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; KOBLINSKY M, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69382-3; KUNST AE, 2001, SAFE MOTHERHOOD STRA, P297; Kusiako T, 2000, B WORLD HEALTH ORGAN, V78, P621; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Moore M, 2003, BEHAV CHANGE PERSPEC; Murray C. J. L., 1998, GLOBAL BURDEN DIS IN, V3; Narayanan I, 2004, COMPONENTS ESSENTIAL; *NAT I ALL INF DIS, 1999, GLOB BURD TUB; PARHURST JO, 2006, HLTH POLICY     0515, DOI DOI 10.1016/J.HEALTHPOL.2006.03.015; Pittrof R, 2002, ACTA OBSTET GYN SCAN, V81, P277, DOI 10.1034/j.1600-0412.2002.810401.x; POWELLJACKSON T, 2006, LANCET          0918, DOI DOI 10.1016/S0140-6736(06)69338-0; Ronsmans C, 2002, B WORLD HEALTH ORGAN, V80, P317; Ronsmans C, 1999, LANCET, V354, P1448, DOI 10.1016/S0140-6736(99)03222-5; RONSMANS C, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69380-X; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Shen C, 1999, SOC SCI MED, V49, P197, DOI 10.1016/S0277-9536(99)00112-4; SHIFFMAN J, 2006, STATE POLITICAL PRIO; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; STORENG K, 2004, BRIT SOC POP STUD 20; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; *UN CHILDR FUND WH, 1997, GUID MON AV US OBST; Van Lerberghe W, 2001, STUDIES HLTH SERVICE, V17, P7; Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6; Weiner R, 2003, B WORLD HEALTH ORGAN, V81, P561; *WHO UN CHILDR FUN, 2001, WHORHR019 UN CHILDR; World Health Organization, 2000, WORLD HLTH REP 2005; World Health Organization, CHILD AD HLTH DEV CH; Yazbeck A. S., 2005, Reaching the poor with health, nutrition, and population services: what works, what doesn't and why, P3	58	289	294	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1535	1541		10.1016/S0140-6736(06)69384-7	http://dx.doi.org/10.1016/S0140-6736(06)69384-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071287				2022-12-28	WOS:000241582700031
J	Moretti, A; Caron, L; Nakano, A; Lam, JT; Bernshausen, A; Chen, YH; Qyang, YB; Bu, L; Sasaki, M; Martin-Puig, S; Sun, YF; Evans, SM; Laugwitz, KL; Chien, KR				Moretti, Alessandra; Caron, Leslie; Nakano, Atsushi; Lam, Jason T.; Bernshausen, Alexandra; Chen, Yinhong; Qyang, Yibing; Bu, Lei; Sasaki, Mika; Martin-Puig, Silvia; Sun, Yunfu; Evans, Sylvia M.; Laugwitz, Karl-Ludwig; Chien, Kenneth R.			Multipotent embryonic Isl1(+) progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification	CELL			English	Article							CONGENITAL HEART-DISEASE; STEM-CELLS; SECONDARY HEART; HEMATOPOIETIC STEM; PROTEIN ISL-1; ARTERIAL POLE; CLONAL ORIGIN; FIELD; VASCULOGENESIS; REGENERATION	Cardiogenesis requires the generation of endothelial, cardiac, and smooth muscle cells, thought to arise from distinct embryonic precursors. We use genetic fate-mapping studies to document that isl1(+) precursors from the second heart field can generate each of these diverse cardiovascular cell types in vivo. Utilizing embryonic stem (ES) cells, we clonally amplified a cellular hierarchy of isl1(+) cardiovascular progenitors, which resemble the developmental precursors in the embryonic heart. The transcriptional signature of isl1(+)/Nkx2.5(+)/flk1(+) defines a multipotent cardiovascular progenitor, which can give rise to cells of all three lineages. These studies document a developmental paradigm for cardiogenesis, where muscle and endothelial lineage diversification arises from a single cell-level decision of a multipotent isl1(+) cardiovascular progenitor cell (MICP). The discovery of ES cell-derived MICPs suggests a strategy for cardiovascular tissue regeneration via their isolation, renewal, and directed differentiation into specific mature cardiac, pacemaker, smooth muscle, and endothelial cell types.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-81675 Munich, Germany; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Skaggs Sch Pharm, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Technical University of Munich; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Pl CPZN 3208,185 Cambridge St, Boston, MA 02114 USA.	kchien@partners.org	Bu, Lei/F-4461-2011; Moretti, Alessandra/O-9271-2015; Evans, Sylvia/G-1980-2015; Caron, Leslie/AAE-3511-2022	Moretti, Alessandra/0000-0001-5782-7832; Caron, Leslie/0000-0003-4118-2974; Qyang, Yibing/0000-0002-0332-2449; Martin-Puig, Silvia/0000-0003-3048-6729; BU, LEI/0000-0003-4476-2157				Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Choi K, 1998, DEVELOPMENT, V125, P725; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Epstein JA, 2000, DEVELOPMENT, V127, P1869; ERMA M, 2006, BLOOD, V107, P111; ERNA M, 2003, GENE DEV, V17, P380; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Gourdie RG, 1998, P NATL ACAD SCI USA, V95, P6815, DOI 10.1073/pnas.95.12.6815; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; LIDA M, 2005, FASEB J, V19, P371; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schwartz RS, 2006, NEW ENGL J MED, V355, P1189, DOI 10.1056/NEJMp068180; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; VERZI MP, 2005, DEV BIOL, V342, P798; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje	49	751	803	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1151	1165		10.1016/j.cell.2006.10.029	http://dx.doi.org/10.1016/j.cell.2006.10.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17123592	Bronze			2022-12-28	WOS:000242991000014
J	de Irala, J; Alonso, A				de Irala, Jokin; Alonso, Alvaro			Changes in sexual behaviours to prevent HIV	LANCET			English	Editorial Material							RISK; UGANDA		Univ Navarra, Dept Prevent Med & Publ Hlth, Fac Med, E-31080 Pamplona, Spain; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Navarra; Harvard University; Harvard T.H. Chan School of Public Health	de Irala, J (corresponding author), Univ Navarra, Dept Prevent Med & Publ Hlth, Fac Med, E-31080 Pamplona, Spain.	jdeirala@unav.es	de Irala, Jokin/H-2936-2017; Alonso, Alvaro/A-4917-2010	de Irala, Jokin/0000-0002-7249-6581; Alonso, Alvaro/0000-0002-2225-8323				Alonso A, 2004, LANCET, V364, P1033, DOI 10.1016/S0140-6736(04)17050-5; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; MCCARTHY M, 1989, J EPIDEMIOL COMMUN H, V43, P218, DOI 10.1136/jech.43.3.218; MURPHY EM, IN PRESS PLOS MED; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166	11	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2006	368	9549					1749	1750		10.1016/S0140-6736(06)69712-2	http://dx.doi.org/10.1016/S0140-6736(06)69712-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113405				2022-12-28	WOS:000242225400006
J	Hogg, PJ				Hogg, Paul J.			Perspectives - Composites in armor	SCIENCE			English	Editorial Material								Composite materials are traditionally regarded as materials that can save energy in large structures associated with transport. They are used to produce lightweight structures for fuel-efficient aircraft such as the new Boeing 787 Dreamliner; lightweight cars from Lotus, Ferrari and TVR; and highspeed trains, speedboats, and racing yachts. Now, however, some of the most interesting applications of composites are those where the materials are used to save lives and protect property by absorbing the energy of projectiles, impacts, and crashes.	Univ London, Queen Mary, Ctr Mat Res, London E1 4NS, England	University of London; Queen Mary University London	Hogg, PJ (corresponding author), Univ London, Queen Mary, Ctr Mat Res, London E1 4NS, England.		Hogg, Paul J/K-9191-2013	Hogg, Paul J/0000-0002-0847-5364				GRUJICIC M, 2006, APP SURF SCI     FEB; Jang JH, 2006, ADV MATER, V18, P2123, DOI 10.1002/adma.200600249; Larsson F, 2002, COMPOS PART A-APPL S, V33, P221, DOI 10.1016/S1359-835X(01)00095-1; Pettersson A, 2005, INT J IMPACT ENG, V32, P387, DOI 10.1016/j.ijimpeng.2005.04.003; SARVA S, 2005, INT J IMP ENG   0915; Tan VBC, 2005, INT J SOLIDS STRUCT, V42, P1561, DOI 10.1016/j.ijsolstr.2004.08.013; van der Jagt OC, 1999, POLYMER, V40, P1035, DOI 10.1016/S0032-3861(98)00306-1; Zhu YQ, 2005, ADV MATER, V17, P1500, DOI 10.1002/adma.200401962	9	88	95	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1100	1101		10.1126/science.1131118	http://dx.doi.org/10.1126/science.1131118			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110565				2022-12-28	WOS:000242045800031
J	Takamori, S; Holt, M; Stenius, K; Lemke, EA; Gronborg, M; Riedel, D; Urlaub, H; Schenck, S; Brugger, B; Ringler, P; Muller, SA; Rammner, B; Grater, F; Hub, JS; De Groot, BL; Mieskes, G; Moriyama, Y; Klingauf, J; Grubmuller, H; Heuser, J; Wieland, F; Jahn, R				Takamori, Shigeo; Holt, Matthew; Stenius, Katinka; Lemke, Edward A.; Gronborg, Mads; Riedel, Dietmar; Urlaub, Henning; Schenck, Stephan; Bruegger, Britta; Ringler, Philippe; Mueller, Shirley A.; Rammner, Burkhard; Graeter, Frauke; Hub, Jochen S.; De Groot, Bert L.; Mieskes, Gottfried; Moriyama, Yoshinori; Klingauf, Juergen; Grubmueller, Helmut; Heuser, John; Wieland, Felix; Jahn, Reinhard			Molecular anatomy of a trafficking organelle	CELL			English	Article							VESICULAR GLUTAMATE TRANSPORTER; CLATHRIN-COATED VESICLES; SYNAPTIC VESICLES; SYNAPSIN-I; PROTEIN-I; MEMBRANE; SNARE; IDENTIFICATION; DEFINES; BRAIN	Membrane traffic in eukaryotic cells involves transport of vesicles that bud from a donor compartment and fuse with an acceptor compartment. Common principles of budding and fusion have emerged, and many of the proteins involved in these events are now known. However, a detailed picture of an entire trafficking organelle is not yet available. Using synaptic vesicles as a model, we have now determined the protein and lipid composition; measured vesicle size, density, and mass; calculated the average protein and lipid mass per vesicle; and determined the copy number of more than a dozen major constituents. A model has been constructed that integrates all quantitative data and includes structural models of abundant proteins. Synaptic vesicles are dominated by proteins, possess a surprising diversity of trafficking proteins, and, with the exception of the V-ATPase that is present in only one to two copies, contain numerous copies of proteins essential for membrane traffic and neurotransmitter uptake.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Lab Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Lab Biomol Dynam, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Heidelberg Univ, Dept Biochem, D-69120 Heidelberg, Germany; Univ Basel, Bioctr, Maurice E Muller Inst High Resolut Electron M, CH-4056 Basel, Switzerland; Scimotion, D-22765 Hamburg, Germany; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Lab Membrane Biochem, Okayama 7008530, Japan; Washington Univ, Dept Cell Biol, St Louis, MO 63110 USA	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Yale University; Ruprecht Karls University Heidelberg; University of Basel; Okayama University; Washington University (WUSTL)	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Hub, Jochen/M-6230-2015; Gräter, Frauke/D-3450-2009; Lemke, Edward A/J-3337-2015; Holt, Matthew/AAJ-1813-2020	Hub, Jochen/0000-0001-7716-1767; Gräter, Frauke/0000-0003-2891-3381; Lemke, Edward A/0000-0002-0634-0503; Holt, Matthew/0000-0002-8958-4027; Jahn, Reinhard/0000-0003-1542-3498				Ahnert-Hilger G, 2004, REV PHYSIOL BIOCH P, V150, P140, DOI 10.1007/s10254-003-0020-2; Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; GOELZ SE, 1981, P NATL ACAD SCI-BIOL, V78, P2130, DOI 10.1073/pnas.78.4.2130; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1984, P NATL ACAD SCI-BIOL, V81, P1684, DOI 10.1073/pnas.81.6.1684; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Janz R, 1998, J NEUROSCI, V18, P9269; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; Muller JD, 2003, METHOD ENZYMOL, V361, P69; MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; NAGY A, 1976, BRAIN RES, V109, P285, DOI 10.1016/0006-8993(76)90531-X; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Peters R, 2003, ANNU REV BIOPH BIOM, V32, P47, DOI 10.1146/annurev.biophys.32.110601.142429; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pothos EN, 2000, J NEUROSCI, V20, P7297; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STADLER H, 1984, EMBO J, V3, P3333, DOI 10.1002/j.1460-2075.1984.tb02300.x; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Williams J, 1997, NEURON, V18, P683, DOI 10.1016/S0896-6273(00)80308-6; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	63	1582	1610	1	229	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					831	846		10.1016/j.cell.2006.10.030	http://dx.doi.org/10.1016/j.cell.2006.10.030			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110340	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000242330600027
J	Friedman, RA				Friedman, Richard A.			Violence and mental illness - How strong is the link?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BEHAVIOR; DISORDER		Weill Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA	Cornell University	Friedman, RA (corresponding author), Weill Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA.							MONAHAN J, 1992, AM PSYCHOL, V47, P511, DOI 10.1037/0003-066X.47.4.511; Shaw J, 2006, BRIT J PSYCHIAT, V188, P143, DOI 10.1192/bjp.188.2.143; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Swanson J. W., 1994, VIOLENCE MENTAL DISO, P101, DOI DOI 10.1371/JOURNAL.PMED.1000120; Swanson JW, 2002, AM J PUBLIC HEALTH, V92, P1523, DOI 10.2105/AJPH.92.9.1523	5	92	97	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2064	2066		10.1056/NEJMp068229	http://dx.doi.org/10.1056/NEJMp068229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104YU	17108340				2022-12-28	WOS:000241997300002
J	Mbanya, JC; Kengne, AP; Assah, F				Mbanya, Jean Claude; Kengne, Andre Pascal; Assah, Felix			Diabetes care in Africa	LANCET			English	Editorial Material							MELLITUS		Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England	University of Yaounde I; University of Sydney; University of Cambridge	Mbanya, JC (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.	jcmbanya@yahoo.co.uk	Kengne, Andre Pascal/ABB-3696-2020; Mbanya, Jean Claude N/T-5147-2018	Kengne, Andre Pascal/0000-0002-5183-131X; Mbanya, Jean Claude N/0000-0001-9651-8653				Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Cruickshank JK, 2001, INT J EPIDEMIOL, V30, P111, DOI 10.1093/ije/30.1.111; Dagogo-Jack S, 2006, J NATL MED ASSOC, V98, P415; Elrayah H, 2005, DIABETES RES CLIN PR, V70, P159, DOI 10.1016/j.diabres.2005.03.034; Gill GV, 2005, DIABETIC MED, V22, P1642, DOI 10.1111/j.1464-5491.2005.01712.x; *INT DIAB FED, 2003, DIAT ATL; Kamel N M, 1999, East Mediterr Health J, V5, P974; KAUSHIK LR, 2004, DIABETES VOICE, V49, P32; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Motala AA, 2002, DIABETES-METAB RES, V18, pS14, DOI 10.1002/dmrr.284; Sobngwi E, 2001, DIABETES METAB, V27, P628	12	30	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1628	1629		10.1016/S0140-6736(06)69673-6	http://dx.doi.org/10.1016/S0140-6736(06)69673-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098063				2022-12-28	WOS:000242099000006
J	Davidson, EH				Davidson, Eric H.			Perspective - The sea urchin genome: Where will it lead us?	SCIENCE			English	Editorial Material							REGULATORY NETWORK		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol, 156-29, Pasadena, CA 91125 USA.	davidson@caltech.edu						Boveri T., 1902, Verb Ges Wurzburg, Vxxxv, P67; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davidson EH, 2006, REG GEN GEN REG; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; MATERNA SC, 2006, DEV BIOL, DOI DOI 10.1016/4.DBIO.2006.09.033; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609	7	41	41	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					939	940		10.1126/science.1136252	http://dx.doi.org/10.1126/science.1136252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095689				2022-12-28	WOS:000241896000037
J	Morse, SS; Garwin, RL; Olsiewski, PJ				Morse, Stephen S.; Garwin, Richard L.; Olsiewski, Paula J.			Public health - Next flu pandemic: What to do until the vaccine arrives?	SCIENCE			English	Editorial Material							NONPHARMACEUTICAL INTERVENTIONS; INFLUENZA; TRANSMISSION		Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Ctr Publ Hlth Preparedness, Natl Ctr Disaster Preparedness, Mailman Sch Publ Hlth, New York, NY 10032 USA; IBM Res Labs, Yorktown Hts, NY 10598 USA; Alfred P Sloan Fdn, New York, NY 10111 USA	Columbia University; Columbia University	Morse, SS (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10032 USA.	ssm20@columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NIAID NIH HHS [5U54AI057158-02] Funding Source: Medline; PHS HHS [U90/CCU224241] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALEDORT JE, 2006, WR408DHHS RAND; BARRY J, 2004, GREAT INFLUENZA; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; *COL U MAILM SCH P, 2006, WORKSH PERS WORKPL P; Crosby A., 1989, AM FORGOTTEN PANDEMI; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Hitchcock PJ, 2006, BIOSECUR BIOTERROR, V4, P41, DOI 10.1089/bsp.2006.4.41; *HOM SEC COUNC DEP, 2005, NAT STRAT PAND INFL; Institute of Medicine Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic, 2006, REUS FAC INFL PAND F; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; LEDERBERG J, 1992, EMERGING INFECT MICR, P156; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426	17	32	32	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					929	929		10.1126/science.1135823	http://dx.doi.org/10.1126/science.1135823			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095681				2022-12-28	WOS:000241896000030
J	Feldl, N; Bilham, R				Feldl, Nicole; Bilham, Roger			Great Himalayan earthquakes and the Tibetan plateau	NATURE			English	Article							GPS MEASUREMENTS; CONTINUOUS DEFORMATION; SEISMIC MOMENTS; RUPTURE; INDIA; SLIP; CONVERGENCE; CONSTRAINTS; KINEMATICS; TECTONICS	It has been assumed that Himalayan earthquakes are driven by the release of compressional strain accumulating close to the Greater Himalaya. However, elastic models of the Indo - Asian collision using recently imaged subsurface interface geometries suggest that a substantial fraction of the southernmost 500 kilometres of the Tibetan plateau participates in driving great ruptures. We show here that this Tibetan reservoir of elastic strain energy is drained in proportion to Himalayan rupture length, and that the consequent growth of slip and magnitude with rupture area, when compared to data from recent earthquakes, can be used to infer a similar to 500-year renewal time for these events. The elastic models also illuminate two puzzling features of plate boundary seismicity: how great earthquakes can re-rupture regions that have already ruptured in recent smaller earthquakes and how mega-earthquakes with greater than 20 metres slip may occur at millennia-long intervals, driven by residual strain following many centuries of smaller earthquakes.	Univ Colorado, CIRES, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Bilham, R (corresponding author), Univ Colorado, CIRES, Boulder, CO 80309 USA.	bilham@colorado.edu		Bilham, Roger/0000-0002-5547-4102				Ambraseys N, 2003, CURR SCI INDIA, V84, P570; Banerjee P, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015184; Bettinelli P, 2006, J GEODESY, V80, P567, DOI 10.1007/s00190-006-0030-3; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; Bilham R, 2005, CURR SCI INDIA, V88, P1658; Bilham R, 2005, SEISMOL RES LETT, V76, P299, DOI 10.1785/gssrl.76.3.299; Bilham R, 2004, ANN GEOPHYS-ITALY, V47, P839; Bilham R., 2005, GEOL SURV INDIA SPEC, V85, P1; BODIN P, 1994, GEOPHYS RES LETT, V21, P2523, DOI 10.1029/94GL02279; Bollinger L, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002911; BRUNE JN, 1993, TECTONOPHYSICS, V218, P59, DOI 10.1016/0040-1951(93)90259-M; BURGMANN R, 1999, HIMAL GEOL, V20, P59; Cattin R, 2000, J GEOPHYS RES-SOL EA, V105, P13389, DOI 10.1029/2000JB900032; CHEN JY, 1996, ACTA GEOPHYS SINICA, V39, P67; Chen QZ, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2002JB002350; CHEN WP, 1977, J GEOPHYS RES, V82, P2945, DOI 10.1029/JB082i020p02945; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; Crouch SL, 1983, BOUNDARY ELEMENT MET, DOI DOI 10.1115/1.3167130; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; England P, 1997, SCIENCE, V278, P647, DOI 10.1126/science.278.5338.647; FELDL N, 2005, THESIS U COLORADO; GOMBERG J, 1994, J GEOPHYS RES-SOL EA, V99, P20299, DOI 10.1029/94JB00039; HOUSEMAN G, 1993, J GEOPHYS RES-SOL EA, V98, P12233, DOI 10.1029/93JB00443; JACKSON M, 1994, J GEOPHYS RES-SOL EA, V99, P13897, DOI 10.1029/94JB00714; Jade S, 2004, GEOL SOC AM BULL, V116, P1385, DOI 10.1130/B25357.1; Jouanne F, 2004, GEOPHYS J INT, V157, P1, DOI 10.1111/j.1365-246X.2004.02180.x; Kumar S, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003309; Larson KM, 1999, J GEOPHYS RES-SOL EA, V104, P1077, DOI 10.1029/1998JB900043; Lave J, 2005, SCIENCE, V307, P1302, DOI 10.1126/science.1104804; Lave J, 2000, J GEOPHYS RES-SOL EA, V105, P5735, DOI 10.1029/1999JB900292; LYONCAEN H, 1985, TECTONICS, V4, P513, DOI 10.1029/TC004i006p00513; MOLNAR P, 1988, PHILOS T R SOC A, V326, P33, DOI 10.1098/rsta.1988.0080; MOLNAR P, 1989, GEOPHYS J INT, V99, P123, DOI 10.1111/j.1365-246X.1989.tb02020.x; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Perfettini H, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002917; Schulte-Pelkum V, 2005, NATURE, V435, P1222, DOI 10.1038/nature03678; Shaw BE, 2001, GEOPHYS RES LETT, V28, P2995, DOI 10.1029/2000GL012762; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Wesnousky SG, 1999, TECTONICS, V18, P967, DOI 10.1029/1999TC900026; Xu CJ, 2000, EARTH PLANETS SPACE, V52, P735, DOI 10.1186/BF03352274; Zhang PZ, 2004, GEOLOGY, V32, P809, DOI 10.1130/G20554.1	42	137	148	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					165	170		10.1038/nature05199	http://dx.doi.org/10.1038/nature05199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093444				2022-12-28	WOS:000241867200032
J	Gomez-Ospina, N; Tsuruta, F; Barreto-Chang, O; Hu, L; Dolmetsch, R				Gomez-Ospina, Natalia; Tsuruta, Fuminori; Barreto-Chang, Odmara; Hu, Linda; Dolmetsch, Ricardo			The C terminus of the L-type voltage-gated calcium channel Ca(v)1.2 encodes a transcription factor	CELL			English	Article							RNA-POLYMERASE-II; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; SUBCELLULAR-DISTRIBUTION; BINDING DOMAIN; SUBUNIT; PHOSPHORYLATION; ALPHA(1C); SURVIVAL; FAMILY	Voltage-gated calcium channels play a central role in regulating the electrical and biochemical properties of neurons and muscle cells. One of the ways in which calcium channels regulate long-lasting neuronal properties is by activating signaling pathways that control gene expression, but the mechanisms that link calcium channels to the nucleus are not well understood. We report that a C-terminal fragment of Ca(v)1.2, an L-type voltage-gated calcium channel (LTC), translocates to the nucleus and regulates transcription. We show that this calcium channel associated transcription regulator (CCAT) binds to a nuclear protein, associates with an endogenous promoter, and regulates the expression of a wide variety of endogenous genes important for neuronal signaling and excitability. The nuclear localization of CCAT is regulated both developmentally and by changes in intracellular calcium. These findings provide evidence that voltage-gated calcium channels can directly activate transcription and suggest a mechanism linking voltage-gated channels to the function and differentiation of excitable cells.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Dolmetsch, R (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, 299 Campus Dr, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu		Barreto Chang, Odmara/0000-0002-4781-404X; Gomez-Ospina, Natalia/0000-0002-6740-1154	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS048564] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies TC, 1996, DEV GENET, V18, P234, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;234::AID-DVG4&gt;3.0.CO;2-A; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DEJONGH KS, 1994, J NEUROCHEM, V63, P1558, DOI 10.1046/j.1471-4159.1994.63041558.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guldenagel M, 2000, J COMP NEUROL, V425, P193; Haase H, 2000, J CELL BIOCHEM, V76, P695, DOI 10.1002/(SICI)1097-4644(20000315)76:4<695::AID-JCB17>3.0.CO;2-Q; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Helguera G, 2002, BBA-GEN SUBJECTS, V1569, P59, DOI 10.1016/S0304-4165(01)00234-3; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; HULME JT, 2006, P NATL ACAD SCI USA, V576, P87; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Kubodera T, 2003, NEUROSCI LETT, V341, P74, DOI 10.1016/S0304-3940(03)00156-3; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Venance L, 2004, J PHYSIOL-LONDON, V559, P215, DOI 10.1113/jphysiol.2004.065672; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Xia ZG, 1996, J NEUROSCI, V16, P5425; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	42	275	279	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					591	606		10.1016/j.cell.2006.10.017	http://dx.doi.org/10.1016/j.cell.2006.10.017			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081980	Green Accepted, Bronze			2022-12-28	WOS:000241937000022
J	Poole, CJ; Earl, HM; Hiller, L; Dunn, JA; Bathers, S; Grieve, RJ; Spooner, DA; Agrawal, RK; Fernando, IN; Brunt, AM; O'Reilly, SM; Crawford, SM; Rea, DW; Simmonds, P; Mansi, JL; Stanley, A; Harvey, P; McAdam, K; Foster, L; Leonard, RCF; Twelves, CJ				Poole, Christopher J.; Earl, Helena M.; Hiller, Louise; Dunn, Janet A.; Bathers, Sarah; Grieve, Robert J.; Spooner, David A.; Agrawal, Rajiv K.; Fernando, Indrajit N.; Brunt, A. Murray; O'Reilly, Susan M.; Crawford, S. Michael; Rea, Daniel W.; Simmonds, Peter; Mansi, Janine L.; Stanley, Andrew; Harvey, Peter; McAdam, Karen; Foster, Liz; Leonard, Robert C. F.; Twelves, Christopher J.		Neat Investigators; SCTBG	Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; POSITIVE AXILLARY NODES; RANDOMIZED-TRIAL; EUROPEAN-ORGANIZATION; PREMENOPAUSAL WOMEN; CLINICAL-TRIALS; CHEMOTHERAPY; DOXORUBICIN; CMF; RISK	BACKGROUND: The National Epirubicin Adjuvant Trial (NEAT) and the BR9601 trial examined the efficacy of anthracyclines in the adjuvant treatment of early breast cancer. METHODS: In NEAT, we compared four cycles of epirubicin followed by four cycles of cyclophosphamide, methotrexate, and fluorouracil (CMF) with six cycles of CMF alone. In the BR9601 trial, we compared four cycles of epirubicin followed by four cycles of CMF, with eight cycles of CMF alone every 3 weeks. The primary end points were relapse-free and overall survival. The secondary end points were adverse effects, dose intensity, and quality of life. RESULTS: The two trials included 2391 women with early breast cancer; the median follow-up was 48 months. Relapse-free and overall survival rates were significantly higher in the epirubicin-CMF groups than in the CMF-alone groups (2-year relapse-free survival, 91% vs. 85%; 5-year relapse-free survival, 76% vs. 69%; 2-year overall survival, 95% vs. 92%; 5-year overall survival, 82% vs. 75%; P<0.001 by the log-rank test for all comparisons). Hazard ratios for relapse (or death without relapse) (0.69; 95% confidence interval [CI], 0.58 to 0.82; P<0.001) and death from any cause (0.67; 95% CI, 0.55 to 0.82; P<0.001) favored epirubicin plus CMF over CMF alone. Independent prognostic factors were nodal status, tumor grade, tumor size, and estrogen-receptor status (P<0.001 for all four factors) and the presence or absence of vascular or lymphatic invasion (P=0.01). These factors did not significantly interact with the effect of epirubicin plus CMF. The overall incidence of adverse effects was significantly higher with epirubicin plus CMF than with CMF alone but did not significantly affect the delivered-dose intensity or the quality of life. CONCLUSIONS: Epirubicin plus CMF is superior to CMF alone as adjuvant treatment for early breast cancer.	Univ Birmingham, Inst Canc Studies, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; Addenbrookes Hosp, Cambridge, England; Walsgrave Gen Hosp, Radiotherapy & Oncol Ctr, Coventry, W Midlands, England; Queen Elizabeth Hosp, Ctr Canc, Birmingham, W Midlands, England; Royal Shrewsbury Hosp, Shrewsbury, Shrops, England; Clatterbridge Hosp, Wirral, Merseyside, England; Airedale Dist Gen Hosp, Keighley, Yorks, England; Royal S Hampshire Hosp, Southampton, Hants, England; Univ London St Georges Hosp, London, England; City Hosp, Birmingham, W Midlands, England; St James Univ Hosp, Leeds, W Yorkshire, England; Peterborough Dist Gen Hosp, Peterborough, Cambs, England; Scottish Canc Therapy Network, Edinburgh, Midlothian, Scotland; Swansea Canc Ctr, Swansea, W Glam, Wales; Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England	Cancer Research UK; University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Birmingham; St Georges University London; University of Birmingham; Saint James's University Hospital; Bradford Royal Infirmary	Poole, CJ (corresponding author), Univ Birmingham, Inst Canc Studies, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England.	poolecj@aol.com	Harvey, Peter/AAB-3147-2019	Dunn, Janet/0000-0001-7313-4446; Earl, Helena/0000-0003-1549-8094				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ABE O, 1992, LANCET, V339, P71; Abe O, 1998, LANCET, V352, P930; Adenis A, 2001, J CLIN ONCOL, V19, P602, DOI 10.1200/JCO.2001.19.3.602; Bonadonna G, 2004, J CLIN ONCOL, V22, P1614, DOI 10.1200/JCO.2004.07.190; BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542; BONADONNA G, 1981, NEW ENGL J MED, V304, P10, DOI 10.1056/NEJM198101013040103; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; BUZZONI R, 1991, J CLIN ONCOL, V9, P2134, DOI 10.1200/JCO.1991.9.12.2134; Coombes RC, 1996, J CLIN ONCOL, V14, P35, DOI 10.1200/JCO.1996.14.1.35; COX DR, 1972, J R STAT SOC B, V34, P187; Crump M, 2003, J CLIN ONCOL, V21, P3066, DOI 10.1200/JCO.2003.08.137; DAY RS, 1986, CANCER RES, V46, P3876; DETOURMIGNIES L, 1992, J CLIN ONCOL, V10, P1430, DOI 10.1200/JCO.1992.10.9.1430; *EARL BREAST CANC, 1990, TREATM EAR BREAST CA, V1; Earl Helena, 2004, Expert Rev Anticancer Ther, V4, P189, DOI 10.1586/14737140.4.2.189; ENGELSMAN E, 1991, EUR J CANCER, V27, P966, DOI 10.1016/0277-5379(91)90259-G; Gianni L, 2005, J CLIN ONCOL, V23, p7S; Goldhirsch A, 1998, ANN ONCOL, V9, P489, DOI 10.1023/A:1008236502420; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; GOLDIE JH, 1982, CANCER TREAT REP, V66, P439; HABESHAW T, 1991, J CLIN ONCOL, V9, P295, DOI 10.1200/JCO.1991.9.2.295; Hopwood P, 2005, J CLIN ONCOL, V23, p43S; HUNTER M, 1992, PSYCHOL HEALTH, V7, P45, DOI 10.1080/08870449208404294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Leonard RCF, 2004, JNCI-J NATL CANCER I, V96, P1076, DOI 10.1093/jnci/djh188; Levine MN, 1998, J CLIN ONCOL, V16, P2651, DOI 10.1200/JCO.1998.16.8.2651; MOLITERNI A, 1991, J CLIN ONCOL, V9, P1124, DOI 10.1200/JCO.1991.9.7.1124; Norton L, 1991, Important Adv Oncol, P57; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Praga C, 2005, J CLIN ONCOL, V23, P4179, DOI 10.1200/JCO.2005.05.029; Pulsoni A, 2002, BLOOD, V100, P1972, DOI 10.1182/blood-2001-12-0312; Qian W, 2000, STAT MED, V19, P2657; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756	35	157	164	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1851	1862		10.1056/NEJMoa052084	http://dx.doi.org/10.1056/NEJMoa052084			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079759	Green Published			2022-12-28	WOS:000241691700003
J	Burns, RB				Burns, Risa B.			A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus, 4 years later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Spechler SJ, 2003, JAMA-J AM MED ASSOC, V289, P466, DOI 10.1001/jama.289.4.466	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2140	2140		10.1001/jama.296.17.2140	http://dx.doi.org/10.1001/jama.296.17.2140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077379				2022-12-28	WOS:000241668000026
J	Wolf, SL; Winstein, CJ; Miller, JP; Taub, E; Uswatte, G; Morris, D; Giuliani, C; Light, KE; Nichols-Larsen, D				Wolf, Steven L.; Winstein, Carolee J.; Miller, J. Philip; Taub, Edward; Uswatte, Gitendra; Morris, David; Giuliani, Carol; Light, Kathye E.; Nichols-Larsen, Deborah		EXCITE Investigators	Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke - The EXCITE randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; MOTOR FUNCTION-TEST; LEARNED NONUSE; FORCED-USE; HEMIPLEGIC PATIENT; SUBACUTE STROKE; IMPACT SCALE; UPPER-LIMB; REHABILITATION; RELIABILITY	Context Single-site studies suggest that a 2-week program of constraint-induced movement therapy (CIMT) for patients more than 1 year after stroke who maintain some hand and wrist movement can improve upper extremity function that persists for at least 1 year. Objective To compare the effects of a 2-week multisite program of CIMT vs usual and customary care on improvement in upper extremity function among patients who had a first stroke within the previous 3 to 9 months. Design and Setting The Extremity Constraint Induced Therapy Evaluation (EXCITE) trial, a prospective, single-blind, randomized, multisite clinical trial conducted at 7 US academic institutions between January 2001 and January 2003. Participants Two hundred twenty-two individuals with predominantly ischemic stroke. Interventions Participants were assigned to receive either CIMT (n = 106; wearing a restraining mitt on the less-affected hand while engaging in repetitive task practice and behavioral shaping with the hemiplegic hand) or usual and customary care (n = 116; ranging from no treatment after concluding formal rehabilitation to pharmacologic or physiotherapeutic interventions); patients were stratified by sex, prestroke dominant side, side of stroke, and level of paretic arm function. Main Outcome Measures The Wolf Motor Function Test (WMFT), a measure of laboratory time and strength-based ability and quality of movement (functional ability), and the Motor Activity Log (MAL), a measure of how well and how often 30 common daily activities are performed. Results From baseline to 12 months, the CIMT group showed greater improvements than the control group in both the WMFT Performance Time (decrease in mean time from 19.3 seconds to 9.3 seconds [52% reduction] vs from 24.0 seconds to 17.7 seconds [26% reduction]; between-group difference, 34% [95% confidence interval {CI}, 12%-51%]; P < .001) and in the MAL Amount of Use (on a 0-5 scale, increase from 1.21 to 2.13 vs from 1.15 to 1.65; between-group difference, 0.43 [95% CI, 0.05-0.80]; P < .001) and MAL Quality of Movement (on a 0-5 scale, increase from 1.26 to 2.23 vs 1.18 to 1.66; between-group difference, 0.48 [95% CI, 0.13-0.84]; P < .001). The CIMT group achieved a decrease of 19.5 in self-perceived hand function difficulty (Stroke Impact Scale hand domain) vs a decrease of 10.1 for the control group (between-group difference, 9.42 [95% CI, 0.27-18.57]; P = .05). Conclusion Among patients who had a stroke within the previous 3 to 9 months, CIMT produced statistically significant and clinically relevant improvements in arm motor function that persisted for at least 1 year.	Emory Univ, Sch Med, Ctr Rehabil Med, Dept Rehabil Med, Atlanta, GA 30322 USA; Ohio State Univ, Sch Allied Hlth Profess, Columbus, OH 43210 USA; Univ Florida, Dept Phys Therapy, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; Univ N Carolina, Sch Med, Div Phys Therapy, Dept Allied Hlth Sci, Chapel Hill, NC 27515 USA; Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA; Univ Alabama, Dept Phys Therapy, Birmingham, AL 35294 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA USA; Univ So Calif, Keck Sch Med, Dept Biokinesiol, Los Angeles, CA USA; Univ So Calif, Keck Sch Med, Dept Phys Therapy, Los Angeles, CA USA	Emory University; University System of Ohio; Ohio State University; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Southern California; University of Southern California; University of Southern California	Wolf, SL (corresponding author), Emory Univ, Sch Med, Ctr Rehabil Med, Dept Rehabil Med, 1441 Clifton Rd NE, Atlanta, GA 30322 USA.	swolf@emory.edu	Wolf, Steve/F-6588-2010; Morris, David/AFV-2928-2022; Larsen, Deborah/E-3465-2011; Uswatte, Gitendra/C-4913-2009	Wolf, Steve/0000-0002-9446-8995; Winstein, Carolee/0000-0001-9789-4626; Miller, J Philip/0000-0003-4568-6846	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037606] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 37606] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alberts JL, 2004, NEUROREHAB NEURAL RE, V18, P250, DOI 10.1177/1545968304271370; Barreca S, 2003, NEUROREHAB NEURAL RE, V17, P220, DOI 10.1177/0888439003259415; Bobath B., 1978, ADULT HEMIPLEGIA EVA; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; Dong Y, 2006, STROKE, V37, P1552, DOI 10.1161/01.STR.0000221281.69373.4e; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fritz SL, 2005, STROKE, V36, P1172, DOI 10.1161/01.STR.0000165922.96430.d0; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Liepert J, 2001, J NEUROL, V248, P315, DOI 10.1007/s004150170207; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Morris D M, 2001, Top Stroke Rehabil, V8, P16; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P14, DOI 10.1016/S0003-9993(03)00481-7; Panyan M. V., 1980, USE SHAPING; Pierce SR, 2003, NEUROREHAB NEURAL RE, V17, P214, DOI 10.1177/0888439003259424; Schmidt R.A., 2011, HUMAN KINETICS; Studenski S, 2005, STROKE, V36, P1764, DOI 10.1161/01.STR.0000174192.87887.70; Suputtitada Areerat, 2004, Journal of the Medical Association of Thailand, V87, P1482; Tarkka IM, 2005, AM J PHYS MED REHAB, V84, P501, DOI 10.1097/01.phm.0000166881.71097.9d; Taub E, 2005, STROKE, V36, P1301, DOI 10.1161/01.STR.0000166043.27545.e8; Taub E, 1998, REHABIL PSYCHOL, V43, P152, DOI 10.1037/0090-5550.43.2.152; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; Uswatte G, 2005, REHABIL PSYCHOL, V50, P34, DOI 10.1037/0090-5550.50.1.34; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; van der Lee JH, 1999, ARCH PHYS MED REHAB, V80, P1606, DOI 10.1016/S0003-9993(99)90339-8; WEINSTEIN CJ, 1991, CONT MANAGEMENT MOTO; Winstein CJ, 2003, NEUROREHAB NEURAL RE, V17, P137, DOI 10.1177/0888439003255511; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; WOLF SL, 1983, PHYS THER, V63, P1393, DOI 10.1093/ptj/63.9.1393; Wolf SL, 2002, NEUROLOGIST, V8, P325, DOI 10.1097/00127893-200211000-00001; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635	43	1264	1330	4	178	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2095	2104		10.1001/jama.296.17.2095	http://dx.doi.org/10.1001/jama.296.17.2095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077374	Bronze			2022-12-28	WOS:000241668000021
J	Christodoulou, C; Gordon, P; Coakley, G				Christodoulou, C.; Gordon, P.; Coakley, G.			Lesson of the week - Polyarticular septic arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Queen Elizabeth Mil Hosp, Dept Rheumatol, London SE18 4QH, England; Kings Coll Hosp London, Dept Rheumatol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Christodoulou, C (corresponding author), Queen Elizabeth Mil Hosp, Dept Rheumatol, London SE18 4QH, England.	chrisc@doctors.org.uk						Coakley G, 2006, RHEUMATOLOGY, V45, P1039, DOI 10.1093/rheumatology/kel163a; DUBOST JJ, 1993, MEDICINE, V72, P296, DOI 10.1097/00005792-199309000-00002; Kaandorp CJE, 1997, ARTHRITIS RHEUM-US, V40, P884, DOI 10.1002/art.1780400516; Saleh SS, 2005, AM J CARDIOL, V96, P1190, DOI 10.1016/j.amjcard.2005.06.054	5	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2006	333	7578					1107	1108		10.1136/bmj.39020.401331.68	http://dx.doi.org/10.1136/bmj.39020.401331.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124222	Green Published			2022-12-28	WOS:000242520200018
J	Lastovicka, J; Akmaev, RA; Beig, G; Bremer, J; Emmert, JT				Lastovicka, J.; Akmaev, R. A.; Beig, G.; Bremer, J.; Emmert, J. T.			Global change in the upper atmosphere	SCIENCE			English	Editorial Material							LONG-TERM TRENDS; THERMOSPHERE; IONOSPHERE; MESOSPHERE; DECREASE; DENSITY		Inst Atmospher Phys, Prague 14131, Czech Republic; Univ Colorado, Boulder, CO 80309 USA; Indian Inst Trop Meteorol, Pune 411008, Maharashtra, India; Leibnitz Inst Atmospher Phys, D-18225 Kuhlungsborn, Germany; USN, Res Lab, Washington, DC 20375 USA	Czech Academy of Sciences; Institute of Atmospheric Physics of the Czech Academy of Sciences; University of Colorado System; University of Colorado Boulder; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Leibniz Institut fur Atmospharenphysik e.V. an der Universitat Rostock (IAP); United States Department of Defense; United States Navy; Naval Research Laboratory	Lastovicka, J (corresponding author), Inst Atmospher Phys, Prague 14131, Czech Republic.	jla@ufa.cas.cz	Lastovicka, Jan/H-6804-2014; Fadnavis, Suvarna S/AAA-7485-2020	Lastovicka, Jan/0000-0002-1454-3183; Fadnavis, Suvarna S/0000-0003-4442-0755; Beig, Gufran/0000-0002-5564-7210				Akmaev RA, 2006, J ATMOS SOL-TERR PHY, V68, P1879, DOI 10.1016/j.jastp.2006.03.008; Akmaev RA, 2002, PHYS CHEM EARTH, V27, P521, DOI 10.1016/S1474-7065(02)00033-5; Beig G, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000121; BOUGHER SW, 1991, J GEOPHYS RES-SPACE, V96, P11045, DOI 10.1029/91JA01162; Bremer J, 2005, ADV SPACE RES, V35, P1398, DOI 10.1016/j.asr.2005.01.021; Bremer J, 2001, ADV SPACE RES-SERIES, V28, P997, DOI 10.1016/S0273-1177(01)80029-6; Emmert JT, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010176; Lastovicka J, 2004, SURV GEOPHYS, V25, P69, DOI 10.1023/B:GEOP.0000015388.75164.e2; Marcos FA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021269; RISHBETH H, 1992, PLANET SPACE SCI, V40, P1011, DOI 10.1016/0032-0633(92)90141-A; RISHBETH H, 1990, PLANET SPACE SCI, V38, P945, DOI 10.1016/0032-0633(90)90061-T; ROBLE RG, 1989, GEOPHYS RES LETT, V16, P1441, DOI 10.1029/GL016i012p01441; ZHANG S, 2005, SPRING AGU M NEW ORL	13	89	89	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1253	1254		10.1126/science.1135134	http://dx.doi.org/10.1126/science.1135134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17124313				2022-12-28	WOS:000242215800030
J	Schaffitzel, C; Oswald, M; Berger, I; Ishikawa, T; Abrahams, JP; Koerten, HK; Koning, RI; Ban, N				Schaffitzel, Christiane; Oswald, Miro; Berger, Imre; Ishikawa, Takashi; Abrahams, Jan Pieter; Koerten, Henk K.; Koning, Roman I.; Ban, Nenad			Structure of the E-coli signal recognition particle bound to a translating ribosome	NATURE			English	Article							TRIGGER FACTOR; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; DENSITY MAPS; RESOLUTION; PROTEINS; BINDING; SRP; RNA; MEMBRANE	The prokaryotic signal recognition particle (SRP) targets membrane proteins into the inner membrane(1-4). It binds translating ribosomes and screens the emerging nascent chain for a hydrophobic signal sequence, such as the transmembrane helix of inner membrane proteins. If such a sequence emerges, the SRP binds tightly, allowing the SRP receptor to lock on. This assembly delivers the ribosome-nascent chain complex to the protein translocation machinery in the membrane. Using cryo-electron microscopy and single-particle reconstruction, we obtained a 16 angstrom structure of the Escherichia coli SRP in complex with a translating E. coli ribosome containing a nascent chain with a transmembrane helix anchor. We also obtained structural information on the SRP bound to an empty E. coli ribosome. The latter might share characteristics with a scanning SRP complex, whereas the former represents the next step: the targeting complex ready for receptor binding. High-resolution structures of the bacterial ribosome and of the bacterial SRP components are available, and their fitting explains our electron microscopic density. The structures reveal the regions that are involved in complex formation, provide insight into the conformation of the SRP on the ribosome and indicate the conformational changes that accompany high-affinity SRP binding to ribosome nascent chain complexes upon recognition of the signal sequence.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Dept Biophys Struct Chem, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Electron Microscopy, NL-2300 RC Leiden, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, HPK Bldg,Schafmattstr 20, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Abrahams, Jan Pieter/AAE-4319-2020; Abrahams, Jan Pieter/G-7287-2016; Ishikawa, Takashi/E-5023-2017	Abrahams, Jan Pieter/0000-0001-8216-1868; Abrahams, Jan Pieter/0000-0001-8216-1868; Ishikawa, Takashi/0000-0002-1976-7477; Koning, Roman/0000-0001-6736-7147; Berger, Imre/0000-0001-7518-9045; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760				Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Padmanabhan S, 2001, STRUCTURE, V9, P859, DOI 10.1016/S0969-2126(01)00641-4; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; Rinke-Appel J, 2002, RNA, V8, P612, DOI 10.1017/S1355838202020095; Rosenblad MA, 2003, NUCLEIC ACIDS RES, V31, P363, DOI 10.1093/nar/gkg107; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	30	108	109	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					503	506		10.1038/nature05182	http://dx.doi.org/10.1038/nature05182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086205				2022-12-28	WOS:000242215700050
J	Trussell, J; Raymond, EG				Trussell, James; Raymond, Elizabeth G.			Preventing unintended pregnancy: let us count the ways	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; EMERGENCY CONTRACEPTIVE PILLS; ADVANCED PROVISION; ABORTION RATES; ACCESS; LEVONORGESTREL; REGIMEN; WOMEN		Princeton Univ, Off Populat Res, Princeton, NJ 08540 USA; Family Hlth Int, Durham, NC USA	Princeton University	Trussell, J (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08540 USA.	Trussell@princeton.edu	Potter, Joseph E/A-3122-2008					Belzer Marvin, 2005, J Pediatr Adolesc Gynecol, V18, P347, DOI 10.1016/j.jpag.2005.06.007; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Glasier A, 2004, CONTRACEPTION, V69, P361, DOI 10.1016/j.contraception.2004.01.002; Grimes D, 1998, LANCET, V352, P428; Hu XY, 2005, CONTRACEPTION, V72, P111, DOI 10.1016/j.contraception.2005.02.004; Jackson RA, 2003, OBSTET GYNECOL, V102, P8, DOI 10.1016/S0029-7844(03)00478-2; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P294, DOI 10.2307/3097748; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Lo SST, 2004, HUM REPROD, V19, P2404, DOI 10.1093/humrep/deh425; Moreau C, 2006, CONTRACEPTION, V73, P602, DOI 10.1016/j.contraception.2006.01.012; MOSHER WD, 2004, ADV DATA VITAL HLTH, V350; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Raymond E, 2004, CONTRACEPTION, V69, P79, DOI 10.1016/j.contraception.2003.09.013; Raymond EG, 2004, CONTRACEPTION, V69, P367, DOI 10.1016/j.contraception.2004.02.003; Trussell J, 2003, CONTRACEPTION, V67, P259, DOI 10.1016/S0010-7824(02)00535-8	16	13	13	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2006	368	9549					1747	1748		10.1016/S0140-6736(06)69711-0	http://dx.doi.org/10.1016/S0140-6736(06)69711-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113404				2022-12-28	WOS:000242225400005
J	Inaba, K; Murakami, S; Suzuki, M; Nakagawa, A; Yamashita, E; Okada, K; Ito, K				Inaba, Kenji; Murakami, Satoshi; Suzuki, Mamoru; Nakagawa, Atsushi; Yamashita, Eiki; Okada, Kengo; Ito, Koreaki			Crystal structure of the DsbB-DsbA complex reveals a mechanism of disulfide bond generation	CELL			English	Article							MEMBRANE-PROTEIN DSBB; ESCHERICHIA-COLI; RESPIRATORY-CHAIN; FORMATION PATHWAY; REDOX PROPERTIES; BINDING DOMAIN; ISOMERASE DSBC; IDENTIFICATION; CYSTEINES; UBIQUINONE	Oxidation of cysteine pairs to disulfide requires cellular factors present in the bacterial periplasmic space. DsbB is an E coli membrane protein that oxidizes DsbA, a periplasmic dithiol oxidase. To gain insight into disulfide bond formation, we determined the crystal structure of the DsbB-DsbA complex at 3.7 angstrom resolution. The structure of DsbB revealed four transmembrane helices and one short horizontal helix juxtaposed with Cys130 in the mobile periplasmic loop. Whereas DsbB in the resting state contains a Cys104-Cys130 disulfide, Cys104 in the binary complex is engaged in the intermolecular disulfide bond and captured by the hydrophobic groove of DsbA, resulting in separation from Cys130. This cysteine relocation prevents the backward resolution of the complex and allows Cys130 to approach and activate the disulfide-generating reaction center composed of Cys41, Cys44, Arg48, and ubiquinone. We propose that DsbB is converted by its specific substrate, DsbA, to a superoxidizing enzyme, capable of oxidizing this extremely oxidizing oxidase.	Japan Sci & Technol Agcy, CREST, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Nara Inst Sci & Technol, Nara 6300192, Japan; Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University; Nara Institute of Science & Technology; Kyoto University	Inaba, K (corresponding author), Kyushu Univ, Div Prot Chem, Post Genome Sci Ctr, Med Inst Bioregulat, Fukuoka 8128582, Japan.	kinaba@virus.kyoto-u.ac.jp; kito@virus.kyoto-u.ac.jp	Murakami, Satoshi/E-8155-2015; Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009; Suzuki, Mamoru/G-6576-2016	Murakami, Satoshi/0000-0001-5553-7663; Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Suzuki, Mamoru/0000-0001-7071-5093; Inaba, Kenji/0000-0001-8229-0467				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sevier CS, 2005, PROTEIN SCI, V14, P1630, DOI 10.1110/ps.051355705; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Takahashi YH, 2006, ANTIOXID REDOX SIGN, V8, P743, DOI 10.1089/ars.2006.8.743; Tan J, 2005, J BACTERIOL, V187, P1504, DOI 10.1128/JB.187.4.1504-1510.2005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Xie T, 2002, J BIOL CHEM, V277, P1649, DOI 10.1074/jbc.M108697200; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	194	200	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					789	801		10.1016/j.cell.2006.10.034	http://dx.doi.org/10.1016/j.cell.2006.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110337	Bronze			2022-12-28	WOS:000242330600024
J	Makadon, HJ; Mayer, KH; Garofalo, R				Makadon, Harvey J.; Mayer, Kenneth H.; Garofalo, Robert			Optimizing primary care for men who have sex with men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; PREVENTION; BEHAVIOR; RATES		Harvard Univ, Sch Med, Harvard Med Int, Boston, MA 02120 USA; Fenway Community Hlth, Fenway Inst, Boston, MA USA; Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; Brown Univ, Providence, RI 02912 USA; Miriam Hosp, Providence, RI 02906 USA; Northwestern Univ, Childrens Mem Hosp, Chicago, IL 60614 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University	Makadon, HJ (corresponding author), Harvard Univ, Sch Med, Harvard Med Int, 1135 Tremmont St,Suite 900, Boston, MA 02120 USA.	hmaka-don@hms.harvard.edu		Garofalo, Robert/0000-0001-9513-9416				Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2004, HIV AIDS SURVEILLANC, V16; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V42, P988; COONEY TG, 1986, MED CLIN N AM, V70, P497, DOI 10.1016/S0025-7125(16)30936-1; Dean L., 2000, J GAY LESBIAN MED AS, V4, P102, DOI DOI 10.1023/A:1009573800168; Elford J, 2003, AIDS EDUC PREV, V15, P294, DOI 10.1521/aeap.15.5.294.23825; ELLINGSON S, 2004, SEXUAL ORG CITY, P93; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Halkitis PN, 2001, J HOMOSEXUAL, V41, P17, DOI 10.1300/J082v41n02_02; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Khan S, 2001, J HOMOSEXUAL, V40, P99, DOI 10.1300/J082v40n03_06; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Makadon HJ, 2006, NEW ENGL J MED, V354, P895, DOI 10.1056/NEJMp058259; McClennen JC, 2005, J INTERPERS VIOLENCE, V20, P149, DOI 10.1177/0886260504268762; Miller V, 2001, J ACQ IMMUN DEF SYND, V26, pS34, DOI 10.1097/00126334-200103011-00005; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; MIMIAGA M, 2006, SEX TRANSM DIS; PALEFSKY J, 2006, UPTODATE; Ryan, 1997, Adolesc Med, V8, P207; Sanchez T., 2006, MMWR MORB MORTAL WKL, V55, P752; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sell RL, 1997, ARCH SEX BEHAV, V26, P643, DOI 10.1023/A:1024528427013; Simmons T., 2003, MARRIED COUPLE UNMAR	23	27	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2362	2365		10.1001/jama.296.19.2362	http://dx.doi.org/10.1001/jama.296.19.2362			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104ZI	17105799				2022-12-28	WOS:000241998700024
J	Walter, LC; Bertenthal, D; Lindquist, K; Konety, BR				Walter, Louise C.; Bertenthal, Daniel; Lindquist, Karla; Konety, Badrinath R.			PSA screening among elderly men with limited life expectancies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOCALIZED PROSTATE-CANCER; UNITED-STATES; COMORBIDITY; GUIDELINES; VIEWPOINT; ACCURACY	Context Most guidelines do not recommend prostate-specific antigen (PSA) screening in elderly men who have limited life expectancies because the known harms of screening outweigh potential benefits. However, there are no large-scale studies of actual PSA screening practices in elderly men, according to life expectancy. Objective To characterize the extent of PSA screening among elderly men, including those with limited life expectancies. Design, Setting, and Participants Cohort study of 597 642 male veterans aged 70 years and older who were seen at 104 US Department of Veterans Affairs facilities during both 2002 and 2003, without a history of prostate cancer, elevated PSA, or prostate cancer symptoms. Charlson comorbidity scores were used to stratify men into 3 groups ranging from best health ( score= 0) to worst health ( score >= 4). Main Outcome Measure Receipt of PSA testing during 2003 was based on US Department of Veterans Affairs data and Medicare claims. Results In 2003, 56% of elderly men had a PSA test performed. Although PSA screening rates decreased with advancing age, within each 5-year age group the percentage of men who underwent a PSA test did not substantially decline with worsening health. For example, among men aged 85 years and older, 34% in best health had a PSA test compared with 36% in worst health. In multivariate analyses, many nonclinical factors, such as marital status and region of the country, had a greater effect on PSA screening than health, and screening rates exceeded 60% for some subgroups of men in worst health. Conclusions Prostate-specific antigen screening rates among elderly veterans with limited life expectancies should be much lower than current practice given the known harms of screening. More attention to prognosis is needed when making screening PSA recommendations to elderly men.	San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA USA; Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, Res Enhancement Award Program Improve Care Older, San Francisco, CA USA; Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Walter, LC (corresponding author), VA Med Ctr, 181G,4150 Clement St, San Francisco, CA 94121 USA.	louise.walter@ucsf.edu		Lindquist, Karla/0000-0002-1971-2273				*AM UR ASS, 2000, ONCOLOGY, V14, P277; Barry MJ, 1998, ANN ONCOL, V9, P1279, DOI 10.1093/oxfordjournals.annonc.a010952; CARTER HB, 1990, J UROLOGY, V143, P742, DOI 10.1016/S0022-5347(17)40078-4; Catalona WJ, 2006, ANN INTERN MED, V144, P441, DOI 10.7326/0003-4819-144-6-200603210-00012; *CDCP, 2003, US LIF TABL, V54; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Demakis JG, 2000, MED CARE, V38, pS17; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; *DSS PROGR OFF, 2003, DAT VER REP DSS DAT; *EJ HIN JR VA HOSP, 2004, VIREC RES US GUID VH; Fowler JE, 1996, J UROLOGY, V156, P1714, DOI 10.1016/S0022-5347(01)65489-2; Freeman JL, 2002, MED CARE, V40, P36; Gilligan T, 2004, ARCH INTERN MED, V164, P1858, DOI 10.1001/archinte.164.17.1858; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Hoffman RM, 2006, ANN INTERN MED, V144, P438, DOI 10.7326/0003-4819-144-6-200603210-00011; Jacobsen SJ, 1996, ARCH INTERN MED, V156, P2462, DOI 10.1001/archinte.156.21.2462; Jerant AF, 2004, ANN FAM MED, V2, P481, DOI 10.1370/afm.118; Krahn MD, 2002, UROLOGY, V60, P258, DOI 10.1016/S0090-4295(02)01712-0; Lu-Yao G, 2003, J NATL CANCER I, V95, P1792, DOI 10.1093/jnci/djg104; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; *NAT VA CTR HLTH P, 2004, PROP NEW CLIN PRACT; Ross LE, 2004, PREV MED, V38, P732, DOI 10.1016/j.ypmed.2004.01.005; *SEER MED PROGR, SAS MACR CHARLS COM; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; Shryock H. S., 1976, METHODS MAT DEMOGRAP; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; SMITH MW, 2005, FEE BASIS DATA GUIDE; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; United States Department of Veterans Affairs, VA INF RES CTR DAT S; US Census Bureau, 2002, CENS 2000 SUMM FIL 3; US Census Bureau, CENS REG DIV US; *VA INF RES CTR, RS FIND VA MED DAT M; *VA OFF QUAL PERF, 2003, FY 2003 VHA PERF MEA; Veterans Affairs Information Resource Center, 2005, VIREC RES US GUID FY; Volk RJ, 2002, AM J PREV MED, V22, P56, DOI 10.1016/S0749-3797(01)00397-X; Volk Robert J, 2003, Ann Fam Med, V1, P22, DOI 10.1370/afm.7; Voss JD, 2001, J GEN INTERN MED, V16, P831, DOI 10.1046/j.1525-1497.2001.10133.x; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Wolf AMD, 1996, ARCH INTERN MED, V156, P1333, DOI 10.1001/archinte.156.12.1333; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112	47	202	204	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2336	2342		10.1001/jama.296.19.2336	http://dx.doi.org/10.1001/jama.296.19.2336			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104ZI	17105796	Bronze			2022-12-28	WOS:000241998700021
J	Cleland, SJ; Sattar, N				Cleland, Stephen J.; Sattar, Naveed			Does rimonabant pull its weight for type 2 diabetes?	LANCET			English	Editorial Material							CANNABINOID-1 RECEPTOR BLOCKER; RISK-FACTORS; OVERWEIGHT PATIENTS; OBESITY		Stobhill Gen Hosp, Glasgow G21 3UW, Lanark, Scotland; Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G31 2ER, Lanark, Scotland	University of Glasgow	Sattar, N (corresponding author), Stobhill Gen Hosp, Glasgow G21 3UW, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk						Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; Haslam D, 2006, BMJ-BRIT MED J, V333, P640, DOI 10.1136/bmj.333.7569.640; LEAN M, IN PRESS BMJ; Padwal R, 2003, INT J OBESITY, V27, P1437, DOI 10.1038/sj.ijo.0802475; PADWAL RS, 2006, OBES REV S, V7, P46; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Simons-Morton DG, 2006, JAMA-J AM MED ASSOC, V295, P826, DOI 10.1001/jama.295.7.826; Tuthill A, 2006, QJM-INT J MED, V99, P317, DOI 10.1093/qjmed/hcl041; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X	13	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1632	1634		10.1016/S0140-6736(06)69572-X	http://dx.doi.org/10.1016/S0140-6736(06)69572-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098066				2022-12-28	WOS:000242099000009
J	Bursi, F; Weston, SA; Redfield, MM; Jacobsen, SJ; Pakhomov, S; Nkomo, VT; Meverden, RA; Roger, VL				Bursi, Francesca; Weston, Susan A.; Redfield, Margaret M.; Jacobsen, Steven J.; Pakhomov, Serguei; Nkomo, Vuyisile T.; Meverden, Ryan A.; Roger, Veronique L.			Systolic and diastolic heart failure in the community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESERVED EJECTION FRACTION; VENTRICULAR FILLING PRESSURES; NATRIURETIC PEPTIDE; DOPPLER-ECHOCARDIOGRAPHY; EMERGENCY DIAGNOSIS; PRACTICE GUIDELINES; CLINICAL-FEATURES; OF-CARDIOLOGY; DISEASE; DYSFUNCTION	Context The heart failure (HF) syndrome is heterogeneous. While it can be defined by ejection fraction (EF) and diastolic function, data on the characteristics of HF in the community are scarce, as most studies are retrospective, hospital-based, and rely on clinically indicated tests. Further, diastolic function is seldom systematically assessed based on standardized techniques. Objective To prospectively measure EF, diastolic function, and brain natriuretic peptide (BNP) in community residents with HF. Main Outcome Measures Echocardiographic measures of EF and diastolic function, measurement of blood levels of BNP, and 6-month mortality. Design, Setting, and Participants Olmsted County residents with incident or prevalent HF (inpatients or outpatients) between September 10, 2003, and October 27, 2005, were prospectively recruited to undergo assessment of EF and diastolic function by echocardiography and measurement of BNP. Results A total of 556 study participants underwent echocardiography at HF diagnosis. Preserved EF (>= 50%) was present in 308 (55%) and was associated with older age, female sex, and no history of myocardial infarction (all P < .001). Isolated diastolic dysfunction (diastolic dysfunction with preserved EF) was present in 242 (44%) patients. For patients with reduced EF, moderate or severe diastolic dysfunction was more common than when EF was preserved (odds ratio, 1.67; 95% confidence interval [CI], 1.11-2.51; P = .01). Both low EF and diastolic dysfunction were independently related to higher levels of BNP. At 6 months, mortality was 16% for both preserved and reduced EF (age- and sex-adjusted hazard ratio, 0.85; 95% CI, 0.61-1.19; P = .33 for preserved vs reduced EF). Conclusions In the community, more than half of patients with HF have preserved EF, and isolated diastolic dysfunction is present in more than 40% of cases. Ejection fraction and diastolic dysfunction are independently related to higher levels of BNP. Heart failure with preserved EF is associated with a high mortality rate, comparable to that of patients with reduced EF.	Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Div Biomed Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Roger, VL (corresponding author), Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020; Bursi, Francesca/ABB-8483-2020	Bursi, Francesca/0000-0001-6632-3871; Jacobsen, Steven/0000-0002-8174-8533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL72435] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMICO AF, 1989, AM HEART J, V118, P1259, DOI 10.1016/0002-8703(89)90018-5; [Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; Berry C, 2005, HEART, V91, P907, DOI 10.1136/hrt.2004.041996; Bess RL, 2006, ECHOCARDIOGR-J CARD, V23, P332, DOI 10.1111/j.1540-8175.2006.00215.x; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Bruch C, 2005, AM J CARDIOL, V95, P892, DOI 10.1016/j.amjcard.2004.12.017; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gonzalez-Vilchez F, 2002, J AM SOC ECHOCARDIOG, V15, P1245, DOI 10.1067/mje.2002.125752; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1116, DOI [DOI 10.1016/j.jacc.2005.08.023, DOI 10.1016/J.JACC.2005.08.023]; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Kass DA, 2005, J CARD FAIL, V11, P188, DOI 10.1016/j.cardfail.2005.01.005; Khan S, 2004, AM J CARDIOL, V94, P1099, DOI 10.1016/j.amjcard.2004.06.080; Kirk V, 2004, EUR J HEART FAIL, V6, P335, DOI 10.1016/j.ejheart.2004.01.002; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Maurer MS, 2005, J CARD FAIL, V11, P177, DOI 10.1016/j.cardfail.2004.10.006; McMurray JJV, 2004, J AM COLL CARDIOL, V44, P2398, DOI 10.1016/j.jacc.2004.09.070; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pakhomov SV, 2005, J BIOMED INFORM, V38, P145, DOI 10.1016/j.jbi.2004.11.016; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Thomas MD, 2004, EUR J HEART FAIL, V6, P125, DOI 10.1016/j.ejheart.2003.11.002; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Yturralde FR, 2005, PROG CARDIOVASC DIS, V47, P314, DOI 10.1016/j.pcad.2005.02.007; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	42	626	663	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2209	2216		10.1001/jama.296.18.2209	http://dx.doi.org/10.1001/jama.296.18.2209			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090767	Bronze			2022-12-28	WOS:000241827700021
J	Glasier, A; Gulmezoglu, AM; Schmid, GP; Moreno, CG; Van Look, PF				Glasier, Anna; Guelmezoglu, A. Metin; Schmid, George P.; Moreno, Claudia Garcia; Van Look, Paul Fa			Sexual and Reproductive Health 1 - Sexual and reproductive health: a matter of life and death	LANCET			English	Article							SIMPLEX-VIRUS TYPE-2; DAR-ES-SALAAM; TRANSMITTED-DISEASES; PARTNER VIOLENCE; DEVELOPING-WORLD; NATIONAL SAMPLE; UNITED-STATES; PREVALENCE; WOMEN; PREGNANCY	Despite the call for universal access to reproductive health at the 4th International Conference on Population and Development in Cairo in 1994, sexual and reproductive health was omitted from the Millennium Development Goals and remains neglected (panel 1). Unsafe sex is the second most important risk factor for disability and death in the world's poorest communities and the ninth most important in developed countries. Cheap effective interventions are available to prevent unintended pregnancy, provide safe abortions, help women safely through pregnancy and child birth, and prevent and treat sexually transmitted infections. Yet every year, more than 120 million couples have an unmet need for contraception, 80 million women have unintended pregnancies (45 million of which end in abortion), more than half a million women die from complications associated with pregnancy, childbirth, and the postpartum period, and 340 million people acquire new gonorrhoea, syphilis, chlamydia, or trichomonas infections. Sexual and reproductive ill-health mostly affects women and adolescents. Women are disempowered in much of the developing world and adolescents, arguably, are disempowered everywhere. Sexual and reproductive health services are absent or of poor quality and underused in many countries because discussion of issues such as sexual intercourse and sexuality make people feel uncomfortable. The increasing influence of conservative political, religious, and cultural forces around the world threatens to undermine progress made since 1994, and arguably provides the best example of the detrimental intrusion of politics into public health.	NHS Lothian Family Planning Serv, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Edinburgh, Midlothian, Scotland; WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; WHO, Dept HIV AIDS, Geneva, Switzerland; WHO, Dept Gender Women & Hlth, Geneva, Switzerland	University of Edinburgh; World Health Organization; World Health Organization; World Health Organization	Glasier, A (corresponding author), NHS Lothian Family Planning Serv, 18 Dean Terrace, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk	Moreno, Claudia/GRJ-1036-2022					*A GUTTM I, 2003, THEIR OWN RIGHT ADDR; *A GUTTM I, 1999, SHAR RESP WOM SOC AB; [Anonymous], [No title captured]; Archer J, 2000, PSYCHOL BULL, V126, P651, DOI [10.1037/0033-2909.126.5.651, 10.1037//0033-2909.126.5.651]; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Berer M, 2004, REPROD HEALTH MATTER, V12, P1, DOI 10.1016/S0968-8080(04)24024-1; Buve A, 2001, TROP MED INT HEALTH, V6, P971, DOI 10.1046/j.1365-3156.2001.00809.x; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cates W, 2001, FAM PLANN PERSPECT, V33, P231, DOI 10.2307/2673787; Chang J, 2005, AM J PUBLIC HEALTH, V95, P471, DOI 10.2105/AJPH.2003.029868; Cleland J, 2005, LANCET, V366, P1899, DOI 10.1016/S0140-6736(05)67603-9; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; *COUNC EUR UN, 2005, COUNC CONCL ACC PROG; DESANJOSE S, 2005, 22 INT PAP C VANC CA; Doncel Gustavo, 2004, Curr HIV/AIDS Rep, V1, P25, DOI 10.1007/s11904-004-0004-0; DONTA B, 2005, ENHANCING MALE PARTN; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Erulkar AS, 2004, INT FAM PLAN PERSPEC, V30, P182, DOI 10.1363/3018204; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fergusson DM, 1997, CHILD ABUSE NEGLECT, V21, P789, DOI 10.1016/S0145-2134(97)00039-2; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garnett GP, 2000, SEX TRANSM DIS, V27, P588, DOI 10.1097/00007435-200011000-00007; Gazmararian J A, 2000, Matern Child Health J, V4, P79, DOI 10.1023/A:1009514119423; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Glander SS, 1998, OBSTET GYNECOL, V91, P1002, DOI 10.1016/S0029-7844(98)00089-1; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Goodwin M M, 2000, Matern Child Health J, V4, P85; Granja AC, 2002, BJOG-INT J OBSTET GY, V109, P5, DOI 10.1111/j.1471-0528.2002.01082.x; Greene M.E., 2005, POVERTY REDUCTION DO; GRIMES DA, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69481-6; Holmes MM, 1996, AM J OBSTET GYNECOL, V175, P320, DOI 10.1016/S0002-9378(96)70141-2; Horton R, 2005, LANCET, V365, P821, DOI 10.1016/S0140-6736(05)71015-1; Jejeebhoy SJ., 2005, SEX CONSENT YOUNG PE, P3; Kamm MA, 2003, BRIT MED J, V327, P1299, DOI 10.1136/bmj.327.7427.1299; KANE R, 1999, REDUCING RATE TEENAG; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Marston C, 2003, INT FAM PLAN PERSPEC, V29, P6, DOI 10.2307/3180995; MARSTON C, 2004, EFFECTS CONTRACEPTIO, P7; Martin SL, 2001, JAMA-J AM MED ASSOC, V285, P1581, DOI 10.1001/jama.285.12.1581; Mathers CD., 2005, EVIDENCE INFORM POLI; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7; OVER M, 1993, HIV INFECTION SEXUAL; Pallitto CC, 2004, INT FAM PLAN PERSPEC, V30, P165, DOI 10.1363/3016504; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Plichta SB, 2001, WOMEN HEALTH ISS, V11, P244, DOI 10.1016/S1049-3867(01)00085-8; *POP REF BUR, 2005, WORLD POP DAT SHEET; *POP REF BUR STAFF, 2004, POPUL B, V59, P1; Potts M., 2005, J REPROD CONTRACEPT, V16, P179; Ravichandran B, 2005, BMJ-BRIT MED J, V331, P57, DOI 10.1136/bmj.331.7507.57; Ross JA, 2002, INT FAM PLAN PERSPEC, V28, P138, DOI 10.2307/3088256; ROWLEY J, 1998, GLOBAL BURDEN DIS IN, V3, P19; Rutstein SO., 2004, DEMOGRAPHIC HLTH SUR, V9; Sami Neelofar, 2006, JPMA Journal of the Pakistan Medical Association, V56, P19; Schmid G, 2005, CLIN INFECT DIS, V41, P1313, DOI 10.1086/496987; SCHMID G, 2004, B WORLD HEALTH ORGAN, V82, P1; Schunmann C, 2006, CONTRACEPTION, V73, P520, DOI 10.1016/j.contraception.2005.12.009; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Slaymaker E., 2004, COMP QUANTIFICATION, P1177; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; *UN, 1995, INT C POP DEV CAIR 5; UN, 2000, ARES552 UN; *UN, 1999, INT C POP DEV NEW YO; *UN DEP EC SOC AFF, 2004, WORLD CONTR US 2003; *UN MILL PROJ, 2006, PUBL CHOIC PRIV DEC; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UNAIDS, 2005, AIDS EP UPD 2005; *UNFPA UNAIDS NIDI, 2006, FIN RES FLOWS POP AI; United Nations, 2001, REPORT SECRETARY GEN; United Nations, 2005, ARES601 UN; United Nations Population Fund, 2005, STAT WORLD POP 2005; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; *WELL CTR RES, UNS SCH LIT REV SCH; *WHO, 2006, WHO REPR HLTH LIB; WHO, 2004, MAT MORT 2000 EST DE; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2006, SKILL ATT BIRTH 2006; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2004, REPR HLTH STRAT ACC; 2003, LANCET, V361, P1; 1999, SEXUALLY TRANSMITTED, P21	89	334	340	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1595	1607		10.1016/S0140-6736(06)69478-6	http://dx.doi.org/10.1016/S0140-6736(06)69478-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084760				2022-12-28	WOS:000242180900029
J	Horton, R				Horton, Richard			Reviving reproductive health	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.								0	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1549	1549		10.1016/S0140-6736(06)69484-1	http://dx.doi.org/10.1016/S0140-6736(06)69484-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084738				2022-12-28	WOS:000242180900004
J	Yano, J; Kern, J; Sauer, K; Latimer, MJ; Pushkar, Y; Biesiadka, J; Loll, B; Saenger, W; Messinger, J; Zouni, A; Yachandra, VK				Yano, Junko; Kern, Jan; Sauer, Kenneth; Latimer, Matthew J.; Pushkar, Yulia; Biesiadka, Jacek; Loll, Bernhard; Saenger, Wolfram; Messinger, Johannes; Zouni, Athina; Yachandra, Vittal K.			Where water is oxidized to dioxygen: Structure of the photosynthetic Mn4Ca cluster	SCIENCE			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYSTEM-II; MN-CLUSTER; CRYSTAL-STRUCTURE; S-0 STATE; UNDERGOES OXIDATION; ANGSTROM RESOLUTION; SINGLE-CRYSTALS; D1 POLYPEPTIDE; MANGANESE ION	The oxidation of water to dioxygen is catalyzed within photosystem II ( PSII) by a Mn4Ca cluster, the structure of which remains elusive. Polarized extended x-ray absorption fine structure (EXAFS) measurements on PSII single crystals constrain the Mn4Ca cluster geometry to a set of three similar high-resolution structures. Combining polarized EXAFS and x-ray diffraction data, the cluster was placed within PSII, taking into account the overall trend of the electron density of the metal site and the putative ligands. The structure of the cluster from the present study is unlike either the 3.0 or 3.5 angstrom - resolution x-ray structures or other previously proposed models.	Max Planck Inst Bioorgan Chem, D-45470 Mulheim, Germany; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Melvin Calvin Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Tech Univ Berlin, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany	Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Technical University of Berlin; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Free University of Berlin	Messinger, J (corresponding author), Max Planck Inst Bioorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	messinger@mpi-muelheim.mpg.de; zouni@phosis1.chem.tu-berlin.de; vkyachandra@lbl.gov	Messinger, Johannes/AAC-4221-2019; Loll, Bernhard/J-4815-2019; Kern, Jan/G-2586-2013	Messinger, Johannes/0000-0003-2790-7721; Loll, Bernhard/0000-0001-7928-4488; Kern, Jan/0000-0002-7272-1603	NIGMS NIH HHS [R56 GM055302, R01 GM055302, GM 55302] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055302, R56GM055302] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrling KA, 1998, BIOCHEMISTRY-US, V37, P8115, DOI 10.1021/bi980117o; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Brudvig GW, 1995, ADV CHEM SER, V246, P249; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Chu HA, 2001, BBA-BIOENERGETICS, V1503, P69, DOI 10.1016/S0005-2728(00)00216-4; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FLANK AM, 1986, J AM CHEM SOC, V108, P1049, DOI 10.1021/ja00265a034; Hasegawa K, 1999, CHEM PHYS LETT, V300, P9, DOI 10.1016/S0009-2614(98)01369-4; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P16072, DOI 10.1021/bi051306r; Kimura Y, 2005, J BIOL CHEM, V280, P2078, DOI 10.1074/jbc.M410627200; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Messinger J, 1997, BIOCHEMISTRY-US, V36, P11055, DOI 10.1021/bi9711285; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Robblee JH, 2002, J AM CHEM SOC, V124, P7459, DOI 10.1021/ja011621a; SCOTT RA, 1982, J AM CHEM SOC, V104, P5364, DOI 10.1021/ja00384a020; Wydrzynski TJ, 2005, ADV PHOTOSYNTHESIS R, V22; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	28	661	671	7	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					821	825		10.1126/science.1128186	http://dx.doi.org/10.1126/science.1128186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082458	Green Accepted, Green Submitted			2022-12-28	WOS:000241729800048
J	Gigan, S; Bohm, HR; Paternostro, M; Blaser, F; Langer, G; Hertzberg, JB; Schwab, KC; Bauerle, D; Aspelmeyer, M; Zeilinger, A				Gigan, S.; Boehm, H. R.; Paternostro, M.; Blaser, F.; Langer, G.; Hertzberg, J. B.; Schwab, K. C.; Baeuerle, D.; Aspelmeyer, M.; Zeilinger, A.			Self-cooling of a micromirror by radiation pressure	NATURE			English	Article							QUANTUM-NOISE; MIRROR; REDUCTION; MECHANICS; STATE	Cooling of mechanical resonators is currently a popular topic in many fields of physics including ultra-high precision measurements(1), detection of gravitational waves(2,3) and the study of the transition between classical and quantum behaviour of a mechanical system(4-6). Here we report the observation of self-cooling of a micromirror by radiation pressure inside a high-finesse optical cavity. In essence, changes in intensity in a detuned cavity, as caused by the thermal vibration of the mirror, provide the mechanism for entropy flow from the mirror's oscillatory motion to the low-entropy cavity field(2). The crucial coupling between radiation and mechanical motion was made possible by producing freestanding micromirrors of low mass (m approximate to 400 ng), high reflectance ( more than 99.6%) and high mechanical quality (Q approximate to 10,000). We observe cooling of the mechanical oscillator by a factor of more than 30; that is, from room temperature to below 10 K. In addition to purely photothermal effects(7) we identify radiation pressure as a relevant mechanism responsible for the cooling. In contrast with earlier experiments, our technique does not need any active feedback(8-10). We expect that improvements of our method will permit cooling ratios beyond 1,000 and will thus possibly enable cooling all the way down to the quantum mechanical ground state of the micromirror.	Univ Vienna, Fac Phys, Inst Expt Phys, A-1090 Vienna, Austria; Austrian Acad Sci, IQOQI, A-1090 Vienna, Austria; Johannes Kepler Univ Linz, Inst Appl Phys, A-4040 Linz, Austria; Univ Maryland, Lab Phys Sci, College Pk, MD 20740 USA; Univ Maryland, Dept Phys, College Pk, MD 20740 USA	University of Vienna; Austrian Academy of Sciences; Johannes Kepler University Linz; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Aspelmeyer, M (corresponding author), Univ Vienna, Fac Phys, Inst Expt Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	markus.aspelmeyer@quantum.at	Aspelmeyer, Markus/C-4098-2017; Zeilinger, Anton/A-1170-2011; Gigan, Sylvain/AAD-6347-2020; Paternostro, Mauro/E-3297-2010	Aspelmeyer, Markus/0000-0003-4499-7335; Gigan, Sylvain/0000-0002-9914-6231; Paternostro, Mauro/0000-0001-8870-9134				Bauerle D., 2000, ADV TEXTS PHYS; Black ED, 2001, AM J PHYS, V69, P79, DOI 10.1119/1.1286663; Bose S, 1997, PHYS REV A, V56, P4175, DOI 10.1103/PhysRevA.56.4175; Braginsky V. B., 1995, QUANTUM MEASUREMENTS; Braginsky VB, 2002, PHYS LETT A, V293, P228, DOI 10.1016/S0375-9601(02)00020-8; Braginsky VB, 2001, PHYS LETT A, V287, P331, DOI 10.1016/S0375-9601(01)00510-2; Bushev P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043003; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; DORSEL A, 1983, PHYS REV LETT, V51, P1550, DOI 10.1103/PhysRevLett.51.1550; Giovannetti V, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.023812; Jacobs K, 1999, PHYS REV A, V60, P538, DOI 10.1103/PhysRevA.60.538; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Leggett AJ, 2002, J PHYS-CONDENS MAT, V14, pR415, DOI 10.1088/0953-8984/14/15/201; MANCINI S, 1994, PHYS REV A, V49, P4055, DOI 10.1103/PhysRevA.49.4055; Marquardt F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.103901; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; MERTZ J, 1993, J OPT SOC AM B, V10, P745, DOI 10.1364/JOSAB.10.000745; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; Paternostro M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/6/107; Pinard M, 2005, EUROPHYS LETT, V72, P747, DOI 10.1209/epl/i2005-10317-6; Pinard M, 1999, EUR PHYS J D, V7, P107; Rokhsari H, 2005, OPT EXPRESS, V13, P5293, DOI 10.1364/OPEX.13.005293; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Sheard BS, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.051801; Tucker RS, 2002, IEEE J SEL TOP QUANT, V8, P88, DOI 10.1109/2944.991403; Vogel M, 2003, APPL PHYS LETT, V83, P1337, DOI 10.1063/1.1600513; Zhang J, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013808	29	731	744	6	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					67	70		10.1038/nature05273	http://dx.doi.org/10.1038/nature05273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080084	Green Submitted, Green Accepted			2022-12-28	WOS:000241701500045
J	Wilt, TJ; Thompson, IM				Wilt, Timothy J.; Thompson, Ian M.			Clinically localised prostate cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RADIATION-THERAPY; RISK; MEN; ADENOCARCINOMA; MANAGEMENT; UPDATE		Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio	Wilt, TJ (corresponding author), Minneapolis VA Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-0, Minneapolis, MN 55417 USA.	Tim.wilt@med.va.gov						*AG HEALTHC RES QU, 2007, COMP THER CLIN LOC P; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; *AM UR ASS, IN PRESS GUID MAN CL; AUS G, 2006, GUIDELINES PROSTATE; Baillargeon J, 2006, INT J ONCOL, V28, P737; Barry MJ, 2006, ARCH INTERN MED, V166, P7, DOI 10.1001/archinte.166.1.7; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Gao X, 2005, JNCI-J NATL CANCER I, V97, P1768, DOI 10.1093/jnci/dji402; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Ilic D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub2; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; *NAT I HLTH CLIN E, LOW DOS RAT BRACH LO; *NAT I HLTH CLIN E, 2007, PROST CANC DIAGN TRE; *NHS CANC SCREEN P, PROST CANC RISK MAN; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Partin MR, 2002, AM J MED, V113, P691, DOI 10.1016/S0002-9343(02)01423-7; PAULSON DF, 1982, J UROLOGY, V128, P502, DOI 10.1016/S0022-5347(17)53016-5; Ransohoff DF, 2002, AM J MED, V113, P663, DOI 10.1016/S0002-9343(02)01235-4; Shahinian VB, 2006, ARCH INTERN MED, V166, P465; Spencer BA, 2003, J CLIN ONCOL, V21, P1928, DOI 10.1200/JCO.2003.05.157; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; WATSON E, 2002, PSA TEST PROSTATE CA; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Wilt TJ, 2004, AM J MED, V117, P796, DOI 10.1016/j.amjmed.2004.10.002; Young JM, 2000, BJU INT, V85, P1037, DOI 10.1046/j.1464-410x.2000.00659.x; Zeliadt SB, 2006, CANCER-AM CANCER SOC, V106, P1865, DOI 10.1002/cncr.21822; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233; COCHRANE LIB	33	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2006	333	7578					1102	1106		10.1136/bmj.39022.423588.DE	http://dx.doi.org/10.1136/bmj.39022.423588.DE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124221	Green Published			2022-12-28	WOS:000242520200017
J	Cannon, CP; Curtis, SP; FitzGerald, GA; Krum, H; Kaur, A; Bolognese, JA; Reicin, AS; Bombardier, C; Weinblatt, ME; van der Heijde, D; Erdmann, E; Laine, L				Cannon, Christopher P.; Curtis, Sean P.; FitzGerald, Garret A.; Krum, Henry; Kaur, Amarjot; Bolognese, James A.; Reicin, Alise S.; Bombardier, Claire; Weinblatt, Michael E.; van der Heijde, Desiree; Erdmann, Erland; Laine, Loren		MEDAL Steering Comm	Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTRODUODENAL ULCERS; INHIBITORS PARECOXIB; COX-2 INHIBITORS; CLINICAL-TRIAL; DOUBLE-BLIND; RISK; CYCLOOXYGENASE; VALDECOXIB; CELECOXIB	Background Cyclo-oxygenase-2 (COX-2) selective inhibitors have been associated with an increased risk of thrombotic cardiovascular events in placebo-controlled trials, but no clinical trial has been reported with the primary aim of assessing relative cardiovascular risk of these drugs compared with traditional non-steroidal anti-inflammatory drugs (NSAIDs). The MEDAL programme was designed to provide a precise estimate of thrombotic cardiovascular events with the COX-2 selective inhibitor etoricoxib versus the traditional NSAID diclofenac. Methods We designed a prespecified pooled analysis of data from three trials in which patients with osteoarthritis or rheumatoid arthritis were randomly assigned to etoricoxib (60 mg or 90 mg daily) or diclofenac (150 mg daily). The primary hypothesis stated that etoricoxib is not inferior to diclofenac, defined as an upper boundary of less than 1.30 for the 95% CI of the hazard ratio for thrombotic cardiovascular events in the per-protocol analysis. Intention-to-treat analyses were also done to assess consistency of results. These trials are registered at http://www. clinicaltrials.gov with the numbers NCT00092703, NCT00092742, and NCT00250445. Findings 34701 patients (24913 with osteoarthritis and 9787 with rheumatoid arthritis) were enrolled. Average treatment duration was 18 months (SD 11.8). 320 patients in the etoricoxib group and 323 in the diclofenac group had thrombotic cardiovascular events, yielding event rates of 1.24 and 1.30 per 100 patient-years and a hazard ratio of 0.95 (95% CI 0.81-1.11) for etoricoxib compared with diclofenac. Rates of upper gastrointestinal clinical events (perforation, bleeding, obstruction, ulcer) were lower with etoricoxib than with diclofenac (0.67 vs 0.97 per 100 patient-years; hazard ratio 0.69 [0.57-0.83]), but the rates of complicated upper gastrointestinal events were similar for etoricoxib (0.30) and diclofenac (0.32). Interpretation Rates of thrombotic cardiovascular events in patients with arthritis on etoricoxib are similar to those in patients on diclofenac with long-term use of these drugs.	Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Cardiovasc Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Univ So Calif, Keck Sch Med, Div Gastrointestinal & Liver Dis, Dept Med, Los Angeles, CA USA; Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; Univ Hosp Maastricht, Dept Internal Med, Div Rheumatol, Maastricht, Netherlands; Univ Cologne, Med Clin 3, Cologne, Germany; Merck Res Labs, Rahway, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Monash University; Monash University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Maastricht University; Maastricht University Medical Centre (MUMC); University of Cologne; Merck & Company	Cannon, CP (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Cardiovasc Div, Boston, MA 02115 USA.	cpcannon@partners.org	Cannon, Christopher P/AAY-7644-2020; FitzGerald, Garret A/A-4222-2010; van der Heijde, Désirée/I-6774-2019	Cannon, Christopher P/0000-0003-4596-2791; van der Heijde, Désirée/0000-0002-5781-158X; Bombardier, Claire/0000-0001-5083-2137				Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; ARMITAGE P, 1998, ENCY BIOSTATISTICS, P1367; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cannon CP, 2006, AM HEART J, V152, P237, DOI 10.1016/j.ahj.2006.05.024; Capone ML, 2005, J AM COLL CARDIOL, V45, P1295, DOI 10.1016/j.jacc.2005.01.045; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COX DR, 1972, J R STAT SOC B, V34, P187; Dallob A, 2003, J CLIN PHARMACOL, V43, P573, DOI 10.1177/0091270003253703; Emery P, 1999, LANCET, V354, P2106, DOI 10.1016/S0140-6736(99)02332-6; *EUR MED AG, ICH HARM TRIP GUID T; *FOOD DRUG ADM, CONC IB ASP POT ATT; Furberg CD, 2006, AM HEART J, V152, P197, DOI 10.1016/j.ahj.2006.05.022; Rodriguez LAG, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-17; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hernandez-Diaz S, 2006, BASIC CLIN PHARMACOL, V98, P266, DOI 10.1111/j.1742-7843.2006.pto_302.x; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; *IMS HLTH, 2006, IMS MIDAS MAT Q2 200; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Laine L, 2003, GASTROENTEROLOGY, V124, P288, DOI 10.1053/gast.2003.50054; Langman M, 2001, PHARMACOEPIDEM DR S, V10, P517, DOI 10.1002/pds.653; Leung AT, 2002, CURR MED RES OPIN, V18, P49, DOI 10.1185/030079902125000282; Matsumoto AK, 2004, DRUG TODAY, V40, P395, DOI 10.1358/dot.2004.40.5.850488; Matsumoto AK, 2002, J RHEUMATOL, V29, P1623; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Mukherjee D, 2003, ARTHRITIS RES THER, V5, P8, DOI 10.1186/ar609; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Nobles-James C, 2004, CARDIOVASC DRUG REV, V22, P215; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Okie S, 2005, NEW ENGL J MED, V352, P1283, DOI 10.1056/NEJMp058055; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Ouellet M, 2001, P NATL ACAD SCI USA, V98, P14583, DOI 10.1073/pnas.251543298; Pavelka K, 2003, RHEUMATOLOGY, V42, P1207, DOI 10.1093/rheumatology/keg359; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; REILLY IAG, 1987, BLOOD, V69, P180; Renda G, 2006, CLIN PHARMACOL THER, V80, P264, DOI 10.1016/j.clpt.2006.05.004; Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Sikes DH, 2002, EUR J GASTROEN HEPAT, V14, P1101, DOI 10.1097/00042737-200210000-00011; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; VANHECKEN A, 2000, J CLIN PHARMACOL, V40, P1; 2002, ARTHRITIS RHEUM, V46, P328	53	324	367	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1771	1781		10.1016/S0140-6736(06)69666-9	http://dx.doi.org/10.1016/S0140-6736(06)69666-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108FJ	17113426				2022-12-28	WOS:000242225400030
J	Noonan, JP; Coop, G; Kudaravalli, S; Smith, D; Krause, J; Alessi, J; Platt, D; Paabo, S; Pritchard, JK; Rubin, EM				Noonan, James P.; Coop, Graham; Kudaravalli, Sridhar; Smith, Doug; Krause, Johannes; Alessi, Joe; Platt, Darren; Paabo, Svante; Pritchard, Jonathan K.; Rubin, Edward M.			Sequencing and analysis of Neanderthal genomic DNA	SCIENCE			English	Article							MODERN HUMANS; METAGENOMICS; AGE	Our knowledge of Neanderthals is based on a limited number of remains and artifacts from which we must make inferences about their biology, behavior, and relationship to ourselves. Here, we describe the characterization of these extinct hominids from a new perspective, based on the development of a Neanderthal metagenomic library and its high-throughput sequencing and analysis. Several lines of evidence indicate that the 65,250 base pairs of hominid sequence so far identified in the library are of Neanderthal origin, the strongest being the ascertainment of sequence identities between Neanderthal and chimpanzee at sites where the human genomic sequence is different. These results enabled us to calculate the human-Neanderthal divergence time based on multiple randomly distributed autosomal loci. Our analyses suggest that on average the Neanderthal genomic sequence we obtained and the reference human genome sequence share a most recent common ancestor similar to 706,000 years ago, and that the human and Neanderthal ancestral populations split similar to 370,000 years ago, before the emergence of anatomically modern humans. Our finding that the Neanderthal and human genomes are at least 99.5% identical led us to develop and successfully implement a targeted method for recovering specific ancient DNA sequences from metagenomic libraries. This initial analysis of the Neanderthal genome advances our understanding of the evolutionary relationship of Homo sapiens and Homo neanderthalensis and signifies the dawn of Neanderthal genomics.	US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Chicago; Max Planck Society	Rubin, EM (corresponding author), US Dept Energy Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Krause, Johannes/E-6640-2015; Krause, Johannes/AFP-2642-2022; Noonan, James/ABF-1320-2021	Krause, Johannes/0000-0001-5475-4690; Krause, Johannes/0000-0001-9144-3920; Coop, Graham/0000-0001-8431-0302	NHGRI NIH HHS [R01 HG002772-01, R01 HG002772, R01 HG002772-1] Funding Source: Medline; NHLBI NIH HHS [HL066681] Funding Source: Medline; NIGMS NIH HHS [F32 GM074367, 1-F32-GM074367] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074367] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PATTERSON N, 2006, IN PRESS NATURE 0517; PLAGNOL V, IN PRESS PLOS GENET; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Smith FH, 1999, P NATL ACAD SCI USA, V96, P12281, DOI 10.1073/pnas.96.22.12281; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102	24	399	426	21	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1113	1118		10.1126/science.1131412	http://dx.doi.org/10.1126/science.1131412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110569	Green Accepted, Green Submitted			2022-12-28	WOS:000242045800035
J	Reibold, M; Paufler, P; Levin, AA; Kochmann, W; Patzke, N; Meyer, DC				Reibold, M.; Paufler, P.; Levin, A. A.; Kochmann, W.; Paetzke, N.; Meyer, D. C.			Materials - Carbon nanotubes in an ancient Damascus sabre	NATURE			English	Article							MICROSTRUCTURE; STEEL; CATALYSTS; NANOWIRES		Tech Univ Dresden, Inst Strukturphys, D-01062 Dresden, Germany; Tech Univ Dresden, Triebenberg Lab, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Reibold, M (corresponding author), Tech Univ Dresden, Inst Strukturphys, D-01062 Dresden, Germany.	paufler@physik.tu-dresden.de	Levin, Aleksandr A./AAE-5471-2019	Levin, Aleksandr A./0000-0001-9258-3204				Chernozatonskii LA, 1997, CARBON, V35, P749, DOI 10.1016/S0008-6223(97)00027-4; Golberg D, 2006, ACTA MATER, V54, P2567, DOI 10.1016/j.actamat.2006.01.040; He CN, 2006, MATER CHEM PHYS, V97, P109, DOI 10.1016/j.matchemphys.2005.07.059; Kochmann W, 2004, J ALLOY COMPD, V372, pL15, DOI 10.1016/j.jallcom.2003.10.005; Levin AA, 2005, CRYST RES TECHNOL, V40, P905, DOI 10.1002/crat.200410456; Ni L, 2006, CARBON, V44, P2265, DOI 10.1016/j.carbon.2006.02.031; Reibold M, 2006, INT J MATER RES, V97, P1172, DOI 10.3139/146.101355; SCHWARZ C, 1901, STAHL EISEN, V21, P209; Verhoeven JD, 2004, JOM-US, V56, P17, DOI 10.1007/s11837-004-0193-4; Verhoeven JD, 2002, STEEL RES, V73, P356, DOI 10.1002/srin.200200221; Wadsworth J, 2002, MRS BULL, V27, P980, DOI 10.1557/mrs2002.305; Zschokke B., 1924, REV MET, P635, DOI DOI 10.1051/METAL/192421110635	12	135	145	3	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					286	286		10.1038/444286a	http://dx.doi.org/10.1038/444286a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108950	Bronze			2022-12-28	WOS:000242018300030
J	Rigby, N; Baillie, K				Rigby, Neville; Baillie, Kate			Challenging the future: the Global Prevention Alliance	LANCET			English	Editorial Material									Int Assoc Study Obes, Int Obes Taskforce, London NW1 2NR, England		Rigby, N (corresponding author), Int Assoc Study Obes, Int Obes Taskforce, London NW1 2NR, England.	nrigby@iaso.org						Hastings G., 2003, REV RES EFFECTS FOOD; *MCGILL HLTH CHALL, 2006, ACC PREV CHILDH OB W; *UN U, 2000, FOOD NUTR B S, V21, P1; *WHO, 2006, NCD GLOB INF; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization/Europe, 2006, WHO EUR MIN C COUNT	7	8	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1629	1631		10.1016/S0140-6736(06)69674-8	http://dx.doi.org/10.1016/S0140-6736(06)69674-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098064				2022-12-28	WOS:000242099000007
J	Valiyaveetil, FI; Leonetti, M; Muir, TW; MacKinnon, R				Valiyaveetil, Francis I.; Leonetti, Manuel; Muir, Tom W.; MacKinnon, Roderick			Ion selectivity in a semisynthetic K+ channel locked in the conductive conformation	SCIENCE			English	Article							POTASSIUM CHANNEL; FILTER	Potassium channels are K+-selective protein pores in cell membrane. The selectivity filter is the functional unit that allows K+ channels to distinguish potassium (K+) and sodium (Na+) ions. The filter's structure depends on whether K+ or Na+ ions are bound inside it. We synthesized a K+ channel containing the D-enantiomer of alanine in place of a conserved glycine and found by x-ray crystallography that its filter maintains the K+ (conductive) structure in the presence of Na+ and very low concentrations of K+. This channel conducts Na+ in the absence of K+ but not in the presence of K+. These findings demonstrate that the ability of the channel to adapt its structure differently to K+ and Na+ is a fundamental aspect of ion selectivity, as is the ability of multiple K+ ions to compete effectively with Na+ for the conductive filter.	Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Ecole Normale Super, Dept Biol, F-75005 Paris, France	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Muir, TW (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu; mackinn@rockefeller.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344; Leonetti, Manuel/0000-0002-4881-405X	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055843, R01GM055843, R01GM043949] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB001991] Funding Source: Medline; NIGMS NIH HHS [GM55843, GM43949] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Hille B., 2001, IONIC CHANNELS EXCIT, P814; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Rivas JCM, 2001, P NATL ACAD SCI USA, V98, P9478, DOI 10.1073/pnas.161257798; Valiyaveetil FI, 2004, P NATL ACAD SCI USA, V101, P17045, DOI 10.1073/pnas.0407820101; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	9	108	110	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					1004	1007		10.1126/science.1133415	http://dx.doi.org/10.1126/science.1133415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095703				2022-12-28	WOS:000241896000057
J	MacLaren, RE; Pearson, RA; MacNeil, A; Douglas, RH; Salt, TE; Akimoto, M; Swaroop, A; Sowden, JC; Ali, RR				MacLaren, R. E.; Pearson, R. A.; MacNeil, A.; Douglas, R. H.; Salt, T. E.; Akimoto, M.; Swaroop, A.; Sowden, J. C.; Ali, R. R.			Retinal repair by transplantation of photoreceptor precursors	NATURE			English	Article							RDS MUTANT MICE; PROGENITOR CELLS; RETINITIS-PIGMENTOSA; MAMMALIAN RETINA; RHODOPSIN GENE; MOUSE RETINA; IN-VIVO; DIFFERENTIATION; DEGENERATION; RODS	Photoreceptor loss causes irreversible blindness in many retinal diseases. Repair of such damage by cell transplantation is one of the most feasible types of central nervous system repair; photoreceptor degeneration initially leaves the inner retinal circuitry intact and new photoreceptors need only make single, short synaptic connections to contribute to the retinotopic map. So far, brain- and retina-derived stem cells transplanted into adult retina have shown little evidence of being able to integrate into the outer nuclear layer and differentiate into new photoreceptors(1-4). Furthermore, there has been no demonstration that transplanted cells form functional synaptic connections with other neurons in the recipient retina or restore visual function. This might be because the mature mammalian retina lacks the ability to accept and incorporate stem cells or to promote photoreceptor differentiation. We hypothesized that committed progenitor or precursor cells at later ontogenetic stages might have a higher probability of success upon transplantation. Here we show that donor cells can integrate into the adult or degenerating retina if they are taken from the developing retina at a time coincident with the peak of rod genesis(5). These transplanted cells integrate, differentiate into rod photoreceptors, form synaptic connections and improve visual function. Furthermore, we use genetically tagged postmitotic rod precursors expressing the transcription factor Nrl (ref. 6) ( neural retina leucine zipper) to show that successfully integrated rod photoreceptors are derived only from immature post-mitotic rod precursors and not from proliferating progenitor or stem cells. These findings define the ontogenetic stage of donor cells for successful rod photoreceptor transplantation.	UCL, Dev Biol Unit, Inst Child Hlth, London WC1N 1EH, England; UCL, Inst Ophthalmol, Div Mol Therapy, London EC1V 9EL, England; Moorfields Eye Hosp, Vitreretinal Serv, London EC1V 2PD, England; City Univ London, Henry Wellcome Lab Vis Sci, Dept Optometry & Visual Sci, London EC1V 0HB, England; Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; UCL, Mol Immunol Unit, Inst Child Hlth, London WC1N 1EH, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; City University London; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; University College London	Swaroop, A (corresponding author), UCL, Dev Biol Unit, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	swaroop@umich.edu; r.ali@ucl.ac.uk	Akimoto, Masayuki/AAP-3676-2020; Salt, Thomas E/A-6405-2009; Pearson, Rachael/Y-3339-2018	Pearson, Rachael/0000-0002-1107-1969; Swaroop, Anand/0000-0002-1975-1141; Ali, Robin/0000-0003-3126-6517; Sowden, Jane/0000-0003-0937-2479; MacLaren, Robert/0000-0002-3096-4682; Akimoto, Masayuki/0000-0002-5899-2925	MRC [G0300341] Funding Source: UKRI; Medical Research Council [G0300341, G0601588] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Chacko DM, 2000, BIOCHEM BIOPH RES CO, V268, P842, DOI 10.1006/bbrc.2000.2153; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Kashofer K, 2005, GENE THER, V12, P1229, DOI 10.1038/sj.gt.3302571; Koulen P, 2002, INVEST OPHTH VIS SCI, V43, P1933; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Sakaguchi DS, 2004, DEV NEUROSCI-BASEL, V26, P336, DOI 10.1159/000082275; SANYAL S, 1988, CURR EYE RES, V7, P1183, DOI 10.3109/02713688809033222; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Van Hoffelen SJ, 2003, INVEST OPHTH VIS SCI, V44, P426, DOI 10.1167/iovs.02-0269; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; Yang P, 2002, J NEUROSCI RES, V69, P466, DOI 10.1002/jnr.10320; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	29	799	846	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					203	207		10.1038/nature05161	http://dx.doi.org/10.1038/nature05161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093405	Green Published			2022-12-28	WOS:000241867200040
J	Van Rie, A; Enarson, D				Van Rie, Annelies; Enarson, Donald			XDR tuberculosis: an indicator of public-health negligence	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS		Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Int Union TB & Lung Dis, Paris, France	University of North Carolina; University of North Carolina Chapel Hill	Van Rie, A (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	vanrie@email.unc.edu	Van Rie, Annelies/C-2082-2017	Van Rie, Annelies/0000-0001-7666-3263				Benatar SR, 2001, AM J RESP CRIT CARE, V163, P1064, DOI 10.1164/ajrccm.163.5.16354; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P5; GANDHI NR, 2006, LANCET          1026; Grimaldo ER, 2001, INT J TUBERC LUNG D, V5, P546; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; PERASON ML, 1992, ANN INTERN MED, V117, P191; *SA HEALTHINFO, 2006, REP EXP CONS DRUG RE; *WHO, 1989, B INT UNION TUBERC L, V64, P8; World Health Organization, 2006, WHOHTMTB2006362; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; 2006, MMWR MORB MORTAL WKL, V55, P301	13	52	56	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1554	1556		10.1016/S0140-6736(06)69575-5	http://dx.doi.org/10.1016/S0140-6736(06)69575-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107OM	17084741				2022-12-28	WOS:000242180900007
J	Fisher, DO; Double, MC; Blomberg, SP; Jennions, MD; Cockburn, A				Fisher, Diana O.; Double, Michael C.; Blomberg, Simon P.; Jennions, Michael D.; Cockburn, Andrew			Post-mating sexual selection increases lifetime fitness of polyandrous females in the wild	NATURE			English	Article							SPERM SELECTION; GOOD GENES; PATERNITY; SUCCESS; EVOLUTION; BENEFITS; POPULATION; CRICKET; MATES; SIZE	Females often mate with several males before producing offspring(1). Field studies of vertebrates suggest, and laboratory experiments on invertebrates confirm, that even when males provide no material benefits, polyandry can enhance offspring survival(2,3). This enhancement is widely attributed to genetic benefits that arise whenever paternity is biased towards males that sire more viable offspring(1,4,5). Field studies suggest that post-mating sexual selection biases fertilization towards genetically more compatible males(6,7) and one controlled experiment has shown that, when females mate with close kin, polyandry reduces the relative number of inbred offspring(8). Another potential genetic benefit of polyandry is that it increases offspring survival because males with more competitive ejaculates sire more viable offspring(9). Surprisingly, however, there is no unequivocal evidence for this process(10). Here, by experimentally assigning mates to females, we show that polyandry greatly increases offspring survival in the Australian marsupial Antechinus stuartii. DNA profiling shows that males that gain high paternity under sperm competition sire offspring that are more viable. This beneficial effect occurs in both the laboratory and the wild. Crucially, there are no confounding non-genetic maternal effects that could arise if polyandry increases female investment in a particular reproductive event(10) because A. stuartii is effectively semelparous. Our results therefore show that polyandry improves female lifetime fitness in nature. The threefold increase in offspring survival is not negated by a decline in maternal lifespan and is too large to be offset by an equivalent decline in the reproductive performance of surviving offspring.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia	Australian National University; Australian National University	Fisher, DO (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	diana.fisher@anu.edu.au	Jennions, Michael D/C-7560-2009; Fisher, Diana O/C-1324-2010; Blomberg, Simone P/B-7613-2008	Jennions, Michael D/0000-0001-9221-2788; Fisher, Diana O/0000-0002-4017-3710; Blomberg, Simone P/0000-0003-1062-0839				BATES D, 2006, MATRIX MATRIX PACKAG; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2005, EVOLUTION, V59, P106; Fisher DO, 2006, ANIM BEHAV, V71, P289, DOI 10.1016/j.anbehav.2005.03.041; Fisher DO, 2006, BEHAV ECOL, V17, P164, DOI 10.1093/beheco/arj012; Fisher DO, 2005, AUST J ZOOL, V53, P103, DOI 10.1071/ZO04068; *GENST COMM, 2005, GENST MAN VERS 8; Holleley CE, 2006, MOL ECOL, V15, P3439, DOI 10.1111/j.1365-294X.2006.03001.x; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kozielska M, 2004, P ROY SOC B-BIOL SCI, V271, P165, DOI 10.1098/rspb.2003.2585; Kraaijeveld-Smit FJL, 2003, MOL ECOL, V12, P475, DOI 10.1046/j.1365-294X.2003.01745.x; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; R Core Development Team, 2006, R LANG ENV STAT COMP; SELWOOD L, 1980, AUST J ZOOL, V28, P649; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Thuman KA, 2005, ANIM BEHAV, V69, P765, DOI 10.1016/j.anbehav.2004.10.003; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 2003, EVOLUTION, V57, P297, DOI 10.1111/j.0014-3820.2003.tb00264.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Weigensberg I, 1998, J EVOLUTION BIOL, V11, P135, DOI 10.1007/s000360050071; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	30	153	154	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					89	92		10.1038/nature05206	http://dx.doi.org/10.1038/nature05206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080089				2022-12-28	WOS:000241701500051
J	O'Brien, KL; Levine, OS				O'Brien, Katherine L.; Levine, Orin S.			Effectiveness of pneumococcal conjugate vaccine	LANCET			English	Editorial Material							STREPTOCOCCUS-PNEUMONIAE; INVASIVE DISEASE; EFFICACY; SURVEILLANCE; CHILDREN; SAFETY; IMPACT		Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, GAVIs PneumoADIP, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	O'Brien, KL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA.	klobrien@jhsph.edu		O'Brien, Katherine/0000-0002-0164-4030				Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Hsu K, 2005, PEDIATR INFECT DIS J, V24, P17, DOI 10.1097/01.inf.0000148891.32134.36; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kellner JD, 2005, CAN MED ASSOC J, V173, P1149, DOI 10.1503/cmaj.051150; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Mahon BE, 2006, VACCINE, V24, P2514, DOI 10.1016/j.vaccine.2005.12.025; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	15	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1469	1470		10.1016/S0140-6736(06)69614-1	http://dx.doi.org/10.1016/S0140-6736(06)69614-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071264				2022-12-28	WOS:000241582700004
J	Ronsmans, C; Holtz, S; Stanton, C				Ronsmans, Carine; Holtz, Sara; Stanton, Cynthia			Socioeconomic differentials in caesarean rates in developing countries: a retrospective analysis	LANCET			English	Article							LATIN-AMERICA; SECTIONS	Background Little is known about socioeconomic differences in access to life-saving obstetric surgery, yet access to a Caesarean for women is essential to achieve low levels of maternal mortality. We examined population-based Caesarean rates by socioeconomic groups in various developing countries. Methods We used data from 42 Demographic and Health Surveys in sub-Saharan Africa, south and southeast Asia, and Latin America and the Caribbean. We report Caesarean rates by wealth quintile and the absolute and relative difference between the richest and poorest quintiles. We also categorise the sample into richer and poorer halves and examine Caesarean rates within rural areas. Findings Caesarean rates were extremely low among the very poor: they were below 1% for the poorest 20% of the population in 20 countries and were below 1% for 80% of the population in six countries. Only in five countries did the very poor have Caesarean rates exceeding 5%. At the other extreme are seven countries, mostly in Latin America, where caesareans are far in excess of the suggested maximum threshold of 15% for at least 40% of the population. Interpretation In the poorest countries-mostly in sub-Saharan Africa-large segments of the population have almost no access to potentially life-saving caesareans, whereas in some mid-income countries more than half the population has rates in excess of medical need. These data deserve the immediate attention of policymakers at national and international levels.	Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ronsmans, C (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	carine.ronsmans@lshtm.ac.uk						Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Buekens P, 2003, BRIT MED J, V326, P136, DOI 10.1136/bmj.326.7381.136; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; DEBROUWERE V, 1998, BESOINS OBSTET NONCO; DUBOURG D, UON NETWORK TACKLING; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Fauveau V, 2006, INT J GYNECOL OBSTET, V93, P308, DOI 10.1016/j.ijgo.2006.01.031; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Graham WJ, 2004, LANCET, V363, P23, DOI 10.1016/S0140-6736(03)15165-3; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Kunst A. E., 2001, STUDIES HLTH SERV OR, V17, P297; LOMAS J, 1989, EFFECTIVE CARE PREGN; *MIN HLTH CHIN, 2004, AN NAT SURV OBST PRA; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; *POP REF BUR, 2005, WORLD POP DAT SHEET; Ronsmans C, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07992-8; Ronsmans C, 2001, TROP MED INT HEALTH, V6, P799, DOI 10.1046/j.1365-3156.2001.00780.x; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Stewart Frances, 1997, OXF DEV STUD, V25, P11, DOI DOI 10.1080/13600819708424120; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; *UNICEF WHO UNFPA, 1997, GUID MON AV US OBST; United Nations, 2004, WORLD POP PROSP 2004; WHO, 2004, MAT MORT 2000 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005	30	203	212	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1516	1523		10.1016/S0140-6736(06)69639-6	http://dx.doi.org/10.1016/S0140-6736(06)69639-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071285				2022-12-28	WOS:000241582700029
J	Mao, WL; Mao, HK; Meng, Y; Eng, PJ; Hu, MY; Chow, P; Cai, YQ; Shu, JF; Hemley, RJ				Mao, Wendy L.; Mao, Ho-kwang; Meng, Yue; Eng, Peter J.; Hu, Michael Y.; Chow, Paul; Cai, Yong Q.; Shu, Jinfu; Hemley, Russell J.			X-ray-induced dissociation of H2O and formation of an O-2-H-2 alloy at high pressure	SCIENCE			English	Article							RAMAN-SPECTROSCOPY; BONDING CHANGES; AMORPHOUS ICE; SOLID OXYGEN; HYDROGEN; PHASE; TRANSITION; COMPRESSION; MIXTURES; WATER	When subjected to high pressure and extensive x-radiation, water (H2O) molecules cleaved, forming O - O and H - H bonds. The oxygen (O) and hydrogen (H) framework in ice VII was converted into a molecular alloy of O-2 and H-2. X-ray diffraction, x-ray Raman scattering, and optical Raman spectroscopy demonstrated that this crystalline solid differs from previously known phases. It remained stable with respect to variations in pressure, temperature, and further x-ray and laser exposure, thus opening new possibilities for studying molecular interactions in the hydrogen-oxygen binary system.	Los Alamos Natl Lab, Los Alamos Neutron Sci Ctr, Los Alamos, NM 87545 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; Argonne Natl Lab, Adv Photon Source, Carnegie Inst Washington, High Pressure Coolaborat Access Team, Argonne, IL 60439 USA; Univ Chicago, Consortium Adv Radiat Sci, Chicago, IL 60637 USA; Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan	United States Department of Energy (DOE); Los Alamos National Laboratory; Carnegie Institution for Science; Carnegie Institution for Science; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; National Synchrotron Radiation Research Center	Mao, WL (corresponding author), Los Alamos Natl Lab, Los Alamos Neutron Sci Ctr, POB 1663, Los Alamos, NM 87545 USA.		Hu, Michael Y./C-7571-2013; Mao, Wendy/D-1885-2009; Eng, Peter/ABA-8842-2021; Cai, Yong/C-5036-2008	Hu, Michael Y./0000-0002-3718-7169; Eng, Peter/0000-0002-8072-3203; Cai, Yong/0000-0002-9957-6426				AKAHAMA Y, 1995, PHYS REV LETT, V74, P4690, DOI 10.1103/PhysRevLett.74.4690; Akahama Y, 1996, PHYS REV B, V54, P15602, DOI 10.1103/PhysRevB.54.R15602; Bernasconi M, 1998, PHYS REV LETT, V81, P1235, DOI 10.1103/PhysRevLett.81.1235; BROWN DM, 1992, PHYS REV A, V45, P6429, DOI 10.1103/PhysRevA.45.6429; Cai YQ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.025502; Cavazzoni C, 1999, SCIENCE, V283, P44, DOI 10.1126/science.283.5398.44; Chou IM, 1998, SCIENCE, V281, P809, DOI 10.1126/science.281.5378.809; Cynn H, 1999, J CHEM PHYS, V110, P6836, DOI 10.1063/1.478588; FEI YW, 1993, J CHEM PHYS, V99, P5369, DOI 10.1063/1.465980; Finney JL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.225503; Freiman YA, 2004, PHYS REP, V401, P1, DOI 10.1016/j.physrep.2004.06.002; Fujihisa H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.085503; Goncharov AF, 1996, SCIENCE, V273, P218, DOI 10.1126/science.273.5272.218; Goncharov AF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.125508; Goncharov AF, 1999, PHYS REV LETT, V83, P1998, DOI 10.1103/PhysRevLett.83.1998; HEMLEY RJ, 1989, NATURE, V338, P638, DOI 10.1038/338638a0; Lee SK, 2005, NAT MATER, V4, P851, DOI 10.1038/nmat1511; Lin JF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022499; Liu L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117802; Lobban C, 1998, NATURE, V391, P268, DOI 10.1038/34622; LOUBEYRE P, 1991, PHYS REV LETT, V67, P3271, DOI 10.1103/PhysRevLett.67.3271; LOUBEYRE P, 1995, NATURE, V378, P44, DOI 10.1038/378044a0; Mao WL, 2003, SCIENCE, V302, P425, DOI 10.1126/science.1089713; Meng Y, 2004, NAT MATER, V3, P111, DOI 10.1038/nmat1060; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Petrenko VF, 1999, PHYS ICE; SHARMA SK, 1980, PHYS REV LETT, V44, P886, DOI 10.1103/PhysRevLett.44.886; Tse JS, 1998, PHYS REV LETT, V81, P2466, DOI 10.1103/PhysRevLett.81.2466; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178; Weck G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevB.88.035504	31	66	71	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					636	638		10.1126/science.1132884	http://dx.doi.org/10.1126/science.1132884			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068259				2022-12-28	WOS:000241557800043
J	Borzi, RA; Grigera, SA; Farrell, J; Perry, RS; Lister, SJS; Lee, SL; Tennant, DA; Maeno, Y; Mackenzie, AP				Borzi, R. A.; Grigera, S. A.; Farrell, J.; Perry, R. S.; Lister, S. J. S.; Lee, S. L.; Tennant, D. A.; Maeno, Y.; Mackenzie, A. P.			Formation of a nematic fluid at high fields in Sr3Ru2O7	SCIENCE			English	Article							QUALITY SINGLE-CRYSTALS; SUPERCONDUCTIVITY; METAMAGNETISM; TRANSPORT; DISORDER; PHASES	In principle, a complex assembly of strongly interacting electrons can self-organize into a wide variety of collective states, but relatively few such states have been identified in practice. We report that, in the close vicinity of a metamagnetic quantum critical point, high-purity strontium ruthenate Sr3Ru2O7 possesses a large magnetoresistive anisotropy, consistent with the existence of an electronic nematic fluid. We discuss a striking phenomenological similarity between our observations and those made in high-purity two-dimensional electron fluids in gallium arsenide devices.	Univ St Andrews, Scottish Univ Phys Alliance, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Natl Univ La Plata, Inst Invest Fis Quim Teor & Aplicadas, CONICET, RA-1900 La Plata, Argentina; Natl Univ La Plata, Dept Fis, Inst Fis La Plata, RA-1900 La Plata, Argentina; UNLP CONICET Comis Invest Cient, Inst Fis Liquidos & Sistemas Biol, RA-1900 La Plata, Argentina; Hahn Meitner Inst Berlin GmbH, D-14109 Berlin, Germany; Kyoto Univ, Dept Phys, Kyoto 6068501, Japan; Kyoto Univ, Int Innovat Ctr, Kyoto 6068501, Japan	University of St Andrews; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; National University of La Plata; Comision de Investigaciones Cientificas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Kyoto University; Kyoto University	Borzi, RA (corresponding author), Univ St Andrews, Scottish Univ Phys Alliance, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	r.chufo@gmail.com; apm9@st-and.ac.uk	Lee, Stephen/G-9791-2016; Mackenzie, Andrew P/K-6742-2015; grigera, santiago a/A-4932-2010; Tennant, David A/Q-2497-2015	Lee, Stephen/0000-0002-2020-3310; Mackenzie, Andrew P/0000-0001-8000-4949; Tennant, David A/0000-0002-9575-3368; Grigera, Santiago/0000-0002-1343-5885	Engineering and Physical Sciences Research Council [EP/C511778/1, EP/C523229/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ando Y, 1999, PHYS REV LETT, V83, P2813, DOI 10.1103/PhysRevLett.83.2813; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Binz B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.196406; Borzi RA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216403; Cooper KB, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.241313; Fradkin E, 2000, PHYS REV LETT, V84, P1982, DOI 10.1103/PhysRevLett.84.1982; Fradkin E, 1999, PHYS REV B, V59, P8065, DOI 10.1103/PhysRevB.59.8065; Gegenwart P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136402; Green AG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.086402; Grigera SA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.214427; Grigera SA, 2004, SCIENCE, V306, P1154, DOI 10.1126/science.1104306; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; Halboth CJ, 2000, PHYS REV LETT, V85, P5162, DOI 10.1103/PhysRevLett.85.5162; Honerkamp C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115103; Kee HY, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.184402; Khavkine I, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155110; Kitagawa K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.127001; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; Lilly MP, 1999, PHYS REV LETT, V83, P824, DOI 10.1103/PhysRevLett.83.824; Mackenzie AP, 1998, PHYS REV LETT, V80, P161, DOI 10.1103/PhysRevLett.80.161; Noda T, 1999, SCIENCE, V286, P265, DOI 10.1126/science.286.5438.265; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; Pan W, 1999, PHYS REV LETT, V83, P820, DOI 10.1103/PhysRevLett.83.820; Perry RS, 2005, J PHYS SOC JPN, V74, P1270, DOI 10.1143/JPSJ.74.1270; Perry RS, 2004, J CRYST GROWTH, V271, P134, DOI 10.1016/j.jcrysgro.2004.07.082; Perry RS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166602; Perry RS, 2001, PHYS REV LETT, V86, P2661, DOI 10.1103/PhysRevLett.86.2661; Radzihovsky L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.216802; Ronning F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.067005; Wexler C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.115312; Yamase H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035114	33	368	368	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					214	217		10.1126/science.1134796	http://dx.doi.org/10.1126/science.1134796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17124288	Green Submitted, Green Published			2022-12-28	WOS:000243407400039
J	Bloom, SL; Spong, CY; Thom, E; Varner, MW; Rouse, DJ; Weininger, S; Ramin, SM; Caritis, SN; Peaceman, A; Sorokin, Y; Sciscione, A; Carpenter, M; Mercer, B; Thorp, J; Malone, F; Harper, M; Iams, J; Anderson, G				Bloom, Steven L.; Spong, Catherine Y.; Thom, Elizabeth; Varner, Michael W.; Rouse, Dwight J.; Weininger, Sandy; Ramin, Susan M.; Caritis, Steve N.; Peaceman, Alan; Sorokin, Yoram; Sciscione, Anthony; Carpenter, Marshall; Mercer, Brian; Thorp, John; Malone, Fergal; Harper, Margaret; Iams, Jay; Anderson, Garland		Natl Inst Child Hlth Human Dev Mat	Fetal pulse oximetry and cesarean delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	26th Annual Meeting of the Society-for-Maternal-Fetal-Medicine	JAN 30-FEB 04, 2006	Miami Beach, FL	Soc Maternal Fetal Med				Background: Knowledge of fetal oxygen saturation, as an adjunct to electronic fetal monitoring, may be associated with a significant change in the rate of cesarean deliveries or the infant's condition at birth. Methods: We randomly assigned 5341 nulliparous women who were at term and in early labor to either "open" or "masked" fetal pulse oximetry. In the open group, fetal oxygen saturation values were displayed to the clinician. In the masked group, the fetal oxygen sensor was inserted and the values were recorded by computer, but the data were hidden. Labor complicated by a nonreassuring fetal heart rate before randomization was documented for subsequent analysis. Results: There was no significant difference in the overall rates of cesarean delivery between the open and masked groups (26.3% and 27.5%, respectively; P=0.31). The rates of cesarean delivery associated with the separate indications of a nonreassuring fetal heart rate (7.1% and 7.9%, respectively; P=0.30) and dystocia (18.6% and 19.2%, respectively; P=0.59) were similar between the two groups. Similar findings were observed in the subgroup of 2168 women in whom a nonreassuring fetal heart rate was detected before randomization. The condition of the infants at birth did not differ significantly between the two groups. Conclusions: Knowledge of the fetal oxygen saturation is not associated with a reduction in the rate of cesarean delivery or with improvement in the condition of the newborn. (ClinicalTrials.gov number, NCT00098709.).	Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Dallas, TX 75390 USA; NICHHD, Bethesda, MD 20892 USA; George Washington Univ, Ctr Biostat, Washington, DC USA; Univ Utah, Salt Lake City, UT USA; Univ Alabama Birmingham, Birmingham, AL USA; US FDA, Rockville, MD 20857 USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA; Univ Pittsburgh, Pittsburgh, PA USA; Northwestern Univ, Chicago, IL 60611 USA; Wayne State Univ, Detroit, MI USA; Drexel Univ, Philadelphia, PA 19104 USA; Brown Univ, Providence, RI 02912 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ N Carolina, Chapel Hill, NC USA; Columbia Univ, New York, NY USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Texas, Med Branch, Galveston, TX 77550 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Washington University; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; US Food & Drug Administration (FDA); University of Texas System; University of Texas Health Science Center Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Wayne State University; Drexel University; Brown University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; Wake Forest University; University System of Ohio; Ohio State University; University of Texas System; University of Texas Medical Branch Galveston	Bloom, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.bloom@utsouthwestern.edu	Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973; caritis, steve/0000-0002-2169-0712; Peaceman, Alan/0000-0002-4515-4850	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD034116, U10HD021410, U10HD040545, U10HD040560, U10HD027917, U10HD027915, U10HD040544, U10HD034208, U10HD040512, U10HD040485, U10HD036801, U10HD027869, U10HD040500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027860, U01HD036801, U01HD021410, U10HD034136] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40545, HD40560, HD21410, HD27860, HD27869, HD27915, HD27917, HD34116, HD34136, HD34208, HD36801, HD40485, HD40500, HD40512, HD40544] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AM COLL OBST GYN, 2005, ACOG PRACT B, V70; American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2001, Obstet Gynecol, V98, P523; Bloom SL, 1999, OBSTET GYNECOL, V93, P1036, DOI 10.1016/S0029-7844(98)00565-1; CUNNINGHAM FG, 2005, WILLIAMS OBSTET, P431; Garite TJ, 2000, AM J OBSTET GYNECOL, V183, P1049, DOI 10.1067/mob.2000.110632; Hamilton B.E., 2005, NATL VITAL STAT REPO, V54; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MARTIN JA, 2005, NATL VITAL STAT REPO, V54; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; Parer JT, 2000, AM J OBSTET GYNECOL, V182, P982, DOI 10.1016/S0002-9378(00)70358-9; Parer JT, 2003, OBSTET GYNECOL SURV, V58, P561, DOI 10.1097/01.OGX.0000083540.83751.85; Porreco RP, 2004, AM J OBSTET GYNECOL, V190, P113, DOI 10.1016/S0002-9378(03)00855-X; Yam J, 2000, OBSTET GYNECOL SURV, V55, P163, DOI 10.1097/00006254-200003000-00025; 2003, M OBST GYN DEV ADV P	14	79	85	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2195	2202		10.1056/NEJMoa061170	http://dx.doi.org/10.1056/NEJMoa061170			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	107KQ	17124017				2022-12-28	WOS:000242170900006
J	Redon, R; Ishikawa, S; Fitch, KR; Feuk, L; Perry, GH; Andrews, TD; Fiegler, H; Shapero, MH; Carson, AR; Chen, WW; Cho, EK; Dallaire, S; Freeman, JL; Gonzalez, JR; Gratacos, M; Huang, J; Kalaitzopoulos, D; Komura, D; MacDonald, JR; Marshall, CR; Mei, R; Montgomery, L; Nishimura, K; Okamura, K; Shen, F; Somerville, MJ; Tchinda, J; Valsesia, A; Woodwark, C; Yang, FT; Zhang, JJ; Zerjal, T; Zhang, J; Armengol, L; Conrad, DF; Estivill, X; Tyler-Smith, C; Carter, NP; Aburatani, H; Lee, C; Jones, KW; Scherer, SW; Hurles, ME				Redon, Richard; Ishikawa, Shumpei; Fitch, Karen R.; Feuk, Lars; Perry, George H.; Andrews, T. Daniel; Fiegler, Heike; Shapero, Michael H.; Carson, Andrew R.; Chen, Wenwei; Cho, Eun Kyung; Dallaire, Stephanie; Freeman, Jennifer L.; Gonzalez, Juan R.; Gratacos, Monica; Huang, Jing; Kalaitzopoulos, Dimitrios; Komura, Daisuke; MacDonald, Jeffrey R.; Marshall, Christian R.; Mei, Rui; Montgomery, Lyndal; Nishimura, Kunihiro; Okamura, Kohji; Shen, Fan; Somerville, Martin J.; Tchinda, Joelle; Valsesia, Armand; Woodwark, Cara; Yang, Fengtang; Zhang, Junjun; Zerjal, Tatiana; Zhang, Jane; Armengol, Lluis; Conrad, Donald F.; Estivill, Xavier; Tyler-Smith, Chris; Carter, Nigel P.; Aburatani, Hiroyuki; Lee, Charles; Jones, Keith W.; Scherer, Stephen W.; Hurles, Matthew E.			Global variation in copy number in the human genome	NATURE			English	Article							SEGMENTAL DUPLICATIONS; LINKAGE DISEQUILIBRIUM; DELETION POLYMORPHISM; STRUCTURAL VARIATION; GENETIC-STRUCTURE; WIDE DETECTION; DNA; SELECTION; DISEASE; REARRANGEMENTS	Copy number variation (CNV) of DNA sequences is functionally significant but has yet to be fully ascertained. We have constructed a first-generation CNV map of the human genome through the study of 270 individuals from four populations with ancestry in Europe, Africa or Asia (the HapMap collection). DNA from these individuals was screened for CNV using two complementary technologies: single-nucleotide polymorphism (SNP) genotyping arrays, and clone-based comparative genomic hybridization. A total of 1,447 copy number variable regions (CNVRs), which can encompass overlapping or adjacent gains or losses, covering 360 megabases (12% of the genome) were identified in these populations. These CNVRs contained hundreds of genes, disease loci, functional elements and segmental duplications. Notably, the CNVRs encompassed more nucleotide content per genome than SNPs, underscoring the importance of CNV in genetic diversity and evolution. The data obtained delineate linkage disequilibrium patterns for many CNVs, and reveal marked variation in copy number among populations. We also demonstrate the utility of this resource for genetic disease studies.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Affymetrix Inc, Santa Clara, CA 95051 USA; Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Fac Med, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Catalonia, Spain; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Pompeu Fabra Univ, Barcelona 08003, Catalonia, Spain; Natl Genotyping Ctr, Barcelona 08003, Catalonia, Spain; Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Harvard Univ, Sch Med, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; University of Tokyo; Affymetrix; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Alberta; University of Alberta; University of Chicago; Pompeu Fabra University; Japan Science & Technology Agency (JST); Harvard University; Harvard Medical School	Scherer, SW (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	steve@genet.sickkids.on.ca; meh@sanger.ac.uk	Freeman, Jennifer/L-3838-2019; Valsesia, Armand/F-1724-2010; Estivill, Xavier/E-2957-2012; Yang, Fan/GYU-4249-2022; MacDonald, Jeffrey Robert/GLU-2255-2022; Andrews, Dan/ABG-4815-2020; Estivill, Xavier/A-3125-2013; zerjal, tatiana/AAO-9473-2020; Komura, Daisuke/A-1612-2011; Gonzalez, Juan R/B-7860-2018; Komura, Daisuke/AAF-2481-2019; Scherer, Stephen W./B-3785-2013; Redon, Richard/F-3303-2014	Estivill, Xavier/0000-0002-0723-2256; Komura, Daisuke/0000-0002-0038-728X; Gonzalez, Juan R/0000-0003-3267-2146; Komura, Daisuke/0000-0002-0038-728X; Scherer, Stephen W./0000-0002-8326-1999; Redon, Richard/0000-0001-7751-2280; Andrews, Dan/0000-0003-3922-6376; Yang, Fengtang/0000-0002-3573-2354; MacDonald, Jeffrey/0000-0001-5058-2393; Freeman, Jennifer/0000-0002-3669-9111; Valsesia, Armand/0000-0003-0746-9664	Wellcome Trust [077009, 077008, 077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aradhya S, 2001, HUM MOL GENET, V10, P2557, DOI 10.1093/hmg/10.22.2557; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Hurles Matthew, 2005, Human Genomics, V2, P179; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 2006, GENOMIC DISORDERS G; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; MATISE TC, 1994, AM J HUM GENET, V54, P1110; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; NEITZ M, 1995, SCIENCE, V267, P1013, DOI 10.1126/science.7863325; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Orru S, 2005, AM J HUM GENET, V76, P164, DOI 10.1086/426948; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pritchard JK, 2000, GENETICS, V155, P945; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sasaki K, 2004, OPHTHALMIC RES, V36, P332, DOI 10.1159/000081636; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SOKAL RR, 1994, BIOMETRY; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Turgeon D, 2003, DRUG METAB DISPOS, V31, P670, DOI 10.1124/dmd.31.5.670; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Wirtenberger M, 2005, HUM GENET, V117, P389, DOI 10.1007/s00439-005-1323-y; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	77	3058	3301	5	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					444	454		10.1038/nature05329	http://dx.doi.org/10.1038/nature05329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122850	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000242215700038
J	Pearse, JS				Pearse, John S.			Perspective - Ecological role of purple sea urchins	SCIENCE			English	Editorial Material							CALIFORNIA KELP FOREST; STRONGYLOCENTROTUS-FRANCISCANUS; COMMUNITY; RECRUITMENT; GENERALITY; PATTERNS; PACIFIC; LIVE; RED		Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95060 USA	University of California System; University of California Santa Cruz	Pearse, JS (corresponding author), Univ Calif Santa Cruz, Long Marine Lab, 100 Shaffer Rd, Santa Cruz, CA 95060 USA.	pearse@biology.ucsc.edu						Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; EBERT TA, 1994, MAR ECOL PROG SER, V111, P41, DOI 10.3354/meps111041; Ebert TA, 2003, FISH B-NOAA, V101, P915; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Harrold C., 1987, Echinoderm Studies, V2, P137; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; PEARSE JS, 1987, MAR ECOL PROG SER, V39, P275, DOI 10.3354/meps039275; Rogers-Bennett L, 2001, CONSERV BIOL, V15, P642, DOI 10.1046/j.1523-1739.2001.015003642.x; Rogers-Bennett L, 2007, DEV AQUAC FISH SCI, V37, P393, DOI 10.1016/S0167-9309(07)80083-4; Sweetnam D, 2005, CAL COOP OCEAN FISH, V46, P10; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; WATANABE JM, 1991, MAR ECOL PROG SER, V71, P125, DOI 10.3354/meps071125	17	108	113	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					940	941		10.1126/science.1131888	http://dx.doi.org/10.1126/science.1131888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095690				2022-12-28	WOS:000241896000038
J	Roberson, ED; Mucke, L				Roberson, Erik D.; Mucke, Lennart			100 years and counting: Prospects for defeating Alzheimer's disease	SCIENCE			English	Review							GAMMA-SECRETASE INHIBITOR; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; APP TRANSGENIC MICE; FACTOR GENE-THERAPY; NEURAL STEM-CELLS; A-BETA; MOUSE MODEL; APOLIPOPROTEIN-E; IN-VIVO; TAU-PROTEIN	This week marks a century since the first description of Alzheimer's disease ( AD). Despite approval of several drugs for AD, the disease continues to rob millions of their memories and their lives. Fortunately, many new therapies directly targeting the mechanisms underlying AD are now in the pipeline. Among the investigative AD therapies in clinical trials are several strategies to block pathogenic amyloid-beta peptides and to rescue vulnerable neurons from degeneration. Complementary but less mature strategies aim to prevent the copathogenic effects of apolipoprotein E and the microtubule-associated protein tau. New insights into selective neuronal vulnerability and the link between aging and AD may provide additional entry points for therapeutic interventions. The predicted increase in AD cases over the next few decades makes the development of better treatments a matter of utmost importance and urgency.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	Roberson, Erik/A-5718-2009	Roberson, Erik/0000-0002-1810-9763; Mucke, Lennart/0000-0001-6256-9559	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, R01AG011385, P01AG022074] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011385, AG011385, P01 AG022074, AG022074, R37 AG011385] Funding Source: Medline; NINDS NIH HHS [K08 NS054811-01, NS054811, K08 NS054811] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bernal GM, 2004, AGING CELL, V3, P345, DOI 10.1111/j.1474-9728.2004.00132.x; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Boothby LA, 2005, ANN PHARMACOTHER, V39, P2073, DOI 10.1345/aph.1E495; Brouwers N, 2006, BRAIN, V129, P2984, DOI 10.1093/brain/awl212; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullock R, 2006, ALZ DIS ASSOC DIS, V20, P23, DOI 10.1097/01.wad.0000201847.29836.a5; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Deeks SG, 2006, BMJ-BRIT MED J, V332, P1489, DOI 10.1136/bmj.332.7556.1489; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dodart JC, 2005, P NATL ACAD SCI USA, V102, P1211, DOI 10.1073/pnas.0409072102; Doraiswamy PM, 2006, EXPERT OPIN PHARMACO, V7, P1, DOI 10.1517/14656566.7.1.1; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Farlow Martin R, 2004, Expert Rev Neurother, V4, P799, DOI 10.1586/14737175.4.5.799; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Frenkel D, 2005, J CLIN INVEST, V115, P2423, DOI 10.1172/JCI23241; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Jacobsen J Steven, 2005, NeuroRx, V2, P612; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maggini M, 2006, PLOS MED, V3, P456, DOI 10.1371/journal.pmed.0030140; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Marr RA, 2003, J NEUROSCI, V23, P1992; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Ritchie CW, 2004, AM J GERIAT PSYCHIAT, V12, P358, DOI 10.1176/appi.ajgp.12.4.358; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Schapira AHV, 2006, ANN NEUROL, V59, P559, DOI 10.1002/ana.20789; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Tucker Stephanie, 2006, Current Alzheimer Research, V3, P221, DOI 10.2174/156720506777632835; Tuszynski MH, 2002, LANCET NEUROL, V1, P51, DOI 10.1016/S1474-4422(02)00006-6; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	88	447	484	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					781	784		10.1126/science.1132813	http://dx.doi.org/10.1126/science.1132813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082448	Green Accepted			2022-12-28	WOS:000241729800035
J	Raine, R; McIvor, M				Raine, Rosalind; McIvor, Martin			9 years on: what progress has been made on achieving UK health-care equity?	LANCET			English	Editorial Material							DISPARITIES		UCL, Dept Epidemiol & Publ Hlth, Hlth Serv Res Unit, London WC1E 6BT, England; Univ Edinburgh, Ctr Int Publ Hlth Policy, Edinburgh, Midlothian, Scotland; Joint UCLH UCL Biomed Res Unit, London, England	University of London; University College London; University of Edinburgh; University College London Hospitals NHS Foundation Trust	Raine, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Hlth Serv Res Unit, Mortimer St, London WC1E 6BT, England.	r.raine@ucl.ac.uk		Raine, Rosalind/0000-0003-0904-749X				Anand S., 2004, PUBLIC HEALTH, P15; *AUD COMM, 2005, EARL LESS PAYM RES; Balsa AI, 2003, J HEALTH ECON, V22, P89, DOI 10.1016/S0167-6296(02)00098-X; DANIELS N, 1985, JUST HLTH CARE; *DEP HLTH, 2005, TACKL HLTH IN STAT R; *DEP HLTH, 2000, NHS PLAN; Department of Health, 1997, NEW NHS MOD DEP; FARRINGTONDOUGL.J, 2005, EQUITABLE CHOICES HL; Gwatkin D. R., 2005, REACHING POOR HLTH N; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; *INT FOR COMM ACC, PROGR STAT; *KINGS FUND, COMMUNICATION; Lane R, 2005, BRIT MED J, V331, P853, DOI 10.1136/bmj.331.7520.853; Le Grand J, 2005, NEW EGALITARIANISM; LEWIS R, 2005, NHS MARKET FUTURES E; MCALISTER F, 2004, BRIT MED J, V328, P1113; Morgan C, 2004, SOC SCI MED, V58, P739, DOI 10.1016/S0277-9536(03)00233-8; *NICE, 2005, SOC VAL JUDGM PRINC; O'Dowd A, 2006, BMJ-BRIT MED J, V332, P623, DOI 10.1136/bmj.332.7542.623; POLLOCK A, POLITICS COLUMN; Pollock A.M., 2005, NHS PLC PRIVATISATIO; PROPPER C, 2005, 05133 U BRIST CTR MA; Rawls J., 1972, SOCIAL JUSTICE LIBER; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; Rosolova H, 2000, EUR HEART J, V21, P1562, DOI 10.1053/euhj.2000.2191; *SEL COMM PUBL ACC, NHS CANC PLAN PROGR; Sen A., 2004, PUBLIC HLTH ETHICS E, P21; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; St John of God Health Care, 2019, OUR VIS; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; STEVENS S, 2003, EQUITY HLTH HEALTHCA; Sutton M, 2002, ALLOCATION RESOURCES; Veugelers PJ, 2003, J EPIDEMIOL COMMUN H, V57, P424, DOI 10.1136/jech.57.6.424; [No title captured]	34	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 28	2006	368	9546					1542	1545		10.1016/S0140-6736(06)69256-8	http://dx.doi.org/10.1016/S0140-6736(06)69256-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071288				2022-12-28	WOS:000241582700032
J	Lagouge, M; Argmann, C; Gerhart-Hines, Z; Meziane, H; Lerin, C; Daussin, F; Messadeq, N; Milne, J; Lambert, P; Elliott, P; Geny, B; Laakso, M; Puigserver, P; Auwerx, J				Lagouge, Marie; Argmann, Carmen; Gerhart-Hines, Zachary; Meziane, Hamid; Lerin, Carles; Daussin, Frederic; Messadeq, Nadia; Milne, Jill; Lambert, Philip; Elliott, Peter; Geny, Bernard; Laakso, Markku; Puigserver, Pere; Auwerx, Johan			Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha	CELL			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MESSENGER-RNA EXPRESSION; CEREVISIAE LIFE-SPAN; ALPHA ERR-ALPHA; SKELETAL-MUSCLE; CALORIE RESTRICTION; RECEPTOR-ALPHA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE-PHOSPHORYLATION; ADAPTIVE THERMOGENESIS	Diminished mitochondrial oxidative phosphorylation and aerobic capacity are associated with reduced longevity. We tested whether resveratrol (RSV), which is known to extend lifespan, impacts mitochondrial function and metabolic homeostasis. Treatment of mice with RSV significantly increased their aerobic capacity, as evidenced by their increased running time and consumption of oxygen in muscle fibers. RSV's effects were associated with an induction of genes for oxidative phosphorylation and mitochondrial biogenesis and were largely explained by an RSV-mediated decrease in PGC-1 alpha acetylation and an increase in PGC-1 alpha activity. This mechanism is consistent with RSV being a known activator of the protein deacetylase, SIRT1, and by the lack of effect of RSV in SIRT1(-/-) MEFs. Importantly, RSV treatment protected mice against diet-induced-obesity and insulin resistance. These pharmacological effects of RSV combined with the association of three Sirt1 SNPs and energy homeostasis in Finnish subjects implicates SIRT1 as a key regulator of energy and metabolic homeostasis.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; Hop Univ, Dept Resp Cardiocirculat & Exercise Physiol, F-67000 Strasbourg, France; Sirtris Pharmaceut, Cambridge, MA 02139 USA; Univ Kuopio, Dept Med, FIN-70211 Kuopio, Finland; ICS, IGBMC, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University; CHU Strasbourg; University of Eastern Finland; Institut National de la Sante et de la Recherche Medicale (Inserm)	Auwerx, J (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	auwerx@igbmc.u-strasbg.fr	Lerin, Carles/AAP-9916-2020; Daussin, Frédéric/O-7583-2019; Auwerx, Johan/ABE-9307-2021; Daussin, Frederic N/G-2866-2013	Lerin, Carles/0000-0003-0950-4363; Daussin, Frédéric/0000-0002-4168-0044; Auwerx, Johan/0000-0002-5065-5393	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966, P01DK059820] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK59820, DK069966] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BAUR JA, 2006, IN PRESS NATURE; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Booth FW, 2002, J PHYSIOL-LONDON, V543, P399, DOI 10.1113/jphysiol.2002.019265; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Ceddia RB, 2000, EUR J BIOCHEM, V267, P5952, DOI 10.1046/j.1432-1327.2000.01664.x; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; FERRANNINI E, 1988, AM J PHYSIOL, V255, pE946, DOI 10.1152/ajpendo.1988.255.6.E946; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; N'Guessan B, 2004, MOL CELL BIOCHEM, V256, P267; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163	58	3121	3277	12	491	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1109	1122		10.1016/j.cell.2006.11.013	http://dx.doi.org/10.1016/j.cell.2006.11.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17112576	Bronze			2022-12-28	WOS:000242991000011
J	Lee, JK; Grace, KA; Taylor, AJ				Lee, Jeannie K.; Grace, Karen A.; Taylor, Allen J.			Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Scientific Session of the American-Heart-Association	NOV   13, 2006	Chicago, IL	Amer Heart Assoc			ALL-CAUSE MORTALITY; MAJOR RISK-FACTORS; HEALTH OUTCOMES; STATIN THERAPY; INTERVENTIONS; CORONARY; HYPERTENSION; METAANALYSIS; PREDICTORS; HOSPITALIZATION	Context Poor medication adherence diminishes the health benefits of pharmacotherapies. Elderly patients with coronary risk factors frequently require treatment with multiple medications, placing them at increased risk for nonadherence. Objective To test the efficacy of a comprehensive pharmacy care program to improve medication adherence and its associated effects on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C). Design, Setting, and Patients A multiphase, prospective study with an observational phase and a randomized controlled trial conducted at the Walter Reed Army Medical Center of 200 community-based patients aged 65 years or older taking at least 4 chronic medications. The study was conducted from June 2004 to August 2006. Intervention After a 2-month run-in phase (measurement of baseline adherence, BP, and LDL-C), patients entered a 6-month intervention phase (standardized medication education, regular follow-up by pharmacists, and medications dispensed in time-specific packs). Following the intervention phase, patients were randomized to continued pharmacy care vs usual care for an additional 6 months. Main Outcome Measures Primary end point of the observation phase was change in the proportion of pills taken vs baseline; secondary end points were the associated changes in BP and LDL-C. Primary end point of the randomization phase was the between-group comparison of medication persistence. Results A total of 200 elderly patients (77.1% men; mean[SD] age, 78 [8.3] years), taking a mean (SD) of 9 (3) chronic medications were enrolled. Coronary risk factors included drug-treated hypertension in 184 patients (91.5%) and drug-treated hyperlipidemia in 162 (80.6%). Mean (SD) baseline medication adherence was 61.2% (13.5%). After 6 months of intervention, medication adherence increased to 96.9% (5.2%; P<.001) and was associated with significant improvements in systolic BP (133.2 [14.9] to 129.9 [16.0] mm Hg; P=.02) and LDL-C (91.7 [26.1] to 86.8 [23.4] mg/dL; P=.001). Six months after randomization, the persistence of medication adherence decreased to 69.1% (16.4%) among those patients assigned to usual care, whereas it was sustained at 95.5% (7.7%) in pharmacy care (P<.001). This was associated with significant reductions in systolic BP in the pharmacy care group (-6.9 mm Hg; 95% CI, -10.7 to -3.1 mm Hg) vs the usual care group (-1.0 mm Hg; 95% CI, -5.9 to 3.9 mm Hg; P=.04), but no significant between-group differences in LDL-C levels or reductions. Conclusions A pharmacy care program led to increases in medication adherence, medication persistence, and clinically meaningful reductions in BP, whereas discontinuation of the program was associated with decreased medication adherence and persistence.	Walter Reed Army Med Ctr, Dept Cardiol, Serv Cardiol, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Dept Pharm, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Taylor, AJ (corresponding author), Walter Reed Army Med Ctr, Dept Cardiol, Serv Cardiol, 6900 Georgia Ave NW,Bldg 2,Room 4A34, Washington, DC 20307 USA.	allen.taylor@na.amedd.army.mil						Abughosh Susan M, 2004, J Manag Care Pharm, V10, P404; Balkrishnan R, 2003, CLIN THER, V25, P2958, DOI 10.1016/S0149-2918(03)80347-8; Balkrishnan R, 1998, CLIN THER, V20, P764, DOI 10.1016/S0149-2918(98)80139-2; Becker M H, 1980, J Community Health, V6, P113, DOI 10.1007/BF01318980; Blackburn DE, 2005, PHARMACOTHERAPY, V25, P1035, DOI 10.1592/phco.2005.25.8.1035; BOTELHO RJ, 1992, J FAM PRACTICE, V35, P61; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; Connor J, 2004, B WORLD HEALTH ORGAN, V82, P935; Flaherty JH, 2000, J GERONTOL A-BIOL, V55, pM554, DOI 10.1093/gerona/55.10.M554; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; HALE WE, 1987, DRUG INTEL CLIN PHAR, V21, P530, DOI 10.1177/106002808702100610; Haynes R B, 2002, Cochrane Database Syst Rev, pCD000011; HAYNES RB, 1976, LANCET, V1, P1265; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; KANNEL WB, 1986, AM HEART J, V112, P825, DOI 10.1016/0002-8703(86)90481-3; Lee JY, 1996, AM J HYPERTENS, V9, P719, DOI 10.1016/0895-7061(96)00056-8; Linjakumpu T, 2002, J CLIN EPIDEMIOL, V55, P809, DOI 10.1016/S0895-4356(02)00411-0; LOGAN AG, 1979, LANCET, V2, P1175; MACMAHON S, 1989, HYPERTENSION S1, V13, P145; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Mojtabai R, 2003, HEALTH AFFAIR, V22, P220, DOI 10.1377/hlthaff.22.4.220; *NAT COUNC PAT INF, 1997, OTH DRUG PROBL STAT; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peterson AM, 2003, AM J HEALTH-SYST PH, V60, P657, DOI 10.1093/ajhp/60.7.657; Quinn ME, 1999, J ADV NURS, V30, P410, DOI 10.1046/j.1365-2648.1999.01088.x; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Takiya LN, 2004, ANN PHARMACOTHER, V38, P1617, DOI 10.1345/aph.1D268; Vik SA, 2004, ANN PHARMACOTHER, V38, P303, DOI 10.1345/aph.1D252; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	553	581	1	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2563	2571		10.1001/jama.296.21.joc60162	http://dx.doi.org/10.1001/jama.296.21.joc60162			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112ND	17101639	Bronze			2022-12-28	WOS:000242532000018
J	Kueng, S; Hegemann, B; Peters, BH; Lipp, JJ; Schleiffer, A; Mechtler, K; Peters, JM				Kueng, Stephanie; Hegemann, Bjoern; Peters, Beate H.; Lipp, Jesse J.; Schleiffer, Alexander; Mechtler, Karl; Peters, Jan-Michael			Wapl controls the dynamic association of cohesin with chromatin	CELL			English	Article							MITOTIC CHROMOSOME; SISTER; SHUGOSHIN; IDENTIFICATION; ANAPHASE; XENOPUS; DNA; CONDENSATION; MAINTENANCE; COMPLEXES	Cohesin establishes sister-chromatid cohesion from S phase until mitosis or meiosis. To allow chromosome segregation, cohesion has to be dissolved. In vertebrate cells, this process is mediated in part by the protease separase, which destroys a small amount of cohesin, but most cohesin is removed from chromosomes without proteolysis. How this is achieved is poorly understood. Here, we show that the interaction between cohesin and chromatin is controlled by Wapl, a protein implicated in heterochromatin formation and tumorigenesis. Wapl is associated with cohesin throughout the cell cycle, and its depletion blocks cohesin dissociation from chromosomes during the early stages of mitosis and prevents the resolution of sister chromatids until anaphase, which occurs after a delay. Wapl depletion also increases the residence time of cohesin on chromatin in interphase. Our data indicate that Wapl is required to unlock cohesin from a particular state in which it is stably bound to chromatin.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	peters@imp.univie.ac.at	Hegemann, Björn/A-8761-2015; Mechtler, Karl/AAF-2717-2019	Hegemann, Björn/0000-0002-1009-2952; Mechtler, Karl/0000-0002-3392-9946; Schleiffer, Alexander/0000-0001-6251-2747				Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Dobie KW, 2001, GENETICS, V157, P1623; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; GRUBER S, 2006, IN PRESS CELL; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; GVOZDEV VA, 1975, MOL GEN GENET, V141, P269, DOI 10.1007/BF00341805; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kwiatkowski BA, 2004, EXP CELL RES, V300, P223, DOI 10.1016/j.yexcr.2004.06.028; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Oikawa K, 2004, CANCER RES, V64, P3545, DOI 10.1158/0008-5472.CAN-03-3822; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; PERRIMON N, 1985, GENETICS, V111, P23; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Verni F, 2000, GENETICS, V154, P1693; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049	43	407	419	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					955	967		10.1016/j.cell.2006.09.040	http://dx.doi.org/10.1016/j.cell.2006.09.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17113138	Bronze			2022-12-28	WOS:000242613800013
J	Suh, EK; Yang, A; Kettenbach, A; Bamberger, C; Michaelis, AH; Zhu, Z; Elvin, JA; Bronson, RT; Crum, CP; McKeon, F				Suh, Eun-Kyung; Yang, Annie; Kettenbach, Arminja; Bamberger, Casimir; Michaelis, Ala H.; Zhu, Zhou; Elvin, Julia A.; Bronson, Roderick T.; Crum, Christopher P.; McKeon, Frank			p63 protects the female germ line during meiotic arrest	NATURE			English	Article							P53 TUMOR-SUPPRESSOR; ELEGANS P53; HOMOLOG; DROSOPHILA-P53; MIGRATION; PATHWAYS; ISOFORMS; MICE	Meiosis in the female germ line of mammals is distinguished by a prolonged arrest in prophase of meiosis I between homologous chromosome recombination and ovulation(1). How DNA damage is detected in these arrested oocytes is poorly understood, but it is variably thought to involve p53, a central tumour suppressor in mammals(2-4). While the function of p53 in monitoring the genome of somatic cells is clear, a consensus for the importance of p53 for germ line integrity has yet to emerge. Here we show that the p53 homologue p63 (refs 5, 6), and specifically the TAp63 isoform, is constitutively expressed in female germ cells during meiotic arrest and is essential in a process of DNA damage-induced oocyte death not involving p53. We also show that DNA damage induces both the phosphorylation of p63 and its binding to p53 cognate DNA sites and that these events are linked to oocyte death. Our data support a model whereby p63 is the primordial member of the p53 family and acts in a conserved process of monitoring the integrity of the female germ line, whereas the functions of p53 are restricted to vertebrate somatic cells for tumour suppression. These findings have implications for understanding female germ line fidelity, the regulation of fertility and the evolution of tumour suppressor mechanisms.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu	Bamberger, Casimir/E-7356-2011; Kutalik, Zoltan/HHZ-5697-2022; Bamberger, Tom Casimir/D-1292-2014	Kutalik, Zoltan/0000-0001-8285-7523; Bamberger, Tom Casimir/0000-0002-3830-4486; Kettenbach, Arminja/0000-0003-3979-4576				Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LANE DP, 1995, PHILOS T ROY SOC B, V347, P83, DOI 10.1098/rstb.1995.0013; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Olivier M, 2005, 25 YEARS OF P53 RESEARCH, P321, DOI 10.1007/1-4020-2922-5_14; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; PETERS H, 1964, J REPROD FERTIL, V7, P37; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YANG A, IN PRESS MOL CELL; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260	30	387	394	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					624	628		10.1038/nature05337	http://dx.doi.org/10.1038/nature05337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17122775				2022-12-28	WOS:000242377600049
J	Kim, SA; Punshon, T; Lanzirotti, A; Li, LT; Alonso, JM; Ecker, JR; Kaplan, J; Guerinot, ML				Kim, Sun A.; Punshon, Tracy; Lanzirotti, Antonio; Li, Liangtao; Alonso, Jose M.; Ecker, Joseph R.; Kaplan, Jerry; Guerinot, Mary Lou			Localization of iron in Arabidopsis seed requires the vacuolar membrane transporter VIT1	SCIENCE			English	Article							THALIANA SEEDS; EXPRESSION; FLUORESCENCE; FERRITIN; ELEMENTS; STORAGE; CCC1	Iron deficiency is a major human nutritional problem wherever plant-based diets are common. Using synchrotron x-ray fluorescence microtomography to directly visualize iron in Arabidopsis seeds, we show that iron is localized primarily to the provascular strands of the embryo. This localization is completely abolished when the vacuolar iron uptake transporter VIT1 is disrupted. Vacuolar iron storage is also critical for seedling development because vit1-1 seedlings grow poorly when iron is limiting. We have uncovered a fundamental aspect of seed biology that will ultimately aid the development of nutrient-rich seed, benefiting both human health and agricultural productivity.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Univ Chicago, Consortium Adv Radiat Sources, Chicago, IL 60637 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Salk Inst Biol Studies, Plant Biol & Genom Anal Labs, La Jolla, CA 92037 USA	Dartmouth College; University of Chicago; Utah System of Higher Education; University of Utah; University of North Carolina; North Carolina State University; Salk Institute	Guerinot, ML (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	guerinot@dartmouth.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Lanzirotti, Antonio/0000-0002-7597-5924	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 30534] Funding Source: Medline; NIEHS NIH HHS [P42 ES07373] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BODE HP, 1995, EUR J BIOCHEM, V228, P337; BOWMAN JL, 1994, ARABIDOPSIS ATLAS MO, P351; Busse JS, 1999, INT J PLANT SCI, V160, P1, DOI 10.1086/314098; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; KUMAR S, 2000, MEGA2 MOL EVOLUTIONA; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lott JNA, 2001, CAN J BOT, V79, P1292, DOI 10.1139/cjb-79-11-1292; Lucca P, 2002, J AM COLL NUTR, V21, p184S, DOI 10.1080/07315724.2002.10719264; McNear DH, 2005, ENVIRON SCI TECHNOL, V39, P2210, DOI 10.1021/es0492034; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Punshon T, 2005, J ENVIRON QUAL, V34, P1165, DOI 10.2134/jeq2004.0461; Qu LQ, 2005, PLANTA, V222, P225, DOI 10.1007/s00425-005-1530-8; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Stuppy WH, 2003, TRENDS PLANT SCI, V8, P2, DOI 10.1016/S1360-1385(02)00004-3; Sutton SR, 2002, REV MINERAL GEOCHEM, V49, P429, DOI 10.2138/rmg.2002.49.8; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Young LW, 2006, J SYNCHROTRON RADIAT, V13, P304, DOI 10.1107/S0909049506019571	26	451	475	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1295	1298		10.1126/science.1132563	http://dx.doi.org/10.1126/science.1132563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17082420				2022-12-28	WOS:000242215800042
J	Simner, J; Ward, J				Simner, Julia; Ward, Jamie			Synaesthesia - The taste of words on the tip of the tongue	NATURE			English	Article							COLOR SYNAESTHESIA; ACTIVATION		Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; UCL, Dept Psychol, London WC1E 6BT, England	University of Edinburgh; University of London; University College London	Simner, J (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	j.simner@ed.ac.uk	Ward, Jamie/F-3609-2011	Ward, Jamie/0000-0001-7007-1902; Simner, Julia/0000-0003-4789-0138				BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; KEMPEN G, 1983, COGNITION, V14, P185, DOI 10.1016/0010-0277(83)90029-X; Levy LM, 1999, J COMPUT ASSIST TOMO, V23, P499, DOI 10.1097/00004728-199907000-00002; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Ward J, 2005, PERCEPTION, V34, P611, DOI 10.1068/p5250; Ward J, 2005, COGN NEUROPSYCHOL, V22, P28, DOI 10.1080/02643290442000022; Ward J, 2003, COGNITION, V89, P237, DOI 10.1016/S0010-0277(03)00122-7; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; Ward J, 2006, CORTEX, V42, P129, DOI 10.1016/S0010-9452(08)70336-8	10	59	61	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					438	438		10.1038/444438a	http://dx.doi.org/10.1038/444438a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BQ	17122848				2022-12-28	WOS:000242215700033
J	Belle, SH; Burgio, L; Burns, R; Coon, D; Czaja, SJ; Gallagher-Thompson, D; Gitlin, LN; Klinger, J; Koepke, KM; Lee, CC; Martindale-Adam, J; Nichols, L; Schulz, R; Stahl, S; Stevens, A; Winter, L; Zhang, S				Belle, Steven H.; Burgio, Louis; Burns, Robert; Coon, David; Czaja, Sara J.; Gallagher-Thompson, Dolores; Gitlin, Laura N.; Klinger, Julie; Koepke, Kathy Mann; Lee, Chin Chin; Martindale-Adam, Jennifer; Nichols, Linda; Schulz, Richard; Stahl, Sidney; Stevens, Alan; Winter, Laraine; Zhang, Song		Resources Enhancing Alzheimers	Enhancing the quality of life of dementia caregivers from different ethnic or racial groups - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIAL SUPPORT; OLDER ADULTS; INTERVENTIONS; DEPRESSION; METAANALYSIS; DESIGN; BURDEN; SCALE; REACH	Background: Caring for a family member with dementia is extremely stressful, contributes to psychiatric and physical illness among caregivers, and increases the risk for caregiver death. Finding better ways to support family caregivers is a major public health challenge. Objective: To test the effects of a structured multicomponent intervention on quality of life and clinical depression in caregivers and on rates of institutional placement of care recipients in 3 diverse racial or ethnic groups. Design: Randomized, controlled trial. Setting: In-home caregivers in 5 U.S. cities. Participants: 212 Hispanic or Latino, 219 white or Caucasian, and 211 black or African-American caregivers and their care recipients with Alzheimer disease or related disorders. Intervention: Caregivers within each racial or ethnic group were randomly assigned to an intervention or to a control group. The intervention addressed caregiver depression, burden, self-care, and social support and care recipient problem behaviors through 12 in-home and telephone sessions over 6 months. Caregivers in the control group received 2 brief "check-in" telephone calls during the 6-month intervention. Measurements: The primary outcome was a quality-of-life indicator comprising measures of 6-month caregiver depression, burden, self-care, and social support and care recipient problem behaviors. Secondary outcomes were caregiver clinical depression and institutional placement of the care recipient at 6 months. Results: Hispanic or Latino and white or Caucasian caregivers in the intervention group experienced significantly greater improvement in quality of life than those in the control group (P < 0.001 and P = 0.037, respectively). Black or African-American spouse caregivers also improved significantly more (P = 0.003). Prevalence of clinical depression was lower among caregivers in the intervention group (12.6% vs. 22.7%; P = 0.001). There were no statistically significant differences in institutionalization at 6 months. Limitations: The study used only a single 6-month follow-up assessment, combined heterogeneous cultures and ethnicities into a single group, and excluded some ethnic groups. Conclusions: A structured multicomponent intervention adapted to individual risk profiles can increase the quality of life of ethnically diverse dementia caregivers.	Univ Pittsburgh, Pittsburgh, PA 15260 USA; Univ Alabama, Tuscaloosa, AL USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Geriatr Grp Memphis, Memphis, TN USA; Arizona State Univ, Tempe, AZ USA; Univ Miami, Miami, FL 33152 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; NINR, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA; Scott & White Mem Hosp & Clin, Temple, TX 76508 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Tuscaloosa; University of Tennessee System; University of Tennessee Health Science Center; Arizona State University; Arizona State University-Tempe; University of Miami; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; Scott & White Medical Center	Schulz, R (corresponding author), Univ Pittsburgh, 121 Univ Pl,6th Floor, Pittsburgh, PA 15260 USA.	schulz@pitt.edu	Janson, Patrick/AAC-7581-2022		NIA NIH HHS [U01 AG020274-03, U01 AG013265, U01 AG020274, AG13305, U01 AG013305, AG13289, U01 AG013313, AG20277, AG13313, U01 AG013289, AG13265] Funding Source: Medline; NINR NIH HHS [U01 NR004261-07, U01 NR004261, NR004261] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG013305, U01AG013289, U01AG013313, U01AG013265, U01AG020274] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BARRERA M, 1981, AM J COMMUN PSYCHOL, V9, P435, DOI 10.1007/BF00918174; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Belle SH, 2003, PSYCHOL AGING, V18, P396, DOI 10.1037/0882-7974.18.3.396; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Bull SB, 1998, STAT MED, V17, P2179, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2179::AID-SIM921>3.0.CO;2-L; Cohen J, 1987, STAT POWER ANAL BEHA; Davison AC, 1997, CAMBRIDGE SERIES STA, V1; DIGGLE PJ, 1994, OXFORD STAT SCI SERI, V13; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; JENNISON C, 1999, GROUP SEQUENTIAL MET, P299; KRAUSE N, 1995, J GERONTOL B-PSYCHOL, V50, pP59, DOI 10.1093/geronb/50B.2.P59; KRAUSE N, 1990, INT J AGING HUM DEV, V30, P37, DOI 10.2190/CY26-XCKW-WY1V-VGK3; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schulz R, 2005, PSYCHIAT CLIN N AM, V28, P1007, DOI 10.1016/j.psc.2005.09.003; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; TANG DI, 1989, J AM STAT ASSOC, V84, P776, DOI 10.2307/2289665; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; *U PITTSB ERP DAT, REACH 2 RES ENH ALZH; WHITFIELD K, 2004, CLOSING GAP IMPROVIN; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; Zarit S.H., 1985, HIDDEN VICTIMS ALZHE	28	497	503	2	82	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					727	738		10.7326/0003-4819-145-10-200611210-00005	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110OB	17116917	Green Accepted			2022-12-28	WOS:000242387100002
J	Heffner, JE				Heffner, John E.			Update in pulmonary medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COMPLICATED PARAPNEUMONIC EFFUSIONS; INTRAPLEURAL STREPTOKINASE; DISEASE; TIOTROPIUM; EMPYEMA; IPRATROPIUM; WITHDRAWAL; COPD		Providence Portland Med Ctr, Portland, OR 97213 USA; Oregon Clin, Portland, OR USA	Providence Portland Medical Center	Heffner, JE (corresponding author), Providence Portland Med Ctr, 5050 NE Hoyt St,Suite 540, Portland, OR 97213 USA.	john_heffner@mac.com						Altose MD, 2000, NEW ENGL J MED, V343, P1902; Annema JT, 2005, JAMA-J AM MED ASSOC, V294, P931, DOI 10.1001/jama.294.8.931; Bouros D, 1999, AM J RESP CRIT CARE, V159, P37, DOI 10.1164/ajrccm.159.1.9803094; Campbell S, 1999, ARCH INTERN MED, V159, P156, DOI 10.1001/archinte.159.2.156; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; Davies RJO, 1997, THORAX, V52, P416, DOI 10.1136/thx.52.5.416; Diacon AH, 2004, AM J RESP CRIT CARE, V170, P49, DOI 10.1164/rccm.200312-1740OC; Frias J, 1998, Rev Esp Quimioter, V11, P255; Global Initiative for Asthma, 2002, NIH PUBL; Heffner JE, 2005, NEW ENGL J MED, V352, P926, DOI 10.1056/NEJMe048352; Jarad NA, 1999, RESP MED, V93, P161, DOI 10.1016/S0954-6111(99)90001-X; Moody A, 2004, THORAX, V59, P1; O'Brien A, 2001, AM J RESP CRIT CARE, V164, P365, DOI 10.1164/ajrccm.164.3.2002052; Oostenbrink JB, 2004, EUR RESPIR J, V23, P241, DOI 10.1183/09031936.03.00083703; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	19	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					765	773		10.7326/0003-4819-145-10-200611210-00009	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110OB	17116921				2022-12-28	WOS:000242387100006
J	Hirano, Y; Ronai, Z				Hirano, Yuko; Ronai, Ze'ev			A new function for p53 ubiquitination	CELL			English	Editorial Material							TRANSCRIPTION FACTOR; TRANSACTIVATION; PROTEIN	The amount of p53 protein in a cell is normally limited by ubiquitin-dependent degradation. In this issue of Cell, Le Cam et al. (2006) reveal that p53 ubiquitination contributes to transcriptional activation rather than protein stability. These results may provide insight into how p53 can modulate diverse cellular processes such as growth arrest and apoptosis.	Burnham Inst Med Res, La Jolla, CA 92130 USA	Sanford Burnham Prebys Medical Discovery Institute	Hirano, Y (corresponding author), Burnham Inst Med Res, La Jolla, CA 92130 USA.	ronai@burnham.org		RONAI, ZEEV/0000-0002-3859-0400				Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Fuchs SY, 1999, MOL CELL BIOL, V19, P3289; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; Liu XF, 2005, J BIOL CHEM, V280, P10807, DOI 10.1074/jbc.M410343200; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381	11	10	12	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					675	677		10.1016/j.cell.2006.11.003	http://dx.doi.org/10.1016/j.cell.2006.11.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110328	Bronze			2022-12-28	WOS:000242330600015
J	Murton, JB; Peterson, R; Ozouf, JC				Murton, Julian B.; Peterson, Rorik; Ozouf, Jean-Claude			Bedrock fracture by ice segregation in cold regions	SCIENCE			English	Article							WESTERN ARCTIC COAST; GROUND ICE; CANADA; BRECCIATION; THANET	The volumetric expansion of freezing pore water is widely assumed to be a major cause of rock fracture in cold humid regions. Data from experiments simulating natural freezing regimes indicate that bedrock fracture results instead from ice segregation. Fracture depth and timing are also numerically simulated by coupling heat and mass transfer with a fracture model. The depth and geometry of fractures match those in Arctic permafrost and ice-age weathering profiles. This agreement supports a conceptual model in which ice segregation in near-surface permafrost leads progressively to rock fracture and heave, whereas permafrost degradation leads episodically to melt of segregated ice and rock settlement.	Univ Sussex, Dept Geog, Brighton BN1 9QJ, E Sussex, England; Univ Alaska, Dept Mech Engn, Fairbanks, AK 99775 USA; Univ Caen, Lab Morphodynam Continentale & Cotiere, CNRS, UMR 6143, F-14032 Caen, France	University of Sussex; University of Alaska System; University of Alaska Fairbanks; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Caen Normandie	Murton, JB (corresponding author), Univ Sussex, Dept Geog, Brighton BN1 9QJ, E Sussex, England.	j.b.murton@sussex.ac.uk		Murton, Julian/0000-0002-9469-5856				ACIA, 2005, IMP WARM ARCT ARCT C; Akagawa S., 1991, Permafrost and Periglacial Processes, V2, P301, DOI 10.1002/ppp.3430020405; Budel J., 1982, CLIMATIC GEOMORPHOLO; Cailleux A., 1943, B SOC GEOLOGIQUE FRA, V13, P511; CHENG GD, 1983, COLD REG SCI TECHNOL, V8, P57; FRENCH HM, 1986, CAN J EARTH SCI, V23, P1389, DOI 10.1139/e86-132; FRENCH HM, 1996, PERIGLACIAL ENV, V2nd; Hall K, 2002, PROG PHYS GEOG, V26, P577, DOI 10.1191/0309133302pp353ra; Hallet B., 1991, Permafrost and Periglacial Processes, V2, P283, DOI 10.1002/ppp.3430020404; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; MACKAY JR, 1983, CAN J EARTH SCI, V20, P120, DOI 10.1139/e83-012; Mackay JR, 1999, PERMAFROST PERIGLAC, V10, P125, DOI 10.1002/(SICI)1099-1530(199904/06)10:2<125::AID-PPP311>3.0.CO;2-L; Matsuoka M, 2001, PERMAFROST PERIGLAC, V12, P299, DOI 10.1002/ppp.393; Murton JB, 2003, PERMAFROST PERIGLAC, V14, P217, DOI 10.1002/ppp.442; Murton JB, 2001, PERMAFROST PERIGLAC, V12, P255, DOI 10.1002/ppp.390; Murton JB, 2000, EARTH SURF PROC LAND, V25, P1281, DOI [10.1002/1096-9837(200011)25:12<1281::AID-ESP137>3.0.CO;2-U, 10.1002/1096-9837(200011)25:12&lt;1281::AID-ESP137&gt;3.0.CO;2-U]; Murton JB, 1996, PERMAFROST PERIGLAC, V7, P153, DOI 10.1002/(SICI)1099-1530(199604)7:2<153::AID-PPP215>3.3.CO;2-Z; Shur Y, 2005, PERMAFROST PERIGLAC, V16, P5, DOI 10.1002/ppp.518; Taber S, 1929, J GEOL, V37, P428, DOI 10.1086/623637; THORN CE, 1992, PERIGLACIAL GEOMORPH, pCH1; WALDER J, 1985, GEOL SOC AM BULL, V96, P336, DOI 10.1130/0016-7606(1985)96<336:ATMOTF>2.0.CO;2; WALDER JS, 1986, ARCTIC ALPINE RES, V18, P27, DOI 10.2307/1551211	22	228	238	7	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1127	1129		10.1126/science.1132127	http://dx.doi.org/10.1126/science.1132127			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110573				2022-12-28	WOS:000242045800039
J	Schiano, P; Provost, A; Clocchiatti, R; Faure, F				Schiano, Pierre; Provost, Ariel; Clocchiatti, Roberto; Faure, Francois			Transcrystalline melt migration and Earth's mantle	SCIENCE			English	Article							GRADIENT MIGRATION; THERMAL-GRADIENT; MIDOCEAN RIDGES; INCLUSIONS; SYSTEM; MAGMAS; MINERALS; OLIVINE; SILICA; GROWTH	Plate tectonics and volcanism involve the formation, migration, and interaction of magma and gas. Experiments show that melt inclusions subjected to a thermal gradient migrate through olivine crystals, under the kinetic control of crystal-melt interface mechanisms. Exsolved gas bubbles remain fixed and eventually separate from the melt. Scaled to thermal gradients in Earth's mantle and geological times, our results account for the grain-scale segregation of primitive melts, reinterpret CO2-rich fluid inclusions as escaped from melt, and question the existence of a free, deeply percolating fluid phase. Melt migration experiments also allow us to quantify crystal growth kinetics at very low undercoolings in conditions appropriate to many natural systems.	Univ Clermont Ferrand, Observ Phys Globe, Lab Magmas & Volcans, F-63038 Clermont Ferrand, France; CNRS, F-63038 Clermont Ferrand, France; CEA, CENS, Lab Pierre Sue, F-91191 Gif Sur Yvette, France; CNRS, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Schiano, P (corresponding author), Univ Clermont Ferrand, Observ Phys Globe, Lab Magmas & Volcans, 5 Rue Kessler, F-63038 Clermont Ferrand, France.	schiano@opgc.univ-bpclermont.fr	Provost, Ariel/H-2373-2013; Faure, François/P-3308-2015	Faure, François/0000-0002-5633-2325				AHARONOV E, 1995, J GEOPHYS RES-SOL EA, V100, P20433, DOI 10.1029/95JB01307; BARONNET A, 1984, FORTSCHR MINERAL, V62, P187; BRANDEIS G, 1984, J GEOPHYS RES, V89, P161, DOI 10.1029/JB089iB12p10161; Bureau H, 1998, CHEM GEOL, V147, P115, DOI 10.1016/S0009-2541(97)00176-9; Chen YSJ, 2004, EARTH PLANET SC LETT, V221, P263, DOI 10.1016/S0012-821X(04)00099-8; CLINE HE, 1972, J APPL PHYS, V43, P10, DOI 10.1063/1.1660792; CORDERY MJ, 1993, J GEOPHYS RES-SOL EA, V98, P19477, DOI 10.1029/93JB01831; DEER WA, 1962, ORTHOSILICATES; Dingwell DB, 1998, EARTH PLANET SC LETT, V158, P31, DOI 10.1016/S0012-821X(98)00046-6; DONALDSON CH, 1975, LITHOS, V8, P163, DOI 10.1016/0024-4937(75)90023-7; Farnetani CG, 2002, EARTH PLANET SC LETT, V196, P1, DOI 10.1016/S0012-821X(01)00597-0; Gioncada A, 1998, B VOLCANOL, V60, P286, DOI 10.1007/s004450050233; Henstock TJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013755; Hirschmann MM, 1998, GEOCHIM COSMOCHIM AC, V62, P883, DOI 10.1016/S0016-7037(98)00028-3; JONES DRH, 1973, J CRYST GROWTH, V20, P145, DOI 10.1016/0022-0248(73)90128-0; Kirkpatrick RJ, 1981, REV MINERAL, V8, P321, DOI DOI 10.1017/CBO9781107415324.004; KUO LC, 1985, AM J SCI, V285, P51, DOI 10.2475/ajs.285.1.51; Mareschal JC, 2004, EARTH PLANET SC LETT, V223, P65, DOI 10.1016/j.epsl.2004.04.002; Massare D, 2002, CHEM GEOL, V183, P87, DOI 10.1016/S0009-2541(01)00373-4; Maumus J, 2004, CONTRIB MINERAL PETR, V148, P1, DOI 10.1007/s00410-004-0595-x; Mungall JE, 1998, AM MINERAL, V83, P685; OLANDER DR, 1982, J APPL PHYS, V53, P669, DOI 10.1063/1.329975; Ritzwoller M.H., 2004, GEOLOGICAL SOC LONDO, V239, P175, DOI [10.1144/GSL.SP.2004.239.01.12, DOI 10.1144/GSL.SP.2004.239.01.12]; Roedder E., 1984, REV MINERALOGY, V12; Schiano P, 2003, EARTH-SCI REV, V63, P121, DOI 10.1016/S0012-8252(03)00034-5; SCHIANO P, 1994, NATURE, V368, P621, DOI 10.1038/368621a0; Schiano P, 1998, EARTH PLANET SC LETT, V160, P537, DOI 10.1016/S0012-821X(98)00109-5; SNYDER D, 1994, J GEOPHYS RES-SOL EA, V99, P15503, DOI 10.1029/94JB01018; SOBOLEV AV, 1980, LUNAR PLANET SCI C, V11, P105; Sobolev SV, 1997, TECTONOPHYSICS, V275, P143, DOI 10.1016/S0040-1951(97)00019-X; Tiller W. A., 1991, SCI CRYSTALLIZATION; WANAMAKER BJ, 1989, CONTRIB MINERAL PETR, V102, P102, DOI 10.1007/BF01160194; Zhang YX, 2003, AM MINERAL, V88, P1741, DOI 10.2138/am-2003-11-1215	33	34	34	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					970	974		10.1126/science.1132485	http://dx.doi.org/10.1126/science.1132485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095697				2022-12-28	WOS:000241896000046
J	Barbante, C; Barnola, JM; Becagli, S; Beer, J; Bigler, M; Boutron, C; Blunier, T; Castellano, E; Cattani, O; Chappellaz, J; Dahl-Jensen, D; Debret, M; Delmonte, B; Dick, D; Falourd, S; Faria, S; Federer, U; Fischer, H; Freitag, J; Frenzel, A; Fritzsche, D; Fundel, F; Gabrielli, P; Gaspari, V; Gersonde, R; Graf, W; Grigoriev, D; Hamann, I; Hansson, M; Hoffmann, G; Hutterli, MA; Huybrechts, P; Isaksson, E; Johnsen, S; Jouzel, J; Kaczmarska, M; Karlin, T; Kaufmann, P; Kipfstuhl, S; Kohno, M; Lambert, F; Lambrecht, A; Lambrecht, A; Landais, A; Lawer, G; Leuenberger, M; Littot, G; Loulergue, L; Luthi, D; Maggi, V; Marino, F; Masson-Delmotte, V; Meyer, H; Miller, H; Mulvaney, R; Narcisi, B; Oerlemans, J; Oerter, H; Parrenin, F; Petit, JR; Raisbeck, G; Raynaud, D; Rothlisberger, R; Ruth, U; Rybak, O; Severi, M; Schmitt, J; Schwander, J; Siegenthaler, U; Siggaard-Andersen, ML; Spahni, R; Steffensen, JP; Stenni, B; Stocker, TF; Tison, JL; Traversi, R; Udisti, R; Valero-Delgado, F; van den Broeke, MR; van de Wal, RSW; Wagenbach, D; Wegner, A; Weiler, K; Wilhelms, F; Winther, JG; Wolff, E				Barbante, C.; Barnola, J. -M.; Becagli, S.; Beer, J.; Bigler, M.; Boutron, C.; Blunier, T.; Castellano, E.; Cattani, O.; Chappellaz, J.; Dahl-Jensen, D.; Debret, M.; Delmonte, B.; Dick, D.; Falourd, S.; Faria, S.; Federer, U.; Fischer, H.; Freitag, J.; Frenzel, A.; Fritzsche, D.; Fundel, F.; Gabrielli, P.; Gaspari, V.; Gersonde, R.; Graf, W.; Grigoriev, D.; Hamann, I.; Hansson, M.; Hoffmann, G.; Hutterli, M. A.; Huybrechts, P.; Isaksson, E.; Johnsen, S.; Jouzel, J.; Kaczmarska, M.; Karlin, T.; Kaufmann, P.; Kipfstuhl, S.; Kohno, M.; Lambert, F.; Lambrecht, Anja; Lambrecht, Astrid; Landais, A.; Lawer, G.; Leuenberger, M.; Littot, G.; Loulergue, L.; Luethi, D.; Maggi, V.; Marino, F.; Masson-Delmotte, V.; Meyer, H.; Miller, H.; Mulvaney, R.; Narcisi, B.; Oerlemans, J.; Oerter, H.; Parrenin, F.; Petit, J. -R.; Raisbeck, G.; Raynaud, D.; Roethlisberger, R.; Ruth, U.; Rybak, O.; Severi, M.; Schmitt, J.; Schwander, J.; Siegenthaler, U.; Siggaard-Andersen, M. -L.; Spahni, R.; Steffensen, J. P.; Stenni, B.; Stocker, T. F.; Tison, J. -L.; Traversi, R.; Udisti, R.; Valero-Delgado, F.; van den Broeke, M. R.; van de Wal, R. S. W.; Wagenbach, D.; Wegner, A.; Weiler, K.; Wilhelms, F.; Winther, J. -G.; Wolff, E.		EPICA Community Members	One-to-one coupling of glacial climate variability in Greenland and Antarctica	NATURE			English	Article							EAST ANTARCTICA; NORTH-ATLANTIC; CIRCULATION; SURFACE; ORIGIN	Precise knowledge of the phase relationship between climate changes in the two hemispheres is a key for understanding the Earth's climate dynamics. For the last glacial period, ice core studies(1,2) have revealed strong coupling of the largest millennial-scale warm events in Antarctica with the longest Dansgaard - Oeschger events in Greenland(3-5) through the Atlantic meridional overturning circulation(6-8). It has been unclear, however, whether the shorter Dansgaard - Oeschger events have counterparts in the shorter and less prominent Antarctic temperature variations, and whether these events are linked by the same mechanism. Here we present a glacial climate record derived from an ice core from Dronning Maud Land, Antarctica, which represents South Atlantic climate at a resolution comparable with the Greenland ice core records. After methane synchronization with an ice core from North Greenland(9), the oxygen isotope record from the Dronning Maud Land ice core shows a one-to-one coupling between all Antarctic warm events and Greenland Dansgaard - Oeschger events by the bipolar seesaw(6). The amplitude of the Antarctic warm events is found to be linearly dependent on the duration of the concurrent stadial in the North, suggesting that they all result from a similar reduction in the meridional overturning circulation.	Univ Ca Foscari, Dept Environm Sci, Venice, Italy; CNR, Inst Dynam Environm Proc, I-30123 Venice, Italy; CNRS UJF, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Univ Florence, Dept Chem, I-50019 Florence, Italy; EAWAG, CH-8600 Dubendorf, Switzerland; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen OE, Denmark; CE Saclay, Lab Sci Climat & Environm LSCE IPSL, CEA CNRS UVSQ, F-91191 Gif Sur Yvette, France; Univ Milano Bicocca, Dept Environm Sci, I-20126 Milan, Italy; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; Alfred Wegener Inst Polar & Marine Res, Res Unit Potsdam, D-14473 Potsdam, Germany; GSF, Natl Ctr Environm & Hlth, D-85764 Neuherberg, Germany; UCL, London WC1E 6BT, England; Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; British Antarctic Survey, Cambridge CB3 0ET, England; Free Univ Brussels, Dept Geog, B-1050 Brussels, Belgium; Norwegian Polar Res Inst, N-9296 Tromso, Norway; ENEA, I-00060 Rome, Italy; Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TA Utrecht, Netherlands; CSNSM IN2P3 CNRS, F-91405 Orsay, France; Univ Trieste, Dept Geol Environm & Marine Sci, I-34127 Trieste, Italy; Free Univ Brussels, Dept Sci Terre, B-1050 Brussels, Belgium; Heidelberg Univ, Inst Environm Phys, D-69120 Heidelberg, Germany; Max Planck Inst Math Sci, D-04103 Leipzig, Germany	Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Florence; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern; University of Copenhagen; Niels Bohr Institute; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Milano-Bicocca; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; University College London; Stockholm University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Norwegian Polar Institute; Italian National Agency New Technical Energy & Sustainable Economics Development; Utrecht University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; University of Trieste; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ruprecht Karls University Heidelberg; Max Planck Society	Fischer, H (corresponding author), Univ Ca Foscari, Dept Environm Sci, Venice, Italy.	hufischer@awi-bremerhaven.de	Fischer, Hubertus/A-1211-2014; Oerlemans, Johannes/G-3802-2011; Schmitt, Jochen/B-7893-2009; Blunier, Thomas/M-4609-2014; Meyer, Hanno/AAQ-4260-2021; Lambert, Fabrice/M-2003-2014; Dahl-Jensen, Dorthe/AAO-6951-2020; raynaud, dominique/ABG-4718-2020; Rybak, Oleg/B-7308-2014; Traversi, Rita/M-7586-2015; Faria, Sérgio Henrique/K-9454-2013; Chappellaz, Jérôme A./A-4872-2011; Raynaud, Dominique/H-9626-2016; Van den Broeke, Michiel R./F-7867-2011; Wolff, Eric/AAB-1097-2021; Wolff, Eric W/D-7925-2014; Karlin, Torbjörn/H-7839-2012; Maggi, Valter/E-1878-2014; Debret, Maxime/L-4236-2017; Leuenberger, Markus C/K-9655-2016; Masson-Delmotte, Valerie L/G-1995-2011; Maggi, Valter/AAX-5728-2020; Stocker, Thomas/B-1273-2013; Severi, Mirko/J-2508-2012; Dahl-Jensen, Dorthe/N-4401-2016; Meyer, Hanno/E-2870-2016; van de wal, roderik/D-1705-2011; Parrenin, Frédéric/H-3054-2014; Mulvaney, Robert/K-3929-2012; Weikusat, Ilka/E-8826-2015; Rybak, Oleg/AAQ-8467-2020; Barbante, Carlo/B-3195-2011; Delmonte, Barbara/L-2555-2015; Udisti, Roberto/M-7966-2015; Fundel, Felix/C-5469-2009; Tison, Jean-Louis/F-4065-2015; Huybrechts, Philippe/J-5278-2013	Fischer, Hubertus/0000-0002-2787-4221; Schmitt, Jochen/0000-0003-4695-3029; Blunier, Thomas/0000-0002-6065-7747; Meyer, Hanno/0000-0003-4129-4706; Lambert, Fabrice/0000-0002-2192-024X; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Rybak, Oleg/0000-0003-3923-7163; Traversi, Rita/0000-0002-9790-2195; Faria, Sérgio Henrique/0000-0002-8825-7518; Van den Broeke, Michiel R./0000-0003-4662-7565; Wolff, Eric/0000-0002-5914-8531; Wolff, Eric W/0000-0002-5914-8531; Karlin, Torbjörn/0000-0003-1479-801X; Debret, Maxime/0000-0002-8852-0152; Leuenberger, Markus C/0000-0003-4299-6793; Masson-Delmotte, Valerie L/0000-0001-8296-381X; Maggi, Valter/0000-0001-6287-1213; Severi, Mirko/0000-0003-1511-6762; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Meyer, Hanno/0000-0003-4129-4706; van de wal, roderik/0000-0003-2543-3892; Parrenin, Frédéric/0000-0002-9489-3991; Mulvaney, Robert/0000-0002-5372-8148; Weikusat, Ilka/0000-0002-3023-6036; Rybak, Oleg/0000-0002-7234-0544; Udisti, Roberto/0000-0003-4440-8238; Wilhelms, Frank/0000-0001-7688-3135; Steffensen, Jorgen Peder/0000-0002-5516-1093; Stenni, Barbara/0000-0003-4950-3664; Becagli, Silvia/0000-0003-3633-4849; Miller, Heinrich/0000-0003-1015-2828; Tison, Jean-Louis/0000-0002-9758-3454; LANDAIS, Amaelle/0000-0002-5620-5465; Barbante, Carlo/0000-0003-4177-2288; Fritzsche, Diedrich/0000-0002-0018-8993; Delmonte, Barbara/0000-0002-9074-2061; Huybrechts, Philippe/0000-0003-1406-0525	Natural Environment Research Council [bas010016] Funding Source: researchfish; NERC [bas010016] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; ANDERSEN KK, IN PRESS QUAT SCI RE; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Basile I, 1997, EARTH PLANET SC LETT, V146, P573, DOI 10.1016/S0012-821X(96)00255-5; Bianchi C, 2002, PALAEOGEOGR PALAEOCL, V187, P151, DOI 10.1016/S0031-0182(02)00516-3; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; de Abreu L, 2003, MAR GEOL, V196, P1, DOI 10.1016/S0025-3227(03)00046-X; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Landais A, 2004, EARTH PLANET SC LETT, V225, P221, DOI 10.1016/j.epsl.2004.06.009; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Oerter H, 2000, ANN GLACIOL-SER, V30, P27, DOI 10.3189/172756400781820705; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; RAISBECK G, 2002, GEOCHIM COSMOCHIM AC, V66; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Reijmer H, 2002, J CLIMATE, V15, P1957, DOI 10.1175/1520-0442(2002)015<1957:APTASR>2.0.CO;2; Roe GH, 2004, J CLIMATE, V17, P1929, DOI [10.1175/1520-0442(2004)017<1929:COMCV>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;1929:COMCV&gt;2.0.CO;2]; Rothlisberger R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015186; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Stenni B, 2004, EARTH PLANET SC LETT, V217, P183, DOI 10.1016/S0012-821X(03)00574-0; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525	30	900	935	15	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					195	198		10.1038/nature05301	http://dx.doi.org/10.1038/nature05301			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17099953	Green Published			2022-12-28	WOS:000241867200038
J	Brennan, DC; Daller, JA; Lake, KD; Cibrik, D; Del Castillo, D				Brennan, Daniel C.; Daller, John A.; Lake, Kathleen D.; Cibrik, Diane; Del Castillo, Domingo		Thymoglobulin Induction Study Grp	Rabbit antithymocyte globulin versus basiliximab in renal transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELAYED GRAFT FUNCTION; THYMOGLOBULIN; RECIPIENTS; IMMUNOSUPPRESSION; REJECTION; APOPTOSIS; SURVIVAL; THERAPY	BACKGROUND: Induction therapy reduces the frequency of acute rejection and delayed graft function after transplantation. A rabbit antithymocyte polyclonal antibody or basiliximab, an interleukin-2 receptor monoclonal antibody, is most commonly used for induction. METHODS: In this prospective, randomized, international study, we compared short courses of antithymocyte globulin and basiliximab in patients at high risk for acute rejection or delayed graft function who received a renal transplant from a deceased donor. Patients taking cyclosporine, mycophenolate mofetil, and prednisone were randomly assigned to receive either rabbit antithymocyte globulin (1.5 mg per kilogram of body weight daily, 141 patients) during transplantation (day 0) and on days 1 through 4 or basiliximab (20 mg, 137 patients) on days 0 and 4. The primary end point was a composite of acute rejection, delayed graft function, graft loss, and death. RESULTS: At 12 months, the incidence of the composite end point was similar in the two groups (P=0.34). The antithymocyte globulin group, as compared with the basiliximab group, had lower incidences of acute rejection (15.6% vs. 25.5%, P=0.02) and of acute rejection that required treatment with antibody (1.4% vs. 8.0%, P=0.005). The antithymocyte globulin group and the basiliximab group had similar incidences of graft loss (9.2% and 10.2%, respectively), delayed graft function (40.4% and 44.5%), and death (4.3% and 4.4%). Though the incidences of all adverse events, serious adverse events, and cancers were also similar between the two groups, patients receiving antithymocyte globulin had a greater incidence of infection (85.8% vs. 75.2%, P=0.03) but a lower incidence of cytomegalovirus disease (7.8% vs. 17.5%, P=0.02). CONCLUSIONS: Among patients at high risk for acute rejection or delayed graft function who received a renal transplant from a deceased donor, induction therapy consisting of a 5-day course of antithymocyte globulin, as compared with basiliximab, reduced the incidence and severity of acute rejection but not the incidence of delayed graft function. Patient and graft survival were similar in the two groups.	Washington Univ, Sch Med, Barnes Jewish Hosp, Div Renal, St Louis, MO USA; Univ Texas, Med Branch, Galveston, TX 77550 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; Hosp Reina Sofia, Cordoba, Spain	Barnes-Jewish Hospital; Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hospital Universitario Reina Sofia - Cordoba	Brennan, DC (corresponding author), Washington Univ, Sch Med, Div Renal, Campus Box 8126, St Louis, MO 63110 USA.	dbrennan@wustl.edu						Agha IA, 2002, TRANSPLANTATION, V73, P473, DOI 10.1097/00007890-200202150-00025; BonnefoyBerard N, 1996, J HEART LUNG TRANSPL, V15, P435; BOURDAGE JS, 1995, TRANSPLANTATION, V59, P1194, DOI 10.1097/00007890-199504270-00020; Brennan DC, 1999, TRANSPLANTATION, V67, P1011, DOI 10.1097/00007890-199904150-00013; Brennan DC, 1999, TRANSPLANTATION, V67, P1386, DOI 10.1097/00007890-199905270-00020; CECKA JM, 1992, TRANSPLANTATION, V53, P59, DOI 10.1097/00007890-199201000-00011; FLEISS JL, 1981, STAT METHODS RATES P, P41; GJERTSON DW, 2000, CLIN TRANSPLANTS 199, P341; Goggins WC, 2003, TRANSPLANTATION, V76, P798, DOI 10.1097/01.TP.0000081042.67285.91; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hariharan S, 2001, AM J KIDNEY DIS, V38, pS44, DOI 10.1053/ajkd.2001.28925; Humar A, 1997, CLIN TRANSPLANT, V11, P623; Lebranchu Y, 2002, AM J TRANSPLANT, V2, P48, DOI 10.1034/j.1600-6143.2002.020109.x; LINDHOLM A, 1993, TRANSPLANTATION, V56, P307, DOI 10.1097/00007890-199308000-00010; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Mourad G, 2004, TRANSPLANTATION, V78, P584, DOI 10.1097/01.TP.0000129812.68794.CC; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sandrini S, 2005, CLIN TRANSPLANT, V19, P705, DOI 10.1111/j.1399-0012.2005.00417.x; Shoskes DA, 1996, J UROLOGY, V155, P1831, DOI 10.1016/S0022-5347(01)66023-3; *US ORG PROC TRANS, 2004, OPTN SRTR ANN REP; WITTES J, 1990, STAT MED, V9, P65, DOI 10.1002/sim.4780090113; Woodside KJ, 2003, TRANSPLANTATION, V75, P1631, DOI 10.1097/01.TP.0000062973.32754.F7; Zand MS, 2005, TRANSPLANTATION, V79, P1507, DOI 10.1097/01.TP.0000164159.20075.16	23	517	538	3	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1967	1977		10.1056/NEJMoa060068	http://dx.doi.org/10.1056/NEJMoa060068			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093248	Bronze			2022-12-28	WOS:000241833000005
J	Gullans, SR				Gullans, Steven R.			Connecting the dots using gene-expression profiles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		RxGen, New Haven, CT USA		Gullans, SR (corresponding author), RxGen, New Haven, CT USA.							Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939	2	6	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					2042	2044		10.1056/NEJMcibr065953	http://dx.doi.org/10.1056/NEJMcibr065953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102SG	17093257				2022-12-28	WOS:000241833000016
J	Kupsch, A; Benecke, R; Muller, J; Trottenberg, T; Schneider, G; Poewe, W; Eisner, W; Wolters, A; Muller, J; Deuschl, G; Pinsker, MO; Skogseid, IM; Roeste, GK; Vollmer-Haase, J; Brentrup, A; Krause, M; Tronnier, V; Schnitzler, A; Voges, J; Nikkhah, G; Vesper, J; Naumann, M; Volkmann, J				Kupsch, Andreas; Benecke, Reiner; Mueller, Joerg; Trottenberg, Thomas; Schneider, Gerd-Helge; Poewe, Werner; Eisner, Wilhelm; Wolters, Alexander; Mueller, Jan-Uwe; Deuschl, Guenther; Pinsker, Marcus O.; Skogseid, Inger Marie; Roeste, Geir Ketil; Vollmer-Haase, Juliane; Brentrup, Angela; Krause, Martin; Tronnier, Volker; Schnitzler, Alfons; Voges, Juergen; Nikkhah, Guido; Vesper, Jan; Naumann, Markus; Volkmann, Jens		Deep-Brain Stimulation Dystonia St	Pallidal deep-brain stimulation in primary generalized or segmental dystonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOBUS-PALLIDUS; CERVICAL DYSTONIA; BOTULINUM TOXIN; DOUBLE-BLIND; INTERNUS; RELIABILITY; EFFICACY	BACKGROUND: Neurostimulation of the internal globus pallidus has been shown to be effective in reducing symptoms of primary dystonia. We compared this surgical treatment with sham stimulation in a randomized, controlled clinical trial. METHODS: Forty patients with primary segmental or generalized dystonia received an implanted device for deep-brain stimulation and were randomly assigned to receive either neurostimulation or sham stimulation for 3 months. The primary end point was the change from baseline to 3 months in the severity of symptoms, according to the movement subscore on the Burke-Fahn-Marsden Dystonia Rating Scale (range, 0 to 120, with higher scores indicating greater impairment). Two investigators who were unaware of treatment status assessed the severity of dystonia by reviewing videotaped sessions. Subsequently, all patients received open-label neurostimulation; blinded assessment was repeated after 6 months of active treatment. RESULTS: Three months after randomization, the change from baseline in the mean (+/-SD) movement score was significantly greater in the neurostimulation group (-15.8+/-14.1 points) than in the sham-stimulation group (-1.4+/-3.8 points, P<0.001). During the open-label extension period, this improvement was sustained among patients originally assigned to the neurostimulation group, and patients in the sham-stimulation group had a similar benefit when they switched to active treatment. The combined analysis of the entire cohort after 6 months of neurostimulation revealed substantial improvement in all movement symptoms (except speech and swallowing), the level of disability, and quality of life, as compared with baseline scores. A total of 22 adverse events occurred in 19 patients, including 4 infections at the stimulator site and 1 lead dislodgment. The most frequent adverse event was dysarthria. CONCLUSIONS: Bilateral pallidal neurostimulation for 3 months was more effective than sham stimulation in patients with primary generalized or segmental dystonia.	Univ Kiel, Dept Neurol, D-24105 Kiel, Germany; Charite Univ Med Berlin, Berlin, Germany; Univ Rostock, Rostock, Germany; Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; Univ Munster, D-4400 Munster, Germany; Heidelberg Univ, Heidelberg, Germany; Univ Dusseldorf, D-4000 Dusseldorf, Germany; Univ Cologne, Cologne, Germany; Univ Freiburg, Freiburg, Germany; Univ Wurzburg, Wurzburg, Germany; Med Univ Innsbruck, A-6020 Innsbruck, Austria; Univ Oslo, Oslo, Norway	University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock; Ernst Moritz Arndt Universitat Greifswald; University of Munster; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; University of Cologne; University of Freiburg; University of Wurzburg; Medical University of Innsbruck; University of Oslo	Volkmann, J (corresponding author), Univ Kiel, Dept Neurol, Schittenhelm Str 10, D-24105 Kiel, Germany.	j.volkmann@neurologie.uni-kiel.de	Schnitzler, Alfons/K-4625-2014; Volkmann, Jens/AAK-7570-2020; Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/AAT-1054-2021; Deuschl, Gunther/A-7986-2010	Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Deuschl, Gunther/0000-0002-4176-9196; Volkmann, Jens/0000-0002-9570-593X; Schneider, Gerd-Helge/0000-0002-1301-2938				Balash Y, 2004, EUR J NEUROL, V11, P361, DOI 10.1111/j.1468-1331.2004.00845.x; Beck A. T., 1997, BECK DEPRESSION INVE; Bereznai B, 2002, MOVEMENT DISORD, V17, P138, DOI 10.1002/mds.1250; Bittar RG, 2005, J CLIN NEUROSCI, V12, P12, DOI 10.1016/j.jocn.2004.03.025; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; BURKE RE, 1986, NEUROLOGY, V36, P160, DOI 10.1212/WNL.36.2.160; Chou KL, 2005, MOVEMENT DISORD, V20, P377, DOI 10.1002/mds.20341; Cif L, 2003, J Neurosurg Sci, V47, P52; Coubes P, 2000, LANCET, V355, P2220, DOI 10.1016/S0140-6736(00)02410-7; Dressler D, 2004, MOVEMENT DISORD, V19, pS92, DOI 10.1002/mds.20022; Eltahawy HA, 2004, CAN J NEUROL SCI, V31, P328, DOI 10.1017/S0317167100003401; Fahn S, 1998, Adv Neurol, V78, P1; FLEMENBAUM A, 1973, PSYCHOL REP, V32, P783, DOI 10.2466/pr0.1973.33.3.783; Foncke EMJ, 2006, NEUROLOGY, V66, P142, DOI 10.1212/01.wnl.0000191328.05752.e2; Foote KD, 2005, NEUROSURGERY, V56, P415, DOI 10.1227/01.NEU.0000147978.67424.42; Goodman RR, 2006, J NEUROL NEUROSUR PS, V77, P12, DOI 10.1136/jnnp.2005.069161; Greene P, 2005, NEW ENGL J MED, V352, P498, DOI 10.1056/NEJMe048333; Halbig TD, 2005, J NEUROL NEUROSUR PS, V76, P1713, DOI 10.1136/jnnp.2004.057992; Horn S, 2002, PARKINSONS DIS MOVEM, P358; Houser M, 2005, MOVEMENT DISORD, V20, P1203, DOI 10.1002/mds.20522; Islekel S, 1999, STEREOT FUNCT NEUROS, V72, P248, DOI 10.1159/000029736; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Klein C, 2002, CURR OPIN NEUROL, V15, P491, DOI 10.1097/00019052-200208000-00014; Krause M, 2004, NEUROSURGERY, V55, P1361, DOI 10.1227/01.NEU.0000143331.86101.5E; Krauss JK, 2003, J NEUROL NEUROSUR PS, V74, P1598, DOI 10.1136/jnnp.74.11.1598; Krauss JK, 2003, J NEUROSURG, V98, P785, DOI 10.3171/jns.2003.98.4.0785; Kumar R, 1999, NEUROLOGY, V53, P871, DOI 10.1212/WNL.53.4.871; Lyons KE, 2004, NEUROLOGY, V63, P612, DOI 10.1212/01.WNL.0000134650.91974.1A; Tronnier VM, 2000, J NEUROSURG, V92, P453, DOI 10.3171/jns.2000.92.3.0453; Truong D, 2005, MOVEMENT DISORD, V20, P783, DOI 10.1002/mds.20403; Vercueil L, 2002, MOVEMENT DISORD, V17, pS89, DOI 10.1002/mds.10148; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Xie J, 2001, J NEUROL, V248, P1068, DOI 10.1007/s004150170027; Yianni J, 2004, J CLIN NEUROSCI, V11, P243, DOI 10.1016/j.jocn.2003.10.003; Yianni J, 2003, MOVEMENT DISORD, V18, P436, DOI 10.1002/mds.10380; Zorzi G, 2005, MOVEMENT DISORD, V20, P1194, DOI 10.1002/mds.20510	37	663	686	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1978	1990		10.1056/NEJMoa063618	http://dx.doi.org/10.1056/NEJMoa063618			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093249				2022-12-28	WOS:000241833000006
J	Markowitz, AJ; McPhee, SJ				Markowitz, Amy J.; McPhee, Stephen J.			Spiritual issues in the care of dying patients: "... It's okay between me and God"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Sulmasy DP, 2006, JAMA-J AM MED ASSOC, V296, P1385, DOI 10.1001/jama.296.11.1385	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2254	2254		10.1001/jama.296.18.2254	http://dx.doi.org/10.1001/jama.296.18.2254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090772				2022-12-28	WOS:000241827700026
J	Basaviah, P; Frost, S				Basaviah, Preetha; Frost, Shaun			Update in hospital medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NONCARDIAC SURGERY; MEDICATION HISTORY; ERRORS		Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Cogent Healthcare, Irvine, CA USA	Stanford University	Basaviah, P (corresponding author), Stanford Univ, Sch Med, Dept Med, 251 Campus Dr MSOB,Room X212,MC 5475, Stanford, CA 94305 USA.	pree@stanford.edu						BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Chimowitz MI, 1998, STROKE, V29, P1389, DOI 10.1161/01.str.29.7.1389; CHIMOWITZ MI, 1995, NEUROLOGY, V45, P1488, DOI 10.1212/WNL.45.8.1488; Del Beccaro MA, 2006, PEDIATRICS, V118, P290, DOI 10.1542/peds.2006-0367; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Dobrzanski S., 2002, BRIT J CLIN GOVERNAN, V7, P187; Greenberger NJ, 2006, ANN INTERN MED, V145, P294, DOI 10.7326/0003-4819-145-4-200608150-00009; Jarcho JA, 2005, NEW ENGL J MED, V352, P1594, DOI 10.1056/NEJMe058065; Juul AB, 2006, BMJ-BRIT MED J, V332, P1482, DOI 10.1136/bmj.332.7556.1482; Kluger DM, 1999, 39 INT C ANT AG CHEM; Knight CL, 2006, ANN INTERN MED, V145, P52, DOI 10.7326/0003-4819-145-1-200607040-00010; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; Lorber B, 2006, ANN INTERN MED, V145, P354, DOI 10.7326/0003-4819-145-5-200609050-00008; Nester TM, 2002, AM J HEALTH-SYST PH, V59, P2221, DOI 10.1093/ajhp/59.22.2221; O'Grady Naomi P, 2005, ACP J Club, V143, P77; Raad I, 2004, ANN INTERN MED, V140, P18, DOI 10.7326/0003-4819-140-1-200401060-00007; Rosenbloom ST, 2006, PEDIATRICS, V117, P1452, DOI 10.1542/peds.2005-3163; RYAN JA, 1974, NEW ENGL J MED, V290, P757, DOI 10.1056/NEJM197404042901401; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Thijs VN, 2000, NEUROLOGY, V55, P490, DOI 10.1212/WNL.55.4.490; YANG H, 2004, CAN J ANAESTH, V51, pA7	21	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					685	691		10.7326/0003-4819-145-9-200611070-00011	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ZD	17088582				2022-12-28	WOS:000241707800007
J	Irvine, D				Irvine, Donald			Good doctors, safer patients - Reactions to the chief medical officer's report - Success relies on winning hearts and minds	BRITISH MEDICAL JOURNAL			English	Editorial Material												Donald@donaldirvine.demon.co.uk						[Anonymous], 2004, SAFEGUARDING PATIENT; Chief Medical Officer, 2006, GOOD DOCT SAF PAT; CHISHOLM A, 2006, SETTING STANDARDS VI; Coulter A, 2005, BMJ-BRIT MED J, V331, P1199, DOI 10.1136/bmj.331.7526.1199; GMC, 2006, GOOD MED PRACT; Irvine D, 2005, BMJ-BRIT MED J, V330, P1265, DOI 10.1136/bmj.330.7502.1265; RCP (Royal College of Physicians), 2005, DOCT SOC MED PROF CH	7	14	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2006	333	7575					965	966		10.1136/bmj.39010.463044.68	http://dx.doi.org/10.1136/bmj.39010.463044.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107GE	17082549	Green Published			2022-12-28	WOS:000242157900024
J	Marston, C; King, E				Marston, Cicely; King, Eleanor			Factors that shape young people's sexual behaviour: a systematic review	LANCET			English	Review							RISK-TAKING; CONDOM USE; GENDER; HEALTH; HIV; KNOWLEDGE; WOMEN; YOUTH; AIDS; COMMUNICATION	Background Since nearly half of new HIV infections worldwide occur among young people aged 15-24 years, changing sexual behaviour in this group will be crucial in tackling the pandemic. Qualitative research is starting to reveal how social and cultural forces shape young people's sexual behaviour and can help explain why information campaigns and condom distribution programmes alone are often not enough to change it. We undertook a systematic review to identify key themes emerging from such research, to help inform policymakers developing sexual health programmes, and guide future research. Methods We reviewed 268 qualitative studies of young people's sexual behaviour published between 1990 and 2004. We developed a method of comparative thematic analysis in which we coded each document according to themes they contained. We then identified relations between codes, grouping them accordingly into broader overall themes. Documents were classified as either primary or secondary depending on their quality and whether they contained empirical data. From the 5452 reports identified, we selected 246 journal articles and 22 books for analysis. Findings Seven key themes emerged: young people assess potential sexual partners as "clean!' or "unclean"; sexual partners have an important influence on behaviour in general; condoms are stigmatising and associated with lack of trust; gender stereotypes are crucial in determining social expectations and, in turn, behaviour; there are penalties and rewards for sex from society; reputations and social displays of sexual activity or inactivity are important; and social expectations hamper communication about sex. The themes do not seem to be exclusive to any particular country or cultural background, and all themes were present, in varying degrees, in all countries assessed. Interpretation This study summarises key qualitative findings that help in understanding young peoples sexual behaviour and why they might have unsafe sex; policymakers must take these into account when designing HIV programmes. Considerable overlap exists between current studies, which indicates the need to broaden the scope of future work.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Marston, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	Cicely.Marston@lshtm.ac.uk	Marston, Cicely/ABB-9376-2020; Marston, Cicely A/T-3551-2017	Marston, Cicely A/0000-0002-5529-4646				Anderson E., 1993, GHETTO UNDERCLASS SO, P76; Ankomah A, 1998, AIDS EDUC PREV, V10, P303; Asencio M., 2002, SEX SEXUALITY NEW YO; Asencio MW, 1999, MED ANTHROPOL Q, V13, P107, DOI 10.1525/maq.1999.13.1.107; Balmer DH, 1997, J ADOLESCENT HEALTH, V21, P33, DOI 10.1016/S1054-139X(96)00293-5; BANISTER E, 2003, CANADIAN J NURSING R, V35, P17; Bedimo A L, 1998, J Assoc Nurses AIDS Care, V9, P48, DOI 10.1016/S1055-3290(98)80019-8; Belk RW, 1998, J PUBLIC POLICY MARK, V17, P197, DOI 10.1177/074391569801700205; Bennett Linda Rae, 2002, COMING AGE S SE ASIA, P96; Berglund S, 1997, SOC SCI MED, V44, P1, DOI 10.1016/S0277-9536(96)00084-6; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Castaneda X., 2001, Culture, Health & Sexuality, V3, P203, DOI 10.1080/136910501750153021; Christianson M, 2003, SCAND J PUBLIC HEALT, V31, P44, DOI 10.1080/14034940210134158; Corlyon J, 1999, PREGNANCY PARENTHOOD; CRAGG A, 1993, TALKING IT YOUNG PEO, P22; de la Cuesta C, 2001, J Transcult Nurs, V12, P180, DOI 10.1177/104365960101200302; de Visser R, 2004, AIDS CARE, V16, P315, DOI 10.1080/09540120410001665321; Eyre SL, 1998, MED ANTHROPOL Q, V12, P467, DOI 10.1525/maq.1998.12.4.467; Farrer James, 2002, OPENING YOUTH SEX CU; FORD NJ, 1994, AIDS CARE, V6, P517, DOI 10.1080/09540129408258667; Foreman FE, 2003, AIDS CARE, V15, P493, DOI 10.1080/0954012031000134737; George A, 2002, CULT HEALTH SEX, V4, P207, DOI 10.1080/13691050110095856; Gilliam Melissa L, 2004, J Pediatr Adolesc Gynecol, V17, P279, DOI 10.1016/j.jpag.2004.05.003; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Harrison A, 2001, REPROD HEALTH MATTER, V9, P63, DOI 10.1016/S0968-8080(01)90009-6; Hassan R, 1995, Plan Parent Chall, P5; Hennink M, 1999, ETHNIC RACIAL STUD, V22, P867, DOI 10.1080/014198799329297; Herrera A. A., 1998, Reproductive Health Matters, V6, P105; Hillier L, 1999, Cult Health Sex, V1, P347, DOI 10.1080/136910599300932; Hird MJ, 2000, J ADOLESCENCE, V23, P69, DOI 10.1006/jado.1999.0292; HOLLAND J, 1991, SOC AS AIDS, P127; Holland J., 2000, SEX RELATSH THER, V15, P221, DOI [DOI 10.1080/14681990050109827, 10.1080/14681990050109827]; HUGHES K, 1999, REDUCING RATE TEENAG; INGHAM R, 1991, J COMMUNITY APPL SOC, V1, P117, DOI 10.1002/casp.2450010206; Kumar Anuradha, 2002, COMING AGE S SE ASIA, P58; LAVOIE F, 2000, VIOLENCE AGAINST WOM, V6, P6, DOI DOI 10.1177/10778010022181688; Lear D, 1996, QUAL HEALTH RES, V6, P112, DOI 10.1177/104973239600600107; LEAR D, 1995, SOC SCI MED, V41, P1311, DOI 10.1016/0277-9536(95)00010-5; LEAR D, 1997, SEX SEXUALITY RISKS; LEE RB, 2002, COMING AGE S SE ASIA, P132; Marston C, 2005, SOCIOL HEALTH ILL, V27, P68, DOI 10.1111/j.1467-9566.2005.00432.x; Marston C, 2004, SOC SCI MED, V59, P445, DOI 10.1016/j.socscimed.2003.11.007; McKernon S, 1996, VENEREOLOGY, V9, P233; Middelthon AL, 2001, AIDS CARE, V13, P515, DOI 10.1080/09540120120058049; Mitchell K, 2002, CULT HEALTH SEX, V4, P393, DOI 10.1080/1369105021000041043; Morrison L, 2004, QUAL HEALTH RES, V14, P328, DOI 10.1177/1049732303261624; Nnko S., 2001, AFRICAN J REPROD HLT, V5, P162, DOI DOI 10.2307/3583333; Nyanzi S, 2001, AIDS CARE, V13, P83, DOI 10.1080/09540120020018206; Osella C, 1998, J ROY ANTHROPOL INST, V4, P189, DOI 10.2307/3034499; PAIVA V, 1993, REPROD HEALTH MATTER, V1, P98; Puri MC, 2004, CULT HEALTH SEX, V6, P145, DOI 10.1080/13691050310001619653; Rasch V, 2000, REPROD HEALTH MATTER, V8, P52, DOI 10.1016/S0968-8080(00)90006-5; Schifter J, 2000, SEXUAL CONSTRUCTION; Smith DJ, 2004, CULT HEALTH SEX, V6, P425, DOI 10.1080/13691050410001680528; STEPHENSON N, 1993, SOC AS AIDS, P61; SwartKruger J, 1997, SOC SCI MED, V45, P957, DOI 10.1016/S0277-9536(96)00417-0; Tarr CM, 1999, AIDS CARE, V11, P375, DOI 10.1080/09540129947992; Thianthai C, 2004, CULT HEALTH SEX, V6, P189, DOI 10.1080/1369105031000156379; THOMSON R, 1998, TEENAGE SEXUALITY HL; Thomson R, 1998, MALE HEAD YOUNG PEOP; *UNDP, 2005, POP HIV AIDS 2005 WA; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Varga CA, 2003, STUD FAMILY PLANN, V34, P160, DOI 10.1111/j.1728-4465.2003.00160.x; VARGA CA, 2000, DEV B, V52, P67; WALDBY C, 1993, SOC AS AIDS, P29; WEEKES D, 2002, SEX ED, V2, P251, DOI DOI 10.1080/1468181022000025802; WIGHT, 1993, AIDS FACING 2 DECADE, P41; Wight D, 1999, SOCIOL HEALTH ILL, V21, P735, DOI 10.1111/1467-9566.00181; WIGHT D, 1994, SOCIOL REV, V42, P703, DOI 10.1111/j.1467-954X.1994.tb00107.x; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; Yeh CH, 2002, PUBLIC HEALTH NURS, V19, P68, DOI 10.1046/j.1525-1446.2002.19009.x	71	349	353	2	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1581	1586		10.1016/S0140-6736(06)69662-1	http://dx.doi.org/10.1016/S0140-6736(06)69662-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084758	Green Accepted			2022-12-28	WOS:000242180900027
J	Wallden, L				Wallden, Lars			Beyond the particle in the box	SCIENCE			English	Editorial Material							QUANTUM-WELL STATES; THIN METAL-FILMS; PHOTOEMISSION		Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Wallden, L (corresponding author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.	wallden@fy.chalmers.se						Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; Corriol C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.176802; HORN K, 1992, APPL SURF SCI, V56-8, P271, DOI 10.1016/0169-4332(92)90246-T; JAKLEVIC RC, 1975, PHYS REV B, V12, P4146, DOI 10.1103/PhysRevB.12.4146; KITTEL C, 2005, INTRO SOLID STATE PH, P506; LINDGREN SA, 2000, HDB SURFACE SCI, V2, P89; MILLER T, 1988, PHYS REV LETT, V61, P1404, DOI 10.1103/PhysRevLett.61.1404; ORTEGA JE, 1993, PHYS REV B, V47, P1540, DOI 10.1103/PhysRevB.47.1540; SCHULTE FK, 1976, SURF SCI, V55, P427, DOI 10.1016/0039-6028(76)90250-8; Speer NJ, 2006, SCIENCE, V314, P804, DOI 10.1126/science.1132941; Tung RT, 2001, MAT SCI ENG R, V35, P1, DOI 10.1016/S0927-796X(01)00037-7	11	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					769	770		10.1126/science.1135737	http://dx.doi.org/10.1126/science.1135737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17082443				2022-12-28	WOS:000241729800030
J	Evans, DAD				Evans, David A. D.			Proterozoic low orbital obliquity and axial-dipolar geomagnetic field from evaporite palaeolatitudes	NATURE			English	Article							NEOPROTEROZOIC SNOWBALL EARTH; PALEOMAGNETIC CONSTRAINTS; NORTH-ATLANTIC; POLAR WANDER; CLIMATE; GLACIATION; HISTORY; PALEOGEOGRAPHY; SIMULATIONS; CONTINENTS	Palaeomagnetism of climatically sensitive sedimentary rock types, such as glacial deposits and evaporites, can test the uniformitarianism of ancient geomagnetic fields and palaeoclimate zones. Proterozoic glacial deposits laid down in near-equatorial palaeomagnetic latitudes can be explained by 'snowball Earth' episodes, high orbital obliquity or markedly non-uniformitarian geomagnetic fields. Here I present a global palaeomagnetic compilation of the Earth's entire basin-scale evaporite record. Magnetic inclinations are consistent with low orbital obliquity and a geocentric-axial-dipole magnetic field for most of the past two billion years, and the snowball Earth hypothesis accordingly remains the most viable model for low-latitude Proterozoic ice ages. Efforts to reconstruct Proterozoic supercontinents are strengthened by this demonstration of a consistently axial and dipolar geomagnetic reference frame, which itself implies stability of geodynamo processes on billion-year timescales.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Yale University	Evans, DAD (corresponding author), Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06520 USA.	dai.evans@yale.edu		Evans, David/0000-0001-8952-5273				[Anonymous], 1993, PALEOMAGNETISM ATLAN, DOI 10.1017/CBO9780511524936; Besse J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000050; Bloxham J, 2000, NATURE, V405, P63, DOI 10.1038/35011045; BORCHERT H, 1964, SALT DEPOSITS; Cocks LRM, 2002, J GEOL SOC LONDON, V159, P631, DOI 10.1144/0016-764901-118; DREWRY GE, 1974, J GEOL, V82, P531, DOI 10.1086/628005; Evans DAD, 2000, AM J SCI, V300, P347, DOI 10.2475/ajs.300.5.347; Evans DAD, 2003, TECTONOPHYSICS, V375, P353, DOI 10.1016/S0040-1951(03)00345-7; Evans DAD, 2003, TECTONOPHYSICS, V362, P303, DOI 10.1016/S0040-1951(02)000642-X; GORDON WA, 1975, J GEOL, V83, P671, DOI 10.1086/628161; HALLAM A, 1984, PALAEOGEOGR PALAEOCL, V47, P195, DOI 10.1016/0031-0182(84)90094-4; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; HUNT BG, 1979, NATURE, V281, P188, DOI 10.1038/281188a0; HUNT BG, 1982, J METEOROL SOC JPN, V60, P309, DOI 10.2151/jmsj1965.60.1_309; Hyde WT, 2000, NATURE, V405, P425, DOI 10.1038/35013005; Idnurm M, 2000, AUST J EARTH SCI, V47, P405, DOI 10.1046/j.1440-0952.2000.00788.x; IRVING E, 1962, NATURE, V196, P425, DOI 10.1038/196425b0; Irving E., 1956, GEOFIS PURA APPL, V33, P23, DOI DOI 10.1007/BF02629944; Jenkins GS, 2001, J GEOPHYS RES-PLANET, V106, P32903, DOI 10.1029/2000JE001427; Jenkins GS, 2000, J GEOPHYS RES-ATMOS, V105, P7357, DOI 10.1029/1999JD901125; Kent DV, 2005, SCIENCE, V307, P240, DOI 10.1126/science.1105826; Kent DV, 1998, EARTH PLANET SC LETT, V160, P391, DOI 10.1016/S0012-821X(98)00099-5; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Levrard B, 2003, GEOPHYS J INT, V154, P970, DOI 10.1046/j.1365-246X.2003.02021.x; LIVERMORE RA, 1983, GEOPHYS J ROY ASTR S, V73, P153, DOI 10.1111/j.1365-246X.1983.tb03812.x; McElhinny MW, 2003, TECTONOPHYSICS, V362, P41, DOI 10.1016/S0040-1951(02)00630-3; Muttoni G, 2003, EARTH PLANET SC LETT, V215, P379, DOI 10.1016/S0012-821X(03)00452-7; Olson P, 2002, GEOPHYS J INT, V151, P809, DOI 10.1046/j.1365-246X.2002.01818.x; Opdyke N.D., 1962, INT GEOPHYS, V3, P41; Pais MA, 1999, EARTH PLANET SC LETT, V174, P155, DOI 10.1016/S0012-821X(99)00249-6; PARK JK, 1991, PRECAMBRIAN RES, V52, P1, DOI 10.1016/0301-9268(91)90011-X; PARRISH JT, 1982, PALAEOGEOGR PALAEOCL, V40, P67, DOI 10.1016/0031-0182(82)90085-2; Pope MC, 2003, J SEDIMENT RES, V73, P280, DOI 10.1306/091302730280; Poulsen CJ, 2003, GEOLOGY, V31, P473, DOI 10.1130/0091-7613(2003)031<0473:AOARIF>2.0.CO;2; RAUB TD, 2006, EOS, V87; Smirnov AV, 2003, GEOLOGY, V31, P415, DOI 10.1130/0091-7613(2003)031<0415:POTEGG>2.0.CO;2; Tauxe L, 2005, EARTH PLANET SC LETT, V233, P247, DOI 10.1016/j.epsl.2005.01.027; Torsvik TH, 2004, J GEOL SOC LONDON, V161, P555, DOI 10.1144/0016-764903-098; Torsvik TH, 2002, GEOPHYS J INT, V151, P771, DOI 10.1046/j.1365-246X.2002.01799.x; Torsvik TH, 2001, EARTH PLANET SC LETT, V187, P55, DOI 10.1016/S0012-821X(01)00284-9; Van der Voo R, 2001, EARTH PLANET SC LETT, V187, P71, DOI 10.1016/S0012-821X(01)00285-0; VANYO JP, 1985, PRECAMBRIAN RES, V29, P121, DOI 10.1016/0301-9268(85)90064-6; WARREN J, 1999, EVAPORITES THEIR EVO; Williams DM, 1998, NATURE, V396, P453, DOI 10.1038/24845; WILLIAMS GE, 1975, GEOL MAG, V112, P441, DOI 10.1017/S0016756800046185; WILLIAMS GE, 1993, EARTH-SCI REV, V34, P1, DOI 10.1016/0012-8252(93)90004-Q; Yang ZY, 2001, TECTONOPHYSICS, V334, P101, DOI 10.1016/S0040-1951(01)00061-0; Zhao X, 1996, AUST J EARTH SCI, V43, P643, DOI 10.1080/08120099608728285; Zharkov M. A., 1981, HIST PALEOZOIC SALT	50	109	111	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					51	55		10.1038/nature05203	http://dx.doi.org/10.1038/nature05203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080082				2022-12-28	WOS:000241701500042
J	Bukanov, NO; Smith, LA; Klinger, KW; Ledbetter, SR; Ibraghimov-Beskrovnaya, O				Bukanov, Nikolay O.; Smith, Laurie A.; Klinger, Katherine W.; Ledbetter, Steven R.; Ibraghimov-Beskrovnaya, Oxana			Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine	NATURE			English	Article							CELL-CYCLE; R-ROSCOVITINE; IN-VITRO; PROTEIN; PROGRESSION; ENCODES; GENE; APOPTOSIS; PATHWAY; KINASE	Polycystic kidney diseases (PKDs) are primarily characterized by the growth of fluid-filled cysts in renal tubules leading to end-stage renal disease(1-3). Mutations in the PKD1 or PKD2 genes lead to autosomal dominant PKD (ADPKD), a slowly developing adult form(4,5). Autosomal recessive polycystic kidney disease results from mutations in the PKHD1 gene, affects newborn infants and progresses very rapidly(6,7). No effective treatment is currently available for PKD. A previously unrecognized site of subcellular localization was recently discovered for all proteins known to be disrupted in PKD: primary cilia(8,9). Because ciliary functions seem to be involved in cell cycle regulation, disruption of proteins associated with cilia or centrioles may directly affect the cell cycle and proliferation, resulting in cystic disease(10-12). We therefore reasoned that the dysregulated cell cycle may be the most proximal cause of cystogenesis, and that intervention targeted at this point could provide significant therapeutic benefit for PKD. Here we show that treatment with the cyclin-dependent kinase (CDK) inhibitor (R)-roscovitine does indeed yield effective arrest of cystic disease in jck and cpk mouse models of PKD. Continuous daily administration of the drug is not required to achieve efficacy; pulse treatment provides a robust, long-lasting effect, indicating potential clinical benefits for a lifelong therapy. Molecular studies of the mechanism of action reveal effective cell-cycle arrest, transcriptional inhibition and attenuation of apoptosis. We found that roscovitine is active against cysts originating from different parts of the nephron, a desirable feature for the treatment of ADPKD, in which cysts form in multiple nephron segments. Our results indicate that inhibition of CDK is a new and effective approach to the treatment of PKD.	Genzyme Corp, Cell Biol, Framingham, MA 01701 USA; Genzyme Corp, Genet & Genom, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation; Sanofi-Aventis; Genzyme Corporation	Ibraghimov-Beskrovnaya, O (corresponding author), Genzyme Corp, Cell Biol, 5 Mt Rd, Framingham, MA 01701 USA.	oxana.beskrovnaya@genzyme.com						Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Ecder T, 2002, KIDNEY INT, V61, P1220, DOI 10.1046/j.1523-1755.2002.00250.x; Ecder Tevfik, 2004, Expert Rev Cardiovasc Ther, V2, P369, DOI 10.1586/14779072.2.3.369; Guzi Timothy, 2004, Curr Opin Investig Drugs, V5, P1311; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Lin L, 2006, CELL DEATH DIFFER, V13, P141, DOI 10.1038/sj.cdd.4401717; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Sweeney WE, 2003, KIDNEY INT, V64, P1310, DOI 10.1046/j.1523-1755.2003.00232.x; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Tao YX, 2005, P NATL ACAD SCI USA, V102, P6954, DOI 10.1073/pnas.0408518102; Tirado OM, 2005, CANCER RES, V65, P9320, DOI 10.1158/0008-5472.CAN-05-1276; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Verdaguer E, 2004, NEUROCHEM INT, V44, P251, DOI 10.1016/S0197-0186(03)00147-5; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WELLING LW, 1996, RENAL PATHOLOGY, P1828; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; WOO DDL, 1994, NATURE, V368, P750, DOI 10.1038/368750a0	30	209	237	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					949	952		10.1038/nature05348	http://dx.doi.org/10.1038/nature05348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17122773				2022-12-28	WOS:000242805400061
J	Low, HH; Lowe, J				Low, Harry H.; Loewe, Jan			A bacterial dynamin-like protein	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; MECHANOCHEMICAL ENZYME DYNAMIN; GTP-BINDING PROTEINS; CRYSTAL-STRUCTURE; MITOCHONDRIAL FUSION; DOMAIN; HOMOLOGY; CONSTRICTION; MORPHOLOGY; ASSEMBLES	Dynamins form a superfamily of large mechano-chemical GTPases that includes the classical dynamins and dynamin-like proteins (DLPs)(1). They are found throughout the Eukarya, functioning in core cellular processes such as endocytosis and organelle division(1). Many bacteria are predicted by sequence to possess large GTPases with the same multidomain architecture that is found in DLPs(2). Mechanistic dissection of dynamin family members has been impeded by a lack of high-resolution structural data currently restricted to the GTPase(3,4) and pleckstrin homology(5) domains, and the dynamin-related human guanylate-binding protein(6). Here we present the crystal structure of a cyanobacterial DLP in both nucleotide-free and GDP-associated conformation. The bacterial DLP shows dynamin-like qualities, such as helical self-assembly and tubulation of a lipid bilayer. In vivo, it localizes to the membrane in a manner reminiscent of FZL(7), a chloroplast-specific dynamin-related protein with which it shares sequence similarity. Our results provide structural and mechanistic insight that may be relevant across the dynamin superfamily. Concurrently, we show compelling similarity between a cyanobacterial and chloroplast DLP that, given the endosymbiotic ancestry of chloroplasts(8), questions the evolutionary origins of dynamins.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lowe, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/B-3882-2011; Low, Harry/T-4482-2019; Löwe, Jan/X-6998-2019	Lowe, Jan/0000-0002-5218-6615	MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gao H, 2006, P NATL ACAD SCI USA, V103, P6759, DOI 10.1073/pnas.0507287103; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; McFadden GI, 1999, CURR OPIN PLANT BIOL, V2, P513, DOI 10.1016/S1369-5266(99)00025-4; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Santel A, 2001, J CELL SCI, V114, P867; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TUMA PL, 1994, J BIOL CHEM, V269, P30842; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	28	167	174	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					766	769		10.1038/nature05312	http://dx.doi.org/10.1038/nature05312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17122778				2022-12-28	WOS:000242581100062
J	Hamon, M; Hamon, M				Hamon, Michele; Hamon, Martial			Images in clinical medicine: Asymptomatic coronary-artery spasm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CHU Caen, F-14033 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie	Hamon, M (corresponding author), CHU Caen, F-14033 Caen, France.	hamon-m@chu-caen.fr; hamon-m@chu-caen.fr							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2236	2236		10.1056/NEJMicm054005	http://dx.doi.org/10.1056/NEJMicm054005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124021				2022-12-28	WOS:000242170900010
J	Vickrey, BG; Mittman, BS; Connor, KI; Pearson, ML; Della Penna, RD; Ganiats, TG; DeMonte, RW; Chodosh, J; Cui, XP; Vassar, S; Duan, NH; Lee, M				Vickrey, Barbara G.; Mittman, Brian S.; Connor, Karen I.; Pearson, Marjorie L.; Della Penna, Richard D.; Ganiats, Theodore G.; DeMonte, Robert W., Jr.; Chodosh, Joshua; Cui, Xinping; Vassar, Stefanie; Duan, Naihua; Lee, Martin			The effect of a disease management intervention on quality and outcomes of dementia care - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							MANAGING ALZHEIMERS-DISEASE; LONGITUDINAL DATA-ANALYSIS; CONTROLLED CLINICAL-TRIAL; IMPROVING PRIMARY-CARE; CHRONIC ILLNESS; HEART-FAILURE; OF-CARE; DEPRESSION; GUIDELINES; HEALTH	Background: Adherence to dementia guidelines is poor despite evidence that some guideline recommendations can improve symptoms and delay institutionalization of patients. Objective: To test the effectiveness of a dementia guideline-based disease management program on quality of care and outcomes for patients with dementia. Design: Clinic-level, cluster randomized, controlled trial. Setting: 3 health care organizations collaborating with 3 community agencies in southern California. Participants: 18 primary care clinics and 408 patients with dementia age 65 years or older paired with 408 informal caregivers. Intervention: Disease management program led by care managers and provided to 238 patient-caregiver pairs at 9 intervention clinics for more than 12 months. Measurements: Adherence to 23 guideline recommendations (primary outcome) and receipt of community resources and patient and caregiver health and quality-of-care measures (secondary outcomes). Results: The mean percentage of per-patient guideline recommendations to which care was adherent was significantly higher in the intervention group than in the usual care group (63.9% vs. 32.9%, respectively; adjusted difference, 30.1% [95% Cl, 25.2% to 34.9%]; P < 0.001). Participants who received the intervention had higher care quality on 21 of 23 guidelines (P <= 0.013 for all), and higher proportions received community agency assistance (P <= 0.03) than those who received usual care. Patient health-related quality of life, overall quality of patient care, caregiving quality, social support, and level of unmet caregiving assistance needs were better for participants in the intervention group than for those in the usual care group (P < 0.05 for all). Caregiver health-related quality of life did not differ between the 2 groups. Limitations: Participants were well-educated, were predominantly white, had a usual source of care, and were not institutionalized. Generalizability to other patients and geographic regions is unknown. Also, costs of a care management program under fee-for-service reimbursement may impede adoption. Conclusions: A dementia guideline-based disease management program led to substantial improvements in quality of care for patients with dementia.	Univ Calif Los Angeles, Dept Neurol, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90095 USA; RAND Corp, Santa Monica, CA USA; Kaiser Permanente Federat, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Scripps Clin, La Jolla, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; Kaiser Permanente; University of California System; University of California San Diego; University of California System; University of California Riverside; Scripps Research Institute	Vickrey, BG (corresponding author), Univ Calif Los Angeles, Dept Neurol, VA Greater Los Angeles Healthcare Syst, C-109 RNRC,Box 951769, Los Angeles, CA 90095 USA.	bvickrey@ucla.edu	Janson, Patrick/AAC-7581-2022	Duan, Naihua/0000-0001-9411-2924; Chodosh, Joshua/0000-0001-7784-4306	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS081764] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM MED ASS, 1999, DIAGN MAN TREATM DEM; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Bass DM, 1996, J GERONTOL B-PSYCHOL, V51, pS121, DOI 10.1093/geronb/51B.3.S121; Bass DM, 2003, GERONTOLOGIST, V43, P73, DOI 10.1093/geront/43.1.73; BAUMGARTEN M, 1994, ANN INTERN MED, V120, P126, DOI 10.7326/0003-4819-120-2-199401150-00005; BEERS M, 1988, JAMA-J AM MED ASSOC, V260, P3016, DOI 10.1001/jama.260.20.3016; Bell R.M., 2002, SURV METHODOL, V28, P169; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; BERENSON R, 2003, HLTH AFFAIRS S; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chodosh J, 2006, J AM GERIATR SOC, V54, P311, DOI 10.1111/j.1532-5415.2005.00564.x; Coon DW, 2004, J AM GERIATR SOC, V52, P150, DOI 10.1111/j.1532-5415.2004.52026.x; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cummings JL, 2002, AM FAM PHYSICIAN, V65, P2525; Cummings JL, 2002, AM FAM PHYSICIAN, V65, P2263; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; Fergusson D, 2004, BRIT MED J, V328, P432, DOI 10.1136/bmj.37952.631667.EE; Fox P, 2000, ALZ DIS ASSOC DIS, V14, P87, DOI 10.1097/00002093-200004000-00006; Garrard J, 1998, J GERONTOL A-BIOL, V53, pM92, DOI 10.1093/gerona/53A.2.M92; Gifford DR, 1999, ANN INTERN MED, V131, P237, DOI 10.7326/0003-4819-131-4-199908170-00002; Glendinning C, 2003, HEALTH POLICY, V65, P139, DOI 10.1016/S0168-8510(02)00205-1; Hays RD, 1999, MED CARE, V37, pMS22, DOI 10.1097/00005650-199903001-00003; HAYS RD, 1995, ARCH GEN PSYCHIAT, V52, P11; HIBBARD JH, 2004, HLTH AFF MILLWOOD S; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Lachs MS, 1997, GERONTOLOGIST, V37, P469, DOI 10.1093/geront/37.4.469; LEMIEUX J, 2003, SEN SPEC COMM AG FOR; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lorig K., 1996, OUTCOME MEASURES HLT, VVol. 2019; Lyketsos CG, 2004, DEMENT GERIATR COGN, V17, P55, DOI 10.1159/000074277; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; MCCAFFREY DF, 2006, STAT MED        0203; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; MOHIDE EA, 1990, J AM GERIATR SOC, V38, P446, DOI 10.1111/j.1532-5415.1990.tb03544.x; Neumann PJ, 2000, MED DECIS MAKING, V20, P413, DOI 10.1177/0272989X0002000405; Pippenger M, 2001, NEUROLOGY, V56, P1206, DOI 10.1212/WNL.56.9.1206; Rosen CS, 2002, ALZ DIS ASSOC DIS, V16, P15, DOI 10.1097/00002093-200201000-00003; Rubenstein LV, 1999, HEALTH AFFAIR, V18, P89, DOI 10.1377/hlthaff.18.5.89; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sperl-Hillen J, 2000, Jt Comm J Qual Improv, V26, P615; Teri L, 2000, NEUROLOGY, V55, P1271, DOI 10.1212/WNL.55.9.1271; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Wagner EH, 2004, ANN INTERN MED, V141, P644, DOI 10.7326/0003-4819-141-8-200410190-00015; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	63	308	309	2	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					713	726		10.7326/0003-4819-145-10-200611210-00004	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110OB	17116916				2022-12-28	WOS:000242387100001
J	Bokel, C; Schwabedissen, A; Entchev, E; Renaud, O; Gonzalez-Gaitan, M				Boekel, Christian; Schwabedissen, Anja; Entchev, Eugeni; Renaud, Olivier; Gonzalez-Gaitan, Marcos			Sara endosomes and the maintenance of Dpp signaling levels across mitosis	SCIENCE			English	Article							TGF-BETA RECEPTOR; MORPHOGEN GRADIENT; DROSOPHILA; CELLS; TRANSDUCTION; APOPTOSIS; PROTEIN; CLATHRIN; RAB11	During development, cells acquire positional information by reading the concentration of morphogens. In the developing fly wing, a gradient of the transforming growth factor - beta ( TGF- beta) type morphogen decapentaplegic ( Dpp) is transduced into a gradient of concentration of the phosphorylated form of the R-Smad transcription factor Mad. The endosomal protein Sara ( Smad anchor for receptor activation) recruits R-Smads for phosphorylation by the type I TGF- beta receptor. We found that Sara, Dpp, and its type I receptor Thickveins were targeted to a subpopulation of apical endosomes in the developing wing epithelial cells. During mitosis, the Sara endosomes and the receptors therein associated with the spindle machinery to segregate into the two daughter cells. Daughter cells thereby inherited equal amounts of signaling molecules and thus retained the Dpp signaling levels of the mother cell.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland	Max Planck Society; University of Geneva; University of Geneva	Gonzalez-Gaitan, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	marcos.gonzalez@biochem.unige.ch	Bökel, Christian/F-6355-2010; Entchev, Eugeni V/D-2606-2009	Bökel, Christian/0000-0001-6603-6557; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Renaud, Olivier/0000-0003-0187-6680; Entchev, Eugeni/0000-0003-0744-5929				Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Bourillot PY, 2002, DEVELOPMENT, V129, P2167; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Jullien J, 2005, GENE DEV, V19, P2682, DOI 10.1101/gad.341605; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Weigmann K, 1999, DEVELOPMENT, V126, P3823; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805	24	83	85	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1135	1139		10.1126/science.1132524	http://dx.doi.org/10.1126/science.1132524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110576				2022-12-28	WOS:000242045800042
J	Sudhof, TC				Sudhof, Thomas C.			Synaptic vesicles: An organelle comes of age	CELL			English	Editorial Material							EXOCYTOSIS; COMPLEX	Synaptic vesicles mediate the release of neurotransmitters at nerve terminals. In this issue of Cell, Takamori et al. (2006) analyze the lipid and protein components of synaptic vesicles, providing the most comprehensive description of synaptic vesicles to date.	Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu						Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; GRAY EG, 1959, J ANAT, V93, P420; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Katz B., 1969, RELEASE NEURAL TRANS; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; STADLER H, 1984, EMBO J, V3, P3333, DOI 10.1002/j.1460-2075.1984.tb02300.x; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P638	11	8	9	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					671	673		10.1016/j.cell.2006.10.033	http://dx.doi.org/10.1016/j.cell.2006.10.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110326	Bronze			2022-12-28	WOS:000242330600013
J	Dame, RT; Noom, MC; Wuite, GJL				Dame, Remus T.; Noom, Maarten C.; Wuite, Gijs J. L.			Bacterial chromatin organization by H-NS protein unravelled using dual DNA manipulation	NATURE			English	Article							SINGLE MOLECULES; RNA-POLYMERASE; REVEALS; DOMAIN; FORCE; OLIGOMERIZATION; ASSOCIATION; COMPACTION; REPRESSES	Both prokaryotic and eukaryotic organisms contain DNA bridging proteins, which can have regulatory or architectural functions (1). The molecular and mechanical details of such proteins are hard to obtain, in particular if they involve non- specific interactions. The bacterial nucleoid consists of hundreds of DNA loops, shaped in part by non- specific DNA bridging proteins such as histone-like nucleoid structuring protein ( H- NS), leucine- responsive regulatory protein ( Lrp) and SMC ( structural maintenance of chromosomes) proteins(2,3). We have developed an optical tweezers instrument that can independently handle two DNA molecules, which allows the systematic investigation of protein- mediated DNA - DNA interactions. Here we use this technique to investigate the abundant non- specific nucleoid- associated protein H- NS, and show that H- NS is dynamically organized between two DNA molecules in register with their helical pitch. Our optical tweezers also allow us to carry out dynamic force spectroscopy on non- specific DNA binding proteins and thereby to determine an energy landscape for the H- NS - DNA interaction. Our results explain how the bacterial nucleoid can be effectively compacted and organized, but be dynamic in nature and accessible to DNA- tracking motor enzymes. Finally, our experimental approach is widely applicable to other DNA bridging proteins, as well as to complex DNA interactions involving multiple DNA molecules.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Dame, RT (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	rtdame@nat.vu.nl	Dame, Remus/AAT-2989-2020; Dame, Remus/A-8570-2008; Dame, Remus T./E-1941-2014	Dame, Remus/0000-0001-9863-1692; Dame, Remus T./0000-0001-9863-1692; wuite, gijs/0000-0002-5706-043X				Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Camacho CJ, 2001, P NATL ACAD SCI USA, V98, P10636, DOI 10.1073/pnas.181147798; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dame RT, 2003, BIOPHYS J, V85, P4146, DOI 10.1016/S0006-3495(03)74826-7; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; Dole S, 2004, MOL MICROBIOL, V52, P589, DOI 10.1111/j.1365-2958.2004.04001.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Eckel R, 2005, ANGEW CHEM INT EDIT, V44, P3921, DOI 10.1002/anie.200500152; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JOHNSON RC, 2005, MAJOR NUCLEOID PROTE; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; ONO S, 2005, BIOCHEM J, V15, P203; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schroder O, 2000, J MOL BIOL, V298, P737, DOI 10.1006/jmbi.2000.3708; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	30	269	276	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					387	390		10.1038/nature05283	http://dx.doi.org/10.1038/nature05283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108966				2022-12-28	WOS:000242018300053
J	Shepherd, GM				Shepherd, Gordon M.			Smell images and the flavour system in the human brain	NATURE			English	Review							RAT OLFACTORY-BULB; ORBITOFRONTAL CORTEX; ODOR MAPS; TASTE; REPRESENTATIONS; SENSITIVITY; ORTHONASAL; RETRONASAL; PERCEPTION; DISCRIMINATION	Flavour perception is one of the most complex of human behaviours. It involves almost all of the senses, particularly the sense of smell, which is involved through odour images generated in the olfactory pathway. In the human brain, the perceptual systems are closely linked to systems for learning, memory, emotion and language, so distributed neural mechanisms contribute to food preference and food cravings. Greater recognition of the role of the brain's flavour system and its connection with eating behaviour is needed for a deeper understanding of why people eat what they do, and to generate better recommendations about diet and nutrition.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Shepherd, GM (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	gordon.shepherd@yale.edu						Acree T. E., 2004, Handbook of flavor characterization. Sensory analysis, chemistry, and physiology, P83; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Bartoshuk LM, 2004, FOOD QUAL PREFER, V15, P617, DOI 10.1016/j.foodqual.2004.05.007; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carpino S, 2004, J DAIRY SCI, V87, P816, DOI 10.3168/jds.S0022-0302(04)73226-9; CORRIHER SO, 1997, COOK WISE; Crasto C, 2002, NUCLEIC ACIDS RES, V30, P354, DOI 10.1093/nar/30.1.354; Deibler K., 2003, HDB FLAVOR CHARACTER; DUFFY VB, 1995, J AM DIET ASSOC, V95, P879, DOI 10.1016/S0002-8223(95)00244-8; Duffy VB, 1999, CHEM SENSES, V24, P671, DOI 10.1093/chemse/24.6.671; FARB P, 1980, CONSUMING PASSIONS; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Johnson BA, 2005, J COMP NEUROL, V483, P192, DOI 10.1002/cne.20415; Koza BJ, 2005, CHEM SENSES, V30, P643, DOI 10.1093/chemse/bji057; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; LICITRA G, 2004, CHEESE ART 2004 RAGU; Linster C, 2003, NEUROBIOL LEARN MEM, V80, P302, DOI 10.1016/S1074-7427(03)00078-9; Lorig TS, 1999, NEUROSCI BIOBEHAV R, V23, P391, DOI 10.1016/S0149-7634(98)00041-4; McGee H, 2004, FLAVORING PLANTS HER; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; MOZELL MM, 1969, ARCH OTOLARYNGOL, V90, P367; MURPHY C, 1977, SENS PROCESS, V1, P204; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; ROLLS ET, 2006, NEUROPSYCHOLOGI 0622; Ross RS, 2005, LEARN MEMORY, V12, P302, DOI 10.1101/lm.91605; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Scalera G, 1997, BEHAV NEUROSCI, V111, P633, DOI 10.1037/0735-7044.111.3.633; Shepherd GM, 2005, CHEM SENSES, V30, pI3, DOI 10.1093/chemse/bjh085; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; SHEPHERDBARR K, 1998, AUTO BIOGRAPHY STUDI, V13, P40; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; SMITH DV, 1993, MECH TASTE TRANSDUCT, P265; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; STEINER JE, 1974, ANN NY ACAD SCI, V237, P229, DOI 10.1111/j.1749-6632.1974.tb49858.x; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Sun BC, 2005, CHEM SENSES, V30, P693, DOI 10.1093/chemse/bji062; Taylor AJ, 2000, FOOD CHEM, V71, P327, DOI 10.1016/S0308-8146(00)00182-5; This H, 2005, NAT MATER, V4, P5, DOI 10.1038/nmat1303; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	58	292	297	13	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					316	321		10.1038/nature05405	http://dx.doi.org/10.1038/nature05405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108956				2022-12-28	WOS:000242018300038
J	Beran, D; Yudkin, JS				Beran, David; Yudkin, John S.			Diabetes care in sub-Saharan Africa	LANCET			English	Review							CHRONIC DISEASES; HEALTH-CARE; INSULIN; EPIDEMIOLOGY; MELLITUS; ACCESS; TYPE-1; GLOBALIZATION; PREVENTION; MANAGEMENT	The increasing numbers of people with type 2 diabetes is a worldwide concern. it presents an added challenge in sub-Saharan Africa, where diabetes must compete for resources with communicable diseases. A scarcity of financial resources and appropriate staff mean that many people with type 2 diabetes have complications and that those with type 1 diabetes have an extremely short life-expectancy, whether or not they have been diagnosed with the disorder. We review the current evidence on diabetes care in sub-Saharan Africa and propose an 11-point action plan to address this problem in the region.	UCL, Int Insulin Fdn, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Beran, D (corresponding author), UCL, Int Insulin Fdn, Int Hlth & Med Educ Ctr, London N19 5LW, England.	david.beran@access2insulin.org	Beran, David/E-4422-2013; Yudkin, John S/C-1988-2008	Beran, David/0000-0001-7229-3920; 				ALBERTI KGM, 1994, WORLD HEALTH FORUM, V15, P6; [Anonymous], 2001, LANCET, V357, P1303; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 2004, WORLD MED SIT; Antoine P., 1995, CHRONIQUE CEPED, V17, P1; Armstrong Timothy, 2003, Ethn Dis, V13, pS13; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beran D, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-17; Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; BERAN D, 2006, IMPLEMENTING NATL DI; Berry J, 2004, HERZ, V29, P456, DOI 10.1007/s00059-004-2605-1; Billo NE, 2006, INT J TUBERC LUNG D, V10, P709; BLISS M, 1993, DIABETES CARE, V16, P4, DOI 10.2337/diacare.16.3.4; CASTLE WM, 1980, DIABETOLOGIA, V18, P121, DOI 10.1007/BF00290487; CHABOT J, 1991, HEALTH POLICY PLANN, V6, P46, DOI 10.1093/heapol/6.1.46; CHALE S, 1997, INT TXB DIABETES MEL; Cook A., 1901, J TROPICAL MED, V4, P175; DEEB LC, 1994, DIABETES CARE, V17, P220, DOI 10.2337/diacare.17.3.220; DUKES G, 2004, INTERIM REPORT TASK; ELAMIN A, 1992, DIABETES CARE, V15, P1556, DOI 10.2337/diacare.15.11.1556; ELRAYAH H, 2005, DIABETES RES CLIN PR, V22, P22; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; GELDERS S, 2006, AVAILABILITY AFFORDA; Gladwin J, 2002, HEALTH POLICY PLANN, V17, P354, DOI 10.1093/heapol/17.4.354; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; *INT DIAB FED, TASK FORC IN; *INT DIAB FED, 2006, IDF TASK FORC INS TE; *INT DIAB FED, 2006, SURV ACC INS DIAB SU; *INT DIAB FED, 2006, IDF AFR REG; *INT DOAB FED, 2003, DIAB ATL; *INT INS FDN, 2005, DIAB FDN REP INS REQ; *INT INS FDN, 2004, REP INT INS FDN RAP; *JOINT UN PROGR HI, 2004, GLOB SUMM HIV AIDS E; KALASA B, 2001, POPULATION AGEING AF; Kleinsmidt A, 2001, Can HIV AIDS Policy Law Rev, V6, P75; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Lewis R, 2004, BMJ-BRIT MED J, V328, P220, DOI 10.1136/bmj.328.7433.220; MAKAME MH, 1992, DIABETIC MED, V9, P571, DOI 10.1111/j.1464-5491.1992.tb01841.x; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; MALDONATO A, 1995, PATIENT EDUC COUNS, V26, P57, DOI 10.1016/0738-3991(95)00736-J; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P97, DOI [10.1097/00043798-200304000-00004, 10.1097/01.hjr.0000060842.48106.78]; McLarty D. G., 1994, International Diabetes Digest, V5, P15; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Motala AA, 2003, J CARDIOVASC RISK, V10, P77, DOI [10.1097/00043798-200304000-00002, 10.1097/01.hjr.0000060843.48106.31]; *NOV NORD, 2003, SUST REP 2003, P28; Pruitt SD, 2005, BMJ-BRIT MED J, V330, P637, DOI 10.1136/bmj.330.7492.637; Ramaiya K, 2005, BMJ-BRIT MED J, V330, P679, DOI 10.1136/bmj.330.7492.679; Sachs J., 2001, MACROECONOMICS HLTH; SAVAGE A, 1994, INT DIABETES DIGEST, V5, P19; Setel Philip W., 2003, Ethnicity & Disease, V13; Sidibe A, 1999, REV FRANCAISE ENDOCR, V40, P513; Sobngwi E, 2001, DIABETES METAB, V27, P628; Stierle F, 1999, INT J HEALTH PLAN M, V14, P81, DOI 10.1002/(SICI)1099-1751(199904/06)14:2<81::AID-HPM543>3.0.CO;2-P; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; SWAI ABM, 1993, BRIT MED J, V306, P1570, DOI 10.1136/bmj.306.6892.1570; Whiting DR, 2003, J CARDIOVASC RISK, V10, P103, DOI 10.1097/00043798-200304000-00005; *WHO, 2006, DIAB ACT NOW; *WHO, 2006, COR HLTH IND LAT DAT; *WHO, 2003, WHO MOD LIST; *WHO, 2006, WHO PREQ MED; WHO, 2002, INNOVATIVE CARE CHRO; *WHO EG OFF AFR, 2000, NONC DIS STRAT AFR R; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2004, DIAB ACT NOW IN WHO; World Health Organization, 2000, HLTH SYST IMPR PERF; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yudkin JS, 2000, LANCET, V355, P919, DOI 10.1016/S0140-6736(99)09225-9; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x; 2006, SANTE DIABETE MALI N	74	153	155	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1689	1695		10.1016/S0140-6736(06)69704-3	http://dx.doi.org/10.1016/S0140-6736(06)69704-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098088				2022-12-28	WOS:000242099000037
J	Boon, JP; Casti, J; Djerassi, C; Johnson, J; Lovett, A; Norretranders, T; Patera, V; Sommerer, C; Taylor, R; Thurner, S				Boon, J. -P.; Casti, J.; Djerassi, C.; Johnson, J.; Lovett, A.; Norretranders, T.; Patera, V.; Sommerer, C.; Taylor, R.; Thurner, S.		Artistic Forms Complexity Grp	A concrete example - When the cracks begin to show.	NATURE			English	Editorial Material													Taylor, Richard P/P-9908-2016	Taylor, Richard/0000-0002-5248-4524					0	0	0	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					122	122		10.1038/444122a	http://dx.doi.org/10.1038/444122a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	100WS	17088935	Bronze			2022-12-28	WOS:000241701500058
J	Laurie, NA; Donovan, SL; Shih, CS; Zhang, JK; Mills, N; Fuller, C; Teunisse, A; Lam, S; Ramos, Y; Mohan, A; Johnson, D; Wilson, M; Rodriguez-Galindo, C; Quarto, M; Francoz, S; Mendrysa, SM; Guy, RK; Marine, JC; Jochemsen, AG; Dyer, MA				Laurie, Nikia A.; Donovan, Stacy L.; Shih, Chie-Schin; Zhang, Jiakun; Mills, Nicholas; Fuller, Christine; Teunisse, Amina; Lam, Suzanne; Ramos, Yolande; Mohan, Adithi; Johnson, Dianna; Wilson, Matthew; Rodriguez-Galindo, Carlos; Quarto, Micaela; Francoz, Sarah; Mendrysa, Susan M.; Guy, R. Kiplin; Marine, Jean-Christophe; Jochemsen, Aart G.; Dyer, Michael A.			Inactivation of the p53 pathway in retinoblastoma	NATURE			English	Article							TUMOR-SUPPRESSOR; RETINAL DEVELOPMENT; MDM2; CELL; CANCER; RB; DEATH; AMPLIFICATION; ACTIVATION; INHIBITORS	Most human tumours have genetic mutations in their Rb and p53 pathways, but retinoblastoma is thought to be an exception. Studies suggest that retinoblastomas, which initiate with mutations in the gene retinoblastoma 1 ( RB1), bypass the p53 pathway because they arise from intrinsically death-resistant cells during retinal development. In contrast to this prevailing theory, here we show that the tumour surveillance pathway mediated by Arf, MDM2, MDMX and p53 is activated after loss of RB1 during retinogenesis. RB1-deficient retinoblasts undergo p53-mediated apoptosis and exit the cell cycle. Subsequently, amplification of the MDMX gene and increased expression of MDMX protein are strongly selected for during tumour progression as a mechanism to suppress the p53 response in RB1-deficient retinal cells. Our data provide evidence that the p53 pathway is inactivated in retinoblastoma and that this cancer does not originate from intrinsically death-resistant cells as previously thought. In addition, they support the idea that MDMX is a specific chemotherapeutic target for treating retinoblastoma.	St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Surg, Div Ophthalmol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RC Leiden, Netherlands; Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; FIRC Inst Mol Oncol, I-20139 Milan, Italy; Flanders Interuniv Biotechnol, Lab Mol Canc Biol, B-9052 Ghent, Belgium; Purdue Univ, W Lafayette, IN 47907 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Tennessee System; University of Tennessee Health Science Center; IFOM - FIRC Institute of Molecular Oncology; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dyer, MA (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Guy, Rodney/J-7107-2013; Francoz, Sarah/K-4328-2014; Dyer, Michael/N-8134-2018; Rodriguez-Galindo, Carlos/N-8071-2018; Ramos, Yolande F. M./C-3774-2018; Marine, Jean-Christophe/K-3292-2016; Marine, Jean Christophe/J-2237-2015	Guy, Rodney/0000-0002-9638-2060; Francoz, Sarah/0000-0002-6589-4207; Ramos, Yolande F. M./0000-0003-1459-413X; Marine, Jean-Christophe/0000-0003-2433-9837; 				Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Dang JJ, 2002, CANCER RES, V62, P1222; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Dyer MA, 2005, NAT REV CANCER, V5, P91, DOI 10.1038/nrc1545; DYER MA, IN PRESS CLIN OCULAR, pCH66; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2001, ACTA ONCOL, V40, P686; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lu F, 2006, J COMB CHEM, V8, P315, DOI 10.1021/cc050142v; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McKenzie PP, 2002, MOL CANCER THER, V1, P1097; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Nork TM, 1997, ARCH OPHTHALMOL-CHIC, V115, P213, DOI 10.1001/archopht.1997.01100150215011; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Prives C, 1999, J PATHOL, V187, P112; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Zhang JK, 2004, CELL CYCLE, V3, P952	36	464	483	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					61	66		10.1038/nature05194	http://dx.doi.org/10.1038/nature05194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080083				2022-12-28	WOS:000241701500044
J	Wenseleers, T; Ratnieks, FLW				Wenseleers, Tom; Ratnieks, Francis L. W.			Enforced altruism in insect societies	NATURE			English	Article							EVOLUTION; COOPERATION		Catholic Univ Louvain, Inst Zool, B-3000 Louvain, Belgium; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Universite Catholique Louvain; University of Sheffield	Wenseleers, T (corresponding author), Catholic Univ Louvain, Inst Zool, Naamsestr 59, B-3000 Louvain, Belgium.	tom.wenseleers@bio.kuleuven.be	Wenseleers, Tom/J-3960-2013	Wenseleers, Tom/0000-0002-1434-861X	Natural Environment Research Council [NE/C512310/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Frank SA, 2003, EVOLUTION, V57, P693; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Levitt SD, 1997, AM ECON REV, V87, P270; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Wenseleers T, 2004, AM NAT, V164, pE154, DOI 10.1086/425223; Wenseleers T, 2004, J EVOLUTION BIOL, V17, P1035, DOI 10.1111/j.1420-9101.2004.00751.x; WENSELEERS T, AM NAT, V168	10	142	147	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					50	50		10.1038/444050a	http://dx.doi.org/10.1038/444050a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080081	Green Published, Bronze			2022-12-28	WOS:000241701500038
J	Bradley, EH; Herrin, J; Wang, YF; Barton, BA; Webster, TR; Mattera, JA; Roumanis, SA; Curtis, JP; Nallamothu, BK; Magid, DJ; McNamara, RL; Parkosewich, J; Loeb, JM; Krumholz, HM				Bradley, Elizabeth H.; Herrin, Jeph; Wang, Yongfei; Barton, Barbara A.; Webster, Tashonna R.; Mattera, Jennifer A.; Roumanis, Sarah A.; Curtis, Jeptha P.; Nallamothu, Brahmajee K.; Magid, David J.; McNamara, Robert L.; Parkosewich, Janet; Loeb, Jerod M.; Krumholz, Harlan M.			Strategies for reducing the door-to-balloon time in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; EMERGENCY MEDICAL-SERVICES; QUALITY-OF-CARE; PREHOSPITAL ELECTROCARDIOGRAM; NATIONAL-REGISTRY; HOSPITALS; ANGIOPLASTY; REPERFUSION; IMPROVEMENT; MORTALITY	BACKGROUND: Prompt reperfusion treatment is essential for patients who have myocardial infarction with ST-segment elevation. Guidelines recommend that the interval between arrival at the hospital and intracoronary balloon inflation (door-to-balloon time) during primary percutaneous coronary intervention should be 90 minutes or less. However, few hospitals meet this objective. We sought to identify hospital strategies that were significantly associated with a faster door-to-balloon time. METHODS: We surveyed 365 hospitals to determine whether each of 28 specific strategies was in use. We used hierarchical generalized linear models and data on patients from the Centers for Medicare and Medicaid Services to determine the association between hospital strategies and the door-to-balloon time. RESULTS: In multivariate analysis, six strategies were significantly associated with a faster door-to-balloon time. These strategies included having emergency medicine physicians activate the catheterization laboratory (mean reduction in door-to-balloon time, 8.2 minutes), having a single call to a central page operator activate the laboratory (13.8 minutes), having the emergency department activate the catheterization laboratory while the patient is en route to the hospital (15.4 minutes), expecting staff to arrive in the catheterization laboratory within 20 minutes after being paged (vs. >30 minutes) (19.3 minutes), having an attending cardiologist always on site (14.6 minutes), and having staff in the emergency department and the catheterization laboratory use real-time data feedback (8.6 minutes). Despite the effectiveness of these strategies, only a minority of hospitals surveyed were using them. CONCLUSIONS: Several specific hospital strategies are associated with a significant reduction in the door-to-balloon time in the management of myocardial infarction with ST-segment elevation.	Yale Univ, Sch Med, Yale New Haven Hosp, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Yale New Haven Hosp, Dept Med, New Haven, CT USA; Yale Univ, Sch Nursing, New Haven, CT 06536 USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Kaiser Permanente, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Joint Commiss Accreditat Healthcare Org, Oak Brook Terrace, IL USA	Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Bradley, EH (corresponding author), Yale Univ, Sch Med, Yale New Haven Hosp, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.		, Harlan/AAI-2875-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072575] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL072575] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Aiken L.S., 1991, MULTIPLE REGRESSION; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Bradley EH, 2005, J AM COLL CARDIOL, V46, P1236, DOI 10.1016/j.jacc.2005.07.009; Burwen DR, 2003, ARCH INTERN MED, V163, P1430, DOI 10.1001/archinte.163.12.1430; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 1997, J AM COLL CARDIOL, V29, P498, DOI 10.1016/S0735-1097(96)00532-3; Canto JG, 2002, CIRCULATION, V106, P3018, DOI 10.1161/01.CIR.0000041246.20352.03; Curtis JP, 2006, J AM COLL CARDIOL, V47, P1544, DOI 10.1016/j.jacc.2005.10.077; Garvey JL, 2006, J AM COLL CARDIOL, V47, P485, DOI 10.1016/j.jacc.2005.08.072; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Jacoby Jeanne, 2005, J Invasive Cardiol, V17, P154; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P2647; *JOINT COMM ACCR H, COMPR REV DEV TEST N; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Lambrew CT, 1997, ARCH INTERN MED, V157, P2577, DOI 10.1001/archinte.157.22.2577; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; Snijders T.A., 1999, INTRO BASIC ADV MULT; Stern S, 1997, J ECON LIT, V35, P2006; Tanner M. A., 1996, TOOLS STAT INFERENCE; Thatcher Jackson L, 2003, J Invasive Cardiol, V15, P693; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	27	605	625	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2308	2320		10.1056/NEJMsa063117	http://dx.doi.org/10.1056/NEJMsa063117			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17101617				2022-12-28	WOS:000242355300006
J	Webster, RG; Govorkova, EA				Webster, Robert G.; Govorkova, Elena A.			Focus on research: H5N1 influenza - Continuing evolution and spread	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Jude Childrens Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.			Govorkova, Elena/0000-0001-9067-5682				Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a	3	284	296	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2174	2177		10.1056/NEJMp068205	http://dx.doi.org/10.1056/NEJMp068205			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124014				2022-12-28	WOS:000242170900003
J	Carlsten, C; Burke, W				Carlsten, Chris; Burke, Wylie			Potential for genetics to promote public health - Genetics research on smoking suggests caution about expectations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NICOTINE DEPENDENCE; CONTROLLED-TRIAL; CESSATION; POLYMORPHISMS; GENOTYPE; SMOKERS; BAN		Univ Washington, Dept Med, Div Pulm & Crit Care Med, Occupat & Environm Med Program, Seattle, WA USA; Univ Washington, Dept Med Hist & Eth, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Carlsten, C (corresponding author), Box 354695,1959 NE Pacific St, Seattle, WA 98195 USA.	carlsten@u.washington.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50HG003374] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		American Cancer Society, CANC FACT FIG; Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; Benhamou S, 2002, CARCINOGENESIS, V23, P1343, DOI 10.1093/carcin/23.8.1343; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Coughlin SS, 1999, AM J PREV MED, V16, P89, DOI 10.1016/S0749-3797(98)00135-4; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; Gottlieb S, 2004, BRIT MED J, V328, P1222, DOI 10.1136/bmj.328.7450.1222; Gu DF, 2000, ANN HUM GENET, V64, P383, DOI 10.1046/j.1469-1809.2000.6450383.x; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Khoury MJ, 2005, AM J EPIDEMIOL, V161, P799, DOI 10.1093/aje/kwi113; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; McClure JB, 2001, BEHAV MED, V27, P37, DOI 10.1080/08964280109595770; McKinney EF, 2000, PHARMACOGENETICS, V10, P483, DOI 10.1097/00008571-200008000-00001; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Olden K, 2005, MED CLIN N AM, V89, P721, DOI 10.1016/j.mcna.2005.02.001; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Ross H, 2003, HEALTH ECON, V12, P217, DOI 10.1002/hec.709; ROTTMAN H, 1898, THESIS U WURZBURG WU; SAMET JM, 1992, MED CLIN N AM, V76, P399, DOI 10.1016/S0025-7125(16)30359-5; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Swan GE, 2006, AM J MED GENET B, V141B, P354, DOI 10.1002/ajmg.b.30315; Weber MD, 2003, TOB CONTROL, V12, P269, DOI 10.1136/tc.12.3.269; Wright AJ, 2003, TOB CONTROL, V12, P227, DOI 10.1136/tc.12.2.227; Yudkin P, 2004, BRIT MED J, V328, P989, DOI 10.1136/bmj.38050.674826.AE	26	44	44	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2480	2482		10.1001/jama.296.20.2480	http://dx.doi.org/10.1001/jama.296.20.2480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107KR	17119145				2022-12-28	WOS:000242171000030
J	Gupta, GP; Massague, J				Gupta, Gaorav P.; Massague, Joan			Cancer metastasis: Building a framework	CELL			English	Review							GROWTH-FACTOR-BETA; BREAST-CANCER; TUMOR-METASTASIS; PROSTATE-CANCER; BONE-MARROW; MATRIX METALLOPROTEINASES; VASCULAR-PERMEABILITY; GENOMIC INSTABILITY; INITIATING CELLS; KAPPA-B	Metastasis occurs when genetically unstable cancer cells adapt to a tissue microenvironment that is distant from the primary tumor. This process involves both the selection of traits that are advantageous to cancer cells and the concomitant recruitment of traits in the tumor stroma that accommodate invasion by metastatic cells. Recent conceptual and technological advances promote our understanding of the origins and nature of cancer metastasis.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Gupta, GP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gupta, Gaorav/AAL-4472-2021	Massague, Joan/0000-0001-9324-8408				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ruiter DJ, 2001, LANCET ONCOL, V2, P109, DOI 10.1016/S1470-2045(00)00229-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Solakoglu O, 2002, P NATL ACAD SCI USA, V99, P2246, DOI 10.1073/pnas.042372199; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; TARIN D, 1984, CANCER RES, V44, P3584; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	104	3088	3262	17	662	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					679	695		10.1016/j.cell.2006.11.001	http://dx.doi.org/10.1016/j.cell.2006.11.001			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110329	Bronze			2022-12-28	WOS:000242330600016
J	Scheller, B; Hehrlein, C; Bocksch, W; Rutsch, W; Haghi, D; Dietz, U; Bohm, M; Speck, U				Scheller, Bruno; Hehrlein, Christoph; Bocksch, Wolfgang; Rutsch, Wolfgang; Haghi, Dariush; Dietz, Ulrich; Boehm, Michael; Speck, Ulrich			Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIROLIMUS-ELUTING STENT; LOCAL-DRUG DELIVERY; RANDOMIZED CONTROLLED-TRIAL; RADIATION-THERAPY; CONTRAST-MEDIA; GAMMA-RADIATION; ARTERY-DISEASE; FOLLOW-UP; ANGIOPLASTY; IMPLANTATION	Background: Treatment of coronary in-stent restenosis is hampered by a high incidence of recurrent in-stent restenosis. We assessed the efficacy and safety of a paclitaxel-coated balloon in this setting. Methods: We enrolled 52 patients with in-stent restenosis in a randomized, double-blind, multicenter trial to compare the effects of a balloon catheter coated with paclitaxel (3 microg per square millimeter of balloon surface area) with those of an uncoated balloon catheter in coronary angioplasty. The primary end point was late luminal loss as seen on angiography. Secondary end points included the rates of restenosis (a binary variable) and major adverse cardiac events. Results: Multivessel disease was present in 80% of patients in both groups. Quantitative coronary angiography revealed no significant differences in baseline measures. At 6 months, angiography showed that the mean (+/-SD) in-segment late luminal loss was 0.74+/-0.86 mm in the uncoated-balloon group versus 0.03+/-0.48 mm in the coated-balloon group (P=0.002). A total of 10 of 23 patients (43%) in the uncoated-balloon group had restenosis, as compared with 1 of 22 patients (5%) in the coated-balloon group (P=0.002). At 12 months, the rate of major adverse cardiac events was 31% in the uncoated-balloon group and 4% in the coated-balloon group (P=0.01). This difference was primarily due to the need for target-lesion revascularization in six patients in the uncoated-balloon group (P=0.02). Conclusions: Treatment of coronary in-stent restenosis with paclitaxel-coated balloon catheters significantly reduced the incidence of restenosis. These data suggest that the inhibition of restenosis by local drug delivery may not require stent implantation and sustained drug release at the site of injury.	Univ Klinikum Saarlandes, Innere Med Klin 3, Homburg, Germany; Univ Klinikum, Freiburg, Germany; Univ Klinikum Charite, Berlin, Germany; Univ Heidelberg, Univ Klinikum Mannheim, D-6800 Mannheim, Germany; Deutsch Klin Diagnost, D-6200 Wiesbaden, Germany	Universitatsklinikum des Saarlandes; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg	Scheller, B (corresponding author), Univ Klinikum Saarlandes, Innere Med Klin 3, Homburg, Germany.	bruno.scheller@uniklinikum-saarland.de	Scheller, Bruno/S-5761-2016; Böhm, Michael/C-3638-2011					Alfonso F, 2003, J AM COLL CARDIOL, V42, P796, DOI 10.1016/S0735-1097(03)00852-0; [Anonymous], 1994, ICH HARM TRIP GUID C; Axel DI, 1997, CIRCULATION, V96, P636; Degertekin M, 2003, J AM COLL CARDIOL, V41, P184, DOI 10.1016/S0735-1097(02)02704-3; Iofina E, 2005, CATHETER CARDIO INTE, V64, P28, DOI 10.1002/ccd.20212; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Lansky AJ, 2004, CIRCULATION, V109, P1948, DOI 10.1161/01.CIR.0000127129.94129.6F; Lemos PA, 2004, CIRCULATION, V109, P1366, DOI 10.1161/01.CIR.0000121358.26097.06; Mauri L, 2005, CIRCULATION, V112, P2833, DOI 10.1161/CIRCULATIONAHA105.570093; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Moliterno DJ, 2005, NEW ENGL J MED, V353, P724, DOI 10.1056/NEJMe058140; Radke PW, 2004, EUR HEART J, V25, P920, DOI 10.1016/j.ehj.2004.02.014; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2003, J AM COLL CARDIOL, V42, P1415, DOI 10.1016/S0735-1097(03)01056-8; Scheller B, 2003, EUR HEART J, V24, P1462, DOI 10.1016/S0195-668X(03)00317-8; Speck U, 2004, INVEST RADIOL, V39, P182, DOI 10.1097/01.rli.0000116125.96544.64; Speck U, 2006, RADIOLOGY, V240, P411, DOI 10.1148/radiol.2402051248; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690; vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347; Waksman R, 2000, CIRCULATION, V101, P2165, DOI 10.1161/01.CIR.101.18.2165; Waksman R, 2003, CIRCULATION, V107, P1744, DOI 10.1161/01.CIR.0000060497.91775.6D; Waksman R, 2002, NEW ENGL J MED, V346, P1194, DOI 10.1056/NEJMoa012579; Werner GS, 2004, CATHETER CARDIO INTE, V63, P259, DOI 10.1002/ccd.20180	26	565	621	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2113	2124		10.1056/NEJMoa061254	http://dx.doi.org/10.1056/NEJMoa061254			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17101615				2022-12-28	WOS:000241997300007
J	Willcox, BJ; He, QM; Chen, R; Yano, K; Masaki, KH; Grove, JS; Donlon, TA; Willcox, DC; Curb, JD				Willcox, Bradley J.; He, Qimei; Chen, Randi; Yano, Katsuhiko; Masaki, Kamal H.; Grove, John S.; Donlon, Timothy A.; Willcox, D. Craig; Curb, J. David			Midlife risk factors and healthy survival in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC SYNDROME; UNITED-STATES; JAPANESE MEN; HEART; LIFE; MORTALITY; HAWAII; PREDICTORS; MORBIDITY; LUNG	Context Healthy survival has no clear phenotypic definition, and little is known about its attributes, particularly in men. Objective To test whether midlife biological, lifestyle, and sociodemographic risk factors are associated with overall survival and exceptional survival ( free of a set of major diseases and impairments). Design, Setting, and Participants Prospective cohort study within the Honolulu Heart Program/Honolulu Asia Aging Study. A total of 5820 Japanese American middle-aged men ( mean age, 54 [ range, 45-68] years) free of morbidity and functional impairments were followed for up to 40 years (1965-2005) to assess overall and exceptional survival. Exceptional survival was defined as survival to a specified age ( 75, 80, 85, or 90 years) without incidence of 6 major chronic diseases and without physical and cognitive impairment. Main Outcome Measure Overall survival and exceptional survival. Results Of 5820 original participants, 2451 participants (42%) survived to age 85 years and 655 participants (11%) met the criteria for exceptional survival to age 85 years. High grip strength and avoidance of overweight, hyperglycemia, hypertension, smoking, and excessive alcohol consumption were associated with both overall and exceptional survival. In addition, high education and avoidance of hypertriglyceridemia were associated with exceptional survival, and lack of a marital partner was associated with mortality before age 85 years. Risk factor models based on cumulative risk factors ( survival risk score) suggest that the probability of survival to oldest age is as high as 69% with no risk factors and as low as 22% with 6 or more risk factors. The probability of exceptional survival to age 85 years was 55% with no risk factors but decreased to 9% with 6 or more risk factors Conclusion These data suggest that avoidance of certain risk factors in midlife is associated with the probability of a long and healthy life among men.	Univ Hawaii Manoa, John A Burns Sch Med, Pacific Hlth Res Inst, Honolulu, HI 96813 USA; Univ Hawaii Manoa, John A Burns Sch Med, Kuakini Med Ctr, Honolulu Heart Program, Honolulu, HI 96813 USA; Univ Hawaii Manoa, John A Burns Sch Med, Dept Geriatr Med & Med, Honolulu, HI 96813 USA; Univ Hawaii Manoa, John A Burns Sch Med, Dept Publ Hlth Sci & Epidemiol, Honolulu, HI 96813 USA; Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; Okinawa Prefectural Univ, Coll Nursing, Okinawa, Japan	Pacific Health Research & Education Institute; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Cancer Research Center of Hawaii; University of Hawaii System	Willcox, BJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Hlth Res Inst, 846 S Hotel St Suite 201, Honolulu, HI 96813 USA.	bjwillcox@phrihawaii.org			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG019349, R01AG027060, K08AG022788, N01AG042149] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; BLACKWELDER WC, 1980, AM J MED, V68, P164, DOI 10.1016/0002-9343(80)90350-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Curb JD, 2006, J AM GERIATR SOC, V54, P737, DOI 10.1111/j.1532-5415.2006.00700.x; CURB JD, 1990, J AM GERIATR SOC, V38, P827, DOI 10.1111/j.1532-5415.1990.tb01478.x; CURB JD, 1990, J GERONTOL, V45, pS206, DOI 10.1093/geronj/45.5.S206; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontanarosa PB, 2006, JAMA-J AM MED ASSOC, V295, P440, DOI 10.1001/jama.295.4.440; Fraser GE, 2001, ARCH INTERN MED, V161, P1645, DOI 10.1001/archinte.161.13.1645; Gavrilov Leonid A, 2003, Sci Aging Knowledge Environ, V2003, pRE5, DOI 10.1126/sageke.2003.28.re5; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity, 2001, GUID DOC US IN VITR; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hsueh Willa A., 1998, American Journal of Medicine, V105, p4S, DOI 10.1016/S0002-9343(98)00205-8; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; Kagan A., 1996, HONOLULU HEART PROGR; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KRACH CA, 1999, CURRENT POP P23199RV; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Mark DH, 2005, JAMA-J AM MED ASSOC, V293, P1918, DOI 10.1001/jama.293.15.1918; Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14; MILLER FD, 1993, INT J EPIDEMIOL, V22, P834, DOI 10.1093/ije/22.5.834; Morley JE, 2004, J GERONTOL A-BIOL, V59, P139; *NAT I AG, 2001, NIH PUBL; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nesto Richard W, 2003, Rev Cardiovasc Med, V4 Suppl 6, pS11; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463; RODRIGUEZ BL, 1998, CARDIOVASC RISK FACT, V8, P99; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; SUZMAN R, 1985, MILBANK FUND Q, V63, P177; Tang W, 2006, DIABETES CARE, V29, P631, DOI 10.2337/diacare.29.03.06.dc05-0679; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Terry DF, 2005, J AM GERIATR SOC, V53, P1944, DOI 10.1111/j.1532-5415.2005.00465.x; US Census Bureau, AM FACTFINDER; *US DEP HHS, 2005, HLTH PEOPL 2010, V1; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6	44	164	168	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2343	2350		10.1001/jama.296.19.2343	http://dx.doi.org/10.1001/jama.296.19.2343			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104ZI	17105797	Bronze			2022-12-28	WOS:000241998700022
J	Drucker, DJ; Nauck, MA				Drucker, Daniel J.; Nauck, Michael A.			The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes	LANCET			English	Review							METFORMIN-TREATED PATIENTS; EXENATIDE SYNTHETIC EXENDIN-4; 2ND-PHASE INSULIN-SECRETION; IMPROVED GLUCOSE-TOLERANCE; IMPROVES GLYCEMIC CONTROL; BETA-CELL FUNCTION; IV INHIBITOR; 7-36 AMIDE; IN-VITRO; INTRAVENOUS GLUCOSE	Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying, and reduces appetite and food intake. Therapeutic approaches for enhancing incretin action include degradation-resistant GLP-1 receptor agonists (incretin mimetics), and inhibitors of dipeptidyl peptidase-4 (DPP-4) activity (incretin enhancers). Clinical trials with the incretin mimetic exenatide (two injections per day or long-acting release form once weekly) and liraglutide (one injection per day) show reductions in fasting and postprandial glucose concentrations, and haemoglobin A(1c) (HbA(1c)) (1-2%), associated with weight loss (2-5 kg). The most common adverse event associated with GLP-1 receptor agonists is mild nausea, which lessens over time. Orally administered DPP-4 inhibitors, such as sitagliptin and vildagliptin, reduce HbA(1c) by 0.5-1.0%, with few adverse events and no weight gain. These new classes of antidiabetic agents, and incretin mimetics and enhancers, also expand beta-cell mass in preclinical studies. However, long-term clinical studies are needed to determine the benefits of targeting the incretin axis for the treatment of type 2 diabetes.	Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Drucker, DJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	d.drucker@utoronto.ca	Drucker, Daniel J/A-4092-2010; Nauck, Michael Albrecht/ABA-9752-2021	Nauck, Michael Albrecht/0000-0002-5749-6954				Abraham EJ, 2002, ENDOCRINOLOGY, V143, P3152, DOI 10.1210/en.143.8.3152; Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; Ahren B, 2005, DIABETES CARE, V28, P1936, DOI 10.2337/diacare.28.8.1936; Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; Ahren B, 2004, DIABETES CARE, V27, P2874, DOI 10.2337/diacare.27.12.2874; ALARCON C, 2006, IN PRESS DIABETOLOGI; Aschner P, 2006, DIABETES, V55, pA462; Augeri DJ, 2005, J MED CHEM, V48, P5025, DOI 10.1021/jm050261p; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; BRAZG R, 2005, DIABETES S1, V54, P3; Bregenholt S, 2001, DIABETES, V50, pA31; Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen YQE, 1997, J BIOL CHEM, V272, P4108, DOI 10.1074/jbc.272.7.4108; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; DARDIK B, 2003, DIABETES S1, V52, P322; De Meester I, 2003, ADV EXP MED BIOL, V524, P3; De Meester I, 2000, ADV EXP MED BIOL, V477, P67; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Deacon CF, 2004, DIABETES, V53, P2181, DOI 10.2337/diabetes.53.9.2181; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Degn KB, 2004, DIABETES, V53, P2397, DOI 10.2337/diabetes.53.9.2397; Dejager S, 2006, DIABETES, V55, pA29; Demuth HU, 2005, BBA-PROTEINS PROTEOM, V1751, P33, DOI 10.1016/j.bbapap.2005.05.010; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; El-Ouaghlidi A, 2003, DIABETES, V52, pA118; Elbrond B, 2002, DIABETES CARE, V25, P1398, DOI 10.2337/diacare.25.8.1398; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; ENG J, 1992, J BIOL CHEM, V267, P7402; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Fineman MS, 2004, DIABETES-METAB RES, V20, P411, DOI 10.1002/dmrr.499; Fineman MS, 2002, CLIN PHARMACOL THER, V71, pP19; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Garber A, 2006, DIABETES, V55, pA29; Gedulin BR, 2005, DIABETOLOGIA, V48, P1380, DOI 10.1007/s00125-005-1795-2; GERICH JE, 1989, DIABETES MELLITUS PA, P127; Hanefeld M, 2005, DIABETOLOGIA, V48, pA287; Hansen BC, 2001, DIABETOLOGIA, V44, pA196; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Herman GA, 2005, CLIN PHARMACOL THER, V78, P675, DOI 10.1016/j.clpt.2005.09.002; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Juhl CB, 2002, DIABETES, V51, P424, DOI 10.2337/diabetes.51.2.424; Karasik A, 2006, DIABETES, V55, pA119; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kim D, 2006, DIABETES, V55, pA116; Kim JG, 2003, DIABETES, V52, P751, DOI 10.2337/diabetes.52.3.751; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; KNUDSEN LB, 2005, DIABETES S1, V52, P321; Kolterman O, 2000, DIABETES, V49, pA114; Kolterman OG, 2005, AM J HEALTH-SYST PH, V62, P173, DOI 10.1093/ajhp/62.2.173; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Madsbad S, 2004, DIABETES CARE, V27, P1335, DOI 10.2337/diacare.27.6.1335; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Meier JJ, 2004, CRIT CARE MED, V32, P848, DOI 10.1097/01.CCM.0000114811.60629.B5; Meier JJ, 2003, J CLIN ENDOCR METAB, V88, P2719, DOI 10.1210/jc.2003-030049; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Nauck M, 2003, DIABETES, V52, pA128; Nauck MA, 2006, EXP CLIN ENDOCR DIAB, V114, P417, DOI 10.1055/s-2006-924230; Nauck MA, 2005, DIABETOLOGIA, V48, P608, DOI 10.1007/s00125-005-1704-8; Nauck MA, 2005, REGUL PEPTIDES, V128, P135, DOI 10.1016/j.regpep.2004.07.014; Nauck MA, 2004, REGUL PEPTIDES, V118, P89, DOI 10.1016/j.regpep.2003.11.003; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nielsen LL, 2004, REGUL PEPTIDES, V117, P77, DOI 10.1016/j.regpep.2003.10.028; Nielsen Loretta L, 2003, Curr Opin Investig Drugs, V4, P401; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; Phillips WT, 1997, J NUCL MED, V38, P207; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Pratley RE, 2006, HORM METAB RES, V38, P423, DOI 10.1055/s-2006-944546; Quddusi S, 2003, DIABETES CARE, V26, P791, DOI 10.2337/diacare.26.3.791; Rachman J, 1997, DIABETOLOGIA, V40, P205, DOI 10.1007/s001250050664; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Riddle MC, 2006, DIABETES-METAB RES, V22, P483, DOI 10.1002/dmrr.646; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; ROSENSTOCK J, 2006, DIABETES S1, V55, P132; Rosenstock J, 2006, DIABETES, V55, pA133; Saad M, 2002, DIABETOLOGIA, V45, pA44; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Scott R, 2005, DIABETES, V54, pA10; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3853, DOI 10.1210/jc.86.8.3853; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Vilsboll T, 2006, DIABETES, V55, pA27; WETTERGREN A, 1993, DIGEST DIS SCI, V38, P665, DOI 10.1007/BF01316798; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zinman B, 2006, DIABETES, V55, pA28	109	2745	2948	23	725	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1696	1705		10.1016/S0140-6736(06)69705-5	http://dx.doi.org/10.1016/S0140-6736(06)69705-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098089				2022-12-28	WOS:000242099000038
J	Boockvar, KS; Meier, DE				Boockvar, Kenneth S.; Meier, Diane E.			Palliative care for frail older adults - "There are things I can't do anymore that I wish I could ..."	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; INSTRUMENTAL ACTIVITIES; FUNCTIONAL DECLINE; PHYSICAL FRAILTY; CONTROLLED-TRIAL; WOMENS HEALTH; DOUBLE-BLIND; END; DISABILITY; HOSPICE	Frailty in older adults is increasingly a recognized syndrome of decline, sometimes subtle, in function and health that may be amenable to available approaches to care. Frailty manifests the following core clinical features: loss of strength, weight loss, low levels of activity, poor endurance or fatigue, and slowed performance. The presence of 3 or more of these features is associated with adverse outcomes including falls, new or worsened function impairment, hospitalization, and death. In this article, we use the case of Mrs K to describe the challenges of recognizing frailty in clinical practice, common problems and symptoms that frail older adults experience, and approaches to these issues that clinicians may incorporate into their practices. We discuss the importance of advance care planning, provider-patient communication, and appropriate palliative care and hospice referral for frail older adults. Frailty is associated with symptomatic long-term disease, decline in function, and abbreviated survival. Therefore, when frailty is severe, delivery of palliative care focused on relief of discomfort and enhancement of quality of life is highly appropriate. The application of multidisciplinary, team-based palliative approaches and of up-to-date geriatrics knowledge is beneficial for treating these patients because of the complexity of their coexisting social, psychological, and medical needs.	James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA; CUNY Mt Sinai Sch Med, New York, NY 10029 USA; Jewish Home & Hosp, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Boockvar, KS (corresponding author), James J Peters Vet Affairs Med Ctr, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.	kenneth.boockvar@mssm.edu	Boockvar, Kenneth S./H-9259-2019	Boockvar, Kenneth/0000-0003-1165-5558				Agency for Healthcare Research and Quality Centers for Disease Control, PHYS ACT OLD AM BEN; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Block SD, 2006, J PALLIAT MED, V9, P751, DOI 10.1089/jpm.2006.9.751; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Bookbinder M, 1996, J PAIN SYMPTOM MANAG, V12, P334, DOI 10.1016/S0885-3924(96)00204-7; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001; *CTR ADV PALL CAR, AB US; Doyle D, 1998, OXFORD TXB PALLIATIV; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Ferrell BA, 2000, CLIN GERIATR MED, V16, P853, DOI 10.1016/S0749-0690(05)70048-3; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Finlay IG, 2002, ANN ONCOL, V13, P257, DOI 10.1093/annonc/mdf668; Flint AJ, 1998, DRUG AGING, V13, P269, DOI 10.2165/00002512-199813040-00003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Larsson L, 2000, DRUG AGING, V17, P303, DOI 10.2165/00002512-200017040-00006; Latham N.K., 2003, COCHRANE DB SYST REV, V2; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lorenz KA, 2004, J AM GERIATR SOC, V52, P725, DOI 10.1111/j.1532-5415.2004.52209.x; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Mackin RS, 2005, PSYCHIAT CLIN N AM, V28, P805, DOI 10.1016/j.psc.2005.09.009; Manfredi PL, 2000, J PAIN SYMPTOM MANAG, V20, P166, DOI 10.1016/S0885-3924(00)00163-9; Marchandin H, 2001, PATHOL BIOL, V49, P522, DOI 10.1016/S0369-8114(01)00212-7; Miller SC, 2003, J PAIN SYMPTOM MANAG, V26, P791, DOI 10.1016/S0885-3924(03)00284-7; Milne AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub2; Morley JE, 1997, CLIN GERIATR MED, V13, P685, DOI 10.1016/s0749-0690(18)30144-7; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Morrison RS., 2003, GERIATRIC PALLIATIVE, V1st; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; *NAT COMPR CANC NE, GUID SUPP CAR PALL C; *NAT HOSP PALL CAR, 1996, MED GUID DET PROGN S; Nourhashemi F, 2001, J GERONTOL A-BIOL, V56, pM448, DOI 10.1093/gerona/56.7.M448; Pantilat SZ, 2004, JAMA-J AM MED ASSOC, V291, P2476, DOI 10.1001/jama.291.20.2476; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Rabow MW, 2004, JAMA-J AM MED ASSOC, V291, P483, DOI 10.1001/jama.291.4.483; Reuben DB, 2005, J AM GERIATR SOC, V53, P970, DOI 10.1111/j.1532-5415.2005.53307.x; Reuben DB, 2006, GERIATRICS YOUR FING; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Sarkisian CA, 2001, J AM GERIATR SOC, V49, P134, DOI 10.1046/j.1532-5415.2001.49033.x; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Shanmugham B, 2005, PSYCHIAT CLIN N AM, V28, P821, DOI 10.1016/j.psc.2005.09.012; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Snyder PJ, 2004, NEW ENGL J MED, V350, P440, DOI 10.1056/NEJMp038207; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; Studenski S, 2004, J AM GERIATR SOC, V52, P1560, DOI 10.1111/j.1532-5415.2004.52423.x; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WALSTON JD, 2003, GERIATRIC PALLIATIVE; Williamson JD, 1996, J AM GERIATR SOC, V44, P1429, DOI 10.1111/j.1532-5415.1996.tb04066.x; Wolf SL, 2003, J AM GERIATR SOC, V51, P1693, DOI 10.1046/j.1532-5415.2003.51552.x; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Yeh SS, 2000, J AM GERIATR SOC, V48, P485, DOI 10.1111/j.1532-5415.2000.tb04993.x	77	65	66	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2245	2253		10.1001/jama.296.18.2245	http://dx.doi.org/10.1001/jama.296.18.2245			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102QM	17090771				2022-12-28	WOS:000241827700025
J	Lopushinsky, SR; Urbach, DR				Lopushinsky, Steven R.; Urbach, David R.			Pneumatic dilatation and surgical myotomy for achalasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC HELLER MYOTOMY; INTRASPHINCTERIC BOTULINUM-TOXIN; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ESOPHAGEAL ACHALASIA; DILATION; SURGERY; EXPERIENCE; ESOPHAGOMYOTOMY; INJECTION	Context Pneumatic dilatation and surgical (Heller) myotomy are the 2 principal methods for treatment of achalasia. There are no population-based studies comparing outcomes of these 2 treatments in typical practice settings. Objective To compare the outcomes of pneumatic dilatation and surgical myotomy for achalasia. Design, Setting, and Participants Retrospective longitudinal study using linked administrative health data in Ontario. A total of 1461 persons aged 18 years or older received treatment for achalasia between July 1991 and December 2002, 1181 (80.8%) of whom had pneumatic dilatation and 280 (19.2%) of whom had surgical myotomy as the first procedure. Main Outcome Measures Use of subsequent interventions for achalasia (pneumatic dilatation, surgical myotomy, or esophagectomy) following the first treatment during the study period, subsequent physician visits, and use of gastrointestinal medications among persons aged 65 years or older. We adjusted for confounding variables using regression models. Results The cumulative risk of any subsequent intervention for achalasia after 1, 5, and 10 years, respectively, was 36.8%, 56.2%, and 63.5% for persons treated initially with pneumatic dilatation and was 16.4%, 30.3%, and 37.5% for persons treated initially with surgical myotomy (adjusted hazard ratio [HR], 2.37; 95% confidence interval [CI], 1.86-3.02; P < .001). Differences in risk were observed only when subsequent pneumatic dilatation was included as an adverse outcome; there was no statistical difference between the 2 groups with respect to the risk of subsequent surgical myotomy or esophagectomy. Compared with persons treated initially with surgical myotomy, those treated with pneumatic dilatation were not statistically different with respect to subsequent physician visits (adjusted rate ratio, 1.01; 95% CI, 1.00-1.03), or time to use of histamine-2 receptor blockers (adjusted HR, 1.19; 95% CI, 0.79-1.80), proton pump inhibitors (HR, 1.02; 95% CI, 0.70-1.49), and prokinetic medications (HR, 0.92; 95% CI, 0.60-1.41). Conclusions Subsequent intervention after the initial treatment of achalasia is common. Although the risk of subsequent interventions among persons treated with surgical myotomy in typical practice settings is higher than previously thought, the risk of subsequent intervention is greater among persons treated with pneumatic dilatation than with surgical myotomy. This difference is attributable to the use of subsequent pneumatic dilatation rather than surgical procedures.	Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Hlth Network, Div Clin Decis Making & Hlth Care, Toronto, ON, Canada; Canc Care Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cancer Care Ontario	Urbach, DR (corresponding author), Toronto Gen Hosp, 200 Elizabeth St,Room 10-NU-214, Toronto, ON M5G 2C4, Canada.	david.urbach@uhn.on.ca						ABID S, 1994, AM J GASTROENTEROL, V89, P979; Achkar E, 1995, Gastroenterologist, V3, P273; [Anonymous], 1996, PATTERNS HLTH CARE O; Bansal R, 2003, J CLIN GASTROENTEROL, V36, P209, DOI 10.1097/00004836-200303000-00005; Ben-Meir A, 2001, AM J SURG, V181, P471, DOI 10.1016/S0002-9610(01)00596-7; Bloomston Mark, 2002, JSLS, V6, P41; Bonatti H, 2005, AM J SURG, V190, P874, DOI 10.1016/j.amjsurg.2005.08.012; CSENDES A, 1989, GUT, V30, P299, DOI 10.1136/gut.30.3.299; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eckardt VF, 2004, GUT, V53, P629, DOI 10.1136/gut.2003.029298; Fernandez AF, 2003, SURG ENDOSC, V17, P153, DOI 10.1007/s00464-002-8576-5; Frantzides CT, 2004, J GASTROINTEST SURG, V8, P18, DOI 10.1016/j.gassur.2003.09.021; Ghoshal UC, 2001, DIS ESOPHAGUS, V14, P227, DOI 10.1046/j.1442-2050.2001.00189.x; JARA FM, 1979, ARCH SURG-CHICAGO, V114, P935; Karamanolis G, 2005, AM J GASTROENTEROL, V100, P270, DOI 10.1111/j.1572-0241.2005.40093.x; KATZ P, 1994, AM J GASTROENTEROL, V89, P969; Lyass S, 2003, SURG ENDOSC, V17, P554, DOI 10.1007/s00464-002-8604-5; MALTHANER RA, 1994, ANN THORAC SURG, V58, P1343, DOI 10.1016/0003-4975(94)91910-0; MEARIN F, 1993, EUR J CLIN INVEST, V23, P724, DOI 10.1111/j.1365-2362.1993.tb01292.x; Mikaeli J, 2001, ALIMENT PHARM THER, V15, P1389, DOI 10.1046/j.1365-2036.2001.01065.x; Mineo TC, 2004, EUR J CARDIO-THORAC, V25, P1089, DOI 10.1016/j.ejcts.2004.01.043; Panaccione R, 1999, GASTROINTEST ENDOSC, V50, P492, DOI 10.1016/S0016-5107(99)70071-4; Patti MG, 2003, J AM COLL SURGEONS, V196, P698, DOI 10.1016/S1072-7515(02)01837-9; PAYNE WS, 1989, ANN THORAC SURG, V48, P876, DOI 10.1016/0003-4975(89)90695-4; Podas T, 1998, AM J GASTROENTEROL, V93, P2345, DOI 10.1016/S0002-9270(98)00567-X; Ramacciato G, 2002, SURG ENDOSC, V16, P1431, DOI 10.1007/s00464-001-9215-2; Richards WO, 2004, ANN SURG, V240, P403, DOI 10.1097/01.sla.0000136940.32255.51; RICHTER JE, 1991, GASTROENTEROLOGY, V97, P1340; Rosemurgy A, 2005, ANN SURG, V241, P725, DOI 10.1097/01.sla.0000160702.31452.d5; SHIMI S, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P152; Shoenut JP, 1997, AM J GASTROENTEROL, V92, P1109; *SOC SURG AL TRACT, 2004, J GASTROINTEST SURG, V8, P367; Spiess AE, 1998, JAMA-J AM MED ASSOC, V280, P638, DOI 10.1001/jama.280.7.638; SWANSTROM LL, 1995, SURG ENDOSC-ULTRAS, V9, P286; TRAUBE M, 1984, JAMA-J AM MED ASSOC, V252, P1733, DOI 10.1001/jama.252.13.1733; Vaezi MF, 1999, GUT, V44, P231, DOI 10.1136/gut.44.2.231; Vela MF, 2006, CLIN GASTROENTEROL H, V4, P580, DOI 10.1016/S1542-3565(05)00986-9; Vela MF, 2004, AM J GASTROENTEROL, V99, P1029, DOI 10.1111/j.1572-0241.2004.30199.x; Zaninotto G, 2004, ANN SURG, V239, P364, DOI 10.1097/01.sla.0000114217.52941.c5	39	81	84	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2227	2233		10.1001/jama.296.18.2227	http://dx.doi.org/10.1001/jama.296.18.2227			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090769				2022-12-28	WOS:000241827700023
J	Ernst, P; McIvor, A; Ducharme, FM; Boulet, LP; FitzGerald, M; Chapman, KR; Bai, T				Ernst, Pierre; McIvor, Andrew; Ducharme, Francine M.; Boulet, Louis-Philippe; FitzGerald, Mark; Chapman, Kenneth R.; Bai, Tony		Canadian Asthma Guideline Grp	Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids	ANNALS OF INTERNAL MEDICINE			English	Article							PERSISTENT ASTHMA; SALMETEROL; EXACERBATIONS; METAANALYSIS; FLUTICASONE; THERAPY; RISK	Long-acting beta-agonists are a pillar of therapy for many patients with asthma because they are the preferred add-on therapy to inhaled corticosteroids. However, a recent meta-analysis documented a substantial increase in severe exacerbations requiring hospital admission and life-threatening asthma exacerbations in patients treated with long-acting beta-agonists. A careful evaluation of this meta-analysis raises several concerns about its applicability to current practice. Pivotal trials evaluating the benefit of adding long-acting beta-agonists; to inhaled corticosteroids were not included. The authors of the current paper call for physicians to continue their usual practice of using long-acting beta-agonists as adjunctive therapy, as well as for an independent meta-analysis of individual patients using inhaled corticosteroids and long-acting beta-agonists concomitantly.	Univ Laval, Quebec City, PQ, Canada; McGill Univ, Montreal, PQ, Canada; McMaster Univ, Hamilton, ON, Canada; Univ Toronto, Toronto, ON, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Laval University; McGill University; McMaster University; University of Toronto; University of British Columbia	McIvor, A (corresponding author), St Josephs Healthcare, Firestone Inst Resp Hlth, 50 Charlton Ave E,Room T2127, Hamilton, ON L8N 4A6, Canada.	amcivor@stjosham.on.ca	Ducharme, Francine/N-8332-2013	Ducharme, Francine/0000-0001-5096-0614				Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Boulet LP, 1999, CAN MED ASSOC J, V161, pS1; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Comino EJ, 2004, MED J AUSTRALIA, V180, P595, DOI 10.5694/j.1326-5377.2004.tb06104.x; Ernst P, 2006, EUR RESPIR J, V27, P1168, DOI 10.1183/09031936.06.00043005; Glassroth J, 2006, ANN INTERN MED, V144, P936, DOI 10.7326/0003-4819-144-12-200606200-00127; Greenstone IR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005533; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Juniper EF, 2000, AM J RESP CRIT CARE, V162, P1330, DOI 10.1164/ajrccm.162.4.9912138; Lawson JA, 2005, CURR OPIN PULM MED, V11, P79, DOI 10.1097/01.mcp.0000147861.60768.24; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Lemiere Catherine, 2004, Can Respir J, V11 Suppl A, p9A; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Masoli M, 2004, THORAX, V59, P16; Matz J, 2001, J ALLERGY CLIN IMMUN, V107, P783, DOI 10.1067/mai.2001.114709; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Ni Chroinin M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005535; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sly RM, 2006, ANN ALLERG ASTHMA IM, V96, P76, DOI 10.1016/S1081-1206(10)61043-5; Suissa S, 2004, AM J RESP CRIT CARE, V169, P83, DOI 10.1164/rccm.200305-640OC	25	50	51	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					692	694		10.7326/0003-4819-145-9-200611070-00012	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ZD	17088583				2022-12-28	WOS:000241707800008
J	Reinstein, E; Clechanover, A				Reinstein, Eyal; Clechanover, Aaron			Narrative review: Protein degradation and human diseases: The ubiquitin connection	ANNALS OF INTERNAL MEDICINE			English	Review							NF-KAPPA-B; PROTEASOME INHIBITOR BORTEZOMIB; HUMAN-PAPILLOMAVIRUS TYPE-16; EPITHELIAL SODIUM-CHANNEL; ONSET PARKINSONS-DISEASE; POSITIVE CANCER-CELLS; NON-HODGKINS-LYMPHOMA; PHASE-I TRIAL; ALPHA-SYNUCLEIN; E6 ONCOPROTEIN	Between the 1950s and 1980s, many scientists focused on the process by which the genetic code is translated into proteome. However, little attention was devoted to the mechanism responsible for protein degradation. When researchers discovered the organelle lysosome, they assumed that cellular proteins were degraded within it. However, several independent lines of evidence strongly suggested that intracellular proteolysis was largely nonlysosomal. The discovery of the ubiquitin proteasome system (UPS) resolved this enigma. It is now recognized that degradation of intracellular proteins by the UPS is involved in the regulation of a broad array of cellular processes, including cell-cycle division; DNA repair, growth, and differentiation; quality control; and regulation of membrane receptors and ion channels. Not surprisingly, aberrations in the system have been implicated in the pathogenesis of numerous human diseases, and it seems that pharmacologic manipulation of the UPS might alter the outcome of many diseases, especially malignant conditions and possibly neurodegenerative and chronic inflammatory diseases. These findings have led to increasing efforts to develop mechanism-based drugs that modulate UPS activity, one of which is already on the market. In the near future, one can expect to see the development of new, potent, and highly specific drugs that target the degradation pathways of a single or a few proteins without affecting other proteins.	Tel Aviv Univ, Dept Internal Med B, Meir Gen Hosp, IL-95847 Kefar Sava, Israel; Technion Israel Inst Technol, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Technion Israel Institute of Technology	Reinstein, E (corresponding author), Tel Aviv Univ, Dept Internal Med B, Meir Gen Hosp, IL-95847 Kefar Sava, Israel.	eyalr@mit.edu	Ciechanover, Aaron J/C-9166-2017					Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BOTEROVELEZ M, 1994, NEW ENGL J MED, V330, P178, DOI 10.1056/NEJM199401203300305; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Cote RJ, 1998, J NATL CANCER I, V90, P916, DOI 10.1093/jnci/90.12.916; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dispenzieri A, 2005, NEW ENGL J MED, V352, P2546, DOI 10.1056/NEJMe058059; Furman MH, 2002, J CLIN INVEST, V110, P875, DOI 10.1172/JCI200216831; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Goy A, 2005, J CLIN ONCOL, V23, P667, DOI 10.1200/JCO.2005.03.108; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Gudkov AV, 2004, NAT MED, V10, P1298, DOI 10.1038/nm1204-1298; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; KAWAMATA N, 1995, CANCER RES, V55, P2266; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kudo Y, 2005, MOL CANCER THER, V4, P471; Lee SH, 2005, J MOL MED, V83, P296, DOI 10.1007/s00109-004-0611-7; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Masucci MG, 2004, ONCOGENE, V23, P2107, DOI 10.1038/sj.onc.1207372; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Maynard MA, 2005, CURR CANCER DRUG TAR, V5, P345, DOI 10.2174/1568009054629672; Metzen E, 2004, BIOL CHEM, V385, P223, DOI 10.1515/BC.2004.016; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOROSETTI R, 1995, BLOOD, V86, P1924, DOI 10.1182/blood.V86.5.1924.bloodjournal8651924; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; Ohta T, 2004, ONCOGENE, V23, P2079, DOI 10.1038/sj.onc.1207371; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Palmqvist R, 1999, J PATHOL, V188, P18, DOI 10.1002/(SICI)1096-9896(199905)188:1<18::AID-PATH311>3.0.CO;2-T; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Scheffner M, 2003, SEMIN CANCER BIOL, V13, P59, DOI 10.1016/S1044-579X(02)00100-1; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spirin KS, 1996, CANCER RES, V56, P2400; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tan P, 1997, CANCER RES, V57, P1259; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WEMESS BA, 1990, SCIENCE, V248, P76; Wilkinson KD, 2004, CELL, V119, P741, DOI 10.1016/S0092-8674(04)01154-7; Yokoi S, 2003, CANCER SCI, V94, P344, DOI 10.1111/j.1349-7006.2003.tb01444.x; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	76	169	183	4	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					676	684		10.7326/0003-4819-145-9-200611070-00010	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ZD	17088581				2022-12-28	WOS:000241707800006
J	Chan, JR; Jolicoeur, C; Yamauchi, J; Elliott, J; Fawcett, JP; Ng, BK; Cayouette, M				Chan, Jonah R.; Jolicoeur, Christine; Yamauchi, Junji; Elliott, Jimmy; Fawcett, James P.; Ng, Benjamin K.; Cayouette, Michel			The polarity protein Par-3 directly interacts with p75(NTR) to regulate myelination	SCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); SCHWANN-CELL MIGRATION; DROSOPHILA NEUROBLASTS; ELEGANS EMBRYOS; C-ELEGANS; BAZOOKA; COLOCALIZES; COMPLEX; SYSTEM	Cell polarity is critical in various cellular processes ranging from cell migration to asymmetric cell division and axon and dendrite specification. Similarly, myelination by Schwann cells is polarized, but the mechanisms involved remain unclear. Here, we show that the polarity protein Par-3 localizes asymmetrically in Schwann cells at the axon-glial junction and that disruption of Par-3 localization, by overexpression and knockdown, inhibits myelination. Additionally, we show that Par-3 directly associates and recruits the p75 neurotrophin receptor to the axon-glial junction, forming a complex necessary for myelination. Together, these results point to a critical role in the establishment of cell polarity for myelination.	Inst Rech Clin Montreal, Cellular Neurobiol Lab, Montreal, PQ H2W 1R7, Canada; Univ So Calif, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; Natl Res Inst Child Hlth & Dev, Dept Mol Pharmacol, Tokyo, Japan; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Southern California; National Center for Child Health & Development - Japan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal	Chan, JR (corresponding author), Inst Rech Clin Montreal, Cellular Neurobiol Lab, Montreal, PQ H2W 1R7, Canada.	jonah.chan@usc.edu; michel.cayouette@ircm.qc.ca		Cayouette, Michel/0000-0003-4655-9048; Fawcett, Jim/0000-0003-0043-2164				Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Hung TJ, 1999, DEVELOPMENT, V126, P127; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nance J, 2002, DEVELOPMENT, V129, P387; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	21	116	122	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					832	836		10.1126/science.1134069	http://dx.doi.org/10.1126/science.1134069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082460				2022-12-28	WOS:000241729800051
J	Matthews, EE; Zoonens, M; Engelman, DM				Matthews, Erin E.; Zoonens, Manuela; Engelman, Donald M.			Dynamic helix interactions in transmembrane signaling	CELL			English	Editorial Material							MEMBRANE-PROTEIN; ERBB RECEPTORS; DOMAIN; ACTIVATION; MECHANISM; MICELLES; BILAYER	Studying how protein transmembrane domains transmit signals across membranes is beset by unique challenges. Here, we discuss the circumstances that have led to success and reflect on what has been learned from these examples. Such efforts suggest that some of the most interesting properties of transmembrane helix interactions may be the least amenable to study by current techniques.	Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Engelman, DM (corresponding author), Yale Univ, Dept Chem, 266 Whitney Ave, New Haven, CT 06520 USA.	donald.engelman@yale.edu		Zoonens, Manuela/0000-0003-2648-7868				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; DILL KA, 1981, P NATL ACAD SCI USA, V78, P676, DOI 10.1073/pnas.78.2.676; Findlay HE, 2006, J PHYS-CONDENS MAT, V18, pS1281, DOI 10.1088/0953-8984/18/28/S11; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Nollert P, 2005, PROG BIOPHYS MOL BIO, V88, P339, DOI 10.1016/j.pbiomolbio.2004.07.006; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Patargias G, 2005, J PHYS CHEM B, V109, P575, DOI 10.1021/jp046727h; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Stanley AM, 2005, J MOL BIOL, V347, P759, DOI 10.1016/j.jmb.2005.01.059; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	19	99	99	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					447	450		10.1016/j.cell.2006.10.016	http://dx.doi.org/10.1016/j.cell.2006.10.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081964	Bronze			2022-12-28	WOS:000241937000006
J	Gramm, F; Baerlocher, C; McCusker, LB; Warrender, SJ; Wright, PA; Han, B; Hong, SB; Liu, Z; Ohsuna, T; Terasaki, O				Gramm, Fabian; Baerlocher, Christian; McCusker, Lynne B.; Warrender, Stewart J.; Wright, Paul A.; Han, Bada; Hong, Suk Bong; Liu, Zheng; Ohsuna, Tetsu; Terasaki, Osamu			Complex zeolite structure solved by combining powder diffraction and electron microscopy	NATURE			English	Article							CRYSTALLOGRAPHY; RESOLUTION	Many industrially important materials, ranging from ceramics to catalysts to pharmaceuticals, are polycrystalline and cannot be grown as single crystals. This means that non-conventional methods of structure analysis must be applied to obtain the structural information that is fundamental to the understanding of the properties of these materials. Electron microscopy might appear to be a natural approach, but only relatively simple structures have been solved by this route. Powder diffraction is another obvious option, but the overlap of reflections with similar diffraction angles causes an ambiguity in the relative intensities of those reflections. Various ways of overcoming or circumventing this problem have been developed(1,2), and several of these involve incorporating chemical information into the structure determination process(3-7). For complex zeolite structures, the FOCUS algorithm(8,9) has proved to be effective. Because it operates in both real and reciprocal space, phase information obtained from high-resolution transmission electron microscopy images can be incorporated directly into this algorithm in a simple way. Here we show that by doing so, the complexity limit can be extended much further. The power of this approach has been demonstrated with the solution of the structure of the zeolite TNU-9 (\H-9.3\[ Al9.3Si182.7O384]; ref. 10) with 24 topologically distinct ( Si, Al) atoms and 52 such O atoms. For comparison, ITQ-22 ( ref. 11), the most complex zeolite known to date, has 16 topologically distinct (Si, Ge) atoms.	ETH, Crystallog Lab, CH-8093 Zurich, Switzerland; Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; Hanbat Natl Univ, Div Appl Chem & Biotechnol, Taejon 305719, South Korea; Stockholm Univ, Arrhenius Lab, S-10691 Stockholm, Sweden; Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki 3058565, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of St Andrews; Hanbat National University; Stockholm University; National Institute of Advanced Industrial Science & Technology (AIST)	McCusker, LB (corresponding author), ETH, Crystallog Lab, CH-8093 Zurich, Switzerland.	mccusker@mat.ethz.ch	Terasaki, Osamu/Y-1137-2018; Liu, Zheng/E-6119-2018	Terasaki, Osamu/0000-0001-5803-0817; Liu, Zheng/0000-0001-9095-7647; Hong, Suk Bong/0000-0002-2855-1600; McCusker, Lynne/0000-0003-0074-1733				Baerlocher C, 2004, Z KRISTALLOGR, V219, P782, DOI 10.1524/zkri.219.12.782.55863; Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW, DOI [10.1016/B978-0-444-53064-6.X5186-X, DOI 10.1016/B978-044453064-6/50201-2]; Brenner S, 2002, J APPL CRYSTALLOGR, V35, P243, DOI 10.1107/S0021889802001759; Brenner S, 1997, J APPL CRYSTALLOGR, V30, P1167, DOI 10.1107/S0021889897011291; Brodski V, 2005, J APPL CRYSTALLOGR, V38, P688, DOI 10.1107/S0021889805015876; Burton AW, 2004, Z KRISTALLOGR, V219, P866, DOI 10.1524/zkri.219.12.866.55858; Corma A, 2003, NAT MATER, V2, P493, DOI 10.1038/nmat921; David W. I. F., 2002, STRUCTURE DETERMINAT; Dorset DL, 2005, ACTA CRYSTALLOGR A, V61, P516, DOI 10.1107/S0108767305024670; ESTERMANN MA, 1993, J APPL CRYSTALLOGR, V26, P396, DOI 10.1107/S0021889892012871; Favre-Nicolin- V, 2004, Z KRISTALLOGR, V219, P847, DOI 10.1524/zkri.219.12.847.55869; Fitch AN, 2004, J RES NATL INST STAN, V109, P133, DOI 10.6028/jres.109.010; Florence AJ, 2005, J APPL CRYSTALLOGR, V38, P249, DOI 10.1107/S0021889804032662; Grosse-Kunstleve RW, 1999, J APPL CRYSTALLOGR, V32, P536, DOI 10.1107/S0021889899003453; Grosse-Kunstleve RW, 1997, J APPL CRYSTALLOGR, V30, P985, DOI 10.1107/S0021889897005013; Harris KDM, 2004, Z KRISTALLOGR, V219, P838, DOI 10.1524/zkri.219.12.838.55856; Hong SB, 2004, J AM CHEM SOC, V126, P5817, DOI 10.1021/ja031981t; HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P; KOKOTAILO GT, 1978, NATURE, V272, P437, DOI 10.1038/272437a0; LE BAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; Ohsuna T, 2002, J PHYS CHEM B, V106, P5673, DOI 10.1021/jp0130463; PAWLEY GS, 1981, J APPL CRYSTALLOGR, V14, P357, DOI 10.1107/S0021889881009618; VONSCHNERING HG, 1991, Z PHYS B CON MAT, V83, P407, DOI 10.1007/BF01313411; Wagner P, 1999, J PHYS CHEM B, V103, P8245, DOI 10.1021/jp991389j	24	164	172	2	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					79	81		10.1038/nature05200	http://dx.doi.org/10.1038/nature05200			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080087				2022-12-28	WOS:000241701500048
J	Wu, SM; Fujiwara, Y; Cibulsky, SM; Clapham, DE; Lien, CL; Schultheiss, TM; Orkin, SH				Wu, Sean M.; Fujiwara, Yuko; Cibulsky, Susan M.; Clapham, David E.; Lien, Ching-ling; Schultheiss, Thomas M.; Orkin, Stuart H.			Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart	CELL			English	Article							CARDIAC NEURAL CREST; CARDIOVASCULAR-SYSTEM; PROGENITOR CELLS; OUTFLOW TRACT; STEM-CELLS; NKX2-5; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; EMBRYOS	Despite recent advances in delineating the mechanisms involved in cardiogenesis, cellular lineage specification remains incompletely understood. To explore the relationship between developmental fate and potential, we isolated a cardiac-specific Nkx2.5(+) cell population from the developing mouse embryo. The majority of these cells differentiated into cardiomyocytes and conduction system cells. Some, surprisingly, adopted a smooth muscle fate. To address the clonal origin of these lineages, we isolated Nkx2.5+ cells from in vitro differentiated murine embryonic stem cells and found similar to 28% of these cells expressed c-kit. These c-kit(+) cells possessed the capacity for long-term in vitro expansion and differentiation into both cardiomyocytes and smooth muscle cells from a single cell. We confirmed these findings by isolating c-kit(+)Nkx2.5(+) cells from mouse embryos and demonstrated their capacity for bipotential differentiation in vivo. Taken together, these results support the existence of a common precursor for cardiovascular lineages in the mammalian heart.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Childrens Hosp Los Angeles, Saban Res Inst, Dept Cardiothorac Surg, Los Angeles, CA 90027 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA; Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Children's Hospital Los Angeles; University of Southern California; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Wu, Sean/0000-0002-0000-3821	NHLBI NIH HHS [T32 HL002807, K08 HL081086, T32 HL007572] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081086] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; COFFIN JD, 1988, DEVELOPMENT, V102, P735; CohenGould L, 1996, DEV BIOL, V177, P265, DOI 10.1006/dbio.1996.0161; EISENBERG CA, 1995, DEV BIOL, V167, P469, DOI 10.1006/dbio.1995.1042; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; HATADA Y, 1994, DEVELOPMENT, V120, P2879; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jain MK, 1998, CIRC RES, V83, P980, DOI 10.1161/01.RES.83.10.980; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lien CL, 1999, DEVELOPMENT, V126, P75; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P111; Samaha FF, 1996, J BIOL CHEM, V271, P395, DOI 10.1074/jbc.271.1.395; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stanley EG, 2002, INT J DEV BIOL, V46, P431; STAVROS T, 1996, DEV BIOL, V178, P430; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x	39	400	422	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1137	1150		10.1016/j.cell.2006.10.028	http://dx.doi.org/10.1016/j.cell.2006.10.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17123591	Bronze			2022-12-28	WOS:000242991000013
J	Sigal, A; Milo, R; Cohen, A; Geva-Zatorsky, N; Klein, Y; Liron, Y; Rosenfeld, N; Danon, T; Perzov, N; Alon, U				Sigal, Alex; Milo, Ron; Cohen, Ariel; Geva-Zatorsky, Naama; Klein, Yael; Liron, Yuvalal; Rosenfeld, Nitzan; Danon, Tamar; Perzov, Natalie; Alon, Uri			Variability and memory of protein levels in human cells	NATURE			English	Article							NOISE-PROPAGATION; GENE-EXPRESSION; STOCHASTICITY; PROTEOMICS; LOCI	Protein expression is a stochastic process that leads to phenotypic variation among cells(1-6). The cell - cell distribution of protein levels in microorganisms has been well characterized(7-23) but little is known about such variability in human cells. Here, we studied the variability of protein levels in human cells, as well as the temporal dynamics of this variability, and addressed whether cells with higher than average protein levels eventually have lower than average levels, and if so, over what timescale does this mixing occur. We measured fluctuations over time in the levels of 20 endogenous proteins in living human cells, tagged by the gene for yellow fluorescent protein at their chromosomal loci(24). We found variability with a standard deviation that ranged, for different proteins, from about 15% to 30% of the mean. Mixing between high and low levels occurred for all proteins, but the mixing time was longer than two cell generations ( more than 40 h) for many proteins. We also tagged pairs of proteins with two colours, and found that the levels of proteins in the same biological pathway were far more correlated than those of proteins in different pathways. The persistent memory for protein levels that we found might underlie individuality in cell behaviour and could set a timescale needed for signals to affect fully every member of a cell population.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021; Sigal, Alex/GWC-7488-2022; Milo, Hilla/C-8767-2016	Geva-Zatorsky, Naama/0000-0002-7303-854X; Sigal, Alex/0000-0001-8571-2004; Milo, Ron/0000-0003-1641-2299				Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alon U., 2006, INTRO SYSTEMS BIOL D; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Clyne PJ, 2003, GENETICS, V165, P1433; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281	29	397	405	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					643	646		10.1038/nature05316	http://dx.doi.org/10.1038/nature05316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17122776				2022-12-28	WOS:000242377600053
J	Faustman, DL; Tran, SD; Kodama, S; Lodde, BM; Szalayova, I; Key, S; Toth, ZE; Mezey, E				Faustman, Denise L.; Tran, Simon D.; Kodama, Shohta; Lodde, Beatrijs M.; Szalayova, Ildiko; Key, Sharon; Toth, Zsuzsanna E.; Mezey, Eva			Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice	SCIENCE			English	Editorial Material									Massachusetts Gen Hosp, Charlestown, MA 02129 USA; McGill Univ, Montreal, PQ, Canada; Brigham & Womens Hosp, Boston, MA 02215 USA; NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; McGill University; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA	Faustman, DL (corresponding author), Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	faustman@helix.mgh.harvard.edu; mezeye@mail.nih.gov	Mezey, Eva/A-8105-2008; Toth, Zsuzsanna/U-2579-2019	Mezey, Eva/0000-0002-5907-4691; 				Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Mezey E, 2003, SCIENCE, V299; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Okubo Y, 2006, DIABETES, V55, pA281; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Tran S, 2006, DIABETES, V55, pA283	10	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803								10.1126/science.1129811	http://dx.doi.org/10.1126/science.1129811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124308				2022-12-28	WOS:000242215800019
J	Chipman, A				Chipman, Andrea			Nuclear's core business	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					415	415		10.1038/444415a	http://dx.doi.org/10.1038/444415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122825	Bronze			2022-12-28	WOS:000242215700012
J	Stone, GW; McLaurin, BT; Cox, DA; Bertrand, ME; Lincoff, AM; Moses, JW; White, HD; Pocock, SJ; Ware, JH; Feit, F; Colombo, A; Aylward, PE; Cequier, AR; Darius, H; Desmet, W; Ebrahimi, R; Hamon, M; Rasmussen, LH; Rupprecht, H; Hoekstra, J; Mehran, R; Ohman, EM				Stone, Gregg W.; McLaurin, Brent T.; Cox, David A.; Bertrand, Michel E.; Lincoff, A. Michael; Moses, Jeffrey W.; White, Harvey D.; Pocock, Stuart J.; Ware, James H.; Feit, Frederick; Colombo, Antonio; Aylward, Philip E.; Cequier, Angel R.; Darius, Harald; Desmet, Walter; Ebrahimi, Ramin; Hamon, Martial; Rasmussen, Lars H.; Rupprecht, Hans-Juergen; Hoekstra, James; Mehran, Roxana; Ohman, E. Magnus		ACUITY Investigators	Bivalirudin for patients with acute coronary syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLATELET GLYCOPROTEIN-IIB/IIIA; ST-SEGMENT ELEVATION; REPLACE-2 RANDOMIZED-TRIAL; UNSTABLE ANGINA; UNFRACTIONATED HEPARIN; MYOCARDIAL-INFARCTION; INTERVENTION; INHIBITION; BLOCKADE; STRATEGY	Background: Current guidelines for patients with moderate- or high-risk acute coronary syndromes recommend an early invasive approach with concomitant antithrombotic therapy, including aspirin, clopidogrel, unfractionated or low-molecular-weight heparin, and glycoprotein IIb/IIIa inhibitors. We evaluated the role of thrombin-specific anticoagulation with bivalirudin in such patients. Methods: We assigned 13,819 patients with acute coronary syndromes to one of three antithrombotic regimens: unfractionated heparin or enoxaparin plus a glycoprotein IIb/IIIa inhibitor, bivalirudin plus a glycoprotein IIb/IIIa inhibitor, or bivalirudin alone. The primary end points were a composite ischemia end point (death, myocardial infarction, or unplanned revascularization for ischemia), major bleeding, and the net clinical outcome, defined as the combination of composite ischemia or major bleeding. Results: Bivalirudin plus a glycoprotein IIb/IIIa inhibitor, as compared with heparin plus a glycoprotein IIb/IIIa inhibitor, was associated with noninferior 30-day rates of the composite ischemia end point (7.7% and 7.3%, respectively), major bleeding (5.3% and 5.7%), and the net clinical outcome end point (11.8% and 11.7%). Bivalirudin alone, as compared with heparin plus a glycoprotein IIb/IIIa inhibitor, was associated with a noninferior rate of the composite ischemia end point (7.8% and 7.3%, respectively; P=0.32; relative risk, 1.08; 95% confidence interval [CI], 0.93 to 1.24) and significantly reduced rates of major bleeding (3.0% vs. 5.7%; P<0.001; relative risk, 0.53; 95% CI, 0.43 to 0.65) and the net clinical outcome end point (10.1% vs. 11.7%; P=0.02; relative risk, 0.86; 95% CI, 0.77 to 0.97). Conclusions: In patients with moderate- or high-risk acute coronary syndromes who were undergoing invasive treatment with glycoprotein IIb/IIIa inhibitors, bivalirudin was associated with rates of ischemia and bleeding that were similar to those with heparin. Bivalirudin alone was associated with similar rates of ischemia and significantly lower rates of bleeding. (ClinicalTrials.gov number, NCT00093158.).	Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; AnMed Hlth, Anderson, SC USA; Mid Carolina Cardiol, Charlotte, NC USA; Hop Cardiol, F-59037 Lille, France; Cleveland Clin, Cleveland, OH 44106 USA; Auckland City Hosp, Auckland, New Zealand; London Sch Hyg & Trop Med, London WC1, England; Harvard Univ, Boston, MA 02115 USA; NYU, Sch Med, New York, NY USA; Osped San Raphael, Milan, Italy; Flinders Med Ctr, Adelaide, SA, Australia; Hosp Univ Bellvitge, Barcelona, Spain; Krankenhaus Neukolln, Berlin, Germany; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Univ Calif Los Angeles, Los Angeles, CA USA; Greater Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA; Univ Hosp, Normandy, France; Aarhus Univ Hosp, Aalborg Hosp, Aalborg, Denmark; GPR Klinikum Russelsheim, Russelsheim, Germany; Wake Forest Univ, Winston Salem, NC 27109 USA; Duke Univ, Med Ctr, Durham, NC USA	Cardiovascular Research Foundation (CRF); Columbia University; Universite de Lille - ISITE; CHU Lille; Cleveland Clinic Foundation; Auckland City Hospital; University of London; London School of Hygiene & Tropical Medicine; Harvard University; New York University; Flinders Medical Centre; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; KU Leuven; University Hospital Leuven; University of California System; University of California Los Angeles; CHU de Caen NORMANDIE; Aalborg University; Aalborg University Hospital; Aarhus University; Wake Forest University; Duke University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Fl, New York, NY 10022 USA.	gs2184@columbia.edu	Colombo, Antonio/N-2960-2015; Mehran, Roxana/ABF-4160-2021	Colombo, Antonio/0000-0002-2940-2455; Aylward, Philip/0000-0002-5358-8552; Cequier, Angel/0000-0002-3230-0011				Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 2002, AM HEART J, V143, P229, DOI 10.1067/mhj.2002.120405; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bertrand ME, 2003, EUR HEART J, V24, P1174, DOI 10.1016/S0195-668X(03)00231-8; Bertrand ME, 2003, EUR HEART J, V24, P485, DOI 10.1016/S0195-668X(03)00080-0; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; BRAUNWALD E, MANAGEMENT PATIENTS; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; FUCHS J, 1995, CIRCULATION, V92, P727, DOI 10.1161/01.CIR.92.4.727; GRAVES EJ, 1998, DHHS PUBLICATION; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Lincoff AM, 2006, JAMA-J AM MED ASSOC, V296, P46; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; LINCOFF AM, 2003, JAMA-J AM MED ASSOC, V289, P1638; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; *PRIMS PLUS STUD I, 1998, NEW ENGL J MED, V339, P415; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Segev A, 2005, AM HEART J, V150, P690, DOI 10.1016/j.ahj.2004.11.012; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Tcheng JE, 2000, LANCET, V356, P2037; The ESPRIT Investigators, 2001, LANCET, V357, P1370; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	32	1110	1162	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2203	2216		10.1056/NEJMoa062437	http://dx.doi.org/10.1056/NEJMoa062437			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124018	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000242170900007
J	Kim, YG; Raunser, S; Munger, C; Wagner, J; Song, YL; Cygler, M; Walz, T; Oh, BH; Sacher, M				Kim, Yeon-Gil; Raunser, Stefan; Munger, Christine; Wagner, John; Song, Young-Lan; Cygler, Miroslaw; Walz, Thomas; Oh, Byung-Ha; Sacher, Michael			The architecture of the multisubunit TRAPP I complex suggests a model for vesicle tethering	CELL			English	Article							CRYSTAL-STRUCTURE; CIS-GOLGI; MEMBRANE; IDENTIFICATION; RECEPTOR; BET3; MECHANISM; TRANSPORT; SUBUNITS; REVEALS	Transport protein particle (TRAPP) 1 is a multi-subunit vesicle tethering factor composed of seven subunits involved in ER-to-Golgi trafficking. The functional mechanism of the complex and how the subunits interact to form a functional unit are unknown. Here, we have used a multidisciplinary approach that includes X-ray crystallography, electron microscopy, biochemistry, and yeast genetics to elucidate the architecture of TRAPP 1. The complex is organized through lateral juxtaposition of the subunits into a flat and elongated particle. We have also localized the site of guanine nucleotide exchange activity to a highly conserved surface encompassing several subunits. We propose that TRAPP 1 attaches to Golgi membranes with its large flat surface containing many highly conserved residues and forms a platform for protein-protein interactions. This study provides the most comprehensive view of a multisubunit vesicle tethering complex to date, based on which a model for the function of this complex, involving Rab1-GTP and long, coiled-coil tethers, is presented.	Pohang Univ Sci & Technol, Ctr Biomol Recognit, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Harvard University; Harvard Medical School; McGill University; National Research Council Canada; Concordia University - Canada	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Ctr Biomol Recognit, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea.	bhoh@postech.ac.kr; msacher@alcor.concordia.ca	Oh, Byung-Ha/C-2061-2011; Raunser, Stefan/AHE-1573-2022	Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62580] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cheng YF, 2006, J MOL BIOL, V355, P1048, DOI 10.1016/j.jmb.2005.11.021; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Jiang Y, 1998, GENETICS, V149, P833; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim MS, 2005, TRAFFIC, V6, P1183, DOI 10.1111/j.1600-0854.2005.00352.x; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; Lowe M, 2000, CURR BIOL, V10, pR407, DOI 10.1016/S0960-9822(00)00505-4; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whyte JRC, 2002, J CELL SCI, V115, P2627	37	141	148	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					817	830		10.1016/j.cell.2006.09.029	http://dx.doi.org/10.1016/j.cell.2006.09.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110339	Bronze			2022-12-28	WOS:000242330600026
J	Avendano, M; Mackenbach, JP				Avendano, Mauricio; Mackenbach, J. P.			Blood glucose levels: facing a global crisis	LANCET			English	Editorial Material							LIFE-STYLE; RISK-FACTORS; PREVENTION; METFORMIN; TOLERANCE; DISEASE		Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Avendano, M (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, NL-3000 CA Rotterdam, Netherlands.	m.avendanopabon@erasmusmc.nl	Avendano, Mauricio/C-9658-2018	Avendano, Mauricio/0000-0002-7295-2911				Avendano M, 2006, STROKE, V37, P1368, DOI 10.1161/01.STR.0000221702.75002.66; Bonow RO, 2004, AM J MED, V116, P2, DOI 10.1016/j.amjmed.2003.10.014; BRUG J, IN PRESS ANN BEHAV M; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Simmons RK, 2006, DIABETOLOGIA, V49, P905, DOI 10.1007/s00125-006-0163-1; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	13	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1631	1632		10.1016/S0140-6736(06)69675-X	http://dx.doi.org/10.1016/S0140-6736(06)69675-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098065				2022-12-28	WOS:000242099000008
J	Gale, EAM				Gale, Edwin A. M.			Dying of diabetes	LANCET			English	Editorial Material									Univ Bristol, Southmead Hosp, Dept Clin Sci, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Dept Clin Sci, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk						[Anonymous], 2006, BRIT NATL FORMULARY; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; McKee RL, 2001, PEOPLE EYE STORIES D, V1st; *NOV NORD, 2005, NOV NORD ANN REP FIN; Pendsey S., 1998, DIABETES VOICE, V11, P4; Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384; 2006, STATES PETITION FDA	8	26	28	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1626	1628		10.1016/S0140-6736(06)69672-4	http://dx.doi.org/10.1016/S0140-6736(06)69672-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098062				2022-12-28	WOS:000242099000005
J	Goldberg, RB				Goldberg, Ronald B.			Lifestyle interventions to prevent type 2 diabetes	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; METFORMIN; TRIAL; MELLITUS; PROGRAM; PEOPLE; IGT		Univ Miami, Diabet Res Inst, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Goldberg, RB (corresponding author), Univ Miami, Diabet Res Inst, Miller Sch Med, Miami, FL 33136 USA.	rgoldber@med.miami.edu						Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Finnish Diabetes Association, 2003, PROGR PREV TYP 2 DIA; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Uusitupa M, 2003, DIABETES, V52, P2532, DOI 10.2337/diabetes.52.10.2532; Wylie-Rosett J, 2006, CURR OPIN LIPIDOL, V17, P37, DOI 10.1097/01.mol.0000203890.27267.eb	14	9	12	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1634	1636		10.1016/S0140-6736(06)69676-1	http://dx.doi.org/10.1016/S0140-6736(06)69676-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098067				2022-12-28	WOS:000242099000010
J	Hannan, SA; Parikh, A				Hannan, S. Alam; Parikh, Abhi			Malignant melanoma of the external ear canal	LANCET			English	Editorial Material									St Marys Hosp, Dept Ear Nose & Throat, London W2 1NY, England	Imperial College London	Hannan, SA (corresponding author), St Marys Hosp, Dept Ear Nose & Throat, Praed St, London W2 1NY, England.	s.a.hannan@doctors.org.uk							0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1680	1680		10.1016/S0140-6736(06)69702-X	http://dx.doi.org/10.1016/S0140-6736(06)69702-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098086				2022-12-28	WOS:000242099000035
J	McNamee, D				McNamee, David			Apostrophe catastrophe	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		McNamee, D (corresponding author), Lancet, London NW1 7BY, England.							Strunk Jr W., 1999, ELEMENTS STYLE	1	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1636	1636		10.1016/S0140-6736(06)69677-3	http://dx.doi.org/10.1016/S0140-6736(06)69677-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098068				2022-12-28	WOS:000242099000011
J	Scheen, AJ; Finer, N; Hollander, P; Jensen, MD; Van Gaal, LF				Scheen, Andre J.; Finer, Nick; Hollander, Priscilla; Jensen, Michael D.; Van Gaal, Luc F.		RIO-Diabet Study Grp	Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study	LANCET			English	Article							CB1 RECEPTOR ANTAGONIST; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PHYSICAL-ACTIVITY; WEIGHT-LOSS; ASSOCIATION; SR141716; ENDOCANNABINOIDS; PARTICIPANTS	Background Rimonabant, a selective cannabinoid type 1 receptor blocker, reduces bodyweight and improves cardiovascular and metabolic risk factors in non-diabetic overweight or obese patients. The aim of the RIO-Diabetes trial was to assess the efficacy and safety of rimonabant in overweight or obese patients with type 2 diabetes that was inadequately controlled by metformin or sulphonylureas. Methods 1047 overweight or obese type 2 diabetes patients (body-mass index 27-40 kg/m(2)) with a haemoglobin A(1c) (HbA(1c)) concentration of 6.5-10.0% (mean 7.3% [SD 0.9] at baseline) already on metformin or sulphonylurea monotherapy were given a mild hypocaloric diet and advice for increased physical activity, and randomly assigned placebo (n=348), 5 mg/day rimonabant (360) or 20 mg/day rimonabant (339) for 1 year. Two individuals in the 5 mg/day group did not receive double-blind treatment and were thus not included in the final analysis. The primary endpoint was weight change from baseline after 1 year of treatment. Analyses were done on an intention-to-treat basis. This trial is registered at ClinicalTrials.gov, number NCT00029848. Findings 692 patients completed the 1 year follow-up; numbers in each group after 1 year were much the same. Weight loss was significantly greater after 1 year in both rimonabant groups than in the placebo group (placebo: -1.4 kg [SD 3.6]; 5 mg/day: -2.3 kg [4.2], p=0.01 vs placebo; 20 mg/day: -5.3 kg [5.2], p<0.0001 vs placebo). Rimonabant was generally well tolerated. The incidence of adverse events that led to discontinuation was slightly greater in the 20 mg/day rimonabant group, mainly due to depressed mood disorders, nausea, and dizziness. Interpretation These data indicate that 20 mg/day rimonabant, in combination with diet and exercise, can produce a clinically meaningful reduction in bodyweight and improve HbA(1c) and a number of cardiovascular and metabolic risk factors in overweight or obese patients with type 2 diabetes inadequately controlled by metformin or sulphonylureas.	CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium; Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; Baylor Univ, Med Ctr, Ruth Collins Diabet Ctr, Dallas, TX USA; Mayo Clin, Endocrine Res Unit, Rochester, MN USA; Univ Antwerp Hosp, Dept Diabetol Metab & Clin Nutr, Antwerp, Belgium	University of Liege; University of Cambridge; Baylor University; Baylor University Medical Center; Mayo Clinic; University of Antwerp	Scheen, AJ (corresponding author), CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B35, B-4000 Liege, Belgium.	andre.scheen@chu.ulg.ac.be	Finer, Nicholas/B-9981-2009	Finer, Nicholas/0000-0003-2468-6804				Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS1; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Buyse M, 1998, BIOMETRICS, V54, P1014, DOI 10.2307/2533853; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GUARE JC, 1995, OBES RES, V3, P329, DOI 10.1002/j.1550-8528.1995.tb00158.x; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HILL AJ, 1995, INT J OBESITY, V19, P361; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; International Diabetes Federation, GLOB GUID TYP 2 DIAB; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolotkin RL, 2002, QUAL LIFE RES, V11, P157, DOI 10.1023/A:1015081805439; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Norris SL, 2004, ARCH INTERN MED, V164, P1395, DOI 10.1001/archinte.164.13.1395; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Padwal R, 2003, INT J OBESITY, V27, P1437, DOI 10.1038/sj.ijo.0802475; PISNYER FX, 2006, JAMA-J AM MED ASSOC, V295, P761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Scheen AJ, 2003, DRUGS, V63, P1165, DOI 10.2165/00003495-200363120-00001; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; WING RR, 1987, ARCH INTERN MED, V147, P1749, DOI 10.1001/archinte.147.10.1749; WING RR, 1987, DIABETES CARE, V10, P563, DOI 10.2337/diacare.10.5.563; Wood AM, 2005, INT J EPIDEMIOL, V34, P89; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	566	589	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1660	1672		10.1016/S0140-6736(06)69571-8	http://dx.doi.org/10.1016/S0140-6736(06)69571-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098084	Green Submitted			2022-12-28	WOS:000242099000033
J	Gheorghiade, M; Abraham, WT; Albert, NM; Greenberg, BH; O'Connor, CM; She, LL; Stough, WG; Yancy, CW; Young, JB; Fonarow, GC				Gheorghiade, Mihai; Abraham, William T.; Albert, Nancy M.; Greenberg, Barry H.; O'Connor, Christopher M.; She, Lilin; Gattis Stough, Wendy; Yancy, Clyde W.; Young, James B.; Fonarow, Gregg C.		OPTIMIZE-HF Investigators Coordina	Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK STRATIFICATION; UNITED-STATES; MORTALITY; HYPERTENSION; RATIONALE; DESIGN	Context The association between systolic blood pressure (SBP) at admission, clinical characteristics, and outcomes in patients hospitalized for heart failure who have reduced or relatively preserved systolic function has not been well studied. Objective To evaluate the relationship between SBP at admission, clinical profile, and outcomes in patients hospitalized for acute heart failure. Design, Setting, and Patients Cohort study using data from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry and performance-improvement program for patients hospitalized with heart failure at 259 US hospitals between March 2003 and December 2004. Patients were divided into quartiles by SBP at hospital admission (< 120, 120-139, 140-161, and > 161 mm Hg). In-hospital outcomes were based on 48 612 patients aged 18 years or older with heart failure. Of the 41 267 patients with left ventricular function assessed, 21 149 (51%) had preserved left ventricular function. Postdischarge outcomes were based on a prespecified subgroup (n = 5791, 10% of patients) with follow-up data assessed between 60 and 90 days. Main Outcome Measures In-hospital and postdischarge mortality. Results Patients with higher SBP were more likely to be female and black and to have preserved systolic function. Fifty percent of the patients had SBP higher than 140 mm Hg at admission. Patients with lower SBP at admission had higher in-hospital and postdischarge mortality rates. Higher SBP at admission was associated with lower in-hospital mortality rates: 7.2% (< 120 mm Hg), 3.6% (120-139 mm Hg), 2.5% (140-161 mm Hg), and 1.7% (> 161 mm Hg) (P < .001 for overall difference). Postdischarge mortality rates in the follow-up cohort by SBP at admission were 14.0%, 8.4%, 6.0%, and 5.4%, respectively (P < .001 for overall difference). Conclusions Systolic hypertension is common in patients hospitalized for heart failure. Systolic blood pressure is an independent predictor of morbidity and mortality in patients with heart failure with either reduced or relatively preserved systolic function. Low SBP (< 120 mm Hg) at hospital admission identifies patients who have a poor prognosis despite medical therapy. These findings may have important therapeutic implications because characteristics and outcomes differ greatly among patients with heart failure with varying SBP.	Univ Calif Los Angeles, Med Ctr, Dept Med, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; Ohio State Univ, Div Cardiol, Columbus, OH 43210 USA; Cleveland Clin Fdn, George M & Linda H Kaufman Ctr Heart Failure, Cleveland, OH 44195 USA; Univ Calif San Diego, Med Ctr, Dept Med, San Diego, CA 92103 USA; Duke Clin Res Inst, Durham, NC USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Campbell Univ, Sch Pharm, Res Triangle Pk, NC USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Northwestern University; Feinberg School of Medicine; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of California System; University of California San Diego; Duke University; Duke University; Campbell University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Med, Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Stough, Wendy G/R-4287-2016; Fonarow, Gregg C/D-5988-2014	Stough, Wendy G/0000-0001-8290-1205; Fonarow, Gregg C/0000-0002-3192-8093				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Cotter G, 2005, CIRCULATION, V112, pU661; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Felker GM, 2004, J CARD FAIL, V10, P460, DOI 10.1016/j.cardfail.2004.02.011; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Mebazaa A, 2005, AM HEART ASS SCI SES; PACKER M, 2005, AM HEART ASS SCI SES; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Teerlink JR, 2005, AM HEART J, V150, P46, DOI 10.1016/j.ahj.2005.04.035; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	20	678	709	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2217	2226		10.1001/jama.296.18.2217	http://dx.doi.org/10.1001/jama.296.18.2217			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090768	Bronze			2022-12-28	WOS:000241827700022
J	Ceglia, L; Lau, J; Pittas, AG				Ceglia, Lisa; Lau, Joseph; Pittas, Anastassios G.			Meta-analysis: Efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							REDUCED PULMONARY-FUNCTION; SUBCUTANEOUS INSULIN; GLYCEMIC CONTROL; TYPE-2; SMOKING; EXUBERA; METFORMIN; REGIMEN; 6-MONTH; PROFILE	Background: Injection insulin therapy is not readily accepted by patients and many health care providers; therefore, less invasive options for insulin therapy are desirable. Purpose: To examine the efficacy, safety, and patient acceptability of inhaled insulin therapy in nonpregnant adults with diabetes mellitus. Data Sources: English-language studies in MEDLINE, the Cochrane Clinical Trials Register (through June 2006), and U.S. Food and Drug Administration review documents of the first formulation of inhaled insulin approved for clinical use. Study Selection: Randomized, controlled trials of at least 12 weeks' duration that compared inhaled insulin with another active therapy and reported hemoglobin A(1c) levels in adults with type 1 or type 2 diabetes mellitus. Data Extraction: Two reviewers independently assessed trials for inclusion and extracted data. Differences were resolved by consensus. Data Synthesis: Sixteen open-label trials met the inclusion criteria (4023 patients; age range, 18 to 80 years). Among patients with type 1 or type 2 diabetes, there was a small decrease in hemoglobin A(1c) level from baseline that favored subcutaneous insulin over inhaled insulin (weighted mean difference, 0.08% [95% Cl, 0.03% to 0.14%]), although there was no difference in the proportion of participants achieving hemoglobin A(1c) levels less than 7%. Inhaled insulin lowered hemoglobin A(1c) levels more (weighted mean difference favoring inhaled insulin, -1.45% [Cl, -1.80% to - 1.10%]) compared with fixed doses of oral agents but much less when compared with oral agents titrated to glycemic efficacy (weighted mean difference favoring inhaled insulin, -0.20% [Cl, -0.34% to - 0.07%]). Severe hypoglycemia was more likely to occur with inhaled insulin than with oral agents (risk ratio, 3.1 [Cl, 1.0 to 9.1]), but there was no increased risk compared with subcutaneous insulin. There was an increased incidence of mild to moderate nonprogressive dry cough in patients treated with inhaled insulin (risk ratio, 3.5 [Cl, 2.2 to 5.6]) and a mild decrease in certain pulmonary function testing variables, which did not progress over 2 years. Patients preferred inhaled insulin over subcutaneous insulin. Limitations: All trials were open label, which may introduce bias. Most of the trials were of 24 weeks' duration or less, limiting assessment of long-term safety. Conclusions: Inhaled insulin offers an alternative noninvasive option for premeal insulin administration, with glycemic efficacy slightly less than subcutaneous regular insulin and increased patient acceptability. Until long-term safety data are available, inhaled insulin should be reserved for nonpregnant adults with diabetes who are opposed to injections and who would otherwise delay appropriate and timely therapy with insulin.	Tufts Univ, New England Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Pittas, AG (corresponding author), Tufts Univ, New England Med Ctr, Div Endocrinol Diabet & Metab, 750 Washington St,268, Boston, MA 02111 USA.	apittas@tufts-nemc.org			NIDDK NIH HHS [K23 DK61506] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK061506] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnett AH, 2006, DIABETES CARE, V29, P1282, DOI 10.2337/dc05-1879; Becker RHA, 2006, DIABETES CARE, V29, P277, DOI 10.2337/diacare.29.02.06.dc05-1913; Cappelleri JC, 2002, CLIN THER, V24, P552, DOI 10.1016/S0149-2918(02)85131-1; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; DeFronzo RA, 2005, DIABETES CARE, V28, P1922, DOI 10.2337/diacare.28.8.1922; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eisenberg JM, 1999, JAMA-J AM MED ASSOC, V282, P1865, DOI 10.1001/jama.282.19.1865; Freemantle N, 2005, DIABETES CARE, V28, P427, DOI 10.2337/diacare.28.2.427; Garg S, 2006, DIABETOLOGIA, V49, P891, DOI 10.1007/s00125-006-0161-3; Goldman MD, 2003, DIABETES CARE, V26, P1915, DOI 10.2337/diacare.26.6.1915; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Haire-Joshu D, 1999, DIABETES CARE, V22, P1887, DOI 10.2337/diacare.22.11.1887; Heise T, 2005, DIABETES CARE, V28, P2161, DOI 10.2337/diacare.28.9.2161; Henry RR, 2003, DIABETES CARE, V26, P764, DOI 10.2337/diacare.26.3.764; Hermansen K, 2004, DIABETES CARE, V27, P162, DOI 10.2337/diacare.27.1.162; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Himmelmann A, 2003, DIABETES CARE, V26, P677, DOI 10.2337/diacare.26.3.677; Hollander PA, 2004, DIABETES CARE, V27, P2356, DOI 10.2337/diacare.27.10.2356; INNOCENTI F, 1994, DIABETES RES CLIN PR, V25, P161, DOI 10.1016/0168-8227(94)90004-3; McElduff A, 2005, BRIT J CLIN PHARMACO, V59, P546, DOI 10.1111/j.1365-2125.2005.02366.x; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; PITTAS AG, 2003, CONTEMPORARY DIAGNOS; Quattrin T, 2004, DIABETES CARE, V27, P2622, DOI 10.2337/diacare.27.11.2622; Rave K, 2005, DIABETES CARE, V28, P1077, DOI 10.2337/diacare.28.5.1077; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rosenstock J, 2005, ANN INTERN MED, V143, P549, DOI 10.7326/0003-4819-143-8-200510180-00005; Royle P, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003890.PUB2; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Skyler JS, 2001, LANCET, V357, P331, DOI 10.1016/S0140-6736(00)03638-2; Smith SA, 2000, DIABETES CARE, V23, P95, DOI 10.2337/diacare.23.1.95; Sreeja C K, 2003, Indian J Physiol Pharmacol, V47, P87; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weiss SR, 2003, ARCH INTERN MED, V163, P2277, DOI 10.1001/archinte.163.19.2277	38	73	106	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					665	675		10.7326/0003-4819-145-9-200611070-00009	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ZD	17088580				2022-12-28	WOS:000241707800005
J	Curado, S; Stainier, DYR				Curado, Silvia; Stainier, Didier Y. R.			The HeArt of regeneration	CELL			English	Review							SMOOTH-MUSCLE; AVIAN HEART; ZEBRAFISH; CELLS	Fish and amphibian hearts are known to regenerate after partial resection, but the molecular mechanisms underlying this process remain unclear. In this issue of Cell, Lepilina et al. (2006) analyze regeneration in the zebrafish heart. Their work indicates that new cardiomyocytes originate from undifferentiated progenitor cells and reveals a critical role for the epicardium, the cellular layer that covers the heart.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Genet & Human Genet, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Inst Cardiovasc Res, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, 1550 4th St, San Francisco, CA 94158 USA.	dstainier@biochem.ucsf.edu		Stainier, Didier/0000-0002-0382-0026				Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; LEPLINA A, 2006, CELL; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961	10	8	9	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					462	464		10.1016/j.cell.2006.10.025	http://dx.doi.org/10.1016/j.cell.2006.10.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081969	Bronze			2022-12-28	WOS:000241937000011
J	Elbaum, M				Elbaum, Michael			Polymers in the pore	SCIENCE			English	Editorial Material							TRANSPORT; MEMBRANES; MOLECULES; MECHANISM; COMPLEX		Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Elbaum, M (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam, Germany.	michael.elbaum@weizmann.ac.il						Brown HG, 1997, BIOCHEMISTRY-US, V36, P15035, DOI 10.1021/bi9721748; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lee NH, 2002, POLYMER, V43, P6255, DOI 10.1016/S0032-3861(02)00555-4; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	10	13	14	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					766	767		10.1126/science.1135924	http://dx.doi.org/10.1126/science.1135924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17082441				2022-12-28	WOS:000241729800028
J	Yashin, VV; Balazs, AC				Yashin, Victor V.; Balazs, Anna C.			Pattern formation and shape changes in self-oscillating polymer gels	SCIENCE			English	Article							BELOUSOV-ZHABOTINSKY REACTION; DRIVEN; GLUCOSE; SYSTEM; MODEL	We developed an efficient model for responsive gels that captures large-scale, two-dimensional (2D) deformations and chemical reactions within a swollen polymer network. The 2D calculations allowed us to probe not only volume changes but also changes in sample shape. By focusing on gels undergoing the oscillatory Belousov-Zhabotinsky reaction, we observed traveling waves of local swelling that form a rich variety of dynamic patterns and give rise to distinctive oscillations in the gel's shape. The observed patterns depend critically on the gel's dimensions. The approach provides a useful computational tool for probing the dynamics of chemomechanical processes and uncovering morphological transformations in responsive gels.	Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Balazs, AC (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.	balazs1@engr.pitt.edu	Yashin, Victor/AAF-8278-2019	Yashin, Victor/0000-0002-9991-0877; Balazs, Anna/0000-0002-5555-2692				Amemiya T, 2000, J PHYS CHEM A, V104, P336, DOI 10.1021/jp9929317; ATKIN RJ, 1980, INTRO THEORY ELASTIC; Barriere B, 2003, J POLYM SCI POL PHYS, V41, P166, DOI 10.1002/polb.10341; Boissonade J, 2005, CHAOS, V15, DOI 10.1063/1.1880592; Boissonade J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188302; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dhanarajan AP, 2002, J PHYS CHEM A, V106, P8835, DOI 10.1021/jp026086v; Diewald M, 1996, PHYS REV LETT, V77, P4466, DOI 10.1103/PhysRevLett.77.4466; Gray P., 1994, CHEM OSCILLATIONS IN; Hill T. L., 2012, INTRO STAT THERMODYN; Howse JR, 2006, NANO LETT, V6, P73, DOI 10.1021/nl0520617; KRUG HJ, 1990, J PHYS CHEM-US, V94, P4862, DOI 10.1021/j100375a021; Labrot V, 2005, J PHYS CHEM B, V109, P21476, DOI 10.1021/jp055095b; Ladd AJC, 1997, PHYS REV E, V55, P3271, DOI 10.1103/PhysRevE.55.3271; Leroux JC, 1999, CHAOS, V9, P267, DOI 10.1063/1.166403; Miyakawa K, 2000, PHYS REV E, V62, P793, DOI 10.1103/PhysRevE.62.793; ONUKI A, 1993, ADV POLYM SCI, V109, P63; POJMAN JA, 2004, ACS S SERIES, V869; SHIBAYAMA M, 1993, ADV POLYM SCI, V109, P1; Tyson J. J., 1985, OSCILLATIONS TRAVELI, P93; TYSON JJ, 1980, J CHEM PHYS, V73, P2224, DOI 10.1063/1.440418; Yashin VV, 2006, MACROMOLECULES, V39, P2024, DOI 10.1021/ma052622g; Yoshida R, 2005, CURR ORG CHEM, V9, P1617, DOI 10.2174/138527205774610949; Yoshida R, 1996, J AM CHEM SOC, V118, P5134, DOI 10.1021/ja9602511; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0	26	171	176	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					798	801		10.1126/science.1132412	http://dx.doi.org/10.1126/science.1132412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082453				2022-12-28	WOS:000241729800040
J	Grenyer, R; Orme, CDL; Jackson, SF; Thomas, GH; Davies, RG; Davies, TJ; Jones, KE; Olson, VA; Ridgely, RS; Rasmussen, PC; Ding, TS; Bennett, PM; Blackburn, TM; Gaston, KJ; Gittleman, JL; Owens, IPF				Grenyer, Richard; Orme, C. David L.; Jackson, Sarah F.; Thomas, Gavin H.; Davies, Richard G.; Davies, T. Jonathan; Jones, Kate E.; Olson, Valerie A.; Ridgely, Robert S.; Rasmussen, Pamela C.; Ding, Tzung-Su; Bennett, Peter M.; Blackburn, Tim M.; Gaston, Kevin J.; Gittleman, John L.; Owens, Ian P. F.			Global distribution and conservation of rare and threatened vertebrates	NATURE			English	Article							RESERVE SELECTION; INDICATOR GROUPS; HOTSPOTS; ECOREGIONS; PATTERNS	Global conservation strategies commonly assume that different taxonomic groups show congruent geographical patterns of diversity, and that the distribution of extinction-prone species in one group can therefore act as a surrogate for vulnerable species in other groups when conservation decisions are being made(1-4). The validity of these assumptions remains unclear, however, because previous tests have been limited in both geographical and taxonomic extent(5-12). Here we use a database on the global distribution of 19,349 living bird, mammal and amphibian species to show that, although the distribution of overall species richness is very similar among these groups, congruence in the distribution of rare and threatened species is markedly lower. Congruence is especially low among the very rarest species. Cross-taxon congruence is also highly scale dependent, being particularly low at the finer spatial resolutions relevant to real protected areas. 'Hotspots' of rarity and threat are therefore largely non-overlapping across groups, as are areas chosen to maximize species complementarity. Overall, our results indicate that 'silver-bullet' conservation strategies alone will not deliver efficient conservation solutions. Instead, priority areas for biodiversity conservation must be based on high-resolution data from multiple taxa.	Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Michigan State Univ Museum, E Lansing, MI 48824 USA; Dept Zool, E Lansing, MI 48824 USA; Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 106, Taiwan; NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	University of Virginia; Imperial College London; University of Sheffield; University of Birmingham; Zoological Society of London; Drexel University; Michigan State University; National Taiwan University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Grenyer, R (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England.	r.grenyer@kew.org; jlg@uga.edu; i.owens@imperial.ac.uk	Blackburn, Tim M/A-7685-2011; Jones, Kate/Y-3317-2019; Blackburn, Tim/AAC-3144-2019; Davies, Richard/H-7447-2019; Jones, Kate E/G-4768-2010; Thomas, Gavin/AAE-8959-2019; DING, Tzung-Su/AAG-7712-2019; Owens, Ian PF/F-1392-2010	Jones, Kate/0000-0001-5231-3293; Blackburn, Tim/0000-0003-0152-2663; Jones, Kate E/0000-0001-5231-3293; Thomas, Gavin/0000-0002-1982-6051; Owens, Ian/0000-0001-6080-3321; DING, Tzung-Su/0000-0002-1102-3879	Natural Environment Research Council [NE/B503492/1, NER/O/S/2001/01230] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baillie J.E.M., 2004, IUCN RED LIST THREAT; *BIRDL INT, 2006, WORLD BIRD DAT; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; CLIFFORD P, 1989, BIOMETRICS, V45, P123, DOI 10.2307/2532039; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Gaston K. J, 1994, RARITY, V13, P1; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; *IUCN, 2006, GLOB MAMM ASS; IUCN, 2006, IUCN RED LIST THREAT; IUCN Conservation International and Nature Serve, 2004, GLOB AMPH ASS; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pearson DL, 1999, J BIOGEOGR, V26, P1079, DOI 10.1046/j.1365-2699.1999.00337.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Rodrigues AS, 2000, ECOGRAPHY, V23, P565, DOI 10.1034/j.1600-0587.2000.230507.x; SECHREST WW, 2003, THESIS U VIRGINIA; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; *WDPA CONS, 2005, WORLD DAT PROT AR; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	30	391	413	6	241	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					93	96		10.1038/nature05237	http://dx.doi.org/10.1038/nature05237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080090				2022-12-28	WOS:000241701500052
J	Zar, HJ; Cotton, MF; Strauss, S; Karpakis, J; Hussey, G; Schaaf, S; Rabie, H; Lombard, CJ				Zar, Heather J.; Cotton, Mark F.; Strauss, Stanzi; Karpakis, Janine; Hussey, Gregory; Schaaf, Simon; Rabie, Helena; Lombard, Carl J.			Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL PRESENTATION; INFECTION; IMPACT	Objectives To investigate the impact of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV. Design Two centre prospective double blind placebo controlled trial. Participants Children aged 8 weeks with HIV. Interventions lsoniazid or placebo given with cotrimoxazole either daily or three times a week. Setting Two tertiary healthcare centres in South Africa. Main outcome measures Mortality, incidence of tuberculosis, and adverse events. Results Data on 263 children (median age 24.7 months) were available when the data safety monitoring board recommended discontinuing the placebo arm; 132 (50%) were taking isoniazid. Median follow-up was 5.7 (interquartile range 2.0-9.7) months. Mortality was lower in the isoniazid group than in the placebo group (11 (8%) v 21 (16%), hazard ratio 0.46, 95% confidence interval 0.22 to 0.95, P=0.015) by intention to treat analysis. The benefit applied across Centers for Disease Control clinical categories and in all ages. The reduction in mortality was similar in children on three times a week or daily isoniazid. The incidence of tuberculosis was lower in the isoniazid group (5 cases, 3.8%) than in the placebo group (13 cases, 9.9%) (hazard ratio 0.28, 0.10 to 0.78, P=0.005). All cases of tuberculosis confirmed by culture were in children in the placebo group. Conclusions Prophylaxis with isoniazid has an early survival benefit and reduces incidence of tuberculosis in children with HIV. Prophylaxis may offer an effective public health intervention to reduce mortality in such children in settings with a high prevalence of tuberculosis.	Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa; Univ Stellenbosch, Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, ZA-7600 Stellenbosch, South Africa; MRC, Biostat Unit, Stellenbosch, South Africa	University of Cape Town; Stellenbosch University	Zar, HJ (corresponding author), Univ Cape Town, Red Cross Childrens Hosp, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa.	hzar@ich.uct.ac.za	Cotton, Mark/AAQ-9936-2020; Zar, Heather/GZL-5350-2022; Rabie, Helena/ABH-1437-2020	Cotton, Mark/0000-0003-2559-6034; Zar, Heather/0000-0002-9046-759X; Rabie, Helena/0000-0001-6336-2963; Schaaf, Hendrik Simon/0000-0001-5755-4133; Lombard, Carl/0000-0002-2136-6533; le Roux, Stanzi/0000-0001-8882-698X				Baldock C, 1998, BIOCHEM PHARMACOL, V55, P1541; BEYERS N, 2001, INT J TUBERC LUNG S1, V5, pS185; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Chintu C, 2005, INT J TUBERC LUNG D, V9, P477; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Choi DW, 2002, FREE RADICAL RES, V36, P893, DOI 10.1080/1071576021000005339; Hesseling AC, 2005, ARCH DIS CHILD, V90, P1171, DOI 10.1136/adc.2004.070466; Mukadi YD, 1997, AIDS, V11, P1151, DOI 10.1097/00002030-199709000-00011; Palme IB, 2002, PEDIATR INFECT DIS J, V21, P1053, DOI 10.1097/00006454-200211000-00016; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; URBASCHEK R, 1991, ANTIMICROB AGENTS CH, V35, P1666, DOI 10.1128/AAC.35.8.1666; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; WOLDEHANNA S, 2006, COCHRANE DB SYST REV; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2	16	169	172	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2007	334	7585					136	139		10.1136/bmj.39000.486400.55	http://dx.doi.org/10.1136/bmj.39000.486400.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130LP	17085459	Green Published, Bronze			2022-12-28	WOS:000243801400033
J	T Brown, C; Yap, T; Cromwell, DA; Rixon, L; Steed, L; Mulligan, K; Mundy, A; Newman, SP; van der Meulen, J; Emberton, M				T Brown, Christian; Yap, Tet; Cromwell, David A.; Rixon, Lorna; Steed, Liz; Mulligan, Kathleen; Mundy, Anthony; Newman, Stanton P.; van der Meulen, Jan; Emberton, Mark			Self management for men with lower urinary tract symptoms: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							BENIGN PROSTATIC HYPERPLASIA; INTERVENTIONS; HEALTH; INDEX	Objective To evaluate the effectiveness of self management as a first line intervention for men with lower urinary tract symptoms. Design Randomised controlled trial. Setting A teaching hospital and a district general hospital in London. Participants 140 men (mean age 63 (SD 10.7) years), recruited between January 2003 and April 2004, referred by general practitioners to urological outpatient departments with uncomplicated lower urinary tract symptoms. Interventions Self management and standard care (n=73) or standard care alone (n=67). The self management group took part in three small group sessions comprising education, lifestyle advice, and training in problem solving and goal setting skills. Main outcome measures The primary outcome measure was treatment failure measured at 3, 6, and 12 months. Symptom severity (international prostate symptom score; higher scores represent a poorer outcome) was used as a secondary outcome. Results At three months, treatment failure had occurred in 7 (10%) of the self management group and in 27 (42%) of the standard care group (difference=32%, 95% confidence interval 18% to 46%). Corresponding differences in the frequency of treatment failure were 42% (27% to 57%) at six months and 48% (32% to 64%) at 12 months. At three months, the mean international prostate symptom score was 10.7 in the self management group and 16.4 in the standard care group (difference=5.7, 3.7 to 7.7). Corresponding differences in score were 6.5 (4.3 to 8.7) at six months and 5.1 (2.7 to 7.6) at 12 months. Conclusions Self management significantly reduced the frequency of treatment failure and reduced urinary symptoms. Because of the large observed benefit of self management, the results of this study support the case for a large multicentre trial to confirm whether self management could be considered as first line treatment for men with lower urinary tract symptoms.	Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1E 7HT, England; Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PE, England; UCL, Ctr Behav & Social Sci Med, Unit Hlth Psychol, London WC1E 6BT, England; UCL, Inst Urol, London W1W 7EY, England	University of London; London School of Hygiene & Tropical Medicine; Royal College of Surgeons of England; University of London; University College London; University of London; University College London	van der Meulen, J (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Keppel St, London WC1E 7HT, England.	Jan.vanderMeulen@LSHTM.ac.uk	Mulligan, Kathleen/M-6670-2019; Newman, Stanton P/D-3972-2011; Cromwell, David/AAD-6519-2019	Mulligan, Kathleen/0000-0002-6003-3029; van der Meulen, Jan/0000-0002-9451-2335; Newman, Stanton/0000-0001-6712-6079				*AM UR ASS, 2003, GUID MAN BEN PROST H; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; BARRY MJ, 1995, MED CARE, V33, P135; Brown CT, 2003, BJU INT, V92, P53, DOI 10.1046/j.1464-410X.2003.04268.x; Brown CT, 2004, EUR UROL, V46, P254, DOI 10.1016/j.eururo.2004.02.008; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016	8	66	71	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 6	2007	334	7583					25	28		10.1136/bmj.39010.551319.AE	http://dx.doi.org/10.1136/bmj.39010.551319.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125CH	17118949	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000243418600035
J	Marshall, L; Helgadottir, H; Molle, M; Born, J				Marshall, Lisa; Helgadottir, Halla; Moelle, Matthias; Born, Jan			Boosting slow oscillations during sleep potentiates memory	NATURE			English	Article							CONSOLIDATION; STIMULATION; CORTEX	There is compelling evidence that sleep contributes to the long-term consolidation of new memories(1). This function of sleep has been linked to slow (<1 Hz) potential oscillations, which predominantly arise from the prefrontal neocortex and characterize slow wave sleep(2-4). However, oscillations in brain potentials are commonly considered to be mere epiphenomena that reflect synchronized activity arising from neuronal networks, which links the membrane and synaptic processes of these neurons in time(5). Whether brain potentials and their extracellular equivalent have any physiological meaning per se is unclear, but can easily be investigated by inducing the extracellular oscillating potential fields of interest(6-8). Here we show that inducing slow oscillation-like potential fields by transcranial application of oscillating potentials (0.75 Hz) during early nocturnal non-rapid-eye-movement sleep, that is, a period of emerging slow wave sleep, enhances the retention of hippocampus-dependent declarative memories in healthy humans. The slowly oscillating potential stimulation induced an immediate increase in slow wave sleep, endogenous cortical slow oscillations and slow spindle activity in the frontal cortex. Brain stimulation with oscillations at 5 Hz - another frequency band that normally predominates during rapid-eye-movement sleep - decreased slow oscillations and left declarative memory unchanged. Our findings indicate that endogenous slow potential oscillations have a causal role in the sleep-associated consolidation of memory, and that this role is enhanced by field effects in cortical extracellular space.	Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany	University of Lubeck	Marshall, L (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Haus 23A,Ratzeburger Allee 160, D-23538 Lubeck, Germany.	marshall@kfg.uni-luebeck.de; born@kfg.uni-luebeck.de	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248				Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Doran S. M., 2003, SLEEP RES ONLINE, V5, P133; Francis JT, 2003, J NEUROSCI, V23, P7255; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Lutzenberger W, 1987, SAFETY ASSESSMENT NM, P36; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Massimini M, 2001, J NEUROPHYSIOL, V85, P1346, DOI 10.1152/jn.2001.85.3.1346; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; RUSH S, 1968, ANESTH ANAL CURR RES, V47, P717; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; Steriade M, 1996, J NEUROSCI, V16, P2788; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Werk CM, 2005, NEUROSCIENCE, V131, P793, DOI 10.1016/j.neuroscience.2004.12.020; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	30	1167	1205	12	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					610	613		10.1038/nature05278	http://dx.doi.org/10.1038/nature05278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17086200				2022-12-28	WOS:000242377600046
J	Hosie, AM; Wilkins, ME; da Silva, HMA; Smart, TG				Hosie, Alastair M.; Wilkins, Megan E.; da Silva, Helena M. A.; Smart, Trevor G.			Endogenous neurosteroids regulate GABA(A) receptors through two discrete transmembrane sites	NATURE			English	Article							AMINOBUTYRIC-ACID RECEPTOR; NEUROACTIVE STEROIDS; A RECEPTOR; STRESS; BRAIN; ACCESSIBILITY; MODULATION; MECHANISMS; RESIDUES; SUBUNIT	Inhibitory neurotransmission mediated by GABA(A) receptors can be modulated by the endogenous neurosteroids, allopregnanolone and tetrahydro-deoxycorticosterone(1). Neurosteroids are synthesized de novo in the brain during stress(2), pregnancy(3) and after ethanol consumption(4), and disrupted steroid regulation of GABAergic transmission is strongly implicated in several debilitating conditions such as panic disorder, major depression, schizophrenia, alcohol dependence and catamenial epilepsy(3,5-8). Determining how neurosteroids interact with the GABA(A) receptor is a prerequisite for understanding their physiological and pathophysiological roles in the brain. Here we identify two discrete binding sites in the receptor's transmembrane domains that mediate the potentiating and direct activation effects of neurosteroids. They potentiate GABA responses from a cavity formed by the alpha-subunit transmembrane domains, whereas direct receptor activation is initiated by interfacial residues between alpha and beta subunits and is enhanced by steroid binding to the potentiation site. Thus, significant receptor activation by neurosteroids relies on occupancy of both the activation and potentiation sites. These sites are highly conserved throughout the GABA(A) receptor family, and their identification provides a unique opportunity for the development of new therapeutic, neurosteroid-based ligands and transgenic disease models of neurosteroid dysfunction.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Hosie, AM (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	alastair.hosie@ucl.ac.uk; t.smart@ucl.ac.uk		Wilkins, Megan/0000-0003-0150-4457	Medical Research Council [G0601529] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Barbaccia ML, 1997, BRIT J PHARMACOL, V120, P1582, DOI 10.1038/sj.bjp.0701046; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 2003, J NEUROSCI, V23, P10013; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CHEN RT, 1994, P NATL ACAD SCI USA, V91, P6069, DOI 10.1073/pnas.91.13.6069; Eser D, 2006, NEUROSCIENCE, V138, P1041, DOI 10.1016/j.neuroscience.2005.07.007; Finn DA, 2004, PHARMACOL THERAPEUT, V101, P91, DOI 10.1016/j.pharmthera.2003.10.006; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Kumar S, 2004, PHARMACOL THERAPEUT, V101, P211, DOI 10.1016/j.pharmthera.2003.12.001; Lobo IA, 2004, J BIOL CHEM, V279, P33919, DOI 10.1074/jbc.M313941200; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marx CE, 2006, NEUROPSYCHOPHARMACOL, V31, P1249, DOI 10.1038/sj.npp.1300952; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Reddy DS, 2003, TRENDS PHARMACOL SCI, V24, P103, DOI 10.1016/S0165-6147(03)00023-3; Rick CE, 1998, NEUROREPORT, V9, P379, DOI 10.1097/00001756-199802160-00004; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stoffel-Wagner B, 2003, ANN NY ACAD SCI, V1007, P64, DOI 10.1196/annals.1286.007; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; Ueno S, 2004, FEBS LETT, V566, P213, DOI 10.1016/j.febslet.2004.04.030; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Zhu WJ, 1997, J NEUROSCI, V17, P4022	28	533	551	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					486	489		10.1038/nature05324	http://dx.doi.org/10.1038/nature05324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17108970				2022-12-28	WOS:000242215700046
J	Martinon-Torres, M; Rehren, T; Freestone, IC				Martinon-Torres, Marcos; Rehren, Thilo; Freestone, Ian C.			Mullite and the mystery of Hessian wares	NATURE			English	Article									UCL, Inst Archaeol, London WC1H 0PY, England; Cardiff Univ, Sch Hist & Archaeol, Cardiff CF10 3EU, Wales	University of London; University College London; Cardiff University	Martinon-Torres, M (corresponding author), UCL, Inst Archaeol, Mortimer St, London WC1H 0PY, England.	m.martinon-torres@ucl.ac.uk	Martinon-Torres, Marcos/C-2397-2008; Rehren, Thilo/C-1567-2008	Rehren, Thilo/0000-0002-9169-1198; Martinon-Torres, Marcos/0000-0003-2124-2837; Freestone, Ian/0000-0002-8223-4649				Chen CY, 2002, J AM CERAM SOC, V85, P1121; COTTER JP, 1992, EVERYDAY EXOTIC POTT, P256; FREESTONE IC, 1997, GERMAN STONEWARE 120, P354; Lee S, 1999, J AM CERAM SOC, V82, P2841; MARTINONTORRES M, 2006, P 34 INT S ARCH ZAR, P515; MARTINONTORRES M, 2005, THESIS U LONDON; PERCY J, 1875, METALLURGY ART EXTRA, V1; Plot R., 1677, NATURAL HIST OXFORD; Schneider H., 2005, MULLITE; STEPHAN HG, 1995, GROSSAIMERADE EUROPA, V2; Tite MS, 2001, ARCHAEOMETRY, V43, P301, DOI 10.1111/1475-4754.00019	11	39	39	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					437	438		10.1038/444437a	http://dx.doi.org/10.1038/444437a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122847				2022-12-28	WOS:000242215700032
J	Pennacchio, LA; Ahituv, N; Moses, AM; Prabhakar, S; Nobrega, MA; Shoukry, M; Minovitsky, S; Dubchak, I; Holt, A; Lewis, KD; Plajzer-Frick, I; Akiyama, J; De Val, S; Afzal, V; Black, BL; Couronne, O; Eisen, MB; Visel, A; Rubin, EM				Pennacchio, Len A.; Ahituv, Nadav; Moses, Alan M.; Prabhakar, Shyam; Nobrega, Marcelo A.; Shoukry, Malak; Minovitsky, Simon; Dubchak, Inna; Holt, Amy; Lewis, Keith D.; Plajzer-Frick, Ingrid; Akiyama, Jennifer; De Val, Sarah; Afzal, Veena; Black, Brian L.; Couronne, Olivier; Eisen, Michael B.; Visel, Axel; Rubin, Edward M.			In vivo enhancer analysis of human conserved non-coding sequences	NATURE			English	Article							EXPRESSION; GENE; MUTATIONS; FORKHEAD; DOMAINS; SALL1	Identifying the sequences that direct the spatial and temporal expression of genes and defining their function in vivo remains a significant challenge in the annotation of vertebrate genomes. One major obstacle is the lack of experimentally validated training sets. In this study, we made use of extreme evolutionary sequence conservation as a filter to identify putative gene regulatory elements, and characterized the in vivo enhancer activity of a large group of non-coding elements in the human genome that are conserved in human-pufferfish, Takifugu (Fugu) rubripes, or ultra-conserved(1) in human-mouse-rat. Wetested 167 of these extremely conserved sequences in a transgenic mouse enhancer assay. Here we report that 45% of these sequences functioned reproducibly as tissue-specific enhancers of gene expression at embryonic day 11.5. While directing expression in a broad range of anatomical structures in the embryo, the majority of the 75 enhancers directed expression to various regions of the developing nervous system. We identified sequence signatures enriched in a subset of these elements that targeted forebrain expression, and used these features to rank all 3,100 non-coding elements in the human genome that are conserved between human and Fugu. The testing of the top predictions in transgenic mice resulted in a threefold enrichment for sequences with forebrain enhancer activity. These data dramatically expand the catalogue of human gene enhancers that have been characterized in vivo, and illustrate the utility of such training sets for a variety of biological applications, including decoding the regulatory vocabulary of the human genome.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Pennacchio, LA (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	LAPennacchio@lbl.gov	Couronne, Olivier Couronne/G-1244-2012; Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Ahituv, Nadav/0000-0002-7434-8144; Eisen, Michael/0000-0002-7528-738X; Pennacchio, Len/0000-0002-8748-3732; Black, Brian/0000-0002-6664-8913				Ahituv N, 2005, HUM MOL GENET, V14, P3057, DOI 10.1093/hmg/ddi338; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Buck A, 2001, MECH DEVELOP, V104, P143, DOI 10.1016/S0925-4773(01)00364-1; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Davidson E. H., 2001, DEV EVOLUTION; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; GOLDBERG ML, 1979, THESIS STANFORD U; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Zhou JM, 1998, P NATL ACAD SCI USA, V95, P13483, DOI 10.1073/pnas.95.23.13483	29	847	880	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					499	502		10.1038/nature05295	http://dx.doi.org/10.1038/nature05295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086198	Green Submitted			2022-12-28	WOS:000242215700049
J	Chertow, DS; Tan, ET; Maslanka, SE; Schulte, J; Bresnitz, EA; Weisman, RS; Bernstein, J; Marcus, SM; Kumar, S; Malecki, J; Sobel, J; Braden, CR				Chertow, Daniel S.; Tan, Esther T.; Maslanka, Susan E.; Schulte, Joann; Bresnitz, Eddy A.; Weisman, Richard S.; Bernstein, Jeffrey; Marcus, Steven M.; Kumar, Savita; Malecki, Jean; Sobel, Jeremy; Braden, Christopher R.			Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOXIN	Context Botulism is a potentially lethal paralytic disease caused primarily by toxins of the anaerobic, spore-forming bacterium Clostridium botulinum. Although botulinum toxin A is available by prescription for cosmetic and therapeutic use, no cases of botulism with detectable serum toxin have previously been attributed to cosmetic or therapeutic botulinum toxin injections. On November 27, 2004, 4 suspected botulism case-patients with a link to cosmetic botulinum toxin injections were reported to the Centers for Disease Control and Prevention. Objective To investigate the clinical, epidemiological, and laboratory aspects of 4 suspected cases of iatrogenic botulism. Design, Setting, and Patients Case series on 4 botulism case-patients. Main Outcome Measures Clinical characteristics of the 4 case-patients, epidemiological associations, and mouse bioassay neutralization test results from case-patient specimens and a toxin sample. Results Clinical characteristics of the 4 case-patients were consistent with those of naturally occurring botulism. All case-patients had been injected with a highly concentrated, unlicensed preparation of botulinum toxin A and may have received doses 2857 times the estimated human lethal dose by injection. Pretreatment serum toxin levels in 3 of the 4 case-patients were equivalent to 21 to 43 times the estimated human lethal dose; pretreatment serum from the fourth epidemiologically linked case-patient was not available. A 100-mu g vial of toxin taken from the same manufacturer's lot as toxin administered to the case-patients contained a toxin amount sufficient to kill approximately 14 286 adults by injection if disseminated evenly. Conclusions These laboratory-confirmed cases of botulism demonstrate that clinical use of unlicensed botulinum toxin A can result in severe, life-threatening illness. Further education and regulation are needed to prevent the inappropriate marketing, sale, and clinical use of unlicensed botulinum toxin products.	Florida Dept Hlth, Bur Epidemiol, Div Dis Control, Tallahassee, FL 32399 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Foodborne Bacterial & Mycot Dis, Natl Ctr Zoonot Vectorborne & Enter Dis, Atlanta, GA USA; State New Jersey Dept Hlth & Senior Serv, Div Epidemiol Environm & Occupat Hlth, Trenton, NJ USA; Univ Miami, Miller Sch Med, Miami, FL 33152 USA; Florida Poison Informat Ctr, Miami, FL USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; New Jersey Poison Informat & Educ Syst, Newark, NJ USA; Florida Dept Hlth, Palm Beach Cty Hlth Dept, Div Epidemiol & Dis Control, W Palm Beach, FL USA	Florida Department of Health; Centers for Disease Control & Prevention - USA; University of Miami; Rutgers State University New Brunswick; Rutgers State University Medical Center; Florida Department of Health	Chertow, DS (corresponding author), Florida Dept Hlth, Bur Epidemiol, Div Dis Control, 2585 Merchants Row Blvd,Prather Bldg,Room 310F, Tallahassee, FL 32399 USA.	sindia4@hotmail.com						Bakheit AMO, 1997, J NEUROL NEUROSUR PS, V62, P198, DOI 10.1136/jnnp.62.2.198; *CDCP, SEL AG PROGR; Centers for Disease Control and Prevention, 1998, HDB EPID CLIN LAB WO; Chang GY, 2003, EUR NEUROL, V49, P151, DOI 10.1159/000069073; COMELLA CL, 1992, NEUROLOGY, V42, P1307, DOI 10.1212/WNL.42.7.1307; HERRERO BA, 1967, EXP MOL PATHOL, V6, P84, DOI 10.1016/0014-4800(67)90007-X; *MICR INC, 1974, MICR HEALTHC SER DAT; Sandrock CE, 2001, CHEST, V120, P562, DOI 10.1378/chest.120.2.562; SCOTT AB, 1988, MOVEMENT DISORD, V3, P333, DOI 10.1002/mds.870030409; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4	10	90	97	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2476	2479		10.1001/jama.296.20.2476	http://dx.doi.org/10.1001/jama.296.20.2476			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119144	Bronze			2022-12-28	WOS:000242171000029
J	West, CP; Popkave, C; Schultz, HJ; Weinberger, SE; Kolars, JC				West, Colin P.; Popkave, Carol; Schultz, Henry J.; Weinberger, Steven E.; Kolars, Joseph C.			Changes in career decisions of internal medicine residents during training	ANNALS OF INTERNAL MEDICINE			English	Article							CONTROLLABLE LIFE-STYLE; SPECIALTY CHOICES; TASK-FORCE; STUDENTS; SOCIETY; CARDIOLOGISTS; SELECTION; SYSTEM; INCOME; DOMAIN	Background: Little is known about the timing and stability of internal medicine resident career decisions during the course of residency training. Objective: To assess changes in reported career plans among internal medicine trainees during their training. Design: Observational cohort using data collected as part of the annual Internal Medicine In-Training Examination (IM-ITE) survey. Setting: 411 internal medicine residency programs in North America participating in the annual IM-ITE. Participants: 2638 internal medicine residents who took the IM-ITE and responded to career plan questions on the test survey in all 3 years of training (2002-2004). Measurements: Self-reported career plans for individual residents during their postgraduate year 1 (PGY-1), postgraduate year 2 (PGY-2), and postgraduate year 3 (PGY-3) of training. Results: 2281 of 2638 residents (86.5%) identified a specific career plan in internal medicine during PGY-3. Of these 2281 residents, 1417 (62.1%) changed career plans at least once during the study period. Career plans reported by PGY-1 and PGY-2 residents matched subsequent PGY-3 plans for 55.1% and 68.4%, respectively. Six hundred eighty-six (26.0%) PGY-1, 278 (10.5%) PGY-2, and 205 (7.8%) PGY-3 residents remained undecided about their career plans at the time of the IM-ITE. Only 25.0% of graduating residents reported plans for a general internal medicine career. Limitations: The study cohort represents a convenience sample and is restricted to the subset of residents sitting for the IM-ITE and responding to career plan questions in all 3 years of postgraduate training. Career plans were assessed by self-report, and it is possible that residents who responded in all years of training differed from those who did not. Conclusions: In a subset of internal medicine residents in the class of 2004, career decisions changed late into residency training and enthusiasm for careers in general internal medicine remained low.	Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; Amer Coll Physicians, Philadelphia, PA USA	Mayo Clinic; American College of Physicians	West, CP (corresponding author), Mayo Clin, Coll Med, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	west.colin@mayo.edu		Kolars, Joseph/0000-0002-2603-188X				*AM BOARD MED SPEC, 2005 ANN REP REF HDB; *AM COLL PHYS, 2004, FIN REP 2004 INT MED; *AM COLL PHYS, 2005, INT MED IN TRAIN EX; Baughman KL, 2004, J AM COLL CARDIOL, V44, P233, DOI 10.1016/j.jacc.2004.05.020; Blackwell TA, 2004, AM J MED, V117, P107, DOI 10.1016/j.amjmed.2004.04.007; Charap MH, 2005, AM J MED, V118, P1042, DOI 10.1016/j.amjmed.2005.06.009; Clayton CP, 2004, AM J MED, V117, P69, DOI 10.1016/j.amjmed.2004.04.006; Dorsey ER, 2005, ACAD MED, V80, P791, DOI 10.1097/00001888-200509000-00002; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; FOGELMAN AM, 1994, ANN INTERN MED, V120, P579, DOI 10.7326/0003-4819-120-7-199404010-00009; Fuster V, 2004, J AM COLL CARDIOL, V44, P267, DOI 10.1016/j.jacc.2004.05.027; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; GARIBALDI RA, 1994, ANN INTERN MED, V121, P117, DOI 10.7326/0003-4819-121-2-199407150-00008; Garibaldi RA, 2002, ANN INTERN MED, V137, P505, DOI 10.7326/0003-4819-137-6-200209170-00011; Goldman L, 2004, AM J MED, V117, P133, DOI 10.1016/j.amjmed.2004.05.001; Hauer KE, 2005, AM J MED, V118, P1164, DOI 10.1016/j.amjmed.2005.03.050; Humphrey HJ, 2004, ANN INTERN MED, V140, P663, DOI 10.7326/0003-4819-140-8-200404200-00019; Kassebaum DG, 1996, ACAD MED, V71, P198, DOI 10.1097/00001888-199602000-00030; KASSEBAUM DG, 1994, ACAD MED, V69, P164; Lambert EM, 2005, ACAD MED, V80, P797, DOI 10.1097/00001888-200509000-00003; Lambert TW, 2003, MED EDUC, V37, P312, DOI 10.1046/j.1365-2923.2003.01473.x; Larson EB, 2004, ANN INTERN MED, V140, P639, DOI 10.7326/0003-4819-140-8-200404200-00011; Larson EB, 2004, J GEN INTERN MED, V19, P69, DOI 10.1111/j.1525-1497.2004.31337.x; *NAT RES MATCH PRO, ADV DAT TABL 2005 MA; Newton DA, 1998, J GEN INTERN MED, V13, P200, DOI 10.1046/j.1525-1497.1998.00057.x; Newton DA, 2005, ACAD MED, V80, P809, DOI 10.1097/00001888-200509000-00005; Rosenblatt RA, 2005, ACAD MED, V80, P815, DOI 10.1097/00001888-200509000-00006; ROSENTHAL MP, 1994, JAMA-J AM MED ASSOC, V271, P914, DOI 10.1001/jama.271.12.914; SCHWARTZ RW, 1990, ACAD MED, V65, P207, DOI 10.1097/00001888-199003000-00016; TARDIFF K, 1986, J MED EDUC, V61, P790; Timmis AD, 2005, HEART, V91, P283, DOI 10.1136/hrt.2004.047340; Warnes CA, 2004, J AM COLL CARDIOL, V44, P238, DOI 10.1016/j.jacc.2004.05.021; Weinberger SE, 2006, ANN INTERN MED, V144, P927, DOI 10.7326/0003-4819-144-12-200606200-00124	33	51	51	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					774	779		10.7326/0003-4819-145-10-200611210-00010	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110OB	17116922				2022-12-28	WOS:000242387100007
J	Cleland, J; Bernstein, S; Ezeh, A; Faundes, A; Glasier, A; Innis, J				Cleland, John; Bernstein, Stan; Ezeh, Alex; Faundes, Anibal; Glasier, Anna; Innis, Jolene			Sexual and Reproductive Health 3 - Family planning: the unfinished agenda	LANCET			English	Review							UNMET NEED; FERTILITY-REGULATION; ORAL-CONTRACEPTIVES; POPULATION-GROWTH; PROGRAMS; POLICY; COUNTRIES; CHOICE; ACCESS; COMMUNITY	Promotion of family planning in countries with high birth rates has the potential to reduce poverty and hunger and avert 32% of all maternal deaths and nearly 10% of childhood deaths. It would also contribute substantially to women's empowerment, achievement of universal primary schooling, and long-term environmental sustainability. In the past 40 years, family-planning programmes have played a major part in raising the prevalence of contraceptive practice from less than 10% to 60% and reducing fertility in developing countries from six to about three births per woman. However, in half the 75 larger low-income and lower-middle income countries (mainly in Africa), contraceptive practice remains low and fertility population growth, and unmet need for family planning are high. The cross-cutting contribution to the achievement of the Millennium Development Goals makes greater investment in family planning in these countries compelling. Despite the size of this unfinished agenda, international funding and promotion of family planning has waned in the past decade. A revitalisation of the agenda is urgently needed. Historically, the USA has taken the lead but other governments or agencies are now needed as champions. Based on the sizeable experience of past decades, the key features of effective programmes are clearly established. Most governments of poor countries already have appropriate population and family-planning policies but are receiving too little international encouragement and funding to implement them with vigour. What is currently missing is political willingness to incorporate family planning into the development arena.	London Sch Hyg & Trop Med, London WC1B 3DP, England; United Nat Populat Fund, New York, NY USA; African Populat & Hlth Res Ctr, Nairobi, Kenya; Univ Estadual Campinas, Sao Paulo, Brazil; NHS Lothian, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Edinburgh, Midlothian, Scotland; Interact Worldwide, London, England	University of London; London School of Hygiene & Tropical Medicine; United Nations Population Fund; African Population & Health Research Centre; Universidade Estadual de Campinas; University of Edinburgh	Cleland, J (corresponding author), London Sch Hyg & Trop Med, London WC1B 3DP, England.	John.Cleland@lshtm.ac.uk	Ezeh, Alex/AAN-8646-2020; Cleland, John G./AAZ-4185-2020	Ezeh, Alex/0000-0002-1309-4697; Cleland, John G./0000-0002-1471-7016				AASSVE A, 2005, INT POP C TOURS FRAN; Ajayi A, 1998, DO POPULATION POLICIES MATTER?, P113; Alexandratos N, 2005, POPUL DEV REV, V31, P237, DOI 10.1111/j.1728-4457.2005.00064.x; Ali MM, 2004, B WORLD HEALTH ORGAN, V82, P180; Amin R, 1996, INT FAM PLAN PERSPEC, V22, P158, DOI 10.2307/2950813; [Anonymous], FAMILY PLANNING PROG; [Anonymous], DEMOGRAPHIC HLTH SUR; Armijo R, 1966, Bol Oficina Sanit Panam, V60, P39; BAIRD D, 1965, BMJ-BRIT MED J, V2, P1141, DOI 10.1136/bmj.2.5471.1141; BANG SS, 1968, STUD FAMILY PLANN, V27, P4; Becker S, 2001, STUD FAMILY PLANN, V32, P111, DOI 10.1111/j.1728-4465.2001.00111.x; Bettiol H, 2000, PAEDIATR PERINAT EP, V14, P30, DOI 10.1046/j.1365-3016.2000.00222.x; BIRDSALL N, 1994, POPULATION ENV DEV, P39; Birdsall N., 2001, POPULATION MATTERS; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Bloom DE, 1998, WORLD BANK ECON REV, V12, P419, DOI 10.1093/wber/12.3.419; BONGAARTS J, 1994, SCIENCE, V263, P771, DOI 10.1126/science.8303293; BONGAARTS J, 1995, STUD FAMILY PLANN, V26, P57, DOI 10.2307/2137932; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; BULATAO RA, 1989, CHOOSING CONTRACEPTI; Caldwell JC, 2002, STUD FAMILY PLANN, V33, P1, DOI 10.1111/j.1728-4465.2002.00001.x; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Campbell White A., 2006, REPROD HLTH MISSING; Casterline JB, 2001, STUD FAMILY PLANN, V32, P95, DOI 10.1111/j.1728-4465.2001.00095.x; Casterline JB, 1997, STUD FAMILY PLANN, V28, P173, DOI 10.2307/2137886; *CENTR BUR STAT OR, 2005, KEN SERV PROV ASS SU; Chen JL, 2003, CONTRACEPTION, V67, P281, DOI 10.1016/S0010-7824(02)00487-0; CHEN S, 2004, WPS3341 WORLD BANK; Chiou CF, 2003, CONTRACEPTION, V68, P3, DOI 10.1016/S0010-7824(03)00078-7; CLELAND JGF, IN PRESS LANCET; Coale A.J., 1958, POPULATION GROWTH EC; Collumbien M., 2004, COMP QUANTIFICATION, P1255; Commission for Africa, 2005, OUR COMMON INTEREST; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; DaVanzo J, 2005, EFFECTS BIRTH SPACIN; *DFID, 2005, MAK MARK SYST WORK B; *DKT INT, 2006, 2004 CONTR SOC MARK; Eastwood R, 1999, J DEV STUD, V36, P1, DOI 10.1080/00220389908422609; Eastwood R, 2001, POPULATION MATTERS D, P213; Entwisle B, 1996, DEMOGRAPHY, V33, P1, DOI 10.2307/2061709; Falkingham J, 2002, MEASURING HLTH POVER; Faria VE, 1999, DYNAMICS VALUES FERT, P252; Feyisetan B, 2000, INT FAM PLAN PERSPEC, V26, P100, DOI 10.2307/2648298; Fuller B., 1989, EDUC RESEARCHER, V18, P12, DOI [DOI 10.3102/0013189X018002012, https://doi.org/10.3102/0013189X018002012]; GLASIER A, 2005, CONTRACEPTION CONTRA; Glasier A, 2006, LANCET, V368, P1550, DOI 10.1016/S0140-6736(06)69485-3; Goto A, 1999, JAMA-J AM MED ASSOC, V282, P2173, DOI 10.1001/jama.282.22.2173; Greene M.E., 2005, POVERTY REDUCTION DO; GUENGART JP, 2001, IMPACT PROXIMATE DET; GWATKIN DR, 2004, INITIAL COUNTRY LEVE; Halpem V, 2006, COCHRANE DB SYST REV, V1; Hanson K, 2001, HEALTH POLICY PLANN, V16, P125, DOI 10.1093/heapol/16.2.125; *HLSP I, 2000, WHICH HLTH POL AR PR; Hoodfar H, 2000, STUD FAMILY PLANN, V31, P19, DOI 10.1111/j.1728-4465.2000.00019.x; JANOWITZ B, 1982, MED CARE, V20, P526, DOI 10.1097/00005650-198205000-00009; JANOWITZ BS, 1990, INV FUT REP COST FAM; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khan A, 1996, HEALTH POLICY PLANN, V11, P30, DOI 10.1093/heapol/11.1.30; Kohler HP, 2001, DEMOGRAPHY, V38, P43, DOI 10.1353/dem.2001.0005; Lee K, 1998, SOC SCI MED, V47, P949, DOI 10.1016/S0277-9536(98)00168-3; LIPTON M, 1998, POPULATION POVERTY D, P25; LLOYD CB, 1994, POPULATION DEV OLD D, P181; Luck M, 2000, STUD FAMILY PLANN, V31, P325, DOI 10.1111/j.1728-4465.2000.00325.x; Mason KO, 2000, DEMOGRAPHY, V37, P299, DOI 10.2307/2648043; Matheny G, 2004, INT FAM PLAN PERSPEC, V30, P134, DOI 10.1363/3013404; Mayhew SH, 2004, HEALTH POLICY PLANN, V19, pI50, DOI 10.1093/heapol/czh045; MAYHEW SH, 2005, INT J HLTH SERV, V35, P24; MEHOTRA SJ, 1998, INT REV EDUC, V44, P461; Meirik O, 2001, OBSTET GYNECOL, V97, P539, DOI 10.1016/S0029-7844(00)01220-5; Millennium Project, 2006, PUBL CHOIC PRIV DEC; Miller Kate, 1998, CLIN BASED FAMILY PL; Miller N H, 1997, Am J Med, V102, P43; *MIN SAUD BRAS, 1999, SIST INF HOSP SIST U; Nazzar A, 1995, STUD FAMILY PLANN, V26, P307, DOI 10.2307/2138097; OSIS MJD, 2006, IN PRESS ATENCAO PLA; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Page HJ., 1981, CHILD SPACING TROPIC; PARIANI S, 1991, STUD FAMILY PLANN, V22, P384, DOI 10.2307/1966452; PARK HJ, 1976, STUD FAMILY PLANN, V7, P275, DOI 10.2307/1966343; PHILLIPS JF, 1999, 121 POP COUNC; Piotrow P. T., 1997, HLTH COMMUNICATION L; *POP COUNC, 2004, UNW PREGN POST AB CO; Potter JE, 2001, BRIT MED J, V323, P1155, DOI 10.1136/bmj.323.7322.1155; Potts M, 1997, POPUL DEV REV, V23, P1, DOI 10.2307/2137459; Prata N, 2005, CONTRACEPTION, V72, P402, DOI 10.1016/j.contraception.2005.06.059; Preston SH, 1996, POPUL RES POLICY REV, V15, P95, DOI 10.1007/BF00126129; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; RICE X, 2006, GUARDIAN LONDON 0825; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; ROSENFIELD AG, 1972, AM J OBSTET GYNECOL, V114, P942, DOI 10.1016/0002-9378(72)90103-2; Ross J, 2002, INT FAM PLAN PERSPEC, V28, P32, DOI 10.2307/3088273; ROSS J, 2006, FAMILY PLANNING PROG; ROSS JA, 1985, VOLUNTARY STERILIZAT; ROSS JA, 1992, FAMILY PLANNING CHIL; Rutenberg N, 1997, STUD FAMILY PLANN, V28, P290, DOI 10.2307/2137860; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Sachs JD, 2004, BROOKINGS PAP ECO AC, P117; SCHULTZ TP, 1993, J HUM RESOUR, V28, P694, DOI 10.2307/146291; Sen Gita, 1994, POPULATION POLICIES; Sharan M, 2002, INT FAM PLAN PERSPEC, V28, P16, DOI 10.2307/3088271; SIMMONS R, 1988, STUD FAMILY PLANN, V19, P29, DOI 10.2307/1966737; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; Stash S, 1999, STUD FAMILY PLANN, V30, P267, DOI 10.1111/j.1728-4465.1999..x; Steiner MJ, 2003, OBSTET GYNECOL, V102, P709, DOI 10.1016/S0029-7844(03)00662-8; Sullivan TM, 2006, J BIOSOC SCI, V38, P501, DOI 10.1017/S0021932005026647; Sultan M, 2002, AM J PUBLIC HEALTH, V92, P1168, DOI 10.2105/AJPH.92.7.1168; TRUSSELL J, 1993, AM J PUBLIC HEALTH, V83, P1094, DOI 10.2105/AJPH.83.8.1094; TRUSSELL J, 1998, CONTRACEPTIVE TECHNO, P779; TSUI AO, 1992, FAMILY PLANNING PROG, P222; *UN, 1995, SOC STAT IND K; *UN DEP EC SOC AFF, 2001, WORLD POP MON 2001; *UN DEP EC SOC AFF, 2004, LEV TRENDS CONTR US; *UN DEP EC SOC AFF, 2002, WORLD POP PROSP 2000, V3; *UN DEP SOC AFF PO, 2004, WORLD POP POL 2003; *UN DEP SOC EC AFF, 2004, LEV TRENDS CONTR US; *UN DEV PROGR WORL, 2001, ATT POV WORLD DEV RE; *UN EC SOC COUNC, 2004, FLOW FIN RES ASS IMP; *UN MILL PROJ, 2005, INV DEV PRACT GUID A; *UN POP FUND, 1988, GLOB POP ASS REP 198; *US NAT AC SCI, 1986, POP GROWTH EC DEV; VANDALEN HP, 2005, PROJECTIONS FUNDS PO; Watkins SC, 2000, POPUL DEV REV, V26, P725, DOI 10.1111/j.1728-4457.2000.00725.x; WESTOFF CF, IN PRESS DEMOGRAPHIC; WESTOFF CF, 1997, 2 ORC MACR; WESTOFF CF, 1999, 10 ORC MACR; *WHO DEP REPR HLTH, 2004, MED EL CRIT CONTR US; *WHO UNAIDS UN POP, 2005, SEX REPR HLTH HIV AI; *WORLD BANK, 2005, 34219NE WORLD BANK; Zhu BP, 2005, INT J GYNECOL OBSTET, V89, pS25, DOI 10.1016/j.ijgo.2004.08.002; 2006, NEWSWEEK        0605, P45	132	545	553	2	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1810	1827		10.1016/S0140-6736(06)69480-4	http://dx.doi.org/10.1016/S0140-6736(06)69480-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113431				2022-12-28	WOS:000242225400035
J	Knaul, FM; Arreola-Ornelas, H; Mendez-Carniado, O; Bryson-Cahn, C; Barofsky, J; Maguire, R; Miranda, M; Sesma, S				Knaul, Felicia Marie; Arreola-Ornelas, Hector; Mendez-Carniado, Oscar; Bryson-Cahn, Chloe; Barofsky, Jeremy; Maguire, Rachel; Miranda, Martha; Sesma, Sergio			Health System Reform in Mexico 4 - Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico	LANCET			English	Article							CARE	Absence of financial protection in health is a recently diagnosed "disease" of health systems. The most obvious symptom is that families face economic ruin and poverty as a consequence of financing their health care. Mexico was one of the first countries to diagnose the problem, attribute it to lack of financial protection, and propose systemic therapy through health reform. In this article we assess how Mexico turned evidence on catastrophic and impoverishing health spending into a catalyst for institutional renovation through the reform that created Segura Popular (Popular Health Insurance). We present 15-year trends on the evolution of catastrophic and impoverishing health spending, including evidence on how the situation is improving. The results of the Mexican experience suggest an important role for the Organisation and financing of the health system in reducing impoverishment and protecting households during periods of individual and collective financial crisis.	Mexican Hlth Fdn, Mexico City, DF, Mexico; Minist Publ Educ Mexico, Mexico City, DF, Mexico; Harvard Univ, Cambridge, MA 02138 USA; Inter Amer Ctr Social Secur Studies, Mexico City, DF, Mexico; Minist Hlth Mexico, Mexico City, DF, Mexico	Harvard University	Knaul, FM (corresponding author), Mexican Hlth Fdn, Periferico Sur 4809,Col Arenal Tepepan, Mexico City, DF, Mexico.	fknaul@funsalud.org.mx	Arreola Ornelas, Héctor/HCG-9350-2022	Arreola Ornelas, Héctor/0000-0002-7615-6218; Knaul, Felicia/0000-0002-0512-4788				Arredondo A, 2001, REV INVEST CLIN, V53, P422; Baeza CC., 2006, SURVIVAL PROTECTING; *BANC MEX, 2006, MERC CAMB CF102 TIP; BERMAN P, 1996, NATL HLTH ACCOUNTS D; Carrin G, 2005, ACHIEVING UNIVERSAL; *COM NAC SAL MIN, 2005, SAL MIM VIG PART EN; *COM TECN MED POBR, 2005, MED POBR 2002 2004; *COMM MACR HLTH, 2003, MACR HLTH INV HLTH E; *FED MEX DIAB AC, 2006, DIAB NUM; FRENK J, 2005, CLOSING RELEVANCE EX, P48; FRENK J, 1994, EC SALUD PROPUESTA A; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Fuchs Victor R., 1998, WHO SHALL LIVE HLTH; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Himmelstein D.U., 2005, HLTH AFF, V24, pW5, DOI 10.1377/hlthaff.W5.63; *I NAC EST GEOGR I, 2004, ENC NAC INGR GAST HO; *I NAC SAL PUBL, 2005, EV EXT IMP PROGR OP; *I NAC SAL PUBL SE, 2006, NAT SURV HLTH NUTR; KNAUL F, 2005, CATASTROPHIC IMP HLT; KNAUL F, IN PRESS HLTH AGING; KNAUL F, 2006, GLOB DEV NETW C ST P; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; Knaul FM, 2005, HEALTH AFFAIR, V24, P1467, DOI 10.1377/hlthaff.24.6.1467; Londono JL, 1997, HEALTH POLICY, V41, P1, DOI 10.1016/S0168-8510(97)00010-9; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Mexican Commission on Macroeconomics and Health, 2004, INV HLTH EC DEV EX S; Murray CJL, 2000, GPE DISCUSSION PAPER, V24; *ORG EC COOP DEV, 2005, OECD REV HLTH CAR SY; *SECR DES SOC, 2005, OP INF LAB 2004; *SECR SAL, 2002, SAL MEX 2001 INF REN; *SECR SAL, 2004, SAL MEX 2003 INF REN; *SECR SAL, 2003, SAL MEX 2002 INF REN; *SECR SAL, 2006, SAL MEX 2001 2005 IN; *SECR SAL, 2003, SIST PROT SAL HAC SI; *SECR SAL, 2005, SAL MEX 2004 INF REN; *SECR TRAB PREV SO, 2005, EST LAB; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 1999, J HEALTH ECON, V18, P263, DOI 10.1016/S0167-6296(98)00044-7; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WAGSTAFF A, 1998, HLTH CARE HLTH EC PE, P179; *WORLD BANK, 2005, INC GEN SOC PROT POO, V2; *WORLD BANK, 2005, INC GEN SOC PROT POO, V1; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K., 2005, DESIGNING HLTH FINAN	48	134	139	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1828	1841		10.1016/S0140-6736(06)69565-2	http://dx.doi.org/10.1016/S0140-6736(06)69565-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113432				2022-12-28	WOS:000242225400036
J	Kapanidis, AN; Margeat, E; Ho, SO; Kortkhonjia, E; Weiss, S; Ebright, RH				Kapanidis, Achillefs N.; Margeat, Emmanuel; Ho, Sam On; Kortkhonjia, Ekaterine; Weiss, Shimon; Ebright, Richard H.			Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism	SCIENCE			English	Article							STRUCTURAL ORGANIZATION; PROMOTER CLEARANCE; ELONGATION; HOLOENZYME; BUBBLE; RELEASE	Using fluorescence resonance energy transfer to monitor distances within single molecules of abortively initiating transcription initiation complexes, we show that initial transcription proceeds through a "scrunching'' mechanism, in which RNA polymerase ( RNAP) remains fixed on promoter DNA and pulls downstream DNA into itself and past its active center. We show further that putative alternative mechanisms for RNAP active-center translocation in initial transcription, involving "transient excursions" of RNAP relative to DNA or "inchworming" of RNAP relative to DNA, do not occur. The results support a model in which a stressed intermediate, with DNA-unwinding stress and DNA-compaction stress, is formed during initial transcription, and in which accumulated stress is used to drive breakage of interactions between RNAP and promoter DNA and between RNAP and initiation factors during promoter escape.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Univ Oxford, IRC Bionanotechnol, Oxford OX1 3PU, England; Rutgers State Univ, Dept Chem, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; University of Oxford; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kapanidis, AN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	a.kapanidis1@physics.ox.ac.uk; sweiss@chem.ucla.edu; ebright@waksman.rutgers.edu	weiss, shimon/B-4164-2009; Ebright, Richard/O-3321-2019; Margeat, Emmanuel/AAY-9167-2021	weiss, shimon/0000-0002-0720-5426; Ebright, Richard/0000-0001-8915-7140; Margeat, Emmanuel/0000-0001-6063-6420	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM069709-01, R01 GM041376-17, R37 GM041376, GM41376, R01 GM069709-01A1, R01 GM041376-15, R01 GM041376-16, R01 GM041376-18, R01 GM069709, R01 GM041376] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069709, R37GM041376, R01GM041376] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	29	307	315	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1144	1147		10.1126/science.1131399	http://dx.doi.org/10.1126/science.1131399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110578	Green Accepted			2022-12-28	WOS:000242045800044
J	Welch, GC; Juan, RRS; Masuda, JD; Stephan, DW				Welch, Gregory C.; Juan, Ronan R. San; Masuda, Jason D.; Stephan, Douglas W.			Reversible, metal-free hydrogen activation	SCIENCE			English	Article							PHOSPHINE-BORANE ADDUCTS; CLUSTER-FREE HYDROGENASE; MAIN-GROUP ELEMENTS; DIHYDROGEN COMPLEXES; MOLECULAR-HYDROGEN; AB-INITIO; HYDRIDES; REACTIVITY; PHOSPHORUS; MECHANISM	Although reversible covalent activation of molecular hydrogen (H-2) is a common reaction at transition metal centers, it has proven elusive in compounds of the lighter elements. We report that the compound (C6H2Me3)(2)PH(C6F4) BH(C6F5)(2) (Me, methyl), which we derived through an unusual reaction involving dimesitylphosphine substitution at a para carbon of tris( pentafluorophenyl) borane, cleanly loses H-2 at temperatures above 100 degrees C. Preliminary kinetic studies reveal this process to be first order. Remarkably, the dehydrogenated product (C6H2Me3)(2)P(C6F4)B(C6F5)(2) is stable and reacts with 1 atmosphere of H-2 at 25 degrees C to reform the starting complex. Deuteration studies were also carried out to probe the mechanism.	Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Windsor	Stephan, DW (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	stephan@uwindsor.ca	Stephan, Douglas W/E-4393-2011; Welch, Gregory/J-2501-2012	Stephan, Douglas W/0000-0001-8140-8355; Welch, Gregory/0000-0002-3768-937X; Masuda, Jason/0000-0002-6195-9691				Aldridge S, 2001, CHEM REV, V101, P3305, DOI 10.1021/cr960151d; BURDETT JK, 1991, TRANSITION METAL HYD, P149; Clark TL, 2005, CHEM-EUR J, V11, P4526, DOI 10.1002/chem.200401296; CRABTREE RH, 1990, ACCOUNTS CHEM RES, V23, P95, DOI 10.1021/ar00172a001; Doring S, 1998, ORGANOMETALLICS, V17, P2183, DOI 10.1021/om9709953; Focante F, 2006, COORDIN CHEM REV, V250, P170, DOI 10.1016/j.ccr.2005.05.005; Heinekey DM, 2004, CHEM SOC REV, V33, P175, DOI 10.1039/b304879a; Himmel HJ, 2003, DALTON T, P3639, DOI 10.1039/b307051b; Himmel HJ, 2002, ORGANOMETALLICS, V21, P5972, DOI 10.1021/om020787x; Horton AD, 1997, ORGANOMETALLICS, V16, P5424, DOI 10.1021/om970504e; Jaska CA, 2004, J AM CHEM SOC, V126, P9776, DOI 10.1021/ja0478431; JESSOP PG, 1992, COORDIN CHEM REV, V121, P155, DOI 10.1016/0010-8545(92)80067-2; Kubas G.J., 2001, METAL DIHYDROGEN SIG; KUBAS GJ, 1988, ACCOUNTS CHEM RES, V21, P120, DOI 10.1021/ar00147a005; Kulkarni SA, 1998, J PHYS CHEM A, V102, P7704, DOI 10.1021/jp9817630; Kulkarni SA, 1999, J PHYS CHEM A, V103, P2836, DOI 10.1021/jp984135r; McGrady GS, 2003, CHEM SOC REV, V32, P383, DOI 10.1039/b207999m; Parks DJ, 2000, J ORG CHEM, V65, P3090, DOI 10.1021/jo991828a; Piers WE, 2005, ADV ORGANOMET CHEM, V52, P1, DOI 10.1016/S0065-3055(04)52001-4; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; Ritter JA, 2003, MATER TODAY, V6, P18, DOI DOI 10.1016/S1369-7021(03)00921-0; Schwarz DE, 2005, CHEM COMMUN, P5919, DOI 10.1039/b511884k; Scott AP, 1998, NEW J CHEM, V22, P1171, DOI 10.1039/a806358c; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Siegbahn PEM, 2004, ADV INORG CHEM, V56, P101, DOI 10.1016/S0898-8838(04)56004-X; Spikes GH, 2005, J AM CHEM SOC, V127, P12232, DOI 10.1021/ja053247a; Teles JH, 1998, J AM CHEM SOC, V120, P1345, DOI 10.1021/ja972320x; Vajo JJ, 2005, J PHYS CHEM B, V109, P3719, DOI 10.1021/jp040769o; Wang J, 2005, ADSORPTION, V11, P811, DOI 10.1007/s10450-005-6028-y; XIAO ZL, 1993, INORG CHEM, V32, P642, DOI 10.1021/ic00057a026; YUAN Z, 1993, J ORGANOMET CHEM, V449, P27, DOI 10.1016/0022-328X(93)80103-I; YUAN Z, 1990, CHEM COMMUN, P1489	32	1476	1486	25	548	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1124	1126		10.1126/science.1134230	http://dx.doi.org/10.1126/science.1134230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	105PW	17110572				2022-12-28	WOS:000242045800038
J	Ji, HT; Burin, M; Schartman, E; Goodman, J				Ji, Hantao; Burin, Michael; Schartman, Ethan; Goodman, Jeremy			Hydrodynamic turbulence cannot transport angular momentum effectively in astrophysical disks	NATURE			English	Article							ROTATING CYLINDERS; ACCRETION DISKS; NONLINEAR STABILITY; SHEAR TURBULENCE; STRATIFIED DISKS; REYNOLDS-NUMBER; INSTABILITY; FLOW; CIRCULATION; EVOLUTION	The most efficient energy sources known in the Universe are accretion disks. Those around black holes convert 5 - 40 per cent of restmass energy to radiation. Like water circling a drain, inflowing mass must lose angular momentum, presumably by vigorous turbulence in disks, which are essentially inviscid(1). The origin of the turbulence is unclear. Hot disks of electrically conducting plasma can become turbulent by way of the linear magnetorotational instability(2). Cool disks, such as the planet- forming disks of protostars, may be too poorly ionized for the magnetorotational instability to occur, and therefore essentially unmagnetized and linearly stable. Nonlinear hydrodynamic instability often occurs in linearly stable flows ( for example, pipe flows) at sufficiently large Reynolds numbers. Although planet- forming disks have extreme Reynolds numbers, keplerian rotation enhances their linear hydrodynamic stability, so the question of whether they can be turbulent and thereby transport angular momentum effectively is controversial(3-15). Here we report a laboratory experiment, demonstrating that non- magnetic quasi- keplerian flows at Reynolds numbers up to millions are essentially steady. Scaled to accretion disks, rates of angular momentum transport lie far below astrophysical requirements. By ruling out purely hydrodynamic turbulence, our results indirectly support the magnetorotational instability as the likely cause of turbulence, even in cool disks.	Princeton Univ, Ctr Magnet Self Org Lab & Astrophys Plasmas, Plasma Phys Lab, Princeton, NJ 08543 USA; Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08543 USA	Princeton University; United States Department of Energy (DOE); Princeton Plasma Physics Laboratory; Princeton University	Ji, HT (corresponding author), Princeton Univ, Ctr Magnet Self Org Lab & Astrophys Plasmas, Plasma Phys Lab, Princeton, NJ 08543 USA.	hji@pppl.gov						Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; Balbus SA, 1996, ASTROPHYS J, V467, P76, DOI 10.1086/177585; BECKLEY HF, 2002, THESIS NEW MEXICO I; Burin MJ, 2006, EXP FLUIDS, V40, P962, DOI 10.1007/s00348-006-0132-y; Chagelishvili GD, 2003, ASTRON ASTROPHYS, V402, P401, DOI 10.1051/0004-6361:20030269; Colebrook C.F., 1939, J I CIV ENG, V11, P133, DOI [DOI 10.1680/IJOTI.1939.13150, 10.1098/rsta.2006.1939]; DUBRULLE B, 1993, ICARUS, V106, P59, DOI 10.1006/icar.1993.1158; Dubrulle B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2008999; Dubrulle B, 2005, ASTRON ASTROPHYS, V429, P1, DOI 10.1051/0004-6361:200400065; Garaud P, 2005, J FLUID MECH, V530, P145, DOI 10.1017/S002211200500368X; GOODMAN J, 2001, STRATIFIED DISKS ARE; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Johnson BM, 2006, ASTROPHYS J, V636, P63, DOI 10.1086/497982; Kageyama A, 2004, J PHYS SOC JPN, V73, P2424, DOI 10.1143/JPSJ.73.2424; Klahr HH, 2003, ASTROPHYS J, V582, P869, DOI 10.1086/344743; LATHROP DP, 1992, PHYS REV LETT, V68, P1515, DOI 10.1103/PhysRevLett.68.1515; Lesur G, 2005, ASTRON ASTROPHYS, V444, P25, DOI 10.1051/0004-6361:20053683; Lewis GS, 1999, PHYS REV E, V59, P5457, DOI 10.1103/PhysRevE.59.5457; Longaretti PY, 2002, ASTROPHYS J, V576, P587, DOI 10.1086/341630; Mukhopadhyay B, 2005, ASTROPHYS J, V629, P383, DOI 10.1086/431419; Rayleigh J W S, 1916, P ROY SOC LOND A MAT, V93, P148, DOI DOI 10.1098/RSPA.1917.0010; Richard D, 1999, ASTRON ASTROPHYS, V347, P734; Richard D., 2001, THESIS U PARIS 7; SCHULZGRUNOW F, 1959, Z ANGEW MATH MECH, V39, P101; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Taylor G, 1936, PROC R SOC LON SER-A, V157, P0546, DOI 10.1098/rspa.1936.0215; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; Umurhan OM, 2004, ASTRON ASTROPHYS, V427, P855, DOI 10.1051/0004-6361:20040573; Wendt F., 1993, ING ARCH, V4, P577, DOI [10.1007/BF02084936, DOI 10.1007/BF02084936]; Yecko PA, 2004, ASTRON ASTROPHYS, V425, P385, DOI 10.1051/0004-6361:20041273; ZELDOVICH YB, 1981, P ROY SOC LOND A MAT, V374, P299, DOI 10.1098/rspa.1981.0024	32	175	178	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					343	346		10.1038/nature05323	http://dx.doi.org/10.1038/nature05323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108959				2022-12-28	WOS:000242018300042
J	Johnson, DM; Liebhold, AM; Tobin, PC; Bjornstad, ON				Johnson, Derek M.; Liebhold, Andrew M.; Tobin, Patrick C.; Bjornstad, Ottar N.			Allee effects and pulsed invasion by the gypsy moth	NATURE			English	Article							BIOLOGICAL INVASIONS; INSECT OUTBREAKS; NORTH-AMERICA; SPREAD; LYMANTRIIDAE; LEPIDOPTERA; DISPERSAL; DYNAMICS; POPULATIONS; SYNCHRONY	Biological invasions pose considerable threats to the world's ecosystems (1) and cause substantial economic losses (2). A prime example is the invasion of the gypsy moth in the United States, for which more than $ 194 million was spent on management and monitoring between 1985 and 2004 alone (3). The spread of the gypsy moth across eastern North America is, perhaps, the most thoroughly studied biological invasion in the world, providing a unique opportunity to explore spatiotemporal variability in rates of spread. Here we describe evidence for periodic pulsed invasions, defined as regularly punctuated range expansions interspersed among periods of range stasis. We use a theoretical model with parameter values estimated from long- term monitoring data to show how an interaction between strong Allee effects ( negative population growth at low densities) (4) and stratified diffusion ( most individuals disperse locally, but a few seed new colonies by long- range movement)(5) can explain the invasion pulses. Our results indicate that suppressing population peaks along range borders might greatly slow invasion.	Univ Louisiana, Dept Biol, Lafayette, LA 70504 USA; US Forest Serv, USDA, No Res Stn, Morgantown, WV 26505 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Louisiana Lafayette; United States Department of Agriculture (USDA); United States Forest Service; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Johnson, DM (corresponding author), Univ Louisiana, Dept Biol, POB 42451, Lafayette, LA 70504 USA.	derekjohnson@louisiana.edu	Bjornstad, Ottar N/I-4518-2012; Johnson, Derek/B-6409-2012; Liebhold, Andrew M./C-1423-2008	Liebhold, Andrew M./0000-0001-7427-6534; Tobin, Patrick/0000-0003-0237-7963				Allee W., 1938, SOCIAL LIFE ANIMALS; Barbier EB, 2001, ECOL ECON, V39, P197, DOI 10.1016/S0921-8009(01)00239-7; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Deutsch C.V., 1992, GSLIB GEOSTATISTICAL; Dwyer G, 2006, AM NAT, V167, P165, DOI 10.1086/498944; Dwyer G, 2004, NATURE, V430, P341, DOI 10.1038/nature02569; Johnson DM, 2005, J ANIM ECOL, V74, P882, DOI 10.1111/j.1365-2656.2005.00980.x; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; LIEBHOLD AM, 1992, J BIOGEOGR, V19, P513, DOI 10.2307/2845770; Mayo JH, 2003, J ECON ENTOMOL, V96, P1448, DOI 10.1603/0022-0493-96.5.1448; MONTGOMERY ME, 1988, DYNAMICS FOREST INSE, P253; Neubert MG, 2000, P ROY SOC B-BIOL SCI, V267, P1603, DOI 10.1098/rspb.2000.1185; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Royama T., 1992, ANAL POPULATION ECOL; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; Sharov AA, 2002, J FOREST, V100, P30; Sharov AA, 1998, ECOL APPL, V8, P833, DOI 10.1890/1051-0761(1998)008[0833:BOMTSO]2.0.CO;2; Sharov AA, 1995, ENVIRON ENTOMOL, V24, P1529, DOI 10.1093/ee/24.6.1529; SHAROV AA, 1995, ENVIRON ENTOMOL, V24, P1239, DOI 10.1093/ee/24.5.1239; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Taylor CM, 2004, ECOLOGY, V85, P3254, DOI 10.1890/03-0640; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tobin Patrick C., 2004, American Entomologist, V50, P200; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; Vitousek PM, 1996, AM SCI, V84, P468; Wang MH, 2001, MATH BIOSCI, V171, P83, DOI 10.1016/S0025-5564(01)00048-7; Whitmire SL, 2006, OECOLOGIA, V147, P230, DOI 10.1007/s00442-005-0271-5	30	177	183	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					361	363		10.1038/nature05242	http://dx.doi.org/10.1038/nature05242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108964				2022-12-28	WOS:000242018300047
J	Vila-Costa, M; Simo, R; Harada, H; Gasol, JM; Slezak, D; Kiene, RP				Vila-Costa, Maria; Simo, Rafel; Harada, Hyakubun; Gasol, Josep M.; Slezak, Doris; Kiene, Ronald P.			Dimethylsulfoniopropionate uptake by marine phytoplankton	SCIENCE			English	Article							GULF-OF-MEXICO; ATMOSPHERIC SULFUR; DIMETHYL SULFIDE; NORTH-ATLANTIC; FOOD-WEB; DMSP; PROCHLOROCOCCUS; BACTERIOPLANKTON; SYNECHOCOCCUS; CYANOBACTERIA	Dimethylsulfoniopropionate (DMSP) accounts for most of the organic sulfur fluxes from primary to secondary producers in marine microbial food webs. Incubations of natural communities and axenic cultures with radio-labeled DMSP showed that dominant phytoplankton groups of the ocean, the unicellular cyanobacteria Prochlorococcus and Synechococcus and diatoms, as well as heterotrophic bacteria take up and assimilate DMSP sulfur, thus diverting a proportion of plankton-produced organic sulfur from emission into the atmosphere.	CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona 08003, Spain; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of South Alabama	Vila-Costa, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Pg Maritim Barceloneta 37-49, Barcelona 08003, Spain.	mariavila@icm.csic.es; rsimo@icm.csic.es	Vila-Costa, Maria/L-4833-2014; Gasol, Josep M M/B-1709-2008	Vila-Costa, Maria/0000-0003-1730-8418; Gasol, Josep M M/0000-0001-5238-2387; Simo, Rafel/0000-0003-3276-7663				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Belviso S, 2001, LIMNOL OCEANOGR, V46, P989, DOI 10.4319/lo.2001.46.4.0989; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; CORN M, 1996, BIOL ENV CHEM DMSP R; JONES RI, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P87; Keller MD, 1989, ACS SYM SER, P167, DOI 10.1021/bk-1989-0393.ch011; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kiene RP, 1998, AQUAT MICROB ECOL, V15, P39, DOI 10.3354/ame015039; Malin G, 1997, J PHYCOL, V33, P889, DOI 10.1111/j.0022-3646.1997.00889.x; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; Malmstrom RR, 2004, LIMNOL OCEANOGR, V49, P597, DOI 10.4319/lo.2004.49.2.0597; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; PAERL HW, 1991, APPL ENVIRON MICROB, V57, P473, DOI 10.1128/AEM.57.2.473-479.1991; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Simo R, 1999, NATURE, V402, P396, DOI 10.1038/46516; Simo R, 2004, CAN J FISH AQUAT SCI, V61, P673, DOI 10.1139/F04-030; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Smetacek V., 1990, P103; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	29	148	154	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					652	654		10.1126/science.1131043	http://dx.doi.org/10.1126/science.1131043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068265				2022-12-28	WOS:000241557800049
J	Murray, JD; Karas, BJ; Sato, S; Tabata, S; Amyot, L; Szczyglowski, K				Murray, Jeremy D.; Karas, Bogumil J.; Sato, Shusei; Tabata, Satoshi; Amyot, Lisa; Szczyglowski, Krzysztof			A cytokinin perception mutant colonized by Rhizobium in the absence of nodule organogenesis	SCIENCE			English	Article							LEGUME LOTUS-JAPONICUS; RECEPTOR-LIKE KINASE; NODULATION FACTOR; FUNGAL SYMBIOSIS; ROOT DEVELOPMENT; BACTERIAL; INDUCTION; ENOD40; EXPRESSION; MELILOTI	In legumes, Nod-factor signaling by rhizobia initiates the development of the nitrogen-fixing nodule symbiosis, but the direct cell division stimulus that brings about nodule primordia inception in the root cortex remains obscure. We showed that Lotus japonicus plants homozygous for a mutation in the HYPERINFECTED 1 (HIT1) locus exhibit abundant infection-thread formation but fail to initiate timely cortical cell divisions in response to rhizobial signaling. We demonstrated that the corresponding gene encodes a cytokinin receptor that is required for the activation of the nodule inception regulator Nin and nodule organogenesis.	Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON N5V 4T3, Canada; Kazusa DNA Res Inst, Chiba 2920812, Japan	Agriculture & Agri Food Canada; Kazusa DNA Research Institute	Szczyglowski, K (corresponding author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, 1391 Sandford St, London, ON N5V 4T3, Canada.	szczyglowskik@agr.gc.ca	Sato, Shusei/A-3616-2015; Murray, Jeremy D./F-8409-2011	Sato, Shusei/0000-0002-0293-5366; Murray, Jeremy D./0000-0003-3000-9199				Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; Fang YW, 1998, PLANT PHYSIOL, V116, P53, DOI 10.1104/pp.116.1.53; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Gronlund M, 2005, MOL PLANT MICROBE IN, V18, P414, DOI 10.1094/MPMI-18-0414; HIRSCH AM, 1989, P NATL ACAD SCI USA, V86, P1244, DOI 10.1073/pnas.86.4.1244; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kanamori N, 2006, P NATL ACAD SCI USA, V103, P359, DOI 10.1073/pnas.0508883103; Karas B, 2005, PLANT PHYSIOL, V137, P1331, DOI 10.1104/pp.104.057513; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Minami E, 1996, PLANT J, V10, P23, DOI 10.1046/j.1365-313X.1996.10010023.x; Murray J, 2006, MOL PLANT MICROBE IN, V19, P1082, DOI 10.1094/MPMI-19-1082; Oldroyd GED, 2005, PLANT PHYSIOL, V137, P1205, DOI 10.1104/pp.104.057661; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862	29	354	370	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					101	104		10.1126/science.1132514	http://dx.doi.org/10.1126/science.1132514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17110535				2022-12-28	WOS:000243259100046
J	Mihaylova, B; Briggs, A; Armitage, J; Parish, S; Cray, A; Collins, R				Mihaylova, Borislava; Briggs, Andrew; Armitage, Jane; Parish, Sarah; Cray, Alastair; Collins, Rory		Heart Protection Study Collabor	Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To evaluate the cost effectiveness of 40 mg simvastatin daily continued for life in people of different ages with differing risks of vascular disease. Design A model developed from a randomised trial was used to estimate lifetime risks of vascular events and costs of treatment and hospital admissions in the United Kingdom. Setting 69 hospitals in the UK. Participants 20 536 men and women (aged 40-80) with coronary disease, other occlusive arterial disease, or diabetes. Interventions 40 mg simvastatin daily versus placebo for an average of 5 years. Main outcome measures Cost effectiveness of 40 mg simvastatin daily expressed as additional cost per life year gained. Major vascular event defined as non-fatal myocardial infarction or death from coronary disease, any smoke, or revascularisation procedure. Results were extrapolated to younger and older age groups at lower risk of vascular disease than were studied directly, as well as to lifetime treatment. Results At die April 2005 UK price of 4.87 pound (E7; $9) per 28 day pack of generic 40 mg simvastatin, lifetime treatment was cost saving in most age groups and vascular disease risk groups studied directly. Gains in life expectancy and cost savings decreased with increasing age and with decreasing risk of vascular disease. People aged 40-49 with 5 year risks of major vascular events of 42% and 12% at start of treatment gained 2.49 and 1.67 life years, respectively. Treatment with statins remained cost saving or cost less than 2500 pound per life year gained in people as young as 35 years or as old as 85 with 5 year risks of a major vascular event as low as 5% at the start of treatment. Conclusions Treatment with statins is cost effective in a eider population than is routinely treated at present.				hps@ctsu.ox.ac.uk	Lindley, Richard/B-8148-2013	Lindley, Richard/0000-0002-0104-5679; Mihaylova, Borislava/0000-0002-0951-1304; Briggs, Andrew/0000-0002-0777-1997				*3 JOINT TASK FORC, 2003, NEW EUR J CARD PR S1, V1, pS1; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Collins R, 2004, LANCET, V363, P757; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Efron B., 1994, MONOGRAPHS STAT APPL; HM Treasury, 2003, GREEN BOOK APPR EV C; Imai K, 2005, LANCET, V365, P1749, DOI 10.1016/S0140-6736(05)66390-8; *JOINT FORM COMM, 2005, BRIT NAT FORM, V49; Kind P, 1996, QUALITY LIFE PHARMAC; Mihaylova B, 2005, LANCET, V365, P1779, DOI 10.1016/S0140-6736(05)63014-0; *NAT I HLTH CLIN E, 2006, TECHN APPR, V94; *OFF NAT STAT, HLTH STAT Q, V18; *OFF NAT STAT, ENGL WAL EST RES POP; *PRESCR PRIC AUTH, NHS EL DRUG TAR; RAWLINS MD, 2004, BMJ-BRIT MED J, V29, P224; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Williams, 1995, 138 CTR HLTH EC; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; VITAL EVENTS REFEREN	22	66	72	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2006	333	7579					1145	1148A		10.1136/bmj.38993.731725.BE	http://dx.doi.org/10.1136/bmj.38993.731725.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114LG	17098764	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000242667100015
J	Hassey, R; Swain, EJ; Hammer, NI; Venkataraman, D; Barnes, MD				Hassey, Ruthanne; Swain, Ellen J.; Hammer, Nathan I.; Venkataraman, Dhandapani; Barnes, Michael D.			Probing the chiroptical response of a single molecule	SCIENCE			English	Article							CIRCULARLY-POLARIZED LUMINESCENCE; SPECTROSCOPY; DICHROISM; FILMS; CHEMISTRY; CRYSTALS; PHYSICS	Chirally sensitive measurement techniques have generally been restricted to bulk samples. Here, we report the observation of fluorescence-detected circular dichroism (FDCD) from single (bridged-triarylamine) helicene molecules by using an excitation wavelength ( 457 nanometers) in the vicinity of an electronic transition that shows circular dichroism in bulk samples. The distributions of dissymmetry ( g) parameters by analysis of signals from pure M- and P-type diastereomers are almost perfect mirror images of one another, each spanning a range of both positive and negative values. In addition, we observe a well-defined structure in the histogram of dissymmetry parameters suggestive of specific molecular orientations at the polymer interface. These single-molecule results highlight strong intrinsic circular dichroism responses that can be obscured by cancellation effects in ensemble measurements of a randomly oriented bulk sample.	Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Barnes, MD (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	mdbarnes@chem.umass.edu	Venkataraman, D/A-8226-2008	Venkataraman, D/0000-0003-2906-0579; Hammer, Nathan/0000-0002-6221-2709				Bai CL, 1999, P NATL ACAD SCI USA, V96, P11075, DOI 10.1073/pnas.96.20.11075; Bartko AP, 1999, J PHYS CHEM B, V103, P11237, DOI 10.1021/jp993364q; Bartko AP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.026101; Berova N., 2000, CIRCULAR DICHROISM P, DOI DOI 10.1038/natrevmats.2016.21; Brokmann X, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.107403; Chen SH, 1999, NATURE, V397, P506, DOI 10.1038/17343; Claborn K, 2003, J AM CHEM SOC, V125, P14825, DOI 10.1021/ja035644w; Fasel R, 2006, NATURE, V439, P449, DOI 10.1038/nature04419; Field JE, 2003, J AM CHEM SOC, V125, P11808, DOI 10.1021/ja035626e; Field JE, 2003, J ORG CHEM, V68, P6071, DOI 10.1021/jo026883p; Kumar P, 2003, J PHYS CHEM B, V107, P6252, DOI 10.1021/jp034107v; Moerner WE, 2002, J PHYS CHEM B, V106, P910, DOI 10.1021/jp012992g; Mucha D, 1997, J PHYS-CONDENS MAT, V9, P10829, DOI 10.1088/0953-8984/9/49/004; Muller T, 2000, J PHYS CHEM A, V104, P5959, DOI 10.1021/jp000705n; Nie SM, 1997, ANNU REV BIOPH BIOM, V26, P567, DOI 10.1146/annurev.biophys.26.1.567; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; RICHARDSON FS, 1977, CHEM REV, V77, P773, DOI 10.1021/cr60310a001; RIEHL JP, 1986, CHEM REV, V86, P1, DOI 10.1021/cr00071a001; Satrijo A, 2006, J AM CHEM SOC, V128, P9030, DOI 10.1021/ja063027c; SCHWARTZ RW, 1977, MOL PHYS, V34, P361, DOI 10.1080/00268977700101781; Sfeir MY, 2006, SCIENCE, V312, P554, DOI 10.1126/science.1124602; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; Wilson JN, 2002, J AM CHEM SOC, V124, P6830, DOI 10.1021/ja026532s; Yu ZH, 2004, J PHYS CHEM B, V108, P11321, DOI 10.1021/jp038005g	24	170	171	3	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1437	1439		10.1126/science.1134231	http://dx.doi.org/10.1126/science.1134231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17082419				2022-12-28	WOS:000242406100036
J	Boukhalil, P; Debek, A				Boukhalil, Pierre; Debek, Ali			Images in clinical medicine: Squamous-cell carcinoma with pericardial metastases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Univ Beirut, Med Ctr, Beirut 11072020, Lebanon	American University of Beirut	Boukhalil, P (corresponding author), Amer Univ Beirut, Med Ctr, Beirut 11072020, Lebanon.	pb05@aub.edu.lb							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					E24	E24		10.1056/NEJMicm053597	http://dx.doi.org/10.1056/NEJMicm053597			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124011				2022-12-28	WOS:000242170900011
J	Hiatt, WR				Hiatt, William R.			Observational studies of drug safety - Aprotinin and the absence of transparency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC-SURGERY		Univ Colorado, Sch Med, Denver, CO 80202 USA; Colorado Prevent Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, Denver, CO 80202 USA.							*FOOD DRUG ADM, 2006, PUBL HLTH ADV APR IN; *FOOD DRUG ADM, 2006, FDA STAT REG NEW TRA; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064	5	32	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2171	2173		10.1056/NEJMp068252	http://dx.doi.org/10.1056/NEJMp068252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124013				2022-12-28	WOS:000242170900002
J	Fineberg, HV				Fineberg, Harvey V.			Health reform in Mexico: a work in progress	LANCET			English	Editorial Material							POLICY		Natl Acad Sci, Inst Med, Washington, DC 20001 USA	National Academies of Sciences, Engineering & Medicine	Fineberg, HV (corresponding author), Natl Acad Sci, Inst Med, Washington, DC 20001 USA.	fineberg@nas.edu						Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1755	1756		10.1016/S0140-6736(06)69714-6	http://dx.doi.org/10.1016/S0140-6736(06)69714-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113409				2022-12-28	WOS:000242225400010
J	Smith, NM; Shay, DK				Smith, Nicole M.; Shay, David K.			Influenza vaccination for elderly people and their care workers	LANCET			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS; EFFICACY		Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Shay, DK (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA.	dks4@cdc.gov		Shay, David/0000-0001-9619-4820				[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; Beyer WEP, 2006, VACCINE, V24, P6602, DOI 10.1016/j.vaccine.2006.05.038; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; EDMONDSON WP, 1971, AM J EPIDEMIOL, V93, P480, DOI 10.1093/oxfordjournals.aje.a121282; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Rudenko LG, 2000, VACCINE, V19, P308, DOI 10.1016/S0264-410X(00)00153-5; Thomas RE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub2; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	13	6	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1752	1753		10.1016/S0140-6736(06)69713-4	http://dx.doi.org/10.1016/S0140-6736(06)69713-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113407				2022-12-28	WOS:000242225400008
J	Skach, WR				Skach, William R.			CFTR: New members join the fold	CELL			English	Editorial Material							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; DEGRADATION; HSP90	The folding, misfolding, and degradation of membrane proteins is controlled by multiple processes within the cell. In this issue of Cell, Wang et al. (2006) present an interactome for CFTR, the chloride channel that is misfolded and prematurely degraded in cystic fibrosis. Among the proteins interacting with CFTR is a new member of the Hsp90 chaperone system, Aha1, that plays a central role in CFTR folding.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Skach, WR (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	skachw@ohsu.edu						Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Kelly JW, 2006, NAT CHEM BIOL, V2, P224, DOI 10.1038/nchembio0506-224; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	9	23	23	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					673	675		10.1016/j.cell.2006.11.002	http://dx.doi.org/10.1016/j.cell.2006.11.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110327	Bronze			2022-12-28	WOS:000242330600014
J	Verdun, RE; Karlseder, J				Verdun, Ramiro E.; Karlseder, Jan			The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres	CELL			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; POLYMERASE-ALPHA; IN-VITRO; S-PHASE; G-TAILS; MAMMALIAN TELOMERES; FLAP ENDONUCLEASE-1; CHECKPOINT PROTEIN	Telomeres protect chromosome ends from being detected as lesions and from triggering DNA damage checkpoints. Paradoxically, telomere function depends on checkpoint proteins such as ATM and ATR, but a molecular model explaining this seemingly contradictory relationship has been missing so far. Here we show that the DNA damage machinery acts on telomeres in at least two independent steps. First, the ATR-dependent machinery is recruited to telomeres before telomere replication is completed, likely in response to single-stranded DNA resulting from replication fork stalling. Second, after replication, telomeres attract ATM and the homologous recombination (HR) machinery. In vivo and in vitro results suggest that the HR machinery is required for formation of a telomere-specific structure at chromosome ends after replication. Our results suggest that telomere ends need to be recognized as DNA damage to complete end replication and to acquire a structure that is essential for function.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Karlseder, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	karlseder@salk.edu			NIGMS NIH HHS [R01 GM06525] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dahlen M, 1998, MOL BIOL CELL, V9, P611, DOI 10.1091/mbc.9.3.611; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Ivanov EL, 1996, GENETICS, V142, P693; Jaco I, 2003, MOL CELL BIOL, V23, P5572, DOI 10.1128/MCB.23.16.5572-5580.2003; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Le S, 1999, GENETICS, V152, P143; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Liu JS, 2003, MUTAT RES-FUND MOL M, V532, P215, DOI 10.1016/j.mrfmmm.2003.08.018; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Stansel RM, 2001, EMBO J, V20, P5532; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Takata H, 2004, MOL CELL, V14, P515, DOI 10.1016/S1097-2765(04)00262-X; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Varley H, 2002, NAT GENET, V30, P301, DOI 10.1038/ng834; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Vespa L, 2005, GENE DEV, V19, P2111, DOI 10.1101/gad.1333805; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; WELLINGER RJ, 1993, COLD SPRING HARB SYM, V58, P725, DOI 10.1101/SQB.1993.058.01.080; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	68	266	271	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					709	720		10.1016/j.cell.2006.09.034	http://dx.doi.org/10.1016/j.cell.2006.09.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110331	Bronze			2022-12-28	WOS:000242330600018
J	Wang, XD; Venable, J; LaPointe, P; Hutt, DM; Koulov, AV; Coppinger, J; Gurkan, C; Kellner, W; Matteson, J; Plutner, H; Riordan, JR; Kelly, JW; Yates, JR; Balch, WE				Wang, Xiaodong; Venable, John; LaPointe, Paul; Hutt, Darren M.; Koulov, Atanas V.; Coppinger, Judith; Gurkan, Cemal; Kellner, Wendy; Matteson, Jeanne; Plutner, Helen; Riordan, John R.; Kelly, Jeffery W.; Yates, John R., III; Balch, William E.			Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; QUALITY-CONTROL; MOLECULAR CHAPERONES; ATPASE ACTIVITY; PROTEIN; DEGRADATION; ACTIVATION; DISEASE; ER; CONTRIBUTES	The pathways that distinguish transport of folded and misfolded cargo through the exocytic (secretory) pathway of eukaryotic cells remain unknown. Using proteomics to assess global cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein interactions (the CFTR interactome), we show that Hsp90 cochaperones modulate Hsp90-dependent stability of CFTR protein folding in the endoplasmic reticulum (ER). Cell-surface rescue of the most common disease variant that is restricted to the ER, Delta F508, can be initiated by partial siRNA silencing of the Hsp90 cochaperone ATPase regulator Aha1. We propose that failure of Delta F508 to achieve an energetically favorable fold in response to the steady-state dynamics of the chaperone folding environment (the "chaperome") is responsible for the pathophysiology of CF. The activity of cargo-associated chaperome components may be a common mechanism regulating folding for ER exit, providing a general framework for correction of misfolding disease.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27510 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Yates, JR (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyates@scripps.edu; webalch@scripps.edu	Gurkan, Cemal/S-5751-2016	Gurkan, Cemal/0000-0001-7379-4559; Koulov, Atanas/0000-0003-0262-7002; LaPointe, Paul/0000-0002-5465-1795; coppinger, judith/0000-0001-6813-9840	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045678, R01GM042336] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11823] Funding Source: Medline; NHLBI NIH HHS [R01 HL079442] Funding Source: Medline; NIDDK NIH HHS [DK51870] Funding Source: Medline; NIGMS NIH HHS [GM78654, GM45678, GM42336] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kelly JW, 2006, NAT CHEM BIOL, V2, P224, DOI 10.1038/nchembio0506-224; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Moyer B D, 2001, Expert Opin Ther Targets, V5, P165, DOI 10.1517/14728222.5.2.165; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Welsh MJ, 1998, NAT STRUCT BIOL, V5, P167, DOI 10.1038/nsb0398-167; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	39	488	499	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					803	815		10.1016/j.cell.2006.09.043	http://dx.doi.org/10.1016/j.cell.2006.09.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110338	Bronze			2022-12-28	WOS:000242330600025
J	Baur, JA; Pearson, KJ; Price, NL; Jamieson, HA; Lerin, C; Kalra, A; Prabhu, VV; Allard, JS; Lopez-Lluch, G; Lewis, K; Pistell, PJ; Poosala, S; Becker, KG; Boss, O; Gwinn, D; Wang, MY; Ramaswamy, S; Fishbein, KW; Spencer, RG; Lakatta, EG; Le Couteur, D; Shaw, RJ; Navas, P; Puigserver, P; Ingram, DK; de Cabo, R; Sinclair, DA				Baur, Joseph A.; Pearson, Kevin J.; Price, Nathan L.; Jamieson, Hamish A.; Lerin, Carles; Kalra, Avash; Prabhu, Vinayakumar V.; Allard, Joanne S.; Lopez-Lluch, Guillermo; Lewis, Kaitlyn; Pistell, Paul J.; Poosala, Suresh; Becker, Kevin G.; Boss, Olivier; Gwinn, Dana; Wang, Mingyi; Ramaswamy, Sharan; Fishbein, Kenneth W.; Spencer, Richard G.; Lakatta, Edward G.; Le Couteur, David; Shaw, Reuben J.; Navas, Placido; Puigserver, Pere; Ingram, Donald K.; de Cabo, Rafael; Sinclair, David A.			Resveratrol improves health and survival of mice on a high-calorie diet	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; REPLICATIVE LIFE-SPAN; GENE SET ENRICHMENT; MITOCHONDRIAL BIOGENESIS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; RESTRICTION MIMETICS; COACTIVATOR PGC-1; DEFICIENT MICE; C-ELEGANS	Resveratrol ( 3,5,4'- trihydroxystilbene) extends the lifespan of diverse species including Saccharomyces cerevisiae, Caenorhabditis elegans and Drosophila melanogaster. In these organisms, lifespan extension is dependent on Sir2, a conserved deacetylase proposed to underlie the beneficial effects of caloric restriction. Here we show that resveratrol shifts the physiology of middle- aged mice on a high- calorie diet towards that of mice on a standard diet and significantly increases their survival. Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin- like growth factor- 1 ( IGF- I) levels, increased AMP- activated protein kinase ( AMPK) and peroxisome proliferator- activated receptor-gamma coactivator 1 alpha ( PGC- 1 alpha) activity, increased mitochondrial number, and improved motor function. Parametric analysis of gene set enrichment revealed that resveratrol opposed the effects of the high- calorie diet in 144 out of 153 significantly altered pathways. These data show that improving general health in mammals using small molecules is an attainable goal, and point to new approaches for treating obesity- related disorders and diseases of ageing.	Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA; NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; NIA, Clin Invest Lab, Res Resources Branch, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA; Univ Sydney, ANZAC Res Inst, Concord, NSW 2139, Australia; Univ Sydney, Ctr Educ, Concord, NSW 2139, Australia; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Univ Pablo Olavide, CSIC, Ctr andaluz Biol Desarrollo, Seville 41013, Spain; Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Louisiana State Univ, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA 70808 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Sydney; ANZAC Research Institute; University of Sydney; Johns Hopkins University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Salk Institute; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	de Cabo, R (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	deCaboRa@grc.nia.nih.gov; david_sinclair@hms.harvard.edu	NAVAS, PLACIDO/R-5943-2019; de Cabo, Rafael/E-7996-2010; Sharan, Ramaswamy/H-4469-2019; Fishbein, Kenneth/AAN-2595-2021; Wang, Mingyi/L-8370-2017; Baur, Joseph A/D-8163-2011; Lerin, Carles/AAP-9916-2020; de Cabo, Rafael Carlos/J-5230-2016; Lakatta, Edward G/AAL-1447-2020; Research Institute, ANZAC/CAE-9030-2022; Lopez-Lluch, Guillermo/N-4742-2014; de Cabo, Rafael/J-5230-2016	NAVAS, PLACIDO/0000-0002-4115-7966; de Cabo, Rafael/0000-0003-2830-5693; Fishbein, Kenneth/0000-0002-6353-4603; Wang, Mingyi/0000-0001-6412-369X; Lerin, Carles/0000-0003-0950-4363; de Cabo, Rafael Carlos/0000-0003-2830-5693; Lopez-Lluch, Guillermo/0000-0001-9830-8502; Price, Nathan/0000-0002-2821-9608; Becker, Kevin/0000-0002-6794-6656; Sinclair, David/0000-0002-9936-436X; Lakatta, Edward/0000-0002-4772-0035; Baur, Joseph/0000-0001-8262-6549; Hardell, Kaitlyn/0000-0002-5502-8145; Le Couteur, David/0000-0002-4227-5817; de Cabo, Rafael/0000-0002-3354-2442	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG019719, Z01AG000368, Z01AG000302, Z01AG000864, R01AG028730, P01AG027916, Z01AG000381, R01AG019972] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG028730, R01 AG019972, R37 AG028730, R01 AG019719, P01 AG027916] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P361, DOI 10.1196/annals.1354.051; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; HOWITZ KT, 2006, HDB BIOL AGING, P63; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Jarolim S, 2004, FEMS YEAST RES, V5, P169, DOI 10.1016/j.femsyr.2004.06.015; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li ZP, 2005, SURG CLIN N AM, V85, P681, DOI 10.1016/j.suc.2005.04.006; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; OLSHANSKY SJ, 2005, HLTH AFF MILLWOOD S2, V24, pWR589; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Raval AP, 2006, J CEREBR BLOOD F MET, V26, P1141, DOI 10.1038/sj.jcbfm.9600262; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scrocchi LA, 1998, ENDOCRINOLOGY, V139, P3127, DOI 10.1210/en.139.7.3127; Siebler J, 2006, WORLD J GASTROENTERO, V12, P2161; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu XW, 1996, AM J PHYSIOL-ENDOC M, V271, pE903, DOI 10.1152/ajpendo.1996.271.5.E903; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	44	3374	3549	22	759	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					337	342		10.1038/nature05354	http://dx.doi.org/10.1038/nature05354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17086191	Green Accepted, Green Submitted			2022-12-28	WOS:000242018300041
J	Caliezi, C; Reber, P				Caliezi, Christoph; Reber, Peter			Fibromuscular dysplasia of the renal artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Lindenhofspital, CH-3001 Bern, Switzerland		Caliezi, C (corresponding author), Lindenhofspital, CH-3001 Bern, Switzerland.	christoph.caliezi@lindenhofspital.ch							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2131	2131		10.1056/NEJMicm053293	http://dx.doi.org/10.1056/NEJMicm053293			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108345				2022-12-28	WOS:000241997300009
J	Suhrcke, M; McKee, M; Arce, RS; Tsolova, S; Mortensen, J				Suhrcke, Marc; McKee, Martin; Arce, Regina Sauto; Tsolova, Svetla; Mortensen, Jorgen			Investment in health could be good for Europe's economies	BRITISH MEDICAL JOURNAL			English	Editorial Material							GROWTH		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; WHO, European Off Investment Hlth & Dev, Venice, Italy; Ctr European Policy Studies, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Suhrcke, Marc/AAE-9024-2019	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Suhrcke, Marc/0000-0001-7263-8626				[Anonymous], 2001, MACR HLTH INV HLTH E; Arora S., 2001, J EC HIST, V61; Averett S, 1996, J HUM RESOUR, V31, P304, DOI 10.2307/146065; BERGER MC, 1983, SOC SCI QUART, V64, P494; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; BRUNELLO G, 2005, 1704 IZA I STUD LAB; CAWLEY J, 2000, 7481 NAT BUR EC RES; CHIRIKOS TN, 1985, REV ECON STAT, V67, P61, DOI 10.2307/1928435; Currie J., 1999, HDB LABOR EC, V3, P3309, DOI DOI 10.1016/S1573-4463(99)30041-9; Ettner SL, 1996, J HUM RESOUR, V31, P189, DOI 10.2307/146047; FOGEL RW, 1994, AM ECON REV, V84, P369; Lechner M., 2004, 4223 CTR EC POL RES; MARTINS JO, 2005, 420 ORG EC COOP DEV; Nordhaus W, 2003, MEASUREMENT EC SOCIA; PALKOWSKI JM, 2004, Q REV EC FINANCE, V44, P102; Sala-I-Martin X, 2004, AM ECON REV, V94, P813, DOI 10.1257/0002828042002570; SIDDIQUI S, 1997, EC HLTH EC, V6, P425; SUHRCKE M, 2006, IS CARDIOVASCULAR DI; Suhrcke M, 2005, CONTRIBUTION HLTH EC; Wanless D., 2004, SECURING GOOD HLTH W	20	21	21	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 11	2006	333	7576					1017	1019		10.1136/bmj.38951.614144.68	http://dx.doi.org/10.1136/bmj.38951.614144.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108GX	17095786	Green Published, Green Accepted			2022-12-28	WOS:000242229400021
J	Frankel, DS; Johnson, PA; Shepard, JAO; Harris, NL; Semigran, GE; Jaffer, FA; Neilan, TG; Walker, JD; Stone, JR; Weinberg, AN				Frankel, David S.; Johnson, Paula A.; Shepard, Jo-Anne O.; Harris, Nancy Lee; Semigran, Gail E.; Jaffer, Farouc A.; Neilan, Tomas G.; Walker, Jennifer D.; Stone, James R.; Weinberg, Arnold N.			Case 34-2006: A 72-year-old woman with nausea followed by hypotension and respiratory failure - Acute myocardial infarction (3 to 5 days old) with rupture of the anterolateral papillary muscle	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENDER-DIFFERENCES; DISEASE		Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Frankel, DS (corresponding author), Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA.		Jaffer, Farouc/AAK-8803-2020	Jaffer, Farouc/0000-0001-7980-384X				Angeja BG, 2002, AM J CARDIOL, V89, P1156, DOI 10.1016/S0002-9149(02)02296-8; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Birnbaum Y, 2002, NEW ENGL J MED, V347, P1426, DOI 10.1056/NEJMra020228; FISHBEIN MC, 1978, CHEST, V73, P843, DOI 10.1378/chest.73.6.843; Linfante A, 2004, CIRCULATION, V110, P664; LODGEPATCH I, 1951, BRIT HEART J, V13, P37; Mallory GK, 1939, AM HEART J, V18, P647; Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Witt BJ, 2004, J AM COLL CARDIOL, V44, P988, DOI 10.1016/j.jacc.2004.05.062; 2001, MMWR MORB MORTAL WKL, V50, P90	12	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					2022	2031		10.1056/NEJMcpc069025	http://dx.doi.org/10.1056/NEJMcpc069025			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093254				2022-12-28	WOS:000241833000013
J	Maki, DG				Maki, Dennis G.			Don't eat the spinach - Controlling foodborne infectious disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESCHERICHIA-COLI		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							*CDCP, 2006, E COLI O157 H7 OUTBR; Diez-Gonzalez F, 1998, SCIENCE, V281, P1666, DOI 10.1126/science.281.5383.1666; Osterholm MT, 2004, NEW ENGL J MED, V350, P1898, DOI 10.1056/NEJMsb032657; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; 2006, MMWR MORB MORTAL WKL, V55, P392	5	43	44	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1952	1955		10.1056/NEJMp068225	http://dx.doi.org/10.1056/NEJMp068225			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102SG	17093245	Bronze			2022-12-28	WOS:000241833000002
J	Doniger, DD; Herzog, AV; Lashof, DA				Doniger, David D.; Herzog, Antonia V.; Lashof, Daniel A.			An ambitious, centrist approach to global warming legislation	SCIENCE			English	Editorial Material									Nat Resources Def Council, Washington, DC 20005 USA		Lashof, DA (corresponding author), Nat Resources Def Council, Washington, DC 20005 USA.	dlashof@nrdc.org						Burtraw D., 2005, ALLOCATION CO2 EMISS; Department Of Energy, 2006, DOEEIA0383; EIA, 2005, IMP MOD REC NAT COMM; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HAWKINS D, 2005, GREENHOUSE GAS CONTR, P1525; Meinshausen M., 2006, AVOIDING DANGEROUS C, P265; *NAT COMM EN POL, 2004, END EN STAL BIP STRA; Schellnhuber H J, 2006, AVOIDING DANGEROUS C; Sijm J, 2006, CLIM POLICY, V6, P49	9	13	14	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					764	765		10.1126/science.1131558	http://dx.doi.org/10.1126/science.1131558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	101GR	17082439				2022-12-28	WOS:000241729800026
J	Lepilina, A; Coon, AN; Kikuchi, K; Holdway, JE; Roberts, RW; Burns, CG; Poss, KD				Lepilina, Alexandra; Coon, Ashley N.; Kikuchi, Kazu; Holdway, Jennifer E.; Roberts, Richard W.; Burns, C. Geoffrey; Poss, Kenneth D.			A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration	CELL			English	Article							RED FLUORESCENT PROTEIN; CARDIOVASCULAR-SYSTEM; TRANSCRIPTION FACTORS; HEMATOPOIETIC STEM; DIFFERENTIATION; GROWTH; EXPRESSION; VERTEBRATES; MYOCARDIUM; ACTIVATION	Zebrafish possess a unique yet poorly understood capacity for cardiac regeneration. Here, we show that regeneration proceeds through two coordinated stages following resection of the ventricular apex. First a blastema is formed, comprised of progenitor cells that express precardiac markers, undergo differentiation, and proliferate. Second, epicardial tissue surrounding both cardiac chambers induces developmental markers and rapidly expands, creating a new epithelial cover for the exposed myocardium. A subpopulation of these epicardial cells undergoes epithelial-to-mesenchymal transition (EMT), invades the wound, and provides new vasculature to regenerating muscle. During regeneration, the ligand fgf17b is induced in myocardium, while receptors fgfr2 and fgfr4 are induced in adjacent epicardial-derived cells. When fibroblast growth factors (Fgf) signaling is experimentally blocked by expression of a dominant-negative Fgf receptor, epicardial EMT and coronary neovascularization fail, prematurely arresting regeneration. Our findings reveal injury responses by myocardial and epicardial tissues that collaborate in an Fgf-dependent manner to achieve cardiac regeneration.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Duke University; Harvard University; Massachusetts General Hospital	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	k.poss@cellbio.duke.edu	Kikuchi, Kazu/A-4097-2017	Kikuchi, Kazu/0000-0002-4681-4275; Poss, Kenneth/0000-0002-6743-5709	NIA NIH HHS [K01 AG023562] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG023562] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akimoto A, 2005, DEV DYNAM, V233, P993, DOI 10.1002/dvdy.20439; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bettencourt-Dias M, 2003, J CELL SCI, V116, P4001, DOI 10.1242/jcs.00698; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Chen JN, 1996, DEVELOPMENT, V123, P293; Chen JN, 1996, DEVELOPMENT, V122, P3809; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; EGUCHI G, 1974, P NATL ACAD SCI USA, V71, P5052, DOI 10.1073/pnas.71.12.5052; Griffin KJP, 2000, DEV BIOL, V218, P235, DOI 10.1006/dbio.1999.9571; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Meilhac SM, 2003, DEVELOPMENT, V130, P3877, DOI 10.1242/dev.00580; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Olivey HE, 2004, TRENDS CARDIOVAS MED, V14, P247, DOI 10.1016/j.tcm.2004.07.001; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Pennisi DJ, 2005, DEV BIOL, V279, P378, DOI 10.1016/j.ydbio.2004.12.028; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; SCADDING SR, 1977, J EXP ZOOL, V202, P57, DOI 10.1002/jez.1402020108; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; Verkhusha VV, 2001, J BIOL CHEM, V276, P29621, DOI 10.1074/jbc.C100200200; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; WAGNER GP, 1992, J EXP ZOOL, V261, P62, DOI 10.1002/jez.1402610108; Yelon D, 2000, DEVELOPMENT, V127, P2573	53	587	613	0	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					607	619		10.1016/j.cell.2006.08.052	http://dx.doi.org/10.1016/j.cell.2006.08.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081981	Bronze			2022-12-28	WOS:000241937000023
J	Fu, KG; Sano, Y				Fu, Kuangi; Sano, Yasushi			Progression of a pedunculated polyp	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Natl Canc Ctr Hosp E, Kashiwa, Chiba 2888577, Japan	National Cancer Center - Japan	Fu, KG (corresponding author), Natl Canc Ctr Hosp E, Kashiwa, Chiba 2888577, Japan.	fukuangi@hotmail.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1912	1912		10.1056/NEJMicm055403	http://dx.doi.org/10.1056/NEJMicm055403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100TM	17079765				2022-12-28	WOS:000241691700009
J	Robertson, KB; Janssen, WJ; Saint, S; Weinberger, SE				Robertson, Kathryn B.; Janssen, William J.; Saint, Sanjay; Weinberger, Steven E.			The missing piece	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PLEUROPULMONARY PARAGONIMIASIS; PULMONARY PARAGONIMIASIS; DISEASE; EOSINOPHILIA; DIAGNOSIS		Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, Denver, CO 80262 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80262 USA; Vet Affairs Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Michigan System; University of Michigan	Robertson, KB (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Div Infect Dis, 4200 E 9th Ave,B168, Denver, CO 80262 USA.	kathryn.robertson@uchsc.edu	Saint, Sanjay/AAF-5126-2019		AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bunnag D, 2000, HUNTERS TROPICAL MED, P847; Choo JD, 2003, AM J TROP MED HYG, V69, P466, DOI 10.4269/ajtmh.2003.69.466; COLLINS MS, 1981, SOUTHERN MED J, V74, P1418, DOI 10.1097/00007611-198111000-00034; COOK GC, 2003, MANSONS TROPICAL DIS, P1481; IM JG, 1992, AM J ROENTGENOL, V159, P39, DOI 10.2214/ajr.159.1.1609718; Meehan AM, 2002, CLIN INFECT DIS, V35, P87, DOI 10.1086/340709; PETERS W, 2002, TROPICAL MED PARASIT, P154; ROMEO DP, 1986, SOUTHERN MED J, V79, P241, DOI 10.1097/00007611-198602000-00024; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Singh T N, 2005, Indian J Med Microbiol, V23, P131; Singh Th Nabakumar, 2004, Indian J Chest Dis Allied Sci, V46, P225; SLEMENDA SB, 1988, AM J TROP MED HYG, V39, P469, DOI 10.4269/ajtmh.1988.39.469; Tefferi A, 2005, MAYO CLIN PROC, V80, P75; YEE B, 1992, WESTERN J MED, V156, P423	14	8	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1913	1918		10.1056/NEJMcps053177	http://dx.doi.org/10.1056/NEJMcps053177			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079766				2022-12-28	WOS:000241691700011
J	Chou, R; Fu, R; Huffman, LH; Korthuis, PT				Chou, Roger; Fu, Rongwei; Huffman, Laurie Hoyt; Korthuis, P. Todd			Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses	LANCET			English	Article							DOUBLE-BLIND TRIAL; RANDOMIZED CLINICAL-TRIALS; HIV-INFECTED PATIENTS; COMBINATION THERAPY; PLUS ZIDOVUDINE; HIV-1-INFECTED PATIENTS; NAIVE PATIENTS; TRIPLE; LAMIVUDINE; EFFICACY	Background The optimum treatment choice between initial highly-active antiretroviral therapy (HAART) with a protease inhibitor (PI) versus a non-nucleoside reverse transcriptase inhibitor (NNRTI) is uncertain. An indirect analysis reported that PI-based HAART was better than NNRTI-based HAART. However, direct evidence for competing interventions is deemed more reliable than indirect evidence for making treatment decisions. We did a meta-analysis of head-to-head trials and compared the results with those of indirect analyses. Methods 12 trials of at least 24 weeks' duration directly compared NNRTI-based versus PI-based HAART in HIV-infected patients with limited or no previous exposure to antiretrovirals. We also identified six trials of NNRTI-based HAART and eight trials of PI-based HAART, each versus two NRTI regimens. We analysed the outcomes of virological suppression, death or disease progression, and withdrawals due to adverse events. Findings In the direct meta-analysis, NNRTI-based regimens were better than PI-based regimens for virological suppression (OR 1.60, 95% Cl 1.31-1.96). The difference was reduced in higher-quality trials, but still favoured NNRTI-based HAART. There were no differences in death or disease progression (0.87, 0.56-1.35) or withdrawal because of adverse events (0.68, 0.43-1.08). By contrast, in indirect analyses NNRTI-based HAART was worse than PI-based HAART for virological suppression (0.26, 0.07-0.91). There were no significant differences for death or disease progression (1.28, 0.56-2.94) and withdrawals because of adverse events (1.46, 0.66-3.24). When trials of delavirdine were excluded, similar results were produced. Interpretation Results from direct analyses suggested that NNRTI-based HAART was more effective than Pi-based HAART for virological suppression and was similar to PI-based HAART for clinical outcomes. Indirect comparisons could be unreliable for complex and rapidly evolving interventions such as HAART.	Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR USA; Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR USA; Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR USA; Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd,Mailcode BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Korthuis, Philip/0000-0001-5556-3597				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; BARTLETT J, 2004, 25 INT AIDS C JUL 11; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Berlin JA, 1994, ONLINE J CURR CLIN T; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; COOPER D, 2005, 12 C RETR OPP INF FE; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Floridia M, 1999, J ACQ IMMUN DEF SYND, V20, P11, DOI 10.1097/00042560-199901010-00002; Friedland GH, 1999, J ACQ IMMUN DEF SYND, V21, P281, DOI 10.1097/00126334-199908010-00005; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Garcia F, 1999, AIDS, V13, P2377, DOI 10.1097/00002030-199912030-00009; Garcia F, 2000, J ACQ IMMUN DEF SYND, V25, P26, DOI 10.1097/00126334-200009010-00004; Gartland M, 2000, AIDS, V14, P367, DOI 10.1097/00002030-200003100-00009; Gartland M, 2001, ANTIVIR THER, V6, P127; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Goodgame JC, 2000, ANTIVIR THER, V5, P215; GUARDIOLA J, 2000, 40 INT C ANT AG CHEM; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Maggiolo F, 2003, ANTIVIR THER, V8, P339; Martinez-Picado J, 2003, ANN INTERN MED, V139, P81, DOI 10.7326/0003-4819-139-2-200307150-00007; MIRO JM, 2005, 10 EUR AIDS C NOV 17; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; MONTANER JSG, 2002, 42 INT C ANT AG CHEM; MOYLE G, 1999, 39 INT C ANT AG CHEM; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Opravil M, 2000, J ACQ IMMUN DEF SYND, V23, P17; *PAN CLIN PRACT TR, 2005, GUID US ANT AG HIV 1; PARA M, 1999, 39 INT C ANT AG CHEM; Phillips A, 2003, AIDS, V17, P619, DOI 10.1097/00002030-200303070-00018; Podzamczer D, 2002, ANTIVIR THER, V7, P81; Raffi F, 2001, HIV Clin Trials, V2, P330; RIDDLER S, 2005, MCT00050895 NIAD; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Saag MS, 2001, AIDS, V15, P1971, DOI 10.1097/00002030-200110190-00009; SKOWRON G, 1997, 37 INT C ANT AG CHEM; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Stellbrink HJ, 2000, CLIN DRUG INVEST, V20, P295, DOI 10.2165/00044011-200020050-00001; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Torre D, 2001, HIV Clin Trials, V2, P113, DOI 10.1310/4KVA-U5H3-UBXT-84G7; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; Yazdanpanah Y, 2004, BMJ-BRIT MED J, V328, P249, DOI 10.1136/bmj.37995.435787.A6; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	54	74	75	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1503	1515		10.1016/S0140-6736(06)69638-4	http://dx.doi.org/10.1016/S0140-6736(06)69638-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071284				2022-12-28	WOS:000241582700028
J	Whitney, CG; Pilishvili, T; Farley, MM; Schaffner, W; Craig, AS; Lynfield, R; Nyquist, AC; Gershman, KA; Vazquez, M; Bennett, NM; Reingold, A; Thomas, A; Glode, MP; Zell, ER; Jorgensen, JH; Beall, B; Schuchat, A				Whitney, Cynthia G.; Pilishvili, Tamor; Farley, Monica M.; Schaffner, William; Craig, Allen S.; Lynfield, Ruth; Nyquist, Ann-Christine; Gershman, Kenneth A.; Vazquez, Marietta; Bennett, Nancy M.; Reingold, Arthur; Thomas, Ann; Glode, Mary P.; Zell, Elizabeth R.; Jorgensen, James H.; Beall, Bernard; Schuchat, Anne			Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study	LANCET			English	Article							STREPTOCOCCUS-PNEUMONIAE; IMMUNOGENICITY; EFFICACY; CHILDREN; SAFETY; SURVEILLANCE; TOLERABILITY; CORRELATE; ADULTS; ERA	Background When seven-valent pneumococcal conjugate vaccine was introduced in the USA, many children were vaccinated on schedules that differed from those tested in clinical trials. Our aim was to assess the effectiveness of the vaccine against various pneumococcal serotypes, and to measure the effectiveness of the recommended dose schedule and of catch-up and incomplete schedules. Methods Invasive disease, defined as isolation of pneumococcus from a sterile site, was identified in children aged 3-59 months through the US Centers for Disease Control and Prevention's Active Bacterial Core surveillance. We tested isolates for serotype and antimicrobial susceptibility. Three controls, matched for age and zip code were selected for each case. We calculated the matched odds ratio for vaccination using conditional logistic regression, controlling for underlying conditions. Vaccine effectiveness was calculated as one minus the adjusted matched odds ratio times 100%. Findings We enrolled 782 cases and 2512 controls. Effectiveness of one or more doses against vaccine serotypes was 96% (95% CI 93-98) in healthy children and 81% (57-92) in those with coexisting disorders. It was 76% (63-85) against infections that were not susceptible to penicillin. Vaccination prevented disease caused by all seven vaccine serotypes, and by vaccine-related serotype 6A. Several schedules were more protective than no vaccination; three infant doses with a booster were more protective against vaccine-type disease than were three infant doses alone (p=0.0323). Interpretation The seven-valent pneumococcal conjugate vaccine prevents invasive disease in both healthy and chronically ill children. The vaccine is effective when used with various non-standard schedules.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Dept Med, Vet Affairs Med Ctr, Atlanta, GA 30322 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Tennessee Dept Hlth, Nashville, TN USA; Minnesota Dept Hlth, Minneapolis, MN USA; Childrens Hosp, Denver, CO 80218 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA; Yale Univ, Dept Pediat, New Haven, CT 06520 USA; Univ Rochester, Dept Med, Rochester, NY USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Oregon State Publ Hlth Div, Portland, OR USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Vanderbilt University; Tennessee Department Health; Minnesota Department of Health (MHD); Children's Hospital Colorado; Colorado Department of Public Health & Environment; Yale University; University of Rochester; University of California System; University of California Berkeley; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), 1600 Clifton Rd NE,Mailstop C23, Atlanta, GA 30333 USA.	cwhitney@cdc.gov						Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1140; *CLIN LAB STAND I, 2006, PERF STAND ANT SUSC; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Doern GV, 2005, CLIN INFECT DIS, V41, P139, DOI 10.1086/430906; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Esposito S, 2005, VACCINE, V23, P1703, DOI 10.1016/j.vaccine.2004.09.029; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5; Jokinen JT, 2004, J INFECT DIS, V190, P545, DOI 10.1086/422531; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; KLUGMAN KP, 1908, NEW ENGL J MED, V349, P1341; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; *PNEUM MOL EP NETW, PNEUM MOL EP NETW; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney Cynthia G, 2004, Semin Pediatr Infect Dis, V15, P86, DOI 10.1053/j.spid.2004.01.011; *WHO, 2003, WKLY EPIDEMIOL REC, V14, P110; WOODIN KA, 1995, ARCH PEDIAT ADOL MED, V149, P845, DOI 10.1001/archpedi.1995.02170210019003	32	448	465	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1495	1502		10.1016/S0140-6736(06)69637-2	http://dx.doi.org/10.1016/S0140-6736(06)69637-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071283	Green Submitted			2022-12-28	WOS:000241582700027
J	Novikov, AP; Kalmykov, SN; Utsunomiya, S; Ewing, RC; Horreard, F; Merkulov, A; Clark, SB; Tkachev, VV; Myasoedov, BF				Novikov, Alexander P.; Kalmykov, Stepan N.; Utsunomiya, Satoshi; Ewing, Rodney C.; Horreard, Francois; Merkulov, Alex; Clark, Sue B.; Tkachev, Vladimir V.; Myasoedov, Boris F.			Colloid transport of plutonium in the far-field of the Mayak Production Association, Russia	SCIENCE			English	Article							ACTINIDE SPECIATION; SHALLOW AQUIFER; GROUNDWATER; ENVIRONMENT; ADSORPTION; CHEMISTRY; WATERS; PU	Sorption of actinides, particularly plutonium, onto submicrometer-sized colloids increases their mobility, but these plutonium colloids are difficult to detect in the far-field. We identified actinides on colloids in the groundwater from the Mayak Production Association, Urals, Russia; at the source, the plutonium activity is similar to 1000 becquerels per liter. Plutonium activities are still 0.16 becquerels per liter at a distance of 3 kilometers, where 70 to 90 mole percent of the plutonium is sorbed onto colloids, confirming that colloids are responsible for the long-distance transport of plutonium. Nano - secondary ion mass spectrometry elemental maps reveal that amorphous iron oxide colloids adsorb Pu(IV) hydroxides or carbonates along with uranium carbonates.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Russian Acad Sci, VI Vernadskii Inst Geochem & Analyt Chem, Moscow 119991, Russia; Moscow MV Lomonosov State Univ, Dept Chem, Div Radiochem, Moscow 119992, Russia; Cameca SA, F-92622 Gennevilliers, France; Washington State Univ, Dept Chem, Pullman, WA 99164 USA; Washington State Univ, Nucl Radiat Ctr, Pullman, WA 99164 USA	University of Michigan System; University of Michigan; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Lomonosov Moscow State University; Washington State University; Washington State University	Ewing, RC (corresponding author), Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA.	rodewing@umich.edu	Novikov, Alexander/J-7741-2013; Kalmykov, Stepan N./Q-9757-2017; Utsunomiya, Satoshi/AAR-8057-2021; Utsunomiya, Satoshi/S-3934-2017; Clark, Sue/V-8603-2018	Kalmykov, Stepan N./0000-0002-2396-4561; Utsunomiya, Satoshi/0000-0002-6197-9705; Utsunomiya, Satoshi/0000-0002-6197-9705; Clark, Sue/0000-0002-6731-6822; Ewing, Rodney/0000-0001-9472-4031				Choppin GR, 2003, RADIOCHIM ACTA, V91, P645, DOI 10.1524/ract.91.11.645.23469; Christensen GC, 1997, SCI TOTAL ENVIRON, V202, P237, DOI 10.1016/S0048-9697(97)00119-8; CLARK DL, 1995, CHEM REV, V95, P25, DOI 10.1021/cr00033a002; Contardi JS, 2001, J CONTAM HYDROL, V47, P323, DOI 10.1016/S0169-7722(00)00160-1; Degueldre C, 2000, APPL GEOCHEM, V15, P1043, DOI 10.1016/S0883-2927(99)00102-X; Duff MC, 1999, ENVIRON SCI TECHNOL, V33, P2163, DOI 10.1021/es9810686; Kantar C, 2005, RADIOCHIM ACTA, V93, P757, DOI 10.1524/ract.2005.93.12.757; KAPLAN DI, 1994, RADIOCHIM ACTA, V66-7, P181; KEENEYKENNICUTT WL, 1985, GEOCHIM COSMOCHIM AC, V49, P2577, DOI 10.1016/0016-7037(85)90127-9; Kersting AB, 1999, NATURE, V397, P56, DOI 10.1038/16231; KIM JI, 1991, RADIOCHIM ACTA, V52-3, P71; KIM JI, 1993, MATER RES SOC SYMP P, V294, P3, DOI 10.1017/CBO9780511625220.002; KIM JI, 1994, MRS BULL, V19, P47, DOI 10.1557/S0883769400048703; Lu NP, 2003, RADIOCHIM ACTA, V91, P713, DOI 10.1524/ract.91.12.713.23422; Marty RC, 1997, ENVIRON SCI TECHNOL, V31, P2020, DOI 10.1021/es960817l; MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602; Myasoedov BF, 1998, J ALLOY COMPD, V271, P216, DOI 10.1016/S0925-8388(98)00057-7; Neck V, 2001, RADIOCHIM ACTA, V89, P1, DOI 10.1524/ract.2001.89.1.001; NOVIKOV AP, 1996, 4698011 LBNL, P42; PENROSE WR, 1990, ENVIRON SCI TECHNOL, V24, P228, DOI 10.1021/es00072a012; PIERCE ML, 1980, ENVIRON SCI TECHNOL, V14, P214, DOI 10.1021/es60162a011; SANCHEZ AL, 1985, GEOCHIM COSMOCHIM AC, V49, P2297, DOI 10.1016/0016-7037(85)90230-3; Solodov IN, 1998, APPL GEOCHEM, V13, P921, DOI 10.1016/S0883-2927(98)00025-0; STUMM W, 1981, AQUATIC CHEM INTRO E, P627; Vitorge P, 2003, RADIOCHIM ACTA, V91, P623, DOI 10.1524/ract.91.11.623.23466	25	345	356	10	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					638	641		10.1126/science.1131307	http://dx.doi.org/10.1126/science.1131307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068260				2022-12-28	WOS:000241557800044
J	Valla, T; Fedorov, AV; Lee, J; Davis, JC; Gu, GD				Valla, T.; Fedorov, A. V.; Lee, Jinho; Davis, J. C.; Gu, G. D.			The ground state of the pseudogap in cuprate superconductors	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; COPPER-OXIDE SUPERCONDUCTORS; QUASI-PARTICLES; BI2SR2CACU2O8+DELTA; CA2-XNAXCUO2CL2; LA2-XBAXCUO4; SPINS	We present studies of the electronic structure of La(2-x)Ba(x)CuO(4), a system where the superconductivity is strongly suppressed as static spin and charge orders or "stripes" develop near the doping level of x = 1/8. Using angle-resolved photoemission and scanning tunneling microscopy, we detect an energy gap at the Fermi surface with magnitude consistent with d-wave symmetry and with linear density of states, vanishing only at four nodal points, even when superconductivity disappears at x = 1/8. Thus, the nonsuperconducting, striped state at x = 1/8 is consistent with a phase-incoherent d-wave superconductor whose Cooper pairs form spin-charge-ordered structures instead of becoming superconducting.	Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cornell University	Valla, T (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.	valla@bnl.gov	Valla, Tonica/ABD-7811-2021; Gu, Genda/D-5410-2013	Valla, Tonica/0000-0002-3237-9102; Gu, Genda/0000-0002-9886-3255; Fedorov, Alexei/0000-0003-3510-3117				Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Carlson E W, 2003, PHYS SUPERCONDUCTIVI, V2; Chen HD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187002; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; EMERY VJ, 1994, PHYSICA C, V235, P189, DOI 10.1016/0921-4534(94)91345-5; Franz M, 2004, SCIENCE, V305, P1410, DOI 10.1126/science.1099569; Franz M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.257003; Fujita M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064505; Granath M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167011; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Homes CC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.257002; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Lake B, 2001, SCIENCE, V291, P1759, DOI 10.1126/science.1056986; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; MOODENBAUGH AR, 1988, PHYS REV B, V38, P4596, DOI 10.1103/PhysRevB.38.4596; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Podolsky D, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094514; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; Sutherland M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147004; Tesanovic Z, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.217004; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; Tranquada JM, 1997, PHYS REV LETT, V78, P338, DOI 10.1103/PhysRevLett.78.338; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zhou XJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187001	31	214	214	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1914	1916		10.1126/science.1134742	http://dx.doi.org/10.1126/science.1134742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17110536	Green Submitted			2022-12-28	WOS:000242996800044
J	Oosterheert, JJ; Bonten, MJM; Schneider, MME; Buskens, E; Lammers, JWJ; Hustinx, WMN; Kramer, MHH; Prins, JM; Slee, PHTJ; Kaasjager, K; Hoepelman, AIM				Oosterheert, Jan Jelrik; Bonten, Marc J. M.; Schneider, Margriet M. E.; Buskens, Erik; Lammers, Jan-Willem J.; Hustinx, Willem M. N.; Kramer, Mark H. H.; Prins, Jan M.; Slee, Peter H. Th. J.; Kaasjager, Karin; Hoepelman, Andy I. M.			Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITALIZED-PATIENTS; PRACTICE GUIDELINE; THERAPY; DISCHARGE; INFECTIONS; DIAGNOSIS; DURATION; OUTCOMES; COST; RISK	Objectives To compare the effectiveness of an early switch to oral antibiotics with the standard 7 day course of intravenous antibiotics in severe community acquired pneumonia. Design Multicentre randomised controlled trial. Setting Five teaching hospitals and 2 university medical centres in the Netherlands. Participants 302 patients in non-intensive care wards with severe community acquired pneumonia. 265 patients fulfilled the stud), requirements. Intervention Three days of treatment with intravenous antibiotics followed, when clinically stable, by oral antibiotics or by 7 days of intravenous antibiotics. Main outcome measures Clinical cure and length of hospital stays Results 302 patients were randomised. (mean age 69.5 (standard deviation 14.0), mean pneumonia severity score 112.7 (26.0)). 37 patients were excluded from analysis because of early dropout before day 3, leaving 265 patients for intention to treat analysis. Mortality at clay 28 was 4% in the intervention group and 6% in the control group (mean difference 2%,95% confidence interval - 3% to 8%). Clinical cure was 83% in the intervention group and 85% in the control group (2%, - 7% to 10%). Duration of intravenous treatment and length of hospital stay were reduced in the intervention group, with mean differences of 3.4 days (3.6 (1.5) v 7.0 (2.0) days; 2.8 to 3.9) and 1.9 days (9.6 (5.0) v 11.5 (4.9) days; 0.6 to 3.2), respectively Conclusions Early switch from intravenous to oral antibiotics in patients with severe community acquired pneumonia is safe and decreases length of hospital stay by 2 days.	Univ Med Ctr, Dept Internal Med & Infect Dis, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr, Dept Pulmonol, NL-3508 GA Utrecht, Netherlands; Diakonessen Hosp, Dept Internal Med, Utrecht, Netherlands; Meander Med Ctr, Dept Internal Med, Amersfoort, Netherlands; Acad Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med & Aids, Amsterdam, Netherlands; St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands; Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; Meander Medisch Centrum; University of Amsterdam; Academic Medical Center Amsterdam; St. Antonius Hospital Utrecht; Rijnstate Hospital	Hoepelman, AIM (corresponding author), Univ Med Ctr, Dept Internal Med & Infect Dis, POB 85500, NL-3508 GA Utrecht, Netherlands.	i.m.hoepelman@umcutrecht.nl	Prins, Jan M./AAF-4945-2020; Kramer, Mark/GWQ-3502-2022	buskens, erik/0000-0002-6463-1106; Oosterheert, Jan Jelrik/0000-0001-6146-3808				Castro-Guardiola A, 2001, AM J MED, V111, P367, DOI 10.1016/S0002-9343(01)00868-3; CHOW AW, 1992, CLIN INFECT DIS, V15, pS62, DOI 10.1093/clind/15.Supplement_1.S62; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Guest JF, 1997, EUR RESPIR J, V10, P1530, DOI 10.1183/09031936.97.10071530; Halm EA, 2002, ARCH INTERN MED, V162, P1278, DOI 10.1001/archinte.162.11.1278; JACOBS E, 1993, CLIN INFECT DIS, V17, pS79, DOI 10.1093/clinids/17.Supplement_1.S79; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Marston Barbara J., 1997, Archives of Internal Medicine, V157, P1709, DOI 10.1001/archinte.157.15.1709; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Omidvari K, 1998, RESP MED, V92, P1032, DOI 10.1016/S0954-6111(98)90351-1; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Ramirez JA, 2001, ARCH INTERN MED, V161, P848, DOI 10.1001/archinte.161.6.848; Ramirez JA, 1999, ARCH INTERN MED, V159, P2449, DOI 10.1001/archinte.159.20.2449; RAMIREZ JA, 1995, ARCH INTERN MED, V155, P1273, DOI 10.1001/archinte.155.12.1273; Rhew DC, 2001, MED CLIN N AM, V85, P1427, DOI 10.1016/S0025-7125(05)70389-8; Rhew DC, 1998, CHEST, V114, P115, DOI 10.1378/chest.114.1.115; Siegel RE, 1996, CHEST, V110, P965, DOI 10.1378/chest.110.4.965; Stout JE, 1997, NEW ENGL J MED, V337, P682, DOI 10.1056/NEJM199709043371006; van der Eerden MM, 2004, CLIN THER, V26, P294, DOI 10.1016/S0149-2918(04)90028-8; van Kasteren M E, 1998, Ned Tijdschr Geneeskd, V142, P952; Weingarten SR, 1996, AM J RESP CRIT CARE, V153, P1110, DOI 10.1164/ajrccm.153.3.8630553	21	122	131	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1193	1195		10.1136/bmj.38993.560984.BE	http://dx.doi.org/10.1136/bmj.38993.560984.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17090560	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000243009600014
J	Hochman, JS; Lamas, GA; Buller, CE; Dzavik, V; Reynolds, HR; Abramsky, SJ; Forman, S; Ruzyllo, W; Maggioni, AP; White, H; Sadowski, Z; Carvalho, AC; Rankin, JM; Renkin, JP; Steg, PG; Mascette, AM; Sopko, G; Pfisterer, ME; Leor, J; Fridrich, V; Mark, DB; Knatterud, GL				Hochman, Judith S.; Lamas, Gervasio A.; Buller, Christopher E.; Dzavik, Vladimir; Reynolds, Harmony R.; Abramsky, Staci J.; Forman, Sandra; Ruzyllo, Witold; Maggioni, Aldo P.; White, Harvey; Sadowski, Zygmunt; Carvalho, Antonio C.; Rankin, Jamie M.; Renkin, Jean P.; Steg, P. Gabriel; Mascette, Alice M.; Sopko, George; Pfisterer, Matthias E.; Leor, Jonathan; Fridrich, Viliam; Mark, Daniel B.; Knatterud, Genell L.		Occluded Artery Trial Invest	Coronary intervention for persistent occlusion after myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT-ELEVATION; LEFT-VENTRICULAR FUNCTION; RANDOMIZED CONTROLLED-TRIAL; REPERFUSION THERAPY; GLOBAL REGISTRY; EVENTS GRACE; BLOOD-FLOW; ARTERY; ANGIOPLASTY; RECANALIZATION	BACKGROUND: It is unclear whether stable, high-risk patients with persistent total occlusion of the infarct-related coronary artery identified after the currently accepted period for myocardial salvage has passed should undergo percutaneous coronary intervention (PCI) in addition to receiving optimal medical therapy to reduce the risk of subsequent events. METHODS: We conducted a randomized study involving 2166 stable patients who had total occlusion of the infarct-related artery 3 to 28 days after myocardial infarction and who met a high-risk criterion (an ejection fraction of <50% or proximal occlusion). Of these patients, 1082 were assigned to routine PCI and stenting with optimal medical therapy, and 1084 were assigned to optimal medical therapy alone. The primary end point was a composite of death, myocardial reinfarction, or New York Heart Association (NYHA) class IV heart failure. RESULTS: The 4-year cumulative primary event rate was 17.2% in the PCI group and 15.6% in the medical therapy group (hazard ratio for death, reinfarction, or heart failure in the PCI group as compared with the medical therapy group, 1.16; 95% confidence interval [CI], 0.92 to 1.45; P=0.20). Rates of myocardial reinfarction (fatal and nonfatal) were 7.0% and 5.3% in the two groups, respectively (hazard ratio, 1.36; 95% CI, 0.92 to 2.00; P=0.13). Rates of nonfatal reinfarction were 6.9% and 5.0%, respectively (hazard ratio, 1.44; 95% CI, 0.96 to 2.16; P=0.08); only six reinfarctions (0.6%) were related to assigned PCI procedures. Rates of NYHA class IV heart failure (4.4% vs. 4.5%) and death (9.1% vs. 9.4%) were similar. There was no interaction between treatment effect and any subgroup variable (age, sex, race or ethnic group, infarct-related artery, ejection fraction, diabetes, Killip class, and the time from myocardial infarction to randomization). CONCLUSIONS: PCI did not reduce the occurrence of death, reinfarction, or heart failure, and there was a trend toward excess reinfarction during 4 years of follow-up in stable patients with occlusion of the infarct-related artery 3 to 28 days after myocardial infarction.	NYU, Sch Med, Cardiovasc Clin Res Ctr, Leon Charney Div Cardiol, New York, NY 10016 USA; Mt Sinai Med Ctr, Miami Beach, FL 33140 USA; Vancouver Gen Hosp, Vancouver, BC, Canada; Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; Maryland Med Res Inst, Baltimore, MD USA; Natl Inst Cardiol, Warsaw, Poland; Italian Assoc Hosp Cardiologists Res Ctr, Florence, Italy; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; Hosp Sao Paulo, Sao Paulo, Brazil; Royal Perth Hosp, Perth, WA, Australia; Clin Univ St Luc, B-1200 Brussels, Belgium; Hop Bichat, F-75877 Paris, France; NHLBI, Bethesda, MD 20892 USA; Univ Hosp, Basel, Switzerland; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Slovak Inst Cardiovasc Dis, Bratislava, Slovakia; Duke Clin Res Inst, Durham, NC USA	New York University; Mount Sinai Medical Center; University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Institute of Cardiology - Poland; Auckland City Hospital; Royal Perth Hospital; University of Western Australia; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Chaim Sheba Medical Center; Duke University	Hochman, JS (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, Leon Charney Div Cardiol, 530 1st Ave,HCC 1173, New York, NY 10016 USA.		Leor, Jonathan/O-2930-2017; Maggioni, Aldo Pietro/AAL-5334-2020; STEG, Philippe Gabriel/Z-1567-2019; Reynolds, Harmony/AAU-3154-2021; Reynolds, Harmony/M-4818-2013; Leor, Jonathan/T-8038-2019	Maggioni, Aldo Pietro/0000-0003-2764-6779; Reynolds, Harmony/0000-0003-0284-0655; STEG, Philippe Gabriel/0000-0001-6896-2941; Mark, Daniel/0000-0001-6340-8087; Hochman, Judith/0000-0002-5889-5981	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067683, U01HL062257, U01HL062511, U01HL062509] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL062509-03, U01 HL062257, R01 HL067683, U01 HL062511, U01 HL062509-02, U01 HL062509-05S1, R01 HL67683, U01 HL062509, U01 HL062509-05, U01 HL062509-01A1, U01 HL062509-04] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Berger AK, 1998, AM HEART J, V135, P349, DOI 10.1016/S0002-8703(98)70104-8; CIGARROA RG, 1989, AM J CARDIOL, V64, P155, DOI 10.1016/0002-9149(89)90449-9; Cohen M, 2003, CIRCULATION, V108, P14, DOI 10.1161/01.CIR.0000086952.14979.32; COX DR, 1972, J R STAT SOC B, V34, P187; DZAVIK V, 1994, AM J CARDIOL, V73, P856, DOI 10.1016/0002-9149(94)90809-5; DZAVIK V, IN PRESS CIRCULATION; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Fox KAA, 2003, EUR HEART J, V24, P1414, DOI 10.1016/S0195-668X(03)00315-4; GALVANI M, 1993, AM J CARDIOL, V71, P1, DOI 10.1016/0002-9149(93)90700-M; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Hochman JS, 2005, AM HEART J, V150, P627, DOI 10.1016/j.ahj.2005.07.002; HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299; Horie H, 1998, CIRCULATION, V98, P2377, DOI 10.1161/01.CIR.98.22.2377; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAMAS GA, 1995, CIRCULATION, V92, P1101, DOI 10.1161/01.CIR.92.5.1101; MEIJER A, 1994, CIRCULATION, V90, P1706, DOI 10.1161/01.CIR.90.4.1706; Monteiro Pedro, 2003, Rev Port Cardiol, V22, P1051; NORDMANN AJ, IN PRESS EUR HEART J; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PFISTERER ME, IN PRESS J AM COLL C; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Porto I, 2006, CIRCULATION, V114, P662, DOI 10.1161/CIRCULATIONAHA.105.593210; Puma JA, 1999, AM J CARDIOL, V83, P482, DOI 10.1016/S0002-9149(98)00899-6; SABIA PJ, 1992, NEW ENGL J MED, V327, P1825, DOI 10.1056/NEJM199212243272601; Silva JC, 2005, EUR HEART J, V26, P36, DOI 10.1093/eurheartj/ehi011; Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045; Smith SC, 2001, CIRCULATION, V103, P3019, DOI 10.1161/01.CIR.103.24.3019; Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; TOPOL EJ, 1992, CIRCULATION, V85, P2090, DOI 10.1161/01.CIR.85.6.2090; *TRIAL INV, 2001, NEW ENGL J MED, V345, P1716; *TRIAL INV, 2001, NEW ENGL J MED, V345, P1506; Werner GS, 2003, CIRCULATION, V108, P2877, DOI 10.1161/01.CIR.0000100724.44398.01; White HD, 1998, EUR HEART J, V19, P1132, DOI 10.1053/euhj.1998.1017; Yousef ZR, 2002, J AM COLL CARDIOL, V40, P869, DOI 10.1016/S0735-1097(02)02058-2; Yusuf S, 2001, NEW ENGL J MED, V345, P494	41	479	532	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2395	2407		10.1056/NEJMoa066139	http://dx.doi.org/10.1056/NEJMoa066139			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17105759	Green Accepted			2022-12-28	WOS:000242581400004
J	Iverson, RM; Dzurisin, D; Gardner, CA; Gerlach, TM; LaHusen, RG; Lisowski, M; Major, JJ; Malone, SD; Messerich, JA; Moran, SC; Pallister, JS; Qamar, AI; Schilling, SP; Vallance, JW				Iverson, Richard M.; Dzurisin, Daniel; Gardner, Cynthia A.; Gerlach, Terrence M.; LaHusen, Richard G.; Lisowski, Michael; Major, Jon J.; Malone, Stephen D.; Messerich, James A.; Moran, Seth C.; Pallister, John S.; Qamar, Anthony I.; Schilling, Steven P.; Vallance, James W.			Dynamics of seismogenic volcanic extrusion at Mount St Helens in 2004-05	NATURE			English	Article							ANDESITE VOLCANOS; MAGMATIC SYSTEM; ERUPTIONS; SEISMICITY; WASHINGTON; MODEL	The 2004-05 eruption of Mount St Helens exhibited sustained, near-equilibrium behaviour characterized by relatively steady extrusion of a solid dacite plug and nearly periodic shallow earthquakes. Here we present a diverse data set to support our hypothesis that these earthquakes resulted from stick-slip motion along the margins of the plug as it was forced incrementally upwards by ascending, solidifying, gas-poor magma. We formalize this hypothesis with a dynamical model that reveals a strong analogy between behaviour of the magma-plug system and that of a variably damped oscillator. Modelled stick-slip oscillations have properties that help constrain the balance of forces governing the earthquakes and eruption, and they imply that magma pressure never deviated much from the steady equilibrium pressure. We infer that the volcano was probably poised in a near-eruptive equilibrium state long before the onset of the 2004-05 eruption.	US Geol Survey, Cascades Volcano Observ, Vancouver, WA 98683 USA; Univ Washington, Seattle, WA 98195 USA; US Geol Survey, Denver Fed Ctr, Lakewood, CO 80225 USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey	Iverson, RM (corresponding author), US Geol Survey, Cascades Volcano Observ, 1300 SE Cardinal Ct 100, Vancouver, WA 98683 USA.	riverson@usgs.gov; dzurisin@usgs.gov; cgardner@usgs.gov		Major, Jon/0000-0003-2449-4466; Pallister, John/0000-0002-2041-2147				Blundy J, 2001, CONTRIB MINERAL PETR, V140, P631, DOI 10.1007/s004100000219; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Denlinger RP, 1999, GEOLOGY, V27, P459, DOI 10.1130/0091-7613(1999)027<0459:CEBOSV>2.3.CO;2; DZURISIN D, 2005, EOS, V86, P29, DOI DOI 10.1029/2005EO030001.FERRAZZINI; Dzurisin D, 2005, EOS T AGU, V86, P25, DOI DOI 10.1029/2005EO030001; LAHR JC, 1994, J VOLCANOL GEOTH RES, V62, P137, DOI 10.1016/0377-0273(94)90031-0; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Mason RM, 2006, J VOLCANOL GEOTH RES, V153, P148, DOI 10.1016/j.jvolgeores.2005.08.011; MASTIN LG, 1994, GEOL SOC AM BULL, V106, P175, DOI 10.1130/0016-7606(1994)106<0175:ETEAMS>2.3.CO;2; MASTIN LG, 2000, 00209 USGS; McGee KA, 2001, GEOPHYS RES LETT, V28, P4479, DOI 10.1029/2001GL013250; Melnik O, 1999, NATURE, V402, P37, DOI 10.1038/46950; MOORE PL, UNPUB VOLCANO REKIND; MORAN SC, 1994, J GEOPHYS RES-SOL EA, V99, P4341, DOI 10.1029/93JB02993; MULLINEAUX DR, 1981, US GEOL SURV PROF PA, V1250, P3; Neuberg J, 2000, PHILOS T ROY SOC A, V358, P1533, DOI 10.1098/rsta.2000.0602; Newman S, 2002, COMPUT GEOSCI-UK, V28, P597, DOI 10.1016/S0098-3004(01)00081-4; Ozerov A, 2003, J VOLCANOL GEOTH RES, V122, P265, DOI 10.1016/S0377-0273(02)00506-1; PALLISTER JS, 2005, EOS, V86, P499; Press W., 1986, NUMERICAL RECIPES; RUTHERFORD MJ, 1993, EOS T AM GEOPHYS UN, V74, P49, DOI DOI 10.1029/93EO00142; Schilling SP, 2004, QUATERNARY RES, V61, P325, DOI 10.1016/j.yqres.2003.11.002; Sparks RSJ, 2000, PHILOS T R SOC A, V358, P1435, DOI 10.1098/rsta.2000.0596; SWANSON DA, 1990, IAVCEI VOLC, V2, P3; Tuffen H, 2005, B VOLCANOL, V67, P370, DOI 10.1007/s00445-004-0383-5; Voight B, 1999, SCIENCE, V283, P1138, DOI 10.1126/science.283.5405.1138; WALDER JS, 2005, EOS, V86, P528; WALDER JS, 2005, EOS, V86, P521, DOI DOI 10.1029/2005EO500002; YANG XM, 1988, J GEOPHYS RES-SOLID, V93, P4249, DOI 10.1029/JB093iB05p04249	29	147	147	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					439	443		10.1038/nature05322	http://dx.doi.org/10.1038/nature05322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122849				2022-12-28	WOS:000242215700037
J	Klibanski, A; Stephen, AE; Greene, MF; Blake, MA; Wu, CL; Utz, AL				Klibanski, Anne; Stephen, Antonia E.; Greene, Michael F.; Blake, Michael A.; Wu, Chin-Lee; Utz, Andrea L.			A pregnant woman with new hypertension - Cushing's syndrome due to adrenal cortical carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LAPAROSCOPIC ADRENALECTOMY; ADRENOCORTICAL TUMORS; DEXAMETHASONE-SUPPRESSION; METYRAPONE; PHEOCHROMOCYTOMA; HYPERCORTISOLISM; DIFFERENTIATION; COMPLICATIONS; DIAGNOSIS; CORTISOL		Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Obstet & Gynecol Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Klibanski, A (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA.							Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Assalia A, 2004, BRIT J SURG, V91, P1259, DOI 10.1002/bjs.4738; BUESCHER MA, 1992, OBSTET GYNECOL, V79, P130; CARR BR, 1981, AM J OBSTET GYNECOL, V139, P416, DOI 10.1016/0002-9378(81)90318-5; CLOSE CF, 1993, CLIN ENDOCRINOL, V39, P375, DOI 10.1111/j.1365-2265.1993.tb02380.x; CONNELL JMC, 1985, BRIT J OBSTET GYNAEC, V92, P1192, DOI 10.1111/j.1471-0528.1985.tb03037.x; Findling JW, 2004, J CLIN ENDOCR METAB, V89, P1222, DOI 10.1210/jc.2003-030207; GAGNER M, 1992, NEW ENGL J MED, V327, P1033; Gagner M, 1997, ANN SURG, V226, P238, DOI 10.1097/00000658-199709000-00003; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; Gonzalez R, 2004, AM SURGEON, V70, P668; GORMLEY MJJ, 1982, CLIN ENDOCRINOL, V16, P283, DOI 10.1111/j.1365-2265.1982.tb00718.x; Hana V, 2001, CLIN ENDOCRINOL, V54, P277, DOI 10.1046/j.1365-2265.2001.01055.x; HUNTER JG, 1995, SURG ENDOSC-ULTRAS, V9, P272; Lack EE, 1997, TUMORS ADRENAL GLAND, P91; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Lindsay JR, 2005, ENDOCR REV, V26, P775, DOI 10.1210/er.2004-0025; Lindsay JR, 2005, J CLIN ENDOCR METAB, V90, P3077, DOI 10.1210/jc.2004-2361; MEDEIROS LJ, 1992, AM J CLIN PATHOL, V97, P73; ODAGIRI E, 1988, ENDOCRINOL JAPON, V35, P685; OUTWATER EK, 1995, AM J ROENTGENOL, V165, P579, DOI 10.2214/ajr.165.3.7645474; Pabon JE, 1996, J CLIN ENDOCR METAB, V81, P2397, DOI 10.1210/jc.81.6.2397; Pickard J, 1990, Obstet Gynecol Surv, V45, P87, DOI 10.1097/00006254-199002000-00002; PRICOLO VE, 1990, SURGERY, V108, P1072; Raff H, 1998, J CLIN ENDOCR METAB, V83, P2681, DOI 10.1210/jc.83.8.2681; Reedy MB, 1997, AM J OBSTET GYNECOL, V177, P673, DOI 10.1016/S0002-9378(97)70163-7; Schmitt A, 2006, HISTOPATHOLOGY, V49, P298, DOI 10.1111/j.1365-2559.2006.02505.x; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P960, DOI 10.1016/0002-9378(90)91297-P; *SOC AM GASTR END, 2000, PUBL SOC AM GASTR EN; SOPER NJ, 1992, SURG ENDOSC-ULTRAS, V6, P115, DOI 10.1007/BF02309081; Varghese JC, 1997, CLIN RADIOL, V52, P603, DOI 10.1016/S0009-9260(97)80252-8; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001; Wolf A, 2004, EXP CLIN ENDOCR DIAB, V112, P98, DOI 10.1055/s-2004-815764	34	25	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2237	2245		10.1056/NEJMcpc069027	http://dx.doi.org/10.1056/NEJMcpc069027			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124022				2022-12-28	WOS:000242170900012
J	Cleland, J; Ali, MM				Cleland, John; Ali, Mohamed M.			Sexual abstinence, contraception, and condom use by young African women: a secondary analysis of survey data	LANCET			English	Article							BALANCED ABC APPROACH; PARTNER REDUCTION; AIDS-PREVENTION; HIV-INFECTION; BEHAVIOR; RISK; COUNTRIES; VIOLENCE	Background Drug therapy for people with AIDS is a humanitarian priority but prevention of HIV infection remains essential. Focusing on young single African women, we aimed to assess trends in a set of behaviours-sexual abstinence, Contraceptive use, and condom use-that are known to affect the rates of HIV transmission. Methods We did a secondary analysis of public-access data sets in 18 African countries (132 800 women), and calculated changes in a set of behavioural. indicators over time. We standardised these trends from nationally representative surveys to adjust for within-country changes in age, education, and type of residential location. Findings Between about 1993 and 2001, the percentage of women reporting no sexual experience changed little. During the same period, the percentage of sexually experienced women who reported no sexual intercourse in the previous 3 months (secondary abstinence) rose significantly in seven of 18 countries and the median for all 18 countries increased from 43.8% to 49.2%. Use of condoms for pregnancy prevention rose significantly in 13 of 18 countries and the median proportion increased from 5.3% to 18.8%. The median rate of annual increase of condom use was 1.41 percentage points (95% CI 1.12-2.25). In the 13 countries with available data, condom use at most recent coitus rose from a median of 19.3% to 28.4%. Over half (58.5%) of condom users were motivated, at least in part, by a wish to avoid pregnancy. Interpretation Condom promotion campaigns in sub-Saharan Africa have affected the behaviour of young single women; the pace of change has matched the rise in contraceptive use by married couples in developing countries over recent decades. Thus continuing efforts to promote condom use with emphasis on pregnancy prevention are justified.	London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1B 3DP, England; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Cleland, J (corresponding author), London Sch Hyg & Trop Med, Ctr Populat Studies, 49-51 Bedford Sq, London WC1B 3DP, England.	John.Cleland@lshtm.ac.uk	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016				AHMAN E, 2004, UNSAFE ABORTION GLOB; Ali MM, 2005, SOC SCI MED, V60, P1175, DOI 10.1016/j.socscimed.2004.07.002; Bass E, 2005, LANCET, V365, P2077, DOI 10.1016/S0140-6736(05)66717-7; Blum RW, 2004, J ADOLESCENT HEALTH, V34, P428, DOI [10.1016/j.jadohealth.2003.09.022, 10.1016/S1054-139X(03)00543-3]; Castle S, 2003, STUD FAMILY PLANN, V34, P186, DOI 10.1111/j.1728-4465.2003.00186.x; Che Y, 2004, CONTRACEPTION, V69, P15, DOI 10.1016/j.contraception.2003.08.006; Cleland J, 2006, AIDS, V20, P1, DOI 10.1097/01.aids.0000194135.35758.cd; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Das P, 2005, LANCET INFECT DIS, V5, P263, DOI 10.1016/S1473-3099(05)70097-9; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Genuis SJ, 2004, BMJ-BRIT MED J, V328, P894, DOI 10.1136/bmj.328.7444.894; Global HIV Prevention Working Group, 2004, HIV PREV ER EXP TREA; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Jemmott JB, 2000, AIDS, V14, pS40; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kim JC, 2005, BMJ-BRIT MED J, V331, P769, DOI 10.1136/bmj.331.7519.769; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; Lesthaeghe RonJ., 1994, NUPTIALITY SUBSAHARA, P25; Mayhew SH, 2004, HEALTH POLICY PLANN, V19, pI50, DOI 10.1093/heapol/czh045; Meekers D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-5; Myer L, 2002, INT J STD AIDS, V13, P62; OAKLEY A, 1995, AIDS, V9, P479, DOI 10.1097/00002030-199509050-00010; *ORC MACR, MEASURE DHS STATCOMP; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; SHAH I, 2004, REPROD HEALTH MATTER, V24, P9; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P13, DOI 10.1136/sti.2004.011635; Stephenson JM, 2000, AIDS, V14, pS115; *UN POP DIV, 1999, LEV TRENDS CONTR US; UNAIDS, 2005, INT HIV PREV; *US AID, MEASURE EV PROJ; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013; *WHO JOINT UN PROG, 2005, AIDS EP UPD	35	94	95	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1788	1793		10.1016/S0140-6736(06)69738-9	http://dx.doi.org/10.1016/S0140-6736(06)69738-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113428				2022-12-28	WOS:000242225400032
J	Burgoyne, CB; Lea, SEG				Burgoyne, Carole B.; Lea, Stephen E. G.			Psychology - Money is material	SCIENCE			English	Editorial Material							ILLUSION		Univ Exeter, Sch Psychol, Exeter EX4 4QG, Devon, England	University of Exeter	Burgoyne, CB (corresponding author), Univ Exeter, Sch Psychol, Exeter EX4 4QG, Devon, England.	s.e.g.lea@exeter.ac.uk	Lea, Stephen/B-4811-2009					Altman M., 2006, HDB CONT BEHAV EC; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; BELK RW, 1990, J ECON PSYCHOL, V11, P35, DOI 10.1016/0167-4870(90)90046-C; BURGOYNE CB, 1991, J ECON PSYCHOL, V12, P47, DOI 10.1016/0167-4870(91)90043-S; Burroughs JE, 2002, J CONSUM RES, V29, P348, DOI 10.1086/344429; CASKEY JP, 1994, J MONEY CREDIT BANK, V26, P495, DOI 10.2307/2078014; Davis J. B., 2006, J I ECON, V1, P1, DOI [10.1017/S1744137405000263, DOI 10.1017/S1744137405000263]; Fehr E, 2001, AM ECON REV, V91, P1239, DOI 10.1257/aer.91.5.1239; Fiske AP, 1997, POLIT PSYCHOL, V18, P255, DOI 10.1111/0162-895X.00058; Furnham Adrian., 1998, PSYCHOL MONEY; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Grierson P., 1978, RES EC ANTHR, V1, P1; Grouzet FME, 2005, J PERS SOC PSYCHOL, V89, P800, DOI 10.1037/0022-3514.89.5.800; Kagel JH, 1995, HDB EXPT EC; Lea SEG, 2006, BEHAV BRAIN SCI, V29, P161; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Ranyard R, 2005, J COMMUNITY APPL SOC, V15, P95, DOI 10.1002/casp.814; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shafir E, 1997, Q J ECON, V112, P341, DOI 10.1162/003355397555208; Srivastava A, 2001, J PERS SOC PSYCHOL, V80, P959, DOI 10.1037/0022-3514.80.6.959; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Webley P., 2001, EC PSYCHOL EVERYDAY; Zelizer VA, 1996, SOCIOL FORUM, V11, P481, DOI 10.1007/BF02408389	24	20	21	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1091	1092		10.1126/science.1135429	http://dx.doi.org/10.1126/science.1135429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105PW	17110558				2022-12-28	WOS:000242045800024
J	Fujita, T				Fujita, Takashi			Virology - Sensing viral RNA amid your own	SCIENCE			English	Editorial Material							RIG-I; ANTIVIRAL RESPONSES; INFLUENZA-A; PROTEIN; VIRUSES; PATHWAY		Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan	Kyoto University	Fujita, T (corresponding author), Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp						Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	8	14	16	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					935	936		10.1126/science.1135756	http://dx.doi.org/10.1126/science.1135756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095686				2022-12-28	WOS:000241896000035
J	Kazantseva, A; Goltsov, A; Zinchenko, R; Grigorenko, AP; Abrukova, AV; Moliaka, YK; Kirillov, AG; Guo, ZR; Lyle, S; Ginter, EK				Kazantseva, Anastasiya; Goltsov, Andrey; Zinchenko, Rena; Grigorenko, Anastasia P.; Abrukova, Anna V.; Moliaka, Yuri K.; Kirillov, Alexander G.; Guo, Zhiru; Lyle, Stephen; Ginter, Evgeny K.			Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH	SCIENCE			English	Article							LYSOPHOSPHATIDIC ACID; STEM-CELLS; CATALYTIC TRIAD; HYPOTRICHOSIS; DIFFERENTIATION; ALOPECIA; A(1); SKIN	The molecular mechanisms controlling human hair growth and scalp hair loss are poorly understood. By screening about 350,000 individuals in two populations from the Volga-Ural region of Russia, we identified a gene mutation in families who show an inherited form of hair loss and a hair growth defect. Affected individuals were homozygous for a deletion in the LIPH gene on chromosome 3q27, caused by short interspersed nuclear element - retrotransposon - mediated recombination. The LIPH gene is expressed in hair follicles and encodes a phospholipase called lipase H ( alternatively known as membrane-associated phosphatidic acid - selective phospholipase A1 alpha), an enzyme that regulates the production of bioactive lipids. These results suggest that lipase H participates in hair growth and development.	Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; Russian Acad Med Sci, Mental Hlth Res Ctr, Lab Mol Brain Genet, Moscow 113152, Russia; Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119992, Russia; Russian Acad Med Sci, Natl Res Ctr Med Genet, Moscow 109801, Russia; GUZ Presidents Prenatal Ctr Chuvash Republ, Cheboksary, Russia; Minist Hlth & Social Dev Chuvash Republ, Cheboksary, Russia; Univ Massachusetts, Sch Med, Dept Canc Biol & Pathol, Worcester, MA 01605 USA; Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia	University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Medical Sciences; Lomonosov Moscow State University; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Ministry of Health of the Russian Federation; University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences; Vavilov Institute of General Genetics	Kazantseva, A (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	Evgeny.Rogaev@umassmed.edu	Kazantseva, Anastasiya/E-7351-2014; Zinchenko, Rena A/A-9554-2016; Rogaev, Evgeny/AAN-7662-2020; Grigorenko, Anastasia/AAN-8226-2020	Zinchenko, Rena A/0000-0003-3586-3458; 	NIAMS NIH HHS [K08-AR02179] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002179] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; CHOI S, 2004, AM J PHYSL GAST 0802; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Hiraoka M, 2005, J LIPID RES, V46, P2441, DOI 10.1194/jlr.M500248-JLR200; Jin WJ, 2002, GENOMICS, V80, P268, DOI 10.1006/geno.2002.6837; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kubiak RJ, 2001, BIOCHEMISTRY-US, V40, P5422, DOI 10.1021/bi002371y; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Lyle S, 1998, J CELL SCI, V111, P3179; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; PIAZZA GA, 1995, EXP CELL RES, V216, P51, DOI 10.1006/excr.1995.1007; Rogaev EI, 1999, LANCET, V354, P1097, DOI 10.1016/S0140-6736(99)02816-0; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209	22	152	162	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					982	985		10.1126/science.1133276	http://dx.doi.org/10.1126/science.1133276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095700				2022-12-28	WOS:000241896000050
J	Gill, CJ				Gill, Christopher J.			Antiretroviral programme in rural Uganda	LANCET			English	Editorial Material							THERAPY		Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA	Boston University	Gill, CJ (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA.	cgill@bu.edu		gill, christopher/0000-0003-3353-0617				Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; Rosen S, 2005, LANCET, V365, P354, DOI 10.1016/S0140-6736(05)70202-6; Sackett DL, 1976, COMPLIANCE THERAPEUT; UNAIDS, 2006, REP GLOB AIDS EP; WEIDLE PJ, 2006, LANCET          0804, DOI DOI 10.1016/S0140-6736(06)69118-6	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1556	1557		10.1016/S0140-6736(06)69119-8	http://dx.doi.org/10.1016/S0140-6736(06)69119-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084742				2022-12-28	WOS:000242180900008
J	Langer, A				Langer, Ana			Cairo after 12 years: successes, setbacks, and challenges	LANCET			English	Editorial Material									EngenderHlth, New York, NY 10001 USA		Langer, A (corresponding author), EngenderHlth, New York, NY 10001 USA.	alanger@engenderhealth.org						Cohen SA., 2004, GUTTMACHER REP PUBLI, V7, P5; FATHALLA MF, 2006, LANCET          1101; GLASIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; GWATKIN D, 2004, COUNTDOWN 2015 SEXUA; GWATKIN DR, 2004, INITIAL COUNTRY LEVE; Haslegrave M, 2005, REPROD HEALTH MATTER, V13, P106, DOI 10.1016/S0968-8080(05)25186-8; Macro International, DEM HLTH SURV DHS; *POP ACT INT, 2001, DAT SOURC METH; *POP COUNC, 2003, HORIZONS REP     DEC; *UN MILL PROJ, 2006, PUBL CHOIC PRIV DEC; *UN POPIN, 1994, INT C POP DEV CAIR S; UNFPA, 2005, STAT WORLD POP 2005; UNFPA, 2004, NEW YORK CALL COMM L; *WHO, 2006, GLOB MON EV DAT; WHO, 2004, GLION CALL ACT FAM P; 2006, FDA NEWS        0608	16	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1552	1554		10.1016/S0140-6736(06)69486-5	http://dx.doi.org/10.1016/S0140-6736(06)69486-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107OM	17084740				2022-12-28	WOS:000242180900006
J	van Rheenen, PF; Brabin, BJ				van Rheenen, Patrick F.; Brabin, Bernard J.			A practical approach to timing cord clamping in resource poor settings	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; UMBILICAL-CORD; PLACENTAL TRANSFUSION; PRETERM INFANTS; DEVELOPING-COUNTRIES; LEBOYER CHILDBIRTH; IRON-DEFICIENCY; BLOOD-VISCOSITY; TERM INFANTS; FETAL ANEMIA		Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, NL-9700 RB Groningen, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands	University of Groningen; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	van Rheenen, PF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, POB 30001, NL-9700 RB Groningen, Netherlands.	p.f.vanrheenen@gmail.com	Brabin, Bernard/AAJ-7389-2020	Brabin, Bernard/0000-0001-6860-2508; /0000-0003-3867-2665				Aladangady N, 2006, PEDIATRICS, V117, P93, DOI 10.1542/peds.2004-1773; [Anonymous], 2004, COCHRANE REV HDB 4 2; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Begley C M, 1990, Midwifery, V6, P3, DOI 10.1016/S0266-6138(05)80091-9; Bhutta ZA, 1999, PEDIATR PULM, V27, P305, DOI 10.1002/(SICI)1099-0496(199905)27:5<305::AID-PPUL2>3.0.CO;2-Q; Brabin B, 2003, T ROY SOC TROP MED H, V97, P36, DOI 10.1016/S0035-9203(03)90014-9; BRABIN B, 1992, ANN TROP PAEDIATR, V12, P303, DOI 10.1080/02724936.1992.11747589; Brabin BJ, 2004, ANN TROP PAEDIATR, V24, P311, DOI 10.1179/027249304225019136; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Cernadas JMC, 2006, PEDIATRICS, V117, pE779, DOI 10.1542/peds.2005-1156; Chaparro CM, 2006, LANCET, V367, P1997, DOI 10.1016/S0140-6736(06)68889-2; CHOCKALINGAM UM, 1987, J PEDIATR-US, V111, P283, DOI 10.1016/S0022-3476(87)80088-4; COTTER A, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001808, DOI 10.1002/14651858.CD001808]; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Emhamed MO, 2004, TROP DOCT, V34, P218, DOI 10.1177/004947550403400410; Geethanath R M, 1997, Indian Pediatr, V34, P103; Grajeda R, 1997, AM J CLIN NUTR, V65, P425, DOI 10.1093/ajcn/65.2.425; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Gupta Rajesh, 2002, Indian Pediatr, V39, P130; Hay WW., 1999, NEONATOLOGY PATHOPHY, P411; HOFMEYR GJ, 1993, ONLINE J CURR CLIN T, V110, P2002; Kambarami R., 2000, Central African Journal of Medicine, V46, P205; Khan GQ, 1997, AM J OBSTET GYNECOL, V177, P770, DOI 10.1016/S0002-9378(97)70266-7; KINMOND S, 1993, BMJ-BRIT MED J, V306, P172, DOI 10.1136/bmj.306.6871.172; Lalonde A, 2006, INT J GYNECOL OBSTET, V94, P243, DOI 10.1016/j.ijgo.2006.04.016; LANZKOWSKY P, 1960, BRIT MED J, V2, P1777, DOI 10.1136/bmj.2.5215.1777; le Cessie S, 2002, ARCH DIS CHILD-FETAL, V86, P182, DOI 10.1136/fn.86.3.F182; LINDERKAMP O, 1992, ACTA PAEDIATR, V81, P745, DOI 10.1111/j.1651-2227.1992.tb12095.x; LINDERKAMP O, 1982, CLIN PERINATOL, V9, P559, DOI 10.1016/S0095-5108(18)31013-3; McDonnell M, 1997, J PAEDIATR CHILD H, V33, P308, DOI 10.1111/j.1440-1754.1997.tb01606.x; Mercer JS, 2006, PEDIATRICS, V117, P1235, DOI 10.1542/peds.2005-1706; Mercer Judith S, 2003, J Perinatol, V23, P466, DOI 10.1038/sj.jp.7210970; MONDKAR FA, 1993, J POSTGRAD MED, V39, P57; NELLE M, 1995, AM J PERINAT, V12, P212, DOI 10.1055/s-2007-994455; NELLE M, 1993, AM J OBSTET GYNECOL, V169, P189, DOI 10.1016/0002-9378(93)90161-B; Nelle M, 1996, J PERINAT MED, V24, P513, DOI 10.1515/jpme.1996.24.5.513; PAOCHEN W, 1960, CHIN MED J, V80, P351; Perlman JM, 2006, PEDIATRICS, V117, pE978, DOI 10.1542/ped.2006-0350; PRENDIVILLE WJ, 1988, BMJ-BRIT MED J, V297, P1295, DOI 10.1136/bmj.297.6659.1295; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Rabe H, 2000, EUR J PEDIATR, V159, P775, DOI 10.1007/PL00008345; Rogers J, 1998, LANCET, V351, P693, DOI 10.1016/S0140-6736(97)09409-9; SAIGAL S, 1972, PEDIATRICS, V49, P406; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; van Eijk AM, 2002, AM J TROP MED HYG, V67, P44, DOI 10.4269/ajtmh.2002.67.44; Van Rheenen P, 2004, ANN TROP PAEDIATR, V24, P3, DOI 10.1179/027249304225013286; van Rheenen PF, 2006, ANN TROP PAEDIATR, V26, P157, DOI 10.1179/146532806X120246; VANRHEENEN PF, DELAYED CORD CLAMPIN; WARDROP CAJ, 1995, J PERINAT MED, V23, P139, DOI 10.1515/jpme.1995.23.1-2.139; YAO AC, 1969, LANCET, V2, P505; YAO AC, 1974, AM J DIS CHILD, V127, P128, DOI 10.1001/archpedi.1974.02110200130021; YAO AC, 1974, BIOL NEONATE, V25, P186; YAO AC, 1968, LANCET, V1, P380; YAO AC, 1969, LANCET, V2, P871	54	44	44	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2006	333	7575					954	958B		10.1136/bmj.39002.389236.BE	http://dx.doi.org/10.1136/bmj.39002.389236.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107GE	17082547	Green Published			2022-12-28	WOS:000242157900022
J	Skordalakes, E; Berger, JM				Skordalakes, Emmanuel; Berger, James M.			Structural insights into RNA-dependent ring closure and ATPase activation by the Rho termination factor	CELL			English	Article							HELICASE DNAB PROTEIN; TRANSCRIPTION-TERMINATION; CRYSTAL-STRUCTURE; BINDING DOMAIN; CONFORMATIONAL-CHANGES; SEQUENTIAL HYDROLYSIS; PHYSICAL-PROPERTIES; MECHANISM; CRYSTALLOGRAPHY; RECOGNITION	Hexameric helicases and translocases are required for numerous essential nucleic-acid transactions. To better understand the mechanisms by which these enzymes recognize target substrates and use nucleotide hydrolysis to power molecular movement, we have determined the structure of the Rho transcription termination factor, a hexameric RNA/DNA helicase, with single-stranded RNA bound to the motor domains of the protein. The structure reveals a closed-ring "trimer of dimers" conformation for the hexamer that contains an unanticipated arrangement of conserved loops required for nucleic-acid translocation. RNA extends across a shallow intersubunit channel formed by conserved amino acids required for RNA-stimulated ATP hydrolysis and translocation and directly contacts a conserved lysine, just upstream of the catalytic GKT triad, in the phosphate-binding (P loop) motif of the ATP-binding pocket. The structure explains the molecular effects of numerous mutations and provides new insights into the links between substrate recognition, ATP turnover, and coordinated strand movement.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 327B Hildebrand Hall 3206, Berkeley, CA 94720 USA.	jmberger@berkeley.edu	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALIFANO P, 1991, CELL, V64, P553; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujalowski W, 2000, BIOCHEMISTRY-US, V39, P2106, DOI 10.1021/bi992413m; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18802; ENGEL D, 1984, NUCLEIC ACIDS RES, V12, P7389, DOI 10.1093/nar/12.19.7389; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P121, DOI 10.1021/bi00116a018; GEISELMANN J, 1992, PROTEIN SCI, V1, P850, DOI 10.1002/pro.5560010703; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Horiguchi T, 1997, J MOL BIOL, V269, P514, DOI 10.1006/jmbi.1997.1059; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeong YJ, 2004, J BIOL CHEM, V279, P18370, DOI 10.1074/jbc.M309162200; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DE, 1999, J BIOL CHEM, V274, P32667, DOI 10.1074/jbc.274.46.32667; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Lisal J, 2005, J BIOL CHEM, V280, P23157, DOI 10.1074/jbc.M502658200; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RICHARDSON JP, 1986, J MOL BIOL, V189, P413, DOI 10.1016/0022-2836(86)90313-X; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Richardson JP, 1996, J BIOL CHEM, V271, P1251, DOI 10.1074/jbc.271.3.1251; RICHARDSON JP, 1980, BIOCHEMISTRY-US, V19, P4293, DOI 10.1021/bi00559a022; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SEIFRIED SE, 1991, J MOL BIOL, V221, P1139; SEIFRIED SE, 1992, P NATL ACAD SCI USA, V89, P10454, DOI 10.1073/pnas.89.21.10454; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Xu Y, 2002, J BIOL CHEM, V277, P30023, DOI 10.1074/jbc.M111009200; XU Y, 2000, J BIOL CHEM, V278, P1279; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	63	95	96	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					553	564		10.1016/j.cell.2006.08.051	http://dx.doi.org/10.1016/j.cell.2006.08.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081977	Bronze			2022-12-28	WOS:000241937000019
J	Yin, QZ; Jacobsen, SB				Yin, Qing-Zhu; Jacobsen, Stein B.			Geochemistry: Does U-Pb date Earth's core formation?	NATURE			English	Letter							HF-W CHRONOMETRY; TERRESTRIAL ACCRETION; TIMESCALE; SYSTEM		Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	University of California System; University of California Davis; Harvard University	Yin, QZ (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	yin@geology.ucdavis.edu	Yin, Qing-Zhu/B-8198-2009; Jacobsen, Stein/B-1759-2013; Jacobsen, Stein/ABA-1063-2021	Yin, Qing-Zhu/0000-0002-4445-5096; Jacobsen, Stein/0000-0003-2164-0720				Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Jacobsen SB, 2003, SCIENCE, V300, P1513, DOI 10.1126/science.1080682; Kleine T, 2005, SCIENCE, V310, P1671, DOI 10.1126/science.1118842; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Schoenberg R, 2002, GEOCHIM COSMOCHIM AC, V66, P3151, DOI 10.1016/S0016-7037(02)00911-0; Wood BJ, 2005, NATURE, V437, P1345, DOI 10.1038/nature04129; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	10	11	11	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115								10.1038/nature05358	http://dx.doi.org/10.1038/nature05358			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080033	Bronze			2022-12-28	WOS:000241701500039
J	Ioannidis, JPA				Ioannidis, John P. A.			Indirect comparisons: the mesh and mess of clinical trials	LANCET			English	Editorial Material							RANDOMIZED-TRIALS; COMPETING INTERVENTIONS; CONSORT STATEMENT; METAANALYSIS; EXTENSION; EFFICACY		Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University of Ioannina; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011					Bloomfield P, 2005, COCHRANE DB SYST REV, V1; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Ioannidis JPA, 2003, EUR J CANCER, V39, P2278, DOI 10.1016/S0959-8049(03)00571-9; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Panidou ET, 2004, AIDS, V18, P2153, DOI 10.1097/00002030-200411050-00007; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Yazdanpanah Y, 2004, BMJ-BRIT MED J, V328, P249, DOI 10.1136/bmj.37995.435787.A6; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	13	70	73	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1470	1472		10.1016/S0140-6736(06)69615-3	http://dx.doi.org/10.1016/S0140-6736(06)69615-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071265				2022-12-28	WOS:000241582700005
J	Lawn, JE; Tinker, A; Munjanja, SP				Lawn, Joy E.; Tinker, Anne; Munjanja, Stephen P.			Where is maternal and child health now?	LANCET			English	Editorial Material							NEONATAL SURVIVAL; MORTALITY; CARE; MANAGEMENT; COUNTRIES; METAANALYSIS; OUTCOMES; DEATHS; TRIAL; CALL		Saving Newborn Lives Save Children USA, ZA-7405 Cape Town, South Africa; Harare Hosp, Harare, Zimbabwe; London Sch Hyg & Trop Med, London WC1, England	Save the Children; University of London; London School of Hygiene & Tropical Medicine	Lawn, JE (corresponding author), Saving Newborn Lives Save Children USA, ZA-7405 Cape Town, South Africa.		Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443				ABOUZHAR C, 2003, MATERNAL MORTALITY 2; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; [Anonymous], 2005, STAT WORLDS CHILDR 2; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BORGHI J, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69383-5; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI69, DOI 10.1093/heapol/czi053; CAMPBELL O, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69381-1; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Graft-Johnson J, 2006, CONTINUUM CARE MATER; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; KOBLINSKY M, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69382-3; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; RONSMANS C, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69381-1; ROSENFIELD A, 1985, LANCET, V2, P83; ROSENFIELD A, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69386-0; *SAV CHILDR, 2006, SAV LIV MOTH NEWB; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; STARRS AM, 2006, LANCET          0928, DOI DOI 10.1016/S0140-6736(06)69385-9; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; World Health Organisation, 2005, WORLD HLTH REP MAK E	30	58	59	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1474	1477		10.1016/S0140-6736(06)69387-2	http://dx.doi.org/10.1016/S0140-6736(06)69387-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071267				2022-12-28	WOS:000241582700007
J	Hummon, AB; Richmond, TA; Verleyen, P; Baggerman, G; Huybrechts, J; Ewing, MA; Vierstraete, E; Rodriguez-Zas, SL; Schoofs, L; Robinson, GE; Sweedler, JV				Hummon, Amanda B.; Richmond, Timothy A.; Verleyen, Peter; Baggerman, Geert; Huybrechts, Jurgen; Ewing, Michael A.; Vierstraete, Evy; Rodriguez-Zas, Sandra L.; Schoofs, Liliane; Robinson, Gene E.; Sweedler, Jonathan V.			From the genome to the proteome: Uncovering peptides in the Apis brain	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; HONEY-BEE; NEUROPEPTIDE; IDENTIFICATION; FAMILY	Neuropeptides, critical brain peptides that modulate animal behavior by affecting the activity of almost every neuronal circuit, are inherently difficult to predict directly from a nascent genome sequence because of extensive posttranslational processing. The combination of bioinformatics and proteomics allows unprecedented neuropeptide discovery from an unannotated genome. Within the Apis mellifera genome, we have inferred more than 200 neuropeptides and have confirmed the sequences of 100 peptides. This study lays the groundwork for future molecular studies of Apis neuropeptides with the identification of 36 genes, 33 of which were previously unreported.	Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Katholieke Univ Leuven, Lab Dev Physiol Genom & Proteom, B-3000 Louvain, Belgium; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; KU Leuven; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	jsweedle@uiuc.edu	schoofs, liliane/ABD-2943-2020; Sweedler, Jonathan V/A-9405-2009; Schoofs, Liliane/F-2815-2010	Sweedler, Jonathan V/0000-0003-3107-9922; Ewing, Michael/0000-0001-5271-5655; Baggerman, Geert/0000-0002-0661-931X; Schoofs, Liliane/0000-0002-1673-432X; Rodriguez-Zas, Sandra/0000-0003-1122-4758	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609, R29NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; NIDA NIH HHS [P30 DA018310, P30 DA01830] Funding Source: Medline; NIDCD NIH HHS [DC006395] Funding Source: Medline; NIGMS NIH HHS [GM068946, R01 GM068946] Funding Source: Medline; NINDS NIH HHS [R01 NS031609, NS31609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Audsley N, 2006, PEPTIDES, V27, P512, DOI 10.1016/j.peptides.2005.08.022; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Bonnard E, 2001, PEPTIDES, V22, P1085, DOI 10.1016/S0196-9781(01)00425-9; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Chartrel N, 2003, P NATL ACAD SCI USA, V100, P15247, DOI 10.1073/pnas.2434676100; Dockray GJ, 2004, EXP PHYSIOL, V89, P229, DOI 10.1113/expphysiol.2004.027169; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hummon AB, 2003, J PROTEOME RES, V2, P650, DOI 10.1021/pr034046d; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nichols R, 1999, ANN NY ACAD SCI, V897, P264, DOI 10.1111/j.1749-6632.1999.tb07897.x; RIEHEL MA, 2002, SCIENCE, V2898, P172; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; Takeuchi H, 2003, INSECT MOL BIOL, V12, P291, DOI 10.1046/j.1365-2583.2003.00414.x; Verleyen P, 2006, PEPTIDES, V27, P493, DOI 10.1016/j.peptides.2005.03.065; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	18	242	261	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					647	649		10.1126/science.1124128	http://dx.doi.org/10.1126/science.1124128			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068263				2022-12-28	WOS:000241557800047
J	Tanaka, K; Lee, WS; Lu, DH; Fujimori, A; Fujii, T; Risdiana; Terasaki, I; Scalapino, DJ; Devereaux, TP; Hussain, Z; Shen, ZX				Tanaka, Kiyohisa; Lee, W. S.; Lu, D. H.; Fujimori, A.; Fujii, T.; Risdiana; Terasaki, I.; Scalapino, D. J.; Devereaux, T. P.; Hussain, Z.; Shen, Z. -X.			Distinct Fermi-momentum-dependent energy gaps in deeply underdoped Bi2212	SCIENCE			English	Article							SUPERCONDUCTING GAP; PSEUDOGAP; TEMPERATURE; STATE	We used angle-resolved photoemission spectroscopy applied to deeply underdoped cuprate superconductors Bi2Sr2Ca(1-x) YxCu2O8 (Bi2212) to reveal the presence of two distinct energy gaps exhibiting different doping dependence. One gap, associated with the antinodal region where no coherent peak is observed, increased with underdoping, a behavior known for more than a decade and considered as the general gap behavior in the underdoped regime. The other gap, associated with the near-nodal regime where a coherent peak in the spectrum can be observed, did not increase with less doping, a behavior not previously observed in the single particle spectra. We propose a two-gap scenario in momentum space that is consistent with other experiments and may contain important information on the mechanism of high-transition temperature superconductivity.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Tokyo, Dept Phys, Chiba 2778561, Japan; Univ Tokyo, Dept Complex Sci & Engn, Chiba 2778561, Japan; Univ Tokyo, Cryogen Ctr, Bunkyo Ku, Tokyo 1130032, Japan; Waseda Univ, Dept Appl Phys, Tokyo 1698555, Japan; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Waterloo, Dept Phys, Waterloo, ON N2L 3G1, Canada; Univ British Columbia, Pacific Inst Theoret Phys, Vancouver, BC V6T 1Z1, Canada	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tokyo; University of Tokyo; University of Tokyo; Waseda University; University of California System; University of California Santa Barbara; University of Waterloo; University of British Columbia	Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	zxshen@stanford.edu	TERASAKI, Ichiro/I-7083-2014; , Risdiana/AAW-2627-2020; Fujimori, Atsushi/G-5099-2014; Fujii, Takenori/T-4751-2018; Fujimori, Atsushi/U-1971-2019	TERASAKI, Ichiro/0000-0002-6073-2639; , Risdiana/0000-0002-9746-165X; Fujimori, Atsushi/0000-0003-4876-0634; Fujii, Takenori/0000-0002-3297-1341; TANAKA, Kiyohisa/0000-0003-2779-5870				Benfatto L, 2000, EUR PHYS J B, V17, P95, DOI 10.1007/s100510070163; Campuzano JC, 1999, PHYS REV LETT, V83, P3709, DOI 10.1103/PhysRevLett.83.3709; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Harris JM, 1996, PHYS REV B, V54, P15665, DOI 10.1103/PhysRevB.54.R15665; Le Tacon M, 2006, NAT PHYS, V2, P537, DOI 10.1038/nphys362; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Loram JW, 2001, J PHYS CHEM SOLIDS, V62, P59, DOI 10.1016/S0022-3697(00)00101-3; Mesot J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224516; Mesot J, 1999, PHYS REV LETT, V83, P840, DOI 10.1103/PhysRevLett.83.840; Mishchenko AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036402; Miyakawa N, 1998, PHYS REV LETT, V80, P157, DOI 10.1103/PhysRevLett.80.157; Opel M, 2000, PHYS REV B, V61, P9752, DOI 10.1103/PhysRevB.61.9752; Panagopoulos C, 1998, PHYS REV B, V57, P13422, DOI 10.1103/PhysRevB.57.13422; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Shen KM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267002; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; Sutherland M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174520; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wang H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.092409; Yamada K, 1998, PHYS REV B, V57, P6165, DOI 10.1103/PhysRevB.57.6165; Yoshida T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.027001	26	320	324	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1910	1913		10.1126/science.1133411	http://dx.doi.org/10.1126/science.1133411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17114172	Green Submitted			2022-12-28	WOS:000242996800043
J	Bustarret, E; Marcenat, C; Achatz, P; Kacmarcik, J; Levy, F; Huxley, A; Ortega, L; Bourgeois, E; Blase, X; Debarre, D; Boulmer, J				Bustarret, E.; Marcenat, C.; Achatz, P.; Kacmarcik, J.; Levy, F.; Huxley, A.; Ortega, L.; Bourgeois, E.; Blase, X.; Debarre, D.; Boulmer, J.			Superconductivity in doped cubic silicon	NATURE			English	Article							ULTRA-SHALLOW; TEMPERATURE; DEPENDENCE; FILMS; JUNCTIONS; DIAMOND; FIELDS; HC2; SI	Although the local resistivity of semiconducting silicon in its standard crystalline form can be changed by many orders of magnitude by doping with elements, superconductivity has so far never been achieved. Hybrid devices combining silicon's semiconducting properties and superconductivity have therefore remained largely underdeveloped. Here we report that superconductivity can be induced when boron is locally introduced into silicon at concentrations above its equilibrium solubility. For sufficiently high boron doping (typically 100 p.p.m.) silicon becomes metallic(1). We find that at a higher boron concentration of several per cent, achieved by gas immersion laser doping, silicon becomes superconducting. Electrical resistivity and magnetic susceptibility measurements show that boron-doped silicon (Si:B) made in this way is a superconductor below a transition temperature T-c approximate to 0.35 K, with a critical field of about 0.4 T. Ab initio calculations, corroborated by Raman measurements, strongly suggest that doping is substitutional. The calculated electron-phonon coupling strength is found to be consistent with a conventional phonon-mediated coupling mechanism(2). Our findings will facilitate the fabrication of new silicon-based superconducting nano-structures and mesoscopic devices with high-quality interfaces.	CNRS, Etud Proprietes Elect Solides Lab, F-38042 Grenoble, France; CNRS, Cristallog Lab, F-38042 Grenoble, France; CEA Grenoble, Dept Rech Fondamentale Mat Condensee, SPSMS, F-38054 Grenoble, France; Slovak Acad Sci, Inst Expt Phys, SK-04001 Kosice, Slovakia; Univ Lyon 1, Lab Phys Mat Condensee & Nanostruct, F-69622 Villeurbanne, France; CNRS, F-69622 Villeurbanne, France; Univ Paris 11, Inst Elect Fondamentale, F-91405 Orsay, France; CNRS, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Slovak Academy of Sciences; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Bustarret, E (corresponding author), CNRS, Etud Proprietes Elect Solides Lab, BP166, F-38042 Grenoble, France.	etienne.bustarret@grenoble.cnrs.fr; christophe.marcenat@cea.fr	Blase, Xavier/H-3588-2018; Lévy-Bertrand, Florence/G-8734-2012	Blase, Xavier/0000-0002-0201-9093; 				Alekseevski N., 1947, J PHYS USSR, V11, P95; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Blase X, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237004; Boeri L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237002; BUCKEL W, 1965, PHYS LETT, V17, P187, DOI 10.1016/0031-9163(65)90473-7; Bustarret E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237005; CHANG KJ, 1985, PHYS REV LETT, V54, P2375, DOI 10.1103/PhysRevLett.54.2375; COHEN ML, 1964, PHYS REV, V134, pA511, DOI 10.1103/PhysRev.134.A511; Connetable D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247001; DAI PH, 1991, PHYS REV LETT, V66, P1914, DOI 10.1103/PhysRevLett.66.1914; Ekimov EA, 2004, NATURE, V428, P542, DOI 10.1038/nature02449; Eremets MI, 2001, SCIENCE, V293, P272, DOI 10.1126/science.1062286; GUYON E, 1967, PHYS REV, V156, P452, DOI 10.1103/PhysRev.156.452; HEIN RA, 1964, PHYS REV LETT, V12, P320, DOI 10.1103/PhysRevLett.12.320; KAWAJI H, 1995, PHYS REV LETT, V74, P1427, DOI 10.1103/PhysRevLett.74.1427; KENT AD, 1987, PHYS REV B, V36, P8827, DOI 10.1103/PhysRevB.36.8827; Kerrien G, 2004, THIN SOLID FILMS, V453, P106, DOI 10.1016/j.tsf.2003.11.151; Kerrien G, 2003, APPL SURF SCI, V208, P277, DOI 10.1016/S0169-4332(02)01354-5; Kerrien G, 2002, APPL SURF SCI, V186, P45, DOI 10.1016/S0169-4332(01)00623-7; LASBLEY A, 1973, SOLID STATE COMMUN, V13, P1045, DOI 10.1016/0038-1098(73)90529-2; Lee KW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.237003; QUATEMAN JH, 1986, PHYS REV B, V34, P1948, DOI 10.1103/PhysRevB.34.1948; Sacepe B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097006; SCHOOLEY JF, 1965, PHYS REV LETT, V14, P305, DOI 10.1103/PhysRevLett.14.305; Stepanov G. N., 1980, Soviet Physics - Solid State, V22, P292; TING CS, 1975, PHYS REV LETT, V34, P870, DOI 10.1103/PhysRevLett.34.870; TINKHAM M, 1980, AIP C P, V58, P1; Vailionis A, 1999, PHYS REV LETT, V82, P4464, DOI 10.1103/PhysRevLett.82.4464; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295; Yokoya T, 2005, NATURE, V438, P647, DOI 10.1038/nature04278	30	208	209	0	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					465	468		10.1038/nature05340	http://dx.doi.org/10.1038/nature05340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122852	Green Submitted			2022-12-28	WOS:000242215700041
J	Rowe, JW				Rowe, John W.			Pay-for-performance and accountability: Related themes in improving health care	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; QUALITY; EXPERIENCE	Value-based purchasing, or pay-for-performance, is a major emerging theme in U.S. health care. Forces enhancing adoption of pay-for-performance programs include continued increases in medical costs beyond overall economic growth, a body of evidence that the quality of health care provided to patients is not directly related to the volume of services received, increasing evidence to serve as a basis for the development of standards against which to measure clinical performance, and increasing acceptance by physician organizations and individual practitioners of the rationale underlying these efforts. In this context, employers, government payers, and health plans are establishing a wide variety of pay-for-performance programs. This article reviews the critical design features of such efforts, describes the current types of programs on offer, and comments on the implications of this emerging movement for the future of health care in the United States.	Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Rowe, JW (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, 600 W 168th St,6th Floor, New York, NY 10032 USA.	Jwr2108@columbia.edu						*AETNA INC, 2005, AETN EXP AV NETW OPT; *ASS HLTH INS PLAN, 2004, NAT SURV PHYS REG PA; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Brenna T, 2003, J AM COLL SURGEONS, V196, P115; Chernew ME, 2003, HEALTH AFFAIR, V22, P15, DOI 10.1377/hlthaff.22.4.15; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; DEBRANTES F, 2003, J CLIN OUTCOMES MANA, P439; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; ENTHOVEN A, 2006, REFORMING AM HLTH CA; Epstein AM, 1998, JAMA-J AM MED ASSOC, V279, P1691, DOI 10.1001/jama.279.21.1691; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Galvin RS, 2005, HEALTH AFFAIR, V24, P228, DOI 10.1377/hlthaff.24.1.228; Glied S, 2002, J HEALTH ECON, V21, P337, DOI 10.1016/S0167-6296(01)00131-X; *I MED, UN TREATM CONF RAC E; LAUER G, 2006, CALIFORNIA PAY PERFO; Lee TH, 2005, NEW ENGL J MED, V353, P1202, DOI 10.1056/NEJMp058209; Milstein A, 2000, Eff Clin Pract, V3, P313; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; *US DEP AGR, 2004, SUMM REQ WAIV, P4	21	75	77	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					695	699		10.7326/0003-4819-145-9-200611070-00013	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ZD	17088584				2022-12-28	WOS:000241707800009
J	Feng, ZY; Li, W; Ward, A; Piggott, BJ; Larkspur, ER; Sternberg, PW; Xu, XZS				Feng, Zhaoyang; Li, Wei; Ward, Alex; Piggott, Beverly J.; Larkspur, Erin R.; Sternberg, Paul W.; Xu, X. Z. Shawn			A C-elegans model of nicotline-dependent behavior: Regulation by TRP-family channels	CELL			English	Article							CAENORHABDITIS-ELEGANS; ACETYLCHOLINE-RECEPTORS; SYNAPTIC-TRANSMISSION; NEMATODE; TOLERANCE; G(Q)ALPHA; NEUROBIOLOGY; ADAPTATION; ENCODES; PATHWAY	Nicotine, the primary addictive substance in tobacco, induces profound behavioral responses in mammals, but the underlying genetic mechanisms are riot well understood. Here we develop a C. elegans model of nicotine-dependent behavior. We show that worms exhibit behavioral responses to nicotine that parallel those observed in mammals, including acute response, tolerance, withdrawal, and sensitization. These Nicotine responses require nicotinic acetylcholine receptor (nAChR) family genes that are known to mediate nicotine dependence in mammals, suggesting functional conservation of nAChRs in nicotine responses. Importantly, we find that mutant worms lacking TRPC (transient receptor potential canonical) channels are defective in their response to nicotine and that such a defect can be rescued by a human TRPC channel, revealing an unexpected role or TRPC channels in regulating nicotine-dependent behavior. Thus, C. elegans can be used to characterize known genes as well as to identify new genes regulating nicotine responses.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Piggott, Beverly/GQH-4796-2022	Sternberg, Paul/0000-0002-7699-0173	NATIONAL EYE INSTITUTE [T32EY017878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276, T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER; NEI NIH HHS [T32EY017878, T32 EY017878] Funding Source: Medline; NIDA NIH HHS [R01 DA018341, 7R01DA018341-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM078276-01, T32GM008322, T32 GM008322, R01 GM078276] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Champtiaux N, 2004, PROG BRAIN RES, V145, P235, DOI 10.1016/S0079-6123(03)45016-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dwoskin LP, 1999, PSYCHOPHARMACOLOGY, V145, P442, DOI 10.1007/s002130051079; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kenny PJ, 2001, PHARMACOL BIOCHEM BE, V70, P531, DOI 10.1016/S0091-3057(01)00651-7; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MARKS MJ, 1986, J PHARMACOL EXP THER, V237, P809; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Waggoner LE, 2000, J NEUROSCI, V20, P8802; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	42	116	140	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					621	633		10.1016/j.cell.2006.09.035	http://dx.doi.org/10.1016/j.cell.2006.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081982	Green Accepted, Bronze			2022-12-28	WOS:000241937000024
J	Klein, HL				Klein, Hannah L.			A SUMOry of DNA replication: Synthesis, damage, and repair	CELL			English	Editorial Material							FORKS; SRS2; PCNA	Recombination at stalled replication forks is regulated at an early stage by sumoylation. In this issue of Cell, Branzei et al. (2006) show that the Ubc9/SUMO modification pathway controls the accumulation of cruciform structures at stalled forks.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Klein, HL (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	hannah.klein@med.nyu.edu		Klein, Hannah/0000-0003-4228-8535				Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kokoska RJ, 2000, MOL CELL BIOL, V20, P7490, DOI 10.1128/MCB.20.20.7490-7504.2000; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	11	10	10	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					455	457		10.1016/j.cell.2006.10.019	http://dx.doi.org/10.1016/j.cell.2006.10.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081966	Bronze			2022-12-28	WOS:000241937000008
J	Fergany, N				Fergany, Nader			Islam and science: Steps towards reform	NATURE			English	Editorial Material									Almishkat Ctr Res, Giza, Egypt		Fergany, N (corresponding author), Almishkat Ctr Res, Giza, Egypt.								0	7	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					33	34		10.1038/444033a	http://dx.doi.org/10.1038/444033a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	100WS	17080066				2022-12-28	WOS:000241701500026
J	Whitfield, CW; Behura, SK; Berlocher, SH; Clark, AG; Johnston, JS; Sheppard, WS; Smith, DR; Suarez, AV; Weaver, D; Tsutsui, ND				Whitfield, Charles W.; Behura, Susanta K.; Berlocher, Stewart H.; Clark, Andrew G.; Johnston, J. Spencer; Sheppard, Walter S.; Smith, Deborah R.; Suarez, Andrew V.; Weaver, Daniel; Tsutsui, Neil D.			Thrice out of Africa: Ancient and recent expansions of the honey bee, Apis mellifera	SCIENCE			English	Article							TROPICAL YUCATAN; 4TH LINEAGE; HYBRIDIZATION; IDENTIFICATION; VARIABILITY; POPULATIONS; COLONIES; AMERICA; MEXICO; EAST	We characterized Apis mellifera in both native and introduced ranges using 1136 single-nucleotide polymorphisms genotyped in 341 individuals. Our results indicate that A. mellifera originated in Africa and expanded into Eurasia at least twice, resulting in populations in eastern and western Europe that are geographically close but genetically distant. A third expansion in the New World has involved the near-replacement of previously introduced "European" honey bees by descendants of more recently introduced A. m. scutellata ("African" or "killer" bees). Our analyses of spatial transects and temporal series in the New World revealed differential replacement of alleles derived from eastern versus western Europe, with admixture evident in all individuals.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Entomol Program, Lawrence, KS 66045 USA; Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; LP & Bee Weaver Apiaries Inc, Bee Power, Navasota, TX 77868 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Texas A&M University System; Texas A&M University College Station; Washington State University; Washington State University; University of Kansas; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Irvine; University of California System; University of California Irvine	Whitfield, CW (corresponding author), Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.	charlie@life.uiuc.edu	Smith, Deborah/V-1676-2019	Smith, Deborah/0000-0002-2581-5009; Clark, Andrew/0000-0001-7159-8511; behura, Susanta/0000-0003-1057-2435				[Anonymous], 2000, CROP POLLINATION BEE; Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Clarke KE, 2002, EVOLUTION, V56, P1462; COMUET JM, 1991, APIDOLOGIE CELLE, V22, P627; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Franck P, 2000, APIDOLOGIE, V31, P167, DOI 10.1051/apido:2000114; *HON BEE GEN SEQ C, IN PRESS NATURE; Kerr W., 1967, S AFR BEE J, V39, P33; KERR WE, 1982, AM BEE J, V122, P196; Page RE, 2002, GENETICS, V160, P375; Palmer MR, 2000, J HERED, V91, P42, DOI 10.1093/jhered/91.1.42; Quezada-Euan JJG, 1998, APIDOLOGIE, V29, P555, DOI 10.1051/apido:19980608; Quezada-Euan JJG, 2000, APIDOLOGIE, V31, P443, DOI 10.1051/apido:2000135; Rinderer T. E., 1993, Scientific American, V269, P52; RINDERER TE, 1993, APIDOLOGIE, V24, P569, DOI 10.1051/apido:19930605; RINDERER TE, 1991, SCIENCE, V253, P309, DOI 10.1126/science.253.5017.309; RUTTNER F, 1978, APIDOLOGIE, V9, P363, DOI 10.1051/apido:19780408; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; SHEPPARD WS, 1989, AM BEE J, V129, P617; SHEPPARD WS, 1989, APIDOLOGIE, V20, P419, DOI 10.1051/apido:19890507; Sheppard WS, 2000, ANN ENTOMOL SOC AM, V93, P159, DOI 10.1603/0013-8746(2000)093[0159:IOADBI]2.0.CO;2; Sheppard WS, 2003, APIDOLOGIE, V34, P367, DOI 10.1051/apido:2003037; Shriver Mark D., 2005, Human Genomics, V2, P81; Smith DR, 1997, APIDOLOGIE, V28, P269, DOI 10.1051/apido:19970503; SUGDEN EA, 1990, GLEANINGS BEE CULT, V119, P18; WILSON EO, 1971, INSECT SOC, P94	29	287	305	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					642	645		10.1126/science.1132772	http://dx.doi.org/10.1126/science.1132772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068261				2022-12-28	WOS:000241557800045
J	Sampaolesi, M; Blot, S; D'Antona, G; Granger, N; Tonlorenzi, R; Innocenzi, A; Mognol, P; Thibaud, JL; Galvez, BG; Barthelemy, I; Perani, L; Mantero, S; Guttinger, M; Pansarasa, O; Rinaldi, C; De Angelis, MGC; Torrente, Y; Bordignon, C; Bottinelli, R; Cossu, G				Sampaolesi, Maurilio; Blot, Stephane; D'Antona, Giuseppe; Granger, Nicolas; Tonlorenzi, Rossana; Innocenzi, Anna; Mognol, Paolo; Thibaud, Jean-Laurent; Galvez, Beatriz G.; Barthelemy, Ines; Perani, Laura; Mantero, Sara; Guttinger, Maria; Pansarasa, Orietta; Rinaldi, Chiara; De Angelis, M. Gabriella Cusella; Torrente, Yvan; Bordignon, Claudio; Bottinelli, Roberto; Cossu, Giulio			Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; T-CELLS; EXPRESSION; MULTIPOTENT; THERAPY; REPAIR; TRANSPLANTATION; POPULATION; DELIVERY	Duchenne muscular dystrophy remains an untreatable genetic disease that severely limits motility and life expectancy in affected children. The only animal model specifically reproducing the alterations in the dystrophin gene and the full spectrum of human pathology is the golden retriever dog model. Affected animals present a single mutation in intron 6, resulting in complete absence of the dystrophin protein, and early and severe muscle degeneration with nearly complete loss of motility and walking ability. Death usually occurs at about 1 year of age as a result of failure of respiratory muscles. Here we report that intra-arterial delivery of wild-type canine mesoangioblasts (vessel-associated stem cells) results in an extensive recovery of dystrophin expression, normal muscle morphology and function ( confirmed by measurement of contraction force on single fibres). The outcome is a remarkable clinical amelioration and preservation of active motility. These data qualify mesoangioblasts as candidates for future stem cell therapy for Duchenne patients.	Univ Vita & Salute, San Raffaele Sci Inst, Stem Cell Res Inst, I-20132 Milan, Italy; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; Univ Pavia, Interuniv Inst Myol, I-27100 Pavia, Italy; Ecole Vet Alfort, Neurobiol Lab, F-94704 Maisons Alfort, France; Politecn Milan, Dept Bioengn, I-20130 Milan, Italy; Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy; Univ Milan, Dept Neurol Sci, IRCCS, Fdn Policlin Milano, I-20122 Milan, Italy; Univ Milan, Dept Biol, I-20130 Milan, Italy; Univ Milan, Ctr Stem Cell Res, I-20130 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; University of Pavia; Ecole Nationale Veterinaire d'Alfort (ENVA); Polytechnic University of Milan; University of Milan; University of Milan; University of Milan	Cossu, G (corresponding author), Univ Vita & Salute, San Raffaele Sci Inst, Stem Cell Res Inst, Via Olgettina 58, I-20132 Milan, Italy.	roberto.bottinelli@unipv.it; cossu.giulio@hsr.it	Sampaolesi, Maurilio/H-6509-2013; Tonlorenzi, Rossana/AAN-2241-2020; Gálvez, Beatriz G./H-1644-2015; Blot, Stephane/K-7573-2019; Mantero, Sara/F-6587-2013; Perani, Laura/AAN-2838-2020; Bottinelli, Roberto/AAC-1904-2020; Pansarasa, Orietta/A-2012-2019; Blot, Stephane/F-7420-2011; TORRENTE, YVAN/A-2964-2015	Sampaolesi, Maurilio/0000-0002-2422-3757; Gálvez, Beatriz G./0000-0002-8082-9323; Perani, Laura/0000-0001-8616-3377; Bottinelli, Roberto/0000-0002-4960-7490; Blot, Stephane/0000-0002-8982-0317; Granger, Nicolas/0000-0002-3036-3908; D'Antona, Giuseppe/0000-0002-0683-5565; TORRENTE, YVAN/0000-0002-2705-3984; Barthelemy, Ines/0000-0002-4747-5893; MANTERO, SARA/0000-0002-1264-0465; Tonlorenzi, Rossana/0000-0002-6060-8208; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	Telethon [GSP030543] Funding Source: Medline	Telethon(Fondazione Telethon)		Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Childers MK, 2005, MUSCLE NERVE, V31, P768, DOI 10.1002/mus.20298; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Dell'Agnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Emery A E, 1989, Prog Clin Biol Res, V306, P15; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; HARPER SQ, 2004, NAT MED, V8, P253; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Karpati G, 1997, CURR OPIN NEUROL, V10, P430, DOI 10.1097/00019052-199710000-00013; Kornegay JN, 2003, NEUROMUSCULAR DISORD, V13, P493, DOI 10.1016/S0960-8966(03)00025-7; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Pavlath GK, 2002, J NEUROIMMUNOL, V125, P42, DOI 10.1016/S0165-5728(02)00026-7; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325	25	554	574	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					574	579		10.1038/nature05282	http://dx.doi.org/10.1038/nature05282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17108972	Green Published			2022-12-28	WOS:000242377600039
J	Rice, M				Rice, Maurice			Superconductivity with a twist	SCIENCE			English	Editorial Material							TIME-REVERSAL SYMMETRY; SR2RUO4		ETH, Inst Theoret Phys, CH-8092 Zurich, Switzerland	ETH Zurich	Rice, M (corresponding author), ETH, Inst Theoret Phys, CH-8092 Zurich, Switzerland.	maurice.rice@itp.phys.ethz.ch						Kidwingira F, 2006, SCIENCE, V314, P1267, DOI 10.1126/science.1133239; Luke GM, 1998, NATURE, V394, P558, DOI 10.1038/29038; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Nelson KD, 2004, SCIENCE, V306, P1151, DOI 10.1126/science.1103881; RICE TM, 1995, J PHYS-CONDENS MAT, V7, P643; SIGRIST M, 1989, PHYS REV LETT, V63, P1727, DOI 10.1103/PhysRevLett.63.1727; Volovik G. E., 1985, Soviet Physics - JETP, V61, P843; Xia J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167002	9	7	7	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1248	1249		10.1126/science.1134921	http://dx.doi.org/10.1126/science.1134921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17124310				2022-12-28	WOS:000242215800026
J	Ma, KF; Tanaka, H; Song, SR; Wang, CY; Hung, JH; Tsai, YB; Mori, J; Song, YF; Yeh, EC; Soh, W; Sone, H; Kuo, LW; Wu, HY				Ma, Kuo-Fong; Tanaka, Hidemi; Song, Sheng-Rong; Wang, Chien-Ying; Hung, Jih-Hao; Tsai, Yi-Ben; Mori, Jim; Song, Yen-Fang; Yeh, Eh-Chao; Soh, Wonn; Sone, Hiroki; Kuo, Li-Wei; Wu, Hung-Yu			Slip zone and energetics of a large earthquake from the Taiwan Chelungpu-fault Drilling Project	NATURE			English	Article							1999 CHI-CHI; SEISMIC SLIP; GOUGE; LUBRICATION; RUPTURE	Determining the seismic fracture energy during an earthquake and understanding the associated creation and development of a fault zone requires a combination of both seismological and geological field data(1). The actual thickness of the zone that slips during the rupture of a large earthquake is not known and is a key seismological parameter in understanding energy dissipation, rupture processes and seismic efficiency. The 1999 magnitude 7.7 earthquake in Chi-Chi, Taiwan, produced large slip (8 to 10 metres) at or near the surface(2), which is accessible to borehole drilling and provides a rare opportunity to sample a fault that had large slip in a recent earthquake. Here we present the retrieved cores from the Taiwan Chelungpu-fault Drilling Project and identify the main slip zone associated with the Chi-Chi earthquake. The surface fracture energy estimated from grain sizes in the gouge zone of the fault sample was directly compared to the seismic fracture energy determined from near-field seismic data(3,4). From the comparison, the contribution of gouge surface energy to the earthquake breakdown work is quantified to be 6 per cent.	Natl Cent Univ, Dept Earth Sci, Chungli 32054, Taiwan; Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Natl Taiwan Univ, Dept Geosci, Taipei 10617, Taiwan; Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Kochi 7838502, Japan; Kyoto Univ, Dept Geol & Mineraol, Kyoto 6068501, Japan	National Central University; University of Tokyo; National Taiwan University; Kyoto University; National Synchrotron Radiation Research Center; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University	Ma, KF (corresponding author), Natl Cent Univ, Dept Earth Sci, Chungli 32054, Taiwan.	fong@earth.ncu.edu.tw	Sone, Hiroki/J-4394-2018; Ma, Kuo-Fong/H-1445-2012; Kuo, Li-Wei/ABC-3051-2020; 丁, 丁/GWC-2027-2022	Sone, Hiroki/0000-0001-5525-1294; Ma, Kuo-Fong/0000-0002-4500-8079; Kuo, Li-Wei/0000-0002-1749-0566; YEH, EN-CHAO/0000-0002-9153-933X; Song, Sheng-Rong/0000-0001-5428-4318				Abercrombie RE, 2005, GEOPHYS J INT, V162, P406, DOI 10.1111/j.1365-246X.2005.02579.x; Andrews DJ, 1999, B SEISMOL SOC AM, V89, P931; Brodsky EE, 2001, J GEOPHYS RES-SOL EA, V106, P16357, DOI 10.1029/2001JB000430; Chester JS, 2005, NATURE, V437, P133, DOI 10.1038/nature03942; Gratier JP, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000380; Heermance R, 2003, B SEISMOL SOC AM, V93, P1034, DOI 10.1785/0120010230; HUSSEINI MI, 1976, B SEISMOL SOC AM, V66, P1173; Ji C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001764; Kadono T, 2006, PLANET SPACE SCI, V54, P212, DOI 10.1016/j.pss.2005.09.002; Kanamori H, 2004, P JPN ACAD B-PHYS, V80, P297, DOI 10.2183/pjab.80.297; Lawn B., 1993, FRACTURE BRITTLE SOL, V2nd, P1; Ma K.F., 1999, EOS T AM GEOPHYS UN, V80, P605, DOI [DOI 10.1029/99EO00405, 10.1029/99EO00405]; Ma KF, 2001, B SEISMOL SOC AM, V91, P1069; Ma KF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015380; MCGARR A, 1979, J GEOPHYS RES, V84, P2251, DOI 10.1029/JB084iB05p02251; Otsuki K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001711; SAMMIS C, 1987, PURE APPL GEOPHYS, V125, P777, DOI 10.1007/BF00878033; Scholz C.H., 2002, MECH EARTHQUAKES FAU, P158; Sibson RH, 2003, B SEISMOL SOC AM, V93, P1169, DOI 10.1785/0120020061; Tanaka H, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026673; Tanaka H, 2002, TERR ATMOS OCEAN SCI, V13, P227, DOI 10.3319/TAO.2002.13.3.227(CCE); TANAKA H, UNPUB J GEOPHYS RES; Tinti E, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003644; Venkataraman A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002548; Wang CY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014496; Wang CY, 2002, GEOPHYSICS, V67, P1465, DOI 10.1190/1.1512791; Wibberley CAJ, 2005, NATURE, V436, P689, DOI 10.1038/nature03901; Wilson B, 2005, NATURE, V434, P749, DOI 10.1038/nature03433; Yue LF, 2005, J STRUCT GEOL, V27, P2058, DOI 10.1016/j.jsg.2005.05.020; Zhang WB, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001889	30	188	208	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					473	476		10.1038/nature05253	http://dx.doi.org/10.1038/nature05253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122854				2022-12-28	WOS:000242215700043
J	Lawlor, DA; Lean, M; Sattar, N				Lawlor, Debbie A.; Lean, Mike; Sattar, Naveed			ABC of obesity - Obesity and vascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METABOLIC SYNDROME; RISK		Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	University of Bristol; University of Glasgow	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England.	nsattar@clinmed.gla.ac.uk		Lawlor, Debbie A/0000-0002-6793-2262				Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lavie CJ, 2005, EUR HEART J, V26, P5, DOI 10.1093/eurheartj/ehi055; Murphy NF, 2006, EUR HEART J, V27, P96, DOI 10.1093/eurheartj/ehi506; Sattar N, 2006, CURR OPIN LIPIDOL, V17, P404, DOI 10.1097/01.mol.0000236366.48593.07; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	9	18	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1060	1063		10.1136/bmj.333.7577.1060	http://dx.doi.org/10.1136/bmj.333.7577.1060			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108HB	17110725	Green Published			2022-12-28	WOS:000242229800023
J	Green, RE; Krause, J; Ptak, SE; Briggs, AW; Ronan, MT; Simons, JF; Du, L; Egholm, M; Rothberg, JM; Paunovic, M; Paabo, S				Green, Richard E.; Krause, Johannes; Ptak, Susan E.; Briggs, Adrian W.; Ronan, Michael T.; Simons, Jan F.; Du, Lei; Egholm, Michael; Rothberg, Jonathan M.; Paunovic, Maja; Paeaebo, Svante			Analysis of one million base pairs of Neanderthal DNA	NATURE			English	Article							ANCESTRAL POPULATION SIZES; MODERN HUMAN ORIGINS; ANCIENT DNA; ENZYMATIC AMPLIFICATION; MITOCHONDRIAL GENOME; DIVERGENCE TIMES; MTDNA SEQUENCE; MODERN HUMANS; DIVERSITY; ARTIFACTS	Neanderthals are the extinct hominid group most closely related to contemporary humans, so their genome offers a unique opportunity to identify genetic changes specific to anatomically fully modern humans. We have identified a 38,000- year- old Neanderthal fossil that is exceptionally free of contamination from modern human DNA. Direct high- throughput sequencing of a DNA extract from this fossil has thus far yielded over one million base pairs of hominoid nuclear DNA sequences. Comparison with the human and chimpanzee genomes reveals that modern human and Neanderthal DNA sequences diverged on average about 500,000 years ago. Existing technology and fossil resources are now sufficient to initiate a Neanderthal genome- sequencing effort.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; 454 Life Sci, Branford, CT 06405 USA; Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, HR-10000 Zagreb, Croatia	Max Planck Society; Croatian Academy of Sciences & Arts	Green, RE (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	green@eva.mpg.de	Krause, Johannes/E-6640-2015; Krause, Johannes/AFP-2642-2022	Krause, Johannes/0000-0001-5475-4690; Krause, Johannes/0000-0001-9144-3920; Green, Richard/0000-0003-0516-5827				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; FRANCISCUS RG, 2002, NEANDERTHALS; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; HUBLIN JJ, 1998, CLIMATIC CHANGES PAL; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Innan H, 2006, MOL BIOL EVOL, V23, P1040, DOI 10.1093/molbev/msj109; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Rannala B, 2003, GENETICS, V164, P1645; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wall JD, 2003, GENETICS, V163, P395; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375	50	466	507	13	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					330	336		10.1038/nature05336	http://dx.doi.org/10.1038/nature05336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108958	Bronze			2022-12-28	WOS:000242018300040
J	Schrier, RW; Gross, P; Gheorghiade, M; Berl, T; Verbalis, JG; Czerwiec, FS; Orlandi, C				Schrier, Robert W.; Gross, Peter; Gheorghiade, Mihai; Berl, Tomas; Verbalis, Joseph G.; Czerwiec, Frank S.; Orlandi, Cesare		SALT Investigators	Tolvaptan, a selective oral vasopressin V-2-receptor antagonist, for hyponatremia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEART-FAILURE; INAPPROPRIATE SECRETION; ANTIDIURETIC-HORMONE; RECEPTOR ANTAGONIST; TERM MORTALITY; SERUM SODIUM; DOUBLE-BLIND; NONPEPTIDE; CIRRHOSIS; BLOCKADE	Background: Hyponatremia (serum sodium concentration, < 135 mmol per liter) is a predictor of death among patients with chronic heart failure and cirrhosis. At present, therapy for acute and chronic hyponatremia is often ineffective and poorly tolerated. We investigated whether tolvaptan, an orally active vasopressin V(sub 2)-receptor antagonist that promotes aquaresis -- excretion of electrolyte-free water -- might be of benefit in hyponatremia. Methods: In two multicenter, randomized, double-blind, placebo-controlled trials, the efficacy of tolvaptan was evaluated in patients with euvolemic or hypervolemic hyponatremia. Patients were randomly assigned to oral placebo (223 patients) or oral tolvaptan (225) at a dose of 15 mg daily. The dose of tolvaptan was increased to 30 mg daily and then to 60 mg daily, if necessary, on the basis of serum sodium concentrations. The two primary end points for all patients were the change in the average daily area under the curve for the serum sodium concentration from baseline to day 4 and the change from baseline to day 30. Results: Serum sodium concentrations increased more in the tolvaptan group than in the placebo group during the first 4 days (P < 0.001) and after the full 30 days of therapy (P < 0.001). The condition of patients with mild or marked hyponatremia improved (P < 0.001 for all comparisons). During the week after discontinuation of tolvaptan on day 30, hyponatremia recurred. Side effects associated with tolvaptan included increased thirst, dry mouth, and increased urination. A planned analysis that combined the two trials showed significant improvement from baseline to day 30 in the tolvaptan group according to scores on the Mental Component of the Medical Outcomes Study 12-item Short-Form General Health Survey. Conclusions: In patients with euvolemic or hypervolemic hyponatremia, tolvaptan, an oral vasopressin V(sub 2)-receptor antagonist, was effective in increasing serum sodium concentrations at day 4 and day 30.	Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, Denver, CO 80262 USA; Univ Klinikum Carl Gustav Carus, Dresden, Germany; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Georgetown Univ, Washington, DC USA; Otsuka Maryland Res Inst, Rockville, MD USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Northwestern University; Feinberg School of Medicine; Georgetown University	Schrier, RW (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Renal Dis & Hypertens, 4200 E 9th Ave, Denver, CO 80262 USA.	robert.schrier@uchsc.edu	Ginès, Pere/C-7730-2014; Ginès, Pere/X-2892-2019; Tesar, Vladimir/O-2312-2017	Ginès, Pere/0000-0003-4657-4504; Ginès, Pere/0000-0003-4657-4504; Tesar, Vladimir/0000-0001-6982-0689; Afdhal, Nezam/0000-0002-7342-6593				Abraham WT, 2006, J AM COLL CARDIOL, V47, P1615, DOI 10.1016/j.jacc.2005.11.071; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Costello-Boerrigter LC, 2006, AM J PHYSIOL-RENAL, V290, pF273, DOI 10.1152/ajprenal.00195.2005; De Luca L, 2005, AM J CARDIOL, V96, p19L, DOI 10.1016/j.amjcard.2005.09.066; Doggrell Sheila A, 2004, Curr Opin Investig Drugs, V5, P977; FLEISS JL, 1999, DESIGN ANAL CLIN EXP, P150; Gerbes AL, 2003, GASTROENTEROLOGY, V124, P933, DOI 10.1053/gast.2003.50143; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2006, AM J CARDIOL, V97, P1064, DOI 10.1016/j.amjcard.2005.10.050; Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Goldberg A, 2006, ARCH INTERN MED, V166, P781, DOI 10.1001/archinte.166.7.781; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; HANTMAN D, 1973, ANN INTERN MED, V78, P870, DOI 10.7326/0003-4819-78-6-870; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Janicic N, 2003, ENDOCRIN METAB CLIN, V32, P459, DOI 10.1016/S0889-8529(03)00004-5; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; Londono MC, 2006, GASTROENTEROLOGY, V130, P1135, DOI 10.1053/j.gastro.2006.02.017; MILLER M, 1995, J AM GERIATR SOC, V43, P1410, DOI 10.1111/j.1532-5415.1995.tb06623.x; MILLER PD, 1980, JAMA-J AM MED ASSOC, V243, P2513, DOI 10.1001/jama.243.24.2513; RENNEBOOG B, 2006, AM J MED, V71; Saito T, 1997, J CLIN ENDOCR METAB, V82, P1054, DOI 10.1210/jc.82.4.1054; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Sica Domenic A, 2005, Congest Heart Fail, V11, P274, DOI 10.1111/j.1527-5299.2005.04180.x; Udelson JE, 2001, CIRCULATION, V104, P2417, DOI 10.1161/hc4501.099313; VERBALIS JG, DIS KIDNEY URINARY T; Ware J.E., 1995, SF 12 SCORE SF 12 PH; Wu CC, 2006, CLIN NEPHROL, V65, P28	28	766	812	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2099	2112		10.1056/NEJMoa065181	http://dx.doi.org/10.1056/NEJMoa065181			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17105757				2022-12-28	WOS:000241997300006
J	Yamada, S; Suzuki, Y; Suzuki, T; Le, MQ; Nidom, CA; Sakai-Tagawa, Y; Muramoto, Y; Ito, M; Kiso, M; Horimoto, T; Shinya, K; Sawada, T; Kiso, M; Usui, T; Murata, T; Lin, YP; Hay, A; Haire, LF; Stevens, DJ; Russell, RJ; Gamblin, SJ; Skehel, JJ; Kawaoka, Y				Yamada, Shinya; Suzuki, Yasuo; Suzuki, Takashi; Le, Mai Q.; Nidom, Chairul A.; Sakai-Tagawa, Yuko; Muramoto, Yukiko; Ito, Mutsumi; Kiso, Maki; Horimoto, Taisuke; Shinya, Kyoko; Sawada, Toshihiko; Kiso, Makoto; Usui, Taiichi; Murata, Takeomi; Lin, Yipu; Hay, Alan; Haire, Lesley F.; Stevens, David J.; Russell, Rupert J.; Gamblin, Steven J.; Skehel, John J.; Kawaoka, Yoshihiro			Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors	NATURE			English	Article							AVIAN INFLUENZA; AMINO-ACID; SPECIFICITY; INFECTION; H2	H5N1 influenza A viruses have spread to numerous countries in Asia, Europe and Africa, infecting not only large numbers of poultry, but also an increasing number of humans, often with lethal effects(1,2). Human and avian influenza A viruses differ in their recognition of host cell receptors: the former preferentially recognize receptors with saccharides terminating in sialic acid-alpha 2,6-galactose ( SA alpha 2,6Gal), whereas the latter prefer those ending in SA alpha 2,3Gal ( refs 3 - 6). A conversion from SA alpha 2,3Gal to SA alpha 2,6Gal recognition is thought to be one of the changes that must occur before avian influenza viruses can replicate efficiently in humans and acquire the potential to cause a pandemic. By identifying mutations in the receptor- binding haemagglutinin ( HA) molecule that would enable avian H5N1 viruses to recognize human- type host cell receptors, it may be possible to predict ( and thus to increase preparedness for) the emergence of pandemic viruses. Here we show that some H5N1 viruses isolated from humans can bind to both human and avian receptors, in contrast to those isolated from chickens and ducks, which recognize the avian receptors exclusively. Mutations at positions 182 and 192 independently convert the HAs of H5N1 viruses known to recognize the avian receptor to ones that recognize the human receptor. Analysis of the crystal structure of the HA from an H5N1 virus used in our genetic experiments shows that the locations of these amino acids in the HA molecule are compatible with an effect on receptor binding. The amino acid changes that we identify might serve as molecular markers for assessing the pandemic potential of H5N1 field isolates.	Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Chubu Univ, Coll Life & Hlth Sci, Aichi 4878501, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; COE Program 21st Century, Shizuoka 4228526, Japan; Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; Airlangga Univ, Trop Dis Ctr, Avian Influenza Lab, Surabaya, Indonesia; Tottori Univ, Avian Zoonosis Res Ctr, Tottori 6808553, Japan; Gifu Univ, United Grad Sch Agr Sci, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; Univ Shizuoka, Dept Appl Biol Chem, Shizuoka 4228529, Japan; MRC, Natl Inst Med Res, London NW7 1AA, England; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Chubu University; University of Shizuoka; National Institute of Hygiene & Epidemiology (NIHE); Airlangga University; Tottori University; Gifu University; University of Shizuoka; MRC National Institute for Medical Research; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp		Yasuo, Suzuki/0000-0003-3518-5642; Gamblin, Steve/0000-0001-5331-639X	MRC [G0600522, MC_U117512711, MC_U117512708] Funding Source: UKRI; Medical Research Council [MC_U117512711, MC_U117512708, G0600522] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLEMENTS ML, 1992, J CLIN MICROBIOL, V30, P655, DOI 10.1128/JCM.30.3.655-662.1992; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Enserink M, 2006, SCIENCE, V311, P932; GUBAREVA LV, 1994, VIROLOGY, V199, P89, DOI 10.1006/viro.1994.1100; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; HARDY CT, 1995, VIROLOGY, V211, P302, DOI 10.1006/viro.1995.1405; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Totani K, 2003, GLYCOBIOLOGY, V13, P315, DOI 10.1093/glycob/cwg032; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Zambon MC, 2001, REV MED VIROL, V11, P227, DOI 10.1002/rmv.319	26	474	524	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					378	382		10.1038/nature05264	http://dx.doi.org/10.1038/nature05264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108965				2022-12-28	WOS:000242018300051
J	Cassar, K				Cassar, Kevin			Intermittent claudication	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERIPHERAL ARTERIAL-DISEASE; QUALITY-OF-LIFE; LOWER-EXTREMITY; ATHEROSCLEROSIS; EPIDEMIOLOGY; PREVENTION; PREVALENCE		Aberdeen Royal Infirm, Vasc Unit, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Cassar, K (corresponding author), Aberdeen Royal Infirm, Vasc Unit, Aberdeen AB25 2ZN, Scotland.	k.cassar@abdn.ac.uk						[Anonymous], J GEOPHYSICAL RES SO, V123, P2028, DOI [10.1002/2016jb013844, DOI 10.1002/2016JB013844, DOI 10.1002/14651858.CD002000]; BACHOO P, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003228; Balasooriya-Smeekens Chantal, 2015, PSYCHO-ONCOLOGY, V24, P1594, DOI [10.1002/pon.3833, DOI 10.1002/PON.3833, DOI 10.1002/14651858.CD003833.PUB2]; Bendermacher BLW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005263.pub2; BIEMANS RGM, 1977, SURG GYNECOL OBSTET, V144, P604; CARTER SA, 1972, NEW ENGL J MED, V287, P578, DOI 10.1056/NEJM197209212871202; Cassar K, 2003, EUR J VASC ENDOVASC, V26, P130, DOI 10.1053/ejvs.2002.1929; Cassar Kevin, 2006, Clin Evid, P164; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; COX GS, 1993, J VASC SURG, V17, P172, DOI 10.1016/0741-5214(93)90021-D; CRONENWETT JL, 1984, ARCH SURG-CHICAGO, V119, P430; CRUICKSHANK JM, 1992, J HYPERTENS, V10, pS21; De Backer TL, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000988, DOI 10.1002/14651858.CD000988]; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Diehm C, 2004, VASA-J VASCULAR DIS, V33, P183, DOI 10.1024/0301-1526.33.4.183; Dormandy J A, 1991, Eur J Vasc Surg, V5, P131, DOI 10.1016/S0950-821X(05)80676-0; Fowkes FG, 1998, COCHRANE DATABASE SY; Garcia LA, 2006, J ENDOVASC THER, V13, P3, DOI 10.1583/05-1751.1; Girolami B, 1999, ARCH INTERN MED, V159, P337, DOI 10.1001/archinte.159.4.337; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; HUYEN T, 2004, JAMA-J AM MED ASSOC, V292, P1867; IWAI T, 1985, J CARDIOVASC SURG, V26, P496; KLEIJNEN J, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000987; Leng GC, 2000, ATHEROSCLEROSIS, V152, P167, DOI 10.1016/S0021-9150(99)00447-5; LENG GC, 2000, COCHRANE DB SYST REV, V2; Levien LJ, 1998, J VASC SURG, V28, P193, DOI 10.1016/S0741-5214(98)70155-7; Lip GYH, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003186.pub3; Marquis P, 1998, DRUGS, V56, P25, DOI 10.2165/00003495-199856003-00004; Muluk SC, 2001, J VASC SURG, V33, P251, DOI 10.1067/mva.2001.112210; Murabito JM, 1997, CIRCULATION, V96, P44; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Robless P, 2001, BRIT J SURG, V88, P787, DOI 10.1046/j.0007-1323.2001.01774.x; SALHIYYAH K, 2005, COCHRANE DB SYST REV; *SCOTT INT GUID NE, 1998, DRUG THER PER VASC D; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; *TASC, 2000, J VASC SURG, V31, pS59; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan Sandeep, 2005, Clin Evid, P491; Wood D, 1998, HEART, V80, pS1	45	24	27	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2006	333	7576					1002	1005		10.1136/bmj.39001.562813.DE	http://dx.doi.org/10.1136/bmj.39001.562813.DE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108GX	17095782	Green Published			2022-12-28	WOS:000242229400017
J	Desai, J; Yassa, L; Marqusee, E; George, S; Frates, MC; Chen, MH; Morgan, JA; Dychter, SS; Larsen, PR; Demetri, GD; Alexander, EK				Desai, Jayesh; Yassa, Leila; Marqusee, Ellen; George, Suzanne; Frates, Mary C.; Chen, Ming Hui; Morgan, Jeffrey A.; Dychter, Samuel S.; Larsen, P. Reed; Demetri, George D.; Alexander, Erik K.			Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	77th Annual Meeting of the American-Thyroid-Association	OCT 11-15, 2006	Phoenix, AZ	Amer Thyroid Assoc			THYROID-DYSFUNCTION; IMATINIB MESYLATE; THERAPY; CANCER; CARCINOMA; INHIBITOR; SU11248	Background: Sunitinib malate is an oral tyrosine kinase inhibitor recently approved for the treatment of gastrointestinal stromal tumors and renal cell carcinoma. Because the ret proto-oncogene is also inhibited by this agent, clinical evaluation of thyroid function was performed. Objective: To describe the prevalence and clinical presentation of thyroid dysfunction related to sunitinib therapy. Design: Prospective, observational cohort study. Setting: Tertiary care hospital. Patients: 42 patients treated for a median of 37 weeks (range, 10 to 167 weeks). Measurements: Following analysis of serial thyroid-stimulating hormone (TSH) measurements collected prospectively during a clinical trial of sunitinib, the authors determined the proportion of patients with thyroid dysfunction. Results: Abnormal serum TSH concentrations were documented in 26 of 42 patients (62%): 15 (36%) developed persistent, primary hypothyroidism; 4 (10%) developed isolated TSH suppression; and 7 (17%) experienced transient, mild TSH elevations. The risk for hypothyroidism increased with the duration of sunitinib therapy. Six of 15 (40%) hypothyroid patients had suppressed TSH concentrations before developing hypothyroidism, suggesting thyroiditis. Two hypothyroid patients evaluated with thyroid ultrasonography had no visualized thyroid tissue despite normal baseline thyroid function. Limitations: The exploratory nature of this study precluded more frequent biochemical and sonographic analysis that may better define the mechanism of sunitinib-associated thyroid dysfunction. Conclusion: Hypothyroidism is a frequent complication of sunitinib therapy. Regular surveillance of thyroid function is warranted in patients receiving the drug. Although the mechanism by which this complication occurs is unknown, the observations of preceding TSH suppression and subsequent absence of visualized thyroid tissue in some patients suggest that sunitinib may induce a destructive thyroiditis through follicular cell apoptosis. This provides a rationale for further investigation of sunitinib treatment in patients with advanced thyroid cancer.	Brigham & Womens Hosp, Div Endocrinol Diabet & Metab, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Pfizer Inc, New York, NY USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Pfizer	Alexander, EK (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Metab, Dana Farber Canc Inst, 75 Francis St,PPB B4, Boston, MA 02115 USA.	ekalexander@partners.org	Desai, Jayesh/AAV-1237-2021	Desai, Jayesh/0000-0003-4246-9344	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bogazzi F, 2001, THYROID, V11, P511, DOI 10.1089/105072501300176471; de Groot JWB, 2005, CLIN PHARMACOL THER, V78, P433, DOI 10.1016/j.clpt.2005.06.010; Demetri GD, 2005, J CLIN ONCOL, V23, p308S, DOI 10.1200/jco.2005.23.16_suppl.4000; Dziba JM, 2004, J CLIN ENDOCR METAB, V89, P2127, DOI 10.1210/jc.2003-031734; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Koh LKH, 1997, THYROID, V7, P891, DOI 10.1089/thy.1997.7.891; Kurebayashi J, 2006, CANCER CHEMOTH PHARM, V58, P460, DOI 10.1007/s00280-006-0185-x; Lazarus JH, 1998, THYROID, V8, P909, DOI 10.1089/thy.1998.8.909; MARTORELLA AJ, 2006, 88 ANN M END SOC BOS; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; *PFIZ INC, 2006, SUT SUN MAL US PACK; Ross D., 2005, WERNER INGBARS THYRO, P1070; SURKS MI, 1995, NEW ENGL J MED, V333, P1688, DOI 10.1056/NEJM199512213332507; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VIALETTES B, 1993, ACTA ENDOCRINOL-COP, V129, P31, DOI 10.1530/acta.0.1290031	17	286	295	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					660	664		10.7326/0003-4819-145-9-200611070-00008	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	100ZD	17088579				2022-12-28	WOS:000241707800004
J	Johnson, J				Johnson, James			Good doctors, safer patients - Reactions to the chief medical officer's report - Independence is key to better regulation	BRITISH MEDICAL JOURNAL			English	Editorial Material									Bristish Med Assoc, London WC1H, England		Johnson, J (corresponding author), Bristish Med Assoc, London WC1H, England.	jjohnson@bma.org.uk						*BETT REG TASK FOR, 20045 BETT REG TASK; Catto G, 2006, BRIT J HOSP MED, V67, P508, DOI 10.12968/hmed.2006.67.10.22054; Chief Medical Officer, 2006, GOOD DOCT SAF PAT; Johnson JN, 1998, BRIT MED J, V316, P1847	4	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 4	2006	333	7575					966	967		10.1136/bmj.39010.462755.68	http://dx.doi.org/10.1136/bmj.39010.462755.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107GE	17082551	Green Published			2022-12-28	WOS:000242157900025
J	Worm, B; Barbier, EB; Beaumont, N; Duffy, JE; Folke, C; Halpern, BS; Jackson, JBC; Lotze, HK; Micheli, F; Palumbi, SR; Sala, E; Selkoe, KA; Stachowicz, JJ; Watson, R				Worm, Boris; Barbier, Edward B.; Beaumont, Nicola; Duffy, J. Emmett; Folke, Carl; Halpern, Benjamin S.; Jackson, Jeremy B. C.; Lotze, Heike K.; Micheli, Fiorenza; Palumbi, Stephen R.; Sala, Enric; Selkoe, Kimberley A.; Stachowicz, John J.; Watson, Reg			Impacts of biodiversity loss on ocean ecosystem services	SCIENCE			English	Article							DIVERSITY; RESISTANCE; RECOVERY; PATTERNS; ECOLOGY	Human-dominated marine ecosystems are experiencing accelerating loss of populations and species, with largely unknown consequences. We analyzed local experiments, long-term regional time series, and global fisheries data to test how biodiversity loss affects marine ecosystem services across temporal and spatial scales. Overall, rates of resource collapse increased and recovery potential, stability, and water quality decreased exponentially with declining diversity. Restoration of biodiversity, in contrast, increased productivity fourfold and decreased variability by 21%, on average. We conclude that marine biodiversity loss is increasingly impairing the ocean's capacity to provide food, maintain water quality, and recover from perturbations. Yet available data suggest that at this point, these trends are still reversible.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Stockholm Univ, Dept Syst Ecol, SE-10691 Stockholm, Sweden; Royal Swedish Acad Sci, Beijer Int Inst Ecol Econ, SE-10405 Stockholm, Sweden; Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Dalhousie University; University of Wyoming; Plymouth Marine Laboratory; William & Mary; Virginia Institute of Marine Science; Stockholm University; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; National Center for Ecological Analysis & Synthesis; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; Stanford University; University of California System; University of California Davis; University of British Columbia	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	bworm@dal.ca	Beaumont, Nicola/AAS-2780-2020; Folke, Carl/Z-1545-2019; Duffy, J. Emmett/ABF-9200-2020; Watson, Reg A/F-4850-2012	Duffy, J. Emmett/0000-0001-8595-6391; Watson, Reg A/0000-0001-7201-8865; Micheli, Fiorenza/0000-0002-6865-1438; Lotze, Heike/0000-0001-6258-1304; Folke, Carl/0000-0002-4050-3281; Beaumont, Nicola/0000-0002-5976-9661; Worm, Boris/0000-0002-5742-8716				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Dame Richard, 2002, Aquatic Ecology, V36, P51, DOI 10.1023/A:1013354807515; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Finnoff D, 2003, J ENVIRON ECON MANAG, V45, P589, DOI 10.1016/S0095-0696(02)00025-6; Froese R., FISHBASE; Froese R., 2002, ICES COUNC M REP CM; Hendriks IE, 2006, SCIENCE, V312, P1715, DOI 10.1126/science.1128548; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Peterson C. H., 1997, Nature's services: societal dependence on natural ecosystems., P177; Raffaelli D, 2004, SCIENCE, V306, P1141, DOI 10.1126/science.1106365; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; ROBERTS CM, 2000, FULLY PROTECTED MARI, P241; Sherman K, 1999, MAR ECOL PROG SER, V190, P271, DOI 10.3354/meps190271; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Wacker H, 1999, RESOUR ENERGY ECON, V21, P89, DOI 10.1016/S0928-7655(98)00029-3; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	28	2787	2904	61	2679	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					787	790		10.1126/science.1132294	http://dx.doi.org/10.1126/science.1132294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082450				2022-12-28	WOS:000241729800037
J	Weinstock, GM; Robinson, GE; Gibbs, RA; Worley, KC; Evans, JD; Maleszka, R; Robertson, HM; Weaver, DB; Beye, M; Bork, P; Elsik, CG; Hartfelder, K; Hunt, GJ; Zdobnov, EM; Amdam, GV; Bitondi, MMG; Collins, AM; Cristino, AS; Lattorff, HMG; Lobo, CH; Moritz, RFA; Nunes, FMF; Page, RE; Simoes, ZLP; Wheeler, D; Carninci, P; Fukuda, S; Hayashizaki, Y; Kai, C; Kawai, J; Sakazume, N; Sasaki, D; Tagami, M; Albert, S; Baggerman, G; Beggs, KT; Bloch, G; Cazzamali, G; Cohen, M; Drapeau, MD; Eisenhardt, D; Emore, C; Ewing, MA; Fahrbach, SE; Foret, S; Grimmelikhuijzen, CJP; Hauser, F; Hummon, AB; Huybrechts, J; Jones, AK; Kadowaki, T; Kaplan, N; Kucharski, R; Leboulle, G; Linial, M; Littleton, JT; Mercer, AR; Richmond, TA; Rodriguez-Zas, SL; Rubin, EB; Sattelle, DB; Schlipalius, D; Schoofs, L; Shemesh, Y; Sweedler, JV; Velarde, R; Verleyen, P; Vierstraete, E; Williamson, MR; Ament, SA; Brown, SJ; Corona, M; Dearden, PK; Dunn, WA; Elekonich, MM; Fujiyuki, T; Gattermeier, I; Gempe, T; Hasselmann, M; Kadowaki, T; Kage, E; Kamikouchi, A; Kubo, T; Kucharski, R; Kunieda, T; Lorenzen, MD; Milshina, NV; Morioka, M; Ohashi, K; Overbeek, R; Ross, CA; Schioett, M; Shippy, T; Takeuchi, H; Toth, AL; Willis, JH; Wilson, MJ; Gordon, KHJ; Letunic, I; Hackett, K; Peterson, J; Felsenfeld, A; Guyer, M; Solignac, M; Agarwala, R; Cornuet, JM; Monnerot, M; Mougel, F; Reese, JT; Vautrin, D; Gillespie, JJ; Cannone, JJ; Gutell, RR; Johnston, JS; Eisen, MB; Iyer, VN; Iyer, V; Kosarev, P; Mackey, AJ; Solovyev, V; Souvorov, A; Aronstein, KA; Bilikova, K; Chen, YP; Clark, AG; Decanini, LI; Gelbart, WM; Hetru, C; Hultmark, D; Imler, JL; Jiang, HB; Kanost, M; Kimura, K; Lazzaro, BP; Lopez, DL; Simuth, J; Thompson, GJ; Zou, Z; De Jong, P; Sodergren, E; Csuros, M; Milosavljevic, A; Osoegawa, K; Richards, S; Shu, CL; Duret, L; Elhaik, E; Graur, D; Anzola, JM; Campbell, KS; Childs, KL; Collinge, D; Crosby, MA; Dickens, CM; Grametes, LS; Grozinger, CM; Jones, PL; Jorda, M; Ling, X; Matthews, BB; Miller, J; Mizzen, C; Peinado, MA; Reid, JG; Russo, SM; Schroeder, AJ; St Pierre, SE; Wang, Y; Zhou, PL; Jiang, HY; Kitts, P; Ruef, B; Venkatraman, A; Zhang, L; Aquino-Perez, G; Whitfield, CW; Behura, SK; Berlocher, SH; Sheppard, WS; Smith, DR; Suarez, AV; Tsutsui, ND; Wei, XH; Wheeler, D; Havlak, P; Li, BS; Liu, Y; Sodergren, E; Jolivet, A; Lee, S; Nazareth, LV; Pu, LL; Thorn, R; Stolc, V; Newman, T; Samanta, M; Tongprasit, WA; Claudianos, C; Berenbaum, MR; Biswas, S; de Graaf, DC; Feyereisen, R; Johnson, RM; Oakeshott, JG; Ranson, H; Schuler, MA; Muzny, D; Chacko, J; Davis, C; Dinh, H; Gill, R; Hernandez, J; Hines, S; Hume, J; Jackson, L; Kovar, C; Lewis, L; Miner, G; Morgan, M; Nguyen, N; Okwuonu, G; Paul, H; Santibanez, J; Savery, G; Svatek, A; Villasana, D; Wright, R				Weinstock, George M.; Robinson, Gene E.; Gibbs, Richard A.; Worley, Kim C.; Evans, Jay D.; Maleszka, Ryszard; Robertson, Hugh M.; Weaver, Daniel B.; Beye, Martin; Bork, Peer; Elsik, Christine G.; Hartfelder, Klaus; Hunt, Greg J.; Zdobnov, Evgeny M.; Amdam, Gro V.; Bitondi, Marcia M. G.; Collins, Anita M.; Cristino, Alexandre S.; Lattorff, H. Michael G.; Lobo, Carlos H.; Moritz, Robin F. A.; Nunes, Francis M. F.; Page, Robert E., Jr.; Simoes, Zila L. P.; Wheeler, Diana; Carninci, Piero; Fukuda, Shiro; Hayashizaki, Yoshihide; Kai, Chikatoshi; Kawai, Jun; Sakazume, Naoko; Sasaki, Daisuke; Tagami, Michihira; Albert, Stefan; Baggerman, Geert; Beggs, Kyle T.; Bloch, Guy; Cazzamali, Giuseppe; Cohen, Mira; Drapeau, Mark David; Eisenhardt, Dorothea; Emore, Christine; Ewing, Michael A.; Fahrbach, Susan E.; Foret, Sylvain; Grimmelikhuijzen, Cornelis J. P.; Hauser, Frank; Hummon, Amanda B.; Huybrechts, Jurgen; Jones, Andrew K.; Kadowaki, Tatsuhiko; Kaplan, Noam; Kucharski, Robert; Leboulle, Gerard; Linial, Michal; Littleton, J. Troy; Mercer, Alison R.; Richmond, Timothy A.; Rodriguez-Zas, Sandra L.; Rubin, Elad B.; Sattelle, David B.; Schlipalius, David; Schoofs, Liliane; Shemesh, Yair; Sweedler, Jonathan V.; Velarde, Rodrigo; Verleyen, Peter; Vierstraete, Evy; Williamson, Michael R.; Ament, Seth A.; Brown, Susan J.; Corona, Miguel; Dearden, Peter K.; Dunn, W. Augustine; Elekonich, Michelle M.; Fujiyuki, Tomoko; Gattermeier, Irene; Gempe, Tanja; Hasselmann, Martin; Kadowaki, Tatsuhiko; Kage, Eriko; Kamikouchi, Azusa; Kubo, Takeo; Kucharski, Robert; Kunieda, Takekazu; Lorenzen, Marce D.; Milshina, Natalia V.; Morioka, Mizue; Ohashi, Kazuaki; Overbeek, Ross; Ross, Christian A.; Schioett, Morten; Shippy, Teresa; Takeuchi, Hideaki; Toth, Amy L.; Willis, Judith H.; Wilson, Megan J.; Gordon, Karl H. J.; Letunic, Ivica; Hackett, Kevin; Peterson, Jane; Felsenfeld, Adam; Guyer, Mark; Solignac, Michel; Agarwala, Richa; Cornuet, Jean Marie; Monnerot, Monique; Mougel, Florence; Reese, Justin T.; Vautrin, Dominique; Gillespie, Joseph J.; Cannone, Jamie J.; Gutell, Robin R.; Johnston, J. Spencer; Eisen, Michael B.; Iyer, Venky N.; Iyer, Vivek; Kosarev, Peter; Mackey, Aaron J.; Solovyev, Victor; Souvorov, Alexandre; Aronstein, Katherine A.; Bilikova, Katarina; Chen, Yan Ping; Clark, Andrew G.; Decanini, Laura I.; Gelbart, William M.; Hetru, Charles; Hultmark, Dan; Imler, Jean-Luc; Jiang, Haobo; Kanost, Michael; Kimura, Kiyoshi; Lazzaro, Brian P.; Lopez, Dawn L.; Simuth, Jozef; Thompson, Graham J.; Zou, Zhen; De Jong, Pieter; Sodergren, Erica; Csuroes, Miklos; Milosavljevic, Aleksandar; Osoegawa, Kazutoyo; Richards, Stephen; Shu, Chung-Li; Duret, Laurent; Elhaik, Eran; Graur, Dan; Anzola, Juan M.; Campbell, Kathryn S.; Childs, Kevin L.; Collinge, Derek; Crosby, Madeline A.; Dickens, C. Michael; Grametes, L. Sian; Grozinger, Christina M.; Jones, Peter L.; Jorda, Mireia; Ling, Xu; Matthews, Beverly B.; Miller, Jonathan; Mizzen, Craig; Peinado, Miguel A.; Reid, Jeffrey G.; Russo, Susan M.; Schroeder, Andrew J.; St Pierre, Susan E.; Wang, Ying; Zhou, Pinglei; Jiang, Huaiyang; Kitts, Paul; Ruef, Barbara; Venkatraman, Anand; Zhang, Lan; Aquino-Perez, Gildardo; Whitfield, Charles W.; Behura, Susanta K.; Berlocher, Stewart H.; Sheppard, Walter S.; Smith, Deborah R.; Suarez, Andrew V.; Tsutsui, Neil D.; Wei, Xuehong; Wheeler, David; Havlak, Paul; Li, Bingshan; Liu, Yue; Sodergren, Erica; Jolivet, Angela; Lee, Sandra; Nazareth, Lynne V.; Pu, Ling-Ling; Thorn, Rachel; Stolc, Viktor; Newman, Thomas; Samanta, Manoj; Tongprasit, Waraporn A.; Claudianos, Charles; Berenbaum, May R.; Biswas, Sunita; de Graaf, Dirk C.; Feyereisen, Rene; Johnson, Reed M.; Oakeshott, John G.; Ranson, Hilary; Schuler, Mary A.; Muzny, Donna; Chacko, Joseph; Davis, Clay; Dinh, Huyen; Gill, Rachel; Hernandez, Judith; Hines, Sandra; Hume, Jennifer; Jackson, LaRonda; Kovar, Christie; Lewis, Lora; Miner, George; Morgan, Margaret; Nguyen, Ngoc; Okwuonu, Geoffrey; Paul, Heidi; Santibanez, Jireh; Savery, Glenford; Svatek, Amanda; Villasana, Donna; Wright, Rita		Honeybee Genome Sequencing Consort	Insights into social insects from the genome of the honeybee Apis mellifera	NATURE			English	Review							DROSOPHILA-NINAG OXIDOREDUCTASE; TRANSPOSABLE ELEMENTS; MITOCHONDRIAL-DNA; ANOPHELES-GAMBIAE; GENE-EXPRESSION; FRUIT-FLY; STATISTICAL-ANALYSIS; MOLECULAR EVOLUTION; MARINER TRANSPOSONS; MALARIA MOSQUITO	Here we report the genome sequence of the honeybee Apis mellifera, a key model for social behaviour and essential to global ecology through pollination. Compared with other sequenced insect genomes, the A. mellifera genome has high A+T and CpG contents, lacks major transposon families, evolves more slowly, and is more similar to vertebrates for circadian rhythm, RNA interference and DNA methylation genes, among others. Furthermore, A. mellifera has fewer genes for innate immunity, detoxification enzymes, cuticle-forming proteins and gustatory receptors, more genes for odorant receptors, and novel genes for nectar and pollen utilization, consistent with its ecology and social organization. Compared to Drosophila, genes in early developmental pathways differ in Apis, whereas similarities exist for functions that differ markedly, such as sex determination, brain function and behaviour. Population genetics suggests a novel African origin for the species A. mellifera and insights into whether Africanized bees spread throughout the New World via hybridization or displacement.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Hum Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; USDA ARS, Bee Res Lab, BARC E, Beltsville, MD 20705 USA; USDA ARS, Natl Program Staff, Beltsville, MD 20705 USA; Australian Natl Univ, ARC, Special Ctr Mol Genet Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia; Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Bee Power LP, Navasota, TX 77868 USA; Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; Univ Houston, Dept Chem, Houston, TX 77204 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil; Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogenicos, Ribeirao Preto, Brazil; Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Biol, BR-14049900 Ribeirao Preto, Brazil; Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; Univ Geneva, Sch Med, CMU, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Sao Paulo, Inst Matemat & Estatist, Sao Paulo, Brazil; Univ Halle Wittenberg, Inst Zool Mol Okol, D-06099 Halle, Saale, Germany; Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; RIKEN, Genom Sci Ctr, Lab Genome Explorat Res Grp, Yokohama, Kanagawa 2300045, Japan; Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Katholieke Univ Leuven, Lab Dev Physiol Genom & Prote, B-3000 Louvain, Belgium; Univ Otago, Dept Biochem, Lab Evolut & Dev, Dunedin, New Zealand; Univ Otago, Dept Zool, Dunedin, New Zealand; Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Univ Copenhagen, Inst Biol, Dept Cell Biol & Comparat Zool, Ctr Funct & Comparat Insect Genom, DK-2100 Copenhagen, Denmark; NYU, Dept Biol, New York, NY 10003 USA; Free Univ Berlin, FB Biol Chem Pharm, D-14195 Berlin, Germany; Univ Oxford, MRC, Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; CSIRO Entomol, Canberra, ACT 2601, Australia; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Ghent, Lab Zoophysiol, B-9000 Ghent, Belgium; Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; USDA ARS, GMPRC, Manhattan, KS 66502 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; CNRS, Lab Evolut Genomes & Speciat, F-91198 Gif Sur Yvette, France; Fellowship Interpretat Genomes, Burr Ridge, IL 60527 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, US Dept HHS, Bethesda, MD 20894 USA; INRA, Ctr Biol & Gest Populat, F-34988 St Gely Du Fesc, France; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Virginia Tech, Bioinformat Facil, Virginia Bioinformat Inst 0477, Blacksburg, VA 24061 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Softberry Inc, Mt Kisco, NY 10549 USA; Univ Penn, Penn Genom Inst, Philadelphia, PA 19104 USA; Univ London Royal Holloway & Bedford New Coll, Egham TW20 0EX, Surrey, England; USDA ARS, Honey Bee Unit, Weslaco, TX 78596 USA; Slovak Acad Sci, Bratislava 84551, Slovakia; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3058517, Japan; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Childrens Hosp Oakland, BACPAC Resources, Oakland, CA 94609 USA; Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; N Carolina State Univ, Dept Entomol, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; Univ Kansas, Dept Ecol & Evolutionary Biol Entomol, Lawrence, KS 66045 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; NASA, Ames Genome Res Facil, Moffett Field, CA 94035 USA; Systemix Inst, Cupertino, CA 95014 USA; Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Oncol Res Inst, Lhospitalet De Llobregat 08907, Catalonia, Spain; INRA, F-06903 Sophia Antipolis, France; Univ Nice Sophia Antipolis, Ctr Rech Sophia Antipolis, UMR 1112, F-06903 Sophia Antipolis, France	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Australian National University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Heinrich Heine University Dusseldorf; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Texas A&M University System; Texas A&M University College Station; University of Houston System; University of Houston; University of Houston System; University of Houston; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Geneva; Arizona State University; Arizona State University-Tempe; Universidade de Sao Paulo; Martin Luther University Halle Wittenberg; University of Arizona; RIKEN; KU Leuven; University of Otago; University of Otago; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Copenhagen; New York University; Free University of Berlin; University of Oxford; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Ghent University; Wake Forest University; United States Department of Agriculture (USDA); Kansas State University; Kansas State University; University System of Georgia; University of Georgia; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Tokyo; Nagoya University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); INRAE; Institut de Recherche pour le Developpement (IRD); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Wellcome Trust Sanger Institute; University of Pennsylvania; University of London; Royal Holloway University London; United States Department of Agriculture (USDA); Slovak Academy of Sciences; Cornell University; Cornell University; Harvard University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Umea University; Oklahoma State University System; Oklahoma State University - Stillwater; National Agriculture & Food Research Organization - Japan; University of Sydney; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of North Carolina; North Carolina State University; Washington State University; University of Kansas; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); Universite de Montreal; Liverpool School of Tropical Medicine; University of Liverpool; INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Weinstock, GM (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	gwstock@bcm.edu	Evans, Jay D/C-8408-2012; Blow, joe/C-8616-2009; Linial, Michal/AAQ-9259-2020; Bork, Peer/F-1813-2013; Bloch, Guy/I-5861-2019; Schlipalius, David/B-8155-2011; Kaplan, Noam/A-3544-2011; Letunic, Ivica/K-1102-2019; Smith, Deborah/V-1676-2019; Hultmark, Dan/C-5058-2013; Cristino, Alexandre S/A-5834-2012; Sweedler, Jonathan V/A-9405-2009; Maleszka, Ryszard/A-6078-2008; Elsik, Christine G/C-4120-2017; Fujiyuki, Tomoko Kaito/GYD-6398-2022; Jordà, Mireia/Z-4519-2019; Gordon, Karl H J/A-1976-2008; Nunes, Francis M. F./F-5871-2010; Zdobnov, Evgeny/AAB-2745-2022; Jiang, Haobo/A-6519-2008; Feyereisen, René/Y-7514-2019; Miller, Jonathan/M-4389-2014; Wilson, Matthew H/K-3193-2013; KUBO, TAKEO/G-4951-2014; Simoes, Zila Luz Paulino/H-7314-2014; Lattorff, Michael/F-6287-2010; Kunieda, Takekazu/G-4946-2014; de Graaf, Dirk C./HGD-4017-2022; Kawai, Jun/A-6451-2016; Weinstock, George M/C-6314-2013; FORET, Sylvain/B-9207-2012; Peinado, Miguel A./A-5591-2008; Imler, Jean-Luc/GXH-4323-2022; Thompson, Graham J/B-6508-2008; Hasselmann, Martin/ABB-6485-2021; schoofs, liliane/ABD-2943-2020; TAKEUCHI, HIDEAKI/G-4969-2014; Moritz, Robin FA/K-6053-2012; Schiøtt, Morten/AAJ-8945-2021; Takeuchi, Hideaki/W-6739-2018; Elhaik, Eran/H-6838-2019; Linial, Michal/B-9143-2011; Kaplan, Noam/K-4383-2019; Hauser, Frank/M-2952-2014; Dearden, Peter/B-7607-2008; Beggs, Kyle/A-5843-2009; Foret, Sylvain/C-7661-2011; Hasselmann, Martin/E-7681-2014; Johnson, Reed M./H-3742-2011; Hartfelder, Klaus/L-2300-2019; Schiøtt, Morten/H-4118-2012; Zdobnov, Evgeny M/K-1133-2012; Feyereisen, René/I-3140-2012; Li, Bingshan/H-1944-2011; Letunic, Ivica/A-6032-2009; zou, zhen/C-6134-2016; Solovyev, Victor/C-4614-2013; Wheeler, David A/M-9740-2018; Hartfelder, Klaus/A-4293-2009; Carninci, Piero/K-1568-2014; Bitondi, Marcia MG/E-8014-2012; Oakeshott, John G/B-5365-2009; Childs, Kevin/C-9513-2014; Schoofs, Liliane/F-2815-2010	Evans, Jay D/0000-0002-0036-4651; Linial, Michal/0000-0002-9357-4526; Bork, Peer/0000-0002-2627-833X; Bloch, Guy/0000-0003-1624-4926; Schlipalius, David/0000-0002-8102-7031; Kaplan, Noam/0000-0001-9940-1987; Letunic, Ivica/0000-0003-3560-4288; Smith, Deborah/0000-0002-2581-5009; Hultmark, Dan/0000-0002-6506-5855; Cristino, Alexandre S/0000-0002-3468-0919; Sweedler, Jonathan V/0000-0003-3107-9922; Maleszka, Ryszard/0000-0003-1855-555X; Elsik, Christine G/0000-0002-4248-7713; Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Gordon, Karl H J/0000-0002-4371-0454; Nunes, Francis M. F./0000-0002-7769-3058; Zdobnov, Evgeny/0000-0002-5178-1498; Feyereisen, René/0000-0002-9560-571X; Miller, Jonathan/0000-0003-2190-6824; Lattorff, Michael/0000-0002-8603-6332; Weinstock, George M/0000-0002-2997-4592; Peinado, Miguel A./0000-0002-4090-793X; Hasselmann, Martin/0000-0003-3305-4024; Moritz, Robin FA/0000-0003-0791-887X; Schiøtt, Morten/0000-0002-4309-8090; Takeuchi, Hideaki/0000-0001-6610-3895; Elhaik, Eran/0000-0003-4795-1084; Kaplan, Noam/0000-0001-9940-1987; Hauser, Frank/0000-0001-5563-2345; Dearden, Peter/0000-0001-7790-9675; Johnson, Reed M./0000-0002-2431-0180; Hartfelder, Klaus/0000-0001-7981-8427; Schiøtt, Morten/0000-0002-4309-8090; Feyereisen, René/0000-0002-9560-571X; zou, zhen/0000-0003-3550-7656; Solovyev, Victor/0000-0001-8885-493X; Wheeler, David A/0000-0002-9056-6299; Hartfelder, Klaus/0000-0001-7981-8427; Carninci, Piero/0000-0001-7202-7243; Bitondi, Marcia MG/0000-0002-5619-6378; Oakeshott, John G/0000-0001-8324-7874; Schroeder, Andrew/0000-0002-5824-7917; Childs, Kevin/0000-0002-3680-062X; Eisen, Michael/0000-0002-7528-738X; Kunieda, Takekazu/0000-0002-6256-1335; Brown, Susan/0000-0002-7984-0445; Kucharski, Robert/0000-0002-1708-1877; behura, Susanta/0000-0003-1057-2435; Ruef, Barbara/0000-0001-8690-979X; Kamikouchi, Azusa/0000-0003-1552-6892; Jiang, Haobo/0000-0003-1357-1315; Ranson, Hilary/0000-0003-2332-8247; Jorda, Mireia/0000-0003-3709-1850; Ewing, Michael/0000-0001-5271-5655; Jones, Andrew/0000-0002-7835-0890; Anzola, Juan/0000-0003-2677-6731; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Simoes, Zila Luz Paulino/0000-0003-2363-6178; Fukuda, Shiro/0000-0002-0065-662X; Littleton, J. Troy/0000-0001-5576-2887; Claudianos, Charles/0000-0002-9799-9572; Baggerman, Geert/0000-0002-0661-931X; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; , Derek/0000-0002-3940-3777; Schoofs, Liliane/0000-0002-1673-432X; Mercer, Alison/0000-0001-8110-4247; Kubo, Takeo/0000-0002-5914-5269; Kanost, Michael/0000-0002-6827-0061; Lorenzen, Marce/0000-0003-2318-1388; Gillespie, Joseph/0000-0002-5447-7264; Worley, Kim/0000-0002-0282-1000; Wilson, Megan/0000-0003-3425-5071; Corona, Miguel/0000-0002-2582-5397; Duret, Laurent/0000-0003-2836-3463; Shippy, Teresa/0000-0003-2305-7432	Medical Research Council [MC_U137761447] Funding Source: Medline; NIGMS NIH HHS [R01 GM058634-08, R01 GM067317, R37 GM041247, R01 GM067317-03] Funding Source: Medline; NINDS NIH HHS [R01 NS043244, R01 NS040296-06, R01 NS040296] Funding Source: Medline; Wellcome Trust [062023] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067317, R01GM058634, R37GM041247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296, R01NS043244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; MRC [MC_U137761447] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahmad ST, 2006, J BIOL CHEM, V281, P9205, DOI 10.1074/jbc.M510293200; Albert S, 1999, J MOL EVOL, V49, P290, DOI 10.1007/PL00006551; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; [Anonymous], 1971, INSECT SOC; Aronstein K, 2005, APIDOLOGIE, V36, P3, DOI 10.1051/apido:2004062; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Baudry E, 2004, GENETICS, V167, P243, DOI 10.1534/genetics.167.1.243; BERENBAUM MR, 1999, MOL BIOL TOXIC RESPO, P553; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BEYE M, 1993, BIOTECHNIQUES, V14, P372; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; BEYE M, 1995, J HERED, V86, P145, DOI 10.1093/oxfordjournals.jhered.a111545; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; BEYE M, IN PRESS GENOME RES; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Biessmann H, 1998, INSECT MOL BIOL, V7, P83, DOI 10.1046/j.1365-2583.1998.71054.x; BIGOT Y, 1992, GENE, V121, P347, DOI 10.1016/0378-1119(92)90142-C; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; Bolshakov VN, 2002, GENOME RES, V12, P57, DOI 10.1101/gr.196101; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; CLAUDIANOS C, IN PRESS INSECT MOL; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cohen N, 2005, MOL BIOL EVOL, V22, P1260, DOI 10.1093/molbev/msi115; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Corona M, 1999, J EXP BIOL, V202, P929; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Danforth BN, 2006, MOL PHYLOGENET EVOL, V39, P358, DOI 10.1016/j.ympev.2005.09.022; Danforth BN, 2006, P NATL ACAD SCI USA, V103, P15118, DOI 10.1073/pnas.0604033103; DAVIDSON EH, 2001, GENOME REGULATORY SY; Dearden PK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-6; DEARDEN PK, IN PRESS GENOME RES; DRAPEAU MD, IN PRESS GENOME RES; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; EBERT PR, 1995, INSECT MOL BIOL, V4, P69, DOI 10.1111/j.1365-2583.1995.tb00010.x; Eiglmeier K, 2005, INSECT BIOCHEM MOLEC, V35, P799, DOI 10.1016/j.ibmb.2005.02.020; EISENHARDT D, IN PRESS INSECT MOL; ELSIK CG, IN PRESS GENOME BIOL; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; EVANS JD, IN PRESS INSECT MOL; Evans JSO, 2000, INT J INORG MATER, V2, P1; Feyereisen R., 2005, P1; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FORET S, IN PRESS GENOME RES; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Franck P, 2000, APIDOLOGIE, V31, P167, DOI 10.1051/apido:2000114; Fujiwara H, 2005, CHROMOSOME RES, V13, P455, DOI 10.1007/s10577-005-0990-9; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gerber S, 2000, HUM GENET, V107, P276, DOI 10.1007/s004390000350; GILLESPIE JJ, IN PRESS INSECT MOL; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Goodwin TJD, 2004, MOL GENET GENOMICS, V272, P47, DOI 10.1007/s00438-004-1028-2; Gregorc A, 1998, CELL BIOL INT, V22, P137, DOI 10.1006/cbir.1998.0232; Grimaldi David, 2005, pi; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hamilton W.D., 1972, Annual Rev Ecol Syst, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hepperle C, 2001, NATURWISSENSCHAFTEN, V88, P113, DOI 10.1007/s001140000196; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; *HON BEE GEN SEQ C, 2002, PROP SEQ NEW TARG GE; *HUM GEN SEQ CTR B, 2006, HON BEE GEN PROJ; HUMMON AB, IN PRESS SCIENCE; HUNT G, IN PRESS NATURWISSEN; HUNT GJ, 1995, GENETICS, V139, P1371; ILTIS H, 1923, LIFE MENDEL; JONES AK, IN PRESS GENOME RES; JORDAN RA, 1974, J INSECT PHYSIOL, V20, P2513, DOI 10.1016/0022-1910(74)90035-3; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Krieger MJB, 2003, INSECT MOL BIOL, V12, P155, DOI 10.1046/j.1365-2583.2003.00397.x; Kucharski R, 2000, GENE, V242, P399, DOI 10.1016/S0378-1119(99)00503-X; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McAllister BF, 1997, MOL BIOL EVOL, V14, P69, DOI 10.1093/oxfordjournals.molbev.a025704; Melnikova L, 2005, CHROMOSOME RES, V13, P431, DOI 10.1007/s10577-005-0992-7; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mongin E, 2004, TRENDS PARASITOL, V20, P49, DOI 10.1016/j.pt.2003.11.003; Morse R.A., 1997, HONEY BEE PESTS PRED; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Ranson H., 2005, P383; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; ROBERTSON HM, 1995, ANNU REV ENTOMOL, V40, P333, DOI 10.1146/annurev.en.40.010195.002001; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; ROBERTSON HM, 2002, MOBILE DNA, V2; ROBERTSON HM, IN PRESS GENOME RES; Robertson Hugh M., 2005, American Entomologist, V51, P166; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Rosellini D, 2000, P FORAG GR, V9, P314; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; RUTTNER F, 1978, APIDOLOGIE, V9, P363, DOI 10.1051/apido:19780408; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; SAVARD J, IN PRESS GENOME RES; Schmid-Hempel P., 1998, Parasites in social insects.; Schroder R, 2006, DEV GENES EVOL, V216, P277, DOI 10.1007/s00427-005-0054-3; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; Sheppard WS, 1999, GENET MOL BIOL, V22, P73, DOI 10.1590/S1415-47571999000100015; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Si A, 2004, PHARMACOL BIOCHEM BE, V77, P191, DOI 10.1016/j.pbb.2003.09.023; SINHA S, IN PRESS P NATL ACAD; SKRZIPEK KH, 1974, Z ZELLFORSCH MIK ANA, V147, P589, DOI 10.1007/BF00307257; SMITH DR, 1988, EXPERIENTIA, V44, P257, DOI 10.1007/BF01941730; SMITH WC, 1990, J MOL EVOL, V30, P72, DOI 10.1007/BF02102454; Solignac M, 2004, GENETICS, V167, P253, DOI 10.1534/genetics.167.1.253; SOLIGNAC M, UNPUB GENOME BIOL; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Tomlinson A, 2001, MOL CELL, V7, P487, DOI 10.1016/S1097-2765(01)00196-4; Townson SM, 1998, J NEUROSCI, V18, P2412; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tremolada P, 2004, ECOTOXICOLOGY, V13, P589, DOI 10.1023/B:ECTX.0000037193.28684.05; *TRIB GEN SEQ PROJ, 2006, TRIB CAST V 2 0 ASS; Tsuchimoto M, 2005, DEV GENES EVOL, V215, P564, DOI 10.1007/s00427-005-0021-z; VARRICCHIO P, 1995, MOL BIOL, V25, P603; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; VELARDE RA, IN PRESS INSECT MOL; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WALLNER K, 1995, AM BEE J, V135, P817; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; WANG Y, IN PRESS SCIENCE; West-Eberhard Mary Jane, 2003, pi; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WHITFIELD CW, IN PRESS SCIENCE; WHITFIELD CW, IN PRESS P NATL ACAD; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; WILLIS JH, 2005, COMPREHENSIVE MOL IN, V4, P79; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Winston M.L., 1991, BIOL HONEY BEE; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; XIONG Y, 1988, NUCLEIC ACIDS RES, V16, P10561, DOI 10.1093/nar/16.22.10561; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; ZDOBNOV E, IN PRESS TRENDS GENE; Zdobnov EM, 2005, FEBS LETT, V579, P3355, DOI 10.1016/j.febslet.2005.04.006; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	180	1340	1443	15	575	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					931	949		10.1038/nature05260	http://dx.doi.org/10.1038/nature05260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17073008	Green Accepted, Bronze			2022-12-28	WOS:000241523400044
J	Tolstoy, M; Cowen, JP; Baker, ET; Fornari, DJ; Rubin, KH; Shank, TM; Waldhauser, F; Bohnenstiehl, DR; Forsyth, DW; Holmes, RC; Love, B; Perfit, MR; Weekly, RT; Soule, SA; Glazer, B				Tolstoy, M.; Cowen, J. P.; Baker, E. T.; Fornari, D. J.; Rubin, K. H.; Shank, T. M.; Waldhauser, F.; Bohnenstiehl, D. R.; Forsyth, D. W.; Holmes, R. C.; Love, B.; Perfit, M. R.; Weekly, R. T.; Soule, S. A.; Glazer, B.			A sea-floor spreading event captured by seismometers	SCIENCE			English	Article							EAST PACIFIC RISE; MIDOCEAN RIDGE; SEGMENTATION; CREST	Two-thirds of Earth's surface is formed at mid-ocean ridges, yet sea-floor spreading events are poorly understood because they occur far beneath the ocean surface. At 9 degrees 50' N on the East Pacific Rise, ocean-bottom seismometers recently recorded the microearthquake character of a mid-ocean ridge eruption, including precursory activity. A gradual ramp-up in activity rates since seismic monitoring began at this site in October 2003 suggests that eruptions may be forecast in the fast-spreading environment. The pattern culminates in an intense but brief (similar to 6-hour) inferred diking event on 22 January 2006, followed by rapid tapering to markedly decreased levels of seismicity.	Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	University of Hawaii System; University of Hawaii Manoa; Columbia University; National Oceanic Atmospheric Admin (NOAA) - USA; Woods Hole Oceanographic Institution; University of Hawaii System; University of Hawaii Manoa; Brown University; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida	Tolstoy, M (corresponding author), Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA.	tolstoy@ldeo.columbia.edu	Rubin, Kenneth H/B-3685-2008; Baker, Edward/C-7688-2015; Glazer, Brian/C-2248-2011	Rubin, Kenneth H/0000-0002-8554-1337; Baker, Edward/0000-0002-8794-4180; Soule, Adam/0000-0002-4691-6300; Perfit, Michael/0000-0002-1399-8928; Holmes, R. Chadwick/0000-0002-7884-9843				CARBOTTE SM, 1994, J GEOPHYS RES-SOL EA, V99, P13609, DOI 10.1029/93JB02971; Daniel J., 2003, EOS T AM GEOPHYS UN, V84, P69, DOI [DOI 10.1029/2003E0080001, 10.1029/2003EO080001, DOI 10.1029/2003EO080001]; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3429, DOI 10.1029/1999GL002332; FERRINI VL, IN PRESS GEOCHEM GEO; Fornari DJ, 1998, J GEOPHYS RES-SOL EA, V103, P9827, DOI 10.1029/98JB00028; Fox CG, 2001, J GEOPHYS RES-SOL EA, V106, P4183, DOI 10.1029/2000JB900404; Haymon RM, 2004, EARTH PLANET SC LETT, V226, P367, DOI 10.1016/j.epsl.2004.08.002; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; HILDEBRAND JA, 1991, RIDGE EVENTS, V2, P6; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13945, DOI 10.1029/93JB00705; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; MACDONALD KC, 1988, NATURE, V335, P217, DOI 10.1038/335217a0; Perfit MR, 1998, GEOPH MONOG SERIES, V106, P59; PERFIT MR, 1994, GEOLOGY, V22, P375, DOI 10.1130/0091-7613(1994)022<0375:SSSATV>2.3.CO;2; RUBIN KH, 1994, NATURE, V368, P841, DOI 10.1038/368841a0; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Sohn RA, 1999, J GEOPHYS RES-SOL EA, V104, P25367, DOI 10.1029/1999JB900263; Soule SA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000912; Tolstoy M, 2001, GEOLOGY, V29, P1139, DOI 10.1130/0091-7613(2001)029<1139:SCOVAA>2.0.CO;2; TOLSTOY M, 2006, RIDG 2000 EPR ISS SC; Von Damm KL, 2004, GEOPH MONOG SERIES, V144, P245, DOI 10.1029/144GM16; VONDAMM KI, COMMUNICATION; White SM, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000571; WHITE SM, GEOCHEM GEOPHYS GEOS	24	149	150	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1920	1922		10.1126/science.1133950	http://dx.doi.org/10.1126/science.1133950			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17124289				2022-12-28	WOS:000242996800046
J	Mansfield, PR				Mansfield, Peter R.			Doctors as lapdogs to drug firms - Independence may be most cost effective way to improve health care	BRITISH MEDICAL JOURNAL			English	Letter									Healthy Skepticism, Willunga, SA 5172, Australia		Mansfield, PR (corresponding author), Healthy Skepticism, 34 Methodist St, Willunga, SA 5172, Australia.	peter@healthyskepticism.org	Mansfield, Peter/Q-8707-2019					Fugh-Berman A, 2006, BMJ-BRIT MED J, V333, P1027, DOI 10.1136/bmj.39024.654086.59; Mansfield P, 2004, BMJ-BRIT MED J, V329, P1487, DOI 10.1136/bmj.329.7480.1487; Mansfield PR, 2006, PLOS MED, V3, P1988, DOI 10.1371/journal.pmed.0030451; Norris P, 2005, DRUG PROMOTION WHAT; HLTH SKEPTICISM LIB	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 25	2006	333	7578					1121	1122		10.1136/bmj.39037.695069.3A	http://dx.doi.org/10.1136/bmj.39037.695069.3A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124226	Green Published, Green Submitted			2022-12-28	WOS:000242520200025
J	Adami, C				Adami, Christoph			Computer science - What do robots dream of?	SCIENCE			English	Editorial Material									Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA	Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Adami, C (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.	adami@kgi.edu	Adami, Chris/A-9675-2011; Adami, Christoph/A-5181-2009	Adami, Chris/0000-0002-2915-9504; 				Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Cover TM, 1991, ELEMENTS INFORM THEO; Koch Christof, 2004, QUEST CONSCIOUSNESS; Thrun S., 2005, PROBABILISTIC ROBOTI	4	28	28	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1093	1094		10.1126/science.1135929	http://dx.doi.org/10.1126/science.1135929			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110560				2022-12-28	WOS:000242045800026
J	Chang, CW; Okawa, D; Majumdar, A; Zettl, A				Chang, C. W.; Okawa, D.; Majumdar, A.; Zettl, A.			Solid-state thermal rectifier	SCIENCE			English	Article							CONDUCTIVITY	We demonstrated nanoscale solid-state thermal rectification. High-thermal-conductivity carbon and boron nitride nanotubes were mass-loaded externally and inhomogeneously with heavy molecules. The resulting nanoscale system yields asymmetric axial thermal conductance with greater heat flow in the direction of decreasing mass density. The effect cannot be explained by ordinary perturbative wave theories, and instead we suggest that solitons may be responsible for the phenomenon. Considering the important role of electrical rectifiers ( diodes) in electronics, thermal rectifiers have substantial implications for diverse thermal management problems, ranging from nanoscale calorimeters to microelectronic processors to macroscopic refrigerators and energy-saving buildings.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Ctr Integrated Nanomech Syst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zettl, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@berkeley.edu	Chang, Chih-Wei/A-5974-2012; Zettl, Alex K/O-4925-2016	Zettl, Alex K/0000-0001-6330-136X; Majumdar, Arunava/0000-0003-4226-9705				Astakhova TY, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.035418; Casati G, 2005, CHAOS, V15, DOI 10.1063/1.1869912; Chang CW, 2005, J VAC SCI TECHNOL B, V23, P1883, DOI 10.1116/1.2008266; COLBERT DT, 1994, SCIENCE, V266, P1218, DOI 10.1126/science.266.5188.1218; Hone J, 1999, PHYS REV B, V59, pR2514, DOI 10.1103/PhysRevB.59.R2514; IIZUKA T, 1992, J PHYS SOC JPN, V61, P3077, DOI 10.1143/JPSJ.61.3077; Lepri S, 2003, PHYS REP, V377, P1, DOI 10.1016/S0370-1573(02)00558-6; Li BW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.184301; Peierls R.F., 1955, QUANTUM THEORY SOLID; SAKAI S, 1987, PHYS REV B, V36, P217, DOI 10.1103/PhysRevB.36.217; Savin AV, 2004, PHYS SOLID STATE+, V46, P383, DOI 10.1134/1.1649441; Segal D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.034301; Shi L, 2003, J HEAT TRANS-T ASME, V125, P881, DOI 10.1115/1.1597619; Tang C, 2002, CHEM COMMUN, P1290, DOI 10.1039/b202177c; Terraneo M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.094302; Woafo P, 1998, PHYS REV E, V58, P1033, DOI 10.1103/PhysRevE.58.1033	16	953	976	9	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1121	1124		10.1126/science.1132898	http://dx.doi.org/10.1126/science.1132898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110571				2022-12-28	WOS:000242045800037
J	Hongay, CF; Grisafi, PL; Galitski, T; Fink, GR				Hongay, Cintia F.; Grisafi, Paula L.; Galitski, Timothy; Fink, Gerald R.			Antisense transcription controls cell fate in Saccharomyces cerevisiae	CELL			English	Article							GENE-EXPRESSION; INVASIVE GROWTH; MESSENGER-RNA; YEAST; GENOME; PROTEIN; DNA; TRANSPOSITION; INTERFERENCE; CASSETTES	Entry into meiosis is a key developmental decision. We show here that meiotic entry in Saccharomyces cerevisiae is controlled by antisense-mediated regulation of IME4, a gene required for initiating meiosis. In MATa/alpha diploids the antisense IME4 transcript is repressed by binding of the a1/alpha 2 heterodimer at a conserved site located downstream of the IME4 coding sequence. MAT a/alpha diploids that produce IME4 antisense transcript have diminished sense transcription and fail to initiate meiosis. Haploids that produce the sense transcript have diminished antisense transcription and manifest several diploid phenotypes. Our data are consistent with transcription interference as a regulatory mechanism at the IME4 locus that determines cell fate.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Inst Syst Biol, Seattle, WA 98103 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Institute for Systems Biology (ISB)	Fink, GR (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02139 USA.	gfink@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R01GM035010, F32GM077738] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM35010-23, R01 GM040266-23, 5F32GM077738] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P682, DOI 10.1093/nar/25.3.682; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; FRASER RSS, 1975, EUR J BIOCHEM, V60, P477, DOI 10.1111/j.1432-1033.1975.tb21026.x; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jin YS, 1999, MOL CELL BIOL, V19, P585; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; KLECKNER N, 1990, ANNU REV CELL BIOL, V6, P297, DOI 10.1146/annurev.cb.06.110190.001501; Lau NC, 2003, SCI AM, V289, P34, DOI 10.1038/scientificamerican0803-34; Ma Zhong-Liang, 2003, Acta Genetica Sinica, V30, P693; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MIYAJIMA I, 1987, CELL, V50, P1011, DOI 10.1016/0092-8674(87)90167-X; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Palecek SP, 2000, GENETICS, V156, P1005; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Purnapatre K, 2005, MOL CELL BIOL, V25, P440, DOI 10.1128/MCB.25.1.440-450.2005; Rose MD., 1990, METHODS YEAST GENETI; Samanta MP, 2006, P NATL ACAD SCI USA, V103, P4192, DOI 10.1073/pnas.0507669103; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	36	269	274	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					735	745		10.1016/j.cell.2006.09.038	http://dx.doi.org/10.1016/j.cell.2006.09.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110333	Bronze			2022-12-28	WOS:000242330600020
J	Losos, JB; Schoener, TW; Langerhans, RB; Spiller, DA				Losos, Jonathan B.; Schoener, Thomas W.; Langerhans, R. Brian; Spiller, David A.			Rapid temporal reversal in predator-driven natural selection	SCIENCE			English	Article							POPULATIONS; LIZARD		Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA	Washington University (WUSTL); University of California System; University of California Davis	Losos, JB (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu	Langerhans, R. Brian/A-4431-2008; Langerhans, R. Brian/ABE-6246-2021; Rohlf, F J/A-8710-2008					Irschick DJ, 1999, AM NAT, V154, P293, DOI 10.1086/303239; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schoener TW, 2002, ECOL MONOGR, V72, P383, DOI 10.1890/0012-9615(2002)072[0383:POACAL]2.0.CO;2; Thorpe RS, 2005, AM NAT, V165, P495, DOI 10.1086/428408; Williams E.E., 1983, P326	7	110	111	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1111	1111		10.1126/science.1133584	http://dx.doi.org/10.1126/science.1133584			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110568				2022-12-28	WOS:000242045800034
J	Zerhouni, EA				Zerhouni, Elias A.			Research funding - NIH in the post-doubling era: Realities and strategies	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Zerhouni, EA (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	zerhounidirect@nih.gov						BARTON J, 2006, COMMUNICATION   0928; MURPHY R, 1999, EC VALUE MED RES; Office of Budget National Institutes of Health (NIH), PRIC IND; Woolley M, 2005, JAMA-J AM MED ASSOC, V294, P1380, DOI 10.1001/jama.294.11.1380	4	75	75	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1088	1090		10.1126/science.1136931	http://dx.doi.org/10.1126/science.1136931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	105PW	17110557				2022-12-28	WOS:000242045800023
J	Wang, JL; Rao, S; Chu, JL; Shen, XH; Levasseur, DN; Theunissen, TW; Orkin, SH				Wang, Jianlong; Rao, Sridhar; Chu, Jianlin; Shen, Xiaohua; Levasseur, Dana N.; Theunissen, Thorold W.; Orkin, Stuart H.			A protein interaction network for pluripotency of embryonic stem cells	NATURE			English	Article							TRANSCRIPTION FACTORS; POZ/BTB PROTEIN; MOUSE EMBRYOS; ES CELLS; NANOG; GENE; EXPRESSION; COMPLEX; DIFFERENTIATION; CULTURES	Embryonic stem ( ES) cells are pluripotent(1,2) and of therapeutic potential in regenerative medicine(3,4). Understanding pluripotency at the molecular level should illuminate fundamental properties of stem cells and the process of cellular reprogramming. Through cell fusion the embryonic cell phenotype can be imposed on somatic cells, a process promoted by the homeodomain protein Nanog(5), which is central to the maintenance of ES cell pluripotency(6,7). Nanog is thought to function in concert with other factors such as Oct4 ( ref. 8) and Sox2 ( ref. 9) to establish ES cell identity. Here we explore the protein network in which Nanog operates in mouse ES cells. Using affinity purification of Nanog under native conditions followed by mass spectrometry, we have identified physically associated proteins. In an iterative fashion we also identified partners of several Nanog- associated proteins ( including Oct4), validated the functional relevance of selected newly identified components and constructed a protein interaction network. The network is highly enriched for nuclear factors that are individually critical for maintenance of the ES cell state and co- regulated on differentiation. The network is linked to multiple co- repressor pathways and is composed of numerous proteins whose encoding genes are putative direct transcriptional targets of its members. This tight protein network seems to function as a cellular module dedicated to pluripotency.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Wang, Jianlong/AAG-9425-2020; Wang, Jianlong/GQR-1191-2022	Wang, Jianlong/0000-0002-1317-6457; Theunissen, Thorold/0000-0001-6943-7858				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Korutla L, 2005, J NEUROCHEM, V94, P786, DOI 10.1111/j.1471-4159.2005.03206.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Law DJ, 1999, BIOCHEM BIOPH RES CO, V262, P113, DOI 10.1006/bbrc.1999.1180; Lee JW, 2005, STEM CELLS, V23, P738, DOI 10.1634/stemcells.2004-0375; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mackler SA, 2003, NEUROSCIENCE, V121, P355, DOI 10.1016/S0306-4522(03)00376-2; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Prelle K, 2002, ANAT HISTOL EMBRYOL, V31, P169, DOI 10.1046/j.1439-0264.2002.00388.x; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson JR, 2002, MOL CELL ENDOCRINOL, V195, P119, DOI 10.1016/S0303-7207(02)00180-6	28	841	889	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					364	368		10.1038/nature05284	http://dx.doi.org/10.1038/nature05284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17093407				2022-12-28	WOS:000242018300048
J	Bottjer, DJ; Davidson, EH; Peterson, KJ; Cameron, RA				Bottjer, David J.; Davidson, Eric H.; Peterson, Kevin J.; Cameron, R. Andrew			Review - Paleogenomics of echinoderms	SCIENCE			English	Review							SPICULE MATRIX PROTEIN; SKELETOGENIC GENE; BIOMINERALIZATION; EVOLUTION; CALCITE; HISTORY	Paleogenomics propels the meaning of genomic studies back through hundreds of millions of years of deep time. Now that the genome of the echinoid Strongylocentrotus purpuratus is sequenced, the operation of its genes can be interpreted in light of the well-understood echinoderm fossil record. Characters that first appear in Early Cambrian forms are still characteristic of echinoderms today. Key genes for one of these characters, the biomineralized tissue stereom, can be identified in the S. purpuratus genome and are likely to be the same genes that were involved with stereom formation in the earliest echinoderms some 520 million years ago.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	University of Southern California; California Institute of Technology; Dartmouth College	Bottjer, DJ (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	dbottjer@usc.edu	Peterson, Kevin J/A-2188-2009	Cameron, R. Andrew/0000-0003-3947-6041	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR015044] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-15044] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amore G, 2006, DEV BIOL, V293, P555, DOI 10.1016/j.ydbio.2006.02.024; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BENSON S, 1983, EXP CELL RES, V148, P249, DOI 10.1016/0014-4827(83)90204-5; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; Birnbaum D, 2000, J EXP ZOOL, V288, P21, DOI 10.1002/(SICI)1097-010X(20000415)288:1<21::AID-JEZ2>3.0.CO;2-Q; Blake DB, 2005, J PALEONTOL, V79, P395, DOI 10.1666/0022-3360(2005)079<0395:IOANEO>2.0.CO;2; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Clausen S, 2005, NATURE, V438, P351, DOI 10.1038/nature04109; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2006, REG GEN GEN REG; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Flugel E., 1982, INTRO FACIES ANAL BT, P1, DOI [10.1007/978-3-642-68423-4_1, DOI 10.1007/978-3-642-68423-4_1]; Grotzinger JP, 2000, PALEOBIOLOGY, V26, P334, DOI 10.1666/0094-8373(2000)026<0334:CMITSR>2.0.CO;2; Guensburg TE, 2001, GEOLOGY, V29, P131, DOI 10.1130/0091-7613(2001)029<0131:ECNEFT>2.0.CO;2; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; KATOHFUKUI Y, 1991, DEV BIOL, V145, P201, DOI 10.1016/0012-1606(91)90226-S; Lee YH, 1999, DEV GROWTH DIFFER, V41, P303; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Peled-Kamar M, 2002, EXP CELL RES, V272, P56, DOI 10.1006/excr.2001.5398; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Smith A.B., 1990, Proceedings of the Yorkshire Geological Society, V48, P47; Smith A.B., 1990, P413; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Smith AB, 2001, T ROY SOC EDIN-EARTH, V92, P137, DOI 10.1017/S0263593300000109; Sprinkle J, 2005, GEOL J, V40, P281, DOI 10.1002/gj.1015; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019	29	80	82	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					956	960		10.1126/science.1132310	http://dx.doi.org/10.1126/science.1132310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095693				2022-12-28	WOS:000241896000041
J	Schultz, PH; Staid, MI; Pieters, CM				Schultz, Peter H.; Staid, Matthew I.; Pieters, Carle M.			Lunar activity from recent gas release	NATURE			English	Article							CLEMENTINE DATA; SURFACE; MATURITY; CRATERS; BASALTS; SOILS; MOON; FEO	Samples of material returned from the Moon have established that widespread lunar volcanism ceased about 3.2 Gyr ago. Crater statistics and degradation models indicate that last-gasp eruptions of thin basalt flows continued until less than 1.0 Gyr ago(1), but the Moon is now considered to be unaffected by internal processes today, other than weak tidally driven moonquakes(2) and young fault systems(3). It is therefore widely assumed that only impact craters have reshaped the lunar landscape over the past billion years. Here we report that patches of the lunar regolith in the Ina structure(2-5) were recently removed. The preservation state of relief, the number of superimposed small craters, and the 'freshness' ( spectral maturity) of the regolith together indicate that features within this structure must be as young as 10 Myr, and perhaps are still forming today. We propose that these features result from recent, episodic out-gassing from deep within the Moon. Such out-gassing probably contributed to the radiogenic gases detected during past lunar missions. Future monitoring ( including Earth-based observations) should reveal the composition of the gas, yielding important clues to volatiles archived at great depth over the past 4 - 4.5 Gyr.	Brown Univ, Providence, RI 02912 USA; Planetary Sci Inst, Tucson, AZ 85719 USA	Brown University	Schultz, PH (corresponding author), Brown Univ, Providence, RI 02912 USA.	peter_schultz@brown.edu						Blewett DT, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002380; Blewett DT, 1997, J GEOPHYS RES-PLANET, V102, P16319, DOI 10.1029/97JE01505; El Baz F., 1972, NASA; El-Baz F., 1973, PRELIM SCI REP, V330; Fischer EM, 1996, J GEOPHYS RES-PLANET, V101, P2225, DOI 10.1029/95JE02983; Hodges R.R., 1975, P LUNAR PLANET SCI C, V6, P3039; Lawson SL, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002433; Le Mouelic S, 2000, J GEOPHYS RES-PLANET, V105, P9445, DOI 10.1029/1999JE001196; Lucey PG, 2000, J GEOPHYS RES-PLANET, V105, P20377, DOI 10.1029/1999JE001110; Lucey PG, 1998, J GEOPHYS RES-PLANET, V103, P3679, DOI 10.1029/97JE03019; LUCEY PG, 1995, SCIENCE, V268, P1150, DOI 10.1126/science.268.5214.1150; Masursky H., 1978, NASA; NAKAMURA Y, 1973, SCIENCE, V181, P49, DOI 10.1126/science.181.4094.49; NOZETTE S, 1994, SCIENCE, V266, P1835, DOI 10.1126/science.266.5192.1835; PIETERS CM, 1994, SCIENCE, V266, P1844, DOI 10.1126/science.266.5192.1844; Schultz P. H., 1976, MOON MORPHOLOGY; Schultz P.H., 1977, PROC LUNAR SCI C, V8th, P3539; SCHULTZ PH, 1983, NATURE, V302, P233, DOI 10.1038/302233a0; SCHULTZ PH, 1976, P LUNAR PLANET SCI C, V7, P985; SCHULTZ PH, 1991, WORKSH MAR VOLC BAS, P37; SCHULTZ PH, 2000, LUNAR PLANET SCI C, V31, P1919; Shkuratov YG, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001971; SODERBLOM LA, 1970, J GEOPHYS RES, V75, P2655, DOI 10.1029/JB075i014p02655; Staid MI, 2001, J GEOPHYS RES-PLANET, V106, P27887, DOI 10.1029/2000JE001387; Staid MI, 2000, ICARUS, V145, P122, DOI 10.1006/icar.1999.6319; STRAIN P, 1980, P LUNAR PLANET SCI C, V11, P2437; Whitaker E. A., 1972, NASA; Wilhelms D., 1987, GEOLOGIC HIST MOON, DOI [10.3133/pp1348, DOI 10.3133/PP1348]; Wilhelms D.E., 1971, GEOLOGIC MAP NEAR SI	29	59	61	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					184	186		10.1038/nature05303	http://dx.doi.org/10.1038/nature05303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093445				2022-12-28	WOS:000241867200035
J	Chen, LH; Wilson, ME; Schlagenhauf, P				Chen, Lin H.; Wilson, Mary E.; Schlagenhauf, Patricia			Prevention of malaria in long-term travelers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ANOPHELES-GAMBIAE COMPLEX; PLACEBO-CONTROLLED TRIAL; INSECT REPELLENTS; FIELD-EVALUATION; VIVAX MALARIA; FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; CLINICAL-FEATURES; STANDBY TREATMENT; UNITED-STATES	Context Long-term travelers, defined here as those traveling for periods of 6 months or longer, face particular challenges regarding malaria prevention. Current guidelines for malaria prevention primarily address prevention of Plasmodium falciparum infections in short-term travelers. Objectives To examine the risk of malaria in long-term travelers, recent developments in personal protective measures, and the safety and tolerability of malaria chemoprophylaxis during long-term use and to consider prevention strategies including continuous chemoprophylaxis, stand-by emergency self-treatment, seasonal prophylaxis, and strategies to prevent primary infection and relapses from P vivax malaria. Evidence Acquisition Comprehensive search of scientific publications including MEDLINE via both OVID and PubMED for relevant studies and articles with a cutoff date of July 2006, using the search terms long-term travel and malaria prevention, long-term malaria chemoprophylaxis, and insect repellent and malaria. Additional references were obtained from searching the bibliographies of the selected articles, from dissertations, and from the proceedings of relevant conferences on travel medicine. There were no language restrictions. Evidence Synthesis Long-term travelers have a higher risk of malaria than short-term travelers. Long-term travelers underuse personal protective measures and adhere poorly to continuous chemoprophylaxis regimens. A number of strategies are used during long-term stays: discontinuation of chemoprophylaxis after the initial period, sequential regimens with different medications for chemoprophylaxis, stand-by emergency self-treatment, and seasonal chemoprophylaxis targeting high-incidence periods or locations. All strategies have advantages and drawbacks. Counterfeit drugs sold in countries endemic for malaria pose serious concern for long-term travelers who purchase their medications overseas. Vivax malaria causes significant illness in travelers, but relapses of vivax malaria are not prevented with the current first-line chemoprophylaxis regimens. Consensus guidelines are needed for prevention of malaria in long-term travelers. Conclusions Prevention of malaria in long-term travelers is a complex issue and requires expert advice from travel medicine specialists. Recommendations for prevention of malaria in long-term travelers must be individualized.	Mt Auburn Hosp, Div Infect Dis, Travel Med Ctr, Cambridge, MA 02238 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Zurich, World Hlth Org Collaborat Ctr Travelers Hlth, Zurich, Switzerland	Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Zurich; World Health Organization	Chen, LH (corresponding author), Mt Auburn Hosp, Div Infect Dis, Travel Med Ctr, 330 Mt Auburn St, Cambridge, MA 02238 USA.	lchen@hms.harvard.edu	Chen, Lin/ADS-6751-2022	Chen, Lin/0000-0002-5684-8436; Schlagenhauf, Patricia/0000-0002-1075-7010				ADERA T, 1995, AM J TROP MED HYG, V52, P207, DOI 10.4269/ajtmh.1995.52.207; Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; ALVING AS, 1955, J LAB CLIN MED, V46, P301; Alweis RL, 2004, INFECT CONT HOSP EP, V25, P55, DOI 10.1086/502293; *AM AC PED, FOLL SAF PREC US DEE; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 1988, Bull World Health Organ, V66, P177; Askling HH, 2005, EMERG INFECT DIS, V11, P436, DOI 10.3201/eid1103.040677; Badolo A, 2004, TROP MED INT HEALTH, V9, P330, DOI 10.1111/j.1365-3156.2004.01206.x; Baird JK, 2001, CLIN INFECT DIS, V33, P1990, DOI 10.1086/324085; Behrens RH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-7; Blanke CH, 2003, TROP DOCT, V33, P117, DOI 10.1177/004947550303300224; Buma APCCH, 1996, J INFECT DIS, V173, P1506, DOI 10.1093/infdis/173.6.1506; Burdon J, 1998, J Travel Med, V5, P36, DOI 10.1111/j.1708-8305.1998.tb00455.x; Causer LM, 2004, CLIN INFECT DIS, V39, P1583, DOI 10.1086/425311; Chatterjee S, 1999, J TRAVEL MED, V6, P7, DOI 10.2310/7060.1999.00003; Chen LH, 2005, INFECT DIS CLIN N AM, V19, P185, DOI 10.1016/j.idc.2004.10.006; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; Costantini C, 2004, T ROY SOC TROP MED H, V98, P644, DOI 10.1016/j.trstmh.2003.12.015; Croft AMJ, 1996, LANCET, V347, P326, DOI 10.1016/S0140-6736(96)90500-0; Durrheim DN, 2002, MED VET ENTOMOL, V16, P112, DOI 10.1046/j.0269-283x.2002.00349.x; DWELLE TL, 1995, PEDIATRICS, V95, P733; EDGCOMB JOHN H., 1950, JOUR NATL MALARIA SOC, V9, P285; Eliades M. James, 2005, Morbidity and Mortality Weekly Report, V54, P25; Elliott JH, 2004, J TRAVEL MED, V11, P213, DOI 10.2310/7060.2004.19004; FEGAN D, 1993, OCCUP MED-OXFORD, V43, P135, DOI 10.1093/occmed/43.3.135; Filler Scott, 2003, MMWR Surveill Summ, V52, P1; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Frances SP, 2004, J MED ENTOMOL, V41, P414, DOI 10.1603/0022-2585-41.3.414; Frances SP, 2002, J MED ENTOMOL, V39, P541, DOI 10.1603/0022-2585-39.3.541; FRYAUFF DJ, 1995, LANCET, V346, P1190, DOI 10.1016/S0140-6736(95)92898-7; Funk M, 1999, T ROY SOC TROP MED H, V93, P268, DOI 10.1016/S0035-9203(99)90018-4; FUNKBAUMANN M, 2001, TRAVELERS MALARIA, P56; GARRISON PL, 1952, JAMA-J AM MED ASSOC, V149, P1562, DOI 10.1001/jama.1952.72930340021010a; Govere J, 2000, MED VET ENTOMOL, V14, P441, DOI 10.1046/j.1365-2915.2000.00261.x; Govere J, 2001, MED VET ENTOMOL, V15, P287, DOI 10.1046/j.0269-283x.2001.00309.x; Grobusch MP, 2003, PARASITOL RES, V89, P354, DOI 10.1007/s00436-002-0764-7; HAMER DH, 2003, 8 C INT SOC TRAV MED; Harris AF, 2006, T ROY SOC TROP MED H, V100, P45, DOI 10.1016/j.trstmh.2005.07.001; HATZ C, 2006, BAG B            MAR; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Hughes C, 2003, Commun Dis Public Health, V6, P200; JELINEK T, 1995, AM J TROP MED HYG, V52, P322, DOI 10.4269/ajtmh.1995.52.322; Jelinek T, 1998, AM J TROP MED HYG, V59, P35, DOI 10.4269/ajtmh.1998.59.35; Jorgensen P, 2006, AM J TROP MED HYG, V74, P750, DOI 10.4269/ajtmh.2006.74.750; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Knobloch J, 2004, J TRAVEL MED, V11, P374, DOI 10.2310/7060.2004.19207; LAMPE AS, 1994, EUR J CLIN MICROBIOL, V13, P322, DOI 10.1007/BF01974611; LANGE WR, 1987, AM J PREV MED, V3, P332; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Lengeler C, 2004, COCHRANE DATABASE SY; Leutscher PDC, 2003, J TRAVEL MED, V10, P263, DOI 10.2310/7060.2003.2690; LOBEL HO, 1993, LANCET, V341, P848, DOI 10.1016/0140-6736(93)93058-9; MAARSCHALK T, 2006, OCCUPATIONAL HLTH SO, V12, P16; McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285; MCLARTY DG, 1984, LANCET, V2, P656; Moore SJ, 2002, J AM MOSQUITO CONTR, V18, P107; Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; NASCI R, 2005, HLTH INFORM INT TRAV, P24; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; NOTHDURFT HD, 1995, TROP MED PARASITOL, V46, P161; Overbosch D, 2003, J TRAVEL MED, V10, pS16; Overbosch D, 2003, J TRAVEL MED, V10, pS22; PARISE M, 2005, HLTH INFORM INT TRAV, P189; PENNIE RA, 1993, T ROY SOC TROP MED H, V87, P459, DOI 10.1016/0035-9203(93)90036-P; PEPPIATT R, 1991, BRIT J GEN PRACT, V41, P159; Peragallo MS, 1999, T ROY SOC TROP MED H, V93, P73, DOI 10.1016/S0035-9203(99)90187-6; PHILLIPSHOWARD PA, 1989, LANCET, V2, P803, DOI 10.1016/S0140-6736(89)90867-2; PHILLIPSHOWARD PA, 1990, BMJ-BRIT MED J, V300, P499, DOI 10.1136/bmj.300.6723.499; *PUBL HLTH AG CAN, 2004, CAN COMM DIS REP S1, V30; Raoult D, 1999, ARCH INTERN MED, V159, P167, DOI 10.1001/archinte.159.2.167; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; ROMBO L, 1993, TROP MED PARASITOL, V44, P254; ROSS MH, 2000, C P MIN INT 2000 PER, P533; Schlagenhauf P, 2003, BMJ-BRIT MED J, V327, P1078, DOI 10.1136/bmj.327.7423.1078; Schlagenhauf P, 1997, AM J TROP MED HYG, V56, P235, DOI 10.4269/ajtmh.1997.56.235; SCHLAGENHAUF P, 1995, B WORLD HEALTH ORGAN, V73, P215; SCHLAGENHAUF P, 1994, J TROP MED HYG, V97, P151; SCHLAGENHAUFLAW.P, 2005, PDQ TRAVELERS MALARI; Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592; Schwartz E, 1998, CLIN INFECT DIS, V26, P1089, DOI 10.1086/520279; SHANKS D, 1995, MIL MED, V160, P443, DOI 10.1093/milmed/160.9.443; Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23; SOTO J, 1995, CLIN INFECT DIS, V21, P599, DOI 10.1093/clinids/21.3.599; STEFFEN R, 1990, B WORLD HEALTH ORGAN, V68, P313; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; STEFFEN R, 1990, AVIAT SPACE ENVIR MD, V61, P942; Trachsler M, 1999, TROP MED INT HEALTH, V4, P442, DOI 10.1046/j.1365-3156.1999.00419.x; Trigg JK, 1996, J AM MOSQUITO CONTR, V12, P243; Trongtokit Yuwadee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1423; *US CDCP, 2001, MMWR-MORBID MORTAL W, V50, P169; *US CDCP, 2001, MMWR-MORBID MORTAL W, V50, P179; Weber R, 2003, J TRAVEL MED, V10, P219, DOI 10.2310/7060.2003.40574; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; Wells TS, 2006, AM J TROP MED HYG, V74, P744, DOI 10.4269/ajtmh.2006.74.744; Whitty CJM, 2000, AM J TROP MED HYG, V63, P295, DOI 10.4269/ajtmh.2000.63.295; *WHO, 2005, INT TRAV HLTH, P132; *WTO, 2006, UNWTO WORLD TOUR BAR; 2003, MED LETT DRUGS THER, V45, P41	102	72	75	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2234	2244		10.1001/jama.296.18.2234	http://dx.doi.org/10.1001/jama.296.18.2234			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090770	Bronze			2022-12-28	WOS:000241827700024
J	Rosenthal, MB; Landon, BE; Normand, ST; Frank, RG; Epstein, AM				Rosenthal, Meredith B.; Landon, Bruce E.; Normand, Sharon-Lise T.; Frank, Richard G.; Epstein, Arnold M.			Pay for performance in commercial HMOs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOR-PERFORMANCE; QUALITY; CARE; MEDICARE; PROVIDERS; PROFIT; ISSUES	BACKGROUND: Pay for performance has increasingly become the subject of intense interest and debate, both of which have been heightened as the Centers for Medicare and Medicaid Services moves closer to adopting this approach for Medicare. Although many claims have been made for the effectiveness of this approach, the extent of its national penetration remains unknown. METHODS: We surveyed a sample of 252 health maintenance organizations (HMOs) (response rate, 96%) drawn from 41 metropolitan areas across the nation about use of pay for performance. We determined the prevalence of pay-for-performance programs, detailed the features of such programs, and examined the adoption of pay for performance as a function of the characteristics of both the health plans and markets. RESULTS: More than half the HMOs, representing more than 80% of persons enrolled, use pay for performance in their provider contracts. Of the 126 health plans with pay-for-performance programs, nearly 90% had programs for physicians and 38% had programs for hospitals. Use of pay for performance was statistically associated with geographic region, use of primary care providers (PCPs) as gatekeepers, use of capitation to pay PCPs, and whether the plans themselves received bonuses or penalties according to performance. CONCLUSIONS: Pay for performance is now commonly used by HMOs, especially those that are situated to assign responsibility for a particular patient to a PCP or medical group. As the design of Medicare with pay for performance moves forward, it will be important to leverage the early experience of pay for performance in the commercial market.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Normand, Sharon-Lise/0000-0001-7027-4769; Rosenthal, Meredith/0000-0003-3410-0184	AHRQ HHS [R01HS13335] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013335] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Baker G, 2004, CASE STUDIES HLTH PL; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Institute of Medicine, 2001, CROSSING QUALITY CHA; *INTERSTUDY, 2004, COMP EDG HMO DAT; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Landon BE, 2001, HEALTH AFFAIR, V20, P162, DOI 10.1377/hlthaff.20.3.162; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; U.S. Census Bureau, 2000, CENS 2000 SUMM FIL 1; Weber David Ollier, 2005, Physician Exec, V31, P20; 2005, LEAPFROGS INCENTIVE	16	268	269	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1895	1902		10.1056/NEJMsa063682	http://dx.doi.org/10.1056/NEJMsa063682			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079763	Bronze			2022-12-28	WOS:000241691700007
J	Horton, R				Horton, Richard			Mexican health reforms: global lessons, local solutions	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Frenk J, 2006, LANCET, V368, P3, DOI 10.1016/S0140-6736(06)68942-3	1	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2006	368	9546					1480	1480		10.1016/S0140-6736(06)69618-9	http://dx.doi.org/10.1016/S0140-6736(06)69618-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071270				2022-12-28	WOS:000241582700010
J	Wang, Y; Jorda, M; Jones, PL; Maleszka, R; Ling, X; Robertson, HM; Mizzen, CA; Peinado, MA; Robinson, GE				Wang, Ying; Jorda, Mireia; Jones, Peter L.; Maleszka, Ryszard; Ling, Xu; Robertson, Hugh M.; Mizzen, Craig A.; Peinado, Miguel A.; Robinson, Gene E.			Functional CpG methylation system in a social insect	SCIENCE			English	Article							DNA METHYLATION; DROSOPHILA; COMPLEX; EXPRESSION; GENES; MI-2	DNA methylation systems are well characterized in vertebrates, but methylation in Drosophila melanogaster and other invertebrates remains controversial. Using the recently sequenced honey bee genome, we present a bioinformatic, molecular, and biochemical characterization of a functional DNA methylation system in an insect. We report on catalytically active orthologs of the vertebrate DNA methyltransferases Dnmt1 and Dnmt3a and b, two isoforms that contain a methyl-DNA binding domain, genomic 5-methyl-deoxycytosine, and CpG-methylated genes. The honey bee provides an opportunity to study the roles of methylation in social contexts.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; IDIBELL Canc Res Inst, Lhospitalet De Llobregat 08907, Catalonia, Spain; Australian Natl Univ, Res Sch Biol Sci, Visual Sci & Australian Res Council Ctr Mol Genet, Canberra, ACT, Australia; Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Australian National University; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	generobi@life.uiuc.edu	Maleszka, Ryszard/A-6078-2008; Blow, joe/C-8616-2009; Jordà, Mireia/Z-4519-2019; Peinado, Miguel A./A-5591-2008	Maleszka, Ryszard/0000-0003-1855-555X; Peinado, Miguel A./0000-0002-4090-793X; Jorda, Mireia/0000-0003-3709-1850				Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; *HON BEE GEN SEQ C, IN PRESS NATURE; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Marhold J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-20; Marhold J, 2004, DEVELOPMENT, V131, P6033, DOI 10.1242/dev.01531; Queller DC, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-15; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P17; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664	19	237	255	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					645	647		10.1126/science.1135213	http://dx.doi.org/10.1126/science.1135213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068262				2022-12-28	WOS:000241557800046
J	Ricci-Vitiani, L; Lombardi, DG; Pilozzi, E; Biffoni, M; Todaro, M; Peschle, C; De Maria, R				Ricci-Vitiani, Lucia; Lombardi, Dario G.; Pilozzi, Emanuela; Biffoni, Mauro; Todaro, Matilde; Peschle, Cesare; De Maria, Ruggero			Identification and expansion of human colon-cancer-initiating cells	NATURE			English	Article							STEM-CELLS; CARCINOEMBRYONIC ANTIGEN; EXPRESSION; MUTATIONS; LEUKEMIA; TUMORS	Colon carcinoma is the second most common cause of death from cancer(1). The isolation and characterization of tumorigenic colon cancer cells may help to devise novel diagnostic and therapeutic procedures. Although there is increasing evidence that a rare population of undifferentiated cells is responsible for tumour formation and maintenance(2-4), this has not been explored for colorectal cancer. Here, we show that tumorigenic cells in colon cancer are included in the high-density CD133(+) population, which accounts for about 2.5% of the tumour cells. Subcutaneous injection of colon cancer CD133(+) cells readily reproduced the original tumour in immunodeficient mice, whereas CD133(-) cells did not form tumours. Such tumours were serially transplanted for several generations, in each of which we observed progressively faster tumour growth without significant phenotypic alterations. Unlike CD133(-) cells, CD133(+) colon cancer cells grew exponentially for more than one year in vitro as undifferentiated tumour spheres in serum-free medium, maintaining the ability to engraft and reproduce the same morphological and antigenic pattern of the original tumour. We conclude that colorectal cancer is created and propagated by a small number of undifferentiated tumorigenic CD133(+) cells, which should therefore be the target of future therapies.	Ist Super Sanita, Dept Hematol & Oncol, I-00161 Rome, Italy; Mediterranean Inst Oncol, I-95029 Catania, Italy; Univ Roma La Sapienza, Sant Andrea Hosp, Dept Lab Med & Pathol, I-00189 Rome, Italy; Univ Palermo, Dept Surg & Oncol Sci, I-90127 Palermo, Italy	Istituto Superiore di Sanita (ISS); Mediterranean Institute of Oncology; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Palermo	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol & Oncol, Viale Regina Elena 299, I-00161 Rome, Italy.	rdemaria@tin.it	todaro, matilde/AAC-1003-2022; Ricci Vitiani, Lucia/J-8320-2016; Biffoni, Mauro/J-8318-2016; PILOZZI, Emanuela/AAC-1854-2022; De Maria, Ruggero/S-6385-2019	todaro, matilde/0000-0001-8686-8043; Ricci Vitiani, Lucia/0000-0001-7336-5615; Biffoni, Mauro/0000-0002-1304-9060; PILOZZI, Emanuela/0000-0002-7110-9172; De Maria, Ruggero/0000-0003-2255-0583				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Davidson B, 2002, AM J CLIN PATHOL, V118, P85; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; EE HC, 1995, AM J PATHOL, V147, P586; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JESSUP JM, 1988, CANCER RES, V48, P1689; Moll R, 1998, Subcell Biochem, V31, P205; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; SHEAHAN K, 1990, AM J CLIN PATHOL, V94, P157, DOI 10.1093/ajcp/94.2.157; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012	22	3145	3403	5	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					111	115		10.1038/nature05384	http://dx.doi.org/10.1038/nature05384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17122771				2022-12-28	WOS:000243225100046
J	Bershtein, S; Segal, M; Bekerman, R; Tokuriki, N; Tawfik, DS				Bershtein, Shimon; Segal, Michal; Bekerman, Roy; Tokuriki, Nobuhiko; Tawfik, Dan S.			Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein	NATURE			English	Article							SEXUAL REPRODUCTION; TOLERANCE; EVOLUTION; SUBSTITUTIONS; MUTATIONS; STABILITY; VIEW	The distribution of fitness effects of protein mutations is still unknown(1,2). Of particular interest is whether accumulating deleterious mutations interact, and how the resulting epistatic effects shape the protein's fitness landscape. Here we apply a model system in which bacterial fitness correlates with the enzymatic activity of TEM-1 beta-lactamase ( antibiotic degradation). Subjecting TEM-1 to random mutational drift and purifying selection ( to purge deleterious mutations) produced changes in its fitness landscape indicative of negative epistasis; that is, the combined deleterious effects of mutations were, on average, larger than expected from the multiplication of their individual effects. As observed in computational systems(3-5), negative epistasis was tightly associated with higher tolerance to mutations ( robustness). Thus, under a low selection pressure, a large fraction of mutations was initially tolerated ( high robustness), but as mutations accumulated, their fitness toll increased, resulting in the observed negative epistasis. These findings, supported by FoldX stability computations of the mutational effects(6), prompt a new model in which the mutational robustness ( or neutrality) observed in proteins, and other biological systems, is due primarily to a stability margin, or threshold, that buffers the deleterious physico-chemical effects of mutations on fitness. Threshold robustness is inherently epistatic - once the stability threshold is exhausted, the deleterious effects of mutations become fully pronounced, thereby making proteins far less robust than generally assumed.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	TOKURIKI, NOBUHIKO/A-2968-2010	Bershtein, Shimon/0000-0003-4322-1025				Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; HOROVITZ A, 1996, FOLDING DESIGN, V1, P121, DOI DOI 10.1016/S1359-0278(96)00056-9; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; SAUER UH, 1992, J BIOL CHEM, V267, P2393; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner GP, 1998, GENETICA, V102-3, P569, DOI 10.1023/A:1017088321094; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Wolf J. B., 2000, EPISTASIS EVOLUTIONA	22	295	299	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					929	932		10.1038/nature05385	http://dx.doi.org/10.1038/nature05385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17122770				2022-12-28	WOS:000242805400056
J	Graff, MJL; Vernooij-Dassen, MJM; Thijssen, M; Dekker, J; Hoefnagels, WHL; Rikkert, MGMO				Graff, Maud J. L.; Vernooij-Dassen, Myrra J. M.; Thijssen, Marjolein; Dekker, Joost; Hoefnagels, Willibrord H. L.; Rikkert, Marcel G. M. Olde			Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; RATING-SCALE; CAREGIVERS; HOME; INTERVENTION; INDIVIDUALS; PROGRAM	Objective To determine the effectiveness of community based occupational therapy on daily functioning of patients with dementia and the sense of competence of their care givers. Design Single blind randomised controlled trial. Assessors were blinded for treatment allocation. Setting Memory clinic and day clinic of a geriatrics department and participants' homes. Participants 135 patients aged >= 65 with mild to moderate dementia living in the community and their primary care givers. Interventions 10 sessions of occupational therapy over five weeks, including cognitive and behavioural interventions, to train patients in the use of aids to compensate for cognitive decline and care givers in coping behaviours and supervision. Main outcome measures Patients' daily functioning assessed with the assessment of motor and process skills (AMPS) and interview of deterioration in daily activities in dementia (IDDD). Care giver burden assessed with the sense of competence questionnaire (SCQ). Participants were evaluated at baseline, six weeks, and three months. Results Scores improved significantly relative to baseline in patients and care givers in the intervention group compared with the controls (differences were 1.5 (95% confidence interval 1.3 to 1.7) for the process scale; - 11.7 (- 13.6 to - 9.7) for the performance scale; and 0 1.0; 9.2 to 12.8) for the competence scale). This improvement was still significant at three months. The number needed to treat to reach a clinically relevant improvement in motor and process skills score was 1.3 (1.2 to 1.4) at six weeks. Effect sizes were 2.5, 2.3, and 1.2, respectively, at six weeks and 2.7, 2.4, and 0.8, respectively, at 12 weeks. Conclusions Occupational therapy improved patients' daily functioning and reduced the burden on the care giver, despite the patients' limited learning ability. Effects were still present at 12 weeks, which justifies implementation of this intervention.	Radboud Univ Nijmegen Med Ctr, Res Grp Allied Hlth Care, Dept Allied Hlth Care Disciplines, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Ctr Qual Care Res, Alzheimer Ctr Nijmegen, NL-6525 JV Nijmegen, Netherlands; Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Rehabil Med, NL-1007 MB Amsterdam, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Geriatr, Alzheimer Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Graff, MJL (corresponding author), Radboud Univ Nijmegen Med Ctr, Res Grp Allied Hlth Care, Dept Allied Hlth Care Disciplines, POB 9101, NL-6500 HB Nijmegen, Netherlands.	rn.graff@ergo.umcn.nl	Vernooij-Dassen, M.J.F.J./H-8107-2014; Rikkert, M.G.M. Olde/H-8078-2014; Graff, M.J.L./L-4333-2015; Rikkert, Marcel Olde/D-9773-2012	Rikkert, M.G.M. Olde/0000-0003-1397-1677; Dekker, Joost/0000-0003-2027-0027				APA, 1994, DIAGN STAT MAN MENT; Brink TL., 1982, CLIN GERON, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Burgener SC, 1998, GERIATR NURS, V19, P121, DOI 10.1016/S0197-4572(98)90055-6; COEN J, 1998, J HLTH GAIN, V2, P5; CORCORAN MA, 1992, AM J OCCUP THER, V46, P801, DOI 10.5014/ajot.46.9.801; Fisher A. G., 2003, ASSESSMENT MOTOR PRO; FISHER AG, 2003, ASSESSMENT MOTOR POR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gitlin LN, 2005, J GERONTOL A-BIOL, V60, P368, DOI 10.1093/gerona/60.3.368; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Graff M.J.L., 2006, DEMENTIA, V5, P503, DOI [10.1177/1471301206069918, DOI 10.1177/1471301206069918]; Graff MJ, 2000, NED TIJDSCHR ERGOTHE, V28, P169; Graff MJL, 2003, OTJR-OCCUP PART HEAL, V23, P155, DOI 10.1177/153944920302300403; HASSELKUS BR, 1990, OCCUPATIONAL THERAPY, V2, P9; Jepson C, 1999, Image J Nurs Sch, V31, P115, DOI 10.1111/j.1547-5069.1999.tb00444.x; JEPSON G, 1999, IMAGE J NURS SCH, V31, P115; LAW M, 1996, CANADIAN OCCUPATIONA; Luijpen MW, 2003, REV NEUROSCIENCE, V14, P343; Miller G. S., 1906, P BIOL SOC WASH, V19, P41; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REISBERG B, 1983, PSYCHOPHARMACOL BULL, V19, P702; RIOPELSMITH R, 1998, OCCUPATIONAL PERFORM, V2; Rockwood K., 2006, TRIAL DESIGNS OUTCOM; Siemonsma PC, 1997, CLIN REHABIL, V11, P273, DOI 10.1177/026921559701100402; Steultjens EMJ, 2004, AGE AGEING, V33, P453, DOI 10.1093/ageing/afh174; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Teunisse S., 1997, CLINIMETRICS DEMENTI; VernooijDassen MJFJ, 1996, SOC SCI MED, V43, P41, DOI 10.1016/0277-9536(95)00332-0; Vernooj-Dassen M, 2000, INT J AGING HUM DEV, V51, P259, DOI 10.2190/P8L1-N8QD-VTJ4-EURT; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; Wimo A, 2006, DEMENT GERIATR COGN, V21, P175, DOI 10.1159/000090733; WITLACH CJ, 1991, GERONTOLOGISTS, V31, P9	34	302	305	1	50	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1196	1199		10.1136/bmj.39001.688843.BE	http://dx.doi.org/10.1136/bmj.39001.688843.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	119JW	17114212	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000243009600015
J	Weinstein, JN; Lurie, JD; Tosteson, TD; Skinner, JS; Hanscom, B; Tosteson, ANA; Herkowitz, H; Fischgrund, J; Cammisa, FP; Albert, T; Deyo, RA				Weinstein, James N.; Lurie, Jon D.; Tosteson, Tor D.; Skinner, Jonathan S.; Hanscom, Brett; Tosteson, Anna N. A.; Herkowitz, Harry; Fischgrund, Jeffrey; Cammisa, Frank P.; Albert, Todd; Deyo, Richard A.			Surgical vs nonoperative treatment for lumbar disk herniation - The Spine Patient Outcomes Research Trial (SPORT) observational cohort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED-TRIALS; RELIABILITY; QUALITY	Context For patients with lumbar disk herniation, the Spine Patient Outcomes Research Trial (SPORT) randomized trial intent-to-treat analysis showed small but not statistically significant differences in favor of diskectomy compared with usual care. However, the large numbers of patients who crossed over between assigned groups precluded any conclusions about the comparative effectiveness of operative therapy vs usual care. Objective To compare the treatment effects of diskectomy and usual care. Design, Setting, and Patients Prospective observational cohort of surgical candidates with imaging-confirmed lumbar intervertebral disk herniation who were treated at 13 spine clinics in 11 US states and who met the SPORT eligibility criteria but declined randomization between March 2000 and March 2003. Interventions Standard open diskectomy vs usual nonoperative care. Main Outcome Measures Changes from baseline in the Medical Outcomes Study Short-Form Health Survey (SF-36) bodily pain and physical function scales and the modified Oswestry Disability Index (American Academy of Orthopaedic Surgeons/MODEMS version). Results Of the 743 patients enrolled in the observational cohort, 528 patients received surgery and 191 received usual nonoperative care. At 3 months, patients who chose surgery had greater improvement in the primary outcome measures of bodily pain (mean change: surgery, 40.9 vs nonoperative care, 26.0; treatment effect, 14.8; 95% confidence interval, 10.8-18.9), physical function (mean change: surgery, 40.7 vs nonoperative care, 25.3; treatment effect, 15.4; 95% CI, 11.6-19.2), and Oswestry Disability Index (mean change: surgery, -36.1 vs nonoperative care, -20.9; treatment effect, -15.2; 95% CI, -18.5. to -11.8). These differences narrowed somewhat at 2 years: bodily pain (mean change: surgery, 42.6 vs nonoperative care, 32.4; treatment effect, 10.2; 95% CI, 5.9-14.5), physical function (mean change: surgery, 43.9 vs nonoperavtive care 31.9; treatment effect, 12.0; 95% CI; 7.9-16.1), and Oswestry Disability Index (mean change: surgery -37.6 vs nonoperative care -24.2; treatment effect, -13.4; 95% CI, -17.0 to -9.7). Conclusions Patients with persistent sciatica from lumbar disk herniation improved in both operated and usual care groups. Those who chose operative intervention reported greater improvements than patients who elected nonoperative care. However, nonrandomized comparisons of self-reported outcomes are subject to potential confounding and must be interpreted cautiously. Trial Registration clinicaltrials.gov Identifier: NCT00000410.	Dartmouth Med Sch, Hanover, NH USA; William Beaumont Hosp, Royal Oak, MI 48072 USA; Hosp Special Surg, New York, NY 10021 USA; Rothman Inst, Philadelphia, PA USA; Univ Washington, Ctr Cost & Outcomes Res, Seattle, WA 98195 USA	Dartmouth College; Beaumont Health; Rothman Institute; University of Washington; University of Washington Seattle	Weinstein, JN (corresponding author), Dartmouth Med Sch, Dept Orthopaed, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	james.n.weinstein@dartmouth.edu			NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR048138, P60AR048094, U01AR045444] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIAMS NIH HHS [1 K23 AR 048138-01, P60-AR048094-01A1, P60 AR048094, U01-AR45444-01A1, U01 AR045444, K23 AR048138, U01 AR045444-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AHCPR, 1994, AC LOW BACK PROBL AD, V14; Arega A, 2006, SPINE, V31, P2263, DOI 10.1097/01.brs.0000232708.66608.ac; Atlas SJ, 1996, SPINE, V21, P1777, DOI 10.1097/00007632-199608010-00011; Atlas SJ, 1996, SPINE, V21, P2885, DOI 10.1097/00007632-199612150-00020; Balding DJ, 2004, APPL LONGITUDINAL AN; Beaton DE, 2001, ARTHRIT RHEUM-ARTHR, V45, P270, DOI 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.0.CO;2-T; Beaton DE, 2000, SPINE, V25, P3192, DOI 10.1097/00007632-200012150-00015; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; Black N, 1996, BRIT MED J, V312, P1215; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Daltroy LH, 1996, SPINE, V21, P741, DOI 10.1097/00007632-199603150-00017; DELAMARTER R, 1996, ADULT SPINE PRINCIPL; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; Fardon DF, 2001, SPINE, V26, P461, DOI 10.1097/00007632-200103010-00007; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; Mannion AF, 2006, EUR SPINE J, V15, P66, DOI 10.1007/s00586-004-0816-z; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441	23	463	476	6	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2451	2459		10.1001/jama.296.20.2451	http://dx.doi.org/10.1001/jama.296.20.2451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119141	Green Accepted, Bronze			2022-12-28	WOS:000242171000026
J	Canals, M; Puig, P; de Madron, XD; Heussner, S; Palanques, A; Fabres, J				Canals, Miquel; Puig, Pere; de Madron, Xavier Durrieu; Heussner, Serge; Palanques, Albert; Fabres, Joan			Flushing submarine canyons	NATURE			English	Article							DENSE WATER; CONTINENTAL-SHELF; GRAVITY FLOW; CASCADES; DYNAMICS	The continental slope is a steep, narrow fringe separating the coastal zone from the deep ocean. During low sea- level stands, slides and dense, sediment- laden flows erode the outer continental shelf and the continental slope, leading to the formation of submarine canyons that funnel large volumes of sediment and organic matter from shallow regions to the deep ocean (1). During high sea-level stands, such as at present, these canyons still experience occasional sediment gravity flows(2 - 5), which are usually thought to be triggered by sediment failure or river flooding. Here we present observations from a submarine canyon on the Gulf of Lions margin, in the northwest Mediterranean Sea, that demonstrate that these flows can also be triggered by dense shelf water cascading ( DSWC) - a type of current that is driven solely by seawater density contrast. Our results show that DSWC can transport large amounts of water and sediment, reshape submarine canyon floors and rapidly affect the deep- sea environment. This cascading is seasonal, resulting from the formation of dense water by cooling and/ or evaporation, and occurs on both high- and low- latitude continental margins(6 - 8). DSWC may therefore transport large amounts of sediment and organic matter to the deep ocean. Furthermore, changes in the frequency and intensity of DSWC driven by future climate change may have a significant impact on the supply of organic matter to deep- sea ecosystems and on the amount of carbon stored on continental margins and in ocean basins.	Univ Barcelona, Dept Stratig Paleontol & Marine Geosci, CRG Marine Geosci, E-08028 Barcelona, Spain; CSIC, Inst Marine Sci, E-08003 Barcelona, Spain; Univ Perpignan, CEFREM, CNRS, UMR 5110, F-66860 Perpignan, France	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia	Canals, M (corresponding author), Univ Barcelona, Dept Stratig Paleontol & Marine Geosci, CRG Marine Geosci, E-08028 Barcelona, Spain.	miquelcanals@ub.edu	Palanques, Albert/C-2661-2013; Canals, Miquel/F-4922-2013; Puig, Pere/E-5422-2013	Canals, Miquel/0000-0001-5267-7601; Puig, Pere/0000-0001-6189-5504; Palanques, Albert/0000-0003-2544-2342				Avril B, 2002, DEEP-SEA RES PT II, V49, P2163, DOI 10.1016/S0967-0645(02)00033-4; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; CAUWET G, 1994, MAR CHEM, V47, P55, DOI 10.1016/0304-4203(94)90013-2; Dasgupta P, 2003, EARTH-SCI REV, V62, P265, DOI 10.1016/S0012-8252(02)00160-5; de Madron XD, 2005, PROG OCEANOGR, V64, P83, DOI 10.1016/j.pocean.2004.08.004; *EARTH RES INF SYS, 1996, GLOB 30 ARC SEC EL D; FLOOD RD, 1983, GEOL SOC AM BULL, V94, P630, DOI 10.1130/0016-7606(1983)94<630:COSFAA>2.0.CO;2; FLOOD RD, 1994, PALEOCEANOGRAPHY, V9, P1049, DOI 10.1029/94PA01801; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Hill AE, 1998, J MAR RES, V56, P87, DOI 10.1357/002224098321836127; HONJO S, 1988, DEEP-SEA RES, V35, P1223, DOI 10.1016/0198-0149(88)90078-7; Houghton J. T., 2001, CLIMATE CHANGE 2001; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Khripounoff A, 2003, MAR GEOL, V194, P151, DOI 10.1016/S0025-3227(02)00677-1; LACOMBE H, 1985, PROG OCEANOGR, V14, P319, DOI 10.1016/0079-6611(85)90015-1; Lopez-Jurado JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024430; MASSON DG, 1996, OCEANOGRAPHY ILLUSTR, P146; Mulder T, 2001, GEO-MAR LETT, V21, P149, DOI 10.1007/s003670100077; Paull CK, 2003, GEO-MAR LETT, V22, P227, DOI 10.1007/s00367-003-0117-2; Posamentier H.W., 1988, SPECIAL PUBLICATION, V42, P110; Puig P, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001918; Shapiro GI, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001610; Shapiro GI, 1997, J PHYS OCEANOGR, V27, P2381, DOI 10.1175/1520-0485(1997)027<2381:DODWCA>2.0.CO;2; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Tsunogai S, 1999, TELLUS B, V51, P701, DOI 10.1034/j.1600-0889.1999.t01-2-00010.x; WHITEHEAD JA, 1987, NATURE, V327, P656, DOI 10.1038/327656a0; YODER JA, 1989, CONT SHELF RES, V9, P547, DOI 10.1016/0278-4343(89)90020-4	27	586	595	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					354	357		10.1038/nature05271	http://dx.doi.org/10.1038/nature05271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108962				2022-12-28	WOS:000242018300045
J	Molnar, P; Houseman, GA; England, PC				Molnar, Peter; Houseman, Gregory A.; England, Philip C.			Earth science - Palaeo-altimetry of Tibet	NATURE			English	Letter							FAULT PLANE SOLUTIONS; PLATEAU; EARTHQUAKES; BASIN		Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Leeds, Sch Earth & Environm, Inst Geophys & Tecton, Leeds LS2 9JT, W Yorkshire, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Leeds; University of Oxford	Molnar, P (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	molnar@cires.colorado.edu	; England, Philip/A-1920-2010	Escorcio Correia Wang, Monica/0000-0002-9205-1993; Smith, Adrian/0000-0002-7657-6191; England, Philip/0000-0002-9024-8901; HAYDAY, ADRIAN/0000-0002-9495-5793; Pennington, Daniel/0000-0001-7889-9923; Silva-Santos, Bruno/0000-0003-4141-9302	Natural Environment Research Council [NE/C004574/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Blisniuk PM, 2001, NATURE, V412, P628, DOI 10.1038/35088045; ENGLAND P, 1986, TECTONICS, V5, P1, DOI 10.1029/TC005i001p00001; ENGLAND P, 1989, J GEOPHYS RES-SOLID, V94, P17561, DOI 10.1029/JB094iB12p17561; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Kapp P, 2005, GEOL SOC AM BULL, V117, P865, DOI 10.1130/B25595.1; MOLNAR P, 1983, J GEOPHYS RES, V88, P1180, DOI 10.1029/JB088iB02p01180; MOLNAR P, 1989, GEOPHYS J INT, V99, P123, DOI 10.1111/j.1365-246X.1989.tb02020.x; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Murphy MA, 1997, GEOLOGY, V25, P719, DOI 10.1130/0091-7613(1997)025<0719:DTIACA>2.3.CO;2; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506	10	12	16	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					E4	E4		10.1038/nature05368	http://dx.doi.org/10.1038/nature05368			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17099703	Bronze			2022-12-28	WOS:000242018300031
J	Kaplan, SA; Roehrborn, CG; Rovner, ES; Carlsson, M; Bavendam, T; Guan, ZH				Kaplan, Steven A.; Roehrborn, Claus G.; Rovner, Eric S.; Carlsson, Martin; Bavendam, Tamara; Guan, Zhonghong			Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BENIGN PROSTATIC HYPERPLASIA; EXTENDED-RELEASE; OUTLET OBSTRUCTION; COMBINATION THERAPY; HEALTH-STATUS; TOLERABILITY; DOXAZOSIN; EFFICACY; FINASTERIDE; QUESTIONNAIRE	Context Men with overactive bladder and other lower urinary tract symptoms may not respond to monotherapy with antimuscarinic agents or alpha-receptor antagonists. Objective To evaluate the efficacy and safety of tolterodine extended release ( ER), tamsulosin, or both in men who met research criteria for both overactive bladder and benign prostatic hyperplasia. Design, Setting, and Participants Randomized, double-blind, placebo-controlled trial conducted at 95 urology clinics in the United States involving men 40 years or older who had a total International Prostate Symptom Score of 12 or higher and, an International Prostate Symptom Score quality-of-life (QOL) item score of 3 or higher, a self-rated bladder condition of at least moderate bother, and a bladder diary documenting micturition frequency ( >= 8 micturitions per 24 hours) and urgency ( >= 3 episodes per 24 hours), with or without urgency urinary incontinence. Patients were recruited between November 2004 and February 2006, and the study was completed May 2006. Interventions Patients were randomly assigned to receive placebo (n= 222), 4 mg of tolterodine ER ( n= 217), 0.4 mg of tamsulosin ( n= 215), or both tolterodine ER plus tamsulosin ( n= 225) for 12 weeks. Main Outcome Measures Patient perception of treatment benefit, bladder diary variables, International Prostate Symptom Scores, and safety and tolerability were assessed. Results A total of 172 men (80%) receiving tolterodine ER plus tamsulosin reported treatment benefit by week 12 compared with 132 patients (62%) receiving placebo ( P <. 001), 146 (71%) receiving tamsulosin (P=. 06 vs placebo), or 135 (65%) receiving tolterodine ER ( P=. 48 vs placebo). Patients receiving tolterodine ER plus tamsulosin compared with placebo experienced significant reductions in urgency urinary incontinence (- 0.88 vs - 0.31, P=. 005), urgency episodes without incontinence (- 3.33 vs - 2.54, P=. 03), micturitions per 24 hours (- 2.54 vs - 1.41, P <. 001), and micturitions per night (- 0.59 vs - 0.39, P. 02). Patients receiving tolterodine ER plus tamsulosin demonstrated significant improvements on the total International Prostate Symptom Score (- 8.02 vs placebo, - 6.19, P=. 003) and QOL item (- 1.61 vs - 1.17, P=. 003). All interventions were well tolerated. The incidence of acute urinary retention requiring catheterization was low ( tolterodine ER plus tamsulosin, 0.4%; tolterodine ER, 0.5%; tamsulosin, 0%; and placebo, 0%). Conclusions These results suggest that treatment with tolterodine ER plus tamsulosin for 12 weeks provides benefit for men with moderate to severe lower urinary tract symptoms including overactive bladder.	Weill Cornell Med Coll, Dept Urol, New York, NY 10021 USA; Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX USA; Med Univ S Carolina, Dept Urol, Charleston, SC 29425 USA; Pfizer Inc, New York, NY USA	Cornell University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Medical University of South Carolina; Pfizer	Kaplan, SA (corresponding author), Weill Cornell Med Coll, New York Presbyterian Hosp, 1300 York Ave, New York, NY 10021 USA.	kaplans@med.cornell.edu		GUTIERREZ, ANDRES/0000-0002-6721-6557				Abdel-Aziz Khaled F, 2002, Curr Urol Rep, V3, P445, DOI 10.1007/s11934-002-0095-3; Abrams P, 2006, J UROLOGY, V175, P999, DOI 10.1016/S0022-5347(05)00483-0; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; *AST PHARM INC, 2006, FLOM PACK INS; Athanasopoulos A, 2003, J UROLOGY, V169, P2253, DOI 10.1097/01.ju.0000067541.73285.eb; *AUA BPH GUID UPD, 2003, AUA GUID MAN BEN PRO; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Chapple CR, 2004, BJU INT, V94, P738, DOI 10.1111/j.1464-410X.2004.05022.x; *COMM PROPR MED PR, 2002, CPMPEWP1801 EUR AG E; COYNE K, 2002, VALUE HEALTH, V5, P277; Coyne KS, 2006, J UROLOGY, V176, P627, DOI 10.1016/j.juro.2006.03.088; Coyne KS, 2005, 35 ANN M INT CONT SO; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Friede T, 2004, PHARM STAT, V3, P269, DOI 10.1002/pst.140; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Homma Y, 2003, BJU INT, V92, P741, DOI 10.1046/j.1464-410X.2003.04468.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Kaplan SA, 2005, J UROLOGY, V174, P2273, DOI 10.1097/01.ju.0000181823.33224.a0; Kaplan SA, 2006, UROLOGY, V68, P328, DOI 10.1016/j.urology.2006.03.006; Kelleher CJ, 2004, BJOG-INT J OBSTET GY, V111, P605, DOI 10.1111/j.1471-0528.2004.00129.x; Kirby RS, 2003, UROLOGY, V61, P119, DOI 10.1016/S0090-4295(02)02114-3; Kirby RS, 2003, BJU INT, V91, P41, DOI 10.1046/j.1464-410X.2003.03077.x; Lee JY, 2004, BJU INT, V94, P817, DOI 10.1111/j.1464-410X.2004.05039.x; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; MEBUST WK, 1996, CONSULTATION BENIGN, P255; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Pleil AM, 2005, VALUE HEALTH, V8, pS25, DOI 10.1111/j.1524-4733.2005.00069.x; Rackley R, 2006, UROLOGY, V67, P731, DOI 10.1016/j.urology.2005.10.061; Roehrborn CG, 2005, EUR UROL, V48, P445, DOI 10.1016/j.eururo.2005.05.010; Roehrborn CG, 2006, BJU INT, V97, P1003, DOI 10.1111/j.1464-410X.2006.06068.x; Sech SM, 1998, UROLOGY, V51, P242, DOI 10.1016/S0090-4295(97)00609-2; Van Kerrebroeck P, 2001, UROLOGY, V57, P414, DOI 10.1016/S0090-4295(00)01113-4; Yotsuyanagi S, 2006, UROL INT, V77, P57, DOI 10.1159/000092936	36	369	393	1	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2319	2328		10.1001/jama.296.19.2319	http://dx.doi.org/10.1001/jama.296.19.2319			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104ZI	17105794	Bronze			2022-12-28	WOS:000241998700019
J	Lewis, BH; Legato, M; Fisch, H				Lewis, Benjamin H.; Legato, Marianne; Fisch, Harry			Medical implications of the male biological clock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TESTOSTERONE-REPLACEMENT THERAPY; ADVANCING PATERNAL AGE; ERECTILE DYSFUNCTION; SEMEN QUALITY; CONCEPTION; SYMPTOMS; RISK; MEN		Columbia Univ, Med Ctr, New York Presbyterian Hosp, Male Reprod Ctr,Dept Urol, New York, NY 10028 USA; Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Med, New York, NY 10028 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Fisch, H (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, Male Reprod Ctr,Dept Urol, 944 Park Ave, New York, NY 10028 USA.	hf4@columbia.edu						[Anonymous], 1995, ANN INTERN MED, V122, P561, DOI 10.7326/0003-4819-122-8-199504150-00001; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; DaSilva FC, 1997, EUR UROL, V31, P272; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fisch H, 2003, J UROLOGY, V169, P2275, DOI 10.1097/01.ju.0000067958.36077.d8; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Marks LS, 2006, JAMA-J AM MED ASSOC, V296, P2351, DOI 10.1001/jama.296.19.2351; MATHIEU C, 1995, HUM REPROD, V10, P1090, DOI 10.1093/oxfordjournals.humrep.a136100; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rhoden EL, 2004, NEW ENGL J MED, V350, P482, DOI 10.1056/NEJMra022251; Shores MM, 2006, ARCH INTERN MED, V166, P1660, DOI 10.1001/archinte.166.15.1660; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; WEI M, 1994, AM J EPIDEMIOL, V140, P930, DOI 10.1093/oxfordjournals.aje.a117181	21	17	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2369	2371		10.1001/jama.296.19.2369	http://dx.doi.org/10.1001/jama.296.19.2369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104ZI	17105801				2022-12-28	WOS:000241998700026
J	Danaei, G; Lawes, CMM; Hoorn, SV; Murray, CJL; Ezzati, M				Danaei, Goodarz; Lawes, Carlene M. M.; Hoorn, Stephen Vander; Murray, Christopher J. L.; Ezzati, Majid			Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment	LANCET			English	Article							CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; HYPERGLYCEMIA; METAANALYSIS; PREVALENCE; GLYCEMIA; CANCER; MEN; ASSOCIATION; HEMOGLOBIN	Background Cardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide. Methods We used population distribution of fasting plasma glucose to measure exposure to higher-than-optimum blood glucose. We collated exposure data in 52 countries from individual-level records in population health surveys, systematic reviews, and data provided by investigators. Relative risks for ischaemic heart disease and stroke mortality were from a meta-analysis of more than 200 000 participants in the Asia-Pacific region, with adjustment for other cardiovascular risk factors. Results In addition to 959 000 deaths directly assigned to diabetes, 1490 000 deaths from ischaemic heart disease and 709000 from stroke were attributable to high blood glucose, accounting for 21% and 13% of all deaths from these conditions. 1.8 million of these 2.2 million cardiovascular deaths (84%) were in low-and-middle-income countries (1224 000 for ischaemic heart disease, 623 000 for stroke). 792 000 (53%) of deaths from ischaemic heart disease and 345 000 (49%) from stroke that were attributable to high blood glucose were in men. Largest numbers of deaths attributable to this risk factor from ischaemic heart disease were in low-and-middle-income countries of South Asia (548 000) and Europe and Central Asia (313 000), and from stroke in South Asia (215 000) and East Asia and Pacific (190 000). Interpretation Higher-than-optimum blood glucose is a leading cause of cardiovascular mortality in most world regions. Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Auckland	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu	Danaei, Goodarz/B-6085-2008		NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01-AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1999, Diabetologia, V42, P647; [Anonymous], 1995, DIABETES AM; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; BARRETTCONNOR E, 1984, J CHRON DIS, V37, P773, DOI 10.1016/0021-9681(84)90046-8; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Epstein F H, 1985, Monogr Atheroscler, V13, P92; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ezzati M, 2004, COMP QUANTIFICATION; Fuller JH, 1996, ANN MED, V28, P319, DOI 10.3109/07853899608999088; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 1996, LANCET, V347, P949, DOI 10.1016/S0140-6736(96)91420-8; Gerstein HC, 1999, DIABETES CARE, V22, P659, DOI 10.2337/diacare.22.5.659; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Lawes C, 2004, COMP QUANTIFICATION, P281; Lawes C. M. M., 2004, COMP QUANTIFICATION, P391; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Miedema K, 2004, DIABETOLOGIA, V47, P1143, DOI 10.1007/s00125-004-1453-0; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; *NAT I PUBL HLTH, 2004, REG PROJ RISK FACT H; Qiao Q, 2003, DIABETES CARE, V26, P688; SCHEIDTNAVE C, 1991, AM J EPIDEMIOL, V133, P565, DOI 10.1093/oxfordjournals.aje.a115928; SCHROLL M, 1979, J CHRON DIS, V32, P699, DOI 10.1016/0021-9681(79)90049-3; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TOMASABADAL L, 1994, EUR HEART J, V15, P1028, DOI 10.1093/oxfordjournals.eurheartj.a060624; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vander Hoorn S, 2004, COMP QUANTIFICATION, P2129; Wei M, 2000, CIRCULATION, V101, P2047, DOI 10.1161/01.CIR.101.17.2047; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; World Health Organization, 1999, WHONCDNCS992; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	45	252	266	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1651	1659		10.1016/S0140-6736(06)69700-6	http://dx.doi.org/10.1016/S0140-6736(06)69700-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098083				2022-12-28	WOS:000242099000032
J	Lozano, R; Soliz, P; Gakidou, E; Abbott-Klafter, J; Feehan, DM; Vidal, C; Ortiz, JP; Murray, CJL				Lozano, Rafael; Soliz, Patricia; Gakidou, Emmanuela; Abbott-Klafter, Jesse; Feehan, Dennis M.; Vidal, Cecilia; Pablo Ortiz, Juan; Murray, Christopher J. L.			Health system reform in Mexico 3 - Benchmarking of performance of Mexican states with effective coverage	LANCET			English	Article							CARE; EQUITY; ACCESS; COUNTRIES; POOR	Benchmarking of the performance of states, provinces, or districts in a decentralised health system is important for fostering of accountability, monitoring of progress, identification of determinants of success and failure, and creation of a culture of evidence. The Mexican Ministry of Health has, since 2001, used a benchmarking approach based on the WHO concept of effective coverage of an intervention, which is defined as the proportion of potential health gain that could be delivered by the health system to that which is actually delivered. Using data collection systems, including state representative examination surveys, vital registration, and hospital discharge registries, we have monitored the delivery of 14 interventions for 2005-06. Overall effective coverage ranges from 54.0% in Chiapas, a poor state, to 65.1% in the Federal District. Effective coverage for maternal and child health interventions is substantially higher than that for interventions that target other health problems. Effective coverage for the lowest wealth quintile is 52% compared with 61% for the highest quintile. Effective coverage is closely related to public-health spending per head across states; this relation is stronger for interventions that are not related to maternal and child health than those for maternal and child health. Considerable variation also exists in effective coverage at similar amounts of spending. We discuss the implications of these issues for the further development of the Mexican health-information system. Benchmarking of performance by measuring effective coverage encourages decision-makers to focus on quality service provision, not only service availability. The effective coverage calculation is an important device for health-system stewardship. in adopting this approach, other countries should select interventions to be measured on the basis of the criteria of affordability, effect on population health, effect on health inequalities, and capacity to measure the effects of the intervention. The national institutions undertaking this benchmarking must have the mandate, skills, resources, and independence to succeed.	Secretaria Salud Mexico, Gen Informat, Mexico City 06600, DF, Mexico; Mexican Minist Hlth, Mexico City, DF, Mexico; Harvard Initiat Global Hlth, Cambridge, MA USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Harvard University; University of Queensland	Lozano, R (corresponding author), Secretaria Salud Mexico, Gen Informat, Reforma 450 Col Juarez, Mexico City 06600, DF, Mexico.	rlozano@salud.gob.mx	Sandall, Jane/D-4146-2009; Lozano, Rafael/T-5352-2018	Sandall, Jane/0000-0003-2000-743X; Lozano, Rafael/0000-0002-7356-8823				[Anonymous], 2003, HLTH SYST PERF ASS; Baldacci E., 2003, J INT DEV, V15, P709, DOI DOI 10.1002/JID.1025; Beaglehole R., 2003, WORLD HLTH REPORT 20; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9; Gupta S, 2003, HEALTH ECON, V12, P685, DOI 10.1002/hec.759; Kelley E., 2006, HLTH CARE QUALITY IN; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Mexican Ministry of Health, 2006, EFF COV HLTH SYST ME; Murray C., 2003, HLTH SYSTEMS PERFORM, P115; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; *NAT HLTH PERF COM, 2000, 4 NSW HLTH NAT HLTH; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; *SECR SAL MEX, 2003, SAL MEX 2003 INF REN; *SECR SAL MEX, 2005, SAL MEX 2005 INF REN; *SECR SAL MEX, 2004, SAL MEX 2004 INF REN; *SECR SAL MEX, 2002, SAL MEX 2002 INF REN; Self S, 2003, APPL ECON, V35, P835, DOI 10.1080/0003684032000056751; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shengelia B., 2003, HLTH SYSTEMSPERFORMA, P221; Smith P C, 2002, Eur J Health Econ, V3, P145, DOI 10.1007/s10198-002-0138-1; TANDON A, 2003, HLTH SYSTEMS PERFORM, P727; TANDON A, 2004, MEASURING HLTH CARE; Turnbull F, 2003, LANCET, V362, P1527; Waters HR, 2000, SOC SCI MED, V51, P599, DOI 10.1016/S0277-9536(00)00003-4; *WHO, 2006, GLOB TUB CONTR SURV, P242; WOLFSON M, 2002, INTEGRATED COHERENT, P133; World Health Organization, 2000, WORLD HLTH REP 2000	33	129	135	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1729	1741		10.1016/S0140-6736(06)69566-4	http://dx.doi.org/10.1016/S0140-6736(06)69566-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098091				2022-12-28	WOS:000242099000040
J	Ambrose, SH				Ambrose, Stanley H.			Anthropology - A tool for all seasons	SCIENCE			English	Editorial Material							ECOLOGY; DIET		Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Ambrose, SH (corresponding author), Univ Illinois, Dept Anthropol, 109 Davenport Hall, Urbana, IL 61801 USA.	ambrose@uiuc.edu						Balasse M, 2003, INT J OSTEOARCHAEOL, V13, P3, DOI 10.1002/oa.656; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; DEMENOCAL PB, 1996, PALEOCLIMATE EVOLUTI, P263; Foley RA, 1987, ANOTHER UNIQUE SPECI; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004	11	5	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					930	931		10.1126/science.1135741	http://dx.doi.org/10.1126/science.1135741			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095682				2022-12-28	WOS:000241896000031
J	Gorvel, JP				Gorvel, Jean-Pierre			Microbiology - Bacterial bushwacking through a microtubule jungle	SCIENCE			English	Editorial Material							ACTIN-BASED MOTILITY; ARP2/3 COMPLEX; N-WASP; PROTEIN; MONOCYTOGENES		Univ Mediterranee, INSERM, CNRS, Ctr Immunol, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Gorvel, JP (corresponding author), Univ Mediterranee, INSERM, CNRS, Ctr Immunol, Parc Sci Luminy Case 906, F-13288 Marseille 9, France.		Gorvel, Jean-Pierre/O-1332-2018	Gorvel, Jean-Pierre/0000-0002-2829-9804				Aepfelbacher M, 2005, CURR TOP MICROBIOL, V291, P167; Alvesalo JKO, 2006, J MED CHEM, V49, P2353, DOI 10.1021/jm051209w; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; HILLERINGMANN M, 1996, MICROBIOLOGY, V152, P2919; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lehmann-Che J, 2005, J VIROL, V79, P9244, DOI 10.1128/JVI.79.14.9244-9253.2005; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Pfeuffer T, 2000, CELL MICROBIOL, V2, P101, DOI 10.1046/j.1462-5822.2000.00034.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	12	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					931	932		10.1126/science.1135742	http://dx.doi.org/10.1126/science.1135742			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095683				2022-12-28	WOS:000241896000032
J	Sodergren, E; Weinstock, GM; Davidson, EH; Cameron, RA; Gibbs, RA; Weinstock, GM; Angerer, RC; Angerer, LM; Arnone, MI; Burgess, DR; Burke, RD; Cameron, RA; Coffman, JA; Davidson, EH; Dean, M; Elphick, MR; Ettensohn, CA; Foltz, KR; Hamdoun, A; Hynes, RO; Klein, WH; Marzluff, W; McClay, DR; Morris, RL; Mushegian, A; Rast, JP; Sodergren, E; Smith, LC; Thorndyke, MC; Vacquier, VD; Weinstock, GM; Wessel, GM; Wray, G; Zhang, L; Sodergren, E; Weinstock, GM; Angerer, RC; Angerer, LM; Cameron, RA; Davidson, EH; Elsik, CG; Ermolaeva, O; Hlavina, W; Hofmann, G; Kitts, P; Landrum, MJ; Mackey, AJ; Maglott, D; Panopoulou, G; Poustka, AJ; Pruitt, K; Sapojnikov, V; Song, XZ; Souvorov, A; Solovyev, V; Wei, Z; Whittaker, CA; Worley, K; Zhang, L; Sodergren, E; Weinstock, GM; Durbin, KJ; Gibbs, RA; Shen, YF; Song, XZ; Worley, K; Zhang, L; Wray, G; Fedrigo, O; Garfield, D; Haygood, R; Primus, A; Satija, R; Severson, T; Zhang, L; Sodergren, E; Weinstock, GM; Gonzalez-Garay, ML; Jackson, AR; Milosavljevic, A; Song, XZ; Tong, M; Worley, K; Ettensohn, CA; Cameron, RA; Killian, CE; Landrum, MJ; Livingston, BT; Wilt, FH; Coffman, JA; Marzluff, W; Mushegian, A; Adams, N; Belle, R; Carbonneau, S; Cheung, R; Cormier, P; Cosson, B; Croce, J; Fernandez-Guerra, A; Geneviere, AM; Goel, M; Kelkar, H; Morales, J; Mulner-Lorillon, O; Robertson, AJ; Hamdoun, A; Goldstone, JV; Adams, N; Cole, B; Dean, M; Epel, D; Gold, B; Hahn, ME; Howard-Ashby, M; Scally, M; Stegeman, JJ; Morris, RL; Allgood, EL; Cool, J; Judkins, KM; McCafferty, SS; Musante, AM; Obar, RA; Rawson, AP; Rossetti, BJ; Burgess, DR; Allgood, EL; Cool, J; Gibbons, IR; Hoffman, MP; Judkins, KM; Leone, A; McCafferty, SS; Morris, RL; Musante, AM; Obar, RA; Rawson, AP; Rossetti, BJ; Wessel, GM; Davidson, EH; Cameron, RA; Istrail, S; Materna, SC; Samanta, MP; Stolc, V; Tongprasit, W; Tu, Q; Angerer, RC; Angerer, LM; Wei, Z; Hynes, RO; Bergeron, KF; Brandhorst, BP; Burke, RD; Whittaker, CA; Whittle, J; Cameron, RA; Berney, K; Bottjer, DJ; Calestani, C; Davidson, EH; Peterson, K; Chow, E; Yuan, QA; Elhaik, E; Elsik, CG; Graur, D; Reese, JT; Bosdet, I; Heesun, S; Marra, MA; Schein, J; Dean, M; Hamdoun, A; Rast, JP; Smith, LC; Anderson, MK; Berney, K; Brockton, V; Buckley, KM; Cameron, RA; Cohen, AH; Fugmann, SD; Hibino, T; Loza-Coll, M; Majeske, AJ; Messier, C; Nair, SV; Pancer, Z; Terwilliger, DP; Burke, RD; Elphick, MR; Klein, WH; Thorndyke, MC; Agca, C; Angerer, LM; Arboleda, E; Arnone, MI; Brandhorst, BP; Chen, NS; Churcher, AM; Hallbook, F; Humphrey, GW; Hynes, RO; Idris, MM; Kiyama, T; Liang, SG; Mellott, D; Mu, XQ; Murray, G; Olinski, RP; Raible, F; Rowe, M; Taylor, JS; Tessmar-Raible, K; Wang, D; Wilson, KH; Yaguchi, S; Foltz, KR; Vacquier, VD; Wessel, GM; Gaasterland, T; Galindo, BE; Gunaratne, HJ; Howard-Ashby, M; Humphrey, GW; Juliano, C; Kinukawa, M; Moy, GW; Neill, AT; Nomura, M; Raisch, M; Reade, A; Roux, MM; Song, JL; Su, YH; Townley, IK; Voronina, E; Wong, JL; Arnone, MI; Thorndyke, MC; Amore, G; Angerer, LM; Arboleda, E; Branno, M; Brown, ER; Cavalieri, V; Duboc, V; Duloquin, L; Elphick, MR; Flytzanis, C; Gache, C; Geneviere, AM; Idris, MM; Lapraz, F; Lepage, T; Locascio, A; Martinez, P; Matassi, G; Matranga, V; McClay, DR; Morales, J; Poustka, AJ; Raible, F; Range, R; Rizzo, F; Rottinger, E; Rowe, M; Tessmar-Raible, K; Sodergren, E; Weinstock, GM; Wilson, K; McClay, DR; Angerer, LM; Arnone, MI; Beane, W; Bradham, C; Byrum, C; Croce, J; Duboc, V; Duloquin, L; Gache, C; Geneviere, AM; Glenn, T; Hibino, T; Hussain, S; Lapraz, F; Lepage, T; Livingston, BT; Loza, M; Manning, G; Miranda, E; Range, R; Rizzo, F; Rottinger, E; Thomason, R; Walton, K; Wei, Z; Wessel, GM; Wikramanayke, A; Wilson, KH; Whittaker, C; Wu, SY; Xu, RH; Davidson, EH; Arnone, MI; Branno, M; Brown, CT; Cameron, RA; Chen, LL; Gray, RF; Howard-Ashby, M; Istrail, S; Lee, PY; Locascio, A; Martinez, P; Materna, SC; Nam, J; Oliveri, P; Rizzo, F; Smith, J; Muzny, D; Sodergren, E; Gibbs, RA; Weinstock, GM; Bell, S; Chacko, J; Cree, A; Curry, S; Davis, C; Dinh, H; Dugan-Rocha, S; Fowler, J; Gill, R; Hamilton, C; Hernandez, J; Hines, S; Hume, J; Jackson, L; Jolivet, A; Kovar, C; Lee, S; Lewis, L; Miner, G; Morgan, M; Nazareth, LV; Okwuonu, G; Parker, D; Pu, LL; Shen, YF; Thom, R; Wright, R				Sodergren, Erica; Weinstock, George M.; Davidson, Eric H.; Cameron, R. Andrew; Gibbs, Richard A.; Weinstock, George M.; Angerer, Robert C.; Angerer, Lynne M.; Arnone, Maria Ina; Burgess, David R.; Burke, Robert D.; Cameron, R. Andrew; Coffman, James A.; Davidson, Eric H.; Dean, Michael; Elphick, Maurice R.; Ettensohn, Charles A.; Foltz, Kathy R.; Hamdoun, Amro; Hynes, Richard O.; Klein, William H.; Marzluff, William; McClay, David R.; Morris, Robert L.; Mushegian, Arcady; Rast, Jonathan P.; Sodergren, Erica; Smith, L. Courtney; Thorndyke, Michael C.; Vacquier, Victor D.; Weinstock, George M.; Wessel, Gary M.; Wray, Greg; Zhang, Lan; Sodergren, Erica; Weinstock, George M.; Angerer, Robert C.; Angerer, Lynne M.; Cameron, R. Andrew; Davidson, Eric H.; Elsik, Christine G.; Ermolaeva, Olga; Hlavina, Wratko; Hofmann, Gretchen; Kitts, Paul; Landrum, Melissa J.; Mackey, Aaron J.; Maglott, Donna; Panopoulou, Georgia; Poustka, Albert J.; Pruitt, Kim; Sapojnikov, Victor; Song, Xingzhi; Souvorov, Alexandre; Solovyev, Victor; Wei, Zheng; Whittaker, Charles A.; Worley, Kim; Zhang, Lan; Sodergren, Erica; Weinstock, George M.; Durbin, K. James; Gibbs, Richard A.; Shen, Yufeng; Song, Xingzhi; Worley, Kim; Zhang, Lan; Wray, Greg; Fedrigo, Olivier; Garfield, David; Haygood, Ralph; Primus, Alexander; Satija, Rahul; Severson, Tonya; Zhang, Lan; Sodergren, Erica; Weinstock, George M.; Gonzalez-Garay, Manuel L.; Jackson, Andrew R.; Milosavljevic, Aleksandar; Song, Xingzhi; Tong, Mark; Worley, Kim; Ettensohn, Charles A.; Cameron, R. Andrew; Killian, Christopher E.; Landrum, Melissa J.; Livingston, Brian T.; Wilt, Fred H.; Coffman, James A.; Marzluff, William; Mushegian, Arcady; Adams, Nikki; Belle, Robert; Carbonneau, Seth; Cheung, Rocky; Cormier, Patrick; Cosson, Bertrand; Croce, Jenifer; Fernandez-Guerra, Antonio; Geneviere, Anne-Marie; Goel, Manisha; Kelkar, Hemant; Morales, Julia; Mulner-Lorillon, Odile; Robertson, Anthony J.; Hamdoun, Amro; Goldstone, Jared V.; Adams, Nikki; Cole, Bryan; Dean, Michael; Epel, David; Gold, Bert; Hahn, Mark E.; Howard-Ashby, Meredith; Scally, Mark; Stegeman, John J.; Morris, Robert L.; Allgood, Erin L.; Cool, Jonah; Judkins, Kyle M.; McCafferty, Shawn S.; Musante, Ashlan M.; Obar, Robert A.; Rawson, Amanda P.; Rossetti, Blair J.; Burgess, David R.; Allgood, Erin L.; Cool, Jonah; Gibbons, Ian R.; Hoffman, Matthew P.; Judkins, Kyle M.; Leone, Andrew; McCafferty, Shawn S.; Morris, Robert L.; Musante, Ashlan M.; Obar, Robert A.; Rawson, Amanda P.; Rossetti, Blair J.; Wessel, Gary M.; Davidson, Eric H.; Cameron, R. Andrew; Istrail, Sorin; Materna, Stefan C.; Samanta, Manoj P.; Stolc, Viktor; Tongprasit, Waraporn; Tu, Qiang; Angerer, Robert C.; Angerer, Lynne M.; Wei, Zheng; Hynes, Richard O.; Bergeron, Karl-Frederik; Brandhorst, Bruce P.; Burke, Robert D.; Whittaker, Charles A.; Whittle, James; Cameron, R. Andrew; Berney, Kevin; Bottjer, David J.; Calestani, Cristina; Davidson, Eric H.; Peterson, Kevin; Chow, Elly; Yuan, Qiu Autumn; Elhaik, Eran; Elsik, Christine G.; Graur, Dan; Reese, Justin T.; Bosdet, Ian; Heesun, Shin; Marra, Marco A.; Schein, Jacqueline; Dean, Michael; Hamdoun, Amro; Rast, Jonathan P.; Smith, L. Courtney; Anderson, Michele K.; Berney, Kevin; Brockton, Virginia; Buckley, Katherine M.; Cameron, R. Andrew; Cohen, Avis H.; Fugmann, Sebastian D.; Hibino, Taku; Loza-Coll, Mariano; Majeske, Audrey J.; Messier, Cynthia; Nair, Sham V.; Pancer, Zeev; Terwilliger, David P.; Burke, Robert D.; Elphick, Maurice R.; Klein, William H.; Thorndyke, Michael C.; Agca, Cavit; Angerer, Lynne M.; Arboleda, Enrique; Arnone, Maria Ina; Brandhorst, Bruce P.; Chen, Nansheng; Churcher, Allison M.; Hallboeoek, F.; Humphrey, Glen W.; Hynes, Richard O.; Idris, Mohammed M.; Kiyama, Takae; Liang, Shuguang; Mellott, Dan; Mu, Xiuqian; Murray, Greg; Olinski, Robert P.; Raible, Florian; Rowe, Matthew; Taylor, John S.; Tessmar-Raible, Kristin; Wang, D.; Wilson, Karen H.; Yaguchi, Shunsuke; Foltz, Kathy R.; Vacquier, Victor D.; Wessel, Gary M.; Gaasterland, Terry; Galindo, Blanca E.; Gunaratne, Herath J.; Howard-Ashby, Meredith; Humphrey, Glen W.; Juliano, Celina; Kinukawa, Masashi; Moy, Gary W.; Neill, Anna T.; Nomura, Mamoru; Raisch, Michael; Reade, Anna; Roux, Michelle M.; Song, Jia L.; Su, Yi-Hsien; Townley, Ian K.; Voronina, Ekaterina; Wong, Julian L.; Arnone, Maria Ina; Thorndyke, Michael C.; Amore, Gabriele; Angerer, Lynne M.; Arboleda, Enrique; Branno, Margherita; Brown, Euan R.; Cavalieri, Vincenzo; Duboc, Veronique; Duloquin, Louise; Elphick, Maurice R.; Flytzanis, Constantin; Gache, Christian; Geneviere, Anne-Marie; Idris, Mohammed M.; Lapraz, Francois; Lepage, Thierry; Locascio, Annamaria; Martinez, Pedro; Matassi, Giorgio; Matranga, Valeria; McClay, David R.; Morales, Julia; Poustka, Albert J.; Raible, Florian; Range, Ryan; Rizzo, Francesca; Roettinger, Eric; Rowe, Matthew; Tessmar-Raible, Kristin; Sodergren, Erica; Weinstock, George M.; Wilson, Karen; McClay, David R.; Angerer, Lynne M.; Arnone, Maria Ina; Beane, Wendy; Bradham, Cynthia; Byrum, Christine; Croce, Jenifer; Duboc, Veronique; Duloquin, Louise; Gache, Christian; Geneviere, Anne-Marie; Glenn, Tom; Hibino, Taku; Hussain, Sofia; Lapraz, Francois; Lepage, Thierry; Livingston, Brian T.; Loza, Mariano; Manning, Gerard; Miranda, Esther; Range, Ryan; Rizzo, Francesca; Roettinger, Eric; Thomason, Rebecca; Walton, Katherine; Wei, Zheng; Wessel, Gary M.; Wikramanayke, Athula; Wilson, Karen H.; Whittaker, Charles; Wu, Shu-Yu; Xu, Ronghui; Davidson, Eric H.; Arnone, Maria Ina; Branno, Margherita; Brown, C. Titus; Cameron, R. Andrew; Chen, Lili; Gray, Rachel F.; Howard-Ashby, Meredith; Istrail, Sorin; Lee, Pei Yun; Locascio, Annamaria; Martinez, Pedro; Materna, Stefan C.; Nam, Jongmin; Oliveri, Paola; Rizzo, Francesca; Smith, Joel; Muzny, Donna; Sodergren, Erica; Gibbs, Richard A.; Weinstock, George M.; Bell, Stephanie; Chacko, Joseph; Cree, Andrew; Curry, Stacey; Davis, Clay; Dinh, Huyen; Dugan-Rocha, Shannon; Fowler, Jerry; Gill, Rachel; Hamilton, Cerrissa; Hernandez, Judith; Hines, Sandra; Hume, Jennifer; Jackson, LaRonda; Jolivet, Angela; Kovar, Christie; Lee, Sandra; Lewis, Lora; Miner, George; Morgan, Margaret; Nazareth, Lynne V.; Okwuonu, Geoffrey; Parker, David; Pu, Ling-Ling; Shen, Yufeng; Thom, Rachel; Wright, Rita		Sea Urchin Genome Sequencing Consortium	Research article - The genome of the sea urchin Strongylocentrotus purpuratus	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; IMMUNE-SYSTEM; EVOLUTION; VERTEBRATE; COMPLEMENT; INSIGHTS; DUPLICATION; CELOMOCYTES; SEQUENCE; CHORDATE		Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Stn Zool A Dohrn, I-70121 Bari, Italy; Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3N5, Canada; Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; NCI, Human Genet Sect, Lab Genom Divers, Frederick, MD 21702 USA; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ N Carolina, Dept Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Wheaton Coll, Dept Biol, Norton, MA 02766 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Microbiol, Kansas City, KS 66160 USA; Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada; George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Royal Swedish Acad Sci, Kristineberg Marine Res Stn, S-45034 Fiskebackskil, Sweden; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Brown Univ, Dept Mol & Cellular Biol & Biochem, Providence, RI 02912 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD 20894 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; Univ Penn, Penn Genom Inst, Philadelphia, PA 19104 USA; Max Planck Inst Mol Genet, Evolut & Dev Grp, D-14195 Berlin, Germany; Royal Holloway Univ London, Egham TW20 0EX, Surrey, England; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ S Florida, Dept Biol, Tampa, FL 33618 USA; Univ Paris 06, UMR 7150, Equipe Cycle Cellulaire & Dev, Stn Biol Roscoff, F-29682 Roscoff, France; CNRS, UMR 7150, Stn Biol Roscoff, F-29682 Roscoff, France; Univ Paris 06, UMR7628, F-66650 Banyuls sur Mer, France; Univ N Carolina, Ctr Bioinformat, Chapel Hill, NC 27599 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Tethys Res LLC, Bangor, ME 04401 USA; Univ Calif Berkeley, Dept Mol Cellular & Dev Biol, Berkeley, CA 94720 USA; Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; NASA, Ames Res Ctr, Genome Res Facil, Moffett Field, CA 94035 USA; Systemix Inst, Cupertino, CA 95014 USA; Simon Fraser Univ, Dept Biochem & Mol Biol, Burnaby, BC V5A 1S6, Canada; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; CALTECH, Beckman Inst, Ctr Computat Regulatory Genom, Pasadena, CA 91125 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia; UMBI, Ctr Marine Biotechnol, Baltimore, MD 21202 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA; Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; Uppsala Univ, Dept Neurosci, Uppsala, Sweden; NICHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; European Mol Biol Lab, Dev Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Computat Unit, D-69117 Heidelberg, Germany; Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62250, Morelos, Mexico; Univ Palermo, Dept Cellular & Dev Biol Alberto Monroy, I-90146 Palermo, Italy; CNRS, UMR 7009, Dev Biol Lab, F-06230 Villefranche Sur Mer, France; Univ Paris 06, Observ Oceanol, F-06230 Villefranche Sur Mer, France; Univ Patras, Dept Biol, Patras, Greece; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; Inst Jacques Monod, CNR, UMR 7592, F-75005 Paris, France; CNR, Ist Biomed & Immunol Mol Alberto Monroy, I-90146 Palermo, Italy; Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, San Diego, CA 92186 USA; Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Boston College; University of Victoria; Mount Desert Island Biological Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Queen Mary University London; Carnegie Mellon University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Stanford University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; George Washington University; Royal Swedish Academy of Sciences; University of California System; University of California San Diego; Scripps Institution of Oceanography; Brown University; Duke University; Duke University; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California Santa Barbara; National Institutes of Health (NIH) - USA; University of Pennsylvania; Max Planck Society; University of London; Royal Holloway University London; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; State University System of Florida; University of South Florida; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; Woods Hole Oceanographic Institution; University of California System; University of California Berkeley; Brown University; Brown University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Simon Fraser University; Massachusetts Institute of Technology (MIT); University of Southern California; State University System of Florida; University of Central Florida; Dartmouth College; California Institute of Technology; University of Houston System; University of Houston; British Columbia Cancer Agency; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Macquarie University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Victoria; Uppsala University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Universidad Nacional Autonoma de Mexico; University of Palermo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Patras; Baylor College of Medicine; University of Barcelona; ICREA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Salk Institute; University of Hawaii System; University of Hawaii Manoa	Weinstock, GM (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	gwstock@bcm.tmc.edu	Locascio, Annamaria/E-8714-2015; Dean, Michael C/G-8172-2012; 拓, 日比野/D-8115-2013; Lepage, Thierry/V-4208-2019; Weinstock, George M/C-6314-2013; Croce, Jenifer C/P-1159-2016; Tu, Qiang/AAJ-1582-2020; Bradham, Cynthia/GXV-9373-2022; Röttinger, Eric/AAX-6277-2021; Manning, Gerard/C-8308-2009; Dean, Michael/R-7501-2019; Agca, Cavit/AAY-9574-2020; Satija, Rahul/AAF-9564-2019; Solovyev, Victor/C-4614-2013; Elsik, Christine G/C-4120-2017; Su, Yi-Hsien/F-2910-2014; Peterson, Kevin J/A-2188-2009; Tessmar-Raible, Kristin/F-9642-2011; Geneviere, Anne-Marie/A-3942-2013; Croce, Jenifer/AGE-1719-2022; Churcher, Allison M/M-6169-2013; Garfield, David/AAG-1524-2020; Brown, Euan R/A-5558-2008; Chen, Nansheng/E-6450-2012; Raible, Florian/G-6019-2011; Mushegian, Arcady/ABF-5387-2021; Brown, Euan Robert/I-2389-2019; Schein, Jacquie E/G-3674-2015; Hamdoun, Amro/AAE-1905-2021; Matassi, Giorgio/G-6301-2014; Yaguchi, Shunsuke/H-7270-2019; Lapraz, Francois/W-4948-2017; Elhaik, Eran/H-6838-2019; Mu, Xiuqian/I-9146-2014; Brandhorst, Bruce Peter/A-3157-2008; Lepage, Thierry/AAF-8925-2019; Hahn, Mark/AAV-7516-2020; Fernandez-Guerra, Antonio/B-2851-2009; Buckley, Katherine Michele/AAY-8151-2021; Marra, Marco A/B-5987-2008; Martinez, Pedro/O-5025-2014; Rizzo, Francesca/K-3057-2016	Locascio, Annamaria/0000-0001-6956-2157; Dean, Michael C/0000-0003-2234-0631; 拓, 日比野/0000-0002-4789-7375; Lepage, Thierry/0000-0003-2889-5064; Weinstock, George M/0000-0002-2997-4592; Croce, Jenifer C/0000-0001-7092-0257; Tu, Qiang/0000-0002-7579-8315; Agca, Cavit/0000-0001-8472-7052; Solovyev, Victor/0000-0001-8885-493X; Elsik, Christine G/0000-0002-4248-7713; Tessmar-Raible, Kristin/0000-0002-8038-1741; Churcher, Allison M/0000-0003-1902-3002; Brown, Euan R/0000-0002-5995-834X; Mushegian, Arcady/0000-0002-6809-9225; Brown, Euan Robert/0000-0002-5995-834X; Matassi, Giorgio/0000-0003-4923-226X; Yaguchi, Shunsuke/0000-0002-8326-5762; Lapraz, Francois/0000-0001-9209-2018; Elhaik, Eran/0000-0003-4795-1084; Mu, Xiuqian/0000-0002-8003-7529; Hahn, Mark/0000-0003-4358-2082; Buckley, Katherine Michele/0000-0002-6585-8943; Marra, Marco A/0000-0001-7146-7175; Martinez, Pedro/0000-0003-3956-7541; Rizzo, Francesca/0000-0003-1783-5015; Latimer, Rebecca Thomason/0000-0002-0254-6803; Walton, Katherine/0000-0001-9108-5617; Elphick, Maurice/0000-0002-9169-0048; Voronina, Ekaterina/0000-0002-0194-4260; Bergeron, Karl-F./0000-0002-7215-9104; Cosson, Bertrand/0000-0003-3401-7137; Rottinger, Eric/0000-0002-2938-6774; Cameron, R. Andrew/0000-0003-3947-6041; Brown, C. Titus/0000-0001-6001-2677; CAVALIERI, Vincenzo/0000-0003-0906-9963; Beane, Wendy/0000-0002-3762-1025; Raisch, Michael/0000-0002-7473-0378; Whittaker, Charles/0000-0002-2400-0094; Oliveri, Paola/0000-0002-3477-8529; MATRANGA, VALERIA/0000-0001-9843-3426; Goldstone, Jared/0000-0002-9618-4961; Morales, Julia/0000-0003-1632-5419; Smith, Joel/0000-0003-0311-7055; Materna, Stefan/0000-0003-1737-2479; Duboc, veronique/0000-0002-2376-5159; Anderson, Michele/0000-0002-8820-5910; Fernandez-Guerra, Antonio/0000-0002-8679-490X; Stegeman, John/0000-0001-8204-5357; Leone, Andrew/0000-0003-4749-9809; Manning, Gerard/0000-0002-5087-9151; Worley, Kim/0000-0002-0282-1000; Calestani, Cristina/0000-0001-8122-9349; Burke, Robert/0000-0001-5527-4410; Loza Coll, Mariano/0000-0002-3123-1229; Arboleda, Enrique/0000-0001-9800-1674; Hallbook, Finn/0000-0001-7552-187X; Cheung, Rocky/0000-0001-6736-9687; Ashby, Meredith/0000-0002-4385-9486; ARNONE, Maria Immacolata/0000-0002-9012-7624; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Rossetti, Blair/0000-0003-2405-4209; Pruitt, Kim/0000-0001-7950-1374	ICREA Funding Source: Custom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD066219, R01HD014483, R01HD028152, P01HD037105] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039948, F32HD047136] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R43CA093106, R44CA093106] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR015044] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011930] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006272, P42ES007381, F32ES012794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058231, T32GM007601, R01GM061464, R01GM061005, R01GM070840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000388] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010959] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [S19916] Funding Source: Medline; NCI NIH HHS [R44 CA093106, P30 CA014051, R43 CA093106, P30-CA14051] Funding Source: Medline; NCRR NIH HHS [RR-15044, P40 RR015044] Funding Source: Medline; NEI NIH HHS [R01 EY011930, EY11930] Funding Source: Medline; NHGRI NIH HHS [5 U54 HG003273, U54 HG003273] Funding Source: Medline; NICHD NIH HHS [F32 HD047136-03, R01 HD066219, HD-37105, F32 HD047136-02, F32 HD047136, F32-HD47136, HD039948, HD14483, R37-HD12896, R01 HD014483, P01 HD037105, P01 HD039948, R01 HD028152, HD66219] Funding Source: Medline; NIEHS NIH HHS [R01 ES006272-13, R01ES006272, R01 ES006272, P42 ES007381, F32 ES012794] Funding Source: Medline; NIGMS NIH HHS [R01 GM058231, GM070840, R01 GM061464, R01 GM061005, GM058231, GM61464, GM61005, R01 GM070840, T32 GM007601] Funding Source: Medline; NIH HHS [P40 OD010959] Funding Source: Medline; PHS HHS [2P42 ESO7381, F32 ESO12794] Funding Source: Medline	ICREA(ICREA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BEANE W, IN PRESS DEV BIOL; BRADHAM C, IN PRESS DEV BIOL; BRITTEN RJ, 1978, CELL, V15, P1175, DOI 10.1016/0092-8674(78)90044-2; BURKE RD, IN PRESS DEV BIOL; BYRUM C, IN PRESS DEV BIOL; Cai WW, 2001, GENOME RES, V11, P1619, DOI 10.1101/gr.198101; Cobb J. L., 1987, NERVOUS SYSTEMS INVE, P483; COBB JLS, 1977, TISSUE CELL, V9, P125, DOI 10.1016/0040-8166(77)90054-4; CROCE J, IN PRESS DEV BIOL; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DAVIDSON EH, 2006, GENE REGULATORY NETW; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; ELSIK CG, IN PRESS GENOME BIOL; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GOLDSTONE J, IN PRESS DEV BIOL; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; HIBINO T, IN PRESS DEV BIOL; HINEGARDNER RT, 1971, ANAL BIOCHEM, V39, P197, DOI 10.1016/0003-2697(71)90476-3; HOWARDASHBY M, IN PRESS DEV BIOL; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; LIVINGSTON BT, IN PRESS DEV BIOL; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MATERNA SC, IN PRESS DEV BIOL; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MORRIS RL, IN PRESS DEV BIOL; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Pancer Z, 1999, IMMUNOGENETICS, V49, P773, DOI 10.1007/s002510050551; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; RAIBLE F, IN PRESS DEV BIOL; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Samanta MP, 2006, SCIENCE, V314, P960, DOI 10.1126/science.1131898; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; WEI Z, IN PRESS DEV BIOL; WHITTAKER CA, IN PRESS DEV BIOL; Xie W, 2001, J BIOL CHEM, V276, P37739, DOI 10.1074/jbc.R100033200	50	841	872	2	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					941	952		10.1126/science.1133609	http://dx.doi.org/10.1126/science.1133609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095691	Green Accepted, Green Published			2022-12-28	WOS:000241896000039
J	Sponheimer, M; Passey, BH; de Ruiter, DJ; Guatelli-Steinberg, D; Cerling, TE; Lee-Thorp, JA				Sponheimer, Matt; Passey, Benjamin H.; de Ruiter, Darryl J.; Guatelli-Steinberg, Debbie; Cerling, Thure E.; Lee-Thorp, Julia A.			Isotopic evidence for dietary variability in the early hominin Paranthropus robustus	SCIENCE			English	Article							HOMO; STERKFONTEIN; CHIMPANZEES; MICROWEAR; TIME; WEST	Traditional methods of dietary reconstruction do not allow the investigation of dietary variability within the lifetimes of individual hominins. However, laser ablation stable isotope analysis reveals that the delta C-13 values of Paranthropus robustus individuals often changed seasonally and interannually. These data suggest that Paranthropus was not a dietary specialist and that by about 1.8 million years ago, savanna-based foods such as grasses or sedges or animals eating these foods made up an important but highly variable part of its diet.	Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Bradford, Dept Archeol Sci, Bradford BD1 7DP, W Yorkshire, England	University of Colorado System; University of Colorado Boulder; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; University of Bradford	Sponheimer, M (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.		Passey, Benjamin/F-9644-2010; Sponheimer, Matt/A-6075-2013	Sponheimer, Matt/0000-0002-8743-1123; Cerling, Thure/0000-0002-3590-294X; de Ruiter, Darryl/0000-0003-1183-0352; Passey, Benjamin/0000-0002-3483-4148				Ambrose SH, 1993, PREHISTORIC HUMAN BO; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; FOLEY R, 1987, ANOTHER UNIQUE SPECI, P210; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; HILL A, 1992, NATURE, V355, P719, DOI 10.1038/355719a0; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; LACRUZ RJ, 2006, J HUM EVOL, DOI DOI 10.1016/J.HJEVOL.2006.05.007; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; MCGREW WC, 1981, J HUM EVOL, V10, P227, DOI 10.1016/S0047-2484(81)80061-9; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; Passey BH, 2006, CHEM GEOL, V235, P238, DOI 10.1016/j.chemgeo.2006.07.002; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; ROBINSON JT, 1954, EVOLUTION, V8, P324, DOI 10.2307/2405779; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; SCHRENK F, 1993, NATURE, V365, P833, DOI 10.1038/365833a0; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sponheimer M, 2005, J HUM EVOL, V48, P301, DOI 10.1016/j.jhevol.2004.11.008; Sponheimer M, 2003, J MAMMAL, V84, P471, DOI 10.1644/1545-1542(2003)084&lt;0471:DOSABS&gt;2.0.CO;2; van der Merwe NJ, 2003, J HUM EVOL, V44, P581, DOI 10.1016/S0047-2484(03)00050-2; VOGEL JC, 1978, S AFR J SCI, V74, P209; Vrba E.S., 1988, P405; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004	30	154	163	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					980	982		10.1126/science.1133827	http://dx.doi.org/10.1126/science.1133827			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095699				2022-12-28	WOS:000241896000049
J	Briscoe, WH; Titmuss, S; Tiberg, F; Thomas, RK; McGillivray, DJ; Klein, J				Briscoe, Wuge H.; Titmuss, Simon; Tiberg, Fredrik; Thomas, Robert K.; McGillivray, Duncan J.; Klein, Jacob			Boundary lubrication under water	NATURE			English	Article							CATIONIC SURFACTANTS; MONOLAYERS; ADHESION; FRICTION; LAYERS; FORCE; SURFACES; SOLIDS	Boundary lubrication, in which the rubbing surfaces are coated with molecular monolayers, has been studied extensively for over half a century(1-7). Such monolayers generally consist of amphiphilic surfactants anchored by their polar headgroups; sliding occurs at the interface between the layers, greatly reducing friction and especially wear of the underlying substrates. This process, widespread in engineering applications, is also predicted to occur in biological lubrication via phospholipid films(8,9), though few systematic studies on friction between surfactant layers in aqueous environments have been carried out(5,10). Here we show that the frictional stress between two sliding surfaces bearing surfactant monolayers may decrease, when immersed in water, to as little as one per cent or less of its value in air ( or oil). We attribute this to the shift of the slip plane from between the surfactant layers, to the surfactant/ substrate interface. The low friction would then be due to the fluid hydration layers surrounding the polar head groups attached to the substrate. These results may have implications for future technological and biomedical applications.	Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Oxford; Weizmann Institute of Science	Klein, J (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	jacob.klein@chem.ox.ac.uk	McGillivray, Duncan/B-9819-2009; Briscoe, Wuge H/H-5435-2018	McGillivray, Duncan/0000-0003-2127-8792; Briscoe, Wuge H/0000-0001-8025-960X	Engineering and Physical Sciences Research Council [EP/C535421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bowden F. P., 1964, FRICTION LUBRICATION, V2; Bowden FP, 1950, FRICTION LUBRICATION, V1; BRISCOE BJ, 1982, P ROY SOC LOND A MAT, V380, P389, DOI 10.1098/rspa.1982.0048; CHEN YL, 1992, J PHYS CHEM-US, V96, P7752, DOI 10.1021/j100198a048; CHEN YLE, 1989, J PHYS CHEM-US, V93, P7057, DOI 10.1021/j100357a008; Christenson HK, 2001, ADV COLLOID INTERFAC, V91, P391, DOI 10.1016/S0001-8686(00)00036-1; DERJAGUIN BV, 1987, SURFACE FORCES, pCH4; Drummond C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066110; Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1; HAMNERIUS Y, 1978, CHEM PHYS LIPIDS, V22, P135, DOI 10.1016/0009-3084(78)90039-7; Hills BA, 2000, P I MECH ENG H, V214, P83, DOI 10.1243/0954411001535264; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Klein J, 1998, J CHEM PHYS, V108, P6996, DOI 10.1063/1.476114; Langmuir I, 1938, SCIENCE, V87, P493, DOI 10.1126/science.87.2266.493; McGillivray DJ, 2003, LANGMUIR, V19, P7719, DOI 10.1021/la026745v; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Sarma AV, 2001, J ORTHOP RES, V19, P671, DOI 10.1016/S0736-0266(00)00064-4; Stern HA, 2003, J CHEM PHYS, V118, P3401, DOI 10.1063/1.1537244; Suda H, 2001, LANGMUIR, V17, P6045, DOI 10.1021/la0106384; Teschke O, 2001, PHYS CHEM CHEM PHYS, V3, P3761, DOI 10.1039/b009744f; Vecchio P, 1999, RHEUMATOLOGY, V38, P1020, DOI 10.1093/rheumatology/38.10.1020; Wennerstrom H., 1975, AM CHEM SOC        S, V9, P253; Williams-Daryn S, 2002, J COLLOID INTERF SCI, V256, P314, DOI 10.1006/jcis.2002.8685; Yamada S, 1998, J PHYS CHEM B, V102, P234, DOI 10.1021/jp972875e; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033; Zhang LZ, 2002, LANGMUIR, V18, P5448, DOI 10.1021/la011718a; Zilberman S, 2001, J CHEM PHYS, V115, P11268, DOI 10.1063/1.1421105	28	258	265	8	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					191	194		10.1038/nature05196	http://dx.doi.org/10.1038/nature05196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093447				2022-12-28	WOS:000241867200037
J	Dong, CJ; Beis, K; Nesper, J; Brunkan-LaMontagne, AL; Clarke, BR; Whitfield, C; Naismith, JH				Dong, Changjiang; Beis, Konstantinos; Nesper, Jutta; Brunkan-LaMontagne, Anne L.; Clarke, Bradley R.; Whitfield, Chris; Naismith, James H.			Wza the translocon for E-coli capsular polysaccharides defines a new class of membrane protein	NATURE			English	Article							COLANIC ACID BIOSYNTHESIS; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; TYROSINE AUTOKINASE; FUNCTIONAL-ANALYSIS; GROUP-1 CAPSULES; COMPLEX; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; LIPOPROTEIN	Many types of bacteria produce extracellular polysaccharides (EPSs). Some are secreted polymers and show only limited association with the cell surface, whereas others are firmly attached to the cell surface and form a discrete structural layer, the capsule, which envelopes the cell and allows the bacteria to evade or counteract the host immune system(1). EPSs have critical roles in bacterial colonization of surfaces(2), such as epithelia and medical implants; in addition some EPSs have important industrial and biomedical applications in their own right(3). Here we describe the 2.26 angstrom resolution structure of the 340 kDa octamer of Wza, an integral outer membrane lipoprotein, which is essential for group 1 capsule export in Escherichia coli. The transmembrane region is a novel alpha-helical barrel. The bulk of the Wza structure is located in the periplasm and comprises three novel domains forming a large central cavity. Wza is open to the extracellular environment but closed to the periplasm. We propose a route and mechanism for translocation of the capsular polysaccharide. This work may provide insight into the export of other large polar molecules such as DNA and proteins.	Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9RH, Fife, Scotland; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of St Andrews; University of Guelph	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9RH, Fife, Scotland.	naismith@st-and.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Beis, Konstantinos/0000-0001-5727-4721	Wellcome Trust [067305, 081862] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Beis K, 2004, J BIOL CHEM, V279, P28227, DOI 10.1074/jbc.M402913200; Beis K, 2004, ACTA CRYSTALLOGR D, V60, P558, DOI 10.1107/S0907444903029494; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Moothoo DN, 1998, GLYCOBIOLOGY, V8, P173, DOI 10.1093/glycob/8.2.173; Nesper J, 2003, J BIOL CHEM, V278, P49763, DOI 10.1074/jbc.M308775200; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	30	265	277	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					226	229		10.1038/nature05267	http://dx.doi.org/10.1038/nature05267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17086202	Green Accepted			2022-12-28	WOS:000241867200045
J	Trachtenberg, B; Bush, R; Ramanathan, V				Trachtenberg, Barry; Bush, Ruth; Ramanathan, Venkat			Abdominal aortic aneurysm presenting as an epigastric mass	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL		Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Trachtenberg, B (corresponding author), Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX 77030 USA.	bht@bcm.tmc.edu						Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; SILVERBERG E, 1990, CA-CANCER J CLIN, V40, P9, DOI 10.3322/canjclin.40.1.9	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1622	1622		10.1016/S0140-6736(06)69664-5	http://dx.doi.org/10.1016/S0140-6736(06)69664-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107OM	17084763				2022-12-28	WOS:000242180900032
J	Sempere, T; Hartley, A; Roperch, P				Sempere, T.; Hartley, A.; Roperch, P.			Comment on "Rapid uplift of the altiplano revealed through C-13-O-18 bonds in paleosol carbonates"	SCIENCE			English	Editorial Material							BOLIVIAN ALTIPLANO; ANDES; RISE		Univ Toulouse 3, Inst Rech Dev, F-31400 Toulouse, France; Univ Toulouse 3, Observ Midi Pyrenees, Lab Mecanismes & Transferts Geol, F-31400 Toulouse, France; Univ Aberdeen, Sch Geosci, Aberdeen AB24 3UE, Scotland; Univ Rennes 1, Inst Rech Dev & Geosci Rennes, F-35042 Rennes, France	Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of Aberdeen; Institut de Recherche pour le Developpement (IRD); Universite de Rennes	Sempere, T (corresponding author), Univ Toulouse 3, Inst Rech Dev, F-31400 Toulouse, France.	sempere@lmtg.obs-mip.fr	Sempere, Thierry/B-7211-2014	Roperch, Pierrick/0000-0002-1145-6658				Beck SL, 1996, GEOLOGY, V24, P407, DOI 10.1130/0091-7613(1996)024<0407:CTVITC>2.3.CO;2; Farias M, 2005, TECTONICS, V24, DOI 10.1029/2004TC001667; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Ghosh P, 2006, SCIENCE, V311, P511, DOI 10.1126/science.1119365; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Horton BK, 2005, TECTONICS, V24, DOI 10.1029/2003TC001619; ISACKS BL, 1988, J GEOPHYS RES-SOLID, V93, P3211, DOI 10.1029/JB093iB04p03211; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; Kowalski EA, 2002, PALAEOGEOGR PALAEOCL, V188, P141, DOI 10.1016/S0031-0182(02)00550-3; Lamb S, 2003, NATURE, V425, P792, DOI 10.1038/nature02049; Rochat P, 1998, CR ACAD SCI II A, V327, P769, DOI 10.1016/S1251-8050(99)80049-4; Roperch P, 1999, J GEOPHYS RES-SOL EA, V104, P20415, DOI 10.1029/1999JB900174; Rousse S, 2005, TECTONICS, V24, DOI 10.1029/2004TC001760; SEBRIER M, 1988, GEODYNAMIQUE, V3, P85; SEMPERE T, 1990, GEOLOGY, V18, P946, DOI 10.1130/0091-7613(1990)018<0946:LOEMMT>2.3.CO;2	15	19	19	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800								10.1126/science.1132837	http://dx.doi.org/10.1126/science.1132837			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082438				2022-12-28	WOS:000241729800022
J	Macilwain, C				Macilwain, Colin			Drilling for nanotech gold	NATURE			English	News Item																			0	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					16	17		10.1038/444016a	http://dx.doi.org/10.1038/444016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080052				2022-12-28	WOS:000241701500013
J	Wake, N; Fang, JC				Wake, Nicole; Fang, James C.			Necrobiosis lipoidica diabeticorum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wake, N (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	nwake@partners.org							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					E20	E20		10.1056/NEJMicm053865	http://dx.doi.org/10.1056/NEJMicm053865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100TM	17079756				2022-12-28	WOS:000241691700010
J	Costello, A; Azad, K; Barnett, S				Costello, Anthony; Azad, Kishwar; Barnett, Sarah			An alternative strategy to reduce maternal mortality	LANCET			English	Editorial Material							RANDOMIZED-TRIAL		UCL, Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1 1EH, England; BIRDEM Hosp, Perinatal Care Project, Dhaka, Bangladesh	University of London; University College London	Costello, A (corresponding author), UCL, Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1 1EH, England.	a.costello@ich.ucl.ac.uk						Afessa B, 2001, CHEST, V120, P1271, DOI 10.1378/chest.120.4.1271; *COMM IMPR BIRTH O, 2003, IMPR BIRTH OUTC M CH; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lema V M, 2005, East Afr Med J, V82, P3; MANANDHAR D, EFFECT PARTICIPATORY; *NAT I POP RES TRA, 2003, BANGL MAT HLTH SERV; *NAT STAT OFF ORC, 2004, MAL DEM HLTH SURV 20; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; Tew M., 1990, SAFER CHILDBIRTH CRI; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; World Health Organization, 2005, WORLD HLTH REP 2005	13	70	71	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 28	2006	368	9546					1477	1479		10.1016/S0140-6736(06)69388-4	http://dx.doi.org/10.1016/S0140-6736(06)69388-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071268				2022-12-28	WOS:000241582700008
J	Kapoor, AS; Kanji, H; Buckingham, J; Devereaux, PJ; McAlister, FA				Kapoor, Anmol S.; Kanji, Hussein; Buckingham, Jeanette; Devereaux, P. J.; McAlister, Finlay A.			Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE CORONARY SYNDROMES; PREOPERATIVE LIPID-CONTROL; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; NONCARDIAC SURGERY; CARDIAC EVENTS; THERAPY; OUTCOMES; MORTALITY; PATHOPHYSIOLOGY	Objective To determine the strength of evidence underlying recommendations for use of statins during the perioperative period to reduce the risk of cardiovascular events. Design Systematic review of studies with concurrent control groups. Data sources Four electronic databases, the references of identified studies, content experts, international experts on perioperative medicine, and the authors of the primary studies. Review methods Two reviewers independently extracted data from studies that reported acute coronary syndromes or mortality in patients receiving or not receiving statins during die perioperative period. Main outcome measure Random effects summary odds ratios for death or acute coronary syndrome during the perioperative period. Results 18 studies-two randomised trials (n=177), 15 cohort studies (n = 799 632), and one case-control study (n=480)-assessed whether statins provide perioperative cardiovascular protection; 12 studies enrolled patients undergoing non-cardiac vascular surgery, four enrolled patients undergoing coronary bypass surgery, and two enrolled patients undergoing various surgical procedures. In the randomised trials the summary odds ratio for death or acute coronary syndrome during the perioperative period with statin use was 0.26 (95% confidence interval 0.07 to 0.99) and in the cohort studies. the summary odds ratio was 0.70 (0.57 to 0.87). Although the pooled cohort data provided a statistically significant result, statins were not randomly allocated, results in retrospective studies were larger (odds ratio 0.65, 0.50 to 0.84) than those in the prospective cohorts (0.91, 0.65 to 1.27), and dose, duration, and safety of statue use was not reported. Conclusion The evidence base for routine administration of stains to reduce perioperative cardiovascular risk is inadequate.	Univ Alberta, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada; Univ Alberta, Dept Cardiovasc Surg, Edmonton, AB T6G 2M7, Canada; Univ Alberta, John W Scott Hlth Sci Lib, Edmonton, AB T6G 2M7, Canada; McMaster Univ, Dept Med Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Alberta; University of Alberta; University of Alberta; McMaster University	McAlister, FA (corresponding author), Univ Alberta, Div Gen Internal Med, 8440 112 St, Edmonton, AB T6G 2R7, Canada.	furlaymcalister@ualberta.ca	McAlister, Finlay/C-4151-2013; Devereaux, PJ/AAY-1757-2021; Devereaux, PJ/AAF-2862-2019	McAlister, Finlay/0000-0001-7435-3341; Devereaux, PJ/0000-0003-2935-637X				Abbruzzese TA, 2004, J VASC SURG, V39, P1178, DOI 10.1016/j.jvs.2003.12.027; Ali IS, 2005, INT J CARDIOL, V103, P12, DOI 10.1016/j.ijcard.2004.06.006; Ali IS, 2005, EUR J CARDIO-THORAC, V27, P1051, DOI 10.1016/j.ejcts.2005.02.014; Amar D, 2005, CHEST, V128, P3421, DOI 10.1378/chest.128.5.3421; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Biccard BM, 2005, ANAESTHESIA, V60, P1106, DOI 10.1111/j.1365-2044.2005.04405.x; Biccard BM, 2005, ANAESTHESIA, V60, P1059, DOI 10.1111/j.1365-2044.2005.04371.x; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; Christenson JT, 2001, CARDIOVASC SURG, V9, P33, DOI 10.1016/S0967-2109(00)00088-0; Christenson JT, 1999, EUR J CARDIO-THORAC, V15, P394, DOI 10.1016/S1010-7940(99)00034-2; Conte MS, 2005, J VASC SURG, V42, P456, DOI 10.1016/j.jvs.2005.05.001; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Dotani MI, 2000, AM J CARDIOL, V86, P1128, DOI 10.1016/S0002-9149(00)01172-3; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Herrington DM, 2003, CIRCULATION, V107, P2, DOI 10.1161/01.CIR.0000048891.81129.2D; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Karthikeyan G, 2006, HEART, V92, P17, DOI 10.1136/hrt.2004.057125; Kennedy J, 2005, STROKE, V36, P2072, DOI 10.1161/01.STR.0000183623.28144.32; Kertai MD, 2004, EUR J VASC ENDOVASC, V28, P343, DOI 10.1016/j.ejvs.2004.07.008; Kertai MD, 2004, AM J MED, V116, P96, DOI 10.1016/j.amjmed.2003.08.029; Knatterud GL, 2000, CIRCULATION, V102, P157, DOI 10.1161/01.CIR.102.2.157; Landesberg G, 2003, CIRCULATION, V108, P177, DOI 10.1161/01.CIR.0000080292.11186.FB; Landesberg G, 2003, J CARDIOTHOR VASC AN, V17, P90, DOI 10.1053/jcan.2003.18; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; MANGANO DT, 1995, J CARDIAC SURG, V10, P366, DOI 10.1111/j.1540-8191.1995.tb00663.x; McGirt MJ, 2005, J VASC SURG, V42, P829, DOI 10.1016/j.jvs.2005.08.039; O'Neil-Callahan K, 2005, J AM COLL CARDIOL, V45, P336, DOI 10.1016/j.jacc.2004.10.048; Pan W, 2004, CIRCULATION, V110, pII45, DOI 10.1161/01.CIR.0000138316.24048.08; Poldermans D, 2003, CIRCULATION, V107, P1848, DOI 10.1161/01.CIR.0000066286.15621.98; Schouten O, 2005, AM J CARDIOL, V95, P658, DOI 10.1016/j.amjcard.2004.10.046; Schouten O, 2005, CURR OPIN ANESTHESIO, V18, P51, DOI 10.1097/00001503-200502000-00009; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Spencer FA, 2004, ARCH INTERN MED, V164, P2162, DOI 10.1001/archinte.164.19.2162; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Ward RP, 2005, INT J CARDIOL, V104, P264, DOI 10.1016/j.ijcard.2004.10.030	38	99	101	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2006	333	7579					1149	1152D		10.1136/bmj.39006.531146.BE	http://dx.doi.org/10.1136/bmj.39006.531146.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114LG	17088313	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000242667100016
J	Bartlett, JG				Bartlett, John G.			Narrative review: The new epidemic of clostridium difficile-associated enteric disease	ANNALS OF INTERNAL MEDICINE			English	Review							CLINDAMYCIN-ASSOCIATED COLITIS; ANTIBIOTIC-ASSOCIATED COLITIS; PSEUDOMEMBRANOUS COLITIS; INTRAVENOUS IMMUNOGLOBULIN; ANTIMICROBIAL AGENTS; TOXIN PRODUCTION; CASE SERIES; DIARRHEA; METRONIDAZOLE; VANCOMYCIN	Anti biotic-associated diarrhea and colitis were well established soon after antibiotics became available. Early work implicated Staphylococcus aureus, but in 1978 Clostridium difficile became the established pathogen in the vast majority of cases. In the first 5 years (1978 through 1983), the most common cause was clindamycin, the standard diagnostic test was the cytotoxin assay, and standard management was to withdraw the implicated antibiotic and treat with oral vancomycin. Most patients responded well, but 25% relapsed when vancomycin was withdrawn. During the next 20 years (1983 through 2003), the most commonly implicated antibiotics were the cephalosporins, which reflected the rates of use; the enzyme immunoassay replaced the cytotoxin assay because of speed of results and technical ease of performance; and metronidazole replaced vancomycin as standard treatment, and principles of containment hospitals became infection control and antibiotic control. During the recent past (2003 to 2006), C. difficile has been more frequent, more severe, more refractory to standard therapy, and more likely to relapse. This pattern is widly distributed in the United States, Canada, and Europe and is now attributed to a new strain of C. difficile designated BI, NAP1, or ribotype 027 (which are synonymous terms). This strain appears more virulent, possibly because of production of large amounts of toxins, and fluoroquinolones are now major inducing agents along with cephalosporins, which presumably reflects newly acquired in vitro resistance and escalating rates of use. The recent experience does not change principles of management of the individual patient, but it does serve to emphasize the need for better diagnostics, early recognition, improved methods to manage severe disease and relapsing disease, and greater attention to infection control and antibiotic restraint.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Bartlett, JG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 1830 Monument St,437, Baltimore, MD 21205 USA.	jb@jhmi.edu						Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Apisarnthanarak A, 2002, CLIN INFECT DIS, V35, P690, DOI 10.1086/342334; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Aslam S, 2005, LANCET INFECT DIS, V5, P549, DOI 10.1016/S1473-3099(05)70215-2; BARTLETT JG, 1985, GASTROENTEROLOGY, V89, P1192, DOI 10.1016/0016-5085(85)90227-6; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; BARTLETT JG, 1980, AM J CLIN NUTR, V33, P2521, DOI 10.1093/ajcn/33.11.2521; BARTLETT JG, 1981, JOHNS HOPKINS MED J, V149, P6; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Borek AP, 2005, J CLIN MICROBIOL, V43, P2994, DOI 10.1128/JCM.43.6.2994-2995.2005; Bricker E, 2005, COCHRANE DB SYST REV, DOI 10.1002/1461858.CD004610.pub2; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Dendukuri N, 2005, CAN MED ASSOC J, V173, P167, DOI 10.1503/cmaj.050350; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Elmer GW, 1996, JAMA-J AM MED ASSOC, V275, P870, DOI 10.1001/jama.275.11.870; FEKETY R, 1981, REV INFECT DIS, V3, pS273; FEKETY R, 1993, JAMA-J AM MED ASSOC, V269, P71, DOI 10.1001/jama.269.1.71; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; GERDING DN, 1989, ANN INTERN MED, V110, P255, DOI 10.7326/0003-4819-110-4-255; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Gerding DN, 1997, CLIN INFECT DIS, V25, pS206, DOI 10.1086/516247; Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368; HUMMEL RP, 1964, ANN SURG, V160, P551, DOI 10.1097/00000658-196409000-00016; Jacobs A, 2001, MEDICINE, V80, P88, DOI 10.1097/00005792-200103000-00002; JOHNSON S, 1989, J INFECT DIS, V160, P1087, DOI 10.1093/infdis/160.6.1087; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; JOHNSON S, 1989, J INFECT DIS, V159, P340, DOI 10.1093/infdis/159.2.340; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; KHAN MY, 1966, ANN INTERN MED, V65, P1, DOI 10.7326/0003-4819-65-1-1; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Koss K, 2006, COLORECTAL DIS, V8, P149, DOI 10.1111/j.1463-1318.2005.00876.x; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Lawrence SJ, 2005, J MED MICROBIOL, V54, P905, DOI 10.1099/jmm.0.46096-0; LIPSETT PA, 1994, SURGERY, V116, P491; Longo WE, 2004, DIS COLON RECTUM, V47, P1620, DOI 10.1007/s10350-004-0672-2; Loo VG, 2004, CAN MED ASSOC J, V171, P47, DOI 10.1503/cmaj.1040836; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MANABE YC, 1995, ANN INTERN MED, V123, P835, DOI 10.7326/0003-4819-123-11-199512010-00004; McDonald L Clifford, 2005, Infect Control Hosp Epidemiol, V26, P672, DOI 10.1086/502600; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McPherson S, 2006, DIS COLON RECTUM, V49, P640, DOI 10.1007/s10350-006-0511-8; Modena S, 2006, J CLIN GASTROENTEROL, V40, P49, DOI 10.1097/01.mcg.0000190761.80615.0f; MOGG GAG, 1979, BRIT J SURG, V66, P738, DOI 10.1002/bjs.1800661017; MOSKOVITZ M, 1981, ARCH INTERN MED, V141, P663, DOI 10.1001/archinte.141.5.663; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Owens RC, 2006, PHARMACOTHERAPY, V26, P299, DOI 10.1592/phco.26.3.299; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Riley TV, 1995, EUR J CLIN MICROBIOL, V14, P1109, DOI 10.1007/BF01590952; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; TEASLEY DG, 1983, LANCET, V2, P1043; TEDESCO FJ, 1974, ANN INTERN MED, V81, P429, DOI 10.7326/0003-4819-81-4-429; Thomas Claudia, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS28; Ticehurst JR, 2006, J CLIN MICROBIOL, V44, P1145, DOI 10.1128/JCM.44.3.1145-1149.2006; Valiquette L, 2004, CAN MED ASSOC J, V171, P27, DOI 10.1503/cmaj.1040957; van den Berg RJ, 2006, CLIN MICROBIOL INFEC, V12, P184, DOI 10.1111/j.1469-0691.2005.01301.x; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; WALKER RC, 1986, DIAGN MICR INFEC DIS, V5, P61, DOI 10.1016/0732-8893(86)90092-1; Wanahita A, 2003, AM J MED, V115, P543, DOI 10.1016/S0002-9343(03)00420-0; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; WILCOX MH, 1995, J ANTIMICROB CHEMOTH, V36, P673, DOI 10.1093/jac/36.4.673; Wistrom J, 2001, J ANTIMICROB CHEMOTH, V47, P43, DOI 10.1093/jac/47.1.43	77	427	455	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					758	764		10.7326/0003-4819-145-10-200611210-00008	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110OB	17116920				2022-12-28	WOS:000242387100005
J	Roden, DM; Altman, RB; Benowitz, NL; Flockhart, DA; Giacomini, KM; Johnson, JA; Krauss, RM; McLeod, HL; Ratain, MJ; Relling, MV; Ring, HZ; Shuldiner, AR; Weinshilboum, RM; Weiss, ST				Roden, Dan M.; Altman, Russ B.; Benowitz, Neal L.; Flockhart, David A.; Giacomini, Kathleen M.; Johnson, Julie A.; Krauss, Ronald M.; McLeod, Howard L.; Ratain, Mark J.; Relling, Mary V.; Ring, Huijun Z.; Shuldiner, Alan R.; Weinshilboum, Richard M.; Weiss, Scott T.		Pharmacogenetics Res Network	Pharmacogenomics: Challenges and opportunities	ANNALS OF INTERNAL MEDICINE			English	Review							DRUG-INDUCED HEPATITIS; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; GENETIC CONTROL; REGULATORY PERSPECTIVE; MYOCARDIAL-INFARCTION; ACTIVATING MUTATIONS; P-GLYCOPROTEIN; LUNG-CANCER; RISK-FACTOR	The outcome of drug therapy is often unpredictable, ranging from beneficial effects to lack of efficacy to serious adverse effects. Variations in single genes are 1 well-recognized cause of such unpredictability, defining the field of pharmacogenetics (see Glossary). Such variations may involve genes controlling drug metabolism, drug transport, disease susceptibility, or drug targets. The sequencing of the human genome and the cataloguing of variants across human genomes are the enabling resources for the nascent field of phafmacogenomics (see Glossary), which tests the idea that genomic variability underlies variability in drug responses. However, there are many challenges that must be overcome to apply rapidly accumulating genomic information to understand variable drug responses, including defining candidate genes and pathways; relating disease genes to drug response genes; precisely defining drug response phenotypes; and addressing analytic, ethical, and technological issues involved in generation and management of large drug response data sets. Overcoming these challenges holds the promise of improving new drug development and ultimately individualizing the selection of appropriate drugs and dosages for individual patients.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Indiana Univ, Indianapolis, IN 46204 USA; Univ Florida, Gainesville, FL USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Univ N Carolina, Chapel Hill, NC 27515 USA; Univ Chicago, Chicago, IL 60637 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; SRI Int, Menlo Pk, CA 94025 USA; Univ Maryland, Baltimore, MD 21201 USA; Mayo Clin, Rochester, MN USA; Channing Labs, Boston, MA USA	Vanderbilt University; Stanford University; University of California System; University of California San Francisco; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; St Jude Children's Research Hospital; SRI International; University System of Maryland; University of Maryland Baltimore; Mayo Clinic	Roden, DM (corresponding author), Vanderbilt Univ, Sch Med, 2215B Garland Ave,Room 1285B,MRB4, Nashville, TN 37232 USA.	dan.roden@vanderbilt.edu	Giacomini, Kathleen/AEF-2452-2022; McLeod, Howard/ABD-8364-2021; Relling, Mary/N-5032-2018; Roden, Dan/ABD-5412-2021	McLeod, Howard/0000-0002-9004-9232; Shuldiner, Alan/0000-0001-9921-4305	NHLBI NIH HHS [U19 HL069757, U01 HL065962, U01 HL069757, U01 HL065899, U19 HL065962, U01 HL65899, U01 HL65962, U01 HL69757] Funding Source: Medline; NIDA NIH HHS [U01 DA020830, U01 DA20830] Funding Source: Medline; NIGMS NIH HHS [U01 GM61388, U01 GM061373, U01 GM61390, U01 GM61393, U01 GM063340, U01 GM061390, U01 GM061393, U19 GM061390, U01 GM074492, U01 GM61373, U19 GM061388, U01 GM061374, U01 GM061388, U01 GM74492, U01 GM63340, U01 GM074518, U01 GM74518, U01 GM61374] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, U19HL069757, U01HL069757, U19HL065962, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340, U01GM074492, U01GM061374, U01GM061390, U01GM061388, U01GM061393, U01GM074518, U19GM061388, U19GM061390, U01GM061373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ando Y, 2000, CANCER RES, V60, P6921; Billings PR, 2005, NAT GENET, V37, P559, DOI 10.1038/ng0605-559; Breckenridge A, 2004, NAT REV GENET, V5, P676, DOI 10.1038/nrg1431; Caraco Y, 1999, J PHARMACOL EXP THER, V290, P413; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Cohen JE, 2004, PLOS BIOL, V2, P2017, DOI 10.1371/journal.pbio.0020439; Couzin J, 2004, SCIENCE, V305, P1222; DAHL ML, 1993, PHARMACOGENETICS, V3, P61, DOI 10.1097/00008571-199304000-00001; DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516; Drolet B, 2005, J CLIN INVEST, V115, P2209, DOI 10.1172/JCI23741; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; EVANS WE, 1991, J PEDIATR-US, V119, P985, DOI 10.1016/S0022-3476(05)83063-X; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Frueh FW, 2005, PHARMACOGENOMICS J, V5, P218, DOI 10.1038/sj.tpj.6500316; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Furuta T, 1998, ANN INTERN MED, V129, P1027, DOI 10.7326/0003-4819-129-12-199812150-00006; Garrod AE, 1923, INBORN ERRORS METABO; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakonarson H, 2005, JAMA-J AM MED ASSOC, V293, P2245, DOI 10.1001/jama.293.18.2245; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; James SP, 2003, GASTROENTEROLOGY, V125, P1008; Kaab S, 2004, Z KARDIOL, V93, P641, DOI 10.1007/s00392-004-0129-6; Kalow Werner, 1963, PHARMACOGENETICS HER; Kim RB, 2002, TOXICOLOGY, V181, P291, DOI 10.1016/S0300-483X(02)00296-2; Kim RB, 2004, CLIN PHARMACOL THER, V75, P381, DOI 10.1016/j.clpt.2004.01.004; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Lee LS, 2005, CLIN PHARMACOL THER, V78, P1, DOI 10.1016/j.clpt.2005.04.006; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lesko LJ, 2004, NAT REV DRUG DISCOV, V3, P763, DOI 10.1038/nrd1499; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PRICEEVANS DA, 1960, BMJ-BRIT MED J, V5197, P485; Raby BA, 2005, AM J RESP CRIT CARE, V172, P552, DOI 10.1164/rccm.200501-010OC; Ratain MJ, 2006, CLIN CANCER RES, V12, P1658, DOI 10.1158/1078-0432.CCR-06-0159; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Roden DA, 2005, CARDIOVASC RES, V67, P419, DOI 10.1016/j.cardiores.2005.04.022; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Rudy Y, 2004, ANN NY ACAD SCI, V1015, P261, DOI 10.1196/annals.1302.022; Sagen JV, 2004, DIABETES, V53, P2713, DOI 10.2337/diabetes.53.10.2713; Salerno RA, 2004, PHARMACOGENOMICS, V5, P503, DOI 10.1517/14622416.5.5.503; SCHUTZ E, 1993, LANCET, V341, P436, DOI 10.1016/0140-6736(93)93028-Y; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shah RR, 2004, DRUG SAFETY, V27, P145, DOI 10.2165/00002018-200427030-00001; Spooner PM, 2001, CIRCULATION, V103, P2447; Stanulla M, 2005, JAMA-J AM MED ASSOC, V293, P1485, DOI 10.1001/jama.293.12.1485; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; VESELL ES, 1968, SCIENCE, V159, P1479, DOI 10.1126/science.159.3822.1479; VESELL ES, 1968, J CLIN INVEST, V47, P2657, DOI 10.1172/JCI105949; VESELL ES, 1968, SCIENCE, V161, P72, DOI 10.1126/science.161.3836.72; Walker DK, 2004, BRIT J CLIN PHARMACO, V58, P601, DOI 10.1111/j.1365-2125.2004.02194.x; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Weiss Scott T, 2004, Proc Am Thorac Soc, V1, P364, DOI 10.1513/pats.200409-043MS; WOOSLEY RL, 1978, NEW ENGL J MED, V298, P1157, DOI 10.1056/NEJM197805252982101; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zhang L, 1998, ANNU REV PHARMACOL, V38, P431, DOI 10.1146/annurev.pharmtox.38.1.431; 2005, MED LETT DRUGS THER, V47, P712	78	167	177	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2006	145	10					749	757		10.7326/0003-4819-145-10-200611210-00007	http://dx.doi.org/10.7326/0003-4819-145-10-200611210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110OB	17116919	Green Accepted, Green Submitted			2022-12-28	WOS:000242387100004
J	Le Cam, L; Linares, LK; Paul, C; Julien, E; Lacroix, M; Hatchi, E; Triboulet, R; Bossis, G; Shmueli, A; Rodriguez, MS; Coux, O; Sardet, C				Le Cam, Laurent; Linares, Laetitia K.; Paul, Conception; Julien, Eric; Lacroix, Matthieu; Hatchi, Elodie; Triboulet, Robinson; Bossis, Guillaume; Shmueli, Ayelet; Rodriguez, Manuel S.; Coux, Olivier; Sardet, Claude			E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation	CELL			English	Article							CELL-CYCLE ARREST; TRANSCRIPTION FACTOR P120(E4F); C-TERMINAL DOMAIN; GROWTH ARREST; DNA-DAMAGE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATES TRANSCRIPTION; NEGATIVE REGULATOR; TUMOR-SUPPRESSOR	p53 is regulated by multiple posttranslational modifications, including Hdm2-mediated ubiquitylation that drives its proteasomal degradation. Here, we identify the p53-associated factor E4F1, a ubiquitously expressed zinc-finger protein first identified as a cellular target of the viral oncoprotein E1A, as an atypical ubiquitin E3 ligase for p53 that modulates its effector functions without promoting proteolysis. E4F1 stimulates oligo-ubiquitylation in the hinge region of p53 on lysine residues distinct from those targeted by Hdm2 and previously described to be acetylated by the acetyltransferase PCAF. E4F1 and PCAF mediate mutually exclusive posttranslational modifications of p53. E4F1-dependent Ub-p53 conjugates are associated with chromatin, and their stimulation coincides with the induction of a p53-dependent transcriptional program specifically involved in cell cycle arrest, and not apoptosis. Collectively, our data reveal that E4F1 is a key posttranslational regulator of p53, which modulates its effector functions involved in alternative cell fates: growth arrest or apoptosis.	UMII, Inst Genet Mol, CNRS, UMR5535, F-34293 Montpellier, France; CNRS, FRE 2593, CRBM, F-34293 Montpellier, France; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; CIC BIOGUNE, Proteom Unit, Derio 48160, Spain; Univ Gottingen, Dept Biochem, D-37073 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Weizmann Institute of Science; CIC bioGUNE; University of Gottingen	Le Cam, L (corresponding author), UMII, Inst Genet Mol, CNRS, UMR5535, IFR122, F-34293 Montpellier, France.	llecam@igmm.cnrs.fr; claude.sardet@igmm.cnrs.fr	Lacroix, Matthieu/O-1928-2018; Le Cam, Laurent/O-1408-2016; Coux, Olivier/P-6847-2019; Coux, Olivier/B-3406-2010; JULIEN, ERIC/Y-5873-2019; Linares, Laetitia LKL/F-9901-2018; Bossis, Guillaume/C-7172-2012	Lacroix, Matthieu/0000-0002-1268-9058; Coux, Olivier/0000-0001-8455-3849; Coux, Olivier/0000-0001-8455-3849; JULIEN, ERIC/0000-0003-2976-666X; Linares, Laetitia LKL/0000-0003-1661-2119; LE CAM, Laurent/0000-0003-0325-878X; bossis, guillaume/0000-0002-3349-8250				Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ahmed-Choudhury J, 2005, CANCER RES, V65, P2690, DOI 10.1158/0008-5472.CAN-04-3593; Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Aurelio ON, 1998, CANCER RES, V58, P2190; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Colombo R, 2003, ONCOGENE, V22, P2541, DOI 10.1038/sj.onc.1206379; Di Stefano V, 2005, ONCOGENE, V24, P5431, DOI 10.1038/sj.onc.1208717; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Fajas L, 2000, P NATL ACAD SCI USA, V97, P7738, DOI 10.1073/pnas.130198397; Fenton SL, 2004, CANCER RES, V64, P102, DOI 10.1158/0008-5472.CAN-03-2622; Fernandes ER, 1999, MOL CELL BIOL, V19, P4739; Fernandes ER, 1997, MOL CELL BIOL, V17, P1890, DOI 10.1128/MCB.17.4.1890; Fernandes ER, 1998, MOL CELL BIOL, V18, P459, DOI 10.1128/MCB.18.1.459; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kong XT, 2001, J BIOL CHEM, V276, P32990, DOI 10.1074/jbc.M103681200; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Le Cam L, 2004, MOL CELL BIOL, V24, P6467, DOI 10.1128/MCB.24.14.6467-6475.2004; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; RAYCHAUDHURI P, 1987, EMBO J, V6, P4073, DOI 10.1002/j.1460-2075.1987.tb02753.x; Rizos H, 2003, J BIOL CHEM, V278, P4981, DOI 10.1074/jbc.M210978200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Rooney RJ, 2001, CELL GROWTH DIFFER, V12, P505; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sandy P, 2000, ONCOGENE, V19, P188, DOI 10.1038/sj.onc.1203250; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Terui T, 2003, CANCER RES, V63, P8948; Tessari MA, 2003, MOL CELL BIOL, V23, P9104, DOI 10.1128/MCB.23.24.9104-9116.2003; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173	78	160	167	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					775	788		10.1016/j.cell.2006.09.031	http://dx.doi.org/10.1016/j.cell.2006.09.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110336	Bronze			2022-12-28	WOS:000242330600023
J	Steiner, FA; Plasterk, RHA				Steiner, Florian A.; Plasterk, Ronald H. A.			Knocking out the argonautes	CELL			English	Editorial Material							RNA INTERFERENCE; C-ELEGANS	Argonaute proteins are key players in gene silencing involving small RNAs. In this issue, Yigit et al. (2006) report a comprehensive study of Argonautes in the worm that places many of the 27 family members into a complex gene-silencing network.	KNAW, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Utrecht, NL-3508 TC Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Steiner, FA (corresponding author), KNAW, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl		Steiner, Florian/0000-0002-0514-5060				Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686	10	4	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					667	668		10.1016/j.cell.2006.11.004	http://dx.doi.org/10.1016/j.cell.2006.11.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110324	Bronze			2022-12-28	WOS:000242330600011
J	Thompson, IM; Tangen, CM; Paradelo, J; Lucia, MS; Miller, G; Troyer, D; Messing, E; Forman, J; Chin, J; Swanson, G; Canby-Hagino, E; Crawford, ED				Thompson, Ian M., Jr.; Tangen, Catherine M.; Paradelo, Jorge; Lucia, M. Scott; Miller, Gary; Troyer, Dean; Messing, Edward; Forman, Jeffrey; Chin, Joseph; Swanson, Gregory; Canby-Hagino, Edith; Crawford, E. David			Adjuvant radiotherapy for pathologically advanced prostate cancer - A randomized clinical trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADICAL PROSTATECTOMY; SALVAGE RADIOTHERAPY; HORMONAL-THERAPY; RECURRENCE; TIME	Context Despite a stage-shift to earlier cancer stages and lower tumor volumes for prostate cancer, pathologically advanced disease is detected at radical prostatectomy in 38% to 52% of patients. However, the optimal management of these patients after radical prostatectomy is unknown. Objective To determine whether adjuvant radiotherapy improves metastasis-free survival in patients with stage pT3 N0 M0 prostate cancer. Design, Setting, and Patients Randomized, prospective, multi-institutional, US clinical trial with enrollment between August 15, 1988, and January 1, 1997 ( with database frozen for statistical analysis on September 21, 2005). Patients were 425 men with pathologically advanced prostate cancer who had undergone radical prostatectomy. Intervention Men were randomly assigned to receive 60 to 64 Gy of external beam radiotherapy delivered to the prostatic fossa (n= 214) or usual care plus observation ( n= 211). Main Outcome Measures Primary outcome was metastasis-free survival, defined as time to first occurrence of metastatic disease or death due to any cause. Secondary outcomes included prostate-specific antigen (PSA) relapse, recurrence-free survival, overall survival, freedom from hormonal therapy, and postoperative complications. Results Among the 425 men, median follow-up was 10.6 years ( interquartile range, 9.2-12.7 years). For metastasis-free survival, 76 (35.5%) of 214 men in the adjuvant radiotherapy group were diagnosed with metastatic disease or died ( median metastasis-free estimate, 14.7 years), compared with 91 (43.1%) of 211 ( median metastasis-free estimate, 13.2 years) of those in the observation group ( hazard ratio [HR], 0.75; 95% CI, 0.55- 1.02; P=. 06). There were no significant between-group differences for overall survival ( 71 deaths, median survival of 14.7 years for radiotherapy vs 83 deaths, median survival of 13.8 years for observation; HR, 0.80; 95% CI, 0.58-1.09; P=. 16). PSA relapse ( median PSA relapse - free survival, 10.3 years for radiotherapy vs 3.1 years for observation; HR, 0.43; 95% CI, 0.31-0.58; P <. 001) and disease recurrence ( median recurrence-free survival, 13.8 years for radiotherapy vs 9.9 years for observation; HR, 0.62; 95% CI, 0.46-0.82; P=. 001) were both significantly reduced with radiotherapy. Adverse effects were more common with radiotherapy vs observation (23.8% vs 11.9%), including rectal complications (3.3% vs 0%), urethral strictures (17.8% vs 9.5%), and total urinary incontinence (6.5% vs 2.8%). Conclusions In men who had undergone radical prostatectomy for pathologically advanced prostate cancer, adjuvant radiotherapy resulted in significantly reduced risk of PSA relapse and disease recurrence, although the improvements in metastasis-free survival and overall survival were not statistically significant.	Univ Texas, Hlth Sci Ctr, Dept Urol, San Antonio, TX 78229 USA; SW Oncol Grp, Ctr Stat, Seattle, WA USA; Kansas City Community Clin Oncol Program, Kansas City, MO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Western Ontario, Dept Surg Oncol, London, ON, Canada	University of Texas System; University of Texas Health San Antonio; Southwest Oncology Group; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Rochester; Wayne State University; Western University (University of Western Ontario)	Thompson, IM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Urol, MC-7845,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu		Swanson, Gregory/0000-0002-7959-1493	NATIONAL CANCER INSTITUTE [U10CA058882, U10CA020319, U10CA035178, U10CA045377, U10CA004919, U10CA046441, U10CA032102, U10CA042777, U10CA046136, U10CA012213, U10CA014028, U10CA074647, U10CA035261, U10CA058861, U10CA067575, U10CA027057, U10CA076447, U10CA035119, U10CA012644, U10CA058416, U10CA035090, U10CA035176, U10CA004920, U10CA058658, U10CA038926, U10CA058723, U10CA037981, U10CA046113, U10CA076429, U10CA022433, U10CA035431, U10CA046282] Funding Source: NIH RePORTER; NCI NIH HHS [CA76447, CA76429, CA76132, CA74647, CA67575, CA58882, CA58861, CA58723, CA58658, CA58416, CA46441, CA46282, CA46136, CA46113, CA45377, CA42777, CA38926, CA37981, CA35431, CA35261, CA35178, CA35176, CA35119, CA35090, CA32102, CA27057, CA22433, CA20319, CA14028, CA12644, CA12213, CA04920, CA04919] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Joint Committee on Cancer, 2002, AJCC CANC STAG MAN, P309; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bott SRJ, 2005, BJU INT, V95, P34, DOI 10.1111/j.1464-410X.2005.05245.x; D'Amico AV, 2004, JNCI-J NATL CANCER I, V96, P509, DOI 10.1093/jnci/djh086; DiPaola RS, 2005, UROLOGY, V65, P23, DOI 10.1016/j.urology.2005.03.042; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; EPSTEIN JI, 1993, J UROLOGY, V150, P135, DOI 10.1016/S0022-5347(17)35415-0; GIBBONS RP, 1986, J UROLOGY, V135, P65, DOI 10.1016/S0022-5347(17)45519-4; Higano CS, 2003, J UROLOGY, V170, pS59, DOI 10.1097/01.ju.0000097351.48848.1f; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Small EJ, 2002, J CLIN ONCOL, V20, P3369, DOI 10.1200/JCO.2002.10.022; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Underwood W, 2005, CANCER-AM CANCER SOC, V103, P538, DOI 10.1002/cncr.20796; Ward JF, 2004, J UROLOGY, V172, P1328, DOI 10.1097/01.ju.0000138681.64035.dc; Ward JF, 2004, J UROLOGY, V172, P2244, DOI 10.1097/01.ju.0000145262.34748.2b; Williams MB, 2005, J UROLOGY, V173, P1067, DOI 10.1097/01.ju.0000143193.81585.5c	18	721	725	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2329	2335		10.1001/jama.296.19.2329	http://dx.doi.org/10.1001/jama.296.19.2329			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104ZI	17105795	Bronze			2022-12-28	WOS:000241998700020
J	Gross, CP; McAvay, GJ; Krumholz, HM; Paltiel, AD; Bhasin, D; Tinetti, ME				Gross, Cary P.; McAvay, Gail J.; Krumholz, Harlan M.; Paltiel, A. David; Bhasin, Devina; Tinetti, Mary E.			The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: Implications for screening	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL-OCCULT-BLOOD; UNITED-STATES; ELDERLY-PATIENTS; COLONOSCOPY; GUIDELINES; MEDICARE; ADULTS; POPULATION; PREDICTORS; RATIONALE	Background: Older adults with shorter life expectancies may receive less benefit from colorectal cancer screening than younger, healthier patients. Objective: To determine the degree to which life expectancy after diagnosis of an early-stage cancer varies according to age or coexisting chronic illness. Design: Retrospective cohort study. Setting: Population-based cancer registry with linked administrative claims data. Patients: Patients 67 years of age or older who received a diagnosis of colorectal cancer from 1993 through 1999. Measurements: Chronic conditions were identified by searching Medicare claims. Using a life-table approach, the authors quantified the degree to which life expectancy associated with each cancer stage at diagnosis varied with patient age, sex, and burden of chronic conditions. Results: The final study sample consisted of 35 755 patients. After accounting for cancer stage at diagnosis, the authors found that life expectancy was strongly related to both age and the burden of chronic illness. Among men who received a diagnosis of stage I cancer at 67 years of age, life expectancy decreased from 19.1 years (95% Cl, 17.8 to 20.5 years) for patients with no chronic conditions to 12.4 years (Cl, 11.4 to 13.5 years) for those with 1 or 2 conditions and 7.6 years (Cl, 6.1 to 9.4 years) for those with 3 or more conditions. A similar trend was noted among female counterparts with life expectancy decreasing from approximately 23 years to 16 years and 7 years for the 3 chronic condition groups, respectively. For men and women 81 years of age with no chronic illnesses, life expectancy after stage I cancer diagnosis was 10.3 years (Cl, 9.2 to 11.9 years) and 13.8 years (Cl, 12.3 to 15.3 years), respectively. Limitations: Administrative claims may not identify all chronic conditions. Life expectancy estimates at the population level are averages and, therefore, may not accurately predict the life expectancy of individual patients. Conclusions: Coexisting chronic illness is associated with a substantial reduction in life expectancy after diagnosis of early-stage colorectal cancer. Physicians should consider this when deciding whether to screen older persons.	Yale Univ, Sch Med, Primary Care Ctr, New Haven, CT 06520 USA; Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu	, Harlan/AAI-2875-2020	Paltiel, A. David/0000-0002-4861-3290	NATIONAL INSTITUTE ON AGING [K08AG024842, P30AG021342] Funding Source: NIH RePORTER; NIA NIH HHS [P30AG21342, 1 K08 AG24842] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM CANC SOC, 2005, CANC FACT FIG 2005; Berg AO, 2002, AM J NURS, V102, P107; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Ioannou GN, 2003, AM J GASTROENTEROL, V98, P2082, DOI 10.1016/S0002-9270(03)00423-4; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lamont EB, 2002, MED CARE, V40, P201, DOI 10.1097/00005650-200203000-00004; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTOSKY AL, 1993, MED CARE, V31, P732; Ries L, 2004, SEER CANC STAT REV 1; Ries L., 2005, SEER CANC STAT REV 1; Schrag D, 2001, J CLIN ONCOL, V19, P3712, DOI 10.1200/JCO.2001.19.17.3712; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594	26	131	133	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					646	653		10.7326/0003-4819-145-9-200611070-00006	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ZD	17088577				2022-12-28	WOS:000241707800002
J	Glasier, A; Gulmezoglu, AM				Glasier, Anna; Guelmezoglu, A. Metin			Putting sexual and reproductive health on the agenda	LANCET			English	Editorial Material									NHS Lothian, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Edinburgh EH4 1NL, Midlothian, Scotland; WHO, Special Programme Res Dev & Res Training Huma, UNDP UNFPA, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Edinburgh; United Nations Population Fund; World Health Organization	Glasier, A (corresponding author), NHS Lothian, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk						CLELAND J, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69480-4; FATHALLA MF, 2006, LANCET          1101; GATES B, 2006, 16 INT AIDS C KEYN S; GLASIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; GRIMES DA, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69481-6; LOW N, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69482-8; WELLINGS K, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69479-8; WHO, 2006, GLOB STRAT PREV CONT	8	19	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1550	1551		10.1016/S0140-6736(06)69485-3	http://dx.doi.org/10.1016/S0140-6736(06)69485-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084739				2022-12-28	WOS:000242180900005
J	Purdy, S; de Berker, D				Purdy, Sarah; de Berker, David			Acne	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FACIAL ACNE; ADOLESCENTS; MODERATE		Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England; Bristol Royal Infirm & Gen Hosp, Bristol Dermatol Ctr, Bristol BS2 8HW, Avon, England	University of Bristol; Bristol Royal Infirmary	Purdy, S (corresponding author), Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS6 6JL, Avon, England.	sarah.purdy@bristol.ac.uk		Purdy, Sarah/0000-0002-3445-986X	Medical Research Council [G0501936] Funding Source: Medline; MRC [G0501936] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AROWOJOLU AO, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004425.PUB2; Bataille V, 2002, J INVEST DERMATOL, V119, P1317, DOI 10.1046/j.1523-1747.2002.19621.x; Chia CY, 2005, ARCH DERMATOL, V141, P557, DOI 10.1001/archderm.141.5.557; Chu TC, 1997, MEDICINE, V25, P30; Cunliffe W J, 1998, J Cutan Med Surg, V2 Suppl 3, P7; Eady AE, 2003, AM J CLIN DERMATOL, V4, P813, DOI 10.2165/00128071-200304120-00002; Garner S, 2003, EVIDENCE BASED DERMA; Goulden V, 1999, J AM ACAD DERMATOL, V41, P577, DOI 10.1016/S0190-9622(99)70300-2; Haider A, 2004, JAMA-J AM MED ASSOC, V292, P726, DOI 10.1001/jama.292.6.726; Jordan RE, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001866, 10.1002/14651858.CD001866]; LEHMANN HP, 2001, AGENCY HEALTHCARE RE; Mallon E, 1999, BRIT J DERMATOL, V140, P672; *NICE, 2001, REF ADV ACN; Ozolins M, 2004, LANCET, V364, P2188, DOI 10.1016/S0140-6736(04)17591-0; Pearl A, 1998, NEW ZEAL MED J, V111, P269; Popescu, 2003, COCHRANE COLLABORATI; Purdy S, 2003, BRIT J GEN PRACT, V53, P525; PURDY S, 2006, CLIN EVID, V15, P553; Witkowski JA, 2004, CLIN DERMATOL, V22, P394, DOI 10.1016/j.clindermatol.2004.03.008; Wolf R, 2004, CLIN DERMATOL, V22, P387, DOI 10.1016/j.clindermatol.2004.03.007	20	30	32	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2006	333	7575					949	953		10.1136/bmj.38987.606701.80	http://dx.doi.org/10.1136/bmj.38987.606701.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107GE	17082546	Green Published			2022-12-28	WOS:000242157900021
J	Raisbeck, GM; Yiou, F; Cattani, O; Jouzel, J				Raisbeck, G. M.; Yiou, F.; Cattani, O.; Jouzel, J.			Be-10 evidence for the Matuyama-Brunhes geomagnetic reversal in the EPICA Dome C ice core	NATURE			English	Article							ASTRONOMICAL CALIBRATION; FIELD; AGES; ANTARCTICA; TRANSITION; BOUNDARY	An ice core drilled at Dome C, Antarctica, is the oldest ice core so far retrieved(1). On the basis of ice flow modelling and a comparison between the deuterium signal in the ice with climate records from marine sediment cores, the ice at a depth of 3,190 m in the Dome C core is believed to have been deposited around 800,000 years ago 2, offering a rare opportunity to study climatic and environmental conditions over this time period. However, an independent determination of this age is important because the deuterium profile below a depth of 3,190 m depth does not show the expected correlation with the marine record(2). Here we present evidence for enhanced 10 Be deposition in the ice at 3,160 - 3,170 m, which we interpret as a result of the low dipole field strength during the Matuyama - Brunhes geomagnetic reversal, which occurred about 780,000 years ago. If correct, this provides a crucial tie point between ice cores, marine cores and a radiometric timescale.	Univ Paris Sud, CNRS, IN2P3, Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Ctr Etud Saclay, CNRS,UVSQ, CEA, Inst Pierre Simon Laplace,Lab Sci Climat & Envrio, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Raisbeck, GM (corresponding author), Univ Paris Sud, CNRS, IN2P3, Ctr Spectrometrie Nucl & Spectrometrie Masse, Bat 108, F-91405 Orsay, France.	raisbeck@csnsm.in2p3.fr						Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Brown LL, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003007; Channell JET, 2000, PHILOS T ROY SOC A, V358, P1027, DOI 10.1098/rsta.2000.0572; Coe RS, 2004, EARTH PLANET SC LETT, V222, P667, DOI 10.1016/j.epsl.2004.03.003; DURAND G, 2004, THESIS U J FOURNIER; Field CV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006410; Guyodo Y, 1999, NATURE, V399, P249, DOI 10.1038/20420; Hartl P, 1996, EARTH PLANET SC LETT, V138, P121, DOI 10.1016/0012-821X(95)00231-Z; Horng CS, 2002, EARTH PLANETS SPACE, V54, P679, DOI 10.1186/BF03351719; Lal D., 1967, HANDBUCH PHYSIK    2, V46, P551, DOI [DOI 10.1007/978-3-642-46079-1_7, 10.1007/978-3-642-46079-1_7]; Langereis CG, 1997, GEOPHYS J INT, V129, P75, DOI 10.1111/j.1365-246X.1997.tb00938.x; Merrill RT, 1999, REV GEOPHYS, V37, P201, DOI 10.1029/1998RG900004; Quidelleur X, 2003, EARTH PLANET SC LETT, V208, P149, DOI 10.1016/S0012-821X(03)00053-0; RAISBECK GM, 1987, NATURE, V326, P273, DOI 10.1038/326273a0; RAISBECK GM, 1985, NATURE, V315, P315, DOI 10.1038/315315a0; RAISBECK GM, 1992, ABSOLUTE RADIOCARBON, P127; Singer BS, 2005, NATURE, V434, P633, DOI 10.1038/nature03431; Souchez R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028424; Steig EJ, 1996, GEOPHYS RES LETT, V23, P523, DOI 10.1029/96GL00255; Tauxe L, 1996, EARTH PLANET SC LETT, V140, P133, DOI 10.1016/0012-821X(96)00030-1; Wagner G, 2000, NUCL INSTRUM METH B, V172, P597, DOI 10.1016/S0168-583X(00)00285-8; Yiou F, 1997, J GEOPHYS RES-OCEANS, V102, P26783, DOI 10.1029/97JC01265; YIOU F, 1985, NATURE, V316, P616, DOI 10.1038/316616a0	24	89	93	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					82	84		10.1038/nature05266	http://dx.doi.org/10.1038/nature05266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080088				2022-12-28	WOS:000241701500049
J	Henderson, M; Wight, D; Raab, GM; Abraham, C; Parkes, A; Scott, S; Hart, G				Henderson, M.; Wight, D.; Raab, G. M.; Abraham, C.; Parkes, A.; Scott, S.; Hart, G.			Impact of a theoretically based sex education programme (SHARE) delivered by teachers on NHS registered conceptions and terminations: final results of cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENT PREGNANCY PREVENTION; INTERVENTIONS; SCHOOL; HIV	Objective To assess the impact of a theoretically based sex education programme (SHARE) delivered by teachers compared with conventional education in terms of conceptions and terminations registered by the NHS. Design Follow-up of cluster randomised trial 4.5 years after intervention. Setting NHS records of women who had attended 25 secondary schools in east Scotland. Participants 4196 women (99.5% of those eligible) Intervention SHARE programme (intervention group) v existing sex education (control group). Main outcome measure NHS recorded conceptions and terminations for the achieved sample linked at age 20. Results In an "intention to treat" analysis there were no significant differences between the groups in registered conceptions per 1000 pupils (300 SHARE v 274 control; difference 26, 95% confidence interval -33 to 86) and terminations per 1000 pupils (127 v 112; difference 15, -13 to 42) between ages 16 and 20. Conclusions This specially designed sex education programme did not reduce conceptions or terminations by age 20 compared with conventional provision. The lack of effect was not due to quality of delivery. Enhancing teacher led school sex education beyond conventional provision in eastern Scotland is unlikely to reduce terminations in teenagers.	MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Napier Univ, Sch Nursing Midwifery & Social Care, Edinburgh EH4 2LD, Midlothian, Scotland; Univ Sussex, Sch Social Sci, Brighton BN1 9SN, E Sussex, England; Univ Keele, Fac Humanities & Social Sci, Keele ST5 5BG, Staffs, England; UCL, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; Edinburgh Napier University; University of Sussex; Keele University; University of London; University College London	Henderson, M (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	marion@msoc.mrc.gta.ac.uk	Abraham, Charles/C-7130-2012; Henderson, Marion Mackay/AAS-2759-2021; Henderson, Marion/G-3310-2019; Henderson, Marion/M-2136-2019	Henderson, Marion/0000-0001-7582-9516; Henderson, Marion/0000-0001-7582-9516; Hart, Graham/0000-0001-9676-6577; Abraham, Charles/0000-0002-0901-1975	Medical Research Council [MC_U130031238] Funding Source: Medline; MRC [MC_U130031238] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham C, 2004, PSYCHOL HEALTH, V19, P689, DOI 10.1080/08870440410001722921; ABRAHAM C, 2001, CHANGING HLTH BEHAV; [Anonymous], 2005, RESP RESP STRAT ACT; Cabezon C, 2005, J ADOLESCENT HEALTH, V36, P64, DOI 10.1016/j.jadohealth.2003.10.011; Coyle K, 2001, PUBLIC HEALTH REP, V116, P82, DOI 10.1093/phr/116.S1.82; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; Kirby D, 2002, J SEX RES, V39, P51, DOI 10.1080/00224490209552120; *NHS CTR REV DISS, 1997, PREV RED ADV EFF UN; Philliber S, 2002, PERSPECT SEX REPRO H, V34, P244, DOI 10.2307/3097823; Raab GM, 2005, CLIN TRIALS, V2, P130, DOI 10.1191/1740774505cn075oa; Robin L, 2004, J ADOLESCENT HEALTH, V34, P3, DOI 10.1016/S1054-139X(03)00244-1; Santelli JS, 2000, AM J PUBLIC HEALTH, V90, P1582, DOI 10.2105/AJPH.90.10.1582; *SOC EXCL UN, 1999, EEN PREGN; Stephenson JM, 2004, LANCET, V364, P338, DOI 10.1016/S0140-6736(04)16722-6; Wight D, 2002, BMJ-BRIT MED J, V324, P1430, DOI 10.1136/bmj.324.7351.1430; Wight D, 2004, ED HLTH, V22, P3; Wight D, 2006, J ADOLESCENCE, V29, P473, DOI 10.1016/j.adolescence.2005.08.007	19	70	71	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2007	334	7585					133	136		10.1136/bmj.39014.503692.55	http://dx.doi.org/10.1136/bmj.39014.503692.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130LP	17118950	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000243801400032
J	Mazzone, T; Meyer, PM; Feinstein, SB; Davidson, MH; Kondos, GT; D'Agostino, RB; Perez, A; Provost, JC; Haffner, SM				Mazzone, Theodore; Meyer, Peter M.; Feinstein, Steven B.; Davidson, Michael H.; Kondos, George T.; D'Agostino, Ralph B., Sr.; Perez, Alfonso; Provost, Jean-Claude; Haffner, Steven M.			Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERIAL-WALL THICKNESS; RECEPTOR-GAMMA AGONIST; CARDIOVASCULAR-DISEASE; NONDIABETIC PATIENTS; ROSIGLITAZONE TREATMENT; CORONARY RISK; PROGRESSION; ATHEROSCLEROSIS; MARKERS; INTERVENTION	Context Carotid artery intima-media thickness (CIMT) is a marker of coronary atherosclerosis and independently predicts cardiovascular events, which are increased in type 2 diabetes mellitus (DM). While studies of relatively short duration have suggested that thiazolidinediones such as pioglitazone might reduce progression of CIMT in persons with diabetes, the results of longer studies have been less clear. Objective To evaluate the effect of pioglitazone vs glimepiride on changes in CIMT of the common carotid artery in patients with type 2 DM. Design, Setting, and Participants Randomized, double-blind, comparator-controlled, multicenter trial in patients with type 2 DM conducted at 28 clinical sites in the multiracial/ethnic Chicago metropolitan area between October 2003 and May 2006. The treatment period was 72 weeks (1-week follow-up). CIMT images were captured by a single ultrasonographer at 1 center and read by a single treatment-blinded reader using automated edge-detection technology. Participants were 462 adults (mean age, 60 [SD, 8.1] years; mean body mass index, 32 [SD, 5.1]) with type 2 DM (mean duration, 7.7 [SD, 7.2] years; mean glycosylated hemoglobin [HbA(1c)] value, 7.4% [SD, 1.0%]), either newly diagnosed or currently treated with diet and exercise, sulfonylurea, metformin, insulin, or a combination thereof. Interventions Pioglitazone hydrochloride (15-45 mg/d) or glimepiride (1-4 mg/d) as an active comparator. Main Outcome Measure Absolute change from baseline to final visit in mean posterior-wall CIMT of the left and right common carotid arteries. Results Mean change in CIMT was less with pioglitazone vs glimepiride at all time points (weeks 24, 48, 72). At week 72, the primary end point of progression of mean CIMT was less with pioglitazone vs glimepiride (-0.001 mm vs +0.012 mm, respectively; difference, -0.013 mm; 95% confidence interval, -0.024 to -0.002; P=.02). Pioglitazone also slowed progression of maximum CIMT compared with glimepiride (0.002 mm vs 0.026 mm, respectively, at 72 weeks; difference, -0.024 mm; 95% confidence interval, -0.042 to -0.006; P=.008). The beneficial effect of pioglitazone on mean CIMT was similar across prespecified subgroups based on age, sex, systolic blood pressure, duration of DM, body mass index, HbA(1c) value, and statin use. Conclusion Over an 18-month treatment period in patients with type 2 DM, pioglitazone slowed progression of CIMT compared with glimepiride.	Univ Illinois, Coll Med, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Cardiol Sect, Chicago, IL 60612 USA; Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; Rush Univ, Med Ctr, Dept Med, Cardiol Sect, Chicago, IL 60612 USA; Boston Univ, Dept Math, Stat & Consulting Unit, Boston, MA 02215 USA; Takeda Global Res & Dev Inc, Lincolnshire, IL USA; Synarc, Paris, France; Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Rush University; Boston University; Synarc; University of Texas System; University of Texas Health San Antonio	Mazzone, T (corresponding author), Univ Illinois, Coll Med, Dept Med, Sect Endocrinol Diabet & Metab, 1819 W Polk St,612 CMW MC 797, Chicago, IL 60612 USA.	tmazzone@uic.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL068139] Funding Source: NIH RePORTER; NHLBI NIH HHS [K25 HL68139-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS74, DOI DOI 10.2337/DIACARE.25.2007.S74; American Diabetes Association, 2002, DIABETES CARE S1, V25, pS33, DOI DOI 10.2337/DIACARE.25.2007.S33; American Diabetes Association, 2002, DIABETES CARE S1, V25, ps71, DOI DOI 10.2337/DIACARE.25.2007.S71; Bernard S, 2005, DIABETES CARE, V28, P1158, DOI 10.2337/diacare.28.5.1158; Blaschke F, 2006, VASC PHARMACOL, V45, P3, DOI 10.1016/j.vph.2005.11.009; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Campia U, 2006, CIRCULATION, V113, P867, DOI 10.1161/CIRCULATIONAHA.105.549618; Chen SY, 2001, SPECTROSC SPECT ANAL, V21, P377; Costa J, 2006, BMJ-BRIT MED J, V332, P1115, DOI 10.1136/bmj.38793.468449.AE; Crouse JR, 2006, J LIPID RES, V47, P1677, DOI 10.1194/jlr.R600012-JLR200; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gariepy J, 1998, ARTERIOSCL THROM VAS, V18, P584, DOI 10.1161/01.ATV.18.4.584; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hetzel J, 2005, ARTERIOSCL THROM VAS, V25, P1804, DOI 10.1161/01.ATV.0000176192.16951.9a; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 2006, DIABETES CARE, V29, P1545, DOI 10.2337/dc05-2462; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Kim SH, 2006, METABOLISM, V55, P1053, DOI 10.1016/j.metabol.2006.03.017; Koshiyama H, 2001, J CLIN ENDOCR METAB, V86, P3452, DOI 10.1210/jc.86.7.3452; Langenfeld MR, 2005, CIRCULATION, V111, P2525, DOI 10.1161/01.CIR.0000165072.01672.21; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Mazzone T, 2005, CURR OPIN CARDIOL, V20, P245, DOI 10.1097/01.hco.0000166598.29464.20; Mazzone T, 2004, AM J CARDIOL, V93, p27C, DOI 10.1016/j.amjcard.2004.02.003; Minamikawa J, 1998, J CLIN ENDOCR METAB, V83, P1818, DOI 10.1210/jc.83.5.1818; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Satoh N, 2003, DIABETES CARE, V26, P2493, DOI 10.2337/diacare.26.9.2493; Sidhu JS, 2004, ARTERIOSCL THROM VAS, V24, P930, DOI 10.1161/01.ATV.0000124890.40436.77; Sidhu JS, 2003, J AM COLL CARDIOL, V42, P1757, DOI 10.1016/j.jacc.2003.04.001; Simon A, 2001, CIRCULATION, V103, P2949, DOI 10.1161/01.CIR.103.24.2949; Sowers JR, 2004, ARCH INTERN MED, V164, P1850, DOI 10.1001/archinte.164.17.1850; Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f; Taylor AJ, 2002, CIRCULATION, V106, P2055, DOI 10.1161/01.CIR.0000034508.55617.65; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Wagenknecht LE, 2003, ARTERIOSCL THROM VAS, V23, P1035, DOI 10.1161/01.ATV.0000072273.67342.6D; Yokoyama H, 2006, STROKE, V37, P2420, DOI 10.1161/01.STR.0000236632.58323.cd; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	39	538	564	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2572	2581		10.1001/jama.296.21.joc60158	http://dx.doi.org/10.1001/jama.296.21.joc60158			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112ND	17101640	Bronze			2022-12-28	WOS:000242532000019
J	Meskhidze, N; Nenes, A				Meskhidze, Nicholas; Nenes, Athanasios			Phytoplankton and cloudiness in the Southern Ocean	SCIENCE			English	Article							SECONDARY ORGANIC AEROSOLS; MARINE BOUNDARY-LAYER; NONMETHANE HYDROCARBONS; DIMETHYL SULFIDE; CAPE GRIM; ISOPRENE; PARAMETERIZATION; MODEL; GEORGIA; FLUXES	The effect of ocean biological productivity on marine clouds is explored over a large phytoplankton bloom in the Southern Ocean with the use of remotely sensed data. Cloud droplet number concentration over the bloom was twice what it was away from the bloom, and cloud effective radius was reduced by 30%. The resulting change in the short-wave radiative flux at the top of the atmosphere was - 15 watts per square meter, comparable to the aerosol indirect effect over highly polluted regions. This observed impact of phytoplankton on clouds is attributed to changes in the size distribution and chemical composition of cloud condensation nuclei. We propose that secondary organic aerosol, formed from the oxidation of phytoplankton-produced isoprene, can affect chemical composition of marine cloud condensation nuclei and influence cloud droplet number. Model simulations support this hypothesis, indicating that 100% of the observed changes in cloud properties can be attributed to the isoprene secondary organic aerosol.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Meskhidze, N (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA.	nmeskhidze@ncsu.edu	Nenes, Athanasios/ABE-6478-2020	Nenes, Athanasios/0000-0003-3873-9970; Meskhidze, Nicholas/0000-0001-5628-8777				Andreae MO, 1999, J GEOPHYS RES-ATMOS, V104, P21695, DOI 10.1029/1999JD900283; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Bian HS, 2002, J ATMOS CHEM, V41, P281, DOI 10.1023/A:1014980619462; BONSANG B, 1992, GEOPHYS RES LETT, V19, P1129, DOI 10.1029/92GL00083; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Bretherton CS, 2004, B AM METEOROL SOC, V85, P967, DOI 10.1175/BAMS-85-7-967; Broadgate WJ, 1997, GEOPHYS RES LETT, V24, P2675, DOI 10.1029/97GL02736; CHARLSON RJ, 1992, SCIENCE, V255, P423, DOI 10.1126/science.255.5043.423; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chylek P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025397; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Decesari S, 2006, ATMOS CHEM PHYS, V6, P375, DOI 10.5194/acp-6-375-2006; Gille ST, 2005, J ATMOS OCEAN TECH, V22, P1353, DOI 10.1175/JTECH1789.1; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Hegg DA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018909; Helmig D, 1998, J GEOPHYS RES-ATMOS, V103, P25519, DOI 10.1029/98JD01023; Henze DK, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025976; JONES A, 1994, NATURE, V370, P450, DOI 10.1038/370450a0; Kamykowski D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001640; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Korb RE, 2004, DEEP-SEA RES PT I, V51, P721, DOI 10.1016/j.dsr.2004.02.006; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Le Clainche Y, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002947; Lim HJ, 2005, ENVIRON SCI TECHNOL, V39, P4441, DOI 10.1021/es048039h; Lin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017141; MARTIN GM, 1994, J ATMOS SCI, V51, P1823, DOI 10.1175/1520-0469(1994)051<1823:TMAPOE>2.0.CO;2; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MATSUNAGA SN, 2005, ATMOS CHEM PHYS DISC, V5, P11143, DOI DOI 10.5194/ACPD-5-11143-2005; Menon S, 2002, J ATMOS SCI, V59, P692, DOI 10.1175/1520-0469(2002)059<0692:GSOTAI>2.0.CO;2; Meredith MP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018039; Meskhidze N, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005082; Meskhidze N, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005703; Meskhidze N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018035; MESKHIDZE N, UNPUB; Middlebrook AM, 1998, J GEOPHYS RES-ATMOS, V103, P16475, DOI 10.1029/97JD03719; MILNE PJ, 1995, MAR CHEM, V48, P237, DOI 10.1016/0304-4203(94)00059-M; Moore RM, 1999, J GEOPHYS RES-OCEANS, V104, P11163, DOI 10.1029/1998JC900073; MOORE RM, 1994, GEOPHYS RES LETT, V21, P2507, DOI 10.1029/94GL02363; NAKAJIMA T, 1991, J ATMOS SCI, V48, P728, DOI 10.1175/1520-0469(1991)048<0728:DOTOTA>2.0.CO;2; Ng NL, 2006, ENVIRON SCI TECHNOL, V40, P2283, DOI 10.1021/es052269u; O'Dowd CD, 2004, NATURE, V431, P676, DOI 10.1038/nature02959; Palmer PI, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022592; Pszenny AAP, 1999, J GEOPHYS RES-ATMOS, V104, P21785, DOI 10.1029/1999JD900114; Shao HF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004286; Shaw SL, 2003, MAR CHEM, V80, P227, DOI 10.1016/S0304-4203(02)00101-9; SLINGO A, 1989, J ATMOS SCI, V46, P1419, DOI 10.1175/1520-0469(1989)046<1419:AGPFTS>2.0.CO;2; Son SH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025065; Surratt JD, 2006, J PHYS CHEM A, V110, P9665, DOI 10.1021/jp061734m; Wang W, 2005, RAPID COMMUN MASS SP, V19, P1343, DOI 10.1002/rcm.1940; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Ward P, 2005, DEEP-SEA RES PT I, V52, P421, DOI 10.1016/j.dsr.2004.10.003; WHITBY KT, 1978, ATMOS ENVIRON, V12, P135, DOI 10.1016/0004-6981(78)90196-8; WINGENTER O, 2005, SOLAS NEWS ISSUE, P5; Wingenter OW, 2004, P NATL ACAD SCI USA, V101, P8537, DOI 10.1073/pnas.0402744101; Yokouchi Y, 1999, J GEOPHYS RES-ATMOS, V104, P8067, DOI 10.1029/1998JD100013; Yum SS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003864	58	247	254	8	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1419	1423		10.1126/science.1131779	http://dx.doi.org/10.1126/science.1131779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17082422				2022-12-28	WOS:000242406100031
J	Pimazoni, A				Pimazoni, Augusto			Doctors as lapdogs to drug firms - Not lapdogs, not pit bulls	BRITISH MEDICAL JOURNAL			English	Letter									MED MARK Med Mkt Consultants, Sao Paulo, Brazil		Pimazoni, A (corresponding author), MED MARK Med Mkt Consultants, Sao Paulo, Brazil.	pimazoni@uol.com.br						Fugh-Berman A, 2006, BMJ-BRIT MED J, V333, P1027, DOI 10.1136/bmj.39024.654086.59	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 25	2006	333	7578					1122	1122		10.1136/bmj.39037.700150.3A	http://dx.doi.org/10.1136/bmj.39037.700150.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112IW	17124231	Green Published			2022-12-28	WOS:000242520200026
J	Raichle, ME				Raichle, Marcus E.			The brain's dark energy	SCIENCE			English	Editorial Material							CORTEX		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Raichle, ME (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	gitlin@kids.wustl.edu						Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gilbert D, 2006, STUMBLING HAPPINESS; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hawkins J, 2004, INTELLIGENCE; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; JAMES W, 1890, PRINCIPLES PSYCHOL, V2, P103; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Llinas R.R., 2001, I VORTEX NEURONS SEL; Olshausen B.A., 2003, VISUAL NEUROSCI, V2, P1603; PETERS A, 1994, CEREB CORTEX, V4, P215, DOI 10.1093/cercor/4.3.215; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819	12	303	317	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1249	1250		10.1126/science.1134405	http://dx.doi.org/10.1126/science.1134405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17124311				2022-12-28	WOS:000242215800027
J	Kandun, IN; Wibisono, H; Sedyaningsih, ER; Yusharmen; Hadisoedarsuno, W; Purba, W; Santoso, H; Septiawati, C; Tresnaningsih, E; Heriyanto, B; Yuwono, D; Harun, S; Soeroso, S; Giriputra, S; Blair, PJ; Jeremijenko, A; Kosasih, H; Putnam, SD; Samaan, G; Silitonga, M; Chan, KH; Poon, LLM; Lim, W; Klimov, A; Lindstrom, S; Guan, Y; Donis, R; Katz, J; Cox, N; Peiris, M; Uyeki, TM				Kandun, I. Nyoman; Wibisono, Hariadi; Sedyaningsih, Endang R.; Yusharmen; Hadisoedarsuno, Widarso; Purba, Wilfried; Santoso, Hari; Septiawati, Chita; Tresnaningsih, Erna; Heriyanto, Bambang; Yuwono, Djoko; Harun, Syahrial; Soeroso, Santoso; Giriputra, Sardikin; Blair, Patrick J.; Jeremijenko, Andrew; Kosasih, Herman; Putnam, Shannon D.; Samaan, Gina; Silitonga, Marlinggom; Chan, K. H.; Poon, Leo L. M.; Lim, Wilina; Klimov, Alexander; Lindstrom, Stephen; Guan, Yi; Donis, Ruben; Katz, Jacqueline; Cox, Nancy; Peiris, Malik; Uyeki, Timothy M.			Three Indonesian clusters of H5N1 virus infection in 2005	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZA-A H5N1; HUMAN-DISEASE	Background: Since 2003, the widespread ongoing epizootic of avian influenza A (H5N1) among poultry and birds has resulted in human H5N1 cases in 10 countries. The first case of H5N1 virus infection in Indonesia was identified in July 2005. Methods: We investigated three clusters of Indonesian cases with at least two ill persons hospitalized with laboratory evidence of H5N1 virus infection from June through October 2005. Epidemiologic, clinical, and virologic data on these patients were collected and analyzed. Results: Severe disease occurred among all three clusters, including deaths in two clusters. Mild illness in children was documented in two clusters. The median age of the eight patients was 8.5 years (range, 1 to 38). Four patients required mechanical ventilation, and four of the eight patients (50%) died. In each cluster, patients with H5N1 virus infection were members of the same family, and most lived in the same home. In two clusters, the source of H5N1 virus infection in the index patient was not determined. Virus isolates were available for one patient in each of two clusters, and molecular sequence analyses determined that the isolates were clade 2 H5N1 viruses of avian origin. Conclusions: In 2005 in Indonesia, clusters of human infection with clade 2 H5N1 viruses included mild, severe, and fatal cases among family members.	Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; Directorate Gen Dis Control & Environm Hlth, Jakarta, Indonesia; Natl Inst Hlth Res & Dev, Jakarta, Indonesia; Infect Dis Hosp Rumah Sakit Penyakit Infeksi Suli, N Jakarta, Indonesia; USN, Med Res Unit 2, Jakarta, Indonesia; WHO, Jakarta, Indonesia; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Hong Kong, Hong Kong, Peoples R China	Centers for Disease Control & Prevention - USA; National Institute of Health Research & Development - Indonesia; University of 19 November Kolaka; World Health Organization; University of Hong Kong	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Mail Stop A-32, Atlanta, GA 30333 USA.	tuyeki@cdc.gov	Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Putnam, Shan D/F-2345-2013; Chan, Kwok Hung/ABD-5399-2021	Poon, Leo Lit Man/0000-0002-9101-7953; Putnam, Shan D/0000-0001-8353-4400; Jeremijenko, Andrew Martin/0000-0002-0375-2713; Guan, Yi/0000-0001-6057-9243				[Anonymous], 2005, WHO REC US RAP TEST; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; *OFF INT EP, 2004, HIGH PATH AV INFL IN; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *WHO, 2006, WHO RAP ADV GUID PHA; *WHO, 2006, WHO CAS DEF HUM INF; *WHO, 2005, AV INFL SIT IND UPD; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2006, WKLY EPIDEMIOL REC, V81, P183	23	266	287	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2186	2194		10.1056/NEJMoa060930	http://dx.doi.org/10.1056/NEJMoa060930			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124016				2022-12-28	WOS:000242170900005
J	Son, YW; Cohen, ML; Louie, SG				Son, Young-Woo; Cohen, Marvin L.; Louie, Steven G.			Half-metallic graphene nanoribbons	NATURE			English	Article							RIBBONS; EDGE; FERROMAGNETISM; ELECTRONICS; GRAPHITE; SYSTEMS; CHAINS; STATE; GAS	Electrical current can be completely spin polarized in a class of materials known as half- metals, as a result of the coexistence of metallic nature for electrons with one spin orientation and insulating nature for electrons with the other. Such asymmetric electronic states for the different spins have been predicted for some ferromagnetic metals - for example, the Heusler compounds(1) and were first observed in a manganese perovskite (2). In view of the potential for use of this property in realizing spin- based electronics, substantial efforts have been made to search for half-metallic materials(3,4). However, organic materials have hardly been investigated in this context even though carbon- based nanostructures hold significant promise for future electronic devices (5). Here we predict half- metallicity in nanometre- scale graphene ribbons by using first- principles calculations. We show that this phenomenon is realizable if in- plane homogeneous electric fields are applied across the zigzag- shaped edges of the graphene nanoribbons, and that their magnetic properties can be controlled by the external electric fields. The results are not only of scientific interest in the interplay between electric fields and electronic spin degree of freedom in solids 6,7 but may also open a new path to explore spintronics(3) at the nanometre scale, based on graphene(8 - 11).	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Louie, SG (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	sglouie@berkeley.edu	son, Young-Woo/B-2566-2010					Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; DEGROOT RA, 1983, PHYS REV LETT, V50, P2024, DOI 10.1103/PhysRevLett.50.2024; Delin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.057201; Dorantes-Davila J, 1998, PHYS REV LETT, V81, P208, DOI 10.1103/PhysRevLett.81.208; Fang CM, 2002, J APPL PHYS, V91, P8340, DOI 10.1063/1.1452238; Fujita M, 1996, J PHYS SOC JPN, V65, P1920, DOI 10.1143/JPSJ.65.1920; Gambardella P, 2002, NATURE, V416, P301, DOI 10.1038/416301a; Kobayashi Y, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.193406; Lee H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174431; McEuen PL, 2002, IEEE T NANOTECHNOL, V1, P78, DOI 10.1109/TNANO.2002.1005429; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; MIN H, 2006, INTRINSIC RASHBA SPI; Miyamoto Y, 1999, PHYS REV B, V59, P9858, DOI 10.1103/PhysRevB.59.9858; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Niimi Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085421; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Okada S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.146803; Park JH, 1998, NATURE, V392, P794, DOI 10.1038/33883; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Son YW, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.216602; Vindigni A, 2006, APPL PHYS A-MATER, V82, P385, DOI 10.1007/s00339-005-3364-4; Wakabayashi K, 1999, PHYS REV B, V59, P8271, DOI 10.1103/PhysRevB.59.8271; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yao YG, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.041401; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	3525	3608	29	1387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					347	349		10.1038/nature05180	http://dx.doi.org/10.1038/nature05180			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108960	Green Submitted			2022-12-28	WOS:000242018300043
J	van Naters, WV; Carlson, JR				van Naters, Wynand van der Goes; Carlson, John R.			Insects as chemosensors of humans and crops	NATURE			English	Review							MOSQUITO ANOPHELES-GAMBIAE; CANDIDATE ODORANT RECEPTORS; PHEROMONE-BINDING PROTEINS; MALARIA VECTOR MOSQUITO; SENSU-STRICTO DIPTERA; TASTE STIMULI; GENE FAMILY; ANTHERAEA-POLYPHEMUS; OLFACTORY RECEPTORS; MOLECULAR-BASIS	Insects transmit disease to hundreds of millions of people a year, and cause enormous losses to the world's agricultural output. Many insects find the human or plant hosts on which they feed, and identify and locate their mates, primarily through olfaction and taste. Major advances have recently been made in understanding insect chemosensation at the molecular and cellular levels. These advances have provided new opportunities to control insects that cause massive damage to health and agriculture across the world.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	van der Goes van Naters, Wynand/0000-0002-6808-0161				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Arn H, 1997, INSECT PHEROMONE RESEARCH, P377; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; del Campo ML, 2001, NATURE, V411, P186, DOI 10.1038/35075559; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; GILBERT IH, 1955, J ECON ENTOMOL, V48, P741, DOI 10.1093/jee/48.6.741; Glare T.R., 2000, BACILLUS THURINGIENS; Glendinning JI, 2002, J NEUROSCI, V22, P7281; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hajek A.E., 2004, NATURAL ENEMIES INTR; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; HANEY PB, 2001, BOLL WEEVIL ERADICAT, P7; Harris K.F., 1980, VECTORS PLANT PATHOG; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; JUDD GJR, 1989, PHYSIOL ENTOMOL, V14, P429, DOI 10.1111/j.1365-3032.1989.tb01112.x; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Koul O., 2005, INSECT ANTIFEEDANTS; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Kuhar TP, 2006, AGR FOREST ENTOMOL, V8, P77, DOI 10.1111/j.1461-9555.2006.00286.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Maida R, 2000, EUR J BIOCHEM, V267, P2899, DOI 10.1046/j.1432-1327.2000.01303.x; METCALF RL, 1980, P NATL ACAD SCI-BIOL, V77, P3769, DOI 10.1073/pnas.77.7.3769; MITCHELL BK, 1976, J EXP BIOL, V65, P259; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Mustaparta H, 1997, INSECT PHEROMONE RESEARCH, P144; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; PIMENTEL D, 1991, CROP PROT, V10, P243, DOI 10.1016/0261-2194(91)90001-8; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SCHMUTTERER H, 1990, ANNU REV ENTOMOL, V35, P271, DOI 10.1146/annurev.en.35.010190.001415; Schoonhoven L. M., 2005, Insect-plant biology; Schoonhoven L.M., 1992, P59; SCHRECK CE, 1990, J AM MOSQUITO CONTR, V6, P406; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; STOTKUHL KF, 2001, P NATL ACAD SCI USA, V98, P9381; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Van Naters WMV, 1998, PHYSIOL ENTOMOL, V23, P278, DOI 10.1046/j.1365-3032.1998.233083.x; VANNATERS WMV, 1993, CHEM SENSES, V18, P437, DOI 10.1093/chemse/18.4.437; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; WHO/UNICEF, 2005, WORLD MAL REP; WITZGALL P, 2004, PHEROLIST PHERO NET; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhang AJ, 1999, J CHEM ECOL, V25, P1221, DOI 10.1023/A:1020910305873	79	104	107	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					302	307		10.1038/nature05403	http://dx.doi.org/10.1038/nature05403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108954				2022-12-28	WOS:000242018300036
J	Dunham, B; Nicol, TL; Ishii, M; Basaria, S				Dunham, Brian; Nicol, Theresa L.; Ishii, Masaru; Basaria, Shehzad			Suppurative thyroiditis	LANCET			English	Editorial Material							FISTULA		Johns Hopkins Univ, Sch Med, Bayview Med Ctr, Dept Med, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Bayview Med Ctr, Dept Otolaryngol, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Bayview Med Ctr, Dept Pathol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Basaria, S (corresponding author), Johns Hopkins Univ, Sch Med, Bayview Med Ctr, Dept Med, 5200 Eastern Ave, Baltimore, MD 21224 USA.	sbasari1@jhmi.edu		Basaria, Shehzad/0000-0002-8533-2383; Basaria, Shehzad/0000-0003-1749-8549				BERGER SA, 1983, REV INFECT DIS, V5, P108; Chaudhary N, 2003, AM J OTOLARYNG, V24, P250, DOI 10.1016/S0196-0709(03)00026-7; Farwell AP, 1996, OTOLARYNG CLIN N AM, V29, P541; RICH EJ, 1987, PEDIATR INFECT DIS J, V6, P936, DOI 10.1097/00006454-198710000-00017; TAKAI S, 1979, LANCET, V1, P751	5	8	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1742	1742		10.1016/S0140-6736(06)69706-7	http://dx.doi.org/10.1016/S0140-6736(06)69706-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098092				2022-12-28	WOS:000242099000041
J	Ngai, JT; Srivastava, DS				Ngai, Jacqueline T.; Srivastava, Diane S.			Predators accelerate nutrient cycling in a bromeliad ecosystem	SCIENCE			English	Article							FOOD-WEB; FISH		Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Ngai, JT (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	ngai@zoology.ubc.ca						Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; POWER ME, 1990, SCIENCE, V250, P811, DOI 10.1126/science.250.4982.811; Ruetz CR, 2002, OECOLOGIA, V132, P307, DOI 10.1007/s00442-002-0953-1; SHORT TM, 1992, FRESHWATER BIOL, V27, P91, DOI 10.1111/j.1365-2427.1992.tb00526.x; Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	8	108	110	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					963	963		10.1126/science.1132598	http://dx.doi.org/10.1126/science.1132598			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095695				2022-12-28	WOS:000241896000043
J	Murad, F				Murad, Ferid			Shattuck Lecture: Nitric oxide and cyclic GMP in cell signaling and drug development	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOLUBLE GUANYLYL CYCLASE; ENDOTHELIUM-DEPENDENT RELAXATION; SODIUM AZIDE; TISSUE PREPARATIONS; SMOOTH-MUSCLE; RAT-LIVER; INCREASES; MONOPHOSPHATE; NITROPRUSSIDE; NITROGLYCERIN		Univ Texas, Hlth Sci Ctr, Brown Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Murad, F (corresponding author), Univ Texas, Hlth Sci Ctr, Brown Inst Mol Med, 1825 Pressler St,Suite 500, Houston, TX 77030 USA.							ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; ARNOLD WP, 1977, SCIENCE, V198, P934, DOI 10.1126/science.22126; ASHMAN DF, 1963, BIOCHEM BIOPH RES CO, V11, P330, DOI 10.1016/0006-291X(63)90566-7; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; DEGUCHI T, 1982, J BIOL CHEM, V257, P147; FISCUS RR, 1984, J CYCLIC NUCL PROT, V9, P415; FURCHGOTT R F, 1988, P401; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARBERS DL, 1991, PHARMACOL THERAPEUT, V50, P337, DOI 10.1016/0163-7258(91)90049-R; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; IGNARRO L, 1988, VASODILATATION VASCU, P27; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P239; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; KATSUKI S, 1977, P 2 JAP CYCL NUCL C, P44; KIMURA H, 1975, J BIOL CHEM, V250, P8016; KIMURA H, 1975, METABOLISM, V24, P439, DOI 10.1016/0026-0495(75)90123-7; KIMURA H, 1975, NATURE, V257, P700, DOI 10.1038/257700a0; KIMURA H, 1974, J BIOL CHEM, V249, P6910; Krumenacker JS, 2006, NITRIC OXIDE-BIOL CH, V14, P1, DOI 10.1016/j.niox.2005.06.010; Krumenacker JS, 2001, P NATL ACAD SCI USA, V98, P717, DOI 10.1073/pnas.98.2.717; KUNO T, 1986, J BIOL CHEM, V261, P5817; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; MITTAL CK, 1979, BIOCHIM BIOPHYS ACTA, V585, P333, DOI 10.1016/0304-4165(79)90078-3; MITTAL CK, 1977, J BIOL CHEM, V252, P4384; MITTAL CK, 1977, J BIOL CHEM, V252, P3136; Murad F, 1994, Adv Pharmacol, V26, P1, DOI 10.1016/S1054-3589(08)60047-2; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Murad F, 1978, Adv Cyclic Nucleotide Res, V9, P145; Murad F, 1999, BIOSCIENCE REP, V19, P133, DOI 10.1023/A:1020265417394; MURAD F, 1962, J BIOL CHEM, V237, P1233; MURAD F, 1978, ADV PHARMACOL THER, V3, P123; MURAD F, 1998, VASCULAR ENDOTHELIUM, P157; RALL TW, 1958, J BIOL CHEM, V232, P1065; RAPOPORT RM, 1983, CIRC RES, V52, P352, DOI 10.1161/01.RES.52.3.352; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; Sharina IG, 2000, P NATL ACAD SCI USA, V97, P10878, DOI 10.1073/pnas.190331697	39	294	322	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					2003	2011		10.1056/NEJMsa063904	http://dx.doi.org/10.1056/NEJMsa063904			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093251				2022-12-28	WOS:000241833000008
J	Bagchi, J; Durret, F; Neto, GBL; Paul, S				Bagchi, Joydeep; Durret, Florence; Lima Neto, Gastao B.; Paul, Surajit			Giant ringlike radio structures around galaxy cluster Abell 3376	SCIENCE			English	Article							MAGNETIC-FIELDS; SHOCK ACCELERATION; MERGER; RADIATION; EMISSION; RELICS; ORIGIN	In the current paradigm of cold dark matter cosmology, large-scale structures are assembling through hierarchical clustering of matter. In this process, an important role is played by megaparsec (Mpc) - scale cosmic shock waves, arising in gravity-driven supersonic flows of intergalactic matter onto dark matter - dominated collapsing structures such as pancakes, filaments, and clusters of galaxies. Here, we report Very Large Array telescope observations of giant (similar to 2 Mpc by 1.6 Mpc), ring-shaped nonthermal radio-emitting structures, found at the outskirts of the rich cluster of galaxies Abell 3376. These structures may trace the elusive shock waves of cosmological large-scale matter flows, which are energetic enough to power them. These radio sources may also be the acceleration sites where magnetic shocks are possibly boosting cosmic-ray particles with energies of up to 10(18) to 10(19) electron volts.	IUCAA, Pune 411007, Maharashtra, India; Univ Paris 06, CNRS, UMR 7095, Inst Astrophys Paris, Paris, France; Observ Paris, LERMA, Paris, France; Univ Sao Paulo, Inst Astron Geofis & Ciencias Atmosfericas, BR-05508900 Sao Paulo, Brazil; Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97070 Wurzburg, Germany	Inter-University Centre for Astronomy & Astrophysics; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universidade de Sao Paulo; University of Wurzburg	Bagchi, J (corresponding author), IUCAA, Post Bag 4,Ganeshkhind,Pune Univ Campus, Pune 411007, Maharashtra, India.	joydeep@iucaa.ernet.in	Neto, Gastao B Lima/J-6117-2014	Neto, Gastao B Lima/0000-0001-5606-4319; Bagchi, Joydeep/0000-0002-2922-2884; Paul, Surajit/0000-0003-4046-6959				Bagchi J, 2002, NEW ASTRON, V7, P249, DOI 10.1016/S1384-1076(02)00137-9; Bagchi J, 1998, MON NOT R ASTRON SOC, V296, pL23, DOI 10.1046/j.1365-8711.1998.01589.x; Bruggen M, 2005, ASTROPHYS J, V631, pL21, DOI 10.1086/497004; Carilli CL, 2002, ANNU REV ASTRON ASTR, V40, P319, DOI 10.1146/annurev.astro.40.060401.093852; Cen RY, 1999, ASTROPHYS J, V519, pL109, DOI 10.1086/312123; Clarke TE, 2001, ASTROPHYS J, V547, pL111, DOI 10.1086/318896; DRURY LOC, 1983, REP PROG PHYS, V46, P973, DOI 10.1088/0034-4885/46/8/002; Ensslin TA, 1998, ASTRON ASTROPHYS, V332, P395; ESCALERA E, 1994, ASTROPHYS J, V423, P539, DOI 10.1086/173833; Flin P, 2006, ASTRON ASTROPHYS, V450, P9, DOI 10.1051/0004-6361:20041635; Gabici S, 2003, ASTROPHYS J, V583, P695, DOI 10.1086/345429; GIOVANNINI GABRIELE, 2004, Journal of the Korean Astronomical Society, V37, P323; Girardi M, 1998, ASTROPHYS J, V505, P74, DOI 10.1086/306157; Govoni F, 2004, INT J MOD PHYS D, V13, P1549, DOI 10.1142/S0218271804005080; Hoeft M, 2004, MON NOT R ASTRON SOC, V347, P389, DOI 10.1111/j.1365-2966.2004.07227.x; Kang H, 2005, ASTROPHYS J, V620, P44, DOI 10.1086/426855; Keshet U, 2004, ASTROPHYS J, V617, P281, DOI 10.1086/424837; Keshet U, 2003, ASTROPHYS J, V585, P128, DOI 10.1086/345946; Kitayama T, 1996, ASTROPHYS J, V469, P480, DOI 10.1086/177797; Kronberg PP, 1999, ASTROPHYS J, V511, P56, DOI 10.1086/306662; Kulsrud RM, 1997, ASTROPHYS J, V480, P481, DOI 10.1086/303987; Miniati F, 2003, MON NOT R ASTRON SOC, V342, P1009, DOI 10.1046/j.1365-8711.2003.06647.x; Miniati F, 2001, ASTROPHYS J, V559, P59, DOI 10.1086/322375; Ricker PM, 2001, ASTROPHYS J, V561, P621, DOI 10.1086/323365; Roettiger K, 1999, ASTROPHYS J, V518, P603, DOI 10.1086/307327; Rottgering HJA, 1997, MON NOT R ASTRON SOC, V290, P577, DOI 10.1093/mnras/290.4.577; Schoenmakers AP, 2001, ASTRON ASTROPHYS, V374, P861, DOI 10.1051/0004-6361:20010746; Smith RJ, 2004, ASTRON J, V128, P1558, DOI 10.1086/423915	28	146	146	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					791	794		10.1126/science.1131189	http://dx.doi.org/10.1126/science.1131189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082451	Green Submitted			2022-12-28	WOS:000241729800038
J	McGill, JK; Beal, MF				McGill, Jetta K.; Beal, M. Flint			PGC-1 alpha, a new therapeutic target in Huntington's disease?	CELL			English	Review							MUTANT HUNTINGTIN; MITOCHONDRIAL DYSFUNCTION; COACTIVATOR; PGC-1; NEURODEGENERATION; DEFECTS; MICE	The coactivator PGC-1 alpha is a key regulator of mitochondrial biogenesis and respiration, mediating expression of several transcription factors required for these programs. Three new studies reveal that PGC-1 alpha expression is downregulated in patients with Huntington's disease (HD) and in several animal models of this neurodegenerative disorder, implicating PGC-1 alpha in HD pathogenesis and providing a connection between impaired energy metabolism and neurodegeneration (Cui et al., 2006; Weydt et al., 2006; St-Pierre et al., 2006).	Cornell Univ, Med Ctr, Dept Neurol, New York, NY 10021 USA	Cornell University	Beal, MF (corresponding author), Cornell Univ, Med Ctr, Dept Neurol, New York, NY 10021 USA.	fbeal@mail.med.cornell.edu						Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Squitieri F, 2006, MECH AGEING DEV, V127, P217, DOI 10.1016/j.mad.2005.09.010; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; WEYDT P, 2006, CELL METAB	20	108	113	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					465	468		10.1016/j.cell.2006.10.023	http://dx.doi.org/10.1016/j.cell.2006.10.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081970	Bronze			2022-12-28	WOS:000241937000012
J	Birks, EJ; Tansley, PD; Hardy, J; George, RS; Bowles, CT; Burke, M; Banner, NR; Khaghani, A; Yacoub, MH				Birks, Emma J.; Tansley, Patrick D.; Hardy, James; George, Robert S.; Bowles, Christopher T.; Burke, Margaret; Banner, Nicholas R.; Khaghani, Asghar; Yacoub, Magdi H.			Left ventricular assist device and drug therapy for the reversal of heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL RECOVERY; BETA(2)-ADRENERGIC RECEPTOR; CLINICAL-IMPLICATIONS; CELLULAR HYPERTROPHY; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; CLENBUTEROL; CARDIOMYOPATHY; MYOCYTES; SUPPORT	BACKGROUND: In patients with severe heart failure, prolonged unloading of the myocardium with the use of a left ventricular assist device has been reported to lead to myocardial recovery in small numbers of patients for varying periods of time. Increasing the frequency and durability of myocardial recovery could reduce or postpone the need for subsequent heart transplantation. METHODS: We enrolled 15 patients with severe heart failure due to nonischemic cardiomyopathy and with no histologic evidence of active myocarditis. All had markedly reduced cardiac output and were receiving inotropes. The patients underwent implantation of left ventricular assist devices and were treated with lisinopril, carvedilol, spironolactone, and losartan to enhance reverse remodeling. Once regression of left ventricular enlargement had been achieved, the (beta)(sub 2)-adrenergic-receptor agonist clenbuterol was administered to prevent myocardial atrophy. RESULTS: Eleven of the 15 patients had sufficient myocardial recovery to undergo explantation of the left ventricular assist device a mean (+/-SD) of 320+/-186 days after implantation of the device. One patient died of intractable arrhythmias 24 hours after explantation; another died of carcinoma of the lung 27 months after explantation. The cumulative rate of freedom from recurrent heart failure among the surviving patients was 100% and 88.9% 1 and 4 years after explantation, respectively. The quality of life as assessed by the Minnesota Living with Heart Failure Questionnaire score at 3 years was nearly normal. Fifty-nine months after explantation, the mean left ventricular ejection fraction was 64+/-12%, the mean left ventricular end-diastolic diameter was 59.4+/-12.1 mm, the mean left ventricular end-systolic diameter was 42.5+/-13.2 mm, and the mean maximal oxygen uptake with exercise was 26.3+/-6.0 ml per kilogram of body weight per minute. CONCLUSIONS: In this single-center study, we found that sustained reversal of severe heart failure secondary to nonischemic cardiomyopathy could be achieved in selected patients with the use of a left ventricular assist device and a specific pharmacologic regimen.	Royal Brompton & Harefield NHS Trust, Harefield, Middx, England; Imperial Coll, Natl Heart & Lung Inst, Heart Sci Ctr, London, England	Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Yacoub, MH (corresponding author), Royal Brompton & Harefield Hosp, Hlth Sci Ctr, Harefield UB9 6JH, Middx, England.	m.yacoub@ic.ac.uk		George, Robert/0000-0002-1248-8299				Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Baughman Kenneth L., 2001, Curr Treat Options Cardiovasc Med, V3, P469, DOI 10.1007/s11936-001-0021-x; Burniston JG, 2005, MUSCLE NERVE, V32, P767, DOI 10.1002/mus.20407; Burniston JG, 2002, J APPL PHYSIOL, V93, P1824, DOI 10.1152/japplphysiol.00139.2002; Communal C, 2005, ARCH MAL COEUR VAISS, V98, P236; Dandel M, 2005, CIRCULATION, V112, pI37, DOI 10.1161/CIRCULATIONAHA.104.525352; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; Duncan ND, 2000, CLIN SCI, V98, P339, DOI 10.1042/CS19990069; *EUR SOC CARD, 2005, EUROHEART FAIL SURV; Farrar DJ, 2002, J HEART LUNG TRANSPL, V21, P516, DOI 10.1016/S1053-2498(01)00408-9; Frazier O H, 2004, Congest Heart Fail, V10, P109, DOI 10.1111/j.1527-5299.2004.03366.x; Frazier OH, 1999, ANN THORAC SURG, V68, P734, DOI 10.1016/S0003-4975(99)00801-2; Gong HB, 2002, CIRCULATION, V105, P2497, DOI 10.1161/01.CIR.0000017187.61348.95; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Groenning BA, 2000, J AM COLL CARDIOL, V36, P2072, DOI 10.1016/S0735-1097(00)01006-8; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; JAMES KB, 1995, CIRCULATION, V92, P191, DOI 10.1161/01.CIR.92.9.191; Kinali M, 2002, NEUROLOGY, V59, P609, DOI 10.1212/WNL.59.4.609; Kinoshita M, 1988, ASAIO Trans, V34, P208; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Mancini DM, 1998, CIRCULATION, V98, P2383, DOI 10.1161/01.CIR.98.22.2383; MARTINEAU L, 1992, CLIN SCI, V83, P615, DOI 10.1042/cs0830615; MARTINEAU L, 1993, CLIN SCI LOND, V84; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pieske B, 2004, EUR HEART J SUPPL, V6, pD66, DOI 10.1016/j.ehjsup.2004.05.019; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Shah AS, 2000, CIRCULATION, V101, P408, DOI 10.1161/01.CIR.101.4.408; Simon MA, 2005, CIRCULATION, V112, pI32, DOI 10.1161/CIRCULATIONAHA.104.524124; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Soloff LA, 1999, CIRCULATION, V100, P1012, DOI 10.1161/circ.100.9.1011/-b; Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH2546, DOI 10.1152/ajpheart.00166.2005; Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004; Starling RC, 2005, J AM COLL CARDIOL, V45, P1425, DOI 10.1016/j.jacc.2005.02.021; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tansley P, 2002, J THORAC CARDIOV SUR, V124, P189, DOI 10.1067/mtc.2002.122786; Terracciano CMN, 2004, CIRCULATION, V109, P2263, DOI 10.1161/01.CIR.0000129233.51320.92; Terracciano CMN, 2003, EUR HEART J, V24, P1329, DOI 10.1016/S0195-668X(03)00242-2; Tevaearai HT, 2002, CIRCULATION, V106, P124, DOI 10.1161/01.CIR.0000020220.79105.FD; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; Wong K, 1998, CARDIOVASC RES, V37, P115, DOI 10.1016/S0008-6363(97)00190-9; Wong K, 1997, CIRCULATION, V96, P2239; Wong M, 2002, J AM COLL CARDIOL, V40, P970, DOI 10.1016/S0735-1097(02)02063-6; Yacoub MH, 2001, EUR HEART J, V22, P534, DOI 10.1053/euhj.2001.2613; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656	44	616	638	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2006	355	18					1873	1884		10.1056/NEJMoa053063	http://dx.doi.org/10.1056/NEJMoa053063			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100TM	17079761	Bronze			2022-12-28	WOS:000241691700005
